data_1akp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1akp _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.788 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 131.78 35.98 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 124.947 1.404 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.88 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.72 141.48 7.39 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 124.773 1.295 . . . . 0.0 109.786 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.74 141.33 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 p -160.42 113.01 1.38 Allowed Pre-proline 0 CA--C 1.608 3.176 0 CA-C-O 115.053 -2.403 . . . . 0.0 109.927 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -65.14 153.21 77.27 Favored 'Cis proline' 1 C--N 1.425 4.595 0 CA-C-N 125.458 2.985 . . . . 0.0 111.222 -3.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.22 -8.65 1.15 Allowed 'General case' 0 N--CA 1.529 3.513 0 O-C-N 125.872 1.983 . . . . 0.0 113.063 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -129.45 153.98 47.41 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.486 1.741 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 28.25 68.39 Favored Glycine 1 N--CA 1.519 4.167 0 O-C-N 124.8 1.313 . . . . 0.0 113.118 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.47 155.75 33.6 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 125.146 1.144 . . . . 0.0 110.282 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.82 -178.52 5.85 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 125.656 1.847 . . . . 0.0 107.222 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.35 142.83 53.9 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 124.592 1.183 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.68 85.62 Favored Glycine 1 N--CA 1.521 4.337 0 O-C-N 124.981 1.426 . . . . 0.0 113.394 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.49 164.72 26.28 Favored 'General case' 0 N--CA 1.52 3.064 0 O-C-N 124.196 0.586 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 m -145.98 121.91 10.66 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.5 -178.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 O-C-N 125.667 1.855 . . . . 0.0 110.047 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -143.25 92.61 2.39 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.76 149.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 p -135.24 162.03 33.71 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 126.141 2.15 . . . . 0.0 109.044 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.5 16.82 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 125.307 1.63 . . . . 0.0 108.68 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -157.04 149.52 23.24 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 125.4 1.687 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 127.42 0.85 Allowed Glycine 1 N--CA 1.52 4.27 0 O-C-N 124.95 1.406 . . . . 0.0 111.988 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -147.98 161.62 40.98 Favored 'General case' 0 N--CA 1.522 3.154 0 C-N-CA 124.269 1.028 . . . . 0.0 109.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.95 -59.15 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.554 0 O-C-N 125.385 1.678 . . . . 0.0 108.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 -53.36 6.73 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.332 1.645 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.2 p -67.83 143.07 55.94 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 124.893 1.371 . . . . 0.0 112.273 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.535 3.801 0 O-C-N 125.689 1.868 . . . . 0.0 109.823 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -168.9 170.61 8.96 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.7 13.31 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 123.858 0.724 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.53 172.89 11.41 Favored 'General case' 0 N--CA 1.524 3.249 0 O-C-N 126.173 2.171 . . . . 0.0 106.212 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.95 66.99 1.31 Allowed 'General case' 0 N--CA 1.531 3.612 0 O-C-N 125.421 1.701 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.24 155.45 28.57 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -137.73 136.54 37.43 Favored 'General case' 0 N--CA 1.521 3.107 0 O-C-N 125.771 1.919 . . . . 0.0 106.669 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.0 m -141.31 150.22 42.24 Favored 'General case' 0 N--CA 1.532 3.635 0 O-C-N 124.584 1.177 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.17 115.7 28.85 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 126.096 2.122 . . . . 0.0 110.963 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.2 137.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -122.08 -175.05 3.03 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.767 1.917 . . . . 0.0 106.294 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.58 97.37 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.303 1.002 . . . . 0.0 111.993 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 -21.81 60.4 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.45 1.719 . . . . 0.0 111.163 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.37 24.42 73.15 Favored Glycine 0 N--CA 1.512 3.75 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.873 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -75.03 145.12 42.68 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.59 75.9 1.19 Allowed Glycine 1 N--CA 1.517 4.098 0 O-C-N 124.813 1.321 . . . . 0.0 114.296 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.83 96.36 8.2 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.35 139.92 52.91 Favored 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.028 1.455 . . . . 0.0 112.575 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -76.85 138.57 39.88 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 125.016 1.447 . . . . 0.0 109.369 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.08 -24.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 O-C-N 125.512 1.758 . . . . 0.0 114.613 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.51 46.37 Favored 'General case' 0 N--CA 1.532 3.67 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.72 1.6 37.92 Favored 'General case' 1 N--CA 1.549 4.482 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -69.69 168.78 14.18 Favored 'General case' 0 N--CA 1.533 3.722 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -133.82 -63.93 0.72 Allowed 'General case' 0 N--CA 1.524 3.229 0 O-C-N 125.614 1.821 . . . . 0.0 109.996 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.41 98.5 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.029 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -157.51 150.01 22.85 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -65.74 167.74 8.82 Favored 'General case' 0 N--CA 1.52 3.07 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -79.29 141.95 36.58 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.7 t -71.54 -25.19 62.12 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 124.408 1.067 . . . . 0.0 112.985 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.55 -39.19 0.06 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.32 18.28 0.02 OUTLIER Glycine 0 N--CA 1.501 3.03 0 O-C-N 125.287 1.228 . . . . 0.0 111.593 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -144.03 165.36 27.99 Favored 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.32 79.98 0.08 OUTLIER Glycine 0 N--CA 1.513 3.799 0 O-C-N 124.074 0.859 . . . . 0.0 111.658 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -74.87 149.72 39.43 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 125.539 1.376 . . . . 0.0 108.986 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.27 137.56 7.17 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.904 1.378 . . . . 0.0 112.93 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -90.04 112.84 24.41 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 125.219 1.575 . . . . 0.0 110.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.75 147.06 13.7 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.125 0 O-C-N 125.385 1.678 . . . . 0.0 107.012 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.28 150.01 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 125.855 1.972 . . . . 0.0 106.705 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.65 92.06 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 125.525 1.766 . . . . 0.0 110.009 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -86.56 154.14 21.29 Favored 'General case' 0 N--CA 1.523 3.218 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.001 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.522 3.135 0 O-C-N 124.721 1.263 . . . . 0.0 113.473 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -156.23 147.06 21.99 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 124.616 1.197 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.87 149.53 21.74 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.879 1.362 . . . . 0.0 111.669 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.0 m -69.47 105.53 2.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.779 1.925 . . . . 0.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.3 159.67 53.45 Favored Glycine 0 N--CA 1.514 3.842 0 O-C-N 124.665 1.228 . . . . 0.0 111.235 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 119.05 14.41 Favored 'General case' 0 N--CA 1.527 3.404 0 O-C-N 125.596 1.409 . . . . 0.0 108.384 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 N--CA 1.535 3.776 0 O-C-N 124.797 1.311 . . . . 0.0 107.607 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.583 4.34 0 CA-C-O 115.688 -2.729 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -67.78 156.49 86.42 Favored 'Cis proline' 0 C--N 1.403 3.446 0 CA-C-N 123.668 3.734 . . . . 0.0 114.291 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.34 142.01 52.21 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 125.512 1.757 . . . . 0.0 109.301 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -38.51 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 O-C-N 125.231 1.582 . . . . 0.0 112.581 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.84 -166.68 23.79 Favored Glycine 0 N--CA 1.501 2.976 0 O-C-N 125.568 1.793 . . . . 0.0 108.93 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.75 116.92 5.64 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 125.823 1.543 . . . . 0.0 113.757 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.43 138.62 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 O-C-N 125.969 2.043 . . . . 0.0 107.407 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.21 144.48 28.12 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 125.303 1.627 . . . . 0.0 110.711 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.4 t -80.36 -32.81 37.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 125.05 1.469 . . . . 0.0 112.77 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.09 -25.65 63.62 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.62 -25.28 41.48 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.408 1.068 . . . . 0.0 113.244 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 91.39 Favored Pre-proline 0 N--CA 1.531 3.604 0 CA-C-O 115.573 -2.156 . . . . 0.0 112.025 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.84 -49.26 0.25 Allowed 'Trans proline' 0 C--N 1.413 3.938 0 CA-C-N 123.305 2.216 . . . . 0.0 113.612 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.55 -42.28 55.69 Favored Glycine 0 N--CA 1.511 3.655 0 O-C-N 124.627 1.205 . . . . 0.0 112.477 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.57 175.38 49.2 Favored Glycine 1 N--CA 1.518 4.116 0 O-C-N 125.163 1.155 . . . . 0.0 111.291 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.8 m -70.02 144.82 52.13 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.569 0.805 . . . . 0.0 112.453 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -146.12 127.67 15.1 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 125.806 1.941 . . . . 0.0 107.235 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.77 137.09 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -129.48 134.61 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.34 136.9 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.9 152.88 10.53 Favored Glycine 0 N--CA 1.509 3.541 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.78 -176.75 49.72 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 125.346 1.262 . . . . 0.0 111.804 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -76.57 -16.6 59.56 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.003 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.98 -65.79 0.68 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 124.67 1.231 . . . . 0.0 112.526 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.74 12.85 0.02 OUTLIER Glycine 0 N--CA 1.515 3.924 0 CA-C-O 118.568 -1.129 . . . . 0.0 112.505 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.36 156.44 39.09 Favored 'General case' 0 N--CA 1.521 3.119 0 O-C-N 124.702 0.884 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -153.9 158.81 41.29 Favored 'General case' 0 N--CA 1.522 3.147 0 O-C-N 124.758 1.286 . . . . 0.0 109.236 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.96 82.91 0.07 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -67.29 155.39 39.0 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 125.421 1.306 . . . . 0.0 113.377 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.69 101.79 1.5 Allowed 'General case' 0 N--CA 1.527 3.415 0 O-C-N 124.655 1.222 . . . . 0.0 110.426 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 155.37 40.72 Favored 'General case' 0 N--CA 1.514 2.732 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.78 177.1 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 126.476 2.36 . . . . 0.0 107.735 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 p -156.13 124.2 5.7 Favored 'General case' 0 N--CA 1.524 3.244 0 O-C-N 123.972 0.795 . . . . 0.0 111.674 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -75.3 158.22 33.18 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 124.11 0.882 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.715 0 CA-C-O 116.31 -2.383 . . . . 0.0 111.338 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.534 3.752 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.22 123.7 3.54 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.676 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.9 146.81 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.57 140.89 16.61 Favored 'General case' 0 N--CA 1.518 2.929 0 O-C-N 125.166 1.541 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.53 144.57 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -160.88 111.85 1.3 Allowed Pre-proline 0 N--CA 1.524 3.228 0 CA-C-O 115.054 -2.403 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.41 151.78 70.21 Favored 'Cis proline' 1 C--N 1.425 4.594 0 CA-C-N 125.286 2.924 . . . . 0.0 112.439 -3.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -3.56 2.0 Favored 'General case' 0 N--CA 1.528 3.452 0 O-C-N 125.98 2.05 . . . . 0.0 112.881 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.1 p -138.42 151.16 47.2 Favored 'General case' 0 N--CA 1.528 3.467 0 O-C-N 124.686 1.241 . . . . 0.0 109.89 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.24 32.25 68.8 Favored Glycine 1 N--CA 1.517 4.045 0 O-C-N 125.036 1.46 . . . . 0.0 112.879 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.8 mt -73.11 155.21 39.93 Favored 'General case' 0 N--CA 1.514 2.747 0 O-C-N 125.456 1.327 . . . . 0.0 110.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.31 -176.29 3.84 Favored 'General case' 0 N--CA 1.518 2.973 0 O-C-N 126.07 2.107 . . . . 0.0 108.574 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 127.49 32.81 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 124.75 1.281 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.95 28.95 71.16 Favored Glycine 0 N--CA 1.516 3.99 0 O-C-N 124.811 1.32 . . . . 0.0 112.977 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.14 123.81 23.68 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 124.935 1.021 . . . . 0.0 112.649 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -79.88 128.03 32.96 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.7 143.54 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 O-C-N 125.596 1.81 . . . . 0.0 109.178 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 m -107.1 102.92 12.22 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 126.231 2.207 . . . . 0.0 110.602 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.81 147.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.5 158.47 43.02 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.23 2.206 . . . . 0.0 108.717 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.28 141.56 12.32 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.244 1.59 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -165.31 122.52 1.51 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.516 1.76 . . . . 0.0 107.875 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 172.16 -90.56 0.09 OUTLIER Glycine 0 N--CA 1.506 3.337 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER 58.9 146.62 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.963 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.88 -37.74 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -136.84 -30.09 0.9 Allowed 'General case' 0 N--CA 1.527 3.416 0 O-C-N 126.007 2.067 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -73.36 109.46 6.9 Favored 'General case' 0 N--CA 1.523 3.19 0 O-C-N 124.658 1.224 . . . . 0.0 109.325 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.64 7.54 41.06 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.827 1.33 . . . . 0.0 112.726 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -160.46 167.72 26.66 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 124.398 1.061 . . . . 0.0 109.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.15 145.13 26.12 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.265 1.603 . . . . 0.0 109.898 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.1 m -142.0 169.77 16.97 Favored 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.38 4.46 Favored 'General case' 0 N--CA 1.527 3.411 0 O-C-N 124.23 0.956 . . . . 0.0 112.229 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.28 139.85 21.57 Favored 'General case' 0 N--CA 1.538 3.931 0 O-C-N 125.262 1.601 . . . . 0.0 109.551 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -87.83 148.74 24.52 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.3 m -142.42 149.54 39.44 Favored 'General case' 0 N--CA 1.524 3.268 0 O-C-N 125.581 1.801 . . . . 0.0 108.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.0 124.77 51.24 Favored 'General case' 0 N--CA 1.526 3.344 0 O-C-N 126.083 2.114 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -76.45 145.52 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.63 -175.76 3.56 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.41 -49.93 69.6 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.54 1.15 . . . . 0.0 111.654 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -23.59 59.9 Favored 'General case' 0 N--CA 1.528 3.431 0 O-C-N 125.564 1.79 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.0 32.93 60.13 Favored Glycine 0 N--CA 1.508 3.49 0 CA-C-O 116.921 -2.044 . . . . 0.0 117.187 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -75.79 150.2 37.78 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.75 89.33 0.38 Allowed Glycine 0 N--CA 1.511 3.676 0 O-C-N 124.722 1.264 . . . . 0.0 113.496 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.34 95.66 6.66 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.45 137.86 47.41 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 125.247 1.592 . . . . 0.0 111.223 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -78.91 117.82 20.35 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.94 1.4 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -21.48 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.369 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.97 -17.44 64.44 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 118.165 2.654 . . . . 0.0 118.165 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -83.04 2.06 36.91 Favored 'General case' 1 N--CA 1.55 4.533 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.38 167.38 12.67 Favored 'General case' 0 N--CA 1.53 3.552 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -146.17 -60.06 0.31 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 126.057 2.098 . . . . 0.0 107.264 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 45.44 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.757 1.911 . . . . 0.0 116.129 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.14 149.98 31.93 Favored 'General case' 0 N--CA 1.528 3.465 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.72 160.77 22.15 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.935 1.397 . . . . 0.0 114.759 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.39 149.82 31.54 Favored 'General case' 0 N--CA 1.517 2.9 0 O-C-N 125.178 1.549 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -76.31 -24.44 54.34 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.025 1.453 . . . . 0.0 112.217 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.2 -30.89 0.05 OUTLIER Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.16 3.66 0.02 OUTLIER Glycine 0 N--CA 1.512 3.749 0 CA-C-O 117.595 -1.67 . . . . 0.0 112.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.22 165.22 23.84 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.19 79.36 0.08 OUTLIER Glycine 0 N--CA 1.514 3.873 0 O-C-N 124.296 0.998 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m -75.03 155.7 37.0 Favored 'General case' 0 N--CA 1.517 2.902 0 O-C-N 125.311 1.242 . . . . 0.0 109.872 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.84 135.81 6.66 Favored 'General case' 0 N--CA 1.524 3.267 0 O-C-N 124.611 1.195 . . . . 0.0 113.065 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -84.49 114.24 21.79 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 124.875 1.359 . . . . 0.0 110.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.42 149.49 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.35 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 N-CA-C 102.395 -3.187 . . . . 0.0 102.395 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.67 125.18 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 O-C-N 125.543 1.777 . . . . 0.0 112.511 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -90.17 159.58 16.68 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.886 1.366 . . . . 0.0 107.73 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -66.24 -32.89 74.59 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.713 1.258 . . . . 0.0 111.952 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 148.41 52.01 Favored 'General case' 0 N--CA 1.529 3.476 0 O-C-N 125.944 2.028 . . . . 0.0 109.763 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.17 145.44 19.42 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.714 1.259 . . . . 0.0 111.926 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -70.45 106.07 3.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.744 1.903 . . . . 0.0 109.037 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.58 151.42 49.48 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.028 1.455 . . . . 0.0 110.739 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -139.98 121.3 14.95 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 125.803 1.531 . . . . 0.0 109.018 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.524 3.264 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.987 0 CA-C-O 115.564 -2.798 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -71.63 139.94 62.26 Favored 'Cis proline' 0 C--N 1.409 3.723 0 CA-C-N 123.19 3.495 . . . . 0.0 113.078 0.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.16 137.56 51.12 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 125.237 1.586 . . . . 0.0 109.583 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.92 -92.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.968 0 O-C-N 125.669 1.855 . . . . 0.0 110.616 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.31 -173.44 43.08 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.46 75.42 3.2 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 125.846 1.557 . . . . 0.0 112.349 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.16 141.74 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.828 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.96 156.05 18.26 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 125.375 1.672 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 t -73.8 -25.73 60.26 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.679 1.237 . . . . 0.0 112.887 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.15 -28.39 57.37 Favored 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -79.6 -21.63 44.75 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.341 1.026 . . . . 0.0 112.538 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.32 88.94 Favored Pre-proline 0 N--CA 1.531 3.578 0 CA-C-O 115.512 -2.185 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.76 -45.44 0.52 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.332 2.226 . . . . 0.0 113.051 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.36 -101.94 0.14 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 124.836 1.335 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.52 159.31 10.55 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 63.3 m -71.23 145.06 49.85 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 125.481 1.342 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -144.4 133.21 22.46 Favored 'General case' 0 N--CA 1.533 3.69 0 O-C-N 125.254 1.596 . . . . 0.0 109.283 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mm -79.72 135.73 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.825 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -131.06 134.31 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.3 140.67 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.044 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.72 145.62 6.88 Favored Glycine 0 N--CA 1.51 3.585 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.69 -170.91 38.68 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.016 1.068 . . . . 0.0 112.405 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -75.07 -12.65 60.37 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.256 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 p -69.9 -70.66 0.27 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.693 1.245 . . . . 0.0 111.384 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.48 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.512 3.722 0 CA-C-O 118.699 -1.056 . . . . 0.0 111.903 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -66.05 119.74 11.92 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 125.039 1.082 . . . . 0.0 112.013 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -86.99 -175.49 5.38 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 125.151 1.532 . . . . 0.0 110.31 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.39 78.16 0.09 OUTLIER Glycine 0 N--CA 1.507 3.394 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.71 152.05 46.25 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.445 1.321 . . . . 0.0 112.946 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 98.36 1.08 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 124.843 1.339 . . . . 0.0 109.737 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 150.32 45.64 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.937 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.06 172.16 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 O-C-N 126.324 2.265 . . . . 0.0 107.08 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.5 m -156.38 118.29 3.94 Favored 'General case' 0 N--CA 1.528 3.447 0 O-C-N 124.153 0.908 . . . . 0.0 111.42 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.21 147.93 44.21 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.507 1.129 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.982 0 CA-C-O 116.08 -2.511 . . . . 0.0 112.815 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.533 3.685 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.24 6.15 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.83 145.44 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -160.96 146.04 14.13 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 124.99 1.432 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.98 144.22 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.23 110.22 2.07 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 114.989 -2.434 . . . . 0.0 110.005 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.91 158.85 68.34 Favored 'Cis proline' 1 C--N 1.424 4.513 0 CA-C-N 125.158 2.878 . . . . 0.0 112.32 -3.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.0 -0.36 2.29 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 125.144 1.528 . . . . 0.0 112.831 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -140.05 151.74 45.65 Favored 'General case' 0 N--CA 1.528 3.462 0 O-C-N 124.74 1.275 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.49 30.95 68.45 Favored Glycine 0 N--CA 1.512 3.703 0 O-C-N 124.953 1.408 . . . . 0.0 113.553 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.58 154.59 39.74 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 125.373 1.278 . . . . 0.0 109.379 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.43 -177.37 3.96 Favored 'General case' 0 N--CA 1.523 3.216 0 O-C-N 125.769 1.918 . . . . 0.0 110.179 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.64 129.87 41.24 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 124.866 1.354 . . . . 0.0 111.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.34 77.18 Favored Glycine 0 N--CA 1.512 3.715 0 O-C-N 124.606 1.191 . . . . 0.0 113.549 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.27 136.11 44.53 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.721 0.895 . . . . 0.0 111.428 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 m -99.6 127.3 45.7 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 125.819 1.949 . . . . 0.0 106.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.87 149.21 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 125.752 1.908 . . . . 0.0 109.924 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 m -103.72 96.38 6.67 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 126.081 2.113 . . . . 0.0 110.648 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.9 147.32 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.119 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -133.91 162.41 32.1 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 125.857 1.973 . . . . 0.0 110.174 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.22 139.2 10.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 125.544 1.777 . . . . 0.0 106.977 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 p -160.59 153.39 21.16 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.749 1.281 . . . . 0.0 110.853 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.35 79.1 0.52 Allowed Glycine 0 N--CA 1.505 3.299 0 O-C-N 124.893 1.37 . . . . 0.0 113.157 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -79.51 173.26 12.77 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 125.677 1.457 . . . . 0.0 110.939 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.38 -38.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.438 1.086 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.99 -46.63 1.38 Allowed 'General case' 0 N--CA 1.525 3.317 0 O-C-N 126.15 2.156 . . . . 0.0 111.414 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.56 121.81 18.54 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 124.847 1.342 . . . . 0.0 113.321 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.02 3.44 38.83 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 125.479 1.737 . . . . 0.0 110.962 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.67 162.69 18.98 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.34 150.56 19.98 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 124.18 0.925 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.1 m -142.07 147.12 36.28 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 125.871 1.982 . . . . 0.0 107.079 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.62 125.04 48.21 Favored 'General case' 0 N--CA 1.526 3.327 0 O-C-N 125.91 2.006 . . . . 0.0 112.448 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -122.46 152.11 40.61 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.587 1.804 . . . . 0.0 107.983 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -135.78 63.26 1.6 Allowed 'General case' 0 N--CA 1.537 3.921 0 O-C-N 125.508 1.755 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 m -72.88 148.94 43.91 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.974 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.21 112.26 24.87 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 126.379 2.3 . . . . 0.0 109.712 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mm -75.54 123.7 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.1 mt -103.22 -173.39 2.3 Favored 'General case' 0 N--CA 1.528 3.473 0 O-C-N 125.223 1.577 . . . . 0.0 106.836 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.51 82.31 Favored 'General case' 0 N--CA 1.515 2.819 0 O-C-N 124.355 1.035 . . . . 0.0 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -21.5 59.86 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 125.192 1.558 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.83 59.45 Favored Glycine 0 N--CA 1.509 3.556 0 CA-C-O 117.49 -1.728 . . . . 0.0 115.118 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.9 142.1 49.51 Favored 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.15 76.06 1.28 Allowed Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.908 1.38 . . . . 0.0 114.37 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.33 97.86 11.44 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.213 1.184 . . . . 0.0 108.171 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 140.29 47.13 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 125.115 1.509 . . . . 0.0 110.896 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -77.11 133.11 39.11 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 125.263 1.602 . . . . 0.0 110.081 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.54 -14.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 O-C-N 125.12 1.512 . . . . 0.0 114.009 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.56 53.57 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.95 -3.12 50.46 Favored 'General case' 1 N--CA 1.546 4.361 0 O-C-N 124.255 0.972 . . . . 0.0 113.57 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -68.13 168.33 12.33 Favored 'General case' 0 N--CA 1.535 3.798 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -143.79 -66.63 0.35 Allowed 'General case' 0 N--CA 1.526 3.339 0 O-C-N 125.486 1.741 . . . . 0.0 109.194 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 52.22 127.81 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -172.84 145.43 1.45 Allowed 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -67.24 163.19 20.98 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.703 1.252 . . . . 0.0 112.657 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.25 149.38 31.88 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 124.83 1.331 . . . . 0.0 109.379 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -73.54 -26.85 61.04 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 124.896 1.372 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.89 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.62 14.43 0.02 OUTLIER Glycine 0 N--CA 1.51 3.609 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.902 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.6 160.16 41.15 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.32 86.46 0.07 OUTLIER Glycine 0 N--CA 1.51 3.63 0 O-C-N 124.49 1.119 . . . . 0.0 111.074 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -74.25 155.54 38.16 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 125.259 1.211 . . . . 0.0 109.189 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -157.6 135.51 10.79 Favored 'General case' 0 N--CA 1.53 3.565 0 O-C-N 124.69 1.244 . . . . 0.0 112.646 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 t -90.69 124.97 35.51 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 125.022 1.451 . . . . 0.0 108.522 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.73 144.57 32.96 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 O-C-N 125.47 1.731 . . . . 0.0 107.062 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 t -115.38 138.46 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.48 119.47 50.39 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.329 0 O-C-N 125.262 1.602 . . . . 0.0 111.777 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -90.46 162.59 15.0 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.078 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -67.35 -29.06 68.51 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.766 1.291 . . . . 0.0 111.766 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 t -148.31 154.3 39.82 Favored 'General case' 0 N--CA 1.533 3.706 0 O-C-N 124.853 1.345 . . . . 0.0 109.084 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -158.58 148.21 19.39 Favored 'General case' 0 N--CA 1.525 3.277 0 O-C-N 124.9 1.375 . . . . 0.0 111.675 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 m -67.95 100.54 0.98 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.783 1.927 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.59 155.41 51.17 Favored Glycine 0 N--CA 1.505 3.249 0 O-C-N 125.116 1.51 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -137.95 123.3 19.46 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 125.901 1.589 . . . . 0.0 107.602 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.523 3.216 0 O-C-N 125.266 1.604 . . . . 0.0 107.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.521 4.348 0 CA-C-O 115.595 -2.781 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.26 152.39 97.18 Favored 'Cis proline' 0 N--CA 1.53 3.649 0 CA-C-N 123.267 3.533 . . . . 0.0 113.08 -1.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -67.35 143.7 56.22 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 125.341 1.651 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -31.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 O-C-N 125.668 1.855 . . . . 0.0 110.72 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.72 -169.03 36.62 Favored Glycine 0 N--CA 1.494 2.539 0 O-C-N 125.498 1.749 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.86 113.42 2.77 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 125.987 1.639 . . . . 0.0 113.886 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.47 132.14 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 O-C-N 126.152 2.158 . . . . 0.0 107.439 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.532 1.145 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 43.9 t -77.12 -30.74 55.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.841 1.338 . . . . 0.0 112.623 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.74 -24.01 62.54 Favored 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -26.59 41.17 Favored 'General case' 0 N--CA 1.533 3.72 0 O-C-N 124.21 0.944 . . . . 0.0 113.014 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.1 154.81 91.88 Favored Pre-proline 0 N--CA 1.53 3.528 0 CA-C-O 115.513 -2.184 . . . . 0.0 111.986 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.09 -51.16 0.17 Allowed 'Trans proline' 0 C--N 1.411 3.849 0 CA-C-N 123.396 2.249 . . . . 0.0 113.577 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 -36.4 57.9 Favored Glycine 0 N--CA 1.51 3.591 0 O-C-N 124.458 1.099 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.09 -179.31 53.0 Favored Glycine 0 N--CA 1.516 3.972 0 O-C-N 125.045 1.085 . . . . 0.0 111.038 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.8 m -70.77 146.63 49.66 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 124.619 0.834 . . . . 0.0 111.73 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -144.92 131.79 20.18 Favored 'General case' 0 N--CA 1.525 3.309 0 O-C-N 125.549 1.781 . . . . 0.0 107.123 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.73 130.28 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.01 134.56 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.83 137.74 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.951 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.41 142.71 5.11 Favored Glycine 0 N--CA 1.509 3.565 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.29 -165.78 40.78 Favored Glycine 0 N--CA 1.515 3.964 0 O-C-N 125.717 1.481 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -77.9 -16.71 58.02 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.358 1.269 . . . . 0.0 112.687 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 p -126.39 -18.31 4.92 Favored 'General case' 0 N--CA 1.528 3.451 0 O-C-N 125.378 1.673 . . . . 0.0 109.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.52 -7.65 65.01 Favored Glycine 1 N--CA 1.523 4.445 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.869 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.251 4.4 mm-40 62.15 -94.19 0.04 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 125.112 1.365 . . . . 0.0 112.644 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -162.44 156.53 21.27 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 123.826 0.704 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.22 92.12 0.12 Allowed Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 163.91 18.63 Favored 'General case' 0 N--CA 1.515 2.793 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.47 94.71 0.98 Allowed 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.588 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.59 144.13 55.73 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.95 172.22 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 126.381 2.3 . . . . 0.0 106.865 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 m -157.25 120.47 4.06 Favored 'General case' 0 N--CA 1.527 3.378 0 O-C-N 124.287 0.992 . . . . 0.0 111.374 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -73.65 154.24 39.8 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 124.595 1.185 . . . . 0.0 110.349 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.018 0 CA-C-O 116.306 -2.385 . . . . 0.0 112.569 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.797 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.07 124.37 3.76 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.139 1.524 . . . . 0.0 109.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.8 137.98 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -163.32 122.75 2.12 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 124.715 1.259 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.1 149.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -154.56 106.87 2.37 Favored Pre-proline 0 N--CA 1.528 3.466 0 CA-C-O 115.308 -2.282 . . . . 0.0 109.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.65 163.01 48.21 Favored 'Cis proline' 2 C--N 1.427 4.696 0 CA-C-N 124.926 2.795 . . . . 0.0 113.025 -3.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.54 -8.18 0.98 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 124.765 1.291 . . . . 0.0 113.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -134.84 153.27 52.11 Favored 'General case' 0 N--CA 1.529 3.495 0 O-C-N 125.091 1.495 . . . . 0.0 110.389 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 28.88 66.42 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 124.926 1.392 . . . . 0.0 113.413 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.0 mt -73.59 154.44 39.79 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 125.289 1.229 . . . . 0.0 109.803 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.44 -175.71 3.39 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.944 2.027 . . . . 0.0 109.802 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.75 129.71 40.76 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.638 1.211 . . . . 0.0 112.014 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.71 28.55 68.92 Favored Glycine 0 N--CA 1.513 3.779 0 O-C-N 124.587 1.18 . . . . 0.0 112.54 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.36 139.81 48.1 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 125.07 1.1 . . . . 0.0 111.96 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.1 m -101.34 131.76 47.24 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 126.159 2.162 . . . . 0.0 105.19 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.95 145.47 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 O-C-N 125.651 1.845 . . . . 0.0 110.208 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.2 m -103.75 99.06 8.84 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 126.251 2.219 . . . . 0.0 109.92 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.79 144.13 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -139.24 155.86 47.49 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 126.018 2.073 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.16 152.23 20.43 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 125.026 1.454 . . . . 0.0 108.015 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -160.88 137.65 8.78 Favored 'General case' 0 N--CA 1.517 2.892 0 O-C-N 124.953 1.408 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.81 67.33 2.01 Favored Glycine 0 N--CA 1.511 3.643 0 O-C-N 124.926 1.391 . . . . 0.0 113.634 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -71.19 149.55 46.2 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 125.476 1.339 . . . . 0.0 110.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.85 -70.55 0.24 Allowed 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.81 -27.37 2.1 Favored 'General case' 1 N--CA 1.541 4.114 0 O-C-N 124.923 1.389 . . . . 0.0 110.633 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -59.27 114.54 2.7 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 125.02 1.45 . . . . 0.0 111.467 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.95 13.51 20.4 Favored 'General case' 0 N--CA 1.53 3.539 0 O-C-N 125.43 1.706 . . . . 0.0 112.756 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -161.85 158.55 25.68 Favored 'General case' 0 N--CA 1.524 3.242 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.13 143.59 13.95 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 124.283 0.989 . . . . 0.0 112.232 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.66 179.14 4.09 Favored 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.646 2.466 . . . . 0.0 105.965 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.44 99.22 2.88 Favored 'General case' 0 N--CA 1.525 3.312 0 O-C-N 125.245 1.59 . . . . 0.0 109.599 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -116.57 157.18 25.71 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.637 1.835 . . . . 0.0 108.742 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.25 121.8 17.32 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.6 m -123.87 151.83 43.03 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.381 1.676 . . . . 0.0 111.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.09 28.59 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 125.613 1.82 . . . . 0.0 110.58 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.3 141.29 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -128.94 -175.05 3.43 Favored 'General case' 0 N--CA 1.525 3.282 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.96 98.21 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 124.59 1.181 . . . . 0.0 112.093 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -22.41 60.67 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 125.283 1.614 . . . . 0.0 111.323 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.42 27.52 67.62 Favored Glycine 0 N--CA 1.513 3.773 0 CA-C-O 117.826 -1.541 . . . . 0.0 115.772 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -74.58 147.34 41.78 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.98 69.63 2.66 Favored Glycine 1 N--CA 1.517 4.073 0 O-C-N 124.937 1.398 . . . . 0.0 114.241 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 99.69 9.24 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.33 146.37 48.37 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 124.592 1.183 . . . . 0.0 111.055 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -83.76 127.1 33.55 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.663 1.852 . . . . 0.0 109.17 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.17 -24.6 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.87 -13.17 61.93 Favored 'General case' 1 N--CA 1.54 4.057 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.95 -6.18 57.03 Favored 'General case' 1 N--CA 1.539 4.017 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -67.44 165.57 16.37 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -146.24 -61.52 0.31 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 125.854 1.971 . . . . 0.0 107.243 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 56.55 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 125.564 1.79 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.42 148.37 19.78 Favored 'General case' 0 N--CA 1.531 3.621 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -70.15 165.86 21.15 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 124.665 1.228 . . . . 0.0 113.43 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.9 mt -79.54 151.0 30.95 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 124.566 1.166 . . . . 0.0 109.413 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.5 t -72.5 -31.37 65.31 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 124.834 1.334 . . . . 0.0 111.562 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.29 -31.56 0.05 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 18.59 0.03 OUTLIER Glycine 0 N--CA 1.51 3.623 0 CA-C-O 118.303 -1.276 . . . . 0.0 112.106 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -143.25 166.37 24.9 Favored 'General case' 0 N--CA 1.539 3.983 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.6 70.7 0.09 OUTLIER Glycine 0 N--CA 1.513 3.778 0 O-C-N 124.268 0.98 . . . . 0.0 111.869 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -74.3 149.55 40.63 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 125.261 1.212 . . . . 0.0 108.977 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -162.23 136.99 6.9 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 124.83 1.331 . . . . 0.0 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -84.23 132.08 34.68 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 125.014 1.446 . . . . 0.0 110.13 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.29 143.71 40.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.399 0 O-C-N 125.417 1.698 . . . . 0.0 106.854 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.1 t -113.02 133.41 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.27 126.02 58.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 O-C-N 125.573 1.796 . . . . 0.0 111.379 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -90.18 158.77 17.08 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 124.711 1.205 . . . . 0.0 108.624 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -69.97 -26.22 63.99 Favored 'General case' 0 N--CA 1.526 3.351 0 O-C-N 124.872 1.358 . . . . 0.0 112.146 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.49 145.88 32.11 Favored 'General case' 0 N--CA 1.527 3.409 0 O-C-N 125.067 1.48 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -157.29 148.95 22.22 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 124.938 1.398 . . . . 0.0 111.892 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.4 m -70.96 101.16 2.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 125.866 1.979 . . . . 0.0 108.404 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.86 152.81 51.75 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.124 1.515 . . . . 0.0 111.082 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -137.56 120.75 16.79 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 126.023 1.66 . . . . 0.0 109.083 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.526 3.35 0 O-C-N 125.303 1.627 . . . . 0.0 107.193 -179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.904 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.92 138.93 56.66 Favored 'Cis proline' 0 C--N 1.41 3.77 0 CA-C-N 123.096 3.448 . . . . 0.0 112.795 0.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.03 138.64 54.62 Favored 'General case' 0 N--CA 1.516 2.873 0 O-C-N 125.21 1.569 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -36.84 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.145 0 O-C-N 125.397 1.686 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.15 -169.77 36.75 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 125.371 1.669 . . . . 0.0 109.24 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.3 108.37 0.91 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 126.004 1.65 . . . . 0.0 113.085 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.32 137.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.013 0 O-C-N 125.938 2.024 . . . . 0.0 108.189 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.62 139.79 36.05 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.986 1.429 . . . . 0.0 109.313 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 t -80.0 -21.84 43.18 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 124.831 1.332 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -73.43 -26.51 60.98 Favored 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -79.74 -22.98 42.61 Favored 'General case' 0 N--CA 1.532 3.643 0 O-C-N 124.487 1.117 . . . . 0.0 113.194 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.16 88.61 Favored Pre-proline 0 N--CA 1.533 3.709 0 CA-C-O 115.588 -2.149 . . . . 0.0 112.254 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.7 -49.7 0.25 Allowed 'Trans proline' 0 C--N 1.412 3.912 0 CA-C-N 123.335 2.227 . . . . 0.0 113.714 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.98 -38.75 59.82 Favored Glycine 0 N--CA 1.512 3.725 0 O-C-N 124.696 1.247 . . . . 0.0 111.791 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.42 52.57 Favored Glycine 0 N--CA 1.511 3.652 0 O-C-N 125.112 1.125 . . . . 0.0 112.241 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 152.17 40.17 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 124.883 0.99 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.49 132.45 12.49 Favored 'General case' 0 N--CA 1.521 3.115 0 O-C-N 125.893 1.996 . . . . 0.0 107.628 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -79.88 136.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.821 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.19 132.72 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -127.33 138.14 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.8 141.53 4.42 Favored Glycine 1 N--CA 1.517 4.089 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.15 -159.06 30.64 Favored Glycine 1 N--CA 1.518 4.132 0 O-C-N 125.198 1.175 . . . . 0.0 112.53 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -8.75 59.57 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 125.625 1.426 . . . . 0.0 113.0 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -70.0 -70.88 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 124.913 1.383 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.16 -24.61 0.18 Allowed Glycine 0 N--CA 1.51 3.588 0 O-C-N 124.184 0.928 . . . . 0.0 111.328 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -65.66 120.77 13.55 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 125.086 1.109 . . . . 0.0 112.771 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -90.31 -169.9 2.57 Favored 'General case' 0 N--CA 1.517 2.911 0 O-C-N 125.317 1.635 . . . . 0.0 109.514 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.26 76.28 0.09 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.34 148.8 49.19 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.391 1.289 . . . . 0.0 112.605 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.3 99.36 1.05 Allowed 'General case' 0 N--CA 1.529 3.507 0 O-C-N 124.972 1.42 . . . . 0.0 110.165 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.38 144.66 49.76 Favored 'General case' 0 N--CA 1.514 2.725 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.628 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 169.16 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 O-C-N 126.287 2.242 . . . . 0.0 107.896 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 t -140.1 159.26 42.59 Favored 'General case' 0 N--CA 1.528 3.432 0 O-C-N 124.68 1.238 . . . . 0.0 110.248 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -107.92 163.22 13.32 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 126.14 2.15 . . . . 0.0 110.06 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.797 0 CA-C-O 116.336 -2.369 . . . . 0.0 111.268 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 2.745 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.1 131.11 35.69 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 124.679 1.237 . . . . 0.0 111.06 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.85 140.49 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -163.7 143.18 8.2 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.973 1.421 . . . . 0.0 110.547 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.13 143.0 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.025 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -157.54 111.56 1.84 Allowed Pre-proline 0 N--CA 1.528 3.439 0 CA-C-O 114.903 -2.475 . . . . 0.0 109.839 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.03 153.03 76.86 Favored 'Cis proline' 1 C--N 1.424 4.519 0 CA-C-N 125.555 3.02 . . . . 0.0 111.57 -2.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.47 -6.58 1.54 Allowed 'General case' 0 N--CA 1.529 3.485 0 O-C-N 125.853 1.971 . . . . 0.0 112.638 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.4 p -134.36 151.55 51.29 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 125.164 1.54 . . . . 0.0 109.978 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.12 31.61 66.39 Favored Glycine 0 N--CA 1.511 3.679 0 O-C-N 125.027 1.454 . . . . 0.0 112.786 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 153.55 39.34 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.359 1.27 . . . . 0.0 109.968 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -176.07 4.16 Favored 'General case' 0 N--CA 1.524 3.232 0 O-C-N 125.834 1.959 . . . . 0.0 108.755 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.41 136.35 56.38 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.756 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.44 60.21 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.587 1.179 . . . . 0.0 111.709 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.98 150.66 43.87 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 125.216 1.186 . . . . 0.0 110.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -128.93 101.16 5.95 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 126.22 2.2 . . . . 0.0 107.382 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.82 157.4 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 O-C-N 126.076 2.11 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -128.48 96.45 4.42 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 126.171 2.169 . . . . 0.0 106.082 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.7 148.29 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -140.47 160.86 39.07 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 126.045 2.091 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 131.83 6.02 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -126.33 13.52 7.68 Favored 'General case' 0 N--CA 1.535 3.824 0 O-C-N 125.583 1.802 . . . . 0.0 112.979 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.02 158.34 30.33 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -141.92 -172.27 3.53 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 126.579 1.987 . . . . 0.0 107.361 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.82 -30.52 0.07 Allowed 'General case' 0 N--CA 1.514 2.768 0 O-C-N 124.369 1.043 . . . . 0.0 111.435 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -40.38 0.3 Allowed 'General case' 0 N--CA 1.527 3.396 0 O-C-N 125.399 1.687 . . . . 0.0 110.548 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 p -67.93 113.21 5.45 Favored 'General case' 0 N--CA 1.521 3.103 0 O-C-N 124.946 1.404 . . . . 0.0 112.011 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.65 7.93 39.19 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 124.741 1.276 . . . . 0.0 112.554 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.54 162.03 18.89 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.09 20.28 Favored 'General case' 0 N--CA 1.522 3.146 0 O-C-N 124.068 0.855 . . . . 0.0 111.552 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -144.65 142.25 29.97 Favored 'General case' 0 N--CA 1.52 3.041 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.04 130.78 55.48 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.676 1.86 . . . . 0.0 114.073 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.47 139.03 19.59 Favored 'General case' 0 N--CA 1.532 3.647 0 O-C-N 125.047 1.467 . . . . 0.0 109.619 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -100.4 150.14 22.92 Favored 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.9 m -144.23 143.23 30.95 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.047 1.467 . . . . 0.0 109.243 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.85 114.72 27.21 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 125.327 1.642 . . . . 0.0 110.881 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.76 120.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.127 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.88 -174.86 2.8 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.64 82.53 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 124.646 1.216 . . . . 0.0 112.404 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -21.9 60.81 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.151 1.532 . . . . 0.0 111.473 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.07 22.66 57.03 Favored Glycine 0 N--CA 1.511 3.679 0 CA-C-O 117.356 -1.802 . . . . 0.0 115.003 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -71.4 140.96 50.32 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 75.01 1.42 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-O 118.173 -1.349 . . . . 0.0 115.154 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.1 100.1 10.3 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.45 146.43 51.3 Favored 'General case' 0 N--CA 1.529 3.497 0 O-C-N 124.949 1.406 . . . . 0.0 110.836 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -91.04 123.82 34.8 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 125.854 1.972 . . . . 0.0 109.559 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.71 -25.71 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.46 -5.38 32.46 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -79.78 -12.57 59.77 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 123.898 0.749 . . . . 0.0 112.982 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.4 159.91 17.29 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -148.25 -44.65 0.16 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 125.685 1.866 . . . . 0.0 109.788 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 63.49 130.88 0.01 OUTLIER 'General case' 0 N--CA 1.534 3.726 0 O-C-N 125.466 1.729 . . . . 0.0 114.794 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.0 154.11 27.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.597 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.5 m -118.99 146.96 44.58 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 126.21 2.194 . . . . 0.0 108.347 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.61 155.16 28.24 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.957 1.411 . . . . 0.0 108.827 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.2 p -134.78 15.84 3.61 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 126.057 2.098 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.89 -62.33 0.1 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.77 24.76 0.02 OUTLIER Glycine 0 N--CA 1.507 3.406 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.6 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -138.45 153.52 48.84 Favored 'General case' 0 N--CA 1.536 3.86 0 O-C-N 125.164 1.156 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.24 74.63 0.06 OUTLIER Glycine 0 N--CA 1.513 3.775 0 O-C-N 124.542 1.151 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.29 150.98 39.93 Favored 'General case' 0 N--CA 1.519 2.987 0 O-C-N 125.045 1.085 . . . . 0.0 109.716 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -156.41 145.21 20.18 Favored 'General case' 0 N--CA 1.538 3.95 0 O-C-N 124.804 1.315 . . . . 0.0 111.232 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.4 m -101.8 136.54 41.46 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 125.942 2.026 . . . . 0.0 109.421 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.5 155.95 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 O-C-N 125.481 1.738 . . . . 0.0 106.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 134.65 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -131.58 126.13 57.33 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 O-C-N 125.353 1.658 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -90.31 159.77 16.48 Favored 'General case' 0 N--CA 1.525 3.307 0 O-C-N 124.692 1.245 . . . . 0.0 108.163 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -69.44 -24.07 63.76 Favored 'General case' 0 N--CA 1.527 3.408 0 O-C-N 124.402 1.064 . . . . 0.0 112.145 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.5 m -142.48 147.42 36.02 Favored 'General case' 0 N--CA 1.532 3.652 0 O-C-N 124.997 1.435 . . . . 0.0 109.564 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.37 148.46 19.93 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.638 1.211 . . . . 0.0 112.042 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.52 102.25 1.78 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 125.741 1.901 . . . . 0.0 109.186 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.01 155.09 51.53 Favored Glycine 0 N--CA 1.506 3.35 0 O-C-N 125.063 1.477 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -139.42 123.21 17.57 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 125.737 1.492 . . . . 0.0 108.258 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.525 3.308 0 O-C-N 125.15 1.531 . . . . 0.0 106.952 -179.85 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.069 0 CA-C-O 115.709 -2.717 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.87 142.61 74.21 Favored 'Cis proline' 0 C--N 1.41 3.792 0 CA-C-N 123.003 3.401 . . . . 0.0 112.919 0.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.93 139.53 55.09 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 125.327 1.642 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.2 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 O-C-N 125.419 1.699 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.54 -167.87 34.23 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 125.444 1.715 . . . . 0.0 109.033 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.93 109.14 1.17 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 126.104 1.708 . . . . 0.0 112.842 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.86 137.08 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.935 0 O-C-N 126.093 2.12 . . . . 0.0 107.963 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.41 144.59 31.31 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 125.028 1.455 . . . . 0.0 110.027 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.5 t -75.99 -35.06 59.73 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 124.855 1.347 . . . . 0.0 112.783 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.38 -24.66 65.7 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -79.67 -24.66 41.66 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 124.252 0.97 . . . . 0.0 112.73 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.44 157.09 88.97 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 115.675 -2.107 . . . . 0.0 111.596 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.49 -50.17 0.19 Allowed 'Trans proline' 0 C--N 1.41 3.779 0 CA-C-N 123.25 2.196 . . . . 0.0 114.32 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.74 -41.37 56.59 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 124.486 1.116 . . . . 0.0 112.308 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.66 179.76 50.02 Favored Glycine 0 N--CA 1.51 3.599 0 O-C-N 125.212 1.184 . . . . 0.0 112.114 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.8 150.82 45.47 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.673 -1.264 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -159.37 134.48 8.21 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 mm -79.6 135.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 t -132.31 132.02 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 O-C-N 125.886 1.991 . . . . 0.0 105.835 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.3 145.97 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 100.978 -3.712 . . . . 0.0 100.978 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.75 139.17 4.12 Favored Glycine 0 N--CA 1.514 3.877 0 O-C-N 124.444 1.09 . . . . 0.0 111.567 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.51 -161.79 37.6 Favored Glycine 1 N--CA 1.517 4.083 0 O-C-N 125.688 1.464 . . . . 0.0 111.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -72.6 -25.17 61.22 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 125.362 1.272 . . . . 0.0 112.371 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -74.46 -25.71 59.58 Favored 'General case' 0 N--CA 1.522 3.142 0 O-C-N 124.464 1.103 . . . . 0.0 110.583 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.85 19.55 47.1 Favored Glycine 0 N--CA 1.512 3.741 0 O-C-N 125.208 1.567 . . . . 0.0 112.115 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -73.11 103.24 3.79 Favored 'General case' 0 N--CA 1.517 2.924 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -70.78 167.16 19.41 Favored 'General case' 0 N--CA 1.519 2.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.398 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.48 73.53 0.08 OUTLIER Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.92 164.46 19.8 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.12 102.19 0.87 Allowed 'General case' 0 N--CA 1.524 3.271 0 O-C-N 124.906 1.379 . . . . 0.0 109.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 154.23 42.17 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 123.984 0.802 . . . . 0.0 112.646 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.24 172.52 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 O-C-N 126.209 2.193 . . . . 0.0 107.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -157.84 131.54 7.89 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 123.993 0.808 . . . . 0.0 111.367 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.78 161.63 28.86 Favored 'General case' 0 N--CA 1.518 2.964 0 O-C-N 124.401 1.063 . . . . 0.0 110.859 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.344 -2.365 . . . . 0.0 109.805 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.486 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.86 129.66 34.67 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 124.731 1.27 . . . . 0.0 111.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.41 139.75 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 102.097 -3.297 . . . . 0.0 102.097 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.39 142.49 9.78 Favored 'General case' 0 N--CA 1.514 2.748 0 O-C-N 124.943 1.402 . . . . 0.0 110.419 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -126.27 141.1 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.39 112.88 1.7 Allowed Pre-proline 0 N--CA 1.526 3.356 0 CA-C-O 114.889 -2.482 . . . . 0.0 110.136 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.53 150.49 73.32 Favored 'Cis proline' 1 C--N 1.423 4.455 0 CA-C-N 125.36 2.95 . . . . 0.0 111.927 -4.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.32 -13.68 1.79 Allowed 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.993 2.058 . . . . 0.0 112.724 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.1 p -127.56 153.91 45.81 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.776 1.922 . . . . 0.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.79 33.11 74.86 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 124.951 1.407 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 mt -75.05 153.75 38.28 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 125.338 1.258 . . . . 0.0 110.633 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.89 -173.96 3.24 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 126.245 2.215 . . . . 0.0 108.444 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.04 127.97 34.22 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.661 1.226 . . . . 0.0 112.849 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 29.48 72.4 Favored Glycine 0 N--CA 1.515 3.907 0 O-C-N 124.761 1.288 . . . . 0.0 113.094 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.56 125.16 26.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 125.021 1.071 . . . . 0.0 112.503 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.06 135.48 35.83 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.82 141.24 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.333 1.645 . . . . 0.0 108.828 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -109.1 102.68 11.63 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 126.236 2.21 . . . . 0.0 109.637 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 147.94 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -134.75 161.97 33.67 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 126.197 2.185 . . . . 0.0 109.503 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.19 14.4 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 125.51 1.756 . . . . 0.0 108.064 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.23 147.36 17.75 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.323 1.64 . . . . 0.0 109.311 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.06 87.51 0.16 Allowed Glycine 0 N--CA 1.509 3.521 0 O-C-N 125.114 1.509 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -156.21 152.4 27.77 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 125.741 1.495 . . . . 0.0 107.433 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.81 -18.64 0.05 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 124.871 1.357 . . . . 0.0 111.156 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.385 1.053 . . . . 0.0 110.247 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -72.53 121.46 19.7 Favored 'General case' 0 N--CA 1.518 2.965 0 O-C-N 124.615 1.197 . . . . 0.0 110.558 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -79.8 -17.11 54.16 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.349 1.031 . . . . 0.0 113.345 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -167.54 153.68 7.76 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.7 135.08 5.51 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 124.562 1.164 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -97.61 153.18 18.37 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 126.168 2.167 . . . . 0.0 108.471 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.88 120.87 41.43 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 126.399 2.312 . . . . 0.0 109.059 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.51 145.88 17.86 Favored 'General case' 0 N--CA 1.527 3.386 0 O-C-N 124.542 1.151 . . . . 0.0 112.362 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -96.17 148.9 22.22 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 125.373 1.671 . . . . 0.0 108.232 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.5 m -146.83 142.96 28.23 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.466 1.729 . . . . 0.0 108.088 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.44 123.63 42.69 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.451 1.72 . . . . 0.0 112.068 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.36 122.56 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.03 -174.48 2.7 Favored 'General case' 0 N--CA 1.526 3.329 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.69 81.63 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.627 1.204 . . . . 0.0 111.321 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -22.45 60.56 Favored 'General case' 0 N--CA 1.524 3.264 0 O-C-N 125.357 1.661 . . . . 0.0 111.181 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.96 25.69 55.14 Favored Glycine 0 N--CA 1.514 3.861 0 CA-C-O 117.54 -1.7 . . . . 0.0 115.485 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 144.63 46.79 Favored 'General case' 0 N--CA 1.526 3.343 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 75.14 1.51 Allowed Glycine 0 N--CA 1.515 3.911 0 CA-C-O 118.19 -1.339 . . . . 0.0 114.977 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.88 104.48 13.99 Favored 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.34 142.93 49.53 Favored 'General case' 0 N--CA 1.531 3.615 0 O-C-N 125.201 1.563 . . . . 0.0 112.396 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -83.39 116.96 22.72 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 125.344 1.652 . . . . 0.0 109.025 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.18 -23.75 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.21 62.15 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -79.87 -7.69 58.87 Favored 'General case' 1 N--CA 1.542 4.173 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -64.67 165.49 10.22 Favored 'General case' 0 N--CA 1.531 3.598 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -145.42 -52.99 0.27 Allowed 'General case' 0 N--CA 1.513 2.71 0 O-C-N 126.136 2.148 . . . . 0.0 107.052 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.6 t70 51.37 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.677 0 O-C-N 125.754 1.908 . . . . 0.0 116.139 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -157.55 147.26 20.28 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.2 p -66.7 157.44 32.67 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 124.841 1.338 . . . . 0.0 113.99 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.58 136.62 36.9 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 125.04 1.463 . . . . 0.0 108.139 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -70.07 -37.78 75.58 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.547 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.57 54.28 0.11 Allowed Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.318 1.636 . . . . 0.0 109.294 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.77 70.73 Favored Glycine 0 N--CA 1.507 3.404 0 O-C-N 125.518 1.363 . . . . 0.0 112.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.65 157.6 44.87 Favored 'General case' 0 N--CA 1.535 3.787 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.22 77.72 0.07 OUTLIER Glycine 0 N--CA 1.515 3.956 0 O-C-N 124.33 1.019 . . . . 0.0 112.38 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 m -75.76 150.83 37.7 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.232 1.195 . . . . 0.0 109.159 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.3 135.48 6.05 Favored 'General case' 0 N--CA 1.529 3.481 0 O-C-N 124.8 1.313 . . . . 0.0 112.973 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -80.81 113.17 18.83 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.923 1.389 . . . . 0.0 111.038 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.66 150.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.4 141.27 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.86 132.3 25.24 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 O-C-N 125.49 1.744 . . . . 0.0 112.279 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -90.22 162.91 15.01 Favored 'General case' 0 N--CA 1.526 3.355 0 O-C-N 125.141 1.526 . . . . 0.0 108.729 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -66.53 -24.59 66.4 Favored 'General case' 0 N--CA 1.525 3.293 0 O-C-N 124.322 1.014 . . . . 0.0 112.669 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -155.72 150.87 26.68 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 124.772 1.295 . . . . 0.0 108.587 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.45 150.03 26.21 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 124.941 1.401 . . . . 0.0 112.172 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 m -68.07 103.77 1.61 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.958 2.036 . . . . 0.0 109.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.23 154.38 52.55 Favored Glycine 0 N--CA 1.509 3.538 0 O-C-N 125.173 1.546 . . . . 0.0 111.177 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -137.44 123.0 19.72 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 126.002 1.648 . . . . 0.0 109.262 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.524 3.232 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.93 0 CA-C-O 115.625 -2.764 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.51 143.2 75.85 Favored 'Cis proline' 0 C--N 1.408 3.71 0 CA-C-N 123.057 3.429 . . . . 0.0 113.074 -0.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.29 137.95 53.44 Favored 'General case' 0 N--CA 1.515 2.803 0 O-C-N 125.306 1.629 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -37.66 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 O-C-N 125.351 1.657 . . . . 0.0 111.646 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.25 -169.75 32.2 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 125.456 1.723 . . . . 0.0 109.749 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.97 111.96 2.13 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 126.08 1.694 . . . . 0.0 113.423 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 142.28 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.974 0 O-C-N 125.988 2.055 . . . . 0.0 107.4 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.37 154.17 17.62 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 125.711 1.882 . . . . 0.0 109.127 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.9 -27.35 61.01 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 124.746 1.279 . . . . 0.0 112.948 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.93 -31.42 68.02 Favored 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.76 -19.56 48.4 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 124.64 1.213 . . . . 0.0 112.821 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.97 155.26 92.24 Favored Pre-proline 0 N--CA 1.53 3.57 0 CA-C-O 115.601 -2.143 . . . . 0.0 111.507 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -43.01 0.79 Allowed 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 123.407 2.253 . . . . 0.0 113.929 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.08 -104.5 0.1 OUTLIER Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.684 1.24 . . . . 0.0 111.329 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.53 147.14 4.96 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.9 m -73.75 159.08 33.47 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 125.077 1.104 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.34 147.3 12.44 Favored 'General case' 0 N--CA 1.518 2.947 0 O-C-N 124.497 1.123 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -79.64 121.2 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.05 120.14 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 t -116.33 132.76 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 101.408 -3.552 . . . . 0.0 101.408 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.4 138.12 3.56 Favored Glycine 1 N--CA 1.517 4.035 0 O-C-N 124.184 0.928 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.08 -166.26 41.48 Favored Glycine 0 N--CA 1.509 3.513 0 O-C-N 125.377 1.281 . . . . 0.0 112.556 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -80.08 -13.52 59.23 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 125.743 1.496 . . . . 0.0 112.856 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -70.0 -68.5 0.41 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 124.894 1.371 . . . . 0.0 111.751 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.68 -19.45 0.07 OUTLIER Glycine 0 N--CA 1.515 3.951 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.758 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.38 143.61 57.62 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.961 1.036 . . . . 0.0 112.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -111.72 -173.16 2.18 Favored 'General case' 0 N--CA 1.524 3.271 0 O-C-N 126.52 2.387 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.07 67.22 0.11 Allowed Glycine 0 N--CA 1.51 3.607 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -68.05 146.35 53.59 Favored 'General case' 0 N--CA 1.519 3.0 0 O-C-N 125.432 1.313 . . . . 0.0 112.926 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.13 109.78 1.03 Allowed 'General case' 0 N--CA 1.528 3.429 0 O-C-N 124.496 1.123 . . . . 0.0 109.633 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.49 170.75 16.14 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.414 1.072 . . . . 0.0 113.038 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -178.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 O-C-N 126.419 2.324 . . . . 0.0 107.99 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -161.19 119.65 2.44 Favored 'General case' 0 N--CA 1.516 2.842 0 O-C-N 124.35 1.031 . . . . 0.0 109.271 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.23 158.48 34.01 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.073 0.858 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 116.282 -2.399 . . . . 0.0 111.497 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.505 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.29 34.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 124.695 1.247 . . . . 0.0 111.168 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.13 139.31 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -161.63 146.82 13.44 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.731 1.269 . . . . 0.0 110.555 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.89 147.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.02 109.51 1.75 Allowed Pre-proline 0 N--CA 1.526 3.344 0 CA-C-O 115.343 -2.265 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.93 162.62 51.23 Favored 'Cis proline' 2 C--N 1.427 4.665 0 CA-C-N 124.908 2.789 . . . . 0.0 112.747 -3.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.15 -5.31 1.12 Allowed 'General case' 0 N--CA 1.537 3.894 0 O-C-N 124.655 1.222 . . . . 0.0 113.291 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.8 p -139.3 151.35 46.37 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.807 1.317 . . . . 0.0 109.669 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.76 32.84 70.57 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.985 1.428 . . . . 0.0 112.987 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.57 150.74 44.44 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 125.632 1.431 . . . . 0.0 109.984 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.73 178.68 4.24 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 126.059 2.1 . . . . 0.0 109.939 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.95 127.4 32.74 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 124.954 1.409 . . . . 0.0 111.335 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.56 25.98 74.83 Favored Glycine 0 N--CA 1.514 3.844 0 O-C-N 124.554 1.158 . . . . 0.0 113.285 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.54 140.97 48.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 124.753 0.913 . . . . 0.0 111.784 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -99.06 132.91 44.02 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.843 1.964 . . . . 0.0 105.816 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.48 147.19 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 125.399 1.687 . . . . 0.0 109.571 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -101.01 96.75 7.45 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 126.064 2.102 . . . . 0.0 110.369 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 t -79.92 147.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -138.57 165.81 25.94 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 125.754 1.909 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.85 15.88 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 125.696 1.873 . . . . 0.0 108.118 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.79 148.53 17.56 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.898 1.374 . . . . 0.0 109.469 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.91 87.79 0.18 Allowed Glycine 0 N--CA 1.508 3.468 0 O-C-N 125.198 1.561 . . . . 0.0 110.444 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -155.81 156.64 35.09 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 125.67 1.453 . . . . 0.0 107.551 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.11 -21.99 0.05 Allowed 'General case' 0 N--CA 1.52 3.042 0 O-C-N 124.621 1.201 . . . . 0.0 111.261 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -79.64 -54.87 5.46 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 124.474 1.109 . . . . 0.0 110.343 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -70.88 117.62 12.62 Favored 'General case' 0 N--CA 1.515 2.793 0 O-C-N 124.681 1.238 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.0 p -79.73 -16.61 55.3 Favored 'General case' 0 N--CA 1.527 3.401 0 O-C-N 124.091 0.869 . . . . 0.0 112.277 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.35 154.95 10.76 Favored 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.9 10.37 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.65 1.219 . . . . 0.0 111.241 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 m -112.54 151.46 29.98 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 126.501 2.375 . . . . 0.0 108.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.92 103.87 13.4 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 126.188 2.18 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -126.24 147.59 49.65 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 124.995 1.434 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.07 142.49 47.35 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 125.951 2.032 . . . . 0.0 106.451 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.3 m -137.13 138.9 40.79 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.356 1.66 . . . . 0.0 109.817 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.31 23.22 Favored 'General case' 0 N--CA 1.516 2.875 0 O-C-N 125.049 1.468 . . . . 0.0 112.143 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mm -77.36 121.36 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.3 mt -100.42 -173.15 2.34 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -47.23 78.61 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.535 1.147 . . . . 0.0 112.229 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.83 -21.33 61.7 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.24 1.588 . . . . 0.0 111.714 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.69 24.56 49.45 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.187 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -73.18 143.64 47.14 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 124.828 0.957 . . . . 0.0 108.641 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.75 72.58 2.2 Favored Glycine 0 N--CA 1.514 3.849 0 CA-C-O 118.105 -1.386 . . . . 0.0 115.165 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.0 108.82 15.81 Favored 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.6 144.89 48.17 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 124.891 1.37 . . . . 0.0 111.956 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.98 127.16 34.07 Favored 'General case' 0 N--CA 1.516 2.829 0 O-C-N 125.499 1.749 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.85 -28.45 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.6 -10.0 58.25 Favored 'General case' 0 N--CA 1.537 3.909 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -79.85 -7.71 58.87 Favored 'General case' 0 N--CA 1.539 3.986 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -65.55 165.98 11.32 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -145.85 -61.35 0.33 Allowed 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.906 2.004 . . . . 0.0 108.266 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 t70 59.43 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.492 0 O-C-N 125.333 1.645 . . . . 0.0 115.32 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -163.27 144.01 9.23 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 p -72.37 152.08 42.26 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 124.407 1.067 . . . . 0.0 112.462 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.52 151.65 30.63 Favored 'General case' 0 N--CA 1.52 3.057 0 O-C-N 124.738 1.274 . . . . 0.0 108.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -70.67 -28.74 65.01 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.813 1.321 . . . . 0.0 112.746 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.32 -36.22 0.06 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.25 28.31 0.04 OUTLIER Glycine 0 N--CA 1.502 3.04 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.667 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.96 156.75 45.47 Favored 'General case' 0 N--CA 1.534 3.74 0 O-C-N 125.288 1.228 . . . . 0.0 108.212 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.46 140.78 4.97 Favored Glycine 0 N--CA 1.502 3.096 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -136.72 150.84 48.65 Favored 'General case' 0 N--CA 1.526 3.345 0 O-C-N 125.722 1.483 . . . . 0.0 107.566 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.03 139.19 8.36 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 125.226 1.579 . . . . 0.0 112.863 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -87.26 118.98 27.05 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 125.063 1.477 . . . . 0.0 108.053 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.22 143.91 30.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.037 0 O-C-N 125.389 1.68 . . . . 0.0 106.641 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.93 139.03 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.47 117.6 43.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 O-C-N 125.23 1.581 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -90.35 157.32 17.69 Favored 'General case' 0 N--CA 1.522 3.173 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.549 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -68.71 -25.64 64.87 Favored 'General case' 0 N--CA 1.525 3.32 0 O-C-N 124.592 1.183 . . . . 0.0 112.106 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 m -148.94 147.56 28.77 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.871 1.357 . . . . 0.0 109.759 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -156.18 147.25 22.25 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 124.899 1.374 . . . . 0.0 111.77 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.62 106.35 2.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 125.8 1.937 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.99 157.25 52.92 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 124.688 1.243 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -142.5 106.34 4.7 Favored 'General case' 0 N--CA 1.517 2.898 0 O-C-N 125.53 1.37 . . . . 0.0 108.942 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.52 3.053 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.595 5.04 0 CA-C-O 113.846 -3.752 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.97 -47.54 0.31 Allowed 'Cis proline' 1 C--N 1.415 4.032 1 CA-C-N 125.937 4.869 . . . . 0.0 113.08 0.79 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.46 129.69 9.68 Favored 'General case' 0 N--CA 1.521 3.12 0 O-C-N 126.03 2.081 . . . . 0.0 108.882 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -36.79 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 125.16 1.537 . . . . 0.0 110.078 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.14 178.36 22.04 Favored Glycine 0 N--CA 1.508 3.498 0 O-C-N 126.166 2.166 . . . . 0.0 109.86 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.47 118.21 7.81 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.876 1.574 . . . . 0.0 113.305 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.41 135.69 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 O-C-N 126.239 2.212 . . . . 0.0 107.833 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 145.62 31.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 124.936 1.398 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.4 t -76.45 -28.45 56.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.745 1.278 . . . . 0.0 111.73 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.69 -27.48 61.25 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.68 -22.8 43.0 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.254 0.971 . . . . 0.0 112.848 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.24 155.21 92.81 Favored Pre-proline 0 N--CA 1.53 3.542 0 CA-C-O 115.423 -2.227 . . . . 0.0 111.297 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.86 -51.4 0.18 Allowed 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 123.466 2.274 . . . . 0.0 113.915 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.34 -43.43 38.27 Favored Glycine 0 N--CA 1.512 3.738 0 O-C-N 124.436 1.085 . . . . 0.0 112.555 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.19 171.6 48.09 Favored Glycine 0 N--CA 1.514 3.884 0 O-C-N 125.349 1.264 . . . . 0.0 110.926 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 25.9 m -70.29 150.27 46.54 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 124.95 1.03 . . . . 0.0 112.331 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -146.54 133.27 19.97 Favored 'General case' 0 N--CA 1.522 3.155 0 O-C-N 125.838 1.961 . . . . 0.0 107.689 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.0 mm -79.58 116.94 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.48 122.02 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 O-C-N 125.8 1.938 . . . . 0.0 106.457 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -118.38 130.33 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.31 138.45 3.51 Favored Glycine 1 N--CA 1.519 4.202 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.9 -170.54 43.18 Favored Glycine 0 N--CA 1.51 3.57 0 O-C-N 125.126 1.133 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.62 -16.72 57.03 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 113.174 -1.513 . . . . 0.0 113.066 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.94 -66.21 0.62 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.759 1.287 . . . . 0.0 112.557 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -7.52 0.05 OUTLIER Glycine 1 N--CA 1.517 4.051 0 CA-C-O 118.404 -1.22 . . . . 0.0 112.578 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.12 147.61 53.08 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.82 0.953 . . . . 0.0 111.265 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -142.81 168.03 20.67 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 125.855 1.972 . . . . 0.0 109.222 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.57 78.86 0.06 OUTLIER Glycine 0 N--CA 1.501 2.983 0 O-C-N 124.984 1.428 . . . . 0.0 109.901 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -67.92 159.47 30.49 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 125.343 1.261 . . . . 0.0 113.006 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.97 101.62 1.44 Allowed 'General case' 0 N--CA 1.529 3.503 0 O-C-N 124.38 1.05 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 148.91 45.18 Favored 'General case' 0 N--CA 1.511 2.576 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -118.06 170.63 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 O-C-N 126.272 2.232 . . . . 0.0 106.907 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -157.19 119.24 3.82 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 124.258 0.974 . . . . 0.0 111.322 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -73.22 154.88 40.06 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 124.604 1.19 . . . . 0.0 110.463 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.976 0 CA-C-O 116.722 -2.154 . . . . 0.0 112.513 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.69 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.91 129.07 34.19 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 124.723 1.264 . . . . 0.0 111.429 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.53 139.36 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.35 142.2 9.69 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 125.001 1.438 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.08 142.85 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 101.486 -3.524 . . . . 0.0 101.486 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -161.3 112.92 1.25 Allowed Pre-proline 0 N--CA 1.524 3.252 0 CA-C-O 115.015 -2.421 . . . . 0.0 110.212 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -63.19 150.64 68.13 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.337 2.942 . . . . 0.0 112.242 -4.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.18 -9.19 1.75 Allowed 'General case' 0 N--CA 1.528 3.439 0 O-C-N 125.964 2.04 . . . . 0.0 113.049 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.3 p -133.19 152.76 51.94 Favored 'General case' 0 N--CA 1.528 3.425 0 O-C-N 125.327 1.642 . . . . 0.0 109.657 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.2 29.53 68.49 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 125.008 1.443 . . . . 0.0 112.51 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.78 154.1 40.8 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 125.347 1.263 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 -175.39 3.57 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 126.184 2.178 . . . . 0.0 107.977 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.9 127.54 32.91 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 124.736 1.272 . . . . 0.0 112.61 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.48 29.72 69.64 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.856 1.347 . . . . 0.0 112.776 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.37 127.46 32.63 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.934 1.02 . . . . 0.0 112.627 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.97 134.04 35.35 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.12 146.44 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 O-C-N 125.281 1.613 . . . . 0.0 108.558 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 m -113.98 103.42 11.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 126.436 2.335 . . . . 0.0 109.689 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.85 147.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.06 159.92 40.48 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 126.139 2.149 . . . . 0.0 109.15 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.61 14.66 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 125.465 1.728 . . . . 0.0 108.143 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.33 148.67 18.43 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 125.314 1.634 . . . . 0.0 109.347 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.28 88.93 0.11 Allowed Glycine 0 N--CA 1.509 3.505 0 O-C-N 125.048 1.467 . . . . 0.0 111.446 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -155.39 150.97 27.31 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.73 -20.73 0.06 Allowed 'General case' 0 N--CA 1.52 3.046 0 O-C-N 124.738 1.274 . . . . 0.0 111.526 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 p -79.47 -45.05 20.13 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.434 1.084 . . . . 0.0 108.93 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 p -73.03 143.5 47.5 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 125.023 1.452 . . . . 0.0 108.64 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.16 11.84 15.33 Favored 'General case' 0 N--CA 1.536 3.84 0 O-C-N 125.774 1.921 . . . . 0.0 111.768 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -166.17 166.14 17.16 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.36 136.57 8.63 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.033 0.833 . . . . 0.0 111.513 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.97 177.06 7.72 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 126.316 2.26 . . . . 0.0 105.363 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.1 117.98 2.28 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.671 1.232 . . . . 0.0 109.393 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.3 136.53 9.75 Favored 'General case' 0 N--CA 1.527 3.376 0 O-C-N 125.031 1.457 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -82.2 152.5 26.41 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 124.911 1.382 . . . . 0.0 107.594 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -145.03 141.17 28.67 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 125.111 1.507 . . . . 0.0 109.174 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.3 118.77 31.23 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.439 1.712 . . . . 0.0 112.462 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.13 143.48 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.856 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.05 -176.11 3.9 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 124.713 1.258 . . . . 0.0 112.049 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -21.74 60.45 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.406 1.691 . . . . 0.0 111.297 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 26.35 71.43 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-O 117.696 -1.613 . . . . 0.0 115.8 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -74.32 147.53 42.18 Favored 'General case' 0 N--CA 1.528 3.428 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.49 74.34 1.74 Allowed Glycine 0 N--CA 1.515 3.955 0 O-C-N 124.886 1.366 . . . . 0.0 113.941 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.8 101.08 11.36 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.4 m -129.54 145.57 51.45 Favored 'General case' 0 N--CA 1.535 3.804 0 O-C-N 124.91 1.381 . . . . 0.0 112.644 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.96 125.05 28.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 125.074 1.484 . . . . 0.0 111.265 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.45 -24.03 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.88 -23.4 63.25 Favored 'General case' 0 N--CA 1.531 3.58 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -79.85 -19.18 48.99 Favored 'General case' 0 N--CA 1.532 3.667 0 O-C-N 124.508 1.13 . . . . 0.0 113.992 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.32 148.18 52.23 Favored 'General case' 1 N--CA 1.54 4.073 0 O-C-N 124.696 1.247 . . . . 0.0 111.296 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -144.87 -54.73 0.32 Allowed 'General case' 0 N--CA 1.522 3.167 0 O-C-N 125.627 1.829 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 67.71 128.58 0.02 OUTLIER 'General case' 1 N--CA 1.544 4.233 0 O-C-N 124.978 1.424 . . . . 0.0 113.194 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.95 147.88 18.55 Favored 'General case' 0 N--CA 1.515 2.789 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.173 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 m -75.99 151.49 37.2 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.998 1.436 . . . . 0.0 107.959 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.3 mt -79.41 127.13 31.72 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.85 1.344 . . . . 0.0 107.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -69.91 -38.5 76.3 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 124.368 1.043 . . . . 0.0 113.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 49.66 0.12 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.74 22.47 74.75 Favored Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.632 1.431 . . . . 0.0 112.926 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -141.85 156.67 45.53 Favored 'General case' 1 N--CA 1.544 4.234 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 77.94 0.06 OUTLIER Glycine 1 N--CA 1.52 4.244 0 O-C-N 124.149 0.906 . . . . 0.0 112.516 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -75.75 153.65 36.86 Favored 'General case' 0 N--CA 1.52 3.071 0 O-C-N 124.912 1.007 . . . . 0.0 109.74 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.63 138.09 5.99 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.806 1.316 . . . . 0.0 113.365 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.2 p -82.69 111.75 18.92 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.844 1.34 . . . . 0.0 109.866 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.29 151.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.38 139.95 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 129.65 16.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 O-C-N 125.52 1.762 . . . . 0.0 112.286 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -90.2 162.21 15.35 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.964 1.415 . . . . 0.0 107.812 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -65.73 -33.81 76.74 Favored 'General case' 0 N--CA 1.522 3.143 0 O-C-N 124.67 1.231 . . . . 0.0 111.779 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.8 151.87 48.56 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 125.761 1.913 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.09 148.85 20.72 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 124.586 1.179 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.58 101.26 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 125.941 2.025 . . . . 0.0 108.749 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.78 153.27 52.17 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 125.141 1.526 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -135.56 122.67 21.51 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 125.974 1.632 . . . . 0.0 109.023 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.522 3.168 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.028 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.65 144.2 79.11 Favored 'Cis proline' 0 C--N 1.41 3.797 0 CA-C-N 123.063 3.432 . . . . 0.0 113.072 -0.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.58 137.66 54.46 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 125.31 1.631 . . . . 0.0 110.494 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -36.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.203 0 O-C-N 125.448 1.718 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.05 -171.79 36.0 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 125.401 1.688 . . . . 0.0 109.695 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.48 110.83 1.57 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 126.039 1.67 . . . . 0.0 113.402 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.64 138.91 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.064 0 O-C-N 125.933 2.021 . . . . 0.0 107.82 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.88 158.13 16.47 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.442 1.714 . . . . 0.0 110.742 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.25 -30.27 57.81 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 124.931 1.394 . . . . 0.0 111.787 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.61 -28.26 67.6 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -30.63 40.87 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 124.429 1.08 . . . . 0.0 112.64 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.94 151.44 97.19 Favored Pre-proline 0 N--CA 1.527 3.419 0 CA-C-O 115.261 -2.304 . . . . 0.0 111.606 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.07 -44.5 0.45 Allowed 'Trans proline' 0 C--N 1.41 3.769 0 CA-C-N 123.643 2.337 . . . . 0.0 113.494 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.23 -45.4 55.73 Favored Glycine 0 N--CA 1.513 3.812 0 O-C-N 124.685 1.241 . . . . 0.0 112.81 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.55 160.37 29.87 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 125.319 1.246 . . . . 0.0 112.125 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.0 145.82 51.51 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 113.958 -1.121 . . . . 0.0 112.902 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.96 139.96 26.56 Favored 'General case' 0 N--CA 1.53 3.546 0 O-C-N 125.621 1.826 . . . . 0.0 108.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -79.9 127.58 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.447 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.93 137.4 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.92 141.49 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.275 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.88 142.65 5.7 Favored Glycine 1 N--CA 1.517 4.057 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -160.5 34.43 Favored Glycine 1 N--CA 1.517 4.081 0 O-C-N 125.469 1.335 . . . . 0.0 112.81 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -71.63 -23.6 61.72 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 125.374 1.279 . . . . 0.0 112.671 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.91 -32.72 71.16 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 124.775 1.297 . . . . 0.0 110.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.21 48.73 Favored Glycine 0 N--CA 1.515 3.93 0 O-C-N 125.809 1.943 . . . . 0.0 113.073 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.69 103.1 3.5 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -74.81 174.63 8.92 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.724 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.45 78.45 0.09 OUTLIER Glycine 0 N--CA 1.506 3.36 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -68.54 155.48 39.88 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.312 1.243 . . . . 0.0 113.292 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.45 100.35 1.18 Allowed 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.088 1.493 . . . . 0.0 109.107 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.14 158.0 34.1 Favored 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.14 176.65 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 O-C-N 126.568 2.418 . . . . 0.0 107.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.3 m -160.77 121.09 2.8 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.785 1.303 . . . . 0.0 109.78 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -72.78 156.73 38.61 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 124.554 1.159 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.627 0 CA-C-O 116.355 -2.358 . . . . 0.0 111.464 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.426 0 N-CA-C 111.302 0.112 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 126.95 31.69 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.47 1.106 . . . . 0.0 111.307 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.33 138.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.1 143.62 9.28 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 124.848 1.343 . . . . 0.0 110.135 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.33 144.03 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -161.84 112.87 1.19 Allowed Pre-proline 0 N--CA 1.524 3.242 0 CA-C-O 115.092 -2.385 . . . . 0.0 109.918 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.34 149.97 67.6 Favored 'Cis proline' 1 C--N 1.424 4.549 0 CA-C-N 125.25 2.911 . . . . 0.0 112.492 -4.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.85 -9.23 1.59 Allowed 'General case' 0 N--CA 1.528 3.437 0 O-C-N 125.916 2.01 . . . . 0.0 112.619 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.5 p -133.64 152.06 51.81 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.102 1.501 . . . . 0.0 109.648 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.31 65.2 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.023 1.452 . . . . 0.0 112.143 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 mt -73.29 154.23 40.24 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 125.349 1.264 . . . . 0.0 110.551 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.59 -175.36 3.63 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 126.274 2.234 . . . . 0.0 107.946 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.41 127.1 30.99 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.659 1.224 . . . . 0.0 112.735 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.32 28.2 72.86 Favored Glycine 0 N--CA 1.513 3.802 0 O-C-N 124.637 1.21 . . . . 0.0 113.318 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 125.52 27.61 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.945 1.027 . . . . 0.0 112.233 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -78.98 134.57 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.09 140.39 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.349 1.655 . . . . 0.0 108.401 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.6 m -107.36 101.77 11.11 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 126.15 2.156 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.87 148.03 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.997 0 N-CA-C 104.492 -2.411 . . . . 0.0 104.492 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -137.69 161.57 36.16 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.969 2.043 . . . . 0.0 109.463 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 146.22 15.51 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 125.467 1.73 . . . . 0.0 108.278 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.92 146.53 16.1 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 124.986 1.429 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.13 88.4 0.14 Allowed Glycine 0 N--CA 1.509 3.566 0 O-C-N 125.007 1.442 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -155.08 152.62 29.76 Favored 'General case' 0 N--CA 1.514 2.751 0 O-C-N 125.573 1.396 . . . . 0.0 107.408 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.76 -18.71 0.05 Allowed 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.774 1.297 . . . . 0.0 111.52 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.58 -53.39 6.9 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 124.309 1.006 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -71.27 129.77 39.71 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.665 1.228 . . . . 0.0 110.704 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -79.93 -28.61 39.72 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 t -154.67 172.26 18.19 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 125.144 1.527 . . . . 0.0 107.574 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.99 144.75 5.92 Favored 'General case' 0 N--CA 1.521 3.113 0 O-C-N 124.535 1.147 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -128.64 133.14 48.18 Favored 'General case' 0 N--CA 1.522 3.172 0 O-C-N 126.147 2.155 . . . . 0.0 107.108 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.46 107.5 19.19 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.922 1.389 . . . . 0.0 110.319 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -123.06 144.13 49.5 Favored 'General case' 0 N--CA 1.528 3.444 0 O-C-N 125.103 1.502 . . . . 0.0 110.568 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.77 141.1 46.96 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m -146.55 138.16 24.57 Favored 'General case' 0 N--CA 1.531 3.58 0 O-C-N 124.832 1.333 . . . . 0.0 110.427 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.58 118.45 29.22 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 125.172 1.545 . . . . 0.0 111.83 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mm -81.3 123.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.88 -177.9 3.91 Favored 'General case' 0 N--CA 1.523 3.183 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -44.51 77.84 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 124.769 1.293 . . . . 0.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -19.16 61.45 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 125.117 1.511 . . . . 0.0 112.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.34 9.98 78.38 Favored Glycine 1 N--CA 1.517 4.043 0 CA-C-O 116.933 -2.037 . . . . 0.0 115.881 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -71.38 137.0 48.02 Favored 'General case' 0 N--CA 1.529 3.484 0 CA-C-N 118.38 1.09 . . . . 0.0 108.228 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.16 106.13 1.81 Allowed Glycine 0 N--CA 1.51 3.598 0 CA-C-O 118.583 -1.121 . . . . 0.0 115.691 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.78 106.18 15.7 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -135.2 143.54 46.47 Favored 'General case' 0 N--CA 1.526 3.349 0 O-C-N 124.865 1.353 . . . . 0.0 110.875 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -84.33 141.03 31.2 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 125.377 1.673 . . . . 0.0 109.896 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.07 -25.06 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 O-C-N 125.537 1.773 . . . . 0.0 114.786 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.03 -22.46 49.18 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -81.49 -1.59 46.56 Favored 'General case' 1 N--CA 1.543 4.215 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.74 160.17 17.71 Favored 'General case' 0 N--CA 1.53 3.562 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -152.75 127.8 9.71 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 125.834 1.959 . . . . 0.0 106.46 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.21 136.6 44.43 Favored 'General case' 0 N--CA 1.524 3.239 0 O-C-N 126.076 2.11 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -160.08 154.29 23.44 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 124.732 1.27 . . . . 0.0 107.776 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 m -126.69 147.47 49.94 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 125.947 2.029 . . . . 0.0 108.212 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.64 150.51 30.95 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 125.016 1.447 . . . . 0.0 108.917 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -148.67 8.39 0.78 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 125.433 1.708 . . . . 0.0 110.037 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.92 22.92 0.05 OUTLIER Glycine 0 N--CA 1.509 3.537 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.34 13.89 82.43 Favored Glycine 0 N--CA 1.512 3.709 0 CA-C-O 117.516 -1.713 . . . . 0.0 114.372 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.42 161.59 34.15 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.83 75.64 0.07 OUTLIER Glycine 1 N--CA 1.516 4.026 0 O-C-N 124.367 1.042 . . . . 0.0 112.123 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.97 153.27 38.62 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.041 1.083 . . . . 0.0 110.162 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.64 138.04 5.96 Favored 'General case' 0 N--CA 1.533 3.705 0 O-C-N 124.918 1.386 . . . . 0.0 112.917 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -83.36 113.37 20.68 Favored 'General case' 0 N--CA 1.521 3.117 0 O-C-N 124.815 1.322 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.69 152.39 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.53 142.53 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.19 127.1 26.73 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.06 0 O-C-N 125.555 1.784 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -90.21 156.59 18.2 Favored 'General case' 0 N--CA 1.524 3.248 0 O-C-N 124.868 1.355 . . . . 0.0 108.467 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -68.46 -26.22 65.39 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 124.578 1.174 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.53 146.86 38.66 Favored 'General case' 0 N--CA 1.53 3.559 0 O-C-N 125.277 1.61 . . . . 0.0 109.795 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -155.79 146.65 22.21 Favored 'General case' 0 N--CA 1.525 3.28 0 O-C-N 124.838 1.336 . . . . 0.0 112.153 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -71.67 109.42 5.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 125.576 1.797 . . . . 0.0 110.038 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.05 145.55 39.8 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -129.65 85.06 2.26 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 125.893 1.584 . . . . 0.0 109.353 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 N--CA 1.524 3.268 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.77 -179.632 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.52 0 CA-C-O 115.333 -2.926 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.81 153.34 83.59 Favored 'Cis proline' 0 C--N 1.404 3.481 0 CA-C-N 124.005 3.902 . . . . 0.0 113.991 -0.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -71.12 137.03 48.5 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 125.578 1.799 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -39.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 O-C-N 125.039 1.462 . . . . 0.0 112.292 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.83 -172.21 21.56 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 125.68 1.863 . . . . 0.0 108.967 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 117.31 6.85 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 125.741 1.495 . . . . 0.0 113.817 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.86 133.46 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 O-C-N 126.132 2.145 . . . . 0.0 107.564 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.035 1.459 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.6 t -80.12 79.84 6.62 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 125.136 1.523 . . . . 0.0 110.397 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.42 -36.78 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.593 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.7 p -79.79 -19.31 48.88 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 125.325 1.64 . . . . 0.0 111.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 147.26 98.64 Favored Pre-proline 0 N--CA 1.519 2.986 0 CA-C-O 114.738 -2.553 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.13 -45.97 0.33 Allowed 'Trans proline' 0 C--N 1.408 3.677 0 CA-C-N 124.091 2.497 . . . . 0.0 112.876 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.47 -47.4 28.36 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.62 1.2 . . . . 0.0 112.764 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.7 162.74 37.69 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 125.496 1.351 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.99 148.1 49.31 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.794 0.937 . . . . 0.0 112.577 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -148.05 133.44 18.57 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 125.839 1.962 . . . . 0.0 107.319 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.85 134.67 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -130.78 134.15 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -128.61 130.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.35 152.16 10.39 Favored Glycine 0 N--CA 1.514 3.846 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -163.08 37.87 Favored Glycine 0 N--CA 1.509 3.565 0 O-C-N 125.735 1.491 . . . . 0.0 112.231 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.58 -6.7 59.14 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.952 1.619 . . . . 0.0 112.697 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.99 -68.12 0.44 Allowed 'General case' 0 N--CA 1.517 2.902 0 O-C-N 124.89 1.369 . . . . 0.0 111.783 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.33 -23.42 0.09 OUTLIER Glycine 1 N--CA 1.519 4.203 0 CA-C-O 118.562 -1.132 . . . . 0.0 112.981 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -67.27 150.45 49.03 Favored 'General case' 0 N--CA 1.525 3.287 0 O-C-N 124.988 1.052 . . . . 0.0 111.976 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.75 147.21 48.32 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 125.94 2.025 . . . . 0.0 109.802 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.38 -65.2 1.81 Allowed Glycine 0 N--CA 1.516 3.975 0 O-C-N 124.597 1.186 . . . . 0.0 113.821 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 66.65 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.536 3.849 0 C-N-CA 125.523 1.529 . . . . 0.0 112.75 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 106.26 1.23 Allowed 'General case' 0 N--CA 1.53 3.544 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 155.52 40.17 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 124.235 0.959 . . . . 0.0 112.586 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.17 167.78 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 126.481 2.363 . . . . 0.0 108.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -137.49 169.09 18.37 Favored 'General case' 0 N--CA 1.523 3.185 0 O-C-N 124.95 1.406 . . . . 0.0 109.301 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.38 148.01 52.62 Favored 'General case' 0 N--CA 1.522 3.171 0 O-C-N 126.246 2.216 . . . . 0.0 109.039 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.585 0 CA-C-O 116.365 -2.353 . . . . 0.0 111.385 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.606 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.11 132.27 6.28 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.443 1.714 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.27 145.52 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -160.71 145.48 14.2 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 125.312 1.632 . . . . 0.0 109.867 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.22 147.32 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.59 108.74 1.64 Allowed Pre-proline 0 N--CA 1.526 3.342 0 CA-C-O 115.416 -2.23 . . . . 0.0 109.788 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -62.02 162.63 45.75 Favored 'Cis proline' 2 C--N 1.426 4.654 0 CA-C-N 124.905 2.788 . . . . 0.0 113.235 -3.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.26 -6.58 0.73 Allowed 'General case' 0 N--CA 1.534 3.743 0 O-C-N 124.764 1.29 . . . . 0.0 112.619 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -138.3 153.58 49.02 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 124.914 1.384 . . . . 0.0 109.551 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.58 30.19 66.83 Favored Glycine 0 N--CA 1.512 3.752 0 O-C-N 124.977 1.423 . . . . 0.0 113.201 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 mt -72.9 153.87 40.82 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 125.296 1.233 . . . . 0.0 109.83 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.15 -175.83 3.62 Favored 'General case' 0 N--CA 1.523 3.221 0 O-C-N 126.003 2.064 . . . . 0.0 109.772 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.11 131.05 45.03 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 124.675 1.234 . . . . 0.0 112.363 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.78 30.04 66.59 Favored Glycine 0 N--CA 1.514 3.896 0 O-C-N 124.699 1.249 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 146.3 48.62 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.154 1.149 . . . . 0.0 111.841 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -115.27 124.3 50.98 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.317 2.261 . . . . 0.0 105.4 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.22 151.53 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.204 0 O-C-N 125.892 1.995 . . . . 0.0 110.559 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -111.02 100.45 9.14 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 126.185 2.178 . . . . 0.0 108.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.78 145.27 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 160.89 36.13 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 126.102 2.126 . . . . 0.0 109.647 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.14 16.72 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 125.423 1.702 . . . . 0.0 108.378 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -156.37 144.91 19.98 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.39 1.681 . . . . 0.0 109.831 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.09 88.11 0.12 Allowed Glycine 0 N--CA 1.51 3.598 0 O-C-N 125.109 1.506 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -154.87 148.74 25.63 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 125.628 1.428 . . . . 0.0 108.036 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.35 -18.92 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 124.801 1.313 . . . . 0.0 111.256 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.6 -41.66 26.62 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 124.255 0.972 . . . . 0.0 110.743 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -67.24 142.11 57.03 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 125.224 1.578 . . . . 0.0 110.424 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 p -79.9 -26.06 40.36 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.956 1.41 . . . . 0.0 113.203 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -170.06 133.57 1.18 Allowed 'General case' 0 N--CA 1.516 2.839 0 O-C-N 124.585 1.178 . . . . 0.0 109.005 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.0 139.95 45.14 Favored 'General case' 0 N--CA 1.515 2.781 0 O-C-N 124.756 1.285 . . . . 0.0 111.411 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.75 169.62 17.38 Favored 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -162.19 126.36 3.19 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 124.925 1.391 . . . . 0.0 110.997 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 144.76 15.06 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.215 1.572 . . . . 0.0 110.434 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 148.54 25.92 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 125.367 1.667 . . . . 0.0 108.977 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -139.73 140.23 36.72 Favored 'General case' 0 N--CA 1.529 3.503 0 O-C-N 125.609 1.818 . . . . 0.0 109.752 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.38 27.46 Favored 'General case' 0 N--CA 1.517 2.887 0 O-C-N 125.15 1.531 . . . . 0.0 113.011 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.31 142.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.002 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -128.05 -176.38 3.77 Favored 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.26 89.85 Favored 'General case' 0 N--CA 1.515 2.787 0 O-C-N 124.811 1.319 . . . . 0.0 112.122 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -20.74 59.63 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 125.408 1.693 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.08 76.67 Favored Glycine 0 N--CA 1.511 3.648 0 CA-C-O 117.377 -1.79 . . . . 0.0 115.853 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -73.5 142.05 46.78 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 93.35 0.35 Allowed Glycine 0 N--CA 1.511 3.693 0 O-C-N 124.811 1.319 . . . . 0.0 114.322 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.23 101.2 10.76 Favored 'General case' 0 N--CA 1.518 2.936 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -138.34 154.44 48.97 Favored 'General case' 0 N--CA 1.527 3.393 0 O-C-N 124.441 1.088 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -99.64 107.24 19.31 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 126.572 2.42 . . . . 0.0 107.958 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.69 -16.76 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.134 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.41 63.78 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -86.42 8.14 22.94 Favored 'General case' 1 N--CA 1.55 4.54 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -69.32 169.69 11.78 Favored 'General case' 0 N--CA 1.534 3.747 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -137.94 -61.18 0.62 Allowed 'General case' 0 N--CA 1.516 2.825 0 O-C-N 125.705 1.878 . . . . 0.0 109.542 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 52.86 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.793 0 O-C-N 125.334 1.646 . . . . 0.0 115.014 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -156.06 153.04 28.78 Favored 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 m -62.0 157.67 18.17 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.44 145.73 33.15 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.911 1.382 . . . . 0.0 108.373 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -71.52 -33.01 68.82 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 124.664 1.227 . . . . 0.0 111.364 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.4 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.5 2.905 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.31 24.58 0.04 OUTLIER Glycine 0 N--CA 1.502 3.069 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.413 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.34 161.06 39.33 Favored 'General case' 0 N--CA 1.537 3.894 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.41 76.59 0.08 OUTLIER Glycine 0 N--CA 1.513 3.787 0 O-C-N 124.275 0.985 . . . . 0.0 112.054 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 m -74.42 147.54 41.95 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 125.284 1.226 . . . . 0.0 109.468 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.44 135.62 7.9 Favored 'General case' 0 N--CA 1.529 3.492 0 O-C-N 124.799 1.312 . . . . 0.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -86.76 114.4 23.4 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.133 1.521 . . . . 0.0 111.425 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.7 t -107.66 149.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.72 142.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.18 134.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 O-C-N 125.346 1.654 . . . . 0.0 112.78 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -90.27 166.69 13.19 Favored 'General case' 0 N--CA 1.517 2.921 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -65.58 -27.95 68.79 Favored 'General case' 0 N--CA 1.532 3.638 0 O-C-N 124.257 0.973 . . . . 0.0 111.896 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.7 151.51 41.42 Favored 'General case' 0 N--CA 1.525 3.319 0 O-C-N 125.53 1.769 . . . . 0.0 108.749 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.21 147.51 24.88 Favored 'General case' 0 N--CA 1.526 3.358 0 O-C-N 124.935 1.397 . . . . 0.0 111.72 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.7 m -65.8 108.44 2.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 125.791 1.932 . . . . 0.0 112.209 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.28 150.56 43.96 Favored Glycine 0 N--CA 1.513 3.774 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -133.92 90.36 2.69 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.589 1.405 . . . . 0.0 109.824 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.524 3.229 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.407 -179.808 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.492 0 CA-C-O 115.442 -2.865 . . . . 0.0 108.658 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.73 156.43 82.71 Favored 'Cis proline' 0 C--N 1.402 3.378 0 CA-C-N 123.931 3.865 . . . . 0.0 114.131 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.17 138.69 52.03 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 125.623 1.827 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -40.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 O-C-N 125.011 1.444 . . . . 0.0 112.61 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.56 -175.11 23.29 Favored Glycine 0 N--CA 1.508 3.448 0 O-C-N 125.516 1.76 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 116.55 5.56 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 125.78 1.517 . . . . 0.0 113.883 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.53 138.46 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 126.046 2.091 . . . . 0.0 108.125 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.67 152.04 21.01 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 125.309 1.631 . . . . 0.0 110.84 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.2 m -75.46 -27.68 58.97 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.583 1.177 . . . . 0.0 111.507 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 -29.16 68.19 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.65 -30.69 41.32 Favored 'General case' 0 N--CA 1.528 3.455 0 O-C-N 124.408 1.068 . . . . 0.0 112.309 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.39 152.78 96.36 Favored Pre-proline 0 N--CA 1.527 3.4 0 CA-C-O 115.125 -2.369 . . . . 0.0 111.364 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -72.73 -47.77 0.34 Allowed 'Trans proline' 0 C--N 1.41 3.795 0 CA-C-N 123.624 2.33 . . . . 0.0 113.317 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.19 -48.24 26.39 Favored Glycine 0 N--CA 1.512 3.759 0 O-C-N 124.712 1.258 . . . . 0.0 111.976 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.13 166.84 38.65 Favored Glycine 0 N--CA 1.515 3.96 0 O-C-N 125.303 1.237 . . . . 0.0 112.404 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.95 151.31 45.77 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-N 114.014 -1.093 . . . . 0.0 112.617 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.61 145.82 19.09 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 125.247 1.592 . . . . 0.0 109.209 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.71 130.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 O-C-N 125.273 1.608 . . . . 0.0 107.16 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 t -123.47 131.12 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.74 142.19 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.44 -153.84 17.44 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.049 0.843 . . . . 0.0 111.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.38 -167.38 24.81 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -69.9 -20.36 63.37 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.26 -22.0 2.02 Favored 'General case' 0 N--CA 1.538 3.965 0 O-C-N 124.751 1.282 . . . . 0.0 111.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.64 -15.23 63.88 Favored Glycine 1 N--CA 1.524 4.542 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.342 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 168.2 0.26 Allowed 'General case' 1 N--CA 1.546 4.366 0 C-N-CA 124.741 1.216 . . . . 0.0 112.428 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -70.0 164.5 23.81 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.922 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.65 90.79 0.12 Allowed Glycine 0 N--CA 1.516 3.986 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.02 149.23 50.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 125.362 1.272 . . . . 0.0 113.619 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.85 0.97 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 124.958 1.411 . . . . 0.0 108.328 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.99 153.51 42.59 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.11 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.71 170.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.758 0 O-C-N 126.396 2.31 . . . . 0.0 107.608 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -156.95 118.22 3.72 Favored 'General case' 0 N--CA 1.525 3.278 0 O-C-N 124.283 0.99 . . . . 0.0 110.736 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -71.21 153.77 42.2 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.522 1.139 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 CA-C-O 116.249 -2.417 . . . . 0.0 109.752 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.724 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 127.0 31.75 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.687 1.242 . . . . 0.0 112.015 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.61 138.88 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.105 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.03 144.73 8.44 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.82 1.325 . . . . 0.0 110.574 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.45 147.5 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -158.18 108.87 1.72 Allowed Pre-proline 0 N--CA 1.525 3.28 0 CA-C-O 115.377 -2.249 . . . . 0.0 110.131 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.1 162.73 51.92 Favored 'Cis proline' 2 C--N 1.425 4.572 0 CA-C-N 124.812 2.754 . . . . 0.0 112.831 -4.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.6 -8.69 1.25 Allowed 'General case' 0 N--CA 1.535 3.823 0 O-C-N 124.753 1.283 . . . . 0.0 112.846 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -136.78 154.41 50.56 Favored 'General case' 0 N--CA 1.525 3.31 0 O-C-N 125.269 1.606 . . . . 0.0 108.556 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.29 30.26 62.97 Favored Glycine 0 N--CA 1.511 3.667 0 O-C-N 124.944 1.402 . . . . 0.0 111.943 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 mt -75.32 154.09 37.52 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 125.378 1.281 . . . . 0.0 109.411 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.09 -175.36 3.47 Favored 'General case' 0 N--CA 1.524 3.228 0 O-C-N 126.026 2.079 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.43 127.57 32.81 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 124.761 1.288 . . . . 0.0 112.521 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.6 28.97 71.65 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.56 1.162 . . . . 0.0 113.013 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.05 127.04 31.3 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 124.91 1.006 . . . . 0.0 112.564 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -89.27 129.93 35.75 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.67 148.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 O-C-N 125.168 1.542 . . . . 0.0 110.465 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -103.05 97.25 7.38 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 125.956 2.035 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.87 148.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.62 161.59 34.22 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 125.804 1.94 . . . . 0.0 110.466 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 139.82 11.15 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.526 1.766 . . . . 0.0 108.042 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.39 142.83 14.58 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 125.129 1.518 . . . . 0.0 109.473 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.82 97.32 0.05 OUTLIER Glycine 0 N--CA 1.512 3.719 0 O-C-N 125.229 1.581 . . . . 0.0 111.432 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -154.21 153.16 31.29 Favored 'General case' 0 N--CA 1.513 2.683 0 O-C-N 125.371 1.277 . . . . 0.0 108.076 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.2 -16.99 0.08 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 125.254 1.596 . . . . 0.0 111.166 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.54 -59.97 2.54 Favored 'General case' 0 N--CA 1.517 2.924 0 O-C-N 124.207 0.942 . . . . 0.0 109.402 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 119.23 15.72 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 124.717 1.26 . . . . 0.0 109.984 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 p -79.9 -13.1 59.63 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 124.466 1.104 . . . . 0.0 112.656 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -167.65 148.6 5.36 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.37 165.67 26.87 Favored 'General case' 0 N--CA 1.519 3.024 0 O-C-N 125.607 1.817 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -158.95 108.22 1.93 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.12 42.91 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 124.379 1.049 . . . . 0.0 113.385 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 143.71 11.51 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 124.897 1.373 . . . . 0.0 111.007 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 147.7 23.97 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.363 1.665 . . . . 0.0 106.756 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.81 144.57 33.99 Favored 'General case' 0 N--CA 1.527 3.399 0 O-C-N 125.434 1.709 . . . . 0.0 109.497 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.52 118.79 32.88 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.451 1.719 . . . . 0.0 111.809 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.7 139.59 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.08 -177.12 3.84 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 125.686 1.867 . . . . 0.0 106.376 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.02 97.8 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.466 1.104 . . . . 0.0 112.245 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -19.13 57.91 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 125.407 1.692 . . . . 0.0 111.206 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.67 78.55 Favored Glycine 0 N--CA 1.511 3.641 0 CA-C-O 117.316 -1.824 . . . . 0.0 115.992 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -73.66 143.62 46.19 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.42 87.84 0.42 Allowed Glycine 0 N--CA 1.514 3.861 0 O-C-N 124.859 1.349 . . . . 0.0 113.84 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.72 92.69 6.31 Favored 'General case' 0 N--CA 1.517 2.891 0 O-C-N 125.725 1.485 . . . . 0.0 107.593 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -129.14 146.57 51.04 Favored 'General case' 0 N--CA 1.527 3.412 0 O-C-N 125.028 1.455 . . . . 0.0 110.873 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -86.05 127.38 34.66 Favored 'General case' 0 N--CA 1.514 2.77 0 O-C-N 125.61 1.819 . . . . 0.0 111.233 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.66 -24.17 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.83 62.32 Favored 'General case' 0 N--CA 1.533 3.684 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.84 5.67 18.09 Favored 'General case' 0 N--CA 1.536 3.873 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -64.32 146.98 53.53 Favored 'General case' 0 N--CA 1.537 3.912 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.043 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -152.42 -64.29 0.16 Allowed 'General case' 0 N--CA 1.533 3.701 0 CA-C-O 117.138 -1.411 . . . . 0.0 114.525 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.72 159.7 29.59 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -136.92 -157.74 0.8 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 126.731 2.52 . . . . 0.0 105.692 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.8 p -53.04 144.5 15.07 Favored 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.5 132.72 36.41 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 125.124 1.515 . . . . 0.0 109.633 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -75.26 -32.77 61.17 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.116 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 48.51 0.13 Allowed Glycine 0 N--CA 1.505 3.235 0 O-C-N 125.158 1.536 . . . . 0.0 110.605 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 28.17 68.9 Favored Glycine 0 N--CA 1.507 3.404 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.271 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -143.1 154.0 43.48 Favored 'General case' 1 N--CA 1.544 4.256 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.9 79.0 0.06 OUTLIER Glycine 1 N--CA 1.517 4.039 0 O-C-N 124.393 1.058 . . . . 0.0 112.403 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -74.9 152.61 38.85 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.079 1.105 . . . . 0.0 108.905 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.51 141.83 7.84 Favored 'General case' 0 N--CA 1.526 3.352 0 O-C-N 124.808 1.317 . . . . 0.0 113.339 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -92.1 110.09 21.46 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.164 1.54 . . . . 0.0 108.541 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.83 149.72 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 O-C-N 125.187 1.554 . . . . 0.0 107.239 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.37 140.0 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.41 124.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 O-C-N 125.626 1.829 . . . . 0.0 112.115 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -90.22 161.48 15.69 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.836 1.335 . . . . 0.0 107.758 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -67.48 -32.4 73.2 Favored 'General case' 0 N--CA 1.518 2.95 0 O-C-N 124.664 1.227 . . . . 0.0 111.687 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.38 147.24 51.77 Favored 'General case' 0 N--CA 1.53 3.561 0 O-C-N 125.988 2.055 . . . . 0.0 109.97 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -157.74 147.75 20.4 Favored 'General case' 0 N--CA 1.528 3.44 0 O-C-N 124.805 1.316 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -72.31 101.53 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 125.78 1.925 . . . . 0.0 108.854 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 155.16 51.98 Favored Glycine 0 N--CA 1.51 3.59 0 O-C-N 124.979 1.425 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -140.53 119.91 13.07 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.696 1.468 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.515 2.803 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.072 0 CA-C-O 115.561 -2.8 . . . . 0.0 108.683 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.66 148.69 92.33 Favored 'Cis proline' 0 N--CA 1.529 3.578 0 CA-C-N 123.172 3.486 . . . . 0.0 113.417 -0.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -73.55 132.61 43.04 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.241 1.588 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.42 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 O-C-N 125.105 1.503 . . . . 0.0 112.099 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 -170.19 37.32 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.22 110.65 1.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.97 1.629 . . . . 0.0 113.221 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.95 135.67 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 126.061 2.101 . . . . 0.0 108.335 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.73 154.53 28.49 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.916 1.385 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.5 t -78.83 -29.47 44.72 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 124.972 1.42 . . . . 0.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.29 -22.07 62.0 Favored 'General case' 0 N--CA 1.515 2.823 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.3 p -79.69 -28.7 40.66 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 124.303 1.002 . . . . 0.0 113.304 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.1 150.74 96.45 Favored Pre-proline 0 N--CA 1.529 3.501 0 CA-C-O 115.26 -2.305 . . . . 0.0 112.183 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -73.61 -46.36 0.35 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.613 2.326 . . . . 0.0 113.515 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.22 -43.98 61.56 Favored Glycine 0 N--CA 1.512 3.751 0 O-C-N 124.608 1.192 . . . . 0.0 112.885 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.7 160.62 30.56 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 125.198 1.175 . . . . 0.0 111.591 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.96 154.72 41.58 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.942 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -162.11 145.97 12.16 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.2 1.562 . . . . 0.0 108.592 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.69 135.99 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.1 t -134.4 132.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.51 140.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.85 -132.5 1.7 Allowed Glycine 1 N--CA 1.52 4.25 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.19 -158.19 15.78 Favored Glycine 0 N--CA 1.505 3.299 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -73.37 -13.28 61.07 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.61 -73.8 0.16 Allowed 'General case' 0 N--CA 1.522 3.138 0 O-C-N 124.685 1.241 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.85 -23.44 0.24 Allowed Glycine 1 N--CA 1.517 4.068 0 CA-C-O 118.617 -1.101 . . . . 0.0 112.229 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.7 108.83 1.83 Allowed 'General case' 0 N--CA 1.521 3.096 0 O-C-N 125.224 1.191 . . . . 0.0 112.325 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -80.12 153.72 28.51 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.615 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.92 -60.98 1.89 Allowed Glycine 1 N--CA 1.518 4.148 0 O-C-N 125.116 1.51 . . . . 0.0 111.479 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.85 121.14 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 125.609 1.563 . . . . 0.0 114.734 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.39 96.86 0.78 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.94 31.63 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.416 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.81 176.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.708 0 O-C-N 126.507 2.38 . . . . 0.0 107.14 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -163.65 115.01 1.4 Allowed 'General case' 0 N--CA 1.519 3.007 0 O-C-N 125.014 1.446 . . . . 0.0 109.01 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.43 153.31 43.11 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.48 1.112 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.273 0 CA-C-O 116.356 -2.358 . . . . 0.0 109.798 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.527 3.422 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 130.57 35.42 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.71 138.87 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.98 143.03 10.72 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 124.855 1.347 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.69 143.04 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -158.51 112.59 1.68 Allowed Pre-proline 0 N--CA 1.523 3.198 0 CA-C-O 114.945 -2.455 . . . . 0.0 109.66 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.04 150.16 75.01 Favored 'Cis proline' 1 C--N 1.423 4.448 0 CA-C-N 125.401 2.965 . . . . 0.0 112.113 -3.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.76 -16.98 1.47 Allowed 'General case' 0 N--CA 1.528 3.464 0 O-C-N 125.897 1.998 . . . . 0.0 112.496 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.58 151.37 44.85 Favored 'General case' 0 N--CA 1.525 3.282 0 O-C-N 125.765 1.916 . . . . 0.0 110.915 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.89 66.1 Favored Glycine 1 N--CA 1.517 4.095 0 O-C-N 124.91 1.381 . . . . 0.0 112.5 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.8 mt -74.15 154.42 39.11 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 125.481 1.342 . . . . 0.0 110.715 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.57 -175.3 3.61 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.393 2.308 . . . . 0.0 108.324 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.46 127.91 34.15 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.767 1.292 . . . . 0.0 112.894 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.75 71.64 Favored Glycine 0 N--CA 1.515 3.922 0 O-C-N 124.703 1.252 . . . . 0.0 113.174 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.51 123.26 22.78 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 124.841 0.965 . . . . 0.0 112.663 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 m -80.65 129.92 34.8 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.11 141.01 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 O-C-N 125.722 1.888 . . . . 0.0 109.249 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.1 m -105.61 101.66 11.16 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 126.145 2.153 . . . . 0.0 110.44 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.79 147.71 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.08 158.75 43.65 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.998 2.061 . . . . 0.0 109.072 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.34 16.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.302 1.626 . . . . 0.0 108.123 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -157.37 145.13 18.9 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 125.2 1.563 . . . . 0.0 109.714 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.6 86.1 0.17 Allowed Glycine 0 N--CA 1.507 3.422 0 O-C-N 125.181 1.55 . . . . 0.0 110.412 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -151.87 149.54 29.09 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 125.732 1.489 . . . . 0.0 108.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.19 -15.55 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.952 0 O-C-N 125.038 1.461 . . . . 0.0 111.166 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.43 -49.65 12.0 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 p -66.89 140.4 57.78 Favored 'General case' 0 N--CA 1.519 3.022 0 O-C-N 124.94 1.4 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -81.12 -18.41 46.55 Favored 'General case' 0 N--CA 1.524 3.226 0 O-C-N 125.051 1.469 . . . . 0.0 113.909 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 m -169.98 133.58 1.2 Allowed 'General case' 0 N--CA 1.518 2.972 0 O-C-N 124.704 1.253 . . . . 0.0 109.531 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.53 145.44 36.94 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.741 1.276 . . . . 0.0 110.072 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -154.15 156.46 37.22 Favored 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.42 115.79 9.0 Favored 'General case' 0 N--CA 1.524 3.243 0 O-C-N 125.1 1.5 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.05 153.56 31.48 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 125.713 1.883 . . . . 0.0 109.188 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -127.34 114.53 17.69 Favored 'General case' 0 N--CA 1.52 3.062 0 O-C-N 126.144 2.152 . . . . 0.0 106.041 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.3 m -126.08 157.03 39.02 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.689 1.868 . . . . 0.0 111.615 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.42 123.89 49.55 Favored 'General case' 0 N--CA 1.523 3.223 0 O-C-N 126.185 2.178 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -80.4 121.06 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 O-C-N 125.076 1.485 . . . . 0.0 107.736 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.53 -175.84 3.2 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.85 -44.83 84.3 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 124.64 1.212 . . . . 0.0 111.799 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.25 61.26 Favored 'General case' 0 N--CA 1.526 3.366 0 O-C-N 125.261 1.601 . . . . 0.0 111.556 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.64 22.57 57.99 Favored Glycine 0 N--CA 1.516 3.972 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.512 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -72.95 142.37 47.81 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.37 72.83 2.29 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.803 1.314 . . . . 0.0 113.311 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.97 12.04 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 124.865 0.979 . . . . 0.0 108.442 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.95 140.7 46.93 Favored 'General case' 0 N--CA 1.521 3.091 0 O-C-N 125.218 1.574 . . . . 0.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -81.78 115.0 20.8 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 125.354 1.659 . . . . 0.0 107.885 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.12 -16.43 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.19 63.04 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -84.16 4.03 32.34 Favored 'General case' 1 N--CA 1.55 4.53 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -68.64 169.94 10.19 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -138.39 -67.37 0.47 Allowed 'General case' 0 N--CA 1.517 2.886 0 O-C-N 125.876 1.985 . . . . 0.0 108.461 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 52.83 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -156.11 153.02 28.67 Favored 'General case' 0 N--CA 1.523 3.212 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -60.4 156.0 16.9 Favored 'General case' 0 N--CA 1.517 2.902 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.48 144.33 34.11 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.9 1.375 . . . . 0.0 107.954 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -72.39 -25.94 61.69 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.379 1.05 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.68 -39.58 0.08 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.13 24.93 0.04 OUTLIER Glycine 0 N--CA 1.501 3.033 0 O-C-N 125.324 1.25 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.24 158.7 43.43 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.69 77.52 0.08 OUTLIER Glycine 0 N--CA 1.513 3.816 0 O-C-N 124.399 1.062 . . . . 0.0 112.04 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -74.69 151.22 39.26 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.232 1.195 . . . . 0.0 109.205 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.11 140.05 7.47 Favored 'General case' 0 N--CA 1.533 3.702 0 O-C-N 124.748 1.28 . . . . 0.0 113.305 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -90.29 122.18 32.97 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 125.188 1.555 . . . . 0.0 110.039 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.08 146.6 24.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 O-C-N 125.722 1.889 . . . . 0.0 107.067 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.47 123.89 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.45 126.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 125.615 1.822 . . . . 0.0 111.196 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -90.25 160.11 16.35 Favored 'General case' 0 N--CA 1.525 3.324 0 O-C-N 124.809 1.318 . . . . 0.0 108.179 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -69.51 -27.27 65.04 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.472 1.107 . . . . 0.0 111.755 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.2 m -139.46 147.61 41.59 Favored 'General case' 0 N--CA 1.529 3.507 0 O-C-N 125.315 1.634 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.26 149.18 22.5 Favored 'General case' 0 N--CA 1.523 3.192 0 O-C-N 124.676 1.235 . . . . 0.0 111.583 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 117.34 9.72 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 125.999 2.062 . . . . 0.0 109.124 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.22 145.46 41.07 Favored Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.8 124.5 15.97 Favored 'General case' 0 N--CA 1.522 3.165 0 O-C-N 125.365 1.274 . . . . 0.0 109.148 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.52 3.066 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.725 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.531 0 CA-C-O 116.814 -2.104 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.16 173.19 50.62 Favored 'Cis proline' 0 N--CA 1.53 3.672 0 CA-C-N 122.795 3.298 . . . . 0.0 113.148 -6.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.52 133.56 55.85 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.087 1.492 . . . . 0.0 110.231 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -85.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 O-C-N 125.616 1.823 . . . . 0.0 111.55 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.71 -171.28 40.12 Favored Glycine 0 N--CA 1.504 3.17 0 CA-C-N 120.609 1.55 . . . . 0.0 109.974 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.68 116.72 7.19 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 125.841 1.553 . . . . 0.0 112.744 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.92 137.29 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 O-C-N 125.927 2.017 . . . . 0.0 107.873 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 145.91 26.8 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 125.311 1.632 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -23.02 45.06 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 124.884 1.365 . . . . 0.0 112.16 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.26 -30.13 57.72 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -79.65 -18.18 52.04 Favored 'General case' 0 N--CA 1.528 3.442 0 O-C-N 124.675 1.235 . . . . 0.0 112.601 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.89 156.89 86.16 Favored Pre-proline 0 N--CA 1.532 3.637 0 CA-C-O 115.771 -2.061 . . . . 0.0 111.757 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.23 -42.92 0.81 Allowed 'Trans proline' 0 C--N 1.407 3.63 0 CA-C-N 123.384 2.244 . . . . 0.0 114.707 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.58 -104.84 0.09 OUTLIER Glycine 0 N--CA 1.504 3.229 0 O-C-N 124.741 1.276 . . . . 0.0 111.627 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.98 161.19 20.02 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 143.4 40.5 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 125.659 1.447 . . . . 0.0 107.957 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -147.6 132.27 17.87 Favored 'General case' 0 N--CA 1.533 3.71 0 O-C-N 125.09 1.494 . . . . 0.0 109.802 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -79.8 134.66 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.45 129.27 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.92 140.17 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.58 -144.37 7.89 Favored Glycine 0 N--CA 1.512 3.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.12 -163.18 25.58 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.39 -18.78 62.33 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -126.94 -13.54 5.74 Favored 'General case' 0 N--CA 1.531 3.616 0 O-C-N 125.278 1.611 . . . . 0.0 109.004 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.42 66.36 Favored Glycine 1 N--CA 1.524 4.509 0 CA-C-O 118.895 -0.947 . . . . 0.0 114.344 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.253 23.9 mt-10 62.7 -85.36 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 125.676 1.59 . . . . 0.0 114.17 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -152.96 157.19 40.23 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 125.056 1.472 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.57 68.23 0.28 Allowed Glycine 0 N--CA 1.512 3.725 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.39 151.01 47.32 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 125.569 1.393 . . . . 0.0 114.359 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.67 102.22 1.34 Allowed 'General case' 0 N--CA 1.526 3.361 0 O-C-N 124.914 1.384 . . . . 0.0 109.625 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.07 28.61 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.24 170.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.917 0 O-C-N 126.369 2.293 . . . . 0.0 107.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -161.05 124.3 3.28 Favored 'General case' 0 N--CA 1.521 3.111 0 O-C-N 124.587 1.179 . . . . 0.0 110.434 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.44 156.8 38.67 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 124.501 1.126 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.357 0 CA-C-O 116.319 -2.378 . . . . 0.0 109.76 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.9 140.01 36.89 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 124.639 1.212 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 139.93 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.97 146.65 19.17 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 124.85 1.344 . . . . 0.0 110.362 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.9 143.9 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.46 109.73 2.03 Favored Pre-proline 0 N--CA 1.528 3.473 0 CA-C-O 115.017 -2.42 . . . . 0.0 109.822 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.17 159.64 62.45 Favored 'Cis proline' 1 C--N 1.425 4.576 0 CA-C-N 125.279 2.921 . . . . 0.0 112.591 -2.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.14 -1.46 1.36 Allowed 'General case' 0 N--CA 1.531 3.576 0 O-C-N 125.033 1.458 . . . . 0.0 112.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -139.49 152.0 46.62 Favored 'General case' 0 N--CA 1.526 3.373 0 O-C-N 124.744 1.277 . . . . 0.0 110.159 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.35 30.67 69.04 Favored Glycine 0 N--CA 1.511 3.695 0 O-C-N 124.877 1.361 . . . . 0.0 113.556 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.6 154.16 40.91 Favored 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.342 1.26 . . . . 0.0 110.1 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.6 -174.37 3.22 Favored 'General case' 0 N--CA 1.522 3.137 0 O-C-N 125.877 1.986 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.04 129.02 38.54 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 124.635 1.21 . . . . 0.0 112.23 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.83 28.67 70.34 Favored Glycine 0 N--CA 1.514 3.864 0 O-C-N 124.704 1.252 . . . . 0.0 112.763 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 126.96 31.11 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 125.065 1.097 . . . . 0.0 112.245 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -88.91 134.27 34.02 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.77 147.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.191 0 O-C-N 125.295 1.622 . . . . 0.0 110.426 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 m -104.93 96.31 6.45 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 126.145 2.153 . . . . 0.0 108.842 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.86 147.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.998 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 p -135.31 164.77 26.97 Favored 'General case' 0 N--CA 1.518 2.972 0 O-C-N 125.944 2.027 . . . . 0.0 110.011 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.12 148.45 16.94 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.611 1.82 . . . . 0.0 108.161 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.34 145.28 16.25 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 124.993 1.433 . . . . 0.0 110.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 143.99 5.55 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 124.939 1.399 . . . . 0.0 112.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.02 168.41 20.05 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.177 1.163 . . . . 0.0 108.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.6 -37.22 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 124.979 1.424 . . . . 0.0 110.546 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.91 -46.69 1.96 Allowed 'General case' 0 N--CA 1.526 3.371 0 O-C-N 126.192 2.183 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.2 p -67.43 153.98 42.44 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 124.785 1.303 . . . . 0.0 112.299 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.33 -2.48 1.81 Allowed 'General case' 0 N--CA 1.538 3.93 0 O-C-N 125.563 1.79 . . . . 0.0 111.375 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -165.7 154.28 11.45 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.44 152.0 19.64 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 124.057 0.848 . . . . 0.0 111.833 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -116.59 -177.64 3.23 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 126.55 2.406 . . . . 0.0 106.157 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 112.6 1.93 Allowed 'General case' 0 N--CA 1.515 2.791 0 O-C-N 124.499 1.124 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 154.17 46.68 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 125.147 1.529 . . . . 0.0 108.66 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.99 146.4 35.33 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.602 2.439 . . . . 0.0 104.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -141.07 144.89 35.2 Favored 'General case' 0 N--CA 1.526 3.365 0 O-C-N 125.382 1.676 . . . . 0.0 109.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.21 114.8 27.44 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 125.428 1.705 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.48 143.32 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.53 -176.64 4.1 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.99 96.22 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.74 1.275 . . . . 0.0 112.062 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.522 3.139 0 O-C-N 125.384 1.678 . . . . 0.0 111.275 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.86 27.29 69.21 Favored Glycine 0 N--CA 1.512 3.76 0 CA-C-O 117.67 -1.628 . . . . 0.0 115.778 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -74.38 147.53 42.05 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.02 74.35 1.63 Allowed Glycine 0 N--CA 1.515 3.925 0 O-C-N 124.958 1.411 . . . . 0.0 113.927 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.92 89.3 6.84 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.37 144.14 51.1 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.046 1.466 . . . . 0.0 110.861 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -79.92 149.92 30.71 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.213 1.571 . . . . 0.0 109.965 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -25.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 O-C-N 125.895 1.997 . . . . 0.0 112.445 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.22 -9.32 58.44 Favored 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.89 -8.86 59.55 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.145 0.903 . . . . 0.0 113.232 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -63.69 156.44 26.94 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -145.54 -43.01 0.22 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 125.464 1.728 . . . . 0.0 108.552 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 55.17 54.62 8.56 Favored 'General case' 0 N--CA 1.523 3.175 0 O-C-N 124.981 1.426 . . . . 0.0 114.627 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -71.51 151.42 43.91 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -115.6 145.56 42.57 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 126.182 2.176 . . . . 0.0 109.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.71 154.02 28.87 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 125.042 1.464 . . . . 0.0 107.923 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -134.45 12.67 3.8 Favored 'General case' 0 N--CA 1.525 3.294 0 O-C-N 125.878 1.986 . . . . 0.0 110.061 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.09 -50.76 0.1 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.344 -2.303 . . . . 0.0 107.344 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -4.66 0.04 OUTLIER Glycine 0 N--CA 1.504 3.167 0 CA-C-O 117.344 -1.809 . . . . 0.0 112.665 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.91 162.61 20.71 Favored 'General case' 0 N--CA 1.537 3.89 0 O-C-N 125.538 1.376 . . . . 0.0 110.485 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.56 85.26 0.06 OUTLIER Glycine 0 N--CA 1.507 3.428 0 O-C-N 124.722 1.264 . . . . 0.0 110.546 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -72.55 153.75 41.15 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.124 1.132 . . . . 0.0 110.481 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -158.46 139.81 13.36 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.878 1.361 . . . . 0.0 111.583 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -91.02 124.23 35.09 Favored 'General case' 0 N--CA 1.521 3.123 0 O-C-N 124.996 1.435 . . . . 0.0 111.026 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.41 150.05 18.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.68 140.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.83 125.15 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 O-C-N 125.54 1.775 . . . . 0.0 112.092 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -90.21 165.08 14.15 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.932 1.395 . . . . 0.0 109.013 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -67.57 -29.55 68.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 124.924 1.39 . . . . 0.0 112.618 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.23 144.05 32.0 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.55 1.781 . . . . 0.0 110.69 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.61 149.25 25.13 Favored 'General case' 0 N--CA 1.523 3.218 0 O-C-N 125.244 1.59 . . . . 0.0 111.774 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 m -71.24 103.85 2.94 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 125.666 1.854 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.57 157.6 52.75 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.959 1.412 . . . . 0.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -141.13 121.8 14.28 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.603 1.414 . . . . 0.0 110.449 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.517 2.886 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.04 0 CA-C-O 115.614 -2.77 . . . . 0.0 108.598 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -72.52 149.78 94.11 Favored 'Cis proline' 0 C--N 1.405 3.512 0 CA-C-N 123.118 3.459 . . . . 0.0 113.246 -0.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -72.26 137.37 46.73 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 125.396 1.685 . . . . 0.0 108.625 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -37.2 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 O-C-N 125.263 1.602 . . . . 0.0 112.196 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.98 -170.15 34.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 125.262 1.601 . . . . 0.0 109.602 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.91 112.8 2.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 126.049 1.676 . . . . 0.0 114.012 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.63 140.59 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 O-C-N 126.063 2.102 . . . . 0.0 107.201 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 148.75 21.8 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.581 1.8 . . . . 0.0 110.678 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.2 t -89.99 71.04 7.48 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.505 1.753 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.89 -32.56 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.292 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.6 -27.2 41.1 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.104 1.502 . . . . 0.0 110.992 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 145.24 98.2 Favored Pre-proline 0 N--CA 1.518 2.959 0 CA-C-O 114.736 -2.554 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -73.57 -45.25 0.42 Allowed 'Trans proline' 0 C--N 1.412 3.878 0 CA-C-N 124.217 2.542 . . . . 0.0 112.732 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.83 -45.59 42.41 Favored Glycine 0 N--CA 1.512 3.753 0 O-C-N 124.729 1.268 . . . . 0.0 112.657 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.73 174.88 49.88 Favored Glycine 1 N--CA 1.519 4.173 0 O-C-N 125.187 1.169 . . . . 0.0 111.736 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.6 m -69.96 145.49 51.82 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.868 0.981 . . . . 0.0 112.348 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -147.48 133.87 19.63 Favored 'General case' 0 N--CA 1.527 3.423 0 O-C-N 125.495 1.747 . . . . 0.0 108.403 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -79.88 135.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.028 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.53 133.13 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.71 139.92 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.23 146.0 6.94 Favored Glycine 0 N--CA 1.514 3.844 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.28 176.03 47.91 Favored Glycine 0 N--CA 1.501 2.969 0 O-C-N 124.833 0.96 . . . . 0.0 112.536 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -72.76 -22.07 60.91 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 113.636 -1.282 . . . . 0.0 112.533 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.01 -61.45 1.77 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 124.91 1.381 . . . . 0.0 112.643 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.29 6.64 0.03 OUTLIER Glycine 1 N--CA 1.523 4.451 0 CA-C-O 117.636 -1.647 . . . . 0.0 114.384 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.68 160.84 31.94 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 118.013 0.906 . . . . 0.0 111.071 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -152.58 157.3 40.84 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.06 1.475 . . . . 0.0 108.485 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.87 82.91 0.08 OUTLIER Glycine 0 N--CA 1.504 3.218 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -69.92 155.78 40.07 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 125.353 1.266 . . . . 0.0 112.042 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.82 98.23 1.48 Allowed 'General case' 0 N--CA 1.527 3.38 0 O-C-N 124.753 1.283 . . . . 0.0 110.505 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.46 151.32 44.08 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.21 176.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.386 0 O-C-N 126.365 2.29 . . . . 0.0 107.812 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -153.47 113.99 4.02 Favored 'General case' 0 N--CA 1.526 3.368 0 O-C-N 124.172 0.92 . . . . 0.0 110.641 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -70.8 154.37 41.9 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 124.424 1.078 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.311 -2.383 . . . . 0.0 109.694 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.586 0 CA-C-O 119.512 -0.28 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.97 122.15 26.36 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.758 1.286 . . . . 0.0 111.684 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.96 137.66 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.329 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.17 146.39 13.98 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 124.865 1.353 . . . . 0.0 110.57 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.8 144.08 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.137 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -155.99 110.66 2.12 Favored Pre-proline 0 N--CA 1.528 3.429 0 CA-C-O 114.981 -2.437 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.25 156.63 72.94 Favored 'Cis proline' 1 C--N 1.424 4.533 0 CA-C-N 125.344 2.944 . . . . 0.0 111.899 -2.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.8 -4.83 1.37 Allowed 'General case' 0 N--CA 1.531 3.594 0 O-C-N 125.46 1.725 . . . . 0.0 112.563 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -136.09 152.59 51.02 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 124.991 1.432 . . . . 0.0 110.093 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.98 28.92 67.74 Favored Glycine 0 N--CA 1.513 3.791 0 O-C-N 124.989 1.431 . . . . 0.0 113.274 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.12 152.83 41.03 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 125.205 1.179 . . . . 0.0 109.794 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.77 4.81 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.68 1.863 . . . . 0.0 109.102 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.66 136.29 57.38 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 124.952 1.408 . . . . 0.0 111.711 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 39.27 33.87 Favored Glycine 0 N--CA 1.511 3.643 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 156.94 38.75 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 125.718 1.481 . . . . 0.0 112.401 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -139.8 119.08 12.82 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 126.361 2.288 . . . . 0.0 105.074 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.26 155.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.043 0 O-C-N 126.053 2.095 . . . . 0.0 109.975 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.9 m -122.74 96.05 4.87 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 126.286 2.241 . . . . 0.0 106.362 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.63 147.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 p -137.85 165.54 26.24 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 126.051 2.094 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.73 15.79 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.502 1.751 . . . . 0.0 108.598 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -160.53 146.8 15.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.888 1.367 . . . . 0.0 108.947 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.69 87.72 0.17 Allowed Glycine 0 N--CA 1.508 3.457 0 O-C-N 125.054 1.471 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -156.89 153.64 28.49 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.713 1.478 . . . . 0.0 107.477 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 -20.24 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.792 1.307 . . . . 0.0 111.28 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.39 1.056 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -70.11 126.09 28.66 Favored 'General case' 0 N--CA 1.521 3.099 0 O-C-N 124.63 1.206 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -80.3 -14.19 58.58 Favored 'General case' 0 N--CA 1.531 3.585 0 O-C-N 124.392 1.058 . . . . 0.0 112.975 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.29 155.85 11.68 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.18 33.26 Favored 'General case' 0 N--CA 1.521 3.116 0 O-C-N 125.111 1.507 . . . . 0.0 111.376 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -179.31 3.66 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 126.594 2.434 . . . . 0.0 107.682 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.55 109.83 2.16 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 124.944 1.402 . . . . 0.0 108.447 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 139.47 23.18 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.595 1.185 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -84.0 145.3 28.59 Favored 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.79 144.59 31.24 Favored 'General case' 0 N--CA 1.529 3.49 0 O-C-N 125.009 1.443 . . . . 0.0 108.713 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.9 118.51 37.08 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.673 1.858 . . . . 0.0 113.202 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.64 135.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.7 mt -113.44 -173.63 2.3 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.54 70.1 Favored 'General case' 0 N--CA 1.518 2.927 0 O-C-N 124.506 1.129 . . . . 0.0 112.604 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -20.65 61.82 Favored 'General case' 0 N--CA 1.526 3.334 0 O-C-N 125.372 1.67 . . . . 0.0 111.948 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.1 24.34 59.73 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 118.237 -1.313 . . . . 0.0 114.244 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.34 144.7 44.35 Favored 'General case' 0 N--CA 1.521 3.118 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.12 118.21 7.27 Favored Glycine 0 N--CA 1.508 3.481 0 O-C-N 124.729 1.268 . . . . 0.0 112.669 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.91 107.36 8.25 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.3 m -147.83 156.09 42.35 Favored 'General case' 0 N--CA 1.526 3.363 0 O-C-N 124.665 1.228 . . . . 0.0 110.112 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -83.44 147.39 27.88 Favored 'General case' 0 N--CA 1.517 2.922 0 O-C-N 125.451 1.72 . . . . 0.0 109.734 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -24.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.46 0 O-C-N 125.753 1.908 . . . . 0.0 112.933 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.89 -17.02 62.14 Favored 'General case' 0 N--CA 1.521 3.084 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.89 -5.65 55.93 Favored 'General case' 0 N--CA 1.537 3.877 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.58 161.84 14.0 Favored 'General case' 0 N--CA 1.533 3.699 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -152.15 -50.14 0.11 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 125.853 1.971 . . . . 0.0 108.093 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 56.82 49.59 13.94 Favored 'General case' 0 N--CA 1.522 3.148 0 O-C-N 125.505 1.753 . . . . 0.0 113.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -67.04 135.2 53.33 Favored 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -91.26 138.16 31.8 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 124.911 1.382 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.83 152.95 29.42 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 124.994 1.434 . . . . 0.0 107.774 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -140.98 6.01 1.96 Allowed 'General case' 0 N--CA 1.529 3.521 0 O-C-N 125.578 1.798 . . . . 0.0 111.768 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.07 22.39 0.05 OUTLIER Glycine 0 N--CA 1.509 3.563 0 O-C-N 124.075 0.859 . . . . 0.0 110.993 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.12 26.41 72.39 Favored Glycine 0 N--CA 1.508 3.454 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.149 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.75 154.66 43.68 Favored 'General case' 1 N--CA 1.54 4.07 0 O-C-N 125.217 1.186 . . . . 0.0 108.372 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 140.88 4.51 Favored Glycine 0 N--CA 1.509 3.55 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -135.54 150.49 49.75 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 125.734 1.491 . . . . 0.0 108.318 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -159.59 139.18 11.42 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 124.962 1.414 . . . . 0.0 111.884 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -93.31 135.62 34.36 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 125.147 1.53 . . . . 0.0 108.827 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.44 154.11 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 O-C-N 125.557 1.785 . . . . 0.0 106.949 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.91 138.92 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.13 139.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 O-C-N 125.394 1.684 . . . . 0.0 111.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -90.0 163.57 14.87 Favored 'General case' 0 N--CA 1.52 3.035 0 O-C-N 125.584 1.802 . . . . 0.0 106.434 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -62.38 -39.12 92.16 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.843 1.339 . . . . 0.0 111.144 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.36 153.93 35.79 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 126.36 2.287 . . . . 0.0 109.94 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -156.31 148.97 23.78 Favored 'General case' 0 N--CA 1.529 3.496 0 O-C-N 124.966 1.416 . . . . 0.0 111.663 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.05 107.01 2.55 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 125.56 1.787 . . . . 0.0 111.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.44 99.05 0.87 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.737 1.273 . . . . 0.0 110.153 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -93.33 103.6 15.82 Favored 'General case' 0 N--CA 1.524 3.242 0 O-C-N 125.294 1.232 . . . . 0.0 112.635 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.519 3.007 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.767 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.589 4.703 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.91 168.83 72.67 Favored 'Cis proline' 0 N--CA 1.527 3.467 0 CA-C-N 123.099 3.449 . . . . 0.0 112.51 -6.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.47 128.15 34.67 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 125.303 1.627 . . . . 0.0 110.537 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -78.66 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 CA-C-O 116.993 -1.479 . . . . 0.0 112.487 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.86 -171.35 42.27 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-N 120.271 1.396 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.64 128.15 35.41 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.665 1.45 . . . . 0.0 113.399 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.85 142.62 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 O-C-N 126.179 2.174 . . . . 0.0 106.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.48 146.32 36.16 Favored 'General case' 0 N--CA 1.529 3.525 0 O-C-N 126.079 2.112 . . . . 0.0 111.445 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.8 m -74.33 79.11 1.85 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 125.521 1.763 . . . . 0.0 111.896 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -37.33 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.66 -28.52 40.78 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 125.424 1.703 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.07 139.5 95.39 Favored Pre-proline 0 N--CA 1.515 2.817 0 CA-C-O 114.472 -2.68 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.97 -43.03 0.63 Allowed 'Trans proline' 0 C--N 1.41 3.809 0 CA-C-N 124.575 2.67 . . . . 0.0 112.786 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.72 61.58 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 124.862 1.351 . . . . 0.0 112.374 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.08 154.43 19.28 Favored Glycine 1 N--CA 1.518 4.101 0 O-C-N 125.287 1.228 . . . . 0.0 111.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.6 m -69.9 140.14 53.09 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 124.856 0.974 . . . . 0.0 111.683 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -145.54 139.27 26.62 Favored 'General case' 0 N--CA 1.526 3.337 0 O-C-N 125.369 1.668 . . . . 0.0 108.596 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.84 133.6 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.0 133.72 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.96 143.87 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.312 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.92 137.47 3.21 Favored Glycine 1 N--CA 1.52 4.268 0 O-C-N 124.151 0.907 . . . . 0.0 111.566 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.81 -160.42 35.6 Favored Glycine 1 N--CA 1.518 4.103 0 O-C-N 125.48 1.341 . . . . 0.0 112.405 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -70.51 -25.03 62.95 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 125.443 1.319 . . . . 0.0 112.941 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -70.88 -32.7 69.76 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.799 1.312 . . . . 0.0 110.436 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.72 14.09 44.79 Favored Glycine 0 N--CA 1.516 3.998 0 O-C-N 125.747 1.904 . . . . 0.0 113.16 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.5 103.24 3.45 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -73.05 173.68 8.99 Favored 'General case' 0 N--CA 1.519 3.011 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.13 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.09 80.13 0.08 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -67.86 154.32 41.83 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 125.307 1.239 . . . . 0.0 113.495 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.17 95.57 0.86 Allowed 'General case' 0 N--CA 1.523 3.212 0 O-C-N 125.127 1.517 . . . . 0.0 108.586 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.34 156.04 39.85 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 173.13 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.689 0 O-C-N 126.663 2.477 . . . . 0.0 107.153 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.6 m -155.19 116.0 3.91 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.056 0.848 . . . . 0.0 110.445 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -69.96 150.26 46.89 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 124.611 1.194 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.674 0 CA-C-O 116.389 -2.339 . . . . 0.0 111.516 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.677 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.09 129.8 5.26 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 124.937 1.398 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.48 144.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -160.24 144.06 14.06 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 124.927 1.392 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.11 142.28 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.062 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.25 112.86 1.72 Allowed Pre-proline 0 N--CA 1.527 3.403 0 CA-C-O 114.892 -2.48 . . . . 0.0 110.082 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -64.28 151.31 73.18 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.428 2.974 . . . . 0.0 112.102 -4.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.97 -8.89 1.58 Allowed 'General case' 0 N--CA 1.528 3.463 0 O-C-N 125.943 2.027 . . . . 0.0 112.817 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.2 p -132.73 151.58 51.95 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.321 1.638 . . . . 0.0 110.106 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.99 31.8 66.59 Favored Glycine 0 N--CA 1.514 3.881 0 O-C-N 124.993 1.433 . . . . 0.0 112.457 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.87 153.99 39.64 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 125.432 1.313 . . . . 0.0 110.234 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.88 -173.89 3.27 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 126.032 2.083 . . . . 0.0 108.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -66.56 128.94 38.18 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.644 1.215 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.08 28.71 69.89 Favored Glycine 0 N--CA 1.514 3.853 0 O-C-N 124.667 1.229 . . . . 0.0 112.794 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.39 127.21 31.87 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 124.924 1.014 . . . . 0.0 112.618 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 m -87.08 130.07 34.65 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 125.307 1.629 . . . . 0.0 106.803 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.63 143.49 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 125.607 1.817 . . . . 0.0 108.981 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.9 m -111.12 102.01 10.49 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 126.268 2.23 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.91 149.13 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.011 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -140.53 164.27 30.61 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 125.703 1.877 . . . . 0.0 110.174 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.24 145.33 14.84 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.53 1.769 . . . . 0.0 108.3 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -159.12 146.79 17.54 Favored 'General case' 0 N--CA 1.515 2.783 0 O-C-N 125.239 1.587 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.13 88.91 0.11 Allowed Glycine 0 N--CA 1.508 3.498 0 O-C-N 125.101 1.5 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -154.96 155.5 34.34 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 125.71 1.477 . . . . 0.0 107.783 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.1 -19.51 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.883 1.364 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -79.56 -51.16 9.66 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 124.427 1.08 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 p -70.87 119.97 15.78 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.894 1.371 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -79.79 -19.92 47.42 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 124.432 1.083 . . . . 0.0 112.909 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -166.38 150.09 7.39 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 125.233 1.583 . . . . 0.0 107.816 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.94 160.16 40.66 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 125.622 1.826 . . . . 0.0 110.373 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -151.14 129.75 12.25 Favored 'General case' 0 N--CA 1.517 2.913 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 121.78 24.25 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.651 1.219 . . . . 0.0 112.046 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 146.47 50.78 Favored 'General case' 0 N--CA 1.53 3.572 0 O-C-N 125.429 1.705 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.57 128.74 35.88 Favored 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.47 142.74 39.43 Favored 'General case' 0 N--CA 1.531 3.604 0 O-C-N 124.719 1.262 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.17 26.56 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 125.187 1.555 . . . . 0.0 111.181 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -79.33 122.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.142 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.95 -174.34 2.59 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.68 84.02 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 124.703 1.252 . . . . 0.0 110.84 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -21.45 59.79 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 125.434 1.709 . . . . 0.0 110.87 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.85 26.69 60.02 Favored Glycine 0 N--CA 1.513 3.789 0 CA-C-O 117.472 -1.738 . . . . 0.0 115.635 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -73.11 146.23 45.88 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.01 74.72 1.17 Allowed Glycine 0 N--CA 1.515 3.917 0 CA-C-O 118.114 -1.381 . . . . 0.0 115.854 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.08 97.88 9.56 Favored 'General case' 0 N--CA 1.515 2.816 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.21 143.3 49.85 Favored 'General case' 0 N--CA 1.527 3.414 0 O-C-N 124.874 1.359 . . . . 0.0 111.792 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -85.87 116.31 24.04 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 125.487 1.742 . . . . 0.0 108.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -65.53 -23.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.07 -12.18 61.45 Favored 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -79.89 -7.18 58.59 Favored 'General case' 1 N--CA 1.541 4.109 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -64.18 160.81 17.64 Favored 'General case' 0 N--CA 1.531 3.604 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -139.18 -52.42 0.55 Allowed 'General case' 0 N--CA 1.52 3.032 0 O-C-N 126.007 2.067 . . . . 0.0 108.071 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 45.58 116.1 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -171.22 144.04 1.98 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 m -65.07 157.0 29.68 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.806 1.316 . . . . 0.0 113.478 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.2 mt -79.5 147.67 32.13 Favored 'General case' 0 N--CA 1.513 2.703 0 O-C-N 125.326 1.641 . . . . 0.0 108.225 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -72.1 -26.04 61.99 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 124.637 1.211 . . . . 0.0 112.483 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.03 -36.5 0.05 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.51 19.67 0.02 OUTLIER Glycine 0 N--CA 1.502 3.076 0 CA-C-O 117.673 -1.626 . . . . 0.0 111.953 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 158.06 34.75 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.497 1.351 . . . . 0.0 109.146 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.37 139.63 4.2 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -142.35 151.16 41.63 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.74 134.98 5.42 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.96 1.412 . . . . 0.0 112.361 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 t -86.46 114.21 23.04 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 125.067 1.479 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.03 144.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 t -122.71 137.23 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.55 131.12 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 O-C-N 125.75 1.906 . . . . 0.0 113.005 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -90.12 161.83 15.59 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 125.225 1.578 . . . . 0.0 106.984 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -65.68 -32.85 74.64 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 124.727 1.267 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 m -131.29 150.21 52.24 Favored 'General case' 0 N--CA 1.528 3.427 0 O-C-N 125.991 2.057 . . . . 0.0 110.173 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -157.8 146.71 19.48 Favored 'General case' 0 N--CA 1.525 3.292 0 O-C-N 124.906 1.379 . . . . 0.0 111.518 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.4 m -69.25 113.0 6.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 125.608 1.818 . . . . 0.0 110.631 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.35 149.55 45.68 Favored Glycine 0 N--CA 1.513 3.828 0 O-C-N 124.974 1.421 . . . . 0.0 109.858 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -137.95 88.37 2.32 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.406 1.298 . . . . 0.0 108.551 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.518 2.964 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.316 -179.692 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.585 4.438 0 CA-C-O 115.305 -2.942 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.47 155.43 82.25 Favored 'Cis proline' 0 C--N 1.402 3.359 0 CA-C-N 123.948 3.874 . . . . 0.0 114.28 -1.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.79 134.14 48.22 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.604 1.815 . . . . 0.0 109.307 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -87.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.224 0 O-C-N 125.252 1.595 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.33 -174.71 42.51 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.97 118.56 12.05 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 125.663 1.449 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.06 133.33 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 O-C-N 125.989 2.056 . . . . 0.0 107.98 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.44 141.31 28.64 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 125.022 1.451 . . . . 0.0 111.338 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.3 t -83.5 72.51 10.26 Favored 'General case' 0 N--CA 1.513 2.724 0 O-C-N 125.232 1.583 . . . . 0.0 110.463 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.15 -32.73 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -79.66 -25.8 41.21 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.106 1.504 . . . . 0.0 111.252 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.96 150.71 97.66 Favored Pre-proline 0 N--CA 1.523 3.199 0 CA-C-O 115.101 -2.38 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.77 -48.79 0.22 Allowed 'Trans proline' 0 C--N 1.408 3.698 0 CA-C-N 123.711 2.361 . . . . 0.0 113.036 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.42 -46.95 24.01 Favored Glycine 0 N--CA 1.51 3.58 0 O-C-N 124.532 1.145 . . . . 0.0 112.558 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.82 172.43 48.85 Favored Glycine 1 N--CA 1.517 4.051 0 O-C-N 125.319 1.246 . . . . 0.0 110.89 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.7 m -70.11 153.42 43.17 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 124.783 0.931 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -157.78 135.24 10.39 Favored 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.77 137.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.857 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.81 131.7 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.16 140.23 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.61 -152.89 16.26 Favored Glycine 1 N--CA 1.517 4.097 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.64 -160.91 13.56 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -68.5 -34.09 75.29 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -125.07 -15.05 6.44 Favored 'General case' 1 N--CA 1.544 4.234 0 O-C-N 125.015 1.447 . . . . 0.0 111.835 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.41 -1.7 30.21 Favored Glycine 1 N--CA 1.527 4.755 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 63.89 173.09 0.18 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.903 1.281 . . . . 0.0 113.373 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -69.83 145.19 52.28 Favored 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.731 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.34 -64.14 2.47 Favored Glycine 0 N--CA 1.512 3.755 0 O-C-N 124.601 1.188 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 62.58 105.82 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.126 0 O-C-N 126.105 1.709 . . . . 0.0 113.568 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.25 95.8 1.27 Allowed 'General case' 0 N--CA 1.532 3.658 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.124 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.27 152.94 42.8 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.089 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pt -116.51 168.63 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 O-C-N 126.253 2.221 . . . . 0.0 108.748 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -140.94 157.57 45.17 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 124.851 1.344 . . . . 0.0 109.21 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -110.29 159.61 17.26 Favored 'General case' 0 N--CA 1.521 3.093 0 O-C-N 126.098 2.124 . . . . 0.0 109.826 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.312 0 CA-C-O 116.345 -2.364 . . . . 0.0 109.668 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 t -70.55 -29.46 65.93 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 125.128 1.518 . . . . 0.0 113.011 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.0 139.24 2.85 Favored 'General case' 0 N--CA 1.515 2.788 0 O-C-N 124.999 1.437 . . . . 0.0 109.359 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 131.78 35.98 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 124.947 1.404 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.88 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.72 141.48 7.39 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 124.773 1.295 . . . . 0.0 109.786 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.74 141.33 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 p -160.42 113.01 1.38 Allowed Pre-proline 0 CA--C 1.608 3.176 0 CA-C-O 115.053 -2.403 . . . . 0.0 109.927 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -65.14 153.21 77.27 Favored 'Cis proline' 1 C--N 1.425 4.595 0 CA-C-N 125.458 2.985 . . . . 0.0 111.222 -3.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.22 -8.65 1.15 Allowed 'General case' 0 N--CA 1.529 3.513 0 O-C-N 125.872 1.983 . . . . 0.0 113.063 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -129.45 153.98 47.41 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.486 1.741 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 28.25 68.39 Favored Glycine 1 N--CA 1.519 4.167 0 O-C-N 124.8 1.313 . . . . 0.0 113.118 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.47 155.75 33.6 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 125.146 1.144 . . . . 0.0 110.282 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.82 -178.52 5.85 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 125.656 1.847 . . . . 0.0 107.222 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.35 142.83 53.9 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 124.592 1.183 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.68 85.62 Favored Glycine 1 N--CA 1.521 4.337 0 O-C-N 124.981 1.426 . . . . 0.0 113.394 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.49 164.72 26.28 Favored 'General case' 0 N--CA 1.52 3.064 0 O-C-N 124.196 0.586 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 m -145.98 121.91 10.66 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.5 -178.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 O-C-N 125.667 1.855 . . . . 0.0 110.047 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -143.25 92.61 2.39 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.76 149.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 p -135.24 162.03 33.71 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 126.141 2.15 . . . . 0.0 109.044 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.5 16.82 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 125.307 1.63 . . . . 0.0 108.68 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -157.04 149.52 23.24 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 125.4 1.687 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 127.42 0.85 Allowed Glycine 1 N--CA 1.52 4.27 0 O-C-N 124.95 1.406 . . . . 0.0 111.988 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -147.98 161.62 40.98 Favored 'General case' 0 N--CA 1.522 3.154 0 C-N-CA 124.269 1.028 . . . . 0.0 109.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.95 -59.15 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.554 0 O-C-N 125.385 1.678 . . . . 0.0 108.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 -53.36 6.73 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.332 1.645 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.2 p -67.83 143.07 55.94 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 124.893 1.371 . . . . 0.0 112.273 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.535 3.801 0 O-C-N 125.689 1.868 . . . . 0.0 109.823 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -168.9 170.61 8.96 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.7 13.31 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 123.858 0.724 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.53 172.89 11.41 Favored 'General case' 0 N--CA 1.524 3.249 0 O-C-N 126.173 2.171 . . . . 0.0 106.212 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.95 66.99 1.31 Allowed 'General case' 0 N--CA 1.531 3.612 0 O-C-N 125.421 1.701 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.24 155.45 28.57 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -137.73 136.54 37.43 Favored 'General case' 0 N--CA 1.521 3.107 0 O-C-N 125.771 1.919 . . . . 0.0 106.669 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.0 m -141.31 150.22 42.24 Favored 'General case' 0 N--CA 1.532 3.635 0 O-C-N 124.584 1.177 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.17 115.7 28.85 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 126.096 2.122 . . . . 0.0 110.963 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.2 137.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -122.08 -175.05 3.03 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.767 1.917 . . . . 0.0 106.294 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.58 97.37 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.303 1.002 . . . . 0.0 111.993 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 -21.81 60.4 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.45 1.719 . . . . 0.0 111.163 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.37 24.42 73.15 Favored Glycine 0 N--CA 1.512 3.75 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.873 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -75.03 145.12 42.68 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.59 75.9 1.19 Allowed Glycine 1 N--CA 1.517 4.098 0 O-C-N 124.813 1.321 . . . . 0.0 114.296 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.83 96.36 8.2 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.35 139.92 52.91 Favored 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.028 1.455 . . . . 0.0 112.575 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -76.85 138.57 39.88 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 125.016 1.447 . . . . 0.0 109.369 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.08 -24.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 O-C-N 125.512 1.758 . . . . 0.0 114.613 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.51 46.37 Favored 'General case' 0 N--CA 1.532 3.67 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.72 1.6 37.92 Favored 'General case' 1 N--CA 1.549 4.482 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -69.69 168.78 14.18 Favored 'General case' 0 N--CA 1.533 3.722 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -133.82 -63.93 0.72 Allowed 'General case' 0 N--CA 1.524 3.229 0 O-C-N 125.614 1.821 . . . . 0.0 109.996 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.41 98.5 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.029 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -157.51 150.01 22.85 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -65.74 167.74 8.82 Favored 'General case' 0 N--CA 1.52 3.07 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -79.29 141.95 36.58 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.7 t -71.54 -25.19 62.12 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 124.408 1.067 . . . . 0.0 112.985 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.55 -39.19 0.06 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.32 18.28 0.02 OUTLIER Glycine 0 N--CA 1.501 3.03 0 O-C-N 125.287 1.228 . . . . 0.0 111.593 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -144.03 165.36 27.99 Favored 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.32 79.98 0.08 OUTLIER Glycine 0 N--CA 1.513 3.799 0 O-C-N 124.074 0.859 . . . . 0.0 111.658 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -74.87 149.72 39.43 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 125.539 1.376 . . . . 0.0 108.986 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.27 137.56 7.17 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.904 1.378 . . . . 0.0 112.93 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -90.04 112.84 24.41 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 125.219 1.575 . . . . 0.0 110.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.75 147.06 13.7 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.125 0 O-C-N 125.385 1.678 . . . . 0.0 107.012 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.28 150.01 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 125.855 1.972 . . . . 0.0 106.705 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.65 92.06 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 125.525 1.766 . . . . 0.0 110.009 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -86.56 154.14 21.29 Favored 'General case' 0 N--CA 1.523 3.218 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.001 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.522 3.135 0 O-C-N 124.721 1.263 . . . . 0.0 113.473 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -156.23 147.06 21.99 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 124.616 1.197 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.87 149.53 21.74 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.879 1.362 . . . . 0.0 111.669 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.0 m -69.47 105.53 2.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.779 1.925 . . . . 0.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.3 159.67 53.45 Favored Glycine 0 N--CA 1.514 3.842 0 O-C-N 124.665 1.228 . . . . 0.0 111.235 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 119.05 14.41 Favored 'General case' 0 N--CA 1.527 3.404 0 O-C-N 125.596 1.409 . . . . 0.0 108.384 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.11 111.5 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 O-C-N 124.797 1.311 . . . . 0.0 107.607 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.2 169.49 0.02 OUTLIER Pre-proline 2 N--CA 1.567 5.377 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.23 -13.34 30.9 Favored 'Trans proline' 1 C--N 1.425 4.592 0 CA-C-N 123.884 2.423 . . . . 0.0 113.953 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.56 -39.27 32.23 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.44 -164.32 52.24 Favored Glycine 2 CA--C 1.583 4.34 0 CA-C-O 115.688 -2.729 . . . . 0.0 109.042 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -67.78 156.49 86.42 Favored 'Cis proline' 0 C--N 1.403 3.446 0 CA-C-N 123.668 3.734 . . . . 0.0 114.291 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.34 142.01 52.21 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 125.512 1.757 . . . . 0.0 109.301 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -38.51 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 O-C-N 125.231 1.582 . . . . 0.0 112.581 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.84 -166.68 23.79 Favored Glycine 0 N--CA 1.501 2.976 0 O-C-N 125.568 1.793 . . . . 0.0 108.93 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.75 116.92 5.64 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 125.823 1.543 . . . . 0.0 113.757 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.43 138.62 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 O-C-N 125.969 2.043 . . . . 0.0 107.407 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.21 144.48 28.12 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 125.303 1.627 . . . . 0.0 110.711 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.4 t -80.36 -32.81 37.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 125.05 1.469 . . . . 0.0 112.77 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.09 -25.65 63.62 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.62 -25.28 41.48 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.408 1.068 . . . . 0.0 113.244 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 91.39 Favored Pre-proline 0 N--CA 1.531 3.604 0 CA-C-O 115.573 -2.156 . . . . 0.0 112.025 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.84 -49.26 0.25 Allowed 'Trans proline' 0 C--N 1.413 3.938 0 CA-C-N 123.305 2.216 . . . . 0.0 113.612 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.55 -42.28 55.69 Favored Glycine 0 N--CA 1.511 3.655 0 O-C-N 124.627 1.205 . . . . 0.0 112.477 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.57 175.38 49.2 Favored Glycine 1 N--CA 1.518 4.116 0 O-C-N 125.163 1.155 . . . . 0.0 111.291 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.8 m -70.02 144.82 52.13 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.569 0.805 . . . . 0.0 112.453 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -146.12 127.67 15.1 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 125.806 1.941 . . . . 0.0 107.235 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.77 137.09 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -129.48 134.61 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.34 136.9 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.9 152.88 10.53 Favored Glycine 0 N--CA 1.509 3.541 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.78 -176.75 49.72 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 125.346 1.262 . . . . 0.0 111.804 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -76.57 -16.6 59.56 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.003 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.98 -65.79 0.68 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 124.67 1.231 . . . . 0.0 112.526 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.74 12.85 0.02 OUTLIER Glycine 0 N--CA 1.515 3.924 0 CA-C-O 118.568 -1.129 . . . . 0.0 112.505 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.36 156.44 39.09 Favored 'General case' 0 N--CA 1.521 3.119 0 O-C-N 124.702 0.884 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -153.9 158.81 41.29 Favored 'General case' 0 N--CA 1.522 3.147 0 O-C-N 124.758 1.286 . . . . 0.0 109.236 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.96 82.91 0.07 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -67.29 155.39 39.0 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 125.421 1.306 . . . . 0.0 113.377 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.69 101.79 1.5 Allowed 'General case' 0 N--CA 1.527 3.415 0 O-C-N 124.655 1.222 . . . . 0.0 110.426 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 155.37 40.72 Favored 'General case' 0 N--CA 1.514 2.732 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.78 177.1 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 126.476 2.36 . . . . 0.0 107.735 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 p -156.13 124.2 5.7 Favored 'General case' 0 N--CA 1.524 3.244 0 O-C-N 123.972 0.795 . . . . 0.0 111.674 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -75.3 158.22 33.18 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 124.11 0.882 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.715 0 CA-C-O 116.31 -2.383 . . . . 0.0 111.338 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -143.42 5.92 1.45 Allowed 'General case' 0 N--CA 1.526 3.347 0 O-C-N 125.985 2.053 . . . . 0.0 110.634 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.4 -173.23 0.11 Allowed 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 124.786 1.234 . . . . 0.0 114.284 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.22 123.7 3.54 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.676 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.9 146.81 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.57 140.89 16.61 Favored 'General case' 0 N--CA 1.518 2.929 0 O-C-N 125.166 1.541 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.53 144.57 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -160.88 111.85 1.3 Allowed Pre-proline 0 N--CA 1.524 3.228 0 CA-C-O 115.054 -2.403 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.41 151.78 70.21 Favored 'Cis proline' 1 C--N 1.425 4.594 0 CA-C-N 125.286 2.924 . . . . 0.0 112.439 -3.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -3.56 2.0 Favored 'General case' 0 N--CA 1.528 3.452 0 O-C-N 125.98 2.05 . . . . 0.0 112.881 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.1 p -138.42 151.16 47.2 Favored 'General case' 0 N--CA 1.528 3.467 0 O-C-N 124.686 1.241 . . . . 0.0 109.89 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.24 32.25 68.8 Favored Glycine 1 N--CA 1.517 4.045 0 O-C-N 125.036 1.46 . . . . 0.0 112.879 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.8 mt -73.11 155.21 39.93 Favored 'General case' 0 N--CA 1.514 2.747 0 O-C-N 125.456 1.327 . . . . 0.0 110.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.31 -176.29 3.84 Favored 'General case' 0 N--CA 1.518 2.973 0 O-C-N 126.07 2.107 . . . . 0.0 108.574 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 127.49 32.81 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 124.75 1.281 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.95 28.95 71.16 Favored Glycine 0 N--CA 1.516 3.99 0 O-C-N 124.811 1.32 . . . . 0.0 112.977 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.14 123.81 23.68 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 124.935 1.021 . . . . 0.0 112.649 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -79.88 128.03 32.96 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.7 143.54 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 O-C-N 125.596 1.81 . . . . 0.0 109.178 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 m -107.1 102.92 12.22 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 126.231 2.207 . . . . 0.0 110.602 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.81 147.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.5 158.47 43.02 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.23 2.206 . . . . 0.0 108.717 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.28 141.56 12.32 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.244 1.59 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -165.31 122.52 1.51 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.516 1.76 . . . . 0.0 107.875 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 172.16 -90.56 0.09 OUTLIER Glycine 0 N--CA 1.506 3.337 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER 58.9 146.62 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.963 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.88 -37.74 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -136.84 -30.09 0.9 Allowed 'General case' 0 N--CA 1.527 3.416 0 O-C-N 126.007 2.067 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -73.36 109.46 6.9 Favored 'General case' 0 N--CA 1.523 3.19 0 O-C-N 124.658 1.224 . . . . 0.0 109.325 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.64 7.54 41.06 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.827 1.33 . . . . 0.0 112.726 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -160.46 167.72 26.66 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 124.398 1.061 . . . . 0.0 109.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.15 145.13 26.12 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.265 1.603 . . . . 0.0 109.898 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.1 m -142.0 169.77 16.97 Favored 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.38 4.46 Favored 'General case' 0 N--CA 1.527 3.411 0 O-C-N 124.23 0.956 . . . . 0.0 112.229 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.28 139.85 21.57 Favored 'General case' 0 N--CA 1.538 3.931 0 O-C-N 125.262 1.601 . . . . 0.0 109.551 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -87.83 148.74 24.52 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.3 m -142.42 149.54 39.44 Favored 'General case' 0 N--CA 1.524 3.268 0 O-C-N 125.581 1.801 . . . . 0.0 108.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.0 124.77 51.24 Favored 'General case' 0 N--CA 1.526 3.344 0 O-C-N 126.083 2.114 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -76.45 145.52 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.63 -175.76 3.56 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.41 -49.93 69.6 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.54 1.15 . . . . 0.0 111.654 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -23.59 59.9 Favored 'General case' 0 N--CA 1.528 3.431 0 O-C-N 125.564 1.79 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.0 32.93 60.13 Favored Glycine 0 N--CA 1.508 3.49 0 CA-C-O 116.921 -2.044 . . . . 0.0 117.187 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -75.79 150.2 37.78 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.75 89.33 0.38 Allowed Glycine 0 N--CA 1.511 3.676 0 O-C-N 124.722 1.264 . . . . 0.0 113.496 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.34 95.66 6.66 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.45 137.86 47.41 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 125.247 1.592 . . . . 0.0 111.223 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -78.91 117.82 20.35 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.94 1.4 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -21.48 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.369 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.97 -17.44 64.44 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 118.165 2.654 . . . . 0.0 118.165 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -83.04 2.06 36.91 Favored 'General case' 1 N--CA 1.55 4.533 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.38 167.38 12.67 Favored 'General case' 0 N--CA 1.53 3.552 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -146.17 -60.06 0.31 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 126.057 2.098 . . . . 0.0 107.264 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 45.44 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.757 1.911 . . . . 0.0 116.129 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.14 149.98 31.93 Favored 'General case' 0 N--CA 1.528 3.465 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.72 160.77 22.15 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.935 1.397 . . . . 0.0 114.759 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.39 149.82 31.54 Favored 'General case' 0 N--CA 1.517 2.9 0 O-C-N 125.178 1.549 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -76.31 -24.44 54.34 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.025 1.453 . . . . 0.0 112.217 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.2 -30.89 0.05 OUTLIER Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.16 3.66 0.02 OUTLIER Glycine 0 N--CA 1.512 3.749 0 CA-C-O 117.595 -1.67 . . . . 0.0 112.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.22 165.22 23.84 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.19 79.36 0.08 OUTLIER Glycine 0 N--CA 1.514 3.873 0 O-C-N 124.296 0.998 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m -75.03 155.7 37.0 Favored 'General case' 0 N--CA 1.517 2.902 0 O-C-N 125.311 1.242 . . . . 0.0 109.872 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.84 135.81 6.66 Favored 'General case' 0 N--CA 1.524 3.267 0 O-C-N 124.611 1.195 . . . . 0.0 113.065 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -84.49 114.24 21.79 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 124.875 1.359 . . . . 0.0 110.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.42 149.49 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.35 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 N-CA-C 102.395 -3.187 . . . . 0.0 102.395 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.67 125.18 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 O-C-N 125.543 1.777 . . . . 0.0 112.511 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -90.17 159.58 16.68 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.886 1.366 . . . . 0.0 107.73 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -66.24 -32.89 74.59 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.713 1.258 . . . . 0.0 111.952 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 148.41 52.01 Favored 'General case' 0 N--CA 1.529 3.476 0 O-C-N 125.944 2.028 . . . . 0.0 109.763 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.17 145.44 19.42 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.714 1.259 . . . . 0.0 111.926 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -70.45 106.07 3.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.744 1.903 . . . . 0.0 109.037 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.58 151.42 49.48 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.028 1.455 . . . . 0.0 110.739 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -139.98 121.3 14.95 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 125.803 1.531 . . . . 0.0 109.018 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.08 146.77 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.52 -50.93 82.52 Favored Pre-proline 0 N--CA 1.537 3.885 0 N-CA-C 121.082 3.734 . . . . 0.0 121.082 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.4 -60.8 0.11 Allowed 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 125.113 2.862 . . . . 0.0 115.174 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.12 -47.33 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.622 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.9 -168.44 39.33 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-O 115.564 -2.798 . . . . 0.0 109.133 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -71.63 139.94 62.26 Favored 'Cis proline' 0 C--N 1.409 3.723 0 CA-C-N 123.19 3.495 . . . . 0.0 113.078 0.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.16 137.56 51.12 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 125.237 1.586 . . . . 0.0 109.583 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.92 -92.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.968 0 O-C-N 125.669 1.855 . . . . 0.0 110.616 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.31 -173.44 43.08 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.46 75.42 3.2 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 125.846 1.557 . . . . 0.0 112.349 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.16 141.74 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.828 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.96 156.05 18.26 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 125.375 1.672 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 t -73.8 -25.73 60.26 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.679 1.237 . . . . 0.0 112.887 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.15 -28.39 57.37 Favored 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -79.6 -21.63 44.75 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.341 1.026 . . . . 0.0 112.538 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.32 88.94 Favored Pre-proline 0 N--CA 1.531 3.578 0 CA-C-O 115.512 -2.185 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.76 -45.44 0.52 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.332 2.226 . . . . 0.0 113.051 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.36 -101.94 0.14 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 124.836 1.335 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.52 159.31 10.55 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 63.3 m -71.23 145.06 49.85 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 125.481 1.342 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -144.4 133.21 22.46 Favored 'General case' 0 N--CA 1.533 3.69 0 O-C-N 125.254 1.596 . . . . 0.0 109.283 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mm -79.72 135.73 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.825 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -131.06 134.31 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.3 140.67 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.044 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.72 145.62 6.88 Favored Glycine 0 N--CA 1.51 3.585 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.69 -170.91 38.68 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.016 1.068 . . . . 0.0 112.405 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -75.07 -12.65 60.37 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.256 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 p -69.9 -70.66 0.27 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.693 1.245 . . . . 0.0 111.384 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.48 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.512 3.722 0 CA-C-O 118.699 -1.056 . . . . 0.0 111.903 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -66.05 119.74 11.92 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 125.039 1.082 . . . . 0.0 112.013 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -86.99 -175.49 5.38 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 125.151 1.532 . . . . 0.0 110.31 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.39 78.16 0.09 OUTLIER Glycine 0 N--CA 1.507 3.394 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.71 152.05 46.25 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.445 1.321 . . . . 0.0 112.946 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 98.36 1.08 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 124.843 1.339 . . . . 0.0 109.737 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 150.32 45.64 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.937 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.06 172.16 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 O-C-N 126.324 2.265 . . . . 0.0 107.08 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.5 m -156.38 118.29 3.94 Favored 'General case' 0 N--CA 1.528 3.447 0 O-C-N 124.153 0.908 . . . . 0.0 111.42 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.21 147.93 44.21 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.507 1.129 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.982 0 CA-C-O 116.08 -2.511 . . . . 0.0 112.815 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -70.44 -27.42 64.24 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 125.185 1.553 . . . . 0.0 113.293 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.02 -172.01 0.15 Allowed 'General case' 0 N--CA 1.533 3.685 0 O-C-N 125.103 1.502 . . . . 0.0 113.339 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.24 6.15 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.83 145.44 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -160.96 146.04 14.13 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 124.99 1.432 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.98 144.22 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.23 110.22 2.07 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 114.989 -2.434 . . . . 0.0 110.005 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.91 158.85 68.34 Favored 'Cis proline' 1 C--N 1.424 4.513 0 CA-C-N 125.158 2.878 . . . . 0.0 112.32 -3.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.0 -0.36 2.29 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 125.144 1.528 . . . . 0.0 112.831 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -140.05 151.74 45.65 Favored 'General case' 0 N--CA 1.528 3.462 0 O-C-N 124.74 1.275 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.49 30.95 68.45 Favored Glycine 0 N--CA 1.512 3.703 0 O-C-N 124.953 1.408 . . . . 0.0 113.553 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.58 154.59 39.74 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 125.373 1.278 . . . . 0.0 109.379 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.43 -177.37 3.96 Favored 'General case' 0 N--CA 1.523 3.216 0 O-C-N 125.769 1.918 . . . . 0.0 110.179 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.64 129.87 41.24 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 124.866 1.354 . . . . 0.0 111.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.34 77.18 Favored Glycine 0 N--CA 1.512 3.715 0 O-C-N 124.606 1.191 . . . . 0.0 113.549 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.27 136.11 44.53 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.721 0.895 . . . . 0.0 111.428 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 m -99.6 127.3 45.7 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 125.819 1.949 . . . . 0.0 106.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.87 149.21 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 125.752 1.908 . . . . 0.0 109.924 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 m -103.72 96.38 6.67 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 126.081 2.113 . . . . 0.0 110.648 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.9 147.32 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.119 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -133.91 162.41 32.1 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 125.857 1.973 . . . . 0.0 110.174 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.22 139.2 10.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 125.544 1.777 . . . . 0.0 106.977 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 p -160.59 153.39 21.16 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.749 1.281 . . . . 0.0 110.853 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.35 79.1 0.52 Allowed Glycine 0 N--CA 1.505 3.299 0 O-C-N 124.893 1.37 . . . . 0.0 113.157 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -79.51 173.26 12.77 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 125.677 1.457 . . . . 0.0 110.939 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.38 -38.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.438 1.086 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.99 -46.63 1.38 Allowed 'General case' 0 N--CA 1.525 3.317 0 O-C-N 126.15 2.156 . . . . 0.0 111.414 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.56 121.81 18.54 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 124.847 1.342 . . . . 0.0 113.321 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.02 3.44 38.83 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 125.479 1.737 . . . . 0.0 110.962 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.67 162.69 18.98 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.34 150.56 19.98 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 124.18 0.925 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.1 m -142.07 147.12 36.28 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 125.871 1.982 . . . . 0.0 107.079 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.62 125.04 48.21 Favored 'General case' 0 N--CA 1.526 3.327 0 O-C-N 125.91 2.006 . . . . 0.0 112.448 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -122.46 152.11 40.61 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.587 1.804 . . . . 0.0 107.983 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -135.78 63.26 1.6 Allowed 'General case' 0 N--CA 1.537 3.921 0 O-C-N 125.508 1.755 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 m -72.88 148.94 43.91 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.974 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.21 112.26 24.87 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 126.379 2.3 . . . . 0.0 109.712 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mm -75.54 123.7 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.1 mt -103.22 -173.39 2.3 Favored 'General case' 0 N--CA 1.528 3.473 0 O-C-N 125.223 1.577 . . . . 0.0 106.836 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.51 82.31 Favored 'General case' 0 N--CA 1.515 2.819 0 O-C-N 124.355 1.035 . . . . 0.0 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -21.5 59.86 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 125.192 1.558 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.83 59.45 Favored Glycine 0 N--CA 1.509 3.556 0 CA-C-O 117.49 -1.728 . . . . 0.0 115.118 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.9 142.1 49.51 Favored 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.15 76.06 1.28 Allowed Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.908 1.38 . . . . 0.0 114.37 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.33 97.86 11.44 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.213 1.184 . . . . 0.0 108.171 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 140.29 47.13 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 125.115 1.509 . . . . 0.0 110.896 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -77.11 133.11 39.11 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 125.263 1.602 . . . . 0.0 110.081 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.54 -14.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 O-C-N 125.12 1.512 . . . . 0.0 114.009 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.56 53.57 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.95 -3.12 50.46 Favored 'General case' 1 N--CA 1.546 4.361 0 O-C-N 124.255 0.972 . . . . 0.0 113.57 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -68.13 168.33 12.33 Favored 'General case' 0 N--CA 1.535 3.798 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -143.79 -66.63 0.35 Allowed 'General case' 0 N--CA 1.526 3.339 0 O-C-N 125.486 1.741 . . . . 0.0 109.194 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 52.22 127.81 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -172.84 145.43 1.45 Allowed 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -67.24 163.19 20.98 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.703 1.252 . . . . 0.0 112.657 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.25 149.38 31.88 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 124.83 1.331 . . . . 0.0 109.379 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -73.54 -26.85 61.04 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 124.896 1.372 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.89 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.62 14.43 0.02 OUTLIER Glycine 0 N--CA 1.51 3.609 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.902 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.6 160.16 41.15 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.32 86.46 0.07 OUTLIER Glycine 0 N--CA 1.51 3.63 0 O-C-N 124.49 1.119 . . . . 0.0 111.074 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -74.25 155.54 38.16 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 125.259 1.211 . . . . 0.0 109.189 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -157.6 135.51 10.79 Favored 'General case' 0 N--CA 1.53 3.565 0 O-C-N 124.69 1.244 . . . . 0.0 112.646 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 t -90.69 124.97 35.51 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 125.022 1.451 . . . . 0.0 108.522 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.73 144.57 32.96 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 O-C-N 125.47 1.731 . . . . 0.0 107.062 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 t -115.38 138.46 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.48 119.47 50.39 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.329 0 O-C-N 125.262 1.602 . . . . 0.0 111.777 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -90.46 162.59 15.0 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.078 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -67.35 -29.06 68.51 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.766 1.291 . . . . 0.0 111.766 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 t -148.31 154.3 39.82 Favored 'General case' 0 N--CA 1.533 3.706 0 O-C-N 124.853 1.345 . . . . 0.0 109.084 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -158.58 148.21 19.39 Favored 'General case' 0 N--CA 1.525 3.277 0 O-C-N 124.9 1.375 . . . . 0.0 111.675 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 m -67.95 100.54 0.98 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.783 1.927 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.59 155.41 51.17 Favored Glycine 0 N--CA 1.505 3.249 0 O-C-N 125.116 1.51 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -137.95 123.3 19.46 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 125.901 1.589 . . . . 0.0 107.602 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.0 144.73 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 O-C-N 125.266 1.604 . . . . 0.0 107.288 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.15 -49.33 94.56 Favored Pre-proline 0 N--CA 1.529 3.496 0 N-CA-C 121.256 3.799 . . . . 0.0 121.256 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.26 -55.33 0.62 Allowed 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 125.498 2.999 . . . . 0.0 115.511 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.05 -60.32 0.06 Allowed 'General case' 0 N--CA 1.536 3.862 0 O-C-N 124.478 1.111 . . . . 0.0 113.029 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.34 -169.07 42.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 115.595 -2.781 . . . . 0.0 108.53 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.26 152.39 97.18 Favored 'Cis proline' 0 N--CA 1.53 3.649 0 CA-C-N 123.267 3.533 . . . . 0.0 113.08 -1.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -67.35 143.7 56.22 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 125.341 1.651 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -31.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 O-C-N 125.668 1.855 . . . . 0.0 110.72 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.72 -169.03 36.62 Favored Glycine 0 N--CA 1.494 2.539 0 O-C-N 125.498 1.749 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.86 113.42 2.77 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 125.987 1.639 . . . . 0.0 113.886 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.47 132.14 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 O-C-N 126.152 2.158 . . . . 0.0 107.439 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.532 1.145 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 43.9 t -77.12 -30.74 55.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.841 1.338 . . . . 0.0 112.623 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.74 -24.01 62.54 Favored 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -26.59 41.17 Favored 'General case' 0 N--CA 1.533 3.72 0 O-C-N 124.21 0.944 . . . . 0.0 113.014 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.1 154.81 91.88 Favored Pre-proline 0 N--CA 1.53 3.528 0 CA-C-O 115.513 -2.184 . . . . 0.0 111.986 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.09 -51.16 0.17 Allowed 'Trans proline' 0 C--N 1.411 3.849 0 CA-C-N 123.396 2.249 . . . . 0.0 113.577 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 -36.4 57.9 Favored Glycine 0 N--CA 1.51 3.591 0 O-C-N 124.458 1.099 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.09 -179.31 53.0 Favored Glycine 0 N--CA 1.516 3.972 0 O-C-N 125.045 1.085 . . . . 0.0 111.038 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.8 m -70.77 146.63 49.66 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 124.619 0.834 . . . . 0.0 111.73 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -144.92 131.79 20.18 Favored 'General case' 0 N--CA 1.525 3.309 0 O-C-N 125.549 1.781 . . . . 0.0 107.123 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.73 130.28 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.01 134.56 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.83 137.74 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.951 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.41 142.71 5.11 Favored Glycine 0 N--CA 1.509 3.565 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.29 -165.78 40.78 Favored Glycine 0 N--CA 1.515 3.964 0 O-C-N 125.717 1.481 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -77.9 -16.71 58.02 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.358 1.269 . . . . 0.0 112.687 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 p -126.39 -18.31 4.92 Favored 'General case' 0 N--CA 1.528 3.451 0 O-C-N 125.378 1.673 . . . . 0.0 109.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.52 -7.65 65.01 Favored Glycine 1 N--CA 1.523 4.445 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.869 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.251 4.4 mm-40 62.15 -94.19 0.04 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 125.112 1.365 . . . . 0.0 112.644 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -162.44 156.53 21.27 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 123.826 0.704 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.22 92.12 0.12 Allowed Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 163.91 18.63 Favored 'General case' 0 N--CA 1.515 2.793 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.47 94.71 0.98 Allowed 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.588 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.59 144.13 55.73 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.95 172.22 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 126.381 2.3 . . . . 0.0 106.865 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 m -157.25 120.47 4.06 Favored 'General case' 0 N--CA 1.527 3.378 0 O-C-N 124.287 0.992 . . . . 0.0 111.374 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -73.65 154.24 39.8 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 124.595 1.185 . . . . 0.0 110.349 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.018 0 CA-C-O 116.306 -2.385 . . . . 0.0 112.569 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -144.63 11.38 1.44 Allowed 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.959 2.037 . . . . 0.0 110.099 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.4 168.45 19.2 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 124.016 0.822 . . . . 0.0 112.889 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.07 124.37 3.76 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.139 1.524 . . . . 0.0 109.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.8 137.98 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -163.32 122.75 2.12 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 124.715 1.259 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.1 149.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -154.56 106.87 2.37 Favored Pre-proline 0 N--CA 1.528 3.466 0 CA-C-O 115.308 -2.282 . . . . 0.0 109.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.65 163.01 48.21 Favored 'Cis proline' 2 C--N 1.427 4.696 0 CA-C-N 124.926 2.795 . . . . 0.0 113.025 -3.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.54 -8.18 0.98 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 124.765 1.291 . . . . 0.0 113.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -134.84 153.27 52.11 Favored 'General case' 0 N--CA 1.529 3.495 0 O-C-N 125.091 1.495 . . . . 0.0 110.389 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 28.88 66.42 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 124.926 1.392 . . . . 0.0 113.413 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.0 mt -73.59 154.44 39.79 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 125.289 1.229 . . . . 0.0 109.803 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.44 -175.71 3.39 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.944 2.027 . . . . 0.0 109.802 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.75 129.71 40.76 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.638 1.211 . . . . 0.0 112.014 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.71 28.55 68.92 Favored Glycine 0 N--CA 1.513 3.779 0 O-C-N 124.587 1.18 . . . . 0.0 112.54 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.36 139.81 48.1 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 125.07 1.1 . . . . 0.0 111.96 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.1 m -101.34 131.76 47.24 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 126.159 2.162 . . . . 0.0 105.19 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.95 145.47 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 O-C-N 125.651 1.845 . . . . 0.0 110.208 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.2 m -103.75 99.06 8.84 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 126.251 2.219 . . . . 0.0 109.92 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.79 144.13 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -139.24 155.86 47.49 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 126.018 2.073 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.16 152.23 20.43 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 125.026 1.454 . . . . 0.0 108.015 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -160.88 137.65 8.78 Favored 'General case' 0 N--CA 1.517 2.892 0 O-C-N 124.953 1.408 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.81 67.33 2.01 Favored Glycine 0 N--CA 1.511 3.643 0 O-C-N 124.926 1.391 . . . . 0.0 113.634 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -71.19 149.55 46.2 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 125.476 1.339 . . . . 0.0 110.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.85 -70.55 0.24 Allowed 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.81 -27.37 2.1 Favored 'General case' 1 N--CA 1.541 4.114 0 O-C-N 124.923 1.389 . . . . 0.0 110.633 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -59.27 114.54 2.7 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 125.02 1.45 . . . . 0.0 111.467 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.95 13.51 20.4 Favored 'General case' 0 N--CA 1.53 3.539 0 O-C-N 125.43 1.706 . . . . 0.0 112.756 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -161.85 158.55 25.68 Favored 'General case' 0 N--CA 1.524 3.242 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.13 143.59 13.95 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 124.283 0.989 . . . . 0.0 112.232 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.66 179.14 4.09 Favored 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.646 2.466 . . . . 0.0 105.965 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.44 99.22 2.88 Favored 'General case' 0 N--CA 1.525 3.312 0 O-C-N 125.245 1.59 . . . . 0.0 109.599 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -116.57 157.18 25.71 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.637 1.835 . . . . 0.0 108.742 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.25 121.8 17.32 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.6 m -123.87 151.83 43.03 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.381 1.676 . . . . 0.0 111.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.09 28.59 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 125.613 1.82 . . . . 0.0 110.58 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.3 141.29 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -128.94 -175.05 3.43 Favored 'General case' 0 N--CA 1.525 3.282 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.96 98.21 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 124.59 1.181 . . . . 0.0 112.093 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -22.41 60.67 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 125.283 1.614 . . . . 0.0 111.323 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.42 27.52 67.62 Favored Glycine 0 N--CA 1.513 3.773 0 CA-C-O 117.826 -1.541 . . . . 0.0 115.772 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -74.58 147.34 41.78 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.98 69.63 2.66 Favored Glycine 1 N--CA 1.517 4.073 0 O-C-N 124.937 1.398 . . . . 0.0 114.241 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 99.69 9.24 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.33 146.37 48.37 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 124.592 1.183 . . . . 0.0 111.055 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -83.76 127.1 33.55 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.663 1.852 . . . . 0.0 109.17 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.17 -24.6 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.87 -13.17 61.93 Favored 'General case' 1 N--CA 1.54 4.057 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.95 -6.18 57.03 Favored 'General case' 1 N--CA 1.539 4.017 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -67.44 165.57 16.37 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -146.24 -61.52 0.31 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 125.854 1.971 . . . . 0.0 107.243 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 56.55 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 125.564 1.79 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.42 148.37 19.78 Favored 'General case' 0 N--CA 1.531 3.621 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -70.15 165.86 21.15 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 124.665 1.228 . . . . 0.0 113.43 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.9 mt -79.54 151.0 30.95 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 124.566 1.166 . . . . 0.0 109.413 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.5 t -72.5 -31.37 65.31 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 124.834 1.334 . . . . 0.0 111.562 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.29 -31.56 0.05 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 18.59 0.03 OUTLIER Glycine 0 N--CA 1.51 3.623 0 CA-C-O 118.303 -1.276 . . . . 0.0 112.106 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -143.25 166.37 24.9 Favored 'General case' 0 N--CA 1.539 3.983 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.6 70.7 0.09 OUTLIER Glycine 0 N--CA 1.513 3.778 0 O-C-N 124.268 0.98 . . . . 0.0 111.869 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -74.3 149.55 40.63 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 125.261 1.212 . . . . 0.0 108.977 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -162.23 136.99 6.9 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 124.83 1.331 . . . . 0.0 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -84.23 132.08 34.68 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 125.014 1.446 . . . . 0.0 110.13 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.29 143.71 40.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.399 0 O-C-N 125.417 1.698 . . . . 0.0 106.854 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.1 t -113.02 133.41 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.27 126.02 58.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 O-C-N 125.573 1.796 . . . . 0.0 111.379 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -90.18 158.77 17.08 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 124.711 1.205 . . . . 0.0 108.624 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -69.97 -26.22 63.99 Favored 'General case' 0 N--CA 1.526 3.351 0 O-C-N 124.872 1.358 . . . . 0.0 112.146 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.49 145.88 32.11 Favored 'General case' 0 N--CA 1.527 3.409 0 O-C-N 125.067 1.48 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -157.29 148.95 22.22 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 124.938 1.398 . . . . 0.0 111.892 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.4 m -70.96 101.16 2.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 125.866 1.979 . . . . 0.0 108.404 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.86 152.81 51.75 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.124 1.515 . . . . 0.0 111.082 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -137.56 120.75 16.79 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 126.023 1.66 . . . . 0.0 109.083 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.49 148.55 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 O-C-N 125.303 1.627 . . . . 0.0 107.193 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.263 9.7 tpt -49.82 -55.42 23.69 Favored Pre-proline 0 N--CA 1.524 3.265 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.06 -64.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 125.028 2.831 . . . . 0.0 115.127 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.27 -43.04 0.05 OUTLIER 'General case' 0 N--CA 1.531 3.624 0 CA-C-N 119.136 0.88 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.39 -171.4 42.41 Favored Glycine 0 N--CA 1.515 3.904 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.438 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.92 138.93 56.66 Favored 'Cis proline' 0 C--N 1.41 3.77 0 CA-C-N 123.096 3.448 . . . . 0.0 112.795 0.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.03 138.64 54.62 Favored 'General case' 0 N--CA 1.516 2.873 0 O-C-N 125.21 1.569 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -36.84 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.145 0 O-C-N 125.397 1.686 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.15 -169.77 36.75 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 125.371 1.669 . . . . 0.0 109.24 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.3 108.37 0.91 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 126.004 1.65 . . . . 0.0 113.085 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.32 137.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.013 0 O-C-N 125.938 2.024 . . . . 0.0 108.189 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.62 139.79 36.05 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.986 1.429 . . . . 0.0 109.313 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 t -80.0 -21.84 43.18 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 124.831 1.332 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -73.43 -26.51 60.98 Favored 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -79.74 -22.98 42.61 Favored 'General case' 0 N--CA 1.532 3.643 0 O-C-N 124.487 1.117 . . . . 0.0 113.194 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.16 88.61 Favored Pre-proline 0 N--CA 1.533 3.709 0 CA-C-O 115.588 -2.149 . . . . 0.0 112.254 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.7 -49.7 0.25 Allowed 'Trans proline' 0 C--N 1.412 3.912 0 CA-C-N 123.335 2.227 . . . . 0.0 113.714 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.98 -38.75 59.82 Favored Glycine 0 N--CA 1.512 3.725 0 O-C-N 124.696 1.247 . . . . 0.0 111.791 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.42 52.57 Favored Glycine 0 N--CA 1.511 3.652 0 O-C-N 125.112 1.125 . . . . 0.0 112.241 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 152.17 40.17 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 124.883 0.99 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.49 132.45 12.49 Favored 'General case' 0 N--CA 1.521 3.115 0 O-C-N 125.893 1.996 . . . . 0.0 107.628 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -79.88 136.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.821 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.19 132.72 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -127.33 138.14 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.8 141.53 4.42 Favored Glycine 1 N--CA 1.517 4.089 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.15 -159.06 30.64 Favored Glycine 1 N--CA 1.518 4.132 0 O-C-N 125.198 1.175 . . . . 0.0 112.53 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -8.75 59.57 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 125.625 1.426 . . . . 0.0 113.0 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -70.0 -70.88 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 124.913 1.383 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.16 -24.61 0.18 Allowed Glycine 0 N--CA 1.51 3.588 0 O-C-N 124.184 0.928 . . . . 0.0 111.328 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -65.66 120.77 13.55 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 125.086 1.109 . . . . 0.0 112.771 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -90.31 -169.9 2.57 Favored 'General case' 0 N--CA 1.517 2.911 0 O-C-N 125.317 1.635 . . . . 0.0 109.514 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.26 76.28 0.09 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.34 148.8 49.19 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.391 1.289 . . . . 0.0 112.605 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.3 99.36 1.05 Allowed 'General case' 0 N--CA 1.529 3.507 0 O-C-N 124.972 1.42 . . . . 0.0 110.165 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.38 144.66 49.76 Favored 'General case' 0 N--CA 1.514 2.725 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.628 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 169.16 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 O-C-N 126.287 2.242 . . . . 0.0 107.896 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 t -140.1 159.26 42.59 Favored 'General case' 0 N--CA 1.528 3.432 0 O-C-N 124.68 1.238 . . . . 0.0 110.248 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -107.92 163.22 13.32 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 126.14 2.15 . . . . 0.0 110.06 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.797 0 CA-C-O 116.336 -2.369 . . . . 0.0 111.268 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -70.01 -35.3 74.25 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 125.45 1.719 . . . . 0.0 112.266 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.85 123.18 1.19 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 125.518 1.761 . . . . 0.0 108.693 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.1 131.11 35.69 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 124.679 1.237 . . . . 0.0 111.06 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.85 140.49 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -163.7 143.18 8.2 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.973 1.421 . . . . 0.0 110.547 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.13 143.0 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.025 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -157.54 111.56 1.84 Allowed Pre-proline 0 N--CA 1.528 3.439 0 CA-C-O 114.903 -2.475 . . . . 0.0 109.839 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.03 153.03 76.86 Favored 'Cis proline' 1 C--N 1.424 4.519 0 CA-C-N 125.555 3.02 . . . . 0.0 111.57 -2.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.47 -6.58 1.54 Allowed 'General case' 0 N--CA 1.529 3.485 0 O-C-N 125.853 1.971 . . . . 0.0 112.638 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.4 p -134.36 151.55 51.29 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 125.164 1.54 . . . . 0.0 109.978 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.12 31.61 66.39 Favored Glycine 0 N--CA 1.511 3.679 0 O-C-N 125.027 1.454 . . . . 0.0 112.786 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 153.55 39.34 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.359 1.27 . . . . 0.0 109.968 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -176.07 4.16 Favored 'General case' 0 N--CA 1.524 3.232 0 O-C-N 125.834 1.959 . . . . 0.0 108.755 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.41 136.35 56.38 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.756 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.44 60.21 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.587 1.179 . . . . 0.0 111.709 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.98 150.66 43.87 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 125.216 1.186 . . . . 0.0 110.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -128.93 101.16 5.95 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 126.22 2.2 . . . . 0.0 107.382 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.82 157.4 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 O-C-N 126.076 2.11 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -128.48 96.45 4.42 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 126.171 2.169 . . . . 0.0 106.082 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.7 148.29 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -140.47 160.86 39.07 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 126.045 2.091 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 131.83 6.02 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -126.33 13.52 7.68 Favored 'General case' 0 N--CA 1.535 3.824 0 O-C-N 125.583 1.802 . . . . 0.0 112.979 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.02 158.34 30.33 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -141.92 -172.27 3.53 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 126.579 1.987 . . . . 0.0 107.361 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.82 -30.52 0.07 Allowed 'General case' 0 N--CA 1.514 2.768 0 O-C-N 124.369 1.043 . . . . 0.0 111.435 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -40.38 0.3 Allowed 'General case' 0 N--CA 1.527 3.396 0 O-C-N 125.399 1.687 . . . . 0.0 110.548 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 p -67.93 113.21 5.45 Favored 'General case' 0 N--CA 1.521 3.103 0 O-C-N 124.946 1.404 . . . . 0.0 112.011 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.65 7.93 39.19 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 124.741 1.276 . . . . 0.0 112.554 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.54 162.03 18.89 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.09 20.28 Favored 'General case' 0 N--CA 1.522 3.146 0 O-C-N 124.068 0.855 . . . . 0.0 111.552 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -144.65 142.25 29.97 Favored 'General case' 0 N--CA 1.52 3.041 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.04 130.78 55.48 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.676 1.86 . . . . 0.0 114.073 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.47 139.03 19.59 Favored 'General case' 0 N--CA 1.532 3.647 0 O-C-N 125.047 1.467 . . . . 0.0 109.619 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -100.4 150.14 22.92 Favored 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.9 m -144.23 143.23 30.95 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.047 1.467 . . . . 0.0 109.243 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.85 114.72 27.21 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 125.327 1.642 . . . . 0.0 110.881 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.76 120.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.127 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.88 -174.86 2.8 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.64 82.53 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 124.646 1.216 . . . . 0.0 112.404 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -21.9 60.81 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.151 1.532 . . . . 0.0 111.473 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.07 22.66 57.03 Favored Glycine 0 N--CA 1.511 3.679 0 CA-C-O 117.356 -1.802 . . . . 0.0 115.003 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -71.4 140.96 50.32 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 75.01 1.42 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-O 118.173 -1.349 . . . . 0.0 115.154 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.1 100.1 10.3 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.45 146.43 51.3 Favored 'General case' 0 N--CA 1.529 3.497 0 O-C-N 124.949 1.406 . . . . 0.0 110.836 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -91.04 123.82 34.8 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 125.854 1.972 . . . . 0.0 109.559 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.71 -25.71 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.46 -5.38 32.46 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -79.78 -12.57 59.77 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 123.898 0.749 . . . . 0.0 112.982 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.4 159.91 17.29 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -148.25 -44.65 0.16 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 125.685 1.866 . . . . 0.0 109.788 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 63.49 130.88 0.01 OUTLIER 'General case' 0 N--CA 1.534 3.726 0 O-C-N 125.466 1.729 . . . . 0.0 114.794 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.0 154.11 27.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.597 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.5 m -118.99 146.96 44.58 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 126.21 2.194 . . . . 0.0 108.347 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.61 155.16 28.24 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.957 1.411 . . . . 0.0 108.827 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.2 p -134.78 15.84 3.61 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 126.057 2.098 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.89 -62.33 0.1 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.77 24.76 0.02 OUTLIER Glycine 0 N--CA 1.507 3.406 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.6 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -138.45 153.52 48.84 Favored 'General case' 0 N--CA 1.536 3.86 0 O-C-N 125.164 1.156 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.24 74.63 0.06 OUTLIER Glycine 0 N--CA 1.513 3.775 0 O-C-N 124.542 1.151 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.29 150.98 39.93 Favored 'General case' 0 N--CA 1.519 2.987 0 O-C-N 125.045 1.085 . . . . 0.0 109.716 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -156.41 145.21 20.18 Favored 'General case' 0 N--CA 1.538 3.95 0 O-C-N 124.804 1.315 . . . . 0.0 111.232 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.4 m -101.8 136.54 41.46 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 125.942 2.026 . . . . 0.0 109.421 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.5 155.95 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 O-C-N 125.481 1.738 . . . . 0.0 106.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 134.65 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -131.58 126.13 57.33 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 O-C-N 125.353 1.658 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -90.31 159.77 16.48 Favored 'General case' 0 N--CA 1.525 3.307 0 O-C-N 124.692 1.245 . . . . 0.0 108.163 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -69.44 -24.07 63.76 Favored 'General case' 0 N--CA 1.527 3.408 0 O-C-N 124.402 1.064 . . . . 0.0 112.145 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.5 m -142.48 147.42 36.02 Favored 'General case' 0 N--CA 1.532 3.652 0 O-C-N 124.997 1.435 . . . . 0.0 109.564 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.37 148.46 19.93 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.638 1.211 . . . . 0.0 112.042 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.52 102.25 1.78 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 125.741 1.901 . . . . 0.0 109.186 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.01 155.09 51.53 Favored Glycine 0 N--CA 1.506 3.35 0 O-C-N 125.063 1.477 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -139.42 123.21 17.57 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 125.737 1.492 . . . . 0.0 108.258 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 147.81 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 O-C-N 125.15 1.531 . . . . 0.0 106.952 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.264 1.7 tmt? -53.18 -52.4 66.2 Favored Pre-proline 0 N--CA 1.526 3.342 0 N-CA-C 120.098 3.37 . . . . 0.0 120.098 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -66.34 -61.83 0.08 OUTLIER 'Trans proline' 0 C--N 1.397 3.089 0 CA-C-N 125.445 2.98 . . . . 0.0 115.1 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.13 -47.5 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.674 0 O-C-N 124.214 0.946 . . . . 0.0 112.815 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.65 -170.57 42.57 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-O 115.709 -2.717 . . . . 0.0 109.333 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.87 142.61 74.21 Favored 'Cis proline' 0 C--N 1.41 3.792 0 CA-C-N 123.003 3.401 . . . . 0.0 112.919 0.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.93 139.53 55.09 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 125.327 1.642 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.2 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 O-C-N 125.419 1.699 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.54 -167.87 34.23 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 125.444 1.715 . . . . 0.0 109.033 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.93 109.14 1.17 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 126.104 1.708 . . . . 0.0 112.842 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.86 137.08 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.935 0 O-C-N 126.093 2.12 . . . . 0.0 107.963 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.41 144.59 31.31 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 125.028 1.455 . . . . 0.0 110.027 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.5 t -75.99 -35.06 59.73 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 124.855 1.347 . . . . 0.0 112.783 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.38 -24.66 65.7 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -79.67 -24.66 41.66 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 124.252 0.97 . . . . 0.0 112.73 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.44 157.09 88.97 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 115.675 -2.107 . . . . 0.0 111.596 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.49 -50.17 0.19 Allowed 'Trans proline' 0 C--N 1.41 3.779 0 CA-C-N 123.25 2.196 . . . . 0.0 114.32 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.74 -41.37 56.59 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 124.486 1.116 . . . . 0.0 112.308 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.66 179.76 50.02 Favored Glycine 0 N--CA 1.51 3.599 0 O-C-N 125.212 1.184 . . . . 0.0 112.114 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.8 150.82 45.47 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.673 -1.264 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -159.37 134.48 8.21 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 mm -79.6 135.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 t -132.31 132.02 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 O-C-N 125.886 1.991 . . . . 0.0 105.835 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.3 145.97 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 100.978 -3.712 . . . . 0.0 100.978 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.75 139.17 4.12 Favored Glycine 0 N--CA 1.514 3.877 0 O-C-N 124.444 1.09 . . . . 0.0 111.567 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.51 -161.79 37.6 Favored Glycine 1 N--CA 1.517 4.083 0 O-C-N 125.688 1.464 . . . . 0.0 111.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -72.6 -25.17 61.22 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 125.362 1.272 . . . . 0.0 112.371 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -74.46 -25.71 59.58 Favored 'General case' 0 N--CA 1.522 3.142 0 O-C-N 124.464 1.103 . . . . 0.0 110.583 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.85 19.55 47.1 Favored Glycine 0 N--CA 1.512 3.741 0 O-C-N 125.208 1.567 . . . . 0.0 112.115 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -73.11 103.24 3.79 Favored 'General case' 0 N--CA 1.517 2.924 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -70.78 167.16 19.41 Favored 'General case' 0 N--CA 1.519 2.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.398 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.48 73.53 0.08 OUTLIER Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.92 164.46 19.8 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.12 102.19 0.87 Allowed 'General case' 0 N--CA 1.524 3.271 0 O-C-N 124.906 1.379 . . . . 0.0 109.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 154.23 42.17 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 123.984 0.802 . . . . 0.0 112.646 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.24 172.52 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 O-C-N 126.209 2.193 . . . . 0.0 107.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -157.84 131.54 7.89 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 123.993 0.808 . . . . 0.0 111.367 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.78 161.63 28.86 Favored 'General case' 0 N--CA 1.518 2.964 0 O-C-N 124.401 1.063 . . . . 0.0 110.859 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.344 -2.365 . . . . 0.0 109.805 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -70.09 -31.37 68.91 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 125.375 1.672 . . . . 0.0 112.846 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.84 120.47 14.82 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 125.517 1.761 . . . . 0.0 111.738 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.86 129.66 34.67 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 124.731 1.27 . . . . 0.0 111.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.41 139.75 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 102.097 -3.297 . . . . 0.0 102.097 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.39 142.49 9.78 Favored 'General case' 0 N--CA 1.514 2.748 0 O-C-N 124.943 1.402 . . . . 0.0 110.419 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -126.27 141.1 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.39 112.88 1.7 Allowed Pre-proline 0 N--CA 1.526 3.356 0 CA-C-O 114.889 -2.482 . . . . 0.0 110.136 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.53 150.49 73.32 Favored 'Cis proline' 1 C--N 1.423 4.455 0 CA-C-N 125.36 2.95 . . . . 0.0 111.927 -4.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.32 -13.68 1.79 Allowed 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.993 2.058 . . . . 0.0 112.724 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.1 p -127.56 153.91 45.81 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.776 1.922 . . . . 0.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.79 33.11 74.86 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 124.951 1.407 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 mt -75.05 153.75 38.28 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 125.338 1.258 . . . . 0.0 110.633 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.89 -173.96 3.24 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 126.245 2.215 . . . . 0.0 108.444 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.04 127.97 34.22 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.661 1.226 . . . . 0.0 112.849 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 29.48 72.4 Favored Glycine 0 N--CA 1.515 3.907 0 O-C-N 124.761 1.288 . . . . 0.0 113.094 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.56 125.16 26.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 125.021 1.071 . . . . 0.0 112.503 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.06 135.48 35.83 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.82 141.24 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.333 1.645 . . . . 0.0 108.828 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -109.1 102.68 11.63 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 126.236 2.21 . . . . 0.0 109.637 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 147.94 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -134.75 161.97 33.67 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 126.197 2.185 . . . . 0.0 109.503 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.19 14.4 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 125.51 1.756 . . . . 0.0 108.064 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.23 147.36 17.75 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.323 1.64 . . . . 0.0 109.311 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.06 87.51 0.16 Allowed Glycine 0 N--CA 1.509 3.521 0 O-C-N 125.114 1.509 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -156.21 152.4 27.77 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 125.741 1.495 . . . . 0.0 107.433 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.81 -18.64 0.05 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 124.871 1.357 . . . . 0.0 111.156 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.385 1.053 . . . . 0.0 110.247 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -72.53 121.46 19.7 Favored 'General case' 0 N--CA 1.518 2.965 0 O-C-N 124.615 1.197 . . . . 0.0 110.558 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -79.8 -17.11 54.16 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.349 1.031 . . . . 0.0 113.345 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -167.54 153.68 7.76 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.7 135.08 5.51 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 124.562 1.164 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -97.61 153.18 18.37 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 126.168 2.167 . . . . 0.0 108.471 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.88 120.87 41.43 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 126.399 2.312 . . . . 0.0 109.059 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.51 145.88 17.86 Favored 'General case' 0 N--CA 1.527 3.386 0 O-C-N 124.542 1.151 . . . . 0.0 112.362 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -96.17 148.9 22.22 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 125.373 1.671 . . . . 0.0 108.232 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.5 m -146.83 142.96 28.23 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.466 1.729 . . . . 0.0 108.088 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.44 123.63 42.69 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.451 1.72 . . . . 0.0 112.068 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.36 122.56 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.03 -174.48 2.7 Favored 'General case' 0 N--CA 1.526 3.329 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.69 81.63 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.627 1.204 . . . . 0.0 111.321 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -22.45 60.56 Favored 'General case' 0 N--CA 1.524 3.264 0 O-C-N 125.357 1.661 . . . . 0.0 111.181 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.96 25.69 55.14 Favored Glycine 0 N--CA 1.514 3.861 0 CA-C-O 117.54 -1.7 . . . . 0.0 115.485 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 144.63 46.79 Favored 'General case' 0 N--CA 1.526 3.343 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 75.14 1.51 Allowed Glycine 0 N--CA 1.515 3.911 0 CA-C-O 118.19 -1.339 . . . . 0.0 114.977 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.88 104.48 13.99 Favored 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.34 142.93 49.53 Favored 'General case' 0 N--CA 1.531 3.615 0 O-C-N 125.201 1.563 . . . . 0.0 112.396 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -83.39 116.96 22.72 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 125.344 1.652 . . . . 0.0 109.025 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.18 -23.75 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.21 62.15 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -79.87 -7.69 58.87 Favored 'General case' 1 N--CA 1.542 4.173 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -64.67 165.49 10.22 Favored 'General case' 0 N--CA 1.531 3.598 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -145.42 -52.99 0.27 Allowed 'General case' 0 N--CA 1.513 2.71 0 O-C-N 126.136 2.148 . . . . 0.0 107.052 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.6 t70 51.37 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.677 0 O-C-N 125.754 1.908 . . . . 0.0 116.139 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -157.55 147.26 20.28 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.2 p -66.7 157.44 32.67 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 124.841 1.338 . . . . 0.0 113.99 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.58 136.62 36.9 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 125.04 1.463 . . . . 0.0 108.139 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -70.07 -37.78 75.58 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.547 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.57 54.28 0.11 Allowed Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.318 1.636 . . . . 0.0 109.294 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.77 70.73 Favored Glycine 0 N--CA 1.507 3.404 0 O-C-N 125.518 1.363 . . . . 0.0 112.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.65 157.6 44.87 Favored 'General case' 0 N--CA 1.535 3.787 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.22 77.72 0.07 OUTLIER Glycine 0 N--CA 1.515 3.956 0 O-C-N 124.33 1.019 . . . . 0.0 112.38 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 m -75.76 150.83 37.7 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.232 1.195 . . . . 0.0 109.159 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.3 135.48 6.05 Favored 'General case' 0 N--CA 1.529 3.481 0 O-C-N 124.8 1.313 . . . . 0.0 112.973 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -80.81 113.17 18.83 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.923 1.389 . . . . 0.0 111.038 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.66 150.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.4 141.27 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.86 132.3 25.24 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 O-C-N 125.49 1.744 . . . . 0.0 112.279 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -90.22 162.91 15.01 Favored 'General case' 0 N--CA 1.526 3.355 0 O-C-N 125.141 1.526 . . . . 0.0 108.729 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -66.53 -24.59 66.4 Favored 'General case' 0 N--CA 1.525 3.293 0 O-C-N 124.322 1.014 . . . . 0.0 112.669 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -155.72 150.87 26.68 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 124.772 1.295 . . . . 0.0 108.587 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.45 150.03 26.21 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 124.941 1.401 . . . . 0.0 112.172 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 m -68.07 103.77 1.61 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.958 2.036 . . . . 0.0 109.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.23 154.38 52.55 Favored Glycine 0 N--CA 1.509 3.538 0 O-C-N 125.173 1.546 . . . . 0.0 111.177 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -137.44 123.0 19.72 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 126.002 1.648 . . . . 0.0 109.262 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.41 148.67 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.261 27.1 tpp -51.58 -54.77 35.81 Favored Pre-proline 0 N--CA 1.524 3.268 0 N-CA-C 119.421 3.119 . . . . 0.0 119.421 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -65.16 -63.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 0 CA-C-N 125.163 2.88 . . . . 0.0 115.575 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.17 -45.23 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.672 0 CA-C-N 119.316 0.962 . . . . 0.0 112.869 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.84 41.95 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 115.625 -2.764 . . . . 0.0 109.393 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.51 143.2 75.85 Favored 'Cis proline' 0 C--N 1.408 3.71 0 CA-C-N 123.057 3.429 . . . . 0.0 113.074 -0.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.29 137.95 53.44 Favored 'General case' 0 N--CA 1.515 2.803 0 O-C-N 125.306 1.629 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -37.66 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 O-C-N 125.351 1.657 . . . . 0.0 111.646 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.25 -169.75 32.2 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 125.456 1.723 . . . . 0.0 109.749 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.97 111.96 2.13 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 126.08 1.694 . . . . 0.0 113.423 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 142.28 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.974 0 O-C-N 125.988 2.055 . . . . 0.0 107.4 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.37 154.17 17.62 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 125.711 1.882 . . . . 0.0 109.127 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.9 -27.35 61.01 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 124.746 1.279 . . . . 0.0 112.948 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.93 -31.42 68.02 Favored 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.76 -19.56 48.4 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 124.64 1.213 . . . . 0.0 112.821 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.97 155.26 92.24 Favored Pre-proline 0 N--CA 1.53 3.57 0 CA-C-O 115.601 -2.143 . . . . 0.0 111.507 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -43.01 0.79 Allowed 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 123.407 2.253 . . . . 0.0 113.929 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.08 -104.5 0.1 OUTLIER Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.684 1.24 . . . . 0.0 111.329 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.53 147.14 4.96 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.9 m -73.75 159.08 33.47 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 125.077 1.104 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.34 147.3 12.44 Favored 'General case' 0 N--CA 1.518 2.947 0 O-C-N 124.497 1.123 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -79.64 121.2 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.05 120.14 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 t -116.33 132.76 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 101.408 -3.552 . . . . 0.0 101.408 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.4 138.12 3.56 Favored Glycine 1 N--CA 1.517 4.035 0 O-C-N 124.184 0.928 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.08 -166.26 41.48 Favored Glycine 0 N--CA 1.509 3.513 0 O-C-N 125.377 1.281 . . . . 0.0 112.556 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -80.08 -13.52 59.23 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 125.743 1.496 . . . . 0.0 112.856 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -70.0 -68.5 0.41 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 124.894 1.371 . . . . 0.0 111.751 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.68 -19.45 0.07 OUTLIER Glycine 0 N--CA 1.515 3.951 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.758 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.38 143.61 57.62 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.961 1.036 . . . . 0.0 112.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -111.72 -173.16 2.18 Favored 'General case' 0 N--CA 1.524 3.271 0 O-C-N 126.52 2.387 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.07 67.22 0.11 Allowed Glycine 0 N--CA 1.51 3.607 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -68.05 146.35 53.59 Favored 'General case' 0 N--CA 1.519 3.0 0 O-C-N 125.432 1.313 . . . . 0.0 112.926 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.13 109.78 1.03 Allowed 'General case' 0 N--CA 1.528 3.429 0 O-C-N 124.496 1.123 . . . . 0.0 109.633 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.49 170.75 16.14 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.414 1.072 . . . . 0.0 113.038 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -178.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 O-C-N 126.419 2.324 . . . . 0.0 107.99 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -161.19 119.65 2.44 Favored 'General case' 0 N--CA 1.516 2.842 0 O-C-N 124.35 1.031 . . . . 0.0 109.271 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.23 158.48 34.01 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.073 0.858 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 116.282 -2.399 . . . . 0.0 111.497 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t -167.47 -40.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.72 0 O-C-N 125.257 1.598 . . . . 0.0 109.568 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.87 116.68 8.81 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 125.845 1.966 . . . . 0.0 112.377 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.29 34.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 124.695 1.247 . . . . 0.0 111.168 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.13 139.31 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -161.63 146.82 13.44 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.731 1.269 . . . . 0.0 110.555 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.89 147.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.02 109.51 1.75 Allowed Pre-proline 0 N--CA 1.526 3.344 0 CA-C-O 115.343 -2.265 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.93 162.62 51.23 Favored 'Cis proline' 2 C--N 1.427 4.665 0 CA-C-N 124.908 2.789 . . . . 0.0 112.747 -3.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.15 -5.31 1.12 Allowed 'General case' 0 N--CA 1.537 3.894 0 O-C-N 124.655 1.222 . . . . 0.0 113.291 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.8 p -139.3 151.35 46.37 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.807 1.317 . . . . 0.0 109.669 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.76 32.84 70.57 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.985 1.428 . . . . 0.0 112.987 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.57 150.74 44.44 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 125.632 1.431 . . . . 0.0 109.984 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.73 178.68 4.24 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 126.059 2.1 . . . . 0.0 109.939 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.95 127.4 32.74 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 124.954 1.409 . . . . 0.0 111.335 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.56 25.98 74.83 Favored Glycine 0 N--CA 1.514 3.844 0 O-C-N 124.554 1.158 . . . . 0.0 113.285 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.54 140.97 48.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 124.753 0.913 . . . . 0.0 111.784 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -99.06 132.91 44.02 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.843 1.964 . . . . 0.0 105.816 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.48 147.19 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 125.399 1.687 . . . . 0.0 109.571 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -101.01 96.75 7.45 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 126.064 2.102 . . . . 0.0 110.369 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 t -79.92 147.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -138.57 165.81 25.94 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 125.754 1.909 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.85 15.88 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 125.696 1.873 . . . . 0.0 108.118 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.79 148.53 17.56 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.898 1.374 . . . . 0.0 109.469 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.91 87.79 0.18 Allowed Glycine 0 N--CA 1.508 3.468 0 O-C-N 125.198 1.561 . . . . 0.0 110.444 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -155.81 156.64 35.09 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 125.67 1.453 . . . . 0.0 107.551 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.11 -21.99 0.05 Allowed 'General case' 0 N--CA 1.52 3.042 0 O-C-N 124.621 1.201 . . . . 0.0 111.261 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -79.64 -54.87 5.46 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 124.474 1.109 . . . . 0.0 110.343 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -70.88 117.62 12.62 Favored 'General case' 0 N--CA 1.515 2.793 0 O-C-N 124.681 1.238 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.0 p -79.73 -16.61 55.3 Favored 'General case' 0 N--CA 1.527 3.401 0 O-C-N 124.091 0.869 . . . . 0.0 112.277 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.35 154.95 10.76 Favored 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.9 10.37 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.65 1.219 . . . . 0.0 111.241 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 m -112.54 151.46 29.98 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 126.501 2.375 . . . . 0.0 108.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.92 103.87 13.4 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 126.188 2.18 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -126.24 147.59 49.65 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 124.995 1.434 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.07 142.49 47.35 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 125.951 2.032 . . . . 0.0 106.451 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.3 m -137.13 138.9 40.79 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.356 1.66 . . . . 0.0 109.817 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.31 23.22 Favored 'General case' 0 N--CA 1.516 2.875 0 O-C-N 125.049 1.468 . . . . 0.0 112.143 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mm -77.36 121.36 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.3 mt -100.42 -173.15 2.34 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -47.23 78.61 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.535 1.147 . . . . 0.0 112.229 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.83 -21.33 61.7 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.24 1.588 . . . . 0.0 111.714 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.69 24.56 49.45 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.187 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -73.18 143.64 47.14 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 124.828 0.957 . . . . 0.0 108.641 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.75 72.58 2.2 Favored Glycine 0 N--CA 1.514 3.849 0 CA-C-O 118.105 -1.386 . . . . 0.0 115.165 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.0 108.82 15.81 Favored 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.6 144.89 48.17 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 124.891 1.37 . . . . 0.0 111.956 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.98 127.16 34.07 Favored 'General case' 0 N--CA 1.516 2.829 0 O-C-N 125.499 1.749 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.85 -28.45 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.6 -10.0 58.25 Favored 'General case' 0 N--CA 1.537 3.909 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -79.85 -7.71 58.87 Favored 'General case' 0 N--CA 1.539 3.986 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -65.55 165.98 11.32 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -145.85 -61.35 0.33 Allowed 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.906 2.004 . . . . 0.0 108.266 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 t70 59.43 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.492 0 O-C-N 125.333 1.645 . . . . 0.0 115.32 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -163.27 144.01 9.23 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 p -72.37 152.08 42.26 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 124.407 1.067 . . . . 0.0 112.462 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.52 151.65 30.63 Favored 'General case' 0 N--CA 1.52 3.057 0 O-C-N 124.738 1.274 . . . . 0.0 108.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -70.67 -28.74 65.01 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.813 1.321 . . . . 0.0 112.746 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.32 -36.22 0.06 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.25 28.31 0.04 OUTLIER Glycine 0 N--CA 1.502 3.04 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.667 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.96 156.75 45.47 Favored 'General case' 0 N--CA 1.534 3.74 0 O-C-N 125.288 1.228 . . . . 0.0 108.212 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.46 140.78 4.97 Favored Glycine 0 N--CA 1.502 3.096 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -136.72 150.84 48.65 Favored 'General case' 0 N--CA 1.526 3.345 0 O-C-N 125.722 1.483 . . . . 0.0 107.566 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.03 139.19 8.36 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 125.226 1.579 . . . . 0.0 112.863 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -87.26 118.98 27.05 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 125.063 1.477 . . . . 0.0 108.053 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.22 143.91 30.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.037 0 O-C-N 125.389 1.68 . . . . 0.0 106.641 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.93 139.03 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.47 117.6 43.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 O-C-N 125.23 1.581 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -90.35 157.32 17.69 Favored 'General case' 0 N--CA 1.522 3.173 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.549 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -68.71 -25.64 64.87 Favored 'General case' 0 N--CA 1.525 3.32 0 O-C-N 124.592 1.183 . . . . 0.0 112.106 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 m -148.94 147.56 28.77 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.871 1.357 . . . . 0.0 109.759 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -156.18 147.25 22.25 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 124.899 1.374 . . . . 0.0 111.77 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.62 106.35 2.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 125.8 1.937 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.99 157.25 52.92 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 124.688 1.243 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -142.5 106.34 4.7 Favored 'General case' 0 N--CA 1.517 2.898 0 O-C-N 125.53 1.37 . . . . 0.0 108.942 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.62 142.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.053 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.9 mtp -69.86 -37.26 7.55 Favored Pre-proline 1 N--CA 1.545 4.281 1 N-CA-C 122.965 4.431 . . . . 0.0 122.965 -179.234 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.03 -38.39 16.37 Favored 'Trans proline' 0 C--N 1.395 2.978 0 CA-C-N 125.99 3.175 . . . . 0.0 117.337 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.53 -39.98 0.06 Allowed 'General case' 0 N--CA 1.532 3.644 0 O-C-N 124.362 1.039 . . . . 0.0 111.741 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.5 -117.01 5.37 Favored Glycine 1 CA--C 1.595 5.04 0 CA-C-O 113.846 -3.752 . . . . 0.0 111.109 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.97 -47.54 0.31 Allowed 'Cis proline' 1 C--N 1.415 4.032 1 CA-C-N 125.937 4.869 . . . . 0.0 113.08 0.79 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.46 129.69 9.68 Favored 'General case' 0 N--CA 1.521 3.12 0 O-C-N 126.03 2.081 . . . . 0.0 108.882 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -36.79 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 125.16 1.537 . . . . 0.0 110.078 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.14 178.36 22.04 Favored Glycine 0 N--CA 1.508 3.498 0 O-C-N 126.166 2.166 . . . . 0.0 109.86 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.47 118.21 7.81 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.876 1.574 . . . . 0.0 113.305 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.41 135.69 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 O-C-N 126.239 2.212 . . . . 0.0 107.833 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 145.62 31.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 124.936 1.398 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.4 t -76.45 -28.45 56.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.745 1.278 . . . . 0.0 111.73 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.69 -27.48 61.25 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.68 -22.8 43.0 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.254 0.971 . . . . 0.0 112.848 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.24 155.21 92.81 Favored Pre-proline 0 N--CA 1.53 3.542 0 CA-C-O 115.423 -2.227 . . . . 0.0 111.297 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.86 -51.4 0.18 Allowed 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 123.466 2.274 . . . . 0.0 113.915 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.34 -43.43 38.27 Favored Glycine 0 N--CA 1.512 3.738 0 O-C-N 124.436 1.085 . . . . 0.0 112.555 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.19 171.6 48.09 Favored Glycine 0 N--CA 1.514 3.884 0 O-C-N 125.349 1.264 . . . . 0.0 110.926 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 25.9 m -70.29 150.27 46.54 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 124.95 1.03 . . . . 0.0 112.331 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -146.54 133.27 19.97 Favored 'General case' 0 N--CA 1.522 3.155 0 O-C-N 125.838 1.961 . . . . 0.0 107.689 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.0 mm -79.58 116.94 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.48 122.02 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 O-C-N 125.8 1.938 . . . . 0.0 106.457 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -118.38 130.33 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.31 138.45 3.51 Favored Glycine 1 N--CA 1.519 4.202 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.9 -170.54 43.18 Favored Glycine 0 N--CA 1.51 3.57 0 O-C-N 125.126 1.133 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.62 -16.72 57.03 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 113.174 -1.513 . . . . 0.0 113.066 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.94 -66.21 0.62 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.759 1.287 . . . . 0.0 112.557 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -7.52 0.05 OUTLIER Glycine 1 N--CA 1.517 4.051 0 CA-C-O 118.404 -1.22 . . . . 0.0 112.578 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.12 147.61 53.08 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.82 0.953 . . . . 0.0 111.265 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -142.81 168.03 20.67 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 125.855 1.972 . . . . 0.0 109.222 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.57 78.86 0.06 OUTLIER Glycine 0 N--CA 1.501 2.983 0 O-C-N 124.984 1.428 . . . . 0.0 109.901 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -67.92 159.47 30.49 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 125.343 1.261 . . . . 0.0 113.006 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.97 101.62 1.44 Allowed 'General case' 0 N--CA 1.529 3.503 0 O-C-N 124.38 1.05 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 148.91 45.18 Favored 'General case' 0 N--CA 1.511 2.576 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -118.06 170.63 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 O-C-N 126.272 2.232 . . . . 0.0 106.907 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -157.19 119.24 3.82 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 124.258 0.974 . . . . 0.0 111.322 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -73.22 154.88 40.06 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 124.604 1.19 . . . . 0.0 110.463 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.976 0 CA-C-O 116.722 -2.154 . . . . 0.0 112.513 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 t -167.56 91.62 0.36 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 125.36 1.663 . . . . 0.0 107.281 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.97 121.95 1.53 Allowed 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.792 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.91 129.07 34.19 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 124.723 1.264 . . . . 0.0 111.429 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.53 139.36 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.35 142.2 9.69 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 125.001 1.438 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.08 142.85 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 101.486 -3.524 . . . . 0.0 101.486 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -161.3 112.92 1.25 Allowed Pre-proline 0 N--CA 1.524 3.252 0 CA-C-O 115.015 -2.421 . . . . 0.0 110.212 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -63.19 150.64 68.13 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.337 2.942 . . . . 0.0 112.242 -4.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.18 -9.19 1.75 Allowed 'General case' 0 N--CA 1.528 3.439 0 O-C-N 125.964 2.04 . . . . 0.0 113.049 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.3 p -133.19 152.76 51.94 Favored 'General case' 0 N--CA 1.528 3.425 0 O-C-N 125.327 1.642 . . . . 0.0 109.657 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.2 29.53 68.49 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 125.008 1.443 . . . . 0.0 112.51 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.78 154.1 40.8 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 125.347 1.263 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 -175.39 3.57 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 126.184 2.178 . . . . 0.0 107.977 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.9 127.54 32.91 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 124.736 1.272 . . . . 0.0 112.61 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.48 29.72 69.64 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.856 1.347 . . . . 0.0 112.776 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.37 127.46 32.63 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.934 1.02 . . . . 0.0 112.627 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.97 134.04 35.35 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.12 146.44 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 O-C-N 125.281 1.613 . . . . 0.0 108.558 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 m -113.98 103.42 11.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 126.436 2.335 . . . . 0.0 109.689 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.85 147.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.06 159.92 40.48 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 126.139 2.149 . . . . 0.0 109.15 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.61 14.66 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 125.465 1.728 . . . . 0.0 108.143 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.33 148.67 18.43 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 125.314 1.634 . . . . 0.0 109.347 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.28 88.93 0.11 Allowed Glycine 0 N--CA 1.509 3.505 0 O-C-N 125.048 1.467 . . . . 0.0 111.446 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -155.39 150.97 27.31 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.73 -20.73 0.06 Allowed 'General case' 0 N--CA 1.52 3.046 0 O-C-N 124.738 1.274 . . . . 0.0 111.526 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 p -79.47 -45.05 20.13 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.434 1.084 . . . . 0.0 108.93 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 p -73.03 143.5 47.5 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 125.023 1.452 . . . . 0.0 108.64 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.16 11.84 15.33 Favored 'General case' 0 N--CA 1.536 3.84 0 O-C-N 125.774 1.921 . . . . 0.0 111.768 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -166.17 166.14 17.16 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.36 136.57 8.63 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.033 0.833 . . . . 0.0 111.513 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.97 177.06 7.72 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 126.316 2.26 . . . . 0.0 105.363 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.1 117.98 2.28 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.671 1.232 . . . . 0.0 109.393 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.3 136.53 9.75 Favored 'General case' 0 N--CA 1.527 3.376 0 O-C-N 125.031 1.457 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -82.2 152.5 26.41 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 124.911 1.382 . . . . 0.0 107.594 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -145.03 141.17 28.67 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 125.111 1.507 . . . . 0.0 109.174 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.3 118.77 31.23 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.439 1.712 . . . . 0.0 112.462 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.13 143.48 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.856 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.05 -176.11 3.9 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 124.713 1.258 . . . . 0.0 112.049 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -21.74 60.45 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.406 1.691 . . . . 0.0 111.297 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 26.35 71.43 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-O 117.696 -1.613 . . . . 0.0 115.8 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -74.32 147.53 42.18 Favored 'General case' 0 N--CA 1.528 3.428 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.49 74.34 1.74 Allowed Glycine 0 N--CA 1.515 3.955 0 O-C-N 124.886 1.366 . . . . 0.0 113.941 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.8 101.08 11.36 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.4 m -129.54 145.57 51.45 Favored 'General case' 0 N--CA 1.535 3.804 0 O-C-N 124.91 1.381 . . . . 0.0 112.644 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.96 125.05 28.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 125.074 1.484 . . . . 0.0 111.265 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.45 -24.03 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.88 -23.4 63.25 Favored 'General case' 0 N--CA 1.531 3.58 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -79.85 -19.18 48.99 Favored 'General case' 0 N--CA 1.532 3.667 0 O-C-N 124.508 1.13 . . . . 0.0 113.992 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.32 148.18 52.23 Favored 'General case' 1 N--CA 1.54 4.073 0 O-C-N 124.696 1.247 . . . . 0.0 111.296 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -144.87 -54.73 0.32 Allowed 'General case' 0 N--CA 1.522 3.167 0 O-C-N 125.627 1.829 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 67.71 128.58 0.02 OUTLIER 'General case' 1 N--CA 1.544 4.233 0 O-C-N 124.978 1.424 . . . . 0.0 113.194 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.95 147.88 18.55 Favored 'General case' 0 N--CA 1.515 2.789 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.173 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 m -75.99 151.49 37.2 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.998 1.436 . . . . 0.0 107.959 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.3 mt -79.41 127.13 31.72 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.85 1.344 . . . . 0.0 107.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -69.91 -38.5 76.3 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 124.368 1.043 . . . . 0.0 113.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 49.66 0.12 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.74 22.47 74.75 Favored Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.632 1.431 . . . . 0.0 112.926 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -141.85 156.67 45.53 Favored 'General case' 1 N--CA 1.544 4.234 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 77.94 0.06 OUTLIER Glycine 1 N--CA 1.52 4.244 0 O-C-N 124.149 0.906 . . . . 0.0 112.516 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -75.75 153.65 36.86 Favored 'General case' 0 N--CA 1.52 3.071 0 O-C-N 124.912 1.007 . . . . 0.0 109.74 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.63 138.09 5.99 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.806 1.316 . . . . 0.0 113.365 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.2 p -82.69 111.75 18.92 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.844 1.34 . . . . 0.0 109.866 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.29 151.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.38 139.95 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 129.65 16.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 O-C-N 125.52 1.762 . . . . 0.0 112.286 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -90.2 162.21 15.35 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.964 1.415 . . . . 0.0 107.812 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -65.73 -33.81 76.74 Favored 'General case' 0 N--CA 1.522 3.143 0 O-C-N 124.67 1.231 . . . . 0.0 111.779 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.8 151.87 48.56 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 125.761 1.913 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.09 148.85 20.72 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 124.586 1.179 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.58 101.26 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 125.941 2.025 . . . . 0.0 108.749 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.78 153.27 52.17 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 125.141 1.526 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -135.56 122.67 21.51 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 125.974 1.632 . . . . 0.0 109.023 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.12 147.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.7 mmt -51.89 -53.17 54.28 Favored Pre-proline 0 N--CA 1.531 3.607 0 N-CA-C 120.381 3.474 . . . . 0.0 120.381 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.58 -62.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.402 3.384 0 CA-C-N 125.233 2.905 . . . . 0.0 115.077 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.15 -46.63 0.05 OUTLIER 'General case' 0 N--CA 1.533 3.7 0 O-C-N 124.191 0.932 . . . . 0.0 112.823 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.66 -170.44 41.81 Favored Glycine 1 N--CA 1.516 4.028 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.28 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.65 144.2 79.11 Favored 'Cis proline' 0 C--N 1.41 3.797 0 CA-C-N 123.063 3.432 . . . . 0.0 113.072 -0.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.58 137.66 54.46 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 125.31 1.631 . . . . 0.0 110.494 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -36.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.203 0 O-C-N 125.448 1.718 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.05 -171.79 36.0 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 125.401 1.688 . . . . 0.0 109.695 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.48 110.83 1.57 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 126.039 1.67 . . . . 0.0 113.402 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.64 138.91 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.064 0 O-C-N 125.933 2.021 . . . . 0.0 107.82 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.88 158.13 16.47 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.442 1.714 . . . . 0.0 110.742 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.25 -30.27 57.81 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 124.931 1.394 . . . . 0.0 111.787 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.61 -28.26 67.6 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -30.63 40.87 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 124.429 1.08 . . . . 0.0 112.64 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.94 151.44 97.19 Favored Pre-proline 0 N--CA 1.527 3.419 0 CA-C-O 115.261 -2.304 . . . . 0.0 111.606 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.07 -44.5 0.45 Allowed 'Trans proline' 0 C--N 1.41 3.769 0 CA-C-N 123.643 2.337 . . . . 0.0 113.494 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.23 -45.4 55.73 Favored Glycine 0 N--CA 1.513 3.812 0 O-C-N 124.685 1.241 . . . . 0.0 112.81 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.55 160.37 29.87 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 125.319 1.246 . . . . 0.0 112.125 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.0 145.82 51.51 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 113.958 -1.121 . . . . 0.0 112.902 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.96 139.96 26.56 Favored 'General case' 0 N--CA 1.53 3.546 0 O-C-N 125.621 1.826 . . . . 0.0 108.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -79.9 127.58 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.447 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.93 137.4 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.92 141.49 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.275 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.88 142.65 5.7 Favored Glycine 1 N--CA 1.517 4.057 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -160.5 34.43 Favored Glycine 1 N--CA 1.517 4.081 0 O-C-N 125.469 1.335 . . . . 0.0 112.81 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -71.63 -23.6 61.72 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 125.374 1.279 . . . . 0.0 112.671 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.91 -32.72 71.16 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 124.775 1.297 . . . . 0.0 110.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.21 48.73 Favored Glycine 0 N--CA 1.515 3.93 0 O-C-N 125.809 1.943 . . . . 0.0 113.073 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.69 103.1 3.5 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -74.81 174.63 8.92 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.724 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.45 78.45 0.09 OUTLIER Glycine 0 N--CA 1.506 3.36 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -68.54 155.48 39.88 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.312 1.243 . . . . 0.0 113.292 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.45 100.35 1.18 Allowed 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.088 1.493 . . . . 0.0 109.107 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.14 158.0 34.1 Favored 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.14 176.65 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 O-C-N 126.568 2.418 . . . . 0.0 107.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.3 m -160.77 121.09 2.8 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.785 1.303 . . . . 0.0 109.78 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -72.78 156.73 38.61 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 124.554 1.159 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.627 0 CA-C-O 116.355 -2.358 . . . . 0.0 111.464 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -163.98 -40.92 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 O-C-N 125.442 1.714 . . . . 0.0 109.595 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 109.16 4.23 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.997 2.06 . . . . 0.0 111.302 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 126.95 31.69 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.47 1.106 . . . . 0.0 111.307 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.33 138.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.1 143.62 9.28 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 124.848 1.343 . . . . 0.0 110.135 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.33 144.03 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -161.84 112.87 1.19 Allowed Pre-proline 0 N--CA 1.524 3.242 0 CA-C-O 115.092 -2.385 . . . . 0.0 109.918 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.34 149.97 67.6 Favored 'Cis proline' 1 C--N 1.424 4.549 0 CA-C-N 125.25 2.911 . . . . 0.0 112.492 -4.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.85 -9.23 1.59 Allowed 'General case' 0 N--CA 1.528 3.437 0 O-C-N 125.916 2.01 . . . . 0.0 112.619 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.5 p -133.64 152.06 51.81 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.102 1.501 . . . . 0.0 109.648 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.31 65.2 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.023 1.452 . . . . 0.0 112.143 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 mt -73.29 154.23 40.24 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 125.349 1.264 . . . . 0.0 110.551 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.59 -175.36 3.63 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 126.274 2.234 . . . . 0.0 107.946 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.41 127.1 30.99 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.659 1.224 . . . . 0.0 112.735 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.32 28.2 72.86 Favored Glycine 0 N--CA 1.513 3.802 0 O-C-N 124.637 1.21 . . . . 0.0 113.318 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 125.52 27.61 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.945 1.027 . . . . 0.0 112.233 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -78.98 134.57 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.09 140.39 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.349 1.655 . . . . 0.0 108.401 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.6 m -107.36 101.77 11.11 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 126.15 2.156 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.87 148.03 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.997 0 N-CA-C 104.492 -2.411 . . . . 0.0 104.492 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -137.69 161.57 36.16 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.969 2.043 . . . . 0.0 109.463 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 146.22 15.51 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 125.467 1.73 . . . . 0.0 108.278 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.92 146.53 16.1 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 124.986 1.429 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.13 88.4 0.14 Allowed Glycine 0 N--CA 1.509 3.566 0 O-C-N 125.007 1.442 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -155.08 152.62 29.76 Favored 'General case' 0 N--CA 1.514 2.751 0 O-C-N 125.573 1.396 . . . . 0.0 107.408 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.76 -18.71 0.05 Allowed 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.774 1.297 . . . . 0.0 111.52 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.58 -53.39 6.9 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 124.309 1.006 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -71.27 129.77 39.71 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.665 1.228 . . . . 0.0 110.704 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -79.93 -28.61 39.72 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 t -154.67 172.26 18.19 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 125.144 1.527 . . . . 0.0 107.574 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.99 144.75 5.92 Favored 'General case' 0 N--CA 1.521 3.113 0 O-C-N 124.535 1.147 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -128.64 133.14 48.18 Favored 'General case' 0 N--CA 1.522 3.172 0 O-C-N 126.147 2.155 . . . . 0.0 107.108 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.46 107.5 19.19 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.922 1.389 . . . . 0.0 110.319 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -123.06 144.13 49.5 Favored 'General case' 0 N--CA 1.528 3.444 0 O-C-N 125.103 1.502 . . . . 0.0 110.568 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.77 141.1 46.96 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m -146.55 138.16 24.57 Favored 'General case' 0 N--CA 1.531 3.58 0 O-C-N 124.832 1.333 . . . . 0.0 110.427 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.58 118.45 29.22 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 125.172 1.545 . . . . 0.0 111.83 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mm -81.3 123.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.88 -177.9 3.91 Favored 'General case' 0 N--CA 1.523 3.183 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -44.51 77.84 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 124.769 1.293 . . . . 0.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -19.16 61.45 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 125.117 1.511 . . . . 0.0 112.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.34 9.98 78.38 Favored Glycine 1 N--CA 1.517 4.043 0 CA-C-O 116.933 -2.037 . . . . 0.0 115.881 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -71.38 137.0 48.02 Favored 'General case' 0 N--CA 1.529 3.484 0 CA-C-N 118.38 1.09 . . . . 0.0 108.228 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.16 106.13 1.81 Allowed Glycine 0 N--CA 1.51 3.598 0 CA-C-O 118.583 -1.121 . . . . 0.0 115.691 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.78 106.18 15.7 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -135.2 143.54 46.47 Favored 'General case' 0 N--CA 1.526 3.349 0 O-C-N 124.865 1.353 . . . . 0.0 110.875 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -84.33 141.03 31.2 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 125.377 1.673 . . . . 0.0 109.896 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.07 -25.06 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 O-C-N 125.537 1.773 . . . . 0.0 114.786 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.03 -22.46 49.18 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -81.49 -1.59 46.56 Favored 'General case' 1 N--CA 1.543 4.215 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.74 160.17 17.71 Favored 'General case' 0 N--CA 1.53 3.562 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -152.75 127.8 9.71 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 125.834 1.959 . . . . 0.0 106.46 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.21 136.6 44.43 Favored 'General case' 0 N--CA 1.524 3.239 0 O-C-N 126.076 2.11 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -160.08 154.29 23.44 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 124.732 1.27 . . . . 0.0 107.776 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 m -126.69 147.47 49.94 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 125.947 2.029 . . . . 0.0 108.212 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.64 150.51 30.95 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 125.016 1.447 . . . . 0.0 108.917 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -148.67 8.39 0.78 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 125.433 1.708 . . . . 0.0 110.037 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.92 22.92 0.05 OUTLIER Glycine 0 N--CA 1.509 3.537 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.34 13.89 82.43 Favored Glycine 0 N--CA 1.512 3.709 0 CA-C-O 117.516 -1.713 . . . . 0.0 114.372 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.42 161.59 34.15 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.83 75.64 0.07 OUTLIER Glycine 1 N--CA 1.516 4.026 0 O-C-N 124.367 1.042 . . . . 0.0 112.123 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.97 153.27 38.62 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.041 1.083 . . . . 0.0 110.162 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.64 138.04 5.96 Favored 'General case' 0 N--CA 1.533 3.705 0 O-C-N 124.918 1.386 . . . . 0.0 112.917 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -83.36 113.37 20.68 Favored 'General case' 0 N--CA 1.521 3.117 0 O-C-N 124.815 1.322 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.69 152.39 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.53 142.53 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.19 127.1 26.73 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.06 0 O-C-N 125.555 1.784 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -90.21 156.59 18.2 Favored 'General case' 0 N--CA 1.524 3.248 0 O-C-N 124.868 1.355 . . . . 0.0 108.467 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -68.46 -26.22 65.39 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 124.578 1.174 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.53 146.86 38.66 Favored 'General case' 0 N--CA 1.53 3.559 0 O-C-N 125.277 1.61 . . . . 0.0 109.795 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -155.79 146.65 22.21 Favored 'General case' 0 N--CA 1.525 3.28 0 O-C-N 124.838 1.336 . . . . 0.0 112.153 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -71.67 109.42 5.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 125.576 1.797 . . . . 0.0 110.038 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.05 145.55 39.8 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -129.65 85.06 2.26 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 125.893 1.584 . . . . 0.0 109.353 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.38 96.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.77 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.9 mtm 56.58 169.01 0.05 OUTLIER Pre-proline 2 N--CA 1.56 5.029 0 C-N-CA 126.298 1.839 . . . . 0.0 114.216 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.59 -11.31 29.55 Favored 'Trans proline' 1 C--N 1.433 5.013 0 CA-C-N 124.859 2.771 . . . . 0.0 114.446 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.52 -39.69 31.4 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 124.333 1.021 . . . . 0.0 113.55 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.96 -159.78 50.95 Favored Glycine 2 CA--C 1.586 4.52 0 CA-C-O 115.333 -2.926 . . . . 0.0 109.109 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.81 153.34 83.59 Favored 'Cis proline' 0 C--N 1.404 3.481 0 CA-C-N 124.005 3.902 . . . . 0.0 113.991 -0.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -71.12 137.03 48.5 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 125.578 1.799 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -39.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 O-C-N 125.039 1.462 . . . . 0.0 112.292 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.83 -172.21 21.56 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 125.68 1.863 . . . . 0.0 108.967 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 117.31 6.85 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 125.741 1.495 . . . . 0.0 113.817 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.86 133.46 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 O-C-N 126.132 2.145 . . . . 0.0 107.564 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.035 1.459 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.6 t -80.12 79.84 6.62 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 125.136 1.523 . . . . 0.0 110.397 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.42 -36.78 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.593 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.7 p -79.79 -19.31 48.88 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 125.325 1.64 . . . . 0.0 111.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 147.26 98.64 Favored Pre-proline 0 N--CA 1.519 2.986 0 CA-C-O 114.738 -2.553 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.13 -45.97 0.33 Allowed 'Trans proline' 0 C--N 1.408 3.677 0 CA-C-N 124.091 2.497 . . . . 0.0 112.876 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.47 -47.4 28.36 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.62 1.2 . . . . 0.0 112.764 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.7 162.74 37.69 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 125.496 1.351 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.99 148.1 49.31 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.794 0.937 . . . . 0.0 112.577 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -148.05 133.44 18.57 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 125.839 1.962 . . . . 0.0 107.319 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.85 134.67 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -130.78 134.15 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -128.61 130.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.35 152.16 10.39 Favored Glycine 0 N--CA 1.514 3.846 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -163.08 37.87 Favored Glycine 0 N--CA 1.509 3.565 0 O-C-N 125.735 1.491 . . . . 0.0 112.231 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.58 -6.7 59.14 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.952 1.619 . . . . 0.0 112.697 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.99 -68.12 0.44 Allowed 'General case' 0 N--CA 1.517 2.902 0 O-C-N 124.89 1.369 . . . . 0.0 111.783 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.33 -23.42 0.09 OUTLIER Glycine 1 N--CA 1.519 4.203 0 CA-C-O 118.562 -1.132 . . . . 0.0 112.981 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -67.27 150.45 49.03 Favored 'General case' 0 N--CA 1.525 3.287 0 O-C-N 124.988 1.052 . . . . 0.0 111.976 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.75 147.21 48.32 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 125.94 2.025 . . . . 0.0 109.802 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.38 -65.2 1.81 Allowed Glycine 0 N--CA 1.516 3.975 0 O-C-N 124.597 1.186 . . . . 0.0 113.821 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 66.65 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.536 3.849 0 C-N-CA 125.523 1.529 . . . . 0.0 112.75 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 106.26 1.23 Allowed 'General case' 0 N--CA 1.53 3.544 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 155.52 40.17 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 124.235 0.959 . . . . 0.0 112.586 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.17 167.78 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 126.481 2.363 . . . . 0.0 108.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -137.49 169.09 18.37 Favored 'General case' 0 N--CA 1.523 3.185 0 O-C-N 124.95 1.406 . . . . 0.0 109.301 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.38 148.01 52.62 Favored 'General case' 0 N--CA 1.522 3.171 0 O-C-N 126.246 2.216 . . . . 0.0 109.039 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.585 0 CA-C-O 116.365 -2.353 . . . . 0.0 111.385 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -75.49 -12.64 60.28 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.06 1.475 . . . . 0.0 114.226 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.95 156.92 36.18 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 124.73 1.269 . . . . 0.0 113.246 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.11 132.27 6.28 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.443 1.714 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.27 145.52 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -160.71 145.48 14.2 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 125.312 1.632 . . . . 0.0 109.867 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.22 147.32 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.59 108.74 1.64 Allowed Pre-proline 0 N--CA 1.526 3.342 0 CA-C-O 115.416 -2.23 . . . . 0.0 109.788 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -62.02 162.63 45.75 Favored 'Cis proline' 2 C--N 1.426 4.654 0 CA-C-N 124.905 2.788 . . . . 0.0 113.235 -3.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.26 -6.58 0.73 Allowed 'General case' 0 N--CA 1.534 3.743 0 O-C-N 124.764 1.29 . . . . 0.0 112.619 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -138.3 153.58 49.02 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 124.914 1.384 . . . . 0.0 109.551 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.58 30.19 66.83 Favored Glycine 0 N--CA 1.512 3.752 0 O-C-N 124.977 1.423 . . . . 0.0 113.201 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 mt -72.9 153.87 40.82 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 125.296 1.233 . . . . 0.0 109.83 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.15 -175.83 3.62 Favored 'General case' 0 N--CA 1.523 3.221 0 O-C-N 126.003 2.064 . . . . 0.0 109.772 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.11 131.05 45.03 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 124.675 1.234 . . . . 0.0 112.363 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.78 30.04 66.59 Favored Glycine 0 N--CA 1.514 3.896 0 O-C-N 124.699 1.249 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 146.3 48.62 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.154 1.149 . . . . 0.0 111.841 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -115.27 124.3 50.98 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.317 2.261 . . . . 0.0 105.4 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.22 151.53 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.204 0 O-C-N 125.892 1.995 . . . . 0.0 110.559 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -111.02 100.45 9.14 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 126.185 2.178 . . . . 0.0 108.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.78 145.27 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 160.89 36.13 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 126.102 2.126 . . . . 0.0 109.647 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.14 16.72 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 125.423 1.702 . . . . 0.0 108.378 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -156.37 144.91 19.98 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.39 1.681 . . . . 0.0 109.831 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.09 88.11 0.12 Allowed Glycine 0 N--CA 1.51 3.598 0 O-C-N 125.109 1.506 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -154.87 148.74 25.63 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 125.628 1.428 . . . . 0.0 108.036 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.35 -18.92 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 124.801 1.313 . . . . 0.0 111.256 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.6 -41.66 26.62 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 124.255 0.972 . . . . 0.0 110.743 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -67.24 142.11 57.03 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 125.224 1.578 . . . . 0.0 110.424 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 p -79.9 -26.06 40.36 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.956 1.41 . . . . 0.0 113.203 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -170.06 133.57 1.18 Allowed 'General case' 0 N--CA 1.516 2.839 0 O-C-N 124.585 1.178 . . . . 0.0 109.005 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.0 139.95 45.14 Favored 'General case' 0 N--CA 1.515 2.781 0 O-C-N 124.756 1.285 . . . . 0.0 111.411 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.75 169.62 17.38 Favored 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -162.19 126.36 3.19 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 124.925 1.391 . . . . 0.0 110.997 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 144.76 15.06 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.215 1.572 . . . . 0.0 110.434 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 148.54 25.92 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 125.367 1.667 . . . . 0.0 108.977 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -139.73 140.23 36.72 Favored 'General case' 0 N--CA 1.529 3.503 0 O-C-N 125.609 1.818 . . . . 0.0 109.752 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.38 27.46 Favored 'General case' 0 N--CA 1.517 2.887 0 O-C-N 125.15 1.531 . . . . 0.0 113.011 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.31 142.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.002 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -128.05 -176.38 3.77 Favored 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.26 89.85 Favored 'General case' 0 N--CA 1.515 2.787 0 O-C-N 124.811 1.319 . . . . 0.0 112.122 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -20.74 59.63 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 125.408 1.693 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.08 76.67 Favored Glycine 0 N--CA 1.511 3.648 0 CA-C-O 117.377 -1.79 . . . . 0.0 115.853 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -73.5 142.05 46.78 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 93.35 0.35 Allowed Glycine 0 N--CA 1.511 3.693 0 O-C-N 124.811 1.319 . . . . 0.0 114.322 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.23 101.2 10.76 Favored 'General case' 0 N--CA 1.518 2.936 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -138.34 154.44 48.97 Favored 'General case' 0 N--CA 1.527 3.393 0 O-C-N 124.441 1.088 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -99.64 107.24 19.31 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 126.572 2.42 . . . . 0.0 107.958 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.69 -16.76 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.134 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.41 63.78 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -86.42 8.14 22.94 Favored 'General case' 1 N--CA 1.55 4.54 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -69.32 169.69 11.78 Favored 'General case' 0 N--CA 1.534 3.747 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -137.94 -61.18 0.62 Allowed 'General case' 0 N--CA 1.516 2.825 0 O-C-N 125.705 1.878 . . . . 0.0 109.542 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 52.86 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.793 0 O-C-N 125.334 1.646 . . . . 0.0 115.014 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -156.06 153.04 28.78 Favored 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 m -62.0 157.67 18.17 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.44 145.73 33.15 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.911 1.382 . . . . 0.0 108.373 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -71.52 -33.01 68.82 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 124.664 1.227 . . . . 0.0 111.364 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.4 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.5 2.905 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.31 24.58 0.04 OUTLIER Glycine 0 N--CA 1.502 3.069 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.413 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.34 161.06 39.33 Favored 'General case' 0 N--CA 1.537 3.894 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.41 76.59 0.08 OUTLIER Glycine 0 N--CA 1.513 3.787 0 O-C-N 124.275 0.985 . . . . 0.0 112.054 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 m -74.42 147.54 41.95 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 125.284 1.226 . . . . 0.0 109.468 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.44 135.62 7.9 Favored 'General case' 0 N--CA 1.529 3.492 0 O-C-N 124.799 1.312 . . . . 0.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -86.76 114.4 23.4 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.133 1.521 . . . . 0.0 111.425 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.7 t -107.66 149.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.72 142.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.18 134.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 O-C-N 125.346 1.654 . . . . 0.0 112.78 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -90.27 166.69 13.19 Favored 'General case' 0 N--CA 1.517 2.921 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -65.58 -27.95 68.79 Favored 'General case' 0 N--CA 1.532 3.638 0 O-C-N 124.257 0.973 . . . . 0.0 111.896 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.7 151.51 41.42 Favored 'General case' 0 N--CA 1.525 3.319 0 O-C-N 125.53 1.769 . . . . 0.0 108.749 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.21 147.51 24.88 Favored 'General case' 0 N--CA 1.526 3.358 0 O-C-N 124.935 1.397 . . . . 0.0 111.72 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.7 m -65.8 108.44 2.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 125.791 1.932 . . . . 0.0 112.209 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.28 150.56 43.96 Favored Glycine 0 N--CA 1.513 3.774 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -133.92 90.36 2.69 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.589 1.405 . . . . 0.0 109.824 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.95 109.49 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.229 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.407 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.8 172.08 0.02 OUTLIER Pre-proline 2 N--CA 1.567 5.422 0 C-N-CA 126.652 1.981 . . . . 0.0 116.287 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.64 -13.64 29.94 Favored 'Trans proline' 1 C--N 1.425 4.588 0 CA-C-N 123.731 2.368 . . . . 0.0 114.095 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.69 -39.59 30.93 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.89 -161.62 51.2 Favored Glycine 2 CA--C 1.586 4.492 0 CA-C-O 115.442 -2.865 . . . . 0.0 108.658 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.73 156.43 82.71 Favored 'Cis proline' 0 C--N 1.402 3.378 0 CA-C-N 123.931 3.865 . . . . 0.0 114.131 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.17 138.69 52.03 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 125.623 1.827 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -40.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 O-C-N 125.011 1.444 . . . . 0.0 112.61 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.56 -175.11 23.29 Favored Glycine 0 N--CA 1.508 3.448 0 O-C-N 125.516 1.76 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 116.55 5.56 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 125.78 1.517 . . . . 0.0 113.883 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.53 138.46 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 126.046 2.091 . . . . 0.0 108.125 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.67 152.04 21.01 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 125.309 1.631 . . . . 0.0 110.84 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.2 m -75.46 -27.68 58.97 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.583 1.177 . . . . 0.0 111.507 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 -29.16 68.19 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.65 -30.69 41.32 Favored 'General case' 0 N--CA 1.528 3.455 0 O-C-N 124.408 1.068 . . . . 0.0 112.309 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.39 152.78 96.36 Favored Pre-proline 0 N--CA 1.527 3.4 0 CA-C-O 115.125 -2.369 . . . . 0.0 111.364 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -72.73 -47.77 0.34 Allowed 'Trans proline' 0 C--N 1.41 3.795 0 CA-C-N 123.624 2.33 . . . . 0.0 113.317 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.19 -48.24 26.39 Favored Glycine 0 N--CA 1.512 3.759 0 O-C-N 124.712 1.258 . . . . 0.0 111.976 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.13 166.84 38.65 Favored Glycine 0 N--CA 1.515 3.96 0 O-C-N 125.303 1.237 . . . . 0.0 112.404 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.95 151.31 45.77 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-N 114.014 -1.093 . . . . 0.0 112.617 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.61 145.82 19.09 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 125.247 1.592 . . . . 0.0 109.209 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.71 130.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 O-C-N 125.273 1.608 . . . . 0.0 107.16 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 t -123.47 131.12 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.74 142.19 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.44 -153.84 17.44 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.049 0.843 . . . . 0.0 111.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.38 -167.38 24.81 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -69.9 -20.36 63.37 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.26 -22.0 2.02 Favored 'General case' 0 N--CA 1.538 3.965 0 O-C-N 124.751 1.282 . . . . 0.0 111.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.64 -15.23 63.88 Favored Glycine 1 N--CA 1.524 4.542 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.342 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 168.2 0.26 Allowed 'General case' 1 N--CA 1.546 4.366 0 C-N-CA 124.741 1.216 . . . . 0.0 112.428 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -70.0 164.5 23.81 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.922 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.65 90.79 0.12 Allowed Glycine 0 N--CA 1.516 3.986 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.02 149.23 50.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 125.362 1.272 . . . . 0.0 113.619 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.85 0.97 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 124.958 1.411 . . . . 0.0 108.328 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.99 153.51 42.59 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.11 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.71 170.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.758 0 O-C-N 126.396 2.31 . . . . 0.0 107.608 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -156.95 118.22 3.72 Favored 'General case' 0 N--CA 1.525 3.278 0 O-C-N 124.283 0.99 . . . . 0.0 110.736 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -71.21 153.77 42.2 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.522 1.139 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 CA-C-O 116.249 -2.417 . . . . 0.0 109.752 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 t -167.52 92.13 0.38 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 125.335 1.647 . . . . 0.0 107.406 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.81 121.47 1.52 Allowed 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.551 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 127.0 31.75 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.687 1.242 . . . . 0.0 112.015 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.61 138.88 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.105 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.03 144.73 8.44 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.82 1.325 . . . . 0.0 110.574 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.45 147.5 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -158.18 108.87 1.72 Allowed Pre-proline 0 N--CA 1.525 3.28 0 CA-C-O 115.377 -2.249 . . . . 0.0 110.131 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.1 162.73 51.92 Favored 'Cis proline' 2 C--N 1.425 4.572 0 CA-C-N 124.812 2.754 . . . . 0.0 112.831 -4.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.6 -8.69 1.25 Allowed 'General case' 0 N--CA 1.535 3.823 0 O-C-N 124.753 1.283 . . . . 0.0 112.846 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -136.78 154.41 50.56 Favored 'General case' 0 N--CA 1.525 3.31 0 O-C-N 125.269 1.606 . . . . 0.0 108.556 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.29 30.26 62.97 Favored Glycine 0 N--CA 1.511 3.667 0 O-C-N 124.944 1.402 . . . . 0.0 111.943 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 mt -75.32 154.09 37.52 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 125.378 1.281 . . . . 0.0 109.411 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.09 -175.36 3.47 Favored 'General case' 0 N--CA 1.524 3.228 0 O-C-N 126.026 2.079 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.43 127.57 32.81 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 124.761 1.288 . . . . 0.0 112.521 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.6 28.97 71.65 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.56 1.162 . . . . 0.0 113.013 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.05 127.04 31.3 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 124.91 1.006 . . . . 0.0 112.564 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -89.27 129.93 35.75 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.67 148.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 O-C-N 125.168 1.542 . . . . 0.0 110.465 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -103.05 97.25 7.38 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 125.956 2.035 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.87 148.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.62 161.59 34.22 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 125.804 1.94 . . . . 0.0 110.466 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 139.82 11.15 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.526 1.766 . . . . 0.0 108.042 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.39 142.83 14.58 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 125.129 1.518 . . . . 0.0 109.473 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.82 97.32 0.05 OUTLIER Glycine 0 N--CA 1.512 3.719 0 O-C-N 125.229 1.581 . . . . 0.0 111.432 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -154.21 153.16 31.29 Favored 'General case' 0 N--CA 1.513 2.683 0 O-C-N 125.371 1.277 . . . . 0.0 108.076 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.2 -16.99 0.08 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 125.254 1.596 . . . . 0.0 111.166 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.54 -59.97 2.54 Favored 'General case' 0 N--CA 1.517 2.924 0 O-C-N 124.207 0.942 . . . . 0.0 109.402 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 119.23 15.72 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 124.717 1.26 . . . . 0.0 109.984 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 p -79.9 -13.1 59.63 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 124.466 1.104 . . . . 0.0 112.656 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -167.65 148.6 5.36 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.37 165.67 26.87 Favored 'General case' 0 N--CA 1.519 3.024 0 O-C-N 125.607 1.817 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -158.95 108.22 1.93 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.12 42.91 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 124.379 1.049 . . . . 0.0 113.385 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 143.71 11.51 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 124.897 1.373 . . . . 0.0 111.007 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 147.7 23.97 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.363 1.665 . . . . 0.0 106.756 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.81 144.57 33.99 Favored 'General case' 0 N--CA 1.527 3.399 0 O-C-N 125.434 1.709 . . . . 0.0 109.497 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.52 118.79 32.88 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.451 1.719 . . . . 0.0 111.809 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.7 139.59 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.08 -177.12 3.84 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 125.686 1.867 . . . . 0.0 106.376 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.02 97.8 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.466 1.104 . . . . 0.0 112.245 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -19.13 57.91 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 125.407 1.692 . . . . 0.0 111.206 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.67 78.55 Favored Glycine 0 N--CA 1.511 3.641 0 CA-C-O 117.316 -1.824 . . . . 0.0 115.992 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -73.66 143.62 46.19 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.42 87.84 0.42 Allowed Glycine 0 N--CA 1.514 3.861 0 O-C-N 124.859 1.349 . . . . 0.0 113.84 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.72 92.69 6.31 Favored 'General case' 0 N--CA 1.517 2.891 0 O-C-N 125.725 1.485 . . . . 0.0 107.593 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -129.14 146.57 51.04 Favored 'General case' 0 N--CA 1.527 3.412 0 O-C-N 125.028 1.455 . . . . 0.0 110.873 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -86.05 127.38 34.66 Favored 'General case' 0 N--CA 1.514 2.77 0 O-C-N 125.61 1.819 . . . . 0.0 111.233 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.66 -24.17 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.83 62.32 Favored 'General case' 0 N--CA 1.533 3.684 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.84 5.67 18.09 Favored 'General case' 0 N--CA 1.536 3.873 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -64.32 146.98 53.53 Favored 'General case' 0 N--CA 1.537 3.912 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.043 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -152.42 -64.29 0.16 Allowed 'General case' 0 N--CA 1.533 3.701 0 CA-C-O 117.138 -1.411 . . . . 0.0 114.525 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.72 159.7 29.59 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -136.92 -157.74 0.8 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 126.731 2.52 . . . . 0.0 105.692 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.8 p -53.04 144.5 15.07 Favored 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.5 132.72 36.41 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 125.124 1.515 . . . . 0.0 109.633 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -75.26 -32.77 61.17 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.116 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 48.51 0.13 Allowed Glycine 0 N--CA 1.505 3.235 0 O-C-N 125.158 1.536 . . . . 0.0 110.605 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 28.17 68.9 Favored Glycine 0 N--CA 1.507 3.404 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.271 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -143.1 154.0 43.48 Favored 'General case' 1 N--CA 1.544 4.256 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.9 79.0 0.06 OUTLIER Glycine 1 N--CA 1.517 4.039 0 O-C-N 124.393 1.058 . . . . 0.0 112.403 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -74.9 152.61 38.85 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.079 1.105 . . . . 0.0 108.905 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.51 141.83 7.84 Favored 'General case' 0 N--CA 1.526 3.352 0 O-C-N 124.808 1.317 . . . . 0.0 113.339 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -92.1 110.09 21.46 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.164 1.54 . . . . 0.0 108.541 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.83 149.72 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 O-C-N 125.187 1.554 . . . . 0.0 107.239 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.37 140.0 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.41 124.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 O-C-N 125.626 1.829 . . . . 0.0 112.115 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -90.22 161.48 15.69 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.836 1.335 . . . . 0.0 107.758 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -67.48 -32.4 73.2 Favored 'General case' 0 N--CA 1.518 2.95 0 O-C-N 124.664 1.227 . . . . 0.0 111.687 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.38 147.24 51.77 Favored 'General case' 0 N--CA 1.53 3.561 0 O-C-N 125.988 2.055 . . . . 0.0 109.97 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -157.74 147.75 20.4 Favored 'General case' 0 N--CA 1.528 3.44 0 O-C-N 124.805 1.316 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -72.31 101.53 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 125.78 1.925 . . . . 0.0 108.854 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 155.16 51.98 Favored Glycine 0 N--CA 1.51 3.59 0 O-C-N 124.979 1.425 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -140.53 119.91 13.07 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.696 1.468 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.9 t -71.3 132.92 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.1 mmt -52.87 -58.62 11.39 Favored Pre-proline 0 N--CA 1.534 3.757 0 CA-C-O 113.129 -3.32 . . . . 0.0 119.611 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -53.68 -57.34 1.97 Allowed 'Trans proline' 0 C--N 1.405 3.52 0 CA-C-N 125.65 3.054 . . . . 0.0 117.334 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.13 -53.33 0.05 Allowed 'General case' 0 N--CA 1.537 3.924 0 CA-C-N 119.962 1.255 . . . . 0.0 112.549 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.72 -168.7 39.27 Favored Glycine 1 N--CA 1.517 4.072 0 CA-C-O 115.561 -2.8 . . . . 0.0 108.683 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.66 148.69 92.33 Favored 'Cis proline' 0 N--CA 1.529 3.578 0 CA-C-N 123.172 3.486 . . . . 0.0 113.417 -0.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -73.55 132.61 43.04 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.241 1.588 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.42 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 O-C-N 125.105 1.503 . . . . 0.0 112.099 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 -170.19 37.32 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.22 110.65 1.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.97 1.629 . . . . 0.0 113.221 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.95 135.67 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 126.061 2.101 . . . . 0.0 108.335 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.73 154.53 28.49 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.916 1.385 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.5 t -78.83 -29.47 44.72 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 124.972 1.42 . . . . 0.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.29 -22.07 62.0 Favored 'General case' 0 N--CA 1.515 2.823 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.3 p -79.69 -28.7 40.66 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 124.303 1.002 . . . . 0.0 113.304 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.1 150.74 96.45 Favored Pre-proline 0 N--CA 1.529 3.501 0 CA-C-O 115.26 -2.305 . . . . 0.0 112.183 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -73.61 -46.36 0.35 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.613 2.326 . . . . 0.0 113.515 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.22 -43.98 61.56 Favored Glycine 0 N--CA 1.512 3.751 0 O-C-N 124.608 1.192 . . . . 0.0 112.885 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.7 160.62 30.56 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 125.198 1.175 . . . . 0.0 111.591 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.96 154.72 41.58 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.942 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -162.11 145.97 12.16 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.2 1.562 . . . . 0.0 108.592 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.69 135.99 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.1 t -134.4 132.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.51 140.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.85 -132.5 1.7 Allowed Glycine 1 N--CA 1.52 4.25 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.19 -158.19 15.78 Favored Glycine 0 N--CA 1.505 3.299 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -73.37 -13.28 61.07 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.61 -73.8 0.16 Allowed 'General case' 0 N--CA 1.522 3.138 0 O-C-N 124.685 1.241 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.85 -23.44 0.24 Allowed Glycine 1 N--CA 1.517 4.068 0 CA-C-O 118.617 -1.101 . . . . 0.0 112.229 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.7 108.83 1.83 Allowed 'General case' 0 N--CA 1.521 3.096 0 O-C-N 125.224 1.191 . . . . 0.0 112.325 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -80.12 153.72 28.51 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.615 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.92 -60.98 1.89 Allowed Glycine 1 N--CA 1.518 4.148 0 O-C-N 125.116 1.51 . . . . 0.0 111.479 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.85 121.14 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 125.609 1.563 . . . . 0.0 114.734 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.39 96.86 0.78 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.94 31.63 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.416 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.81 176.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.708 0 O-C-N 126.507 2.38 . . . . 0.0 107.14 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -163.65 115.01 1.4 Allowed 'General case' 0 N--CA 1.519 3.007 0 O-C-N 125.014 1.446 . . . . 0.0 109.01 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.43 153.31 43.11 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.48 1.112 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.273 0 CA-C-O 116.356 -2.358 . . . . 0.0 109.798 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -166.8 90.89 0.4 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.29 1.619 . . . . 0.0 107.091 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.79 80.04 0.18 Allowed 'General case' 0 N--CA 1.527 3.422 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.929 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 130.57 35.42 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.71 138.87 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.98 143.03 10.72 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 124.855 1.347 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.69 143.04 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -158.51 112.59 1.68 Allowed Pre-proline 0 N--CA 1.523 3.198 0 CA-C-O 114.945 -2.455 . . . . 0.0 109.66 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.04 150.16 75.01 Favored 'Cis proline' 1 C--N 1.423 4.448 0 CA-C-N 125.401 2.965 . . . . 0.0 112.113 -3.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.76 -16.98 1.47 Allowed 'General case' 0 N--CA 1.528 3.464 0 O-C-N 125.897 1.998 . . . . 0.0 112.496 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.58 151.37 44.85 Favored 'General case' 0 N--CA 1.525 3.282 0 O-C-N 125.765 1.916 . . . . 0.0 110.915 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.89 66.1 Favored Glycine 1 N--CA 1.517 4.095 0 O-C-N 124.91 1.381 . . . . 0.0 112.5 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.8 mt -74.15 154.42 39.11 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 125.481 1.342 . . . . 0.0 110.715 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.57 -175.3 3.61 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.393 2.308 . . . . 0.0 108.324 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.46 127.91 34.15 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.767 1.292 . . . . 0.0 112.894 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.75 71.64 Favored Glycine 0 N--CA 1.515 3.922 0 O-C-N 124.703 1.252 . . . . 0.0 113.174 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.51 123.26 22.78 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 124.841 0.965 . . . . 0.0 112.663 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 m -80.65 129.92 34.8 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.11 141.01 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 O-C-N 125.722 1.888 . . . . 0.0 109.249 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.1 m -105.61 101.66 11.16 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 126.145 2.153 . . . . 0.0 110.44 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.79 147.71 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.08 158.75 43.65 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.998 2.061 . . . . 0.0 109.072 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.34 16.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.302 1.626 . . . . 0.0 108.123 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -157.37 145.13 18.9 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 125.2 1.563 . . . . 0.0 109.714 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.6 86.1 0.17 Allowed Glycine 0 N--CA 1.507 3.422 0 O-C-N 125.181 1.55 . . . . 0.0 110.412 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -151.87 149.54 29.09 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 125.732 1.489 . . . . 0.0 108.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.19 -15.55 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.952 0 O-C-N 125.038 1.461 . . . . 0.0 111.166 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.43 -49.65 12.0 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 p -66.89 140.4 57.78 Favored 'General case' 0 N--CA 1.519 3.022 0 O-C-N 124.94 1.4 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -81.12 -18.41 46.55 Favored 'General case' 0 N--CA 1.524 3.226 0 O-C-N 125.051 1.469 . . . . 0.0 113.909 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 m -169.98 133.58 1.2 Allowed 'General case' 0 N--CA 1.518 2.972 0 O-C-N 124.704 1.253 . . . . 0.0 109.531 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.53 145.44 36.94 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.741 1.276 . . . . 0.0 110.072 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -154.15 156.46 37.22 Favored 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.42 115.79 9.0 Favored 'General case' 0 N--CA 1.524 3.243 0 O-C-N 125.1 1.5 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.05 153.56 31.48 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 125.713 1.883 . . . . 0.0 109.188 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -127.34 114.53 17.69 Favored 'General case' 0 N--CA 1.52 3.062 0 O-C-N 126.144 2.152 . . . . 0.0 106.041 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.3 m -126.08 157.03 39.02 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.689 1.868 . . . . 0.0 111.615 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.42 123.89 49.55 Favored 'General case' 0 N--CA 1.523 3.223 0 O-C-N 126.185 2.178 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -80.4 121.06 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 O-C-N 125.076 1.485 . . . . 0.0 107.736 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.53 -175.84 3.2 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.85 -44.83 84.3 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 124.64 1.212 . . . . 0.0 111.799 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.25 61.26 Favored 'General case' 0 N--CA 1.526 3.366 0 O-C-N 125.261 1.601 . . . . 0.0 111.556 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.64 22.57 57.99 Favored Glycine 0 N--CA 1.516 3.972 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.512 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -72.95 142.37 47.81 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.37 72.83 2.29 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.803 1.314 . . . . 0.0 113.311 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.97 12.04 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 124.865 0.979 . . . . 0.0 108.442 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.95 140.7 46.93 Favored 'General case' 0 N--CA 1.521 3.091 0 O-C-N 125.218 1.574 . . . . 0.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -81.78 115.0 20.8 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 125.354 1.659 . . . . 0.0 107.885 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.12 -16.43 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.19 63.04 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -84.16 4.03 32.34 Favored 'General case' 1 N--CA 1.55 4.53 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -68.64 169.94 10.19 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -138.39 -67.37 0.47 Allowed 'General case' 0 N--CA 1.517 2.886 0 O-C-N 125.876 1.985 . . . . 0.0 108.461 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 52.83 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -156.11 153.02 28.67 Favored 'General case' 0 N--CA 1.523 3.212 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -60.4 156.0 16.9 Favored 'General case' 0 N--CA 1.517 2.902 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.48 144.33 34.11 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.9 1.375 . . . . 0.0 107.954 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -72.39 -25.94 61.69 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.379 1.05 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.68 -39.58 0.08 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.13 24.93 0.04 OUTLIER Glycine 0 N--CA 1.501 3.033 0 O-C-N 125.324 1.25 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.24 158.7 43.43 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.69 77.52 0.08 OUTLIER Glycine 0 N--CA 1.513 3.816 0 O-C-N 124.399 1.062 . . . . 0.0 112.04 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -74.69 151.22 39.26 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.232 1.195 . . . . 0.0 109.205 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.11 140.05 7.47 Favored 'General case' 0 N--CA 1.533 3.702 0 O-C-N 124.748 1.28 . . . . 0.0 113.305 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -90.29 122.18 32.97 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 125.188 1.555 . . . . 0.0 110.039 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.08 146.6 24.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 O-C-N 125.722 1.889 . . . . 0.0 107.067 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.47 123.89 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.45 126.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 125.615 1.822 . . . . 0.0 111.196 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -90.25 160.11 16.35 Favored 'General case' 0 N--CA 1.525 3.324 0 O-C-N 124.809 1.318 . . . . 0.0 108.179 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -69.51 -27.27 65.04 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.472 1.107 . . . . 0.0 111.755 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.2 m -139.46 147.61 41.59 Favored 'General case' 0 N--CA 1.529 3.507 0 O-C-N 125.315 1.634 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.26 149.18 22.5 Favored 'General case' 0 N--CA 1.523 3.192 0 O-C-N 124.676 1.235 . . . . 0.0 111.583 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 117.34 9.72 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 125.999 2.062 . . . . 0.0 109.124 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.22 145.46 41.07 Favored Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.8 124.5 15.97 Favored 'General case' 0 N--CA 1.522 3.165 0 O-C-N 125.365 1.274 . . . . 0.0 109.148 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.54 98.27 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.066 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.254 21.4 ttp -58.08 -56.58 33.45 Favored Pre-proline 0 N--CA 1.518 2.947 0 CA-C-O 114.057 -2.878 . . . . 0.0 117.436 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.81 -51.1 0.95 Allowed 'Trans proline' 0 C--N 1.392 2.865 0 CA-C-N 124.612 2.683 . . . . 0.0 115.958 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.93 -72.53 0.4 Allowed 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.34 -176.47 44.63 Favored Glycine 2 CA--C 1.586 4.531 0 CA-C-O 116.814 -2.104 . . . . 0.0 110.128 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.16 173.19 50.62 Favored 'Cis proline' 0 N--CA 1.53 3.672 0 CA-C-N 122.795 3.298 . . . . 0.0 113.148 -6.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.52 133.56 55.85 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.087 1.492 . . . . 0.0 110.231 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -85.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 O-C-N 125.616 1.823 . . . . 0.0 111.55 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.71 -171.28 40.12 Favored Glycine 0 N--CA 1.504 3.17 0 CA-C-N 120.609 1.55 . . . . 0.0 109.974 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.68 116.72 7.19 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 125.841 1.553 . . . . 0.0 112.744 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.92 137.29 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 O-C-N 125.927 2.017 . . . . 0.0 107.873 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 145.91 26.8 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 125.311 1.632 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -23.02 45.06 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 124.884 1.365 . . . . 0.0 112.16 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.26 -30.13 57.72 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -79.65 -18.18 52.04 Favored 'General case' 0 N--CA 1.528 3.442 0 O-C-N 124.675 1.235 . . . . 0.0 112.601 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.89 156.89 86.16 Favored Pre-proline 0 N--CA 1.532 3.637 0 CA-C-O 115.771 -2.061 . . . . 0.0 111.757 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.23 -42.92 0.81 Allowed 'Trans proline' 0 C--N 1.407 3.63 0 CA-C-N 123.384 2.244 . . . . 0.0 114.707 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.58 -104.84 0.09 OUTLIER Glycine 0 N--CA 1.504 3.229 0 O-C-N 124.741 1.276 . . . . 0.0 111.627 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.98 161.19 20.02 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 143.4 40.5 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 125.659 1.447 . . . . 0.0 107.957 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -147.6 132.27 17.87 Favored 'General case' 0 N--CA 1.533 3.71 0 O-C-N 125.09 1.494 . . . . 0.0 109.802 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -79.8 134.66 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.45 129.27 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.92 140.17 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.58 -144.37 7.89 Favored Glycine 0 N--CA 1.512 3.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.12 -163.18 25.58 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.39 -18.78 62.33 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -126.94 -13.54 5.74 Favored 'General case' 0 N--CA 1.531 3.616 0 O-C-N 125.278 1.611 . . . . 0.0 109.004 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.42 66.36 Favored Glycine 1 N--CA 1.524 4.509 0 CA-C-O 118.895 -0.947 . . . . 0.0 114.344 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.253 23.9 mt-10 62.7 -85.36 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 125.676 1.59 . . . . 0.0 114.17 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -152.96 157.19 40.23 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 125.056 1.472 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.57 68.23 0.28 Allowed Glycine 0 N--CA 1.512 3.725 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.39 151.01 47.32 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 125.569 1.393 . . . . 0.0 114.359 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.67 102.22 1.34 Allowed 'General case' 0 N--CA 1.526 3.361 0 O-C-N 124.914 1.384 . . . . 0.0 109.625 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.07 28.61 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.24 170.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.917 0 O-C-N 126.369 2.293 . . . . 0.0 107.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -161.05 124.3 3.28 Favored 'General case' 0 N--CA 1.521 3.111 0 O-C-N 124.587 1.179 . . . . 0.0 110.434 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.44 156.8 38.67 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 124.501 1.126 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.357 0 CA-C-O 116.319 -2.378 . . . . 0.0 109.76 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.3 t -70.04 -37.0 75.46 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 125.433 1.708 . . . . 0.0 111.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.07 116.98 10.14 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.711 1.882 . . . . 0.0 111.991 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.9 140.01 36.89 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 124.639 1.212 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 139.93 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.97 146.65 19.17 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 124.85 1.344 . . . . 0.0 110.362 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.9 143.9 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.46 109.73 2.03 Favored Pre-proline 0 N--CA 1.528 3.473 0 CA-C-O 115.017 -2.42 . . . . 0.0 109.822 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.17 159.64 62.45 Favored 'Cis proline' 1 C--N 1.425 4.576 0 CA-C-N 125.279 2.921 . . . . 0.0 112.591 -2.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.14 -1.46 1.36 Allowed 'General case' 0 N--CA 1.531 3.576 0 O-C-N 125.033 1.458 . . . . 0.0 112.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -139.49 152.0 46.62 Favored 'General case' 0 N--CA 1.526 3.373 0 O-C-N 124.744 1.277 . . . . 0.0 110.159 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.35 30.67 69.04 Favored Glycine 0 N--CA 1.511 3.695 0 O-C-N 124.877 1.361 . . . . 0.0 113.556 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.6 154.16 40.91 Favored 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.342 1.26 . . . . 0.0 110.1 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.6 -174.37 3.22 Favored 'General case' 0 N--CA 1.522 3.137 0 O-C-N 125.877 1.986 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.04 129.02 38.54 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 124.635 1.21 . . . . 0.0 112.23 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.83 28.67 70.34 Favored Glycine 0 N--CA 1.514 3.864 0 O-C-N 124.704 1.252 . . . . 0.0 112.763 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 126.96 31.11 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 125.065 1.097 . . . . 0.0 112.245 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -88.91 134.27 34.02 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.77 147.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.191 0 O-C-N 125.295 1.622 . . . . 0.0 110.426 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 m -104.93 96.31 6.45 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 126.145 2.153 . . . . 0.0 108.842 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.86 147.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.998 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 p -135.31 164.77 26.97 Favored 'General case' 0 N--CA 1.518 2.972 0 O-C-N 125.944 2.027 . . . . 0.0 110.011 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.12 148.45 16.94 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.611 1.82 . . . . 0.0 108.161 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.34 145.28 16.25 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 124.993 1.433 . . . . 0.0 110.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 143.99 5.55 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 124.939 1.399 . . . . 0.0 112.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.02 168.41 20.05 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.177 1.163 . . . . 0.0 108.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.6 -37.22 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 124.979 1.424 . . . . 0.0 110.546 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.91 -46.69 1.96 Allowed 'General case' 0 N--CA 1.526 3.371 0 O-C-N 126.192 2.183 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.2 p -67.43 153.98 42.44 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 124.785 1.303 . . . . 0.0 112.299 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.33 -2.48 1.81 Allowed 'General case' 0 N--CA 1.538 3.93 0 O-C-N 125.563 1.79 . . . . 0.0 111.375 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -165.7 154.28 11.45 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.44 152.0 19.64 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 124.057 0.848 . . . . 0.0 111.833 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -116.59 -177.64 3.23 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 126.55 2.406 . . . . 0.0 106.157 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 112.6 1.93 Allowed 'General case' 0 N--CA 1.515 2.791 0 O-C-N 124.499 1.124 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 154.17 46.68 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 125.147 1.529 . . . . 0.0 108.66 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.99 146.4 35.33 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.602 2.439 . . . . 0.0 104.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -141.07 144.89 35.2 Favored 'General case' 0 N--CA 1.526 3.365 0 O-C-N 125.382 1.676 . . . . 0.0 109.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.21 114.8 27.44 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 125.428 1.705 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.48 143.32 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.53 -176.64 4.1 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.99 96.22 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.74 1.275 . . . . 0.0 112.062 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.522 3.139 0 O-C-N 125.384 1.678 . . . . 0.0 111.275 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.86 27.29 69.21 Favored Glycine 0 N--CA 1.512 3.76 0 CA-C-O 117.67 -1.628 . . . . 0.0 115.778 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -74.38 147.53 42.05 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.02 74.35 1.63 Allowed Glycine 0 N--CA 1.515 3.925 0 O-C-N 124.958 1.411 . . . . 0.0 113.927 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.92 89.3 6.84 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.37 144.14 51.1 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.046 1.466 . . . . 0.0 110.861 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -79.92 149.92 30.71 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.213 1.571 . . . . 0.0 109.965 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -25.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 O-C-N 125.895 1.997 . . . . 0.0 112.445 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.22 -9.32 58.44 Favored 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.89 -8.86 59.55 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.145 0.903 . . . . 0.0 113.232 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -63.69 156.44 26.94 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -145.54 -43.01 0.22 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 125.464 1.728 . . . . 0.0 108.552 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 55.17 54.62 8.56 Favored 'General case' 0 N--CA 1.523 3.175 0 O-C-N 124.981 1.426 . . . . 0.0 114.627 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -71.51 151.42 43.91 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -115.6 145.56 42.57 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 126.182 2.176 . . . . 0.0 109.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.71 154.02 28.87 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 125.042 1.464 . . . . 0.0 107.923 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -134.45 12.67 3.8 Favored 'General case' 0 N--CA 1.525 3.294 0 O-C-N 125.878 1.986 . . . . 0.0 110.061 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.09 -50.76 0.1 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.344 -2.303 . . . . 0.0 107.344 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -4.66 0.04 OUTLIER Glycine 0 N--CA 1.504 3.167 0 CA-C-O 117.344 -1.809 . . . . 0.0 112.665 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.91 162.61 20.71 Favored 'General case' 0 N--CA 1.537 3.89 0 O-C-N 125.538 1.376 . . . . 0.0 110.485 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.56 85.26 0.06 OUTLIER Glycine 0 N--CA 1.507 3.428 0 O-C-N 124.722 1.264 . . . . 0.0 110.546 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -72.55 153.75 41.15 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.124 1.132 . . . . 0.0 110.481 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -158.46 139.81 13.36 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.878 1.361 . . . . 0.0 111.583 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -91.02 124.23 35.09 Favored 'General case' 0 N--CA 1.521 3.123 0 O-C-N 124.996 1.435 . . . . 0.0 111.026 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.41 150.05 18.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.68 140.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.83 125.15 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 O-C-N 125.54 1.775 . . . . 0.0 112.092 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -90.21 165.08 14.15 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.932 1.395 . . . . 0.0 109.013 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -67.57 -29.55 68.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 124.924 1.39 . . . . 0.0 112.618 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.23 144.05 32.0 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.55 1.781 . . . . 0.0 110.69 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.61 149.25 25.13 Favored 'General case' 0 N--CA 1.523 3.218 0 O-C-N 125.244 1.59 . . . . 0.0 111.774 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 m -71.24 103.85 2.94 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 125.666 1.854 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.57 157.6 52.75 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.959 1.412 . . . . 0.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -141.13 121.8 14.28 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.603 1.414 . . . . 0.0 110.449 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 t -71.06 133.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.886 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.279 24.7 ttm -53.56 -59.16 10.16 Favored Pre-proline 0 N--CA 1.532 3.653 0 CA-C-O 113.267 -3.254 . . . . 0.0 118.678 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -52.7 -57.28 2.16 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 125.386 2.959 . . . . 0.0 117.725 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -56.3 0.06 Allowed 'General case' 0 N--CA 1.537 3.915 0 CA-C-N 120.049 1.295 . . . . 0.0 112.344 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.22 -169.32 41.03 Favored Glycine 1 N--CA 1.517 4.04 0 CA-C-O 115.614 -2.77 . . . . 0.0 108.598 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -72.52 149.78 94.11 Favored 'Cis proline' 0 C--N 1.405 3.512 0 CA-C-N 123.118 3.459 . . . . 0.0 113.246 -0.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -72.26 137.37 46.73 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 125.396 1.685 . . . . 0.0 108.625 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -37.2 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 O-C-N 125.263 1.602 . . . . 0.0 112.196 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.98 -170.15 34.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 125.262 1.601 . . . . 0.0 109.602 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.91 112.8 2.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 126.049 1.676 . . . . 0.0 114.012 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.63 140.59 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 O-C-N 126.063 2.102 . . . . 0.0 107.201 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 148.75 21.8 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.581 1.8 . . . . 0.0 110.678 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.2 t -89.99 71.04 7.48 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.505 1.753 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.89 -32.56 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.292 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.6 -27.2 41.1 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.104 1.502 . . . . 0.0 110.992 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 145.24 98.2 Favored Pre-proline 0 N--CA 1.518 2.959 0 CA-C-O 114.736 -2.554 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -73.57 -45.25 0.42 Allowed 'Trans proline' 0 C--N 1.412 3.878 0 CA-C-N 124.217 2.542 . . . . 0.0 112.732 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.83 -45.59 42.41 Favored Glycine 0 N--CA 1.512 3.753 0 O-C-N 124.729 1.268 . . . . 0.0 112.657 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.73 174.88 49.88 Favored Glycine 1 N--CA 1.519 4.173 0 O-C-N 125.187 1.169 . . . . 0.0 111.736 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.6 m -69.96 145.49 51.82 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.868 0.981 . . . . 0.0 112.348 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -147.48 133.87 19.63 Favored 'General case' 0 N--CA 1.527 3.423 0 O-C-N 125.495 1.747 . . . . 0.0 108.403 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -79.88 135.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.028 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.53 133.13 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.71 139.92 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.23 146.0 6.94 Favored Glycine 0 N--CA 1.514 3.844 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.28 176.03 47.91 Favored Glycine 0 N--CA 1.501 2.969 0 O-C-N 124.833 0.96 . . . . 0.0 112.536 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -72.76 -22.07 60.91 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 113.636 -1.282 . . . . 0.0 112.533 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.01 -61.45 1.77 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 124.91 1.381 . . . . 0.0 112.643 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.29 6.64 0.03 OUTLIER Glycine 1 N--CA 1.523 4.451 0 CA-C-O 117.636 -1.647 . . . . 0.0 114.384 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.68 160.84 31.94 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 118.013 0.906 . . . . 0.0 111.071 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -152.58 157.3 40.84 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.06 1.475 . . . . 0.0 108.485 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.87 82.91 0.08 OUTLIER Glycine 0 N--CA 1.504 3.218 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -69.92 155.78 40.07 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 125.353 1.266 . . . . 0.0 112.042 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.82 98.23 1.48 Allowed 'General case' 0 N--CA 1.527 3.38 0 O-C-N 124.753 1.283 . . . . 0.0 110.505 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.46 151.32 44.08 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.21 176.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.386 0 O-C-N 126.365 2.29 . . . . 0.0 107.812 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -153.47 113.99 4.02 Favored 'General case' 0 N--CA 1.526 3.368 0 O-C-N 124.172 0.92 . . . . 0.0 110.641 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -70.8 154.37 41.9 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 124.424 1.078 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.311 -2.383 . . . . 0.0 109.694 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -163.15 89.95 0.65 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 125.669 1.856 . . . . 0.0 107.066 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.58 120.94 14.28 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.613 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.97 122.15 26.36 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.758 1.286 . . . . 0.0 111.684 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.96 137.66 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.329 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.17 146.39 13.98 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 124.865 1.353 . . . . 0.0 110.57 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.8 144.08 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.137 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -155.99 110.66 2.12 Favored Pre-proline 0 N--CA 1.528 3.429 0 CA-C-O 114.981 -2.437 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.25 156.63 72.94 Favored 'Cis proline' 1 C--N 1.424 4.533 0 CA-C-N 125.344 2.944 . . . . 0.0 111.899 -2.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.8 -4.83 1.37 Allowed 'General case' 0 N--CA 1.531 3.594 0 O-C-N 125.46 1.725 . . . . 0.0 112.563 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -136.09 152.59 51.02 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 124.991 1.432 . . . . 0.0 110.093 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.98 28.92 67.74 Favored Glycine 0 N--CA 1.513 3.791 0 O-C-N 124.989 1.431 . . . . 0.0 113.274 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.12 152.83 41.03 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 125.205 1.179 . . . . 0.0 109.794 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.77 4.81 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.68 1.863 . . . . 0.0 109.102 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.66 136.29 57.38 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 124.952 1.408 . . . . 0.0 111.711 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 39.27 33.87 Favored Glycine 0 N--CA 1.511 3.643 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 156.94 38.75 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 125.718 1.481 . . . . 0.0 112.401 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -139.8 119.08 12.82 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 126.361 2.288 . . . . 0.0 105.074 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.26 155.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.043 0 O-C-N 126.053 2.095 . . . . 0.0 109.975 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.9 m -122.74 96.05 4.87 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 126.286 2.241 . . . . 0.0 106.362 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.63 147.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 p -137.85 165.54 26.24 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 126.051 2.094 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.73 15.79 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.502 1.751 . . . . 0.0 108.598 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -160.53 146.8 15.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.888 1.367 . . . . 0.0 108.947 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.69 87.72 0.17 Allowed Glycine 0 N--CA 1.508 3.457 0 O-C-N 125.054 1.471 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -156.89 153.64 28.49 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.713 1.478 . . . . 0.0 107.477 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 -20.24 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.792 1.307 . . . . 0.0 111.28 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.39 1.056 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -70.11 126.09 28.66 Favored 'General case' 0 N--CA 1.521 3.099 0 O-C-N 124.63 1.206 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -80.3 -14.19 58.58 Favored 'General case' 0 N--CA 1.531 3.585 0 O-C-N 124.392 1.058 . . . . 0.0 112.975 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.29 155.85 11.68 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.18 33.26 Favored 'General case' 0 N--CA 1.521 3.116 0 O-C-N 125.111 1.507 . . . . 0.0 111.376 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -179.31 3.66 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 126.594 2.434 . . . . 0.0 107.682 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.55 109.83 2.16 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 124.944 1.402 . . . . 0.0 108.447 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 139.47 23.18 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.595 1.185 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -84.0 145.3 28.59 Favored 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.79 144.59 31.24 Favored 'General case' 0 N--CA 1.529 3.49 0 O-C-N 125.009 1.443 . . . . 0.0 108.713 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.9 118.51 37.08 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.673 1.858 . . . . 0.0 113.202 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.64 135.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.7 mt -113.44 -173.63 2.3 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.54 70.1 Favored 'General case' 0 N--CA 1.518 2.927 0 O-C-N 124.506 1.129 . . . . 0.0 112.604 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -20.65 61.82 Favored 'General case' 0 N--CA 1.526 3.334 0 O-C-N 125.372 1.67 . . . . 0.0 111.948 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.1 24.34 59.73 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 118.237 -1.313 . . . . 0.0 114.244 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.34 144.7 44.35 Favored 'General case' 0 N--CA 1.521 3.118 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.12 118.21 7.27 Favored Glycine 0 N--CA 1.508 3.481 0 O-C-N 124.729 1.268 . . . . 0.0 112.669 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.91 107.36 8.25 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.3 m -147.83 156.09 42.35 Favored 'General case' 0 N--CA 1.526 3.363 0 O-C-N 124.665 1.228 . . . . 0.0 110.112 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -83.44 147.39 27.88 Favored 'General case' 0 N--CA 1.517 2.922 0 O-C-N 125.451 1.72 . . . . 0.0 109.734 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -24.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.46 0 O-C-N 125.753 1.908 . . . . 0.0 112.933 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.89 -17.02 62.14 Favored 'General case' 0 N--CA 1.521 3.084 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.89 -5.65 55.93 Favored 'General case' 0 N--CA 1.537 3.877 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.58 161.84 14.0 Favored 'General case' 0 N--CA 1.533 3.699 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -152.15 -50.14 0.11 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 125.853 1.971 . . . . 0.0 108.093 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 56.82 49.59 13.94 Favored 'General case' 0 N--CA 1.522 3.148 0 O-C-N 125.505 1.753 . . . . 0.0 113.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -67.04 135.2 53.33 Favored 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -91.26 138.16 31.8 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 124.911 1.382 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.83 152.95 29.42 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 124.994 1.434 . . . . 0.0 107.774 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -140.98 6.01 1.96 Allowed 'General case' 0 N--CA 1.529 3.521 0 O-C-N 125.578 1.798 . . . . 0.0 111.768 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.07 22.39 0.05 OUTLIER Glycine 0 N--CA 1.509 3.563 0 O-C-N 124.075 0.859 . . . . 0.0 110.993 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.12 26.41 72.39 Favored Glycine 0 N--CA 1.508 3.454 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.149 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.75 154.66 43.68 Favored 'General case' 1 N--CA 1.54 4.07 0 O-C-N 125.217 1.186 . . . . 0.0 108.372 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 140.88 4.51 Favored Glycine 0 N--CA 1.509 3.55 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -135.54 150.49 49.75 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 125.734 1.491 . . . . 0.0 108.318 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -159.59 139.18 11.42 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 124.962 1.414 . . . . 0.0 111.884 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -93.31 135.62 34.36 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 125.147 1.53 . . . . 0.0 108.827 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.44 154.11 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 O-C-N 125.557 1.785 . . . . 0.0 106.949 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.91 138.92 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.13 139.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 O-C-N 125.394 1.684 . . . . 0.0 111.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -90.0 163.57 14.87 Favored 'General case' 0 N--CA 1.52 3.035 0 O-C-N 125.584 1.802 . . . . 0.0 106.434 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -62.38 -39.12 92.16 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.843 1.339 . . . . 0.0 111.144 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.36 153.93 35.79 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 126.36 2.287 . . . . 0.0 109.94 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -156.31 148.97 23.78 Favored 'General case' 0 N--CA 1.529 3.496 0 O-C-N 124.966 1.416 . . . . 0.0 111.663 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.05 107.01 2.55 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 125.56 1.787 . . . . 0.0 111.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.44 99.05 0.87 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.737 1.273 . . . . 0.0 110.153 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -93.33 103.6 15.82 Favored 'General case' 0 N--CA 1.524 3.242 0 O-C-N 125.294 1.232 . . . . 0.0 112.635 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.53 107.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.007 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.256 17.6 ttt -63.8 -58.95 12.8 Favored Pre-proline 0 N--CA 1.519 2.987 0 CA-C-O 114.345 -2.741 . . . . 0.0 117.515 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.76 -50.72 0.8 Allowed 'Trans proline' 0 C--N 1.395 2.991 0 CA-C-N 124.796 2.748 . . . . 0.0 117.515 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.9 -72.14 0.42 Allowed 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.35 -178.64 47.07 Favored Glycine 2 CA--C 1.589 4.703 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.781 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.91 168.83 72.67 Favored 'Cis proline' 0 N--CA 1.527 3.467 0 CA-C-N 123.099 3.449 . . . . 0.0 112.51 -6.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.47 128.15 34.67 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 125.303 1.627 . . . . 0.0 110.537 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -78.66 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 CA-C-O 116.993 -1.479 . . . . 0.0 112.487 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.86 -171.35 42.27 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-N 120.271 1.396 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.64 128.15 35.41 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.665 1.45 . . . . 0.0 113.399 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.85 142.62 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 O-C-N 126.179 2.174 . . . . 0.0 106.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.48 146.32 36.16 Favored 'General case' 0 N--CA 1.529 3.525 0 O-C-N 126.079 2.112 . . . . 0.0 111.445 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.8 m -74.33 79.11 1.85 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 125.521 1.763 . . . . 0.0 111.896 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -37.33 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.66 -28.52 40.78 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 125.424 1.703 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.07 139.5 95.39 Favored Pre-proline 0 N--CA 1.515 2.817 0 CA-C-O 114.472 -2.68 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.97 -43.03 0.63 Allowed 'Trans proline' 0 C--N 1.41 3.809 0 CA-C-N 124.575 2.67 . . . . 0.0 112.786 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.72 61.58 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 124.862 1.351 . . . . 0.0 112.374 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.08 154.43 19.28 Favored Glycine 1 N--CA 1.518 4.101 0 O-C-N 125.287 1.228 . . . . 0.0 111.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.6 m -69.9 140.14 53.09 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 124.856 0.974 . . . . 0.0 111.683 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -145.54 139.27 26.62 Favored 'General case' 0 N--CA 1.526 3.337 0 O-C-N 125.369 1.668 . . . . 0.0 108.596 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.84 133.6 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.0 133.72 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.96 143.87 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.312 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.92 137.47 3.21 Favored Glycine 1 N--CA 1.52 4.268 0 O-C-N 124.151 0.907 . . . . 0.0 111.566 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.81 -160.42 35.6 Favored Glycine 1 N--CA 1.518 4.103 0 O-C-N 125.48 1.341 . . . . 0.0 112.405 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -70.51 -25.03 62.95 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 125.443 1.319 . . . . 0.0 112.941 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -70.88 -32.7 69.76 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.799 1.312 . . . . 0.0 110.436 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.72 14.09 44.79 Favored Glycine 0 N--CA 1.516 3.998 0 O-C-N 125.747 1.904 . . . . 0.0 113.16 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.5 103.24 3.45 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -73.05 173.68 8.99 Favored 'General case' 0 N--CA 1.519 3.011 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.13 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.09 80.13 0.08 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -67.86 154.32 41.83 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 125.307 1.239 . . . . 0.0 113.495 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.17 95.57 0.86 Allowed 'General case' 0 N--CA 1.523 3.212 0 O-C-N 125.127 1.517 . . . . 0.0 108.586 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.34 156.04 39.85 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 173.13 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.689 0 O-C-N 126.663 2.477 . . . . 0.0 107.153 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.6 m -155.19 116.0 3.91 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.056 0.848 . . . . 0.0 110.445 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -69.96 150.26 46.89 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 124.611 1.194 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.674 0 CA-C-O 116.389 -2.339 . . . . 0.0 111.516 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 p -69.87 -33.01 71.68 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 125.418 1.698 . . . . 0.0 112.622 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.8 170.8 14.58 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 125.036 1.46 . . . . 0.0 112.63 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.09 129.8 5.26 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 124.937 1.398 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.48 144.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -160.24 144.06 14.06 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 124.927 1.392 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.11 142.28 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.062 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.25 112.86 1.72 Allowed Pre-proline 0 N--CA 1.527 3.403 0 CA-C-O 114.892 -2.48 . . . . 0.0 110.082 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -64.28 151.31 73.18 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.428 2.974 . . . . 0.0 112.102 -4.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.97 -8.89 1.58 Allowed 'General case' 0 N--CA 1.528 3.463 0 O-C-N 125.943 2.027 . . . . 0.0 112.817 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.2 p -132.73 151.58 51.95 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.321 1.638 . . . . 0.0 110.106 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.99 31.8 66.59 Favored Glycine 0 N--CA 1.514 3.881 0 O-C-N 124.993 1.433 . . . . 0.0 112.457 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.87 153.99 39.64 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 125.432 1.313 . . . . 0.0 110.234 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.88 -173.89 3.27 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 126.032 2.083 . . . . 0.0 108.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -66.56 128.94 38.18 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.644 1.215 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.08 28.71 69.89 Favored Glycine 0 N--CA 1.514 3.853 0 O-C-N 124.667 1.229 . . . . 0.0 112.794 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.39 127.21 31.87 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 124.924 1.014 . . . . 0.0 112.618 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 m -87.08 130.07 34.65 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 125.307 1.629 . . . . 0.0 106.803 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.63 143.49 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 125.607 1.817 . . . . 0.0 108.981 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.9 m -111.12 102.01 10.49 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 126.268 2.23 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.91 149.13 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.011 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -140.53 164.27 30.61 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 125.703 1.877 . . . . 0.0 110.174 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.24 145.33 14.84 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.53 1.769 . . . . 0.0 108.3 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -159.12 146.79 17.54 Favored 'General case' 0 N--CA 1.515 2.783 0 O-C-N 125.239 1.587 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.13 88.91 0.11 Allowed Glycine 0 N--CA 1.508 3.498 0 O-C-N 125.101 1.5 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -154.96 155.5 34.34 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 125.71 1.477 . . . . 0.0 107.783 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.1 -19.51 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.883 1.364 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -79.56 -51.16 9.66 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 124.427 1.08 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 p -70.87 119.97 15.78 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.894 1.371 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -79.79 -19.92 47.42 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 124.432 1.083 . . . . 0.0 112.909 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -166.38 150.09 7.39 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 125.233 1.583 . . . . 0.0 107.816 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.94 160.16 40.66 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 125.622 1.826 . . . . 0.0 110.373 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -151.14 129.75 12.25 Favored 'General case' 0 N--CA 1.517 2.913 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 121.78 24.25 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.651 1.219 . . . . 0.0 112.046 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 146.47 50.78 Favored 'General case' 0 N--CA 1.53 3.572 0 O-C-N 125.429 1.705 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.57 128.74 35.88 Favored 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.47 142.74 39.43 Favored 'General case' 0 N--CA 1.531 3.604 0 O-C-N 124.719 1.262 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.17 26.56 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 125.187 1.555 . . . . 0.0 111.181 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -79.33 122.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.142 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.95 -174.34 2.59 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.68 84.02 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 124.703 1.252 . . . . 0.0 110.84 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -21.45 59.79 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 125.434 1.709 . . . . 0.0 110.87 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.85 26.69 60.02 Favored Glycine 0 N--CA 1.513 3.789 0 CA-C-O 117.472 -1.738 . . . . 0.0 115.635 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -73.11 146.23 45.88 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.01 74.72 1.17 Allowed Glycine 0 N--CA 1.515 3.917 0 CA-C-O 118.114 -1.381 . . . . 0.0 115.854 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.08 97.88 9.56 Favored 'General case' 0 N--CA 1.515 2.816 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.21 143.3 49.85 Favored 'General case' 0 N--CA 1.527 3.414 0 O-C-N 124.874 1.359 . . . . 0.0 111.792 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -85.87 116.31 24.04 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 125.487 1.742 . . . . 0.0 108.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -65.53 -23.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.07 -12.18 61.45 Favored 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -79.89 -7.18 58.59 Favored 'General case' 1 N--CA 1.541 4.109 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -64.18 160.81 17.64 Favored 'General case' 0 N--CA 1.531 3.604 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -139.18 -52.42 0.55 Allowed 'General case' 0 N--CA 1.52 3.032 0 O-C-N 126.007 2.067 . . . . 0.0 108.071 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 45.58 116.1 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -171.22 144.04 1.98 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 m -65.07 157.0 29.68 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.806 1.316 . . . . 0.0 113.478 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.2 mt -79.5 147.67 32.13 Favored 'General case' 0 N--CA 1.513 2.703 0 O-C-N 125.326 1.641 . . . . 0.0 108.225 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -72.1 -26.04 61.99 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 124.637 1.211 . . . . 0.0 112.483 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.03 -36.5 0.05 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.51 19.67 0.02 OUTLIER Glycine 0 N--CA 1.502 3.076 0 CA-C-O 117.673 -1.626 . . . . 0.0 111.953 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 158.06 34.75 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.497 1.351 . . . . 0.0 109.146 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.37 139.63 4.2 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -142.35 151.16 41.63 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.74 134.98 5.42 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.96 1.412 . . . . 0.0 112.361 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 t -86.46 114.21 23.04 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 125.067 1.479 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.03 144.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 t -122.71 137.23 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.55 131.12 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 O-C-N 125.75 1.906 . . . . 0.0 113.005 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -90.12 161.83 15.59 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 125.225 1.578 . . . . 0.0 106.984 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -65.68 -32.85 74.64 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 124.727 1.267 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 m -131.29 150.21 52.24 Favored 'General case' 0 N--CA 1.528 3.427 0 O-C-N 125.991 2.057 . . . . 0.0 110.173 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -157.8 146.71 19.48 Favored 'General case' 0 N--CA 1.525 3.292 0 O-C-N 124.906 1.379 . . . . 0.0 111.518 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.4 m -69.25 113.0 6.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 125.608 1.818 . . . . 0.0 110.631 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.35 149.55 45.68 Favored Glycine 0 N--CA 1.513 3.828 0 O-C-N 124.974 1.421 . . . . 0.0 109.858 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -137.95 88.37 2.32 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.406 1.298 . . . . 0.0 108.551 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 t -72.34 115.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.316 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.4 mmt 48.07 163.23 0.03 OUTLIER Pre-proline 2 N--CA 1.567 5.375 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.93 -14.08 43.15 Favored 'Trans proline' 1 C--N 1.427 4.659 0 CA-C-N 123.323 2.222 . . . . 0.0 114.868 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.72 -40.6 28.53 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.68 49.92 Favored Glycine 2 CA--C 1.585 4.438 0 CA-C-O 115.305 -2.942 . . . . 0.0 108.631 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.47 155.43 82.25 Favored 'Cis proline' 0 C--N 1.402 3.359 0 CA-C-N 123.948 3.874 . . . . 0.0 114.28 -1.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.79 134.14 48.22 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.604 1.815 . . . . 0.0 109.307 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -87.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.224 0 O-C-N 125.252 1.595 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.33 -174.71 42.51 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.97 118.56 12.05 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 125.663 1.449 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.06 133.33 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 O-C-N 125.989 2.056 . . . . 0.0 107.98 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.44 141.31 28.64 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 125.022 1.451 . . . . 0.0 111.338 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.3 t -83.5 72.51 10.26 Favored 'General case' 0 N--CA 1.513 2.724 0 O-C-N 125.232 1.583 . . . . 0.0 110.463 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.15 -32.73 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -79.66 -25.8 41.21 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.106 1.504 . . . . 0.0 111.252 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.96 150.71 97.66 Favored Pre-proline 0 N--CA 1.523 3.199 0 CA-C-O 115.101 -2.38 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.77 -48.79 0.22 Allowed 'Trans proline' 0 C--N 1.408 3.698 0 CA-C-N 123.711 2.361 . . . . 0.0 113.036 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.42 -46.95 24.01 Favored Glycine 0 N--CA 1.51 3.58 0 O-C-N 124.532 1.145 . . . . 0.0 112.558 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.82 172.43 48.85 Favored Glycine 1 N--CA 1.517 4.051 0 O-C-N 125.319 1.246 . . . . 0.0 110.89 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.7 m -70.11 153.42 43.17 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 124.783 0.931 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -157.78 135.24 10.39 Favored 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.77 137.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.857 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.81 131.7 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.16 140.23 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.61 -152.89 16.26 Favored Glycine 1 N--CA 1.517 4.097 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.64 -160.91 13.56 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -68.5 -34.09 75.29 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -125.07 -15.05 6.44 Favored 'General case' 1 N--CA 1.544 4.234 0 O-C-N 125.015 1.447 . . . . 0.0 111.835 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.41 -1.7 30.21 Favored Glycine 1 N--CA 1.527 4.755 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 63.89 173.09 0.18 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.903 1.281 . . . . 0.0 113.373 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -69.83 145.19 52.28 Favored 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.731 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.34 -64.14 2.47 Favored Glycine 0 N--CA 1.512 3.755 0 O-C-N 124.601 1.188 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 62.58 105.82 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.126 0 O-C-N 126.105 1.709 . . . . 0.0 113.568 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.25 95.8 1.27 Allowed 'General case' 0 N--CA 1.532 3.658 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.124 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.27 152.94 42.8 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.089 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pt -116.51 168.63 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 O-C-N 126.253 2.221 . . . . 0.0 108.748 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -140.94 157.57 45.17 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 124.851 1.344 . . . . 0.0 109.21 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -110.29 159.61 17.26 Favored 'General case' 0 N--CA 1.521 3.093 0 O-C-N 126.098 2.124 . . . . 0.0 109.826 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.312 0 CA-C-O 116.345 -2.364 . . . . 0.0 109.668 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.788 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 131.78 35.98 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 124.947 1.404 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.88 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.72 141.48 7.39 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 124.773 1.295 . . . . 0.0 109.786 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.74 141.33 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 p -160.42 113.01 1.38 Allowed Pre-proline 0 CA--C 1.608 3.176 0 CA-C-O 115.053 -2.403 . . . . 0.0 109.927 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -65.14 153.21 77.27 Favored 'Cis proline' 1 C--N 1.425 4.595 0 CA-C-N 125.458 2.985 . . . . 0.0 111.222 -3.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.22 -8.65 1.15 Allowed 'General case' 0 N--CA 1.529 3.513 0 O-C-N 125.872 1.983 . . . . 0.0 113.063 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -129.45 153.98 47.41 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.486 1.741 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 28.25 68.39 Favored Glycine 1 N--CA 1.519 4.167 0 O-C-N 124.8 1.313 . . . . 0.0 113.118 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.47 155.75 33.6 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 125.146 1.144 . . . . 0.0 110.282 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.82 -178.52 5.85 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 125.656 1.847 . . . . 0.0 107.222 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.35 142.83 53.9 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 124.592 1.183 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.68 85.62 Favored Glycine 1 N--CA 1.521 4.337 0 O-C-N 124.981 1.426 . . . . 0.0 113.394 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.49 164.72 26.28 Favored 'General case' 0 N--CA 1.52 3.064 0 O-C-N 124.196 0.586 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 m -145.98 121.91 10.66 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.5 -178.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 O-C-N 125.667 1.855 . . . . 0.0 110.047 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -143.25 92.61 2.39 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.76 149.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 p -135.24 162.03 33.71 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 126.141 2.15 . . . . 0.0 109.044 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.5 16.82 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 125.307 1.63 . . . . 0.0 108.68 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -157.04 149.52 23.24 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 125.4 1.687 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 127.42 0.85 Allowed Glycine 1 N--CA 1.52 4.27 0 O-C-N 124.95 1.406 . . . . 0.0 111.988 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -147.98 161.62 40.98 Favored 'General case' 0 N--CA 1.522 3.154 0 C-N-CA 124.269 1.028 . . . . 0.0 109.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.95 -59.15 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.554 0 O-C-N 125.385 1.678 . . . . 0.0 108.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 -53.36 6.73 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.332 1.645 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.2 p -67.83 143.07 55.94 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 124.893 1.371 . . . . 0.0 112.273 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.535 3.801 0 O-C-N 125.689 1.868 . . . . 0.0 109.823 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -168.9 170.61 8.96 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.7 13.31 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 123.858 0.724 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.53 172.89 11.41 Favored 'General case' 0 N--CA 1.524 3.249 0 O-C-N 126.173 2.171 . . . . 0.0 106.212 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.95 66.99 1.31 Allowed 'General case' 0 N--CA 1.531 3.612 0 O-C-N 125.421 1.701 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.24 155.45 28.57 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -137.73 136.54 37.43 Favored 'General case' 0 N--CA 1.521 3.107 0 O-C-N 125.771 1.919 . . . . 0.0 106.669 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.0 m -141.31 150.22 42.24 Favored 'General case' 0 N--CA 1.532 3.635 0 O-C-N 124.584 1.177 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.17 115.7 28.85 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 126.096 2.122 . . . . 0.0 110.963 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.2 137.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -122.08 -175.05 3.03 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.767 1.917 . . . . 0.0 106.294 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.58 97.37 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.303 1.002 . . . . 0.0 111.993 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 -21.81 60.4 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.45 1.719 . . . . 0.0 111.163 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.37 24.42 73.15 Favored Glycine 0 N--CA 1.512 3.75 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.873 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -75.03 145.12 42.68 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.59 75.9 1.19 Allowed Glycine 1 N--CA 1.517 4.098 0 O-C-N 124.813 1.321 . . . . 0.0 114.296 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.83 96.36 8.2 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.35 139.92 52.91 Favored 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.028 1.455 . . . . 0.0 112.575 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.85 138.57 39.88 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 125.016 1.447 . . . . 0.0 109.369 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.08 -24.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 O-C-N 125.512 1.758 . . . . 0.0 114.613 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.51 46.37 Favored 'General case' 0 N--CA 1.532 3.67 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.72 1.6 37.92 Favored 'General case' 1 N--CA 1.549 4.482 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -69.69 168.78 14.18 Favored 'General case' 0 N--CA 1.533 3.722 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -133.82 -63.93 0.72 Allowed 'General case' 0 N--CA 1.524 3.229 0 O-C-N 125.614 1.821 . . . . 0.0 109.996 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.41 98.5 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.029 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -157.51 150.01 22.85 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -65.74 167.74 8.82 Favored 'General case' 0 N--CA 1.52 3.07 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -79.29 141.95 36.58 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.7 t -71.54 -25.19 62.12 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 124.408 1.067 . . . . 0.0 112.985 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.55 -39.19 0.06 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.32 18.28 0.02 OUTLIER Glycine 0 N--CA 1.501 3.03 0 O-C-N 125.287 1.228 . . . . 0.0 111.593 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -144.03 165.36 27.99 Favored 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.32 79.98 0.08 OUTLIER Glycine 0 N--CA 1.513 3.799 0 O-C-N 124.074 0.859 . . . . 0.0 111.658 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -74.87 149.72 39.43 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 125.539 1.376 . . . . 0.0 108.986 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.27 137.56 7.17 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.904 1.378 . . . . 0.0 112.93 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -90.04 112.84 24.41 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 125.219 1.575 . . . . 0.0 110.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.75 147.06 13.7 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.125 0 O-C-N 125.385 1.678 . . . . 0.0 107.012 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.28 150.01 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 125.855 1.972 . . . . 0.0 106.705 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.65 92.06 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 125.525 1.766 . . . . 0.0 110.009 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -86.56 154.14 21.29 Favored 'General case' 0 N--CA 1.523 3.218 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.001 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.522 3.135 0 O-C-N 124.721 1.263 . . . . 0.0 113.473 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -156.23 147.06 21.99 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 124.616 1.197 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.87 149.53 21.74 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.879 1.362 . . . . 0.0 111.669 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.0 m -69.47 105.53 2.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.779 1.925 . . . . 0.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.3 159.67 53.45 Favored Glycine 0 N--CA 1.514 3.842 0 O-C-N 124.665 1.228 . . . . 0.0 111.235 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 119.05 14.41 Favored 'General case' 0 N--CA 1.527 3.404 0 O-C-N 125.596 1.409 . . . . 0.0 108.384 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 N--CA 1.535 3.776 0 O-C-N 124.797 1.311 . . . . 0.0 107.607 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.583 4.34 0 CA-C-O 115.688 -2.729 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -67.78 156.49 86.42 Favored 'Cis proline' 0 C--N 1.403 3.446 0 CA-C-N 123.668 3.734 . . . . 0.0 114.291 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.34 142.01 52.21 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 125.512 1.757 . . . . 0.0 109.301 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -38.51 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 O-C-N 125.231 1.582 . . . . 0.0 112.581 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.84 -166.68 23.79 Favored Glycine 0 N--CA 1.501 2.976 0 O-C-N 125.568 1.793 . . . . 0.0 108.93 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.75 116.92 5.64 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 125.823 1.543 . . . . 0.0 113.757 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.43 138.62 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 O-C-N 125.969 2.043 . . . . 0.0 107.407 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.21 144.48 28.12 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 125.303 1.627 . . . . 0.0 110.711 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.4 t -80.36 -32.81 37.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 125.05 1.469 . . . . 0.0 112.77 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.09 -25.65 63.62 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.62 -25.28 41.48 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.408 1.068 . . . . 0.0 113.244 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 91.39 Favored Pre-proline 0 N--CA 1.531 3.604 0 CA-C-O 115.573 -2.156 . . . . 0.0 112.025 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.84 -49.26 0.25 Allowed 'Trans proline' 0 C--N 1.413 3.938 0 CA-C-N 123.305 2.216 . . . . 0.0 113.612 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.55 -42.28 55.69 Favored Glycine 0 N--CA 1.511 3.655 0 O-C-N 124.627 1.205 . . . . 0.0 112.477 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.57 175.38 49.2 Favored Glycine 1 N--CA 1.518 4.116 0 O-C-N 125.163 1.155 . . . . 0.0 111.291 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.8 m -70.02 144.82 52.13 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.569 0.805 . . . . 0.0 112.453 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -146.12 127.67 15.1 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 125.806 1.941 . . . . 0.0 107.235 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.77 137.09 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -129.48 134.61 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.34 136.9 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.9 152.88 10.53 Favored Glycine 0 N--CA 1.509 3.541 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.78 -176.75 49.72 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 125.346 1.262 . . . . 0.0 111.804 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -76.57 -16.6 59.56 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.003 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.98 -65.79 0.68 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 124.67 1.231 . . . . 0.0 112.526 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.74 12.85 0.02 OUTLIER Glycine 0 N--CA 1.515 3.924 0 CA-C-O 118.568 -1.129 . . . . 0.0 112.505 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.36 156.44 39.09 Favored 'General case' 0 N--CA 1.521 3.119 0 O-C-N 124.702 0.884 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -153.9 158.81 41.29 Favored 'General case' 0 N--CA 1.522 3.147 0 O-C-N 124.758 1.286 . . . . 0.0 109.236 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.96 82.91 0.07 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -67.29 155.39 39.0 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 125.421 1.306 . . . . 0.0 113.377 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.69 101.79 1.5 Allowed 'General case' 0 N--CA 1.527 3.415 0 O-C-N 124.655 1.222 . . . . 0.0 110.426 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 155.37 40.72 Favored 'General case' 0 N--CA 1.514 2.732 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.78 177.1 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 126.476 2.36 . . . . 0.0 107.735 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 p -156.13 124.2 5.7 Favored 'General case' 0 N--CA 1.524 3.244 0 O-C-N 123.972 0.795 . . . . 0.0 111.674 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -75.3 158.22 33.18 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 124.11 0.882 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.715 0 CA-C-O 116.31 -2.383 . . . . 0.0 111.338 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.534 3.752 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.22 123.7 3.54 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.676 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.9 146.81 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.57 140.89 16.61 Favored 'General case' 0 N--CA 1.518 2.929 0 O-C-N 125.166 1.541 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.53 144.57 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -160.88 111.85 1.3 Allowed Pre-proline 0 N--CA 1.524 3.228 0 CA-C-O 115.054 -2.403 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.41 151.78 70.21 Favored 'Cis proline' 1 C--N 1.425 4.594 0 CA-C-N 125.286 2.924 . . . . 0.0 112.439 -3.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -3.56 2.0 Favored 'General case' 0 N--CA 1.528 3.452 0 O-C-N 125.98 2.05 . . . . 0.0 112.881 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.1 p -138.42 151.16 47.2 Favored 'General case' 0 N--CA 1.528 3.467 0 O-C-N 124.686 1.241 . . . . 0.0 109.89 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.24 32.25 68.8 Favored Glycine 1 N--CA 1.517 4.045 0 O-C-N 125.036 1.46 . . . . 0.0 112.879 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.8 mt -73.11 155.21 39.93 Favored 'General case' 0 N--CA 1.514 2.747 0 O-C-N 125.456 1.327 . . . . 0.0 110.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.31 -176.29 3.84 Favored 'General case' 0 N--CA 1.518 2.973 0 O-C-N 126.07 2.107 . . . . 0.0 108.574 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 127.49 32.81 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 124.75 1.281 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.95 28.95 71.16 Favored Glycine 0 N--CA 1.516 3.99 0 O-C-N 124.811 1.32 . . . . 0.0 112.977 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.14 123.81 23.68 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 124.935 1.021 . . . . 0.0 112.649 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -79.88 128.03 32.96 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.7 143.54 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 O-C-N 125.596 1.81 . . . . 0.0 109.178 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 m -107.1 102.92 12.22 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 126.231 2.207 . . . . 0.0 110.602 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.81 147.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.5 158.47 43.02 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.23 2.206 . . . . 0.0 108.717 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.28 141.56 12.32 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.244 1.59 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -165.31 122.52 1.51 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.516 1.76 . . . . 0.0 107.875 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 172.16 -90.56 0.09 OUTLIER Glycine 0 N--CA 1.506 3.337 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER 58.9 146.62 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.963 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.88 -37.74 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -136.84 -30.09 0.9 Allowed 'General case' 0 N--CA 1.527 3.416 0 O-C-N 126.007 2.067 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -73.36 109.46 6.9 Favored 'General case' 0 N--CA 1.523 3.19 0 O-C-N 124.658 1.224 . . . . 0.0 109.325 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.64 7.54 41.06 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.827 1.33 . . . . 0.0 112.726 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -160.46 167.72 26.66 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 124.398 1.061 . . . . 0.0 109.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.15 145.13 26.12 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.265 1.603 . . . . 0.0 109.898 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.1 m -142.0 169.77 16.97 Favored 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.38 4.46 Favored 'General case' 0 N--CA 1.527 3.411 0 O-C-N 124.23 0.956 . . . . 0.0 112.229 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.28 139.85 21.57 Favored 'General case' 0 N--CA 1.538 3.931 0 O-C-N 125.262 1.601 . . . . 0.0 109.551 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -87.83 148.74 24.52 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.3 m -142.42 149.54 39.44 Favored 'General case' 0 N--CA 1.524 3.268 0 O-C-N 125.581 1.801 . . . . 0.0 108.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.0 124.77 51.24 Favored 'General case' 0 N--CA 1.526 3.344 0 O-C-N 126.083 2.114 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -76.45 145.52 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.63 -175.76 3.56 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.41 -49.93 69.6 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.54 1.15 . . . . 0.0 111.654 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -23.59 59.9 Favored 'General case' 0 N--CA 1.528 3.431 0 O-C-N 125.564 1.79 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.0 32.93 60.13 Favored Glycine 0 N--CA 1.508 3.49 0 CA-C-O 116.921 -2.044 . . . . 0.0 117.187 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -75.79 150.2 37.78 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.75 89.33 0.38 Allowed Glycine 0 N--CA 1.511 3.676 0 O-C-N 124.722 1.264 . . . . 0.0 113.496 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.34 95.66 6.66 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.45 137.86 47.41 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 125.247 1.592 . . . . 0.0 111.223 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -78.91 117.82 20.35 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.94 1.4 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -21.48 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.369 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.97 -17.44 64.44 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 118.165 2.654 . . . . 0.0 118.165 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -83.04 2.06 36.91 Favored 'General case' 1 N--CA 1.55 4.533 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.38 167.38 12.67 Favored 'General case' 0 N--CA 1.53 3.552 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -146.17 -60.06 0.31 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 126.057 2.098 . . . . 0.0 107.264 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 45.44 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.757 1.911 . . . . 0.0 116.129 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.14 149.98 31.93 Favored 'General case' 0 N--CA 1.528 3.465 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.72 160.77 22.15 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.935 1.397 . . . . 0.0 114.759 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.39 149.82 31.54 Favored 'General case' 0 N--CA 1.517 2.9 0 O-C-N 125.178 1.549 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -76.31 -24.44 54.34 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.025 1.453 . . . . 0.0 112.217 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.2 -30.89 0.05 OUTLIER Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.16 3.66 0.02 OUTLIER Glycine 0 N--CA 1.512 3.749 0 CA-C-O 117.595 -1.67 . . . . 0.0 112.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.22 165.22 23.84 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.19 79.36 0.08 OUTLIER Glycine 0 N--CA 1.514 3.873 0 O-C-N 124.296 0.998 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m -75.03 155.7 37.0 Favored 'General case' 0 N--CA 1.517 2.902 0 O-C-N 125.311 1.242 . . . . 0.0 109.872 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.84 135.81 6.66 Favored 'General case' 0 N--CA 1.524 3.267 0 O-C-N 124.611 1.195 . . . . 0.0 113.065 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -84.49 114.24 21.79 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 124.875 1.359 . . . . 0.0 110.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.42 149.49 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.35 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 N-CA-C 102.395 -3.187 . . . . 0.0 102.395 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.67 125.18 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 O-C-N 125.543 1.777 . . . . 0.0 112.511 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -90.17 159.58 16.68 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.886 1.366 . . . . 0.0 107.73 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -66.24 -32.89 74.59 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.713 1.258 . . . . 0.0 111.952 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 148.41 52.01 Favored 'General case' 0 N--CA 1.529 3.476 0 O-C-N 125.944 2.028 . . . . 0.0 109.763 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.17 145.44 19.42 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.714 1.259 . . . . 0.0 111.926 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -70.45 106.07 3.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.744 1.903 . . . . 0.0 109.037 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.58 151.42 49.48 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.028 1.455 . . . . 0.0 110.739 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -139.98 121.3 14.95 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 125.803 1.531 . . . . 0.0 109.018 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.524 3.264 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.987 0 CA-C-O 115.564 -2.798 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -71.63 139.94 62.26 Favored 'Cis proline' 0 C--N 1.409 3.723 0 CA-C-N 123.19 3.495 . . . . 0.0 113.078 0.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.16 137.56 51.12 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 125.237 1.586 . . . . 0.0 109.583 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.92 -92.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.968 0 O-C-N 125.669 1.855 . . . . 0.0 110.616 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.31 -173.44 43.08 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.46 75.42 3.2 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 125.846 1.557 . . . . 0.0 112.349 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.16 141.74 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.828 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.96 156.05 18.26 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 125.375 1.672 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 t -73.8 -25.73 60.26 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.679 1.237 . . . . 0.0 112.887 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.15 -28.39 57.37 Favored 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -79.6 -21.63 44.75 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.341 1.026 . . . . 0.0 112.538 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.32 88.94 Favored Pre-proline 0 N--CA 1.531 3.578 0 CA-C-O 115.512 -2.185 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.76 -45.44 0.52 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.332 2.226 . . . . 0.0 113.051 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.36 -101.94 0.14 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 124.836 1.335 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.52 159.31 10.55 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 63.3 m -71.23 145.06 49.85 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 125.481 1.342 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -144.4 133.21 22.46 Favored 'General case' 0 N--CA 1.533 3.69 0 O-C-N 125.254 1.596 . . . . 0.0 109.283 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mm -79.72 135.73 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.825 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -131.06 134.31 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.3 140.67 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.044 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.72 145.62 6.88 Favored Glycine 0 N--CA 1.51 3.585 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.69 -170.91 38.68 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.016 1.068 . . . . 0.0 112.405 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -75.07 -12.65 60.37 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.256 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 p -69.9 -70.66 0.27 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.693 1.245 . . . . 0.0 111.384 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.48 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.512 3.722 0 CA-C-O 118.699 -1.056 . . . . 0.0 111.903 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -66.05 119.74 11.92 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 125.039 1.082 . . . . 0.0 112.013 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -86.99 -175.49 5.38 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 125.151 1.532 . . . . 0.0 110.31 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.39 78.16 0.09 OUTLIER Glycine 0 N--CA 1.507 3.394 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.71 152.05 46.25 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.445 1.321 . . . . 0.0 112.946 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 98.36 1.08 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 124.843 1.339 . . . . 0.0 109.737 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 150.32 45.64 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.937 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.06 172.16 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 O-C-N 126.324 2.265 . . . . 0.0 107.08 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.5 m -156.38 118.29 3.94 Favored 'General case' 0 N--CA 1.528 3.447 0 O-C-N 124.153 0.908 . . . . 0.0 111.42 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.21 147.93 44.21 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.507 1.129 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.982 0 CA-C-O 116.08 -2.511 . . . . 0.0 112.815 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.533 3.685 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.24 6.15 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.83 145.44 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -160.96 146.04 14.13 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 124.99 1.432 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.98 144.22 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.23 110.22 2.07 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 114.989 -2.434 . . . . 0.0 110.005 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.91 158.85 68.34 Favored 'Cis proline' 1 C--N 1.424 4.513 0 CA-C-N 125.158 2.878 . . . . 0.0 112.32 -3.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.0 -0.36 2.29 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 125.144 1.528 . . . . 0.0 112.831 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -140.05 151.74 45.65 Favored 'General case' 0 N--CA 1.528 3.462 0 O-C-N 124.74 1.275 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.49 30.95 68.45 Favored Glycine 0 N--CA 1.512 3.703 0 O-C-N 124.953 1.408 . . . . 0.0 113.553 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.58 154.59 39.74 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 125.373 1.278 . . . . 0.0 109.379 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.43 -177.37 3.96 Favored 'General case' 0 N--CA 1.523 3.216 0 O-C-N 125.769 1.918 . . . . 0.0 110.179 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.64 129.87 41.24 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 124.866 1.354 . . . . 0.0 111.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.34 77.18 Favored Glycine 0 N--CA 1.512 3.715 0 O-C-N 124.606 1.191 . . . . 0.0 113.549 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.27 136.11 44.53 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.721 0.895 . . . . 0.0 111.428 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 m -99.6 127.3 45.7 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 125.819 1.949 . . . . 0.0 106.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.87 149.21 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 125.752 1.908 . . . . 0.0 109.924 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 m -103.72 96.38 6.67 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 126.081 2.113 . . . . 0.0 110.648 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.9 147.32 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.119 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -133.91 162.41 32.1 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 125.857 1.973 . . . . 0.0 110.174 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.22 139.2 10.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 125.544 1.777 . . . . 0.0 106.977 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 p -160.59 153.39 21.16 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.749 1.281 . . . . 0.0 110.853 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.35 79.1 0.52 Allowed Glycine 0 N--CA 1.505 3.299 0 O-C-N 124.893 1.37 . . . . 0.0 113.157 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -79.51 173.26 12.77 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 125.677 1.457 . . . . 0.0 110.939 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.38 -38.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.438 1.086 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.99 -46.63 1.38 Allowed 'General case' 0 N--CA 1.525 3.317 0 O-C-N 126.15 2.156 . . . . 0.0 111.414 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.56 121.81 18.54 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 124.847 1.342 . . . . 0.0 113.321 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.02 3.44 38.83 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 125.479 1.737 . . . . 0.0 110.962 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.67 162.69 18.98 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.34 150.56 19.98 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 124.18 0.925 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.1 m -142.07 147.12 36.28 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 125.871 1.982 . . . . 0.0 107.079 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.62 125.04 48.21 Favored 'General case' 0 N--CA 1.526 3.327 0 O-C-N 125.91 2.006 . . . . 0.0 112.448 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -122.46 152.11 40.61 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.587 1.804 . . . . 0.0 107.983 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -135.78 63.26 1.6 Allowed 'General case' 0 N--CA 1.537 3.921 0 O-C-N 125.508 1.755 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 m -72.88 148.94 43.91 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.974 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.21 112.26 24.87 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 126.379 2.3 . . . . 0.0 109.712 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mm -75.54 123.7 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.1 mt -103.22 -173.39 2.3 Favored 'General case' 0 N--CA 1.528 3.473 0 O-C-N 125.223 1.577 . . . . 0.0 106.836 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.51 82.31 Favored 'General case' 0 N--CA 1.515 2.819 0 O-C-N 124.355 1.035 . . . . 0.0 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -21.5 59.86 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 125.192 1.558 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.83 59.45 Favored Glycine 0 N--CA 1.509 3.556 0 CA-C-O 117.49 -1.728 . . . . 0.0 115.118 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.9 142.1 49.51 Favored 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.15 76.06 1.28 Allowed Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.908 1.38 . . . . 0.0 114.37 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.33 97.86 11.44 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.213 1.184 . . . . 0.0 108.171 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 140.29 47.13 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 125.115 1.509 . . . . 0.0 110.896 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -77.11 133.11 39.11 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 125.263 1.602 . . . . 0.0 110.081 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.54 -14.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 O-C-N 125.12 1.512 . . . . 0.0 114.009 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.56 53.57 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.95 -3.12 50.46 Favored 'General case' 1 N--CA 1.546 4.361 0 O-C-N 124.255 0.972 . . . . 0.0 113.57 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -68.13 168.33 12.33 Favored 'General case' 0 N--CA 1.535 3.798 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -143.79 -66.63 0.35 Allowed 'General case' 0 N--CA 1.526 3.339 0 O-C-N 125.486 1.741 . . . . 0.0 109.194 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 52.22 127.81 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -172.84 145.43 1.45 Allowed 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -67.24 163.19 20.98 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.703 1.252 . . . . 0.0 112.657 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.25 149.38 31.88 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 124.83 1.331 . . . . 0.0 109.379 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -73.54 -26.85 61.04 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 124.896 1.372 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.89 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.62 14.43 0.02 OUTLIER Glycine 0 N--CA 1.51 3.609 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.902 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.6 160.16 41.15 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.32 86.46 0.07 OUTLIER Glycine 0 N--CA 1.51 3.63 0 O-C-N 124.49 1.119 . . . . 0.0 111.074 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -74.25 155.54 38.16 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 125.259 1.211 . . . . 0.0 109.189 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -157.6 135.51 10.79 Favored 'General case' 0 N--CA 1.53 3.565 0 O-C-N 124.69 1.244 . . . . 0.0 112.646 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 t -90.69 124.97 35.51 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 125.022 1.451 . . . . 0.0 108.522 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.73 144.57 32.96 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 O-C-N 125.47 1.731 . . . . 0.0 107.062 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 t -115.38 138.46 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.48 119.47 50.39 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.329 0 O-C-N 125.262 1.602 . . . . 0.0 111.777 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -90.46 162.59 15.0 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.078 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -67.35 -29.06 68.51 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.766 1.291 . . . . 0.0 111.766 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 t -148.31 154.3 39.82 Favored 'General case' 0 N--CA 1.533 3.706 0 O-C-N 124.853 1.345 . . . . 0.0 109.084 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -158.58 148.21 19.39 Favored 'General case' 0 N--CA 1.525 3.277 0 O-C-N 124.9 1.375 . . . . 0.0 111.675 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 m -67.95 100.54 0.98 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.783 1.927 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.59 155.41 51.17 Favored Glycine 0 N--CA 1.505 3.249 0 O-C-N 125.116 1.51 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -137.95 123.3 19.46 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 125.901 1.589 . . . . 0.0 107.602 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.523 3.216 0 O-C-N 125.266 1.604 . . . . 0.0 107.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.521 4.348 0 CA-C-O 115.595 -2.781 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.26 152.39 97.18 Favored 'Cis proline' 0 N--CA 1.53 3.649 0 CA-C-N 123.267 3.533 . . . . 0.0 113.08 -1.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -67.35 143.7 56.22 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 125.341 1.651 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -31.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 O-C-N 125.668 1.855 . . . . 0.0 110.72 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.72 -169.03 36.62 Favored Glycine 0 N--CA 1.494 2.539 0 O-C-N 125.498 1.749 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.86 113.42 2.77 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 125.987 1.639 . . . . 0.0 113.886 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.47 132.14 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 O-C-N 126.152 2.158 . . . . 0.0 107.439 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.532 1.145 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 43.9 t -77.12 -30.74 55.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.841 1.338 . . . . 0.0 112.623 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.74 -24.01 62.54 Favored 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -26.59 41.17 Favored 'General case' 0 N--CA 1.533 3.72 0 O-C-N 124.21 0.944 . . . . 0.0 113.014 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.1 154.81 91.88 Favored Pre-proline 0 N--CA 1.53 3.528 0 CA-C-O 115.513 -2.184 . . . . 0.0 111.986 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.09 -51.16 0.17 Allowed 'Trans proline' 0 C--N 1.411 3.849 0 CA-C-N 123.396 2.249 . . . . 0.0 113.577 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 -36.4 57.9 Favored Glycine 0 N--CA 1.51 3.591 0 O-C-N 124.458 1.099 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.09 -179.31 53.0 Favored Glycine 0 N--CA 1.516 3.972 0 O-C-N 125.045 1.085 . . . . 0.0 111.038 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.8 m -70.77 146.63 49.66 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 124.619 0.834 . . . . 0.0 111.73 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -144.92 131.79 20.18 Favored 'General case' 0 N--CA 1.525 3.309 0 O-C-N 125.549 1.781 . . . . 0.0 107.123 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.73 130.28 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.01 134.56 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.83 137.74 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.951 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.41 142.71 5.11 Favored Glycine 0 N--CA 1.509 3.565 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.29 -165.78 40.78 Favored Glycine 0 N--CA 1.515 3.964 0 O-C-N 125.717 1.481 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -77.9 -16.71 58.02 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.358 1.269 . . . . 0.0 112.687 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 p -126.39 -18.31 4.92 Favored 'General case' 0 N--CA 1.528 3.451 0 O-C-N 125.378 1.673 . . . . 0.0 109.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.52 -7.65 65.01 Favored Glycine 1 N--CA 1.523 4.445 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.869 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.251 4.4 mm-40 62.15 -94.19 0.04 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 125.112 1.365 . . . . 0.0 112.644 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -162.44 156.53 21.27 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 123.826 0.704 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.22 92.12 0.12 Allowed Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 163.91 18.63 Favored 'General case' 0 N--CA 1.515 2.793 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.47 94.71 0.98 Allowed 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.588 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.59 144.13 55.73 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.95 172.22 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 126.381 2.3 . . . . 0.0 106.865 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 m -157.25 120.47 4.06 Favored 'General case' 0 N--CA 1.527 3.378 0 O-C-N 124.287 0.992 . . . . 0.0 111.374 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -73.65 154.24 39.8 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 124.595 1.185 . . . . 0.0 110.349 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.018 0 CA-C-O 116.306 -2.385 . . . . 0.0 112.569 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.797 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.07 124.37 3.76 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.139 1.524 . . . . 0.0 109.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.8 137.98 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -163.32 122.75 2.12 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 124.715 1.259 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.1 149.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -154.56 106.87 2.37 Favored Pre-proline 0 N--CA 1.528 3.466 0 CA-C-O 115.308 -2.282 . . . . 0.0 109.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.65 163.01 48.21 Favored 'Cis proline' 2 C--N 1.427 4.696 0 CA-C-N 124.926 2.795 . . . . 0.0 113.025 -3.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.54 -8.18 0.98 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 124.765 1.291 . . . . 0.0 113.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -134.84 153.27 52.11 Favored 'General case' 0 N--CA 1.529 3.495 0 O-C-N 125.091 1.495 . . . . 0.0 110.389 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 28.88 66.42 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 124.926 1.392 . . . . 0.0 113.413 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.0 mt -73.59 154.44 39.79 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 125.289 1.229 . . . . 0.0 109.803 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.44 -175.71 3.39 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.944 2.027 . . . . 0.0 109.802 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.75 129.71 40.76 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.638 1.211 . . . . 0.0 112.014 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.71 28.55 68.92 Favored Glycine 0 N--CA 1.513 3.779 0 O-C-N 124.587 1.18 . . . . 0.0 112.54 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.36 139.81 48.1 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 125.07 1.1 . . . . 0.0 111.96 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.1 m -101.34 131.76 47.24 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 126.159 2.162 . . . . 0.0 105.19 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.95 145.47 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 O-C-N 125.651 1.845 . . . . 0.0 110.208 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.2 m -103.75 99.06 8.84 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 126.251 2.219 . . . . 0.0 109.92 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.79 144.13 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -139.24 155.86 47.49 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 126.018 2.073 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.16 152.23 20.43 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 125.026 1.454 . . . . 0.0 108.015 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -160.88 137.65 8.78 Favored 'General case' 0 N--CA 1.517 2.892 0 O-C-N 124.953 1.408 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.81 67.33 2.01 Favored Glycine 0 N--CA 1.511 3.643 0 O-C-N 124.926 1.391 . . . . 0.0 113.634 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -71.19 149.55 46.2 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 125.476 1.339 . . . . 0.0 110.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.85 -70.55 0.24 Allowed 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.81 -27.37 2.1 Favored 'General case' 1 N--CA 1.541 4.114 0 O-C-N 124.923 1.389 . . . . 0.0 110.633 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -59.27 114.54 2.7 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 125.02 1.45 . . . . 0.0 111.467 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.95 13.51 20.4 Favored 'General case' 0 N--CA 1.53 3.539 0 O-C-N 125.43 1.706 . . . . 0.0 112.756 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -161.85 158.55 25.68 Favored 'General case' 0 N--CA 1.524 3.242 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.13 143.59 13.95 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 124.283 0.989 . . . . 0.0 112.232 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.66 179.14 4.09 Favored 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.646 2.466 . . . . 0.0 105.965 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.44 99.22 2.88 Favored 'General case' 0 N--CA 1.525 3.312 0 O-C-N 125.245 1.59 . . . . 0.0 109.599 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -116.57 157.18 25.71 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.637 1.835 . . . . 0.0 108.742 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.25 121.8 17.32 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.6 m -123.87 151.83 43.03 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.381 1.676 . . . . 0.0 111.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.09 28.59 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 125.613 1.82 . . . . 0.0 110.58 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.3 141.29 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -128.94 -175.05 3.43 Favored 'General case' 0 N--CA 1.525 3.282 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.96 98.21 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 124.59 1.181 . . . . 0.0 112.093 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -22.41 60.67 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 125.283 1.614 . . . . 0.0 111.323 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.42 27.52 67.62 Favored Glycine 0 N--CA 1.513 3.773 0 CA-C-O 117.826 -1.541 . . . . 0.0 115.772 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -74.58 147.34 41.78 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.98 69.63 2.66 Favored Glycine 1 N--CA 1.517 4.073 0 O-C-N 124.937 1.398 . . . . 0.0 114.241 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 99.69 9.24 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.33 146.37 48.37 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 124.592 1.183 . . . . 0.0 111.055 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -83.76 127.1 33.55 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.663 1.852 . . . . 0.0 109.17 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.17 -24.6 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.87 -13.17 61.93 Favored 'General case' 1 N--CA 1.54 4.057 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.95 -6.18 57.03 Favored 'General case' 1 N--CA 1.539 4.017 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -67.44 165.57 16.37 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -146.24 -61.52 0.31 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 125.854 1.971 . . . . 0.0 107.243 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 56.55 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 125.564 1.79 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.42 148.37 19.78 Favored 'General case' 0 N--CA 1.531 3.621 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -70.15 165.86 21.15 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 124.665 1.228 . . . . 0.0 113.43 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.9 mt -79.54 151.0 30.95 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 124.566 1.166 . . . . 0.0 109.413 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.5 t -72.5 -31.37 65.31 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 124.834 1.334 . . . . 0.0 111.562 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.29 -31.56 0.05 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 18.59 0.03 OUTLIER Glycine 0 N--CA 1.51 3.623 0 CA-C-O 118.303 -1.276 . . . . 0.0 112.106 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -143.25 166.37 24.9 Favored 'General case' 0 N--CA 1.539 3.983 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.6 70.7 0.09 OUTLIER Glycine 0 N--CA 1.513 3.778 0 O-C-N 124.268 0.98 . . . . 0.0 111.869 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -74.3 149.55 40.63 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 125.261 1.212 . . . . 0.0 108.977 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -162.23 136.99 6.9 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 124.83 1.331 . . . . 0.0 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -84.23 132.08 34.68 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 125.014 1.446 . . . . 0.0 110.13 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.29 143.71 40.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.399 0 O-C-N 125.417 1.698 . . . . 0.0 106.854 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.1 t -113.02 133.41 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.27 126.02 58.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 O-C-N 125.573 1.796 . . . . 0.0 111.379 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -90.18 158.77 17.08 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 124.711 1.205 . . . . 0.0 108.624 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -69.97 -26.22 63.99 Favored 'General case' 0 N--CA 1.526 3.351 0 O-C-N 124.872 1.358 . . . . 0.0 112.146 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.49 145.88 32.11 Favored 'General case' 0 N--CA 1.527 3.409 0 O-C-N 125.067 1.48 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -157.29 148.95 22.22 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 124.938 1.398 . . . . 0.0 111.892 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.4 m -70.96 101.16 2.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 125.866 1.979 . . . . 0.0 108.404 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.86 152.81 51.75 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.124 1.515 . . . . 0.0 111.082 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -137.56 120.75 16.79 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 126.023 1.66 . . . . 0.0 109.083 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.526 3.35 0 O-C-N 125.303 1.627 . . . . 0.0 107.193 -179.917 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.904 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.92 138.93 56.66 Favored 'Cis proline' 0 C--N 1.41 3.77 0 CA-C-N 123.096 3.448 . . . . 0.0 112.795 0.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.03 138.64 54.62 Favored 'General case' 0 N--CA 1.516 2.873 0 O-C-N 125.21 1.569 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -36.84 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.145 0 O-C-N 125.397 1.686 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.15 -169.77 36.75 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 125.371 1.669 . . . . 0.0 109.24 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.3 108.37 0.91 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 126.004 1.65 . . . . 0.0 113.085 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.32 137.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.013 0 O-C-N 125.938 2.024 . . . . 0.0 108.189 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.62 139.79 36.05 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.986 1.429 . . . . 0.0 109.313 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 t -80.0 -21.84 43.18 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 124.831 1.332 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -73.43 -26.51 60.98 Favored 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -79.74 -22.98 42.61 Favored 'General case' 0 N--CA 1.532 3.643 0 O-C-N 124.487 1.117 . . . . 0.0 113.194 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.16 88.61 Favored Pre-proline 0 N--CA 1.533 3.709 0 CA-C-O 115.588 -2.149 . . . . 0.0 112.254 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.7 -49.7 0.25 Allowed 'Trans proline' 0 C--N 1.412 3.912 0 CA-C-N 123.335 2.227 . . . . 0.0 113.714 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.98 -38.75 59.82 Favored Glycine 0 N--CA 1.512 3.725 0 O-C-N 124.696 1.247 . . . . 0.0 111.791 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.42 52.57 Favored Glycine 0 N--CA 1.511 3.652 0 O-C-N 125.112 1.125 . . . . 0.0 112.241 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 152.17 40.17 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 124.883 0.99 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.49 132.45 12.49 Favored 'General case' 0 N--CA 1.521 3.115 0 O-C-N 125.893 1.996 . . . . 0.0 107.628 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -79.88 136.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.821 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.19 132.72 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -127.33 138.14 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.8 141.53 4.42 Favored Glycine 1 N--CA 1.517 4.089 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.15 -159.06 30.64 Favored Glycine 1 N--CA 1.518 4.132 0 O-C-N 125.198 1.175 . . . . 0.0 112.53 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.75 -8.75 59.57 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 125.625 1.426 . . . . 0.0 113.0 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -70.0 -70.88 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 124.913 1.383 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.16 -24.61 0.18 Allowed Glycine 0 N--CA 1.51 3.588 0 O-C-N 124.184 0.928 . . . . 0.0 111.328 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -65.66 120.77 13.55 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 125.086 1.109 . . . . 0.0 112.771 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -90.31 -169.9 2.57 Favored 'General case' 0 N--CA 1.517 2.911 0 O-C-N 125.317 1.635 . . . . 0.0 109.514 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.26 76.28 0.09 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.34 148.8 49.19 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.391 1.289 . . . . 0.0 112.605 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.3 99.36 1.05 Allowed 'General case' 0 N--CA 1.529 3.507 0 O-C-N 124.972 1.42 . . . . 0.0 110.165 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.38 144.66 49.76 Favored 'General case' 0 N--CA 1.514 2.725 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.628 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 169.16 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 O-C-N 126.287 2.242 . . . . 0.0 107.896 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 t -140.1 159.26 42.59 Favored 'General case' 0 N--CA 1.528 3.432 0 O-C-N 124.68 1.238 . . . . 0.0 110.248 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -107.92 163.22 13.32 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 126.14 2.15 . . . . 0.0 110.06 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.797 0 CA-C-O 116.336 -2.369 . . . . 0.0 111.268 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 2.745 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.1 131.11 35.69 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 124.679 1.237 . . . . 0.0 111.06 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.85 140.49 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -163.7 143.18 8.2 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.973 1.421 . . . . 0.0 110.547 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.13 143.0 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.025 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -157.54 111.56 1.84 Allowed Pre-proline 0 N--CA 1.528 3.439 0 CA-C-O 114.903 -2.475 . . . . 0.0 109.839 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.03 153.03 76.86 Favored 'Cis proline' 1 C--N 1.424 4.519 0 CA-C-N 125.555 3.02 . . . . 0.0 111.57 -2.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.47 -6.58 1.54 Allowed 'General case' 0 N--CA 1.529 3.485 0 O-C-N 125.853 1.971 . . . . 0.0 112.638 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.4 p -134.36 151.55 51.29 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 125.164 1.54 . . . . 0.0 109.978 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.12 31.61 66.39 Favored Glycine 0 N--CA 1.511 3.679 0 O-C-N 125.027 1.454 . . . . 0.0 112.786 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 153.55 39.34 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.359 1.27 . . . . 0.0 109.968 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -176.07 4.16 Favored 'General case' 0 N--CA 1.524 3.232 0 O-C-N 125.834 1.959 . . . . 0.0 108.755 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.41 136.35 56.38 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.756 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.44 60.21 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.587 1.179 . . . . 0.0 111.709 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.98 150.66 43.87 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 125.216 1.186 . . . . 0.0 110.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -128.93 101.16 5.95 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 126.22 2.2 . . . . 0.0 107.382 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.82 157.4 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 O-C-N 126.076 2.11 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -128.48 96.45 4.42 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 126.171 2.169 . . . . 0.0 106.082 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.7 148.29 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -140.47 160.86 39.07 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 126.045 2.091 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 131.83 6.02 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -126.33 13.52 7.68 Favored 'General case' 0 N--CA 1.535 3.824 0 O-C-N 125.583 1.802 . . . . 0.0 112.979 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.02 158.34 30.33 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -141.92 -172.27 3.53 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 126.579 1.987 . . . . 0.0 107.361 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.82 -30.52 0.07 Allowed 'General case' 0 N--CA 1.514 2.768 0 O-C-N 124.369 1.043 . . . . 0.0 111.435 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -40.38 0.3 Allowed 'General case' 0 N--CA 1.527 3.396 0 O-C-N 125.399 1.687 . . . . 0.0 110.548 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 p -67.93 113.21 5.45 Favored 'General case' 0 N--CA 1.521 3.103 0 O-C-N 124.946 1.404 . . . . 0.0 112.011 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.65 7.93 39.19 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 124.741 1.276 . . . . 0.0 112.554 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.54 162.03 18.89 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.09 20.28 Favored 'General case' 0 N--CA 1.522 3.146 0 O-C-N 124.068 0.855 . . . . 0.0 111.552 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -144.65 142.25 29.97 Favored 'General case' 0 N--CA 1.52 3.041 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.04 130.78 55.48 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.676 1.86 . . . . 0.0 114.073 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.47 139.03 19.59 Favored 'General case' 0 N--CA 1.532 3.647 0 O-C-N 125.047 1.467 . . . . 0.0 109.619 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -100.4 150.14 22.92 Favored 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.9 m -144.23 143.23 30.95 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.047 1.467 . . . . 0.0 109.243 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.85 114.72 27.21 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 125.327 1.642 . . . . 0.0 110.881 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.76 120.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.127 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.88 -174.86 2.8 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.64 82.53 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 124.646 1.216 . . . . 0.0 112.404 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -21.9 60.81 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.151 1.532 . . . . 0.0 111.473 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.07 22.66 57.03 Favored Glycine 0 N--CA 1.511 3.679 0 CA-C-O 117.356 -1.802 . . . . 0.0 115.003 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -71.4 140.96 50.32 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 75.01 1.42 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-O 118.173 -1.349 . . . . 0.0 115.154 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.1 100.1 10.3 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.45 146.43 51.3 Favored 'General case' 0 N--CA 1.529 3.497 0 O-C-N 124.949 1.406 . . . . 0.0 110.836 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -91.04 123.82 34.8 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 125.854 1.972 . . . . 0.0 109.559 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.71 -25.71 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.46 -5.38 32.46 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -79.78 -12.57 59.77 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 123.898 0.749 . . . . 0.0 112.982 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.4 159.91 17.29 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -148.25 -44.65 0.16 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 125.685 1.866 . . . . 0.0 109.788 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 63.49 130.88 0.01 OUTLIER 'General case' 0 N--CA 1.534 3.726 0 O-C-N 125.466 1.729 . . . . 0.0 114.794 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.0 154.11 27.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.597 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.5 m -118.99 146.96 44.58 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 126.21 2.194 . . . . 0.0 108.347 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.61 155.16 28.24 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.957 1.411 . . . . 0.0 108.827 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.2 p -134.78 15.84 3.61 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 126.057 2.098 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.89 -62.33 0.1 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.77 24.76 0.02 OUTLIER Glycine 0 N--CA 1.507 3.406 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.6 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -138.45 153.52 48.84 Favored 'General case' 0 N--CA 1.536 3.86 0 O-C-N 125.164 1.156 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.24 74.63 0.06 OUTLIER Glycine 0 N--CA 1.513 3.775 0 O-C-N 124.542 1.151 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.29 150.98 39.93 Favored 'General case' 0 N--CA 1.519 2.987 0 O-C-N 125.045 1.085 . . . . 0.0 109.716 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -156.41 145.21 20.18 Favored 'General case' 0 N--CA 1.538 3.95 0 O-C-N 124.804 1.315 . . . . 0.0 111.232 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.4 m -101.8 136.54 41.46 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 125.942 2.026 . . . . 0.0 109.421 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.5 155.95 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 O-C-N 125.481 1.738 . . . . 0.0 106.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 134.65 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -131.58 126.13 57.33 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 O-C-N 125.353 1.658 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -90.31 159.77 16.48 Favored 'General case' 0 N--CA 1.525 3.307 0 O-C-N 124.692 1.245 . . . . 0.0 108.163 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -69.44 -24.07 63.76 Favored 'General case' 0 N--CA 1.527 3.408 0 O-C-N 124.402 1.064 . . . . 0.0 112.145 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.5 m -142.48 147.42 36.02 Favored 'General case' 0 N--CA 1.532 3.652 0 O-C-N 124.997 1.435 . . . . 0.0 109.564 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.37 148.46 19.93 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.638 1.211 . . . . 0.0 112.042 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.52 102.25 1.78 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 125.741 1.901 . . . . 0.0 109.186 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.01 155.09 51.53 Favored Glycine 0 N--CA 1.506 3.35 0 O-C-N 125.063 1.477 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -139.42 123.21 17.57 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 125.737 1.492 . . . . 0.0 108.258 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.525 3.308 0 O-C-N 125.15 1.531 . . . . 0.0 106.952 -179.85 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.069 0 CA-C-O 115.709 -2.717 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.87 142.61 74.21 Favored 'Cis proline' 0 C--N 1.41 3.792 0 CA-C-N 123.003 3.401 . . . . 0.0 112.919 0.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.93 139.53 55.09 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 125.327 1.642 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.2 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 O-C-N 125.419 1.699 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.54 -167.87 34.23 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 125.444 1.715 . . . . 0.0 109.033 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.93 109.14 1.17 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 126.104 1.708 . . . . 0.0 112.842 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.86 137.08 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.935 0 O-C-N 126.093 2.12 . . . . 0.0 107.963 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.41 144.59 31.31 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 125.028 1.455 . . . . 0.0 110.027 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.5 t -75.99 -35.06 59.73 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 124.855 1.347 . . . . 0.0 112.783 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.38 -24.66 65.7 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -79.67 -24.66 41.66 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 124.252 0.97 . . . . 0.0 112.73 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.44 157.09 88.97 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 115.675 -2.107 . . . . 0.0 111.596 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.49 -50.17 0.19 Allowed 'Trans proline' 0 C--N 1.41 3.779 0 CA-C-N 123.25 2.196 . . . . 0.0 114.32 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.74 -41.37 56.59 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 124.486 1.116 . . . . 0.0 112.308 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.66 179.76 50.02 Favored Glycine 0 N--CA 1.51 3.599 0 O-C-N 125.212 1.184 . . . . 0.0 112.114 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.8 150.82 45.47 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.673 -1.264 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -159.37 134.48 8.21 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 mm -79.6 135.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 t -132.31 132.02 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 O-C-N 125.886 1.991 . . . . 0.0 105.835 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.3 145.97 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 100.978 -3.712 . . . . 0.0 100.978 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.75 139.17 4.12 Favored Glycine 0 N--CA 1.514 3.877 0 O-C-N 124.444 1.09 . . . . 0.0 111.567 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.51 -161.79 37.6 Favored Glycine 1 N--CA 1.517 4.083 0 O-C-N 125.688 1.464 . . . . 0.0 111.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -72.6 -25.17 61.22 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 125.362 1.272 . . . . 0.0 112.371 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -74.46 -25.71 59.58 Favored 'General case' 0 N--CA 1.522 3.142 0 O-C-N 124.464 1.103 . . . . 0.0 110.583 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.85 19.55 47.1 Favored Glycine 0 N--CA 1.512 3.741 0 O-C-N 125.208 1.567 . . . . 0.0 112.115 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -73.11 103.24 3.79 Favored 'General case' 0 N--CA 1.517 2.924 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -70.78 167.16 19.41 Favored 'General case' 0 N--CA 1.519 2.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.398 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.48 73.53 0.08 OUTLIER Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.92 164.46 19.8 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.12 102.19 0.87 Allowed 'General case' 0 N--CA 1.524 3.271 0 O-C-N 124.906 1.379 . . . . 0.0 109.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 154.23 42.17 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 123.984 0.802 . . . . 0.0 112.646 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.24 172.52 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 O-C-N 126.209 2.193 . . . . 0.0 107.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -157.84 131.54 7.89 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 123.993 0.808 . . . . 0.0 111.367 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.78 161.63 28.86 Favored 'General case' 0 N--CA 1.518 2.964 0 O-C-N 124.401 1.063 . . . . 0.0 110.859 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.344 -2.365 . . . . 0.0 109.805 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.486 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.86 129.66 34.67 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 124.731 1.27 . . . . 0.0 111.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.41 139.75 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 102.097 -3.297 . . . . 0.0 102.097 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.39 142.49 9.78 Favored 'General case' 0 N--CA 1.514 2.748 0 O-C-N 124.943 1.402 . . . . 0.0 110.419 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -126.27 141.1 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.39 112.88 1.7 Allowed Pre-proline 0 N--CA 1.526 3.356 0 CA-C-O 114.889 -2.482 . . . . 0.0 110.136 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.53 150.49 73.32 Favored 'Cis proline' 1 C--N 1.423 4.455 0 CA-C-N 125.36 2.95 . . . . 0.0 111.927 -4.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.32 -13.68 1.79 Allowed 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.993 2.058 . . . . 0.0 112.724 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.1 p -127.56 153.91 45.81 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.776 1.922 . . . . 0.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.79 33.11 74.86 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 124.951 1.407 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 mt -75.05 153.75 38.28 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 125.338 1.258 . . . . 0.0 110.633 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.89 -173.96 3.24 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 126.245 2.215 . . . . 0.0 108.444 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.04 127.97 34.22 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.661 1.226 . . . . 0.0 112.849 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 29.48 72.4 Favored Glycine 0 N--CA 1.515 3.907 0 O-C-N 124.761 1.288 . . . . 0.0 113.094 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.56 125.16 26.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 125.021 1.071 . . . . 0.0 112.503 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.06 135.48 35.83 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.82 141.24 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.333 1.645 . . . . 0.0 108.828 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -109.1 102.68 11.63 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 126.236 2.21 . . . . 0.0 109.637 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 147.94 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -134.75 161.97 33.67 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 126.197 2.185 . . . . 0.0 109.503 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.19 14.4 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 125.51 1.756 . . . . 0.0 108.064 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.23 147.36 17.75 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.323 1.64 . . . . 0.0 109.311 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.06 87.51 0.16 Allowed Glycine 0 N--CA 1.509 3.521 0 O-C-N 125.114 1.509 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -156.21 152.4 27.77 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 125.741 1.495 . . . . 0.0 107.433 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.81 -18.64 0.05 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 124.871 1.357 . . . . 0.0 111.156 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.385 1.053 . . . . 0.0 110.247 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -72.53 121.46 19.7 Favored 'General case' 0 N--CA 1.518 2.965 0 O-C-N 124.615 1.197 . . . . 0.0 110.558 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -79.8 -17.11 54.16 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.349 1.031 . . . . 0.0 113.345 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -167.54 153.68 7.76 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.7 135.08 5.51 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 124.562 1.164 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -97.61 153.18 18.37 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 126.168 2.167 . . . . 0.0 108.471 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.88 120.87 41.43 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 126.399 2.312 . . . . 0.0 109.059 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.51 145.88 17.86 Favored 'General case' 0 N--CA 1.527 3.386 0 O-C-N 124.542 1.151 . . . . 0.0 112.362 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -96.17 148.9 22.22 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 125.373 1.671 . . . . 0.0 108.232 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.5 m -146.83 142.96 28.23 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.466 1.729 . . . . 0.0 108.088 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.44 123.63 42.69 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.451 1.72 . . . . 0.0 112.068 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.36 122.56 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.03 -174.48 2.7 Favored 'General case' 0 N--CA 1.526 3.329 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.69 81.63 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.627 1.204 . . . . 0.0 111.321 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -22.45 60.56 Favored 'General case' 0 N--CA 1.524 3.264 0 O-C-N 125.357 1.661 . . . . 0.0 111.181 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.96 25.69 55.14 Favored Glycine 0 N--CA 1.514 3.861 0 CA-C-O 117.54 -1.7 . . . . 0.0 115.485 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 144.63 46.79 Favored 'General case' 0 N--CA 1.526 3.343 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 75.14 1.51 Allowed Glycine 0 N--CA 1.515 3.911 0 CA-C-O 118.19 -1.339 . . . . 0.0 114.977 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.88 104.48 13.99 Favored 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.34 142.93 49.53 Favored 'General case' 0 N--CA 1.531 3.615 0 O-C-N 125.201 1.563 . . . . 0.0 112.396 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -83.39 116.96 22.72 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 125.344 1.652 . . . . 0.0 109.025 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.18 -23.75 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.21 62.15 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -79.87 -7.69 58.87 Favored 'General case' 1 N--CA 1.542 4.173 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -64.67 165.49 10.22 Favored 'General case' 0 N--CA 1.531 3.598 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -145.42 -52.99 0.27 Allowed 'General case' 0 N--CA 1.513 2.71 0 O-C-N 126.136 2.148 . . . . 0.0 107.052 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.6 t70 51.37 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.677 0 O-C-N 125.754 1.908 . . . . 0.0 116.139 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -157.55 147.26 20.28 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.2 p -66.7 157.44 32.67 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 124.841 1.338 . . . . 0.0 113.99 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.58 136.62 36.9 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 125.04 1.463 . . . . 0.0 108.139 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -70.07 -37.78 75.58 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.547 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.57 54.28 0.11 Allowed Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.318 1.636 . . . . 0.0 109.294 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.77 70.73 Favored Glycine 0 N--CA 1.507 3.404 0 O-C-N 125.518 1.363 . . . . 0.0 112.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.65 157.6 44.87 Favored 'General case' 0 N--CA 1.535 3.787 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.22 77.72 0.07 OUTLIER Glycine 0 N--CA 1.515 3.956 0 O-C-N 124.33 1.019 . . . . 0.0 112.38 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 m -75.76 150.83 37.7 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.232 1.195 . . . . 0.0 109.159 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.3 135.48 6.05 Favored 'General case' 0 N--CA 1.529 3.481 0 O-C-N 124.8 1.313 . . . . 0.0 112.973 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -80.81 113.17 18.83 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.923 1.389 . . . . 0.0 111.038 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.66 150.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.4 141.27 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.86 132.3 25.24 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 O-C-N 125.49 1.744 . . . . 0.0 112.279 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -90.22 162.91 15.01 Favored 'General case' 0 N--CA 1.526 3.355 0 O-C-N 125.141 1.526 . . . . 0.0 108.729 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -66.53 -24.59 66.4 Favored 'General case' 0 N--CA 1.525 3.293 0 O-C-N 124.322 1.014 . . . . 0.0 112.669 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -155.72 150.87 26.68 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 124.772 1.295 . . . . 0.0 108.587 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.45 150.03 26.21 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 124.941 1.401 . . . . 0.0 112.172 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 m -68.07 103.77 1.61 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.958 2.036 . . . . 0.0 109.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.23 154.38 52.55 Favored Glycine 0 N--CA 1.509 3.538 0 O-C-N 125.173 1.546 . . . . 0.0 111.177 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -137.44 123.0 19.72 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 126.002 1.648 . . . . 0.0 109.262 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.524 3.232 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.93 0 CA-C-O 115.625 -2.764 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.51 143.2 75.85 Favored 'Cis proline' 0 C--N 1.408 3.71 0 CA-C-N 123.057 3.429 . . . . 0.0 113.074 -0.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.29 137.95 53.44 Favored 'General case' 0 N--CA 1.515 2.803 0 O-C-N 125.306 1.629 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -37.66 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 O-C-N 125.351 1.657 . . . . 0.0 111.646 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.25 -169.75 32.2 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 125.456 1.723 . . . . 0.0 109.749 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.97 111.96 2.13 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 126.08 1.694 . . . . 0.0 113.423 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 142.28 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.974 0 O-C-N 125.988 2.055 . . . . 0.0 107.4 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.37 154.17 17.62 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 125.711 1.882 . . . . 0.0 109.127 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.9 -27.35 61.01 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 124.746 1.279 . . . . 0.0 112.948 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.93 -31.42 68.02 Favored 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.76 -19.56 48.4 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 124.64 1.213 . . . . 0.0 112.821 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.97 155.26 92.24 Favored Pre-proline 0 N--CA 1.53 3.57 0 CA-C-O 115.601 -2.143 . . . . 0.0 111.507 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -43.01 0.79 Allowed 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 123.407 2.253 . . . . 0.0 113.929 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.08 -104.5 0.1 OUTLIER Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.684 1.24 . . . . 0.0 111.329 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.53 147.14 4.96 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.9 m -73.75 159.08 33.47 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 125.077 1.104 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.34 147.3 12.44 Favored 'General case' 0 N--CA 1.518 2.947 0 O-C-N 124.497 1.123 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -79.64 121.2 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.05 120.14 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 t -116.33 132.76 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 101.408 -3.552 . . . . 0.0 101.408 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.4 138.12 3.56 Favored Glycine 1 N--CA 1.517 4.035 0 O-C-N 124.184 0.928 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.08 -166.26 41.48 Favored Glycine 0 N--CA 1.509 3.513 0 O-C-N 125.377 1.281 . . . . 0.0 112.556 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -80.08 -13.52 59.23 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 125.743 1.496 . . . . 0.0 112.856 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -70.0 -68.5 0.41 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 124.894 1.371 . . . . 0.0 111.751 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.68 -19.45 0.07 OUTLIER Glycine 0 N--CA 1.515 3.951 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.758 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.38 143.61 57.62 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.961 1.036 . . . . 0.0 112.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -111.72 -173.16 2.18 Favored 'General case' 0 N--CA 1.524 3.271 0 O-C-N 126.52 2.387 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.07 67.22 0.11 Allowed Glycine 0 N--CA 1.51 3.607 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -68.05 146.35 53.59 Favored 'General case' 0 N--CA 1.519 3.0 0 O-C-N 125.432 1.313 . . . . 0.0 112.926 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.13 109.78 1.03 Allowed 'General case' 0 N--CA 1.528 3.429 0 O-C-N 124.496 1.123 . . . . 0.0 109.633 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.49 170.75 16.14 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.414 1.072 . . . . 0.0 113.038 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -178.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 O-C-N 126.419 2.324 . . . . 0.0 107.99 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -161.19 119.65 2.44 Favored 'General case' 0 N--CA 1.516 2.842 0 O-C-N 124.35 1.031 . . . . 0.0 109.271 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.23 158.48 34.01 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.073 0.858 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 116.282 -2.399 . . . . 0.0 111.497 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.505 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.29 34.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 124.695 1.247 . . . . 0.0 111.168 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.13 139.31 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -161.63 146.82 13.44 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.731 1.269 . . . . 0.0 110.555 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.89 147.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.02 109.51 1.75 Allowed Pre-proline 0 N--CA 1.526 3.344 0 CA-C-O 115.343 -2.265 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.93 162.62 51.23 Favored 'Cis proline' 2 C--N 1.427 4.665 0 CA-C-N 124.908 2.789 . . . . 0.0 112.747 -3.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.15 -5.31 1.12 Allowed 'General case' 0 N--CA 1.537 3.894 0 O-C-N 124.655 1.222 . . . . 0.0 113.291 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.8 p -139.3 151.35 46.37 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.807 1.317 . . . . 0.0 109.669 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.76 32.84 70.57 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.985 1.428 . . . . 0.0 112.987 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.57 150.74 44.44 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 125.632 1.431 . . . . 0.0 109.984 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.73 178.68 4.24 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 126.059 2.1 . . . . 0.0 109.939 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.95 127.4 32.74 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 124.954 1.409 . . . . 0.0 111.335 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.56 25.98 74.83 Favored Glycine 0 N--CA 1.514 3.844 0 O-C-N 124.554 1.158 . . . . 0.0 113.285 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.54 140.97 48.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 124.753 0.913 . . . . 0.0 111.784 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -99.06 132.91 44.02 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.843 1.964 . . . . 0.0 105.816 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.48 147.19 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 125.399 1.687 . . . . 0.0 109.571 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -101.01 96.75 7.45 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 126.064 2.102 . . . . 0.0 110.369 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 t -79.92 147.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -138.57 165.81 25.94 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 125.754 1.909 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.85 15.88 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 125.696 1.873 . . . . 0.0 108.118 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.79 148.53 17.56 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.898 1.374 . . . . 0.0 109.469 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.91 87.79 0.18 Allowed Glycine 0 N--CA 1.508 3.468 0 O-C-N 125.198 1.561 . . . . 0.0 110.444 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -155.81 156.64 35.09 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 125.67 1.453 . . . . 0.0 107.551 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.11 -21.99 0.05 Allowed 'General case' 0 N--CA 1.52 3.042 0 O-C-N 124.621 1.201 . . . . 0.0 111.261 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -79.64 -54.87 5.46 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 124.474 1.109 . . . . 0.0 110.343 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -70.88 117.62 12.62 Favored 'General case' 0 N--CA 1.515 2.793 0 O-C-N 124.681 1.238 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.0 p -79.73 -16.61 55.3 Favored 'General case' 0 N--CA 1.527 3.401 0 O-C-N 124.091 0.869 . . . . 0.0 112.277 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.35 154.95 10.76 Favored 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.9 10.37 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.65 1.219 . . . . 0.0 111.241 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 m -112.54 151.46 29.98 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 126.501 2.375 . . . . 0.0 108.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.92 103.87 13.4 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 126.188 2.18 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -126.24 147.59 49.65 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 124.995 1.434 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.07 142.49 47.35 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 125.951 2.032 . . . . 0.0 106.451 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.3 m -137.13 138.9 40.79 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.356 1.66 . . . . 0.0 109.817 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.31 23.22 Favored 'General case' 0 N--CA 1.516 2.875 0 O-C-N 125.049 1.468 . . . . 0.0 112.143 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mm -77.36 121.36 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.3 mt -100.42 -173.15 2.34 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -47.23 78.61 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.535 1.147 . . . . 0.0 112.229 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.83 -21.33 61.7 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.24 1.588 . . . . 0.0 111.714 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.69 24.56 49.45 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.187 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -73.18 143.64 47.14 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 124.828 0.957 . . . . 0.0 108.641 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.75 72.58 2.2 Favored Glycine 0 N--CA 1.514 3.849 0 CA-C-O 118.105 -1.386 . . . . 0.0 115.165 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.0 108.82 15.81 Favored 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.6 144.89 48.17 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 124.891 1.37 . . . . 0.0 111.956 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.98 127.16 34.07 Favored 'General case' 0 N--CA 1.516 2.829 0 O-C-N 125.499 1.749 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.85 -28.45 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.6 -10.0 58.25 Favored 'General case' 0 N--CA 1.537 3.909 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -79.85 -7.71 58.87 Favored 'General case' 0 N--CA 1.539 3.986 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -65.55 165.98 11.32 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -145.85 -61.35 0.33 Allowed 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.906 2.004 . . . . 0.0 108.266 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 t70 59.43 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.492 0 O-C-N 125.333 1.645 . . . . 0.0 115.32 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -163.27 144.01 9.23 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 p -72.37 152.08 42.26 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 124.407 1.067 . . . . 0.0 112.462 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.52 151.65 30.63 Favored 'General case' 0 N--CA 1.52 3.057 0 O-C-N 124.738 1.274 . . . . 0.0 108.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -70.67 -28.74 65.01 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.813 1.321 . . . . 0.0 112.746 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.32 -36.22 0.06 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.25 28.31 0.04 OUTLIER Glycine 0 N--CA 1.502 3.04 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.667 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.96 156.75 45.47 Favored 'General case' 0 N--CA 1.534 3.74 0 O-C-N 125.288 1.228 . . . . 0.0 108.212 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.46 140.78 4.97 Favored Glycine 0 N--CA 1.502 3.096 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -136.72 150.84 48.65 Favored 'General case' 0 N--CA 1.526 3.345 0 O-C-N 125.722 1.483 . . . . 0.0 107.566 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.03 139.19 8.36 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 125.226 1.579 . . . . 0.0 112.863 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -87.26 118.98 27.05 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 125.063 1.477 . . . . 0.0 108.053 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.22 143.91 30.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.037 0 O-C-N 125.389 1.68 . . . . 0.0 106.641 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.93 139.03 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.47 117.6 43.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 O-C-N 125.23 1.581 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -90.35 157.32 17.69 Favored 'General case' 0 N--CA 1.522 3.173 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.549 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -68.71 -25.64 64.87 Favored 'General case' 0 N--CA 1.525 3.32 0 O-C-N 124.592 1.183 . . . . 0.0 112.106 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 m -148.94 147.56 28.77 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.871 1.357 . . . . 0.0 109.759 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -156.18 147.25 22.25 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 124.899 1.374 . . . . 0.0 111.77 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.62 106.35 2.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 125.8 1.937 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.99 157.25 52.92 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 124.688 1.243 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -142.5 106.34 4.7 Favored 'General case' 0 N--CA 1.517 2.898 0 O-C-N 125.53 1.37 . . . . 0.0 108.942 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.52 3.053 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.595 5.04 0 CA-C-O 113.846 -3.752 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.97 -47.54 0.31 Allowed 'Cis proline' 1 C--N 1.415 4.032 1 CA-C-N 125.937 4.869 . . . . 0.0 113.08 0.79 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.46 129.69 9.68 Favored 'General case' 0 N--CA 1.521 3.12 0 O-C-N 126.03 2.081 . . . . 0.0 108.882 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -36.79 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 125.16 1.537 . . . . 0.0 110.078 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.14 178.36 22.04 Favored Glycine 0 N--CA 1.508 3.498 0 O-C-N 126.166 2.166 . . . . 0.0 109.86 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.47 118.21 7.81 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.876 1.574 . . . . 0.0 113.305 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.41 135.69 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 O-C-N 126.239 2.212 . . . . 0.0 107.833 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 145.62 31.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 124.936 1.398 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.4 t -76.45 -28.45 56.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.745 1.278 . . . . 0.0 111.73 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.69 -27.48 61.25 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.68 -22.8 43.0 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.254 0.971 . . . . 0.0 112.848 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.24 155.21 92.81 Favored Pre-proline 0 N--CA 1.53 3.542 0 CA-C-O 115.423 -2.227 . . . . 0.0 111.297 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.86 -51.4 0.18 Allowed 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 123.466 2.274 . . . . 0.0 113.915 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.34 -43.43 38.27 Favored Glycine 0 N--CA 1.512 3.738 0 O-C-N 124.436 1.085 . . . . 0.0 112.555 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.19 171.6 48.09 Favored Glycine 0 N--CA 1.514 3.884 0 O-C-N 125.349 1.264 . . . . 0.0 110.926 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 25.9 m -70.29 150.27 46.54 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 124.95 1.03 . . . . 0.0 112.331 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -146.54 133.27 19.97 Favored 'General case' 0 N--CA 1.522 3.155 0 O-C-N 125.838 1.961 . . . . 0.0 107.689 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.0 mm -79.58 116.94 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.48 122.02 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 O-C-N 125.8 1.938 . . . . 0.0 106.457 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -118.38 130.33 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.31 138.45 3.51 Favored Glycine 1 N--CA 1.519 4.202 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.9 -170.54 43.18 Favored Glycine 0 N--CA 1.51 3.57 0 O-C-N 125.126 1.133 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -78.62 -16.72 57.03 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 113.174 -1.513 . . . . 0.0 113.066 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.94 -66.21 0.62 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.759 1.287 . . . . 0.0 112.557 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -7.52 0.05 OUTLIER Glycine 1 N--CA 1.517 4.051 0 CA-C-O 118.404 -1.22 . . . . 0.0 112.578 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.12 147.61 53.08 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.82 0.953 . . . . 0.0 111.265 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -142.81 168.03 20.67 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 125.855 1.972 . . . . 0.0 109.222 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.57 78.86 0.06 OUTLIER Glycine 0 N--CA 1.501 2.983 0 O-C-N 124.984 1.428 . . . . 0.0 109.901 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -67.92 159.47 30.49 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 125.343 1.261 . . . . 0.0 113.006 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.97 101.62 1.44 Allowed 'General case' 0 N--CA 1.529 3.503 0 O-C-N 124.38 1.05 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 148.91 45.18 Favored 'General case' 0 N--CA 1.511 2.576 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -118.06 170.63 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 O-C-N 126.272 2.232 . . . . 0.0 106.907 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -157.19 119.24 3.82 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 124.258 0.974 . . . . 0.0 111.322 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -73.22 154.88 40.06 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 124.604 1.19 . . . . 0.0 110.463 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.976 0 CA-C-O 116.722 -2.154 . . . . 0.0 112.513 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.69 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.91 129.07 34.19 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 124.723 1.264 . . . . 0.0 111.429 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.53 139.36 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.35 142.2 9.69 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 125.001 1.438 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.08 142.85 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 101.486 -3.524 . . . . 0.0 101.486 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -161.3 112.92 1.25 Allowed Pre-proline 0 N--CA 1.524 3.252 0 CA-C-O 115.015 -2.421 . . . . 0.0 110.212 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -63.19 150.64 68.13 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.337 2.942 . . . . 0.0 112.242 -4.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.18 -9.19 1.75 Allowed 'General case' 0 N--CA 1.528 3.439 0 O-C-N 125.964 2.04 . . . . 0.0 113.049 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.3 p -133.19 152.76 51.94 Favored 'General case' 0 N--CA 1.528 3.425 0 O-C-N 125.327 1.642 . . . . 0.0 109.657 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.2 29.53 68.49 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 125.008 1.443 . . . . 0.0 112.51 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.78 154.1 40.8 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 125.347 1.263 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 -175.39 3.57 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 126.184 2.178 . . . . 0.0 107.977 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.9 127.54 32.91 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 124.736 1.272 . . . . 0.0 112.61 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.48 29.72 69.64 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.856 1.347 . . . . 0.0 112.776 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.37 127.46 32.63 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.934 1.02 . . . . 0.0 112.627 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.97 134.04 35.35 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.12 146.44 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 O-C-N 125.281 1.613 . . . . 0.0 108.558 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 m -113.98 103.42 11.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 126.436 2.335 . . . . 0.0 109.689 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.85 147.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.06 159.92 40.48 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 126.139 2.149 . . . . 0.0 109.15 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.61 14.66 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 125.465 1.728 . . . . 0.0 108.143 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.33 148.67 18.43 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 125.314 1.634 . . . . 0.0 109.347 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.28 88.93 0.11 Allowed Glycine 0 N--CA 1.509 3.505 0 O-C-N 125.048 1.467 . . . . 0.0 111.446 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -155.39 150.97 27.31 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.73 -20.73 0.06 Allowed 'General case' 0 N--CA 1.52 3.046 0 O-C-N 124.738 1.274 . . . . 0.0 111.526 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 p -79.47 -45.05 20.13 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.434 1.084 . . . . 0.0 108.93 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 p -73.03 143.5 47.5 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 125.023 1.452 . . . . 0.0 108.64 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.16 11.84 15.33 Favored 'General case' 0 N--CA 1.536 3.84 0 O-C-N 125.774 1.921 . . . . 0.0 111.768 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -166.17 166.14 17.16 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.36 136.57 8.63 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.033 0.833 . . . . 0.0 111.513 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.97 177.06 7.72 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 126.316 2.26 . . . . 0.0 105.363 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.1 117.98 2.28 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.671 1.232 . . . . 0.0 109.393 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.3 136.53 9.75 Favored 'General case' 0 N--CA 1.527 3.376 0 O-C-N 125.031 1.457 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -82.2 152.5 26.41 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 124.911 1.382 . . . . 0.0 107.594 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -145.03 141.17 28.67 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 125.111 1.507 . . . . 0.0 109.174 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.3 118.77 31.23 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.439 1.712 . . . . 0.0 112.462 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.13 143.48 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.856 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.05 -176.11 3.9 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 124.713 1.258 . . . . 0.0 112.049 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -21.74 60.45 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.406 1.691 . . . . 0.0 111.297 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 26.35 71.43 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-O 117.696 -1.613 . . . . 0.0 115.8 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -74.32 147.53 42.18 Favored 'General case' 0 N--CA 1.528 3.428 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.49 74.34 1.74 Allowed Glycine 0 N--CA 1.515 3.955 0 O-C-N 124.886 1.366 . . . . 0.0 113.941 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.8 101.08 11.36 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.4 m -129.54 145.57 51.45 Favored 'General case' 0 N--CA 1.535 3.804 0 O-C-N 124.91 1.381 . . . . 0.0 112.644 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.96 125.05 28.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 125.074 1.484 . . . . 0.0 111.265 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.45 -24.03 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.88 -23.4 63.25 Favored 'General case' 0 N--CA 1.531 3.58 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -79.85 -19.18 48.99 Favored 'General case' 0 N--CA 1.532 3.667 0 O-C-N 124.508 1.13 . . . . 0.0 113.992 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.32 148.18 52.23 Favored 'General case' 1 N--CA 1.54 4.073 0 O-C-N 124.696 1.247 . . . . 0.0 111.296 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -144.87 -54.73 0.32 Allowed 'General case' 0 N--CA 1.522 3.167 0 O-C-N 125.627 1.829 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 67.71 128.58 0.02 OUTLIER 'General case' 1 N--CA 1.544 4.233 0 O-C-N 124.978 1.424 . . . . 0.0 113.194 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.95 147.88 18.55 Favored 'General case' 0 N--CA 1.515 2.789 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.173 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 m -75.99 151.49 37.2 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.998 1.436 . . . . 0.0 107.959 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.3 mt -79.41 127.13 31.72 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.85 1.344 . . . . 0.0 107.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -69.91 -38.5 76.3 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 124.368 1.043 . . . . 0.0 113.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 49.66 0.12 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.74 22.47 74.75 Favored Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.632 1.431 . . . . 0.0 112.926 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -141.85 156.67 45.53 Favored 'General case' 1 N--CA 1.544 4.234 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 77.94 0.06 OUTLIER Glycine 1 N--CA 1.52 4.244 0 O-C-N 124.149 0.906 . . . . 0.0 112.516 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -75.75 153.65 36.86 Favored 'General case' 0 N--CA 1.52 3.071 0 O-C-N 124.912 1.007 . . . . 0.0 109.74 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.63 138.09 5.99 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.806 1.316 . . . . 0.0 113.365 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.2 p -82.69 111.75 18.92 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.844 1.34 . . . . 0.0 109.866 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.29 151.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.38 139.95 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 129.65 16.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 O-C-N 125.52 1.762 . . . . 0.0 112.286 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -90.2 162.21 15.35 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.964 1.415 . . . . 0.0 107.812 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -65.73 -33.81 76.74 Favored 'General case' 0 N--CA 1.522 3.143 0 O-C-N 124.67 1.231 . . . . 0.0 111.779 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.8 151.87 48.56 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 125.761 1.913 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.09 148.85 20.72 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 124.586 1.179 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.58 101.26 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 125.941 2.025 . . . . 0.0 108.749 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.78 153.27 52.17 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 125.141 1.526 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -135.56 122.67 21.51 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 125.974 1.632 . . . . 0.0 109.023 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.522 3.168 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.028 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.65 144.2 79.11 Favored 'Cis proline' 0 C--N 1.41 3.797 0 CA-C-N 123.063 3.432 . . . . 0.0 113.072 -0.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.58 137.66 54.46 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 125.31 1.631 . . . . 0.0 110.494 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -36.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.203 0 O-C-N 125.448 1.718 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.05 -171.79 36.0 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 125.401 1.688 . . . . 0.0 109.695 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.48 110.83 1.57 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 126.039 1.67 . . . . 0.0 113.402 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.64 138.91 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.064 0 O-C-N 125.933 2.021 . . . . 0.0 107.82 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.88 158.13 16.47 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.442 1.714 . . . . 0.0 110.742 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.25 -30.27 57.81 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 124.931 1.394 . . . . 0.0 111.787 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.61 -28.26 67.6 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -30.63 40.87 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 124.429 1.08 . . . . 0.0 112.64 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.94 151.44 97.19 Favored Pre-proline 0 N--CA 1.527 3.419 0 CA-C-O 115.261 -2.304 . . . . 0.0 111.606 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.07 -44.5 0.45 Allowed 'Trans proline' 0 C--N 1.41 3.769 0 CA-C-N 123.643 2.337 . . . . 0.0 113.494 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.23 -45.4 55.73 Favored Glycine 0 N--CA 1.513 3.812 0 O-C-N 124.685 1.241 . . . . 0.0 112.81 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.55 160.37 29.87 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 125.319 1.246 . . . . 0.0 112.125 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.0 145.82 51.51 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 113.958 -1.121 . . . . 0.0 112.902 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.96 139.96 26.56 Favored 'General case' 0 N--CA 1.53 3.546 0 O-C-N 125.621 1.826 . . . . 0.0 108.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -79.9 127.58 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.447 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.93 137.4 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.92 141.49 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.275 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.88 142.65 5.7 Favored Glycine 1 N--CA 1.517 4.057 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -160.5 34.43 Favored Glycine 1 N--CA 1.517 4.081 0 O-C-N 125.469 1.335 . . . . 0.0 112.81 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -71.63 -23.6 61.72 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 125.374 1.279 . . . . 0.0 112.671 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.91 -32.72 71.16 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 124.775 1.297 . . . . 0.0 110.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.21 48.73 Favored Glycine 0 N--CA 1.515 3.93 0 O-C-N 125.809 1.943 . . . . 0.0 113.073 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.69 103.1 3.5 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -74.81 174.63 8.92 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.724 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.45 78.45 0.09 OUTLIER Glycine 0 N--CA 1.506 3.36 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -68.54 155.48 39.88 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.312 1.243 . . . . 0.0 113.292 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.45 100.35 1.18 Allowed 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.088 1.493 . . . . 0.0 109.107 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.14 158.0 34.1 Favored 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.14 176.65 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 O-C-N 126.568 2.418 . . . . 0.0 107.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.3 m -160.77 121.09 2.8 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.785 1.303 . . . . 0.0 109.78 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -72.78 156.73 38.61 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 124.554 1.159 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.627 0 CA-C-O 116.355 -2.358 . . . . 0.0 111.464 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.426 0 N-CA-C 111.302 0.112 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 126.95 31.69 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.47 1.106 . . . . 0.0 111.307 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.33 138.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.1 143.62 9.28 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 124.848 1.343 . . . . 0.0 110.135 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.33 144.03 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -161.84 112.87 1.19 Allowed Pre-proline 0 N--CA 1.524 3.242 0 CA-C-O 115.092 -2.385 . . . . 0.0 109.918 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.34 149.97 67.6 Favored 'Cis proline' 1 C--N 1.424 4.549 0 CA-C-N 125.25 2.911 . . . . 0.0 112.492 -4.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.85 -9.23 1.59 Allowed 'General case' 0 N--CA 1.528 3.437 0 O-C-N 125.916 2.01 . . . . 0.0 112.619 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.5 p -133.64 152.06 51.81 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.102 1.501 . . . . 0.0 109.648 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.31 65.2 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.023 1.452 . . . . 0.0 112.143 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 mt -73.29 154.23 40.24 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 125.349 1.264 . . . . 0.0 110.551 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.59 -175.36 3.63 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 126.274 2.234 . . . . 0.0 107.946 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.41 127.1 30.99 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.659 1.224 . . . . 0.0 112.735 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.32 28.2 72.86 Favored Glycine 0 N--CA 1.513 3.802 0 O-C-N 124.637 1.21 . . . . 0.0 113.318 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 125.52 27.61 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.945 1.027 . . . . 0.0 112.233 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -78.98 134.57 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.09 140.39 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.349 1.655 . . . . 0.0 108.401 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.6 m -107.36 101.77 11.11 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 126.15 2.156 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.87 148.03 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.997 0 N-CA-C 104.492 -2.411 . . . . 0.0 104.492 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -137.69 161.57 36.16 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.969 2.043 . . . . 0.0 109.463 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 146.22 15.51 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 125.467 1.73 . . . . 0.0 108.278 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.92 146.53 16.1 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 124.986 1.429 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.13 88.4 0.14 Allowed Glycine 0 N--CA 1.509 3.566 0 O-C-N 125.007 1.442 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -155.08 152.62 29.76 Favored 'General case' 0 N--CA 1.514 2.751 0 O-C-N 125.573 1.396 . . . . 0.0 107.408 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.76 -18.71 0.05 Allowed 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.774 1.297 . . . . 0.0 111.52 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.58 -53.39 6.9 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 124.309 1.006 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -71.27 129.77 39.71 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.665 1.228 . . . . 0.0 110.704 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -79.93 -28.61 39.72 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 t -154.67 172.26 18.19 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 125.144 1.527 . . . . 0.0 107.574 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.99 144.75 5.92 Favored 'General case' 0 N--CA 1.521 3.113 0 O-C-N 124.535 1.147 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -128.64 133.14 48.18 Favored 'General case' 0 N--CA 1.522 3.172 0 O-C-N 126.147 2.155 . . . . 0.0 107.108 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.46 107.5 19.19 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.922 1.389 . . . . 0.0 110.319 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -123.06 144.13 49.5 Favored 'General case' 0 N--CA 1.528 3.444 0 O-C-N 125.103 1.502 . . . . 0.0 110.568 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.77 141.1 46.96 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m -146.55 138.16 24.57 Favored 'General case' 0 N--CA 1.531 3.58 0 O-C-N 124.832 1.333 . . . . 0.0 110.427 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.58 118.45 29.22 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 125.172 1.545 . . . . 0.0 111.83 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mm -81.3 123.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.88 -177.9 3.91 Favored 'General case' 0 N--CA 1.523 3.183 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -44.51 77.84 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 124.769 1.293 . . . . 0.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -19.16 61.45 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 125.117 1.511 . . . . 0.0 112.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.34 9.98 78.38 Favored Glycine 1 N--CA 1.517 4.043 0 CA-C-O 116.933 -2.037 . . . . 0.0 115.881 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -71.38 137.0 48.02 Favored 'General case' 0 N--CA 1.529 3.484 0 CA-C-N 118.38 1.09 . . . . 0.0 108.228 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.16 106.13 1.81 Allowed Glycine 0 N--CA 1.51 3.598 0 CA-C-O 118.583 -1.121 . . . . 0.0 115.691 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.78 106.18 15.7 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -135.2 143.54 46.47 Favored 'General case' 0 N--CA 1.526 3.349 0 O-C-N 124.865 1.353 . . . . 0.0 110.875 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -84.33 141.03 31.2 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 125.377 1.673 . . . . 0.0 109.896 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.07 -25.06 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 O-C-N 125.537 1.773 . . . . 0.0 114.786 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.03 -22.46 49.18 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -81.49 -1.59 46.56 Favored 'General case' 1 N--CA 1.543 4.215 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.74 160.17 17.71 Favored 'General case' 0 N--CA 1.53 3.562 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -152.75 127.8 9.71 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 125.834 1.959 . . . . 0.0 106.46 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.21 136.6 44.43 Favored 'General case' 0 N--CA 1.524 3.239 0 O-C-N 126.076 2.11 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -160.08 154.29 23.44 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 124.732 1.27 . . . . 0.0 107.776 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 m -126.69 147.47 49.94 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 125.947 2.029 . . . . 0.0 108.212 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.64 150.51 30.95 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 125.016 1.447 . . . . 0.0 108.917 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -148.67 8.39 0.78 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 125.433 1.708 . . . . 0.0 110.037 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.92 22.92 0.05 OUTLIER Glycine 0 N--CA 1.509 3.537 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.34 13.89 82.43 Favored Glycine 0 N--CA 1.512 3.709 0 CA-C-O 117.516 -1.713 . . . . 0.0 114.372 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.42 161.59 34.15 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.83 75.64 0.07 OUTLIER Glycine 1 N--CA 1.516 4.026 0 O-C-N 124.367 1.042 . . . . 0.0 112.123 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.97 153.27 38.62 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.041 1.083 . . . . 0.0 110.162 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.64 138.04 5.96 Favored 'General case' 0 N--CA 1.533 3.705 0 O-C-N 124.918 1.386 . . . . 0.0 112.917 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -83.36 113.37 20.68 Favored 'General case' 0 N--CA 1.521 3.117 0 O-C-N 124.815 1.322 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.69 152.39 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.53 142.53 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.19 127.1 26.73 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.06 0 O-C-N 125.555 1.784 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -90.21 156.59 18.2 Favored 'General case' 0 N--CA 1.524 3.248 0 O-C-N 124.868 1.355 . . . . 0.0 108.467 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -68.46 -26.22 65.39 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 124.578 1.174 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.53 146.86 38.66 Favored 'General case' 0 N--CA 1.53 3.559 0 O-C-N 125.277 1.61 . . . . 0.0 109.795 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -155.79 146.65 22.21 Favored 'General case' 0 N--CA 1.525 3.28 0 O-C-N 124.838 1.336 . . . . 0.0 112.153 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -71.67 109.42 5.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 125.576 1.797 . . . . 0.0 110.038 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.05 145.55 39.8 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -129.65 85.06 2.26 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 125.893 1.584 . . . . 0.0 109.353 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 N--CA 1.524 3.268 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.77 -179.632 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.52 0 CA-C-O 115.333 -2.926 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.81 153.34 83.59 Favored 'Cis proline' 0 C--N 1.404 3.481 0 CA-C-N 124.005 3.902 . . . . 0.0 113.991 -0.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -71.12 137.03 48.5 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 125.578 1.799 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -39.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 O-C-N 125.039 1.462 . . . . 0.0 112.292 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.83 -172.21 21.56 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 125.68 1.863 . . . . 0.0 108.967 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 117.31 6.85 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 125.741 1.495 . . . . 0.0 113.817 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.86 133.46 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 O-C-N 126.132 2.145 . . . . 0.0 107.564 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.035 1.459 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.6 t -80.12 79.84 6.62 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 125.136 1.523 . . . . 0.0 110.397 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.42 -36.78 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.593 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.7 p -79.79 -19.31 48.88 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 125.325 1.64 . . . . 0.0 111.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 147.26 98.64 Favored Pre-proline 0 N--CA 1.519 2.986 0 CA-C-O 114.738 -2.553 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.13 -45.97 0.33 Allowed 'Trans proline' 0 C--N 1.408 3.677 0 CA-C-N 124.091 2.497 . . . . 0.0 112.876 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.47 -47.4 28.36 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.62 1.2 . . . . 0.0 112.764 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.7 162.74 37.69 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 125.496 1.351 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.99 148.1 49.31 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.794 0.937 . . . . 0.0 112.577 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -148.05 133.44 18.57 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 125.839 1.962 . . . . 0.0 107.319 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.85 134.67 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -130.78 134.15 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -128.61 130.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.35 152.16 10.39 Favored Glycine 0 N--CA 1.514 3.846 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -163.08 37.87 Favored Glycine 0 N--CA 1.509 3.565 0 O-C-N 125.735 1.491 . . . . 0.0 112.231 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.58 -6.7 59.14 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.952 1.619 . . . . 0.0 112.697 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.99 -68.12 0.44 Allowed 'General case' 0 N--CA 1.517 2.902 0 O-C-N 124.89 1.369 . . . . 0.0 111.783 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.33 -23.42 0.09 OUTLIER Glycine 1 N--CA 1.519 4.203 0 CA-C-O 118.562 -1.132 . . . . 0.0 112.981 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -67.27 150.45 49.03 Favored 'General case' 0 N--CA 1.525 3.287 0 O-C-N 124.988 1.052 . . . . 0.0 111.976 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.75 147.21 48.32 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 125.94 2.025 . . . . 0.0 109.802 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.38 -65.2 1.81 Allowed Glycine 0 N--CA 1.516 3.975 0 O-C-N 124.597 1.186 . . . . 0.0 113.821 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 66.65 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.536 3.849 0 C-N-CA 125.523 1.529 . . . . 0.0 112.75 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 106.26 1.23 Allowed 'General case' 0 N--CA 1.53 3.544 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 155.52 40.17 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 124.235 0.959 . . . . 0.0 112.586 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.17 167.78 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 126.481 2.363 . . . . 0.0 108.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -137.49 169.09 18.37 Favored 'General case' 0 N--CA 1.523 3.185 0 O-C-N 124.95 1.406 . . . . 0.0 109.301 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.38 148.01 52.62 Favored 'General case' 0 N--CA 1.522 3.171 0 O-C-N 126.246 2.216 . . . . 0.0 109.039 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.585 0 CA-C-O 116.365 -2.353 . . . . 0.0 111.385 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.606 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.11 132.27 6.28 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.443 1.714 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.27 145.52 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -160.71 145.48 14.2 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 125.312 1.632 . . . . 0.0 109.867 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.22 147.32 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.59 108.74 1.64 Allowed Pre-proline 0 N--CA 1.526 3.342 0 CA-C-O 115.416 -2.23 . . . . 0.0 109.788 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -62.02 162.63 45.75 Favored 'Cis proline' 2 C--N 1.426 4.654 0 CA-C-N 124.905 2.788 . . . . 0.0 113.235 -3.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.26 -6.58 0.73 Allowed 'General case' 0 N--CA 1.534 3.743 0 O-C-N 124.764 1.29 . . . . 0.0 112.619 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -138.3 153.58 49.02 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 124.914 1.384 . . . . 0.0 109.551 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.58 30.19 66.83 Favored Glycine 0 N--CA 1.512 3.752 0 O-C-N 124.977 1.423 . . . . 0.0 113.201 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 mt -72.9 153.87 40.82 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 125.296 1.233 . . . . 0.0 109.83 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.15 -175.83 3.62 Favored 'General case' 0 N--CA 1.523 3.221 0 O-C-N 126.003 2.064 . . . . 0.0 109.772 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.11 131.05 45.03 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 124.675 1.234 . . . . 0.0 112.363 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.78 30.04 66.59 Favored Glycine 0 N--CA 1.514 3.896 0 O-C-N 124.699 1.249 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 146.3 48.62 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.154 1.149 . . . . 0.0 111.841 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -115.27 124.3 50.98 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.317 2.261 . . . . 0.0 105.4 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.22 151.53 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.204 0 O-C-N 125.892 1.995 . . . . 0.0 110.559 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -111.02 100.45 9.14 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 126.185 2.178 . . . . 0.0 108.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.78 145.27 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 160.89 36.13 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 126.102 2.126 . . . . 0.0 109.647 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.14 16.72 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 125.423 1.702 . . . . 0.0 108.378 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -156.37 144.91 19.98 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.39 1.681 . . . . 0.0 109.831 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.09 88.11 0.12 Allowed Glycine 0 N--CA 1.51 3.598 0 O-C-N 125.109 1.506 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -154.87 148.74 25.63 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 125.628 1.428 . . . . 0.0 108.036 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.35 -18.92 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 124.801 1.313 . . . . 0.0 111.256 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.6 -41.66 26.62 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 124.255 0.972 . . . . 0.0 110.743 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -67.24 142.11 57.03 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 125.224 1.578 . . . . 0.0 110.424 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 p -79.9 -26.06 40.36 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.956 1.41 . . . . 0.0 113.203 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -170.06 133.57 1.18 Allowed 'General case' 0 N--CA 1.516 2.839 0 O-C-N 124.585 1.178 . . . . 0.0 109.005 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.0 139.95 45.14 Favored 'General case' 0 N--CA 1.515 2.781 0 O-C-N 124.756 1.285 . . . . 0.0 111.411 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.75 169.62 17.38 Favored 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -162.19 126.36 3.19 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 124.925 1.391 . . . . 0.0 110.997 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 144.76 15.06 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.215 1.572 . . . . 0.0 110.434 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 148.54 25.92 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 125.367 1.667 . . . . 0.0 108.977 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -139.73 140.23 36.72 Favored 'General case' 0 N--CA 1.529 3.503 0 O-C-N 125.609 1.818 . . . . 0.0 109.752 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.38 27.46 Favored 'General case' 0 N--CA 1.517 2.887 0 O-C-N 125.15 1.531 . . . . 0.0 113.011 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.31 142.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.002 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -128.05 -176.38 3.77 Favored 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.26 89.85 Favored 'General case' 0 N--CA 1.515 2.787 0 O-C-N 124.811 1.319 . . . . 0.0 112.122 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -20.74 59.63 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 125.408 1.693 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.08 76.67 Favored Glycine 0 N--CA 1.511 3.648 0 CA-C-O 117.377 -1.79 . . . . 0.0 115.853 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -73.5 142.05 46.78 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 93.35 0.35 Allowed Glycine 0 N--CA 1.511 3.693 0 O-C-N 124.811 1.319 . . . . 0.0 114.322 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.23 101.2 10.76 Favored 'General case' 0 N--CA 1.518 2.936 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -138.34 154.44 48.97 Favored 'General case' 0 N--CA 1.527 3.393 0 O-C-N 124.441 1.088 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -99.64 107.24 19.31 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 126.572 2.42 . . . . 0.0 107.958 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.69 -16.76 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.134 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.41 63.78 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -86.42 8.14 22.94 Favored 'General case' 1 N--CA 1.55 4.54 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -69.32 169.69 11.78 Favored 'General case' 0 N--CA 1.534 3.747 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -137.94 -61.18 0.62 Allowed 'General case' 0 N--CA 1.516 2.825 0 O-C-N 125.705 1.878 . . . . 0.0 109.542 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 52.86 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.793 0 O-C-N 125.334 1.646 . . . . 0.0 115.014 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -156.06 153.04 28.78 Favored 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 m -62.0 157.67 18.17 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.44 145.73 33.15 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.911 1.382 . . . . 0.0 108.373 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -71.52 -33.01 68.82 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 124.664 1.227 . . . . 0.0 111.364 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.4 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.5 2.905 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.31 24.58 0.04 OUTLIER Glycine 0 N--CA 1.502 3.069 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.413 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.34 161.06 39.33 Favored 'General case' 0 N--CA 1.537 3.894 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.41 76.59 0.08 OUTLIER Glycine 0 N--CA 1.513 3.787 0 O-C-N 124.275 0.985 . . . . 0.0 112.054 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 m -74.42 147.54 41.95 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 125.284 1.226 . . . . 0.0 109.468 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.44 135.62 7.9 Favored 'General case' 0 N--CA 1.529 3.492 0 O-C-N 124.799 1.312 . . . . 0.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -86.76 114.4 23.4 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.133 1.521 . . . . 0.0 111.425 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.7 t -107.66 149.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.72 142.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.18 134.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 O-C-N 125.346 1.654 . . . . 0.0 112.78 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -90.27 166.69 13.19 Favored 'General case' 0 N--CA 1.517 2.921 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -65.58 -27.95 68.79 Favored 'General case' 0 N--CA 1.532 3.638 0 O-C-N 124.257 0.973 . . . . 0.0 111.896 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.7 151.51 41.42 Favored 'General case' 0 N--CA 1.525 3.319 0 O-C-N 125.53 1.769 . . . . 0.0 108.749 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.21 147.51 24.88 Favored 'General case' 0 N--CA 1.526 3.358 0 O-C-N 124.935 1.397 . . . . 0.0 111.72 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.7 m -65.8 108.44 2.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 125.791 1.932 . . . . 0.0 112.209 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.28 150.56 43.96 Favored Glycine 0 N--CA 1.513 3.774 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -133.92 90.36 2.69 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.589 1.405 . . . . 0.0 109.824 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.524 3.229 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.407 -179.808 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.492 0 CA-C-O 115.442 -2.865 . . . . 0.0 108.658 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.73 156.43 82.71 Favored 'Cis proline' 0 C--N 1.402 3.378 0 CA-C-N 123.931 3.865 . . . . 0.0 114.131 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.17 138.69 52.03 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 125.623 1.827 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -40.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 O-C-N 125.011 1.444 . . . . 0.0 112.61 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.56 -175.11 23.29 Favored Glycine 0 N--CA 1.508 3.448 0 O-C-N 125.516 1.76 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 116.55 5.56 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 125.78 1.517 . . . . 0.0 113.883 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.53 138.46 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 126.046 2.091 . . . . 0.0 108.125 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.67 152.04 21.01 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 125.309 1.631 . . . . 0.0 110.84 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.2 m -75.46 -27.68 58.97 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.583 1.177 . . . . 0.0 111.507 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 -29.16 68.19 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.65 -30.69 41.32 Favored 'General case' 0 N--CA 1.528 3.455 0 O-C-N 124.408 1.068 . . . . 0.0 112.309 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.39 152.78 96.36 Favored Pre-proline 0 N--CA 1.527 3.4 0 CA-C-O 115.125 -2.369 . . . . 0.0 111.364 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -72.73 -47.77 0.34 Allowed 'Trans proline' 0 C--N 1.41 3.795 0 CA-C-N 123.624 2.33 . . . . 0.0 113.317 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.19 -48.24 26.39 Favored Glycine 0 N--CA 1.512 3.759 0 O-C-N 124.712 1.258 . . . . 0.0 111.976 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.13 166.84 38.65 Favored Glycine 0 N--CA 1.515 3.96 0 O-C-N 125.303 1.237 . . . . 0.0 112.404 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.95 151.31 45.77 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-N 114.014 -1.093 . . . . 0.0 112.617 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.61 145.82 19.09 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 125.247 1.592 . . . . 0.0 109.209 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.71 130.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 O-C-N 125.273 1.608 . . . . 0.0 107.16 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 t -123.47 131.12 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.74 142.19 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.44 -153.84 17.44 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.049 0.843 . . . . 0.0 111.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.38 -167.38 24.81 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -69.9 -20.36 63.37 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.26 -22.0 2.02 Favored 'General case' 0 N--CA 1.538 3.965 0 O-C-N 124.751 1.282 . . . . 0.0 111.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.64 -15.23 63.88 Favored Glycine 1 N--CA 1.524 4.542 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.342 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 168.2 0.26 Allowed 'General case' 1 N--CA 1.546 4.366 0 C-N-CA 124.741 1.216 . . . . 0.0 112.428 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -70.0 164.5 23.81 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.922 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.65 90.79 0.12 Allowed Glycine 0 N--CA 1.516 3.986 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.02 149.23 50.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 125.362 1.272 . . . . 0.0 113.619 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.85 0.97 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 124.958 1.411 . . . . 0.0 108.328 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.99 153.51 42.59 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.11 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.71 170.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.758 0 O-C-N 126.396 2.31 . . . . 0.0 107.608 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -156.95 118.22 3.72 Favored 'General case' 0 N--CA 1.525 3.278 0 O-C-N 124.283 0.99 . . . . 0.0 110.736 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -71.21 153.77 42.2 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.522 1.139 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 CA-C-O 116.249 -2.417 . . . . 0.0 109.752 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.724 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 127.0 31.75 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.687 1.242 . . . . 0.0 112.015 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.61 138.88 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.105 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.03 144.73 8.44 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.82 1.325 . . . . 0.0 110.574 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.45 147.5 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -158.18 108.87 1.72 Allowed Pre-proline 0 N--CA 1.525 3.28 0 CA-C-O 115.377 -2.249 . . . . 0.0 110.131 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.1 162.73 51.92 Favored 'Cis proline' 2 C--N 1.425 4.572 0 CA-C-N 124.812 2.754 . . . . 0.0 112.831 -4.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.6 -8.69 1.25 Allowed 'General case' 0 N--CA 1.535 3.823 0 O-C-N 124.753 1.283 . . . . 0.0 112.846 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -136.78 154.41 50.56 Favored 'General case' 0 N--CA 1.525 3.31 0 O-C-N 125.269 1.606 . . . . 0.0 108.556 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.29 30.26 62.97 Favored Glycine 0 N--CA 1.511 3.667 0 O-C-N 124.944 1.402 . . . . 0.0 111.943 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 mt -75.32 154.09 37.52 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 125.378 1.281 . . . . 0.0 109.411 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.09 -175.36 3.47 Favored 'General case' 0 N--CA 1.524 3.228 0 O-C-N 126.026 2.079 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.43 127.57 32.81 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 124.761 1.288 . . . . 0.0 112.521 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.6 28.97 71.65 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.56 1.162 . . . . 0.0 113.013 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.05 127.04 31.3 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 124.91 1.006 . . . . 0.0 112.564 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -89.27 129.93 35.75 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.67 148.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 O-C-N 125.168 1.542 . . . . 0.0 110.465 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -103.05 97.25 7.38 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 125.956 2.035 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.87 148.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.62 161.59 34.22 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 125.804 1.94 . . . . 0.0 110.466 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 139.82 11.15 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.526 1.766 . . . . 0.0 108.042 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.39 142.83 14.58 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 125.129 1.518 . . . . 0.0 109.473 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.82 97.32 0.05 OUTLIER Glycine 0 N--CA 1.512 3.719 0 O-C-N 125.229 1.581 . . . . 0.0 111.432 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -154.21 153.16 31.29 Favored 'General case' 0 N--CA 1.513 2.683 0 O-C-N 125.371 1.277 . . . . 0.0 108.076 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.2 -16.99 0.08 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 125.254 1.596 . . . . 0.0 111.166 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.54 -59.97 2.54 Favored 'General case' 0 N--CA 1.517 2.924 0 O-C-N 124.207 0.942 . . . . 0.0 109.402 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 119.23 15.72 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 124.717 1.26 . . . . 0.0 109.984 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 p -79.9 -13.1 59.63 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 124.466 1.104 . . . . 0.0 112.656 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -167.65 148.6 5.36 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.37 165.67 26.87 Favored 'General case' 0 N--CA 1.519 3.024 0 O-C-N 125.607 1.817 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -158.95 108.22 1.93 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.12 42.91 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 124.379 1.049 . . . . 0.0 113.385 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 143.71 11.51 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 124.897 1.373 . . . . 0.0 111.007 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 147.7 23.97 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.363 1.665 . . . . 0.0 106.756 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.81 144.57 33.99 Favored 'General case' 0 N--CA 1.527 3.399 0 O-C-N 125.434 1.709 . . . . 0.0 109.497 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.52 118.79 32.88 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.451 1.719 . . . . 0.0 111.809 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.7 139.59 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.08 -177.12 3.84 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 125.686 1.867 . . . . 0.0 106.376 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.02 97.8 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.466 1.104 . . . . 0.0 112.245 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -19.13 57.91 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 125.407 1.692 . . . . 0.0 111.206 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.67 78.55 Favored Glycine 0 N--CA 1.511 3.641 0 CA-C-O 117.316 -1.824 . . . . 0.0 115.992 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -73.66 143.62 46.19 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.42 87.84 0.42 Allowed Glycine 0 N--CA 1.514 3.861 0 O-C-N 124.859 1.349 . . . . 0.0 113.84 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.72 92.69 6.31 Favored 'General case' 0 N--CA 1.517 2.891 0 O-C-N 125.725 1.485 . . . . 0.0 107.593 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -129.14 146.57 51.04 Favored 'General case' 0 N--CA 1.527 3.412 0 O-C-N 125.028 1.455 . . . . 0.0 110.873 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -86.05 127.38 34.66 Favored 'General case' 0 N--CA 1.514 2.77 0 O-C-N 125.61 1.819 . . . . 0.0 111.233 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.66 -24.17 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.83 62.32 Favored 'General case' 0 N--CA 1.533 3.684 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.84 5.67 18.09 Favored 'General case' 0 N--CA 1.536 3.873 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -64.32 146.98 53.53 Favored 'General case' 0 N--CA 1.537 3.912 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.043 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -152.42 -64.29 0.16 Allowed 'General case' 0 N--CA 1.533 3.701 0 CA-C-O 117.138 -1.411 . . . . 0.0 114.525 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.72 159.7 29.59 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -136.92 -157.74 0.8 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 126.731 2.52 . . . . 0.0 105.692 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.8 p -53.04 144.5 15.07 Favored 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.5 132.72 36.41 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 125.124 1.515 . . . . 0.0 109.633 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -75.26 -32.77 61.17 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.116 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 48.51 0.13 Allowed Glycine 0 N--CA 1.505 3.235 0 O-C-N 125.158 1.536 . . . . 0.0 110.605 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 28.17 68.9 Favored Glycine 0 N--CA 1.507 3.404 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.271 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -143.1 154.0 43.48 Favored 'General case' 1 N--CA 1.544 4.256 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.9 79.0 0.06 OUTLIER Glycine 1 N--CA 1.517 4.039 0 O-C-N 124.393 1.058 . . . . 0.0 112.403 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -74.9 152.61 38.85 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.079 1.105 . . . . 0.0 108.905 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.51 141.83 7.84 Favored 'General case' 0 N--CA 1.526 3.352 0 O-C-N 124.808 1.317 . . . . 0.0 113.339 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -92.1 110.09 21.46 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.164 1.54 . . . . 0.0 108.541 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.83 149.72 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 O-C-N 125.187 1.554 . . . . 0.0 107.239 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.37 140.0 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.41 124.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 O-C-N 125.626 1.829 . . . . 0.0 112.115 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -90.22 161.48 15.69 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.836 1.335 . . . . 0.0 107.758 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -67.48 -32.4 73.2 Favored 'General case' 0 N--CA 1.518 2.95 0 O-C-N 124.664 1.227 . . . . 0.0 111.687 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.38 147.24 51.77 Favored 'General case' 0 N--CA 1.53 3.561 0 O-C-N 125.988 2.055 . . . . 0.0 109.97 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -157.74 147.75 20.4 Favored 'General case' 0 N--CA 1.528 3.44 0 O-C-N 124.805 1.316 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -72.31 101.53 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 125.78 1.925 . . . . 0.0 108.854 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 155.16 51.98 Favored Glycine 0 N--CA 1.51 3.59 0 O-C-N 124.979 1.425 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -140.53 119.91 13.07 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.696 1.468 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.515 2.803 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.072 0 CA-C-O 115.561 -2.8 . . . . 0.0 108.683 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.66 148.69 92.33 Favored 'Cis proline' 0 N--CA 1.529 3.578 0 CA-C-N 123.172 3.486 . . . . 0.0 113.417 -0.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -73.55 132.61 43.04 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.241 1.588 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.42 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 O-C-N 125.105 1.503 . . . . 0.0 112.099 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 -170.19 37.32 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.22 110.65 1.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.97 1.629 . . . . 0.0 113.221 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.95 135.67 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 126.061 2.101 . . . . 0.0 108.335 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.73 154.53 28.49 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.916 1.385 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.5 t -78.83 -29.47 44.72 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 124.972 1.42 . . . . 0.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.29 -22.07 62.0 Favored 'General case' 0 N--CA 1.515 2.823 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.3 p -79.69 -28.7 40.66 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 124.303 1.002 . . . . 0.0 113.304 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.1 150.74 96.45 Favored Pre-proline 0 N--CA 1.529 3.501 0 CA-C-O 115.26 -2.305 . . . . 0.0 112.183 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -73.61 -46.36 0.35 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.613 2.326 . . . . 0.0 113.515 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.22 -43.98 61.56 Favored Glycine 0 N--CA 1.512 3.751 0 O-C-N 124.608 1.192 . . . . 0.0 112.885 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.7 160.62 30.56 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 125.198 1.175 . . . . 0.0 111.591 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.96 154.72 41.58 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.942 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -162.11 145.97 12.16 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.2 1.562 . . . . 0.0 108.592 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.69 135.99 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.1 t -134.4 132.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.51 140.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.85 -132.5 1.7 Allowed Glycine 1 N--CA 1.52 4.25 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.19 -158.19 15.78 Favored Glycine 0 N--CA 1.505 3.299 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.37 -13.28 61.07 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.61 -73.8 0.16 Allowed 'General case' 0 N--CA 1.522 3.138 0 O-C-N 124.685 1.241 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.85 -23.44 0.24 Allowed Glycine 1 N--CA 1.517 4.068 0 CA-C-O 118.617 -1.101 . . . . 0.0 112.229 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.7 108.83 1.83 Allowed 'General case' 0 N--CA 1.521 3.096 0 O-C-N 125.224 1.191 . . . . 0.0 112.325 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -80.12 153.72 28.51 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.615 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.92 -60.98 1.89 Allowed Glycine 1 N--CA 1.518 4.148 0 O-C-N 125.116 1.51 . . . . 0.0 111.479 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.85 121.14 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 125.609 1.563 . . . . 0.0 114.734 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.39 96.86 0.78 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.94 31.63 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.416 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.81 176.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.708 0 O-C-N 126.507 2.38 . . . . 0.0 107.14 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -163.65 115.01 1.4 Allowed 'General case' 0 N--CA 1.519 3.007 0 O-C-N 125.014 1.446 . . . . 0.0 109.01 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.43 153.31 43.11 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.48 1.112 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.273 0 CA-C-O 116.356 -2.358 . . . . 0.0 109.798 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.527 3.422 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 130.57 35.42 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.71 138.87 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.98 143.03 10.72 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 124.855 1.347 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.69 143.04 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -158.51 112.59 1.68 Allowed Pre-proline 0 N--CA 1.523 3.198 0 CA-C-O 114.945 -2.455 . . . . 0.0 109.66 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.04 150.16 75.01 Favored 'Cis proline' 1 C--N 1.423 4.448 0 CA-C-N 125.401 2.965 . . . . 0.0 112.113 -3.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.76 -16.98 1.47 Allowed 'General case' 0 N--CA 1.528 3.464 0 O-C-N 125.897 1.998 . . . . 0.0 112.496 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.58 151.37 44.85 Favored 'General case' 0 N--CA 1.525 3.282 0 O-C-N 125.765 1.916 . . . . 0.0 110.915 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.89 66.1 Favored Glycine 1 N--CA 1.517 4.095 0 O-C-N 124.91 1.381 . . . . 0.0 112.5 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.8 mt -74.15 154.42 39.11 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 125.481 1.342 . . . . 0.0 110.715 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.57 -175.3 3.61 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.393 2.308 . . . . 0.0 108.324 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.46 127.91 34.15 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.767 1.292 . . . . 0.0 112.894 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.75 71.64 Favored Glycine 0 N--CA 1.515 3.922 0 O-C-N 124.703 1.252 . . . . 0.0 113.174 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.51 123.26 22.78 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 124.841 0.965 . . . . 0.0 112.663 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 m -80.65 129.92 34.8 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.11 141.01 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 O-C-N 125.722 1.888 . . . . 0.0 109.249 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.1 m -105.61 101.66 11.16 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 126.145 2.153 . . . . 0.0 110.44 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.79 147.71 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.08 158.75 43.65 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.998 2.061 . . . . 0.0 109.072 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.34 16.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.302 1.626 . . . . 0.0 108.123 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -157.37 145.13 18.9 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 125.2 1.563 . . . . 0.0 109.714 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.6 86.1 0.17 Allowed Glycine 0 N--CA 1.507 3.422 0 O-C-N 125.181 1.55 . . . . 0.0 110.412 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -151.87 149.54 29.09 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 125.732 1.489 . . . . 0.0 108.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.19 -15.55 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.952 0 O-C-N 125.038 1.461 . . . . 0.0 111.166 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.43 -49.65 12.0 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 p -66.89 140.4 57.78 Favored 'General case' 0 N--CA 1.519 3.022 0 O-C-N 124.94 1.4 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -81.12 -18.41 46.55 Favored 'General case' 0 N--CA 1.524 3.226 0 O-C-N 125.051 1.469 . . . . 0.0 113.909 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 m -169.98 133.58 1.2 Allowed 'General case' 0 N--CA 1.518 2.972 0 O-C-N 124.704 1.253 . . . . 0.0 109.531 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.53 145.44 36.94 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.741 1.276 . . . . 0.0 110.072 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -154.15 156.46 37.22 Favored 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.42 115.79 9.0 Favored 'General case' 0 N--CA 1.524 3.243 0 O-C-N 125.1 1.5 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.05 153.56 31.48 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 125.713 1.883 . . . . 0.0 109.188 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -127.34 114.53 17.69 Favored 'General case' 0 N--CA 1.52 3.062 0 O-C-N 126.144 2.152 . . . . 0.0 106.041 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.3 m -126.08 157.03 39.02 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.689 1.868 . . . . 0.0 111.615 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.42 123.89 49.55 Favored 'General case' 0 N--CA 1.523 3.223 0 O-C-N 126.185 2.178 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -80.4 121.06 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 O-C-N 125.076 1.485 . . . . 0.0 107.736 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.53 -175.84 3.2 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.85 -44.83 84.3 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 124.64 1.212 . . . . 0.0 111.799 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.25 61.26 Favored 'General case' 0 N--CA 1.526 3.366 0 O-C-N 125.261 1.601 . . . . 0.0 111.556 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.64 22.57 57.99 Favored Glycine 0 N--CA 1.516 3.972 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.512 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -72.95 142.37 47.81 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.37 72.83 2.29 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.803 1.314 . . . . 0.0 113.311 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.97 12.04 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 124.865 0.979 . . . . 0.0 108.442 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.95 140.7 46.93 Favored 'General case' 0 N--CA 1.521 3.091 0 O-C-N 125.218 1.574 . . . . 0.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -81.78 115.0 20.8 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 125.354 1.659 . . . . 0.0 107.885 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.12 -16.43 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.19 63.04 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -84.16 4.03 32.34 Favored 'General case' 1 N--CA 1.55 4.53 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -68.64 169.94 10.19 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -138.39 -67.37 0.47 Allowed 'General case' 0 N--CA 1.517 2.886 0 O-C-N 125.876 1.985 . . . . 0.0 108.461 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 52.83 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -156.11 153.02 28.67 Favored 'General case' 0 N--CA 1.523 3.212 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -60.4 156.0 16.9 Favored 'General case' 0 N--CA 1.517 2.902 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.48 144.33 34.11 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.9 1.375 . . . . 0.0 107.954 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -72.39 -25.94 61.69 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.379 1.05 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.68 -39.58 0.08 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.13 24.93 0.04 OUTLIER Glycine 0 N--CA 1.501 3.033 0 O-C-N 125.324 1.25 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.24 158.7 43.43 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.69 77.52 0.08 OUTLIER Glycine 0 N--CA 1.513 3.816 0 O-C-N 124.399 1.062 . . . . 0.0 112.04 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -74.69 151.22 39.26 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.232 1.195 . . . . 0.0 109.205 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.11 140.05 7.47 Favored 'General case' 0 N--CA 1.533 3.702 0 O-C-N 124.748 1.28 . . . . 0.0 113.305 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -90.29 122.18 32.97 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 125.188 1.555 . . . . 0.0 110.039 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.08 146.6 24.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 O-C-N 125.722 1.889 . . . . 0.0 107.067 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.47 123.89 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.45 126.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 125.615 1.822 . . . . 0.0 111.196 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -90.25 160.11 16.35 Favored 'General case' 0 N--CA 1.525 3.324 0 O-C-N 124.809 1.318 . . . . 0.0 108.179 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -69.51 -27.27 65.04 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.472 1.107 . . . . 0.0 111.755 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.2 m -139.46 147.61 41.59 Favored 'General case' 0 N--CA 1.529 3.507 0 O-C-N 125.315 1.634 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.26 149.18 22.5 Favored 'General case' 0 N--CA 1.523 3.192 0 O-C-N 124.676 1.235 . . . . 0.0 111.583 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 117.34 9.72 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 125.999 2.062 . . . . 0.0 109.124 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.22 145.46 41.07 Favored Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.8 124.5 15.97 Favored 'General case' 0 N--CA 1.522 3.165 0 O-C-N 125.365 1.274 . . . . 0.0 109.148 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.52 3.066 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.725 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.531 0 CA-C-O 116.814 -2.104 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.16 173.19 50.62 Favored 'Cis proline' 0 N--CA 1.53 3.672 0 CA-C-N 122.795 3.298 . . . . 0.0 113.148 -6.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.52 133.56 55.85 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.087 1.492 . . . . 0.0 110.231 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -85.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 O-C-N 125.616 1.823 . . . . 0.0 111.55 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.71 -171.28 40.12 Favored Glycine 0 N--CA 1.504 3.17 0 CA-C-N 120.609 1.55 . . . . 0.0 109.974 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.68 116.72 7.19 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 125.841 1.553 . . . . 0.0 112.744 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.92 137.29 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 O-C-N 125.927 2.017 . . . . 0.0 107.873 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 145.91 26.8 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 125.311 1.632 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -23.02 45.06 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 124.884 1.365 . . . . 0.0 112.16 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.26 -30.13 57.72 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -79.65 -18.18 52.04 Favored 'General case' 0 N--CA 1.528 3.442 0 O-C-N 124.675 1.235 . . . . 0.0 112.601 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.89 156.89 86.16 Favored Pre-proline 0 N--CA 1.532 3.637 0 CA-C-O 115.771 -2.061 . . . . 0.0 111.757 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.23 -42.92 0.81 Allowed 'Trans proline' 0 C--N 1.407 3.63 0 CA-C-N 123.384 2.244 . . . . 0.0 114.707 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.58 -104.84 0.09 OUTLIER Glycine 0 N--CA 1.504 3.229 0 O-C-N 124.741 1.276 . . . . 0.0 111.627 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.98 161.19 20.02 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 143.4 40.5 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 125.659 1.447 . . . . 0.0 107.957 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -147.6 132.27 17.87 Favored 'General case' 0 N--CA 1.533 3.71 0 O-C-N 125.09 1.494 . . . . 0.0 109.802 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -79.8 134.66 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.45 129.27 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.92 140.17 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.58 -144.37 7.89 Favored Glycine 0 N--CA 1.512 3.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.12 -163.18 25.58 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.39 -18.78 62.33 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -126.94 -13.54 5.74 Favored 'General case' 0 N--CA 1.531 3.616 0 O-C-N 125.278 1.611 . . . . 0.0 109.004 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.42 66.36 Favored Glycine 1 N--CA 1.524 4.509 0 CA-C-O 118.895 -0.947 . . . . 0.0 114.344 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.253 23.9 mt-10 62.7 -85.36 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 125.676 1.59 . . . . 0.0 114.17 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -152.96 157.19 40.23 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 125.056 1.472 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.57 68.23 0.28 Allowed Glycine 0 N--CA 1.512 3.725 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.39 151.01 47.32 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 125.569 1.393 . . . . 0.0 114.359 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.67 102.22 1.34 Allowed 'General case' 0 N--CA 1.526 3.361 0 O-C-N 124.914 1.384 . . . . 0.0 109.625 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.07 28.61 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.24 170.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.917 0 O-C-N 126.369 2.293 . . . . 0.0 107.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -161.05 124.3 3.28 Favored 'General case' 0 N--CA 1.521 3.111 0 O-C-N 124.587 1.179 . . . . 0.0 110.434 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.44 156.8 38.67 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 124.501 1.126 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.357 0 CA-C-O 116.319 -2.378 . . . . 0.0 109.76 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.9 140.01 36.89 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 124.639 1.212 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 139.93 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.97 146.65 19.17 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 124.85 1.344 . . . . 0.0 110.362 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.9 143.9 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.46 109.73 2.03 Favored Pre-proline 0 N--CA 1.528 3.473 0 CA-C-O 115.017 -2.42 . . . . 0.0 109.822 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.17 159.64 62.45 Favored 'Cis proline' 1 C--N 1.425 4.576 0 CA-C-N 125.279 2.921 . . . . 0.0 112.591 -2.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.14 -1.46 1.36 Allowed 'General case' 0 N--CA 1.531 3.576 0 O-C-N 125.033 1.458 . . . . 0.0 112.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -139.49 152.0 46.62 Favored 'General case' 0 N--CA 1.526 3.373 0 O-C-N 124.744 1.277 . . . . 0.0 110.159 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.35 30.67 69.04 Favored Glycine 0 N--CA 1.511 3.695 0 O-C-N 124.877 1.361 . . . . 0.0 113.556 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.6 154.16 40.91 Favored 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.342 1.26 . . . . 0.0 110.1 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.6 -174.37 3.22 Favored 'General case' 0 N--CA 1.522 3.137 0 O-C-N 125.877 1.986 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.04 129.02 38.54 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 124.635 1.21 . . . . 0.0 112.23 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.83 28.67 70.34 Favored Glycine 0 N--CA 1.514 3.864 0 O-C-N 124.704 1.252 . . . . 0.0 112.763 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 126.96 31.11 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 125.065 1.097 . . . . 0.0 112.245 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -88.91 134.27 34.02 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.77 147.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.191 0 O-C-N 125.295 1.622 . . . . 0.0 110.426 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 m -104.93 96.31 6.45 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 126.145 2.153 . . . . 0.0 108.842 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.86 147.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.998 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 p -135.31 164.77 26.97 Favored 'General case' 0 N--CA 1.518 2.972 0 O-C-N 125.944 2.027 . . . . 0.0 110.011 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.12 148.45 16.94 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.611 1.82 . . . . 0.0 108.161 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.34 145.28 16.25 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 124.993 1.433 . . . . 0.0 110.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 143.99 5.55 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 124.939 1.399 . . . . 0.0 112.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.02 168.41 20.05 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.177 1.163 . . . . 0.0 108.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.6 -37.22 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 124.979 1.424 . . . . 0.0 110.546 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.91 -46.69 1.96 Allowed 'General case' 0 N--CA 1.526 3.371 0 O-C-N 126.192 2.183 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.2 p -67.43 153.98 42.44 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 124.785 1.303 . . . . 0.0 112.299 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.33 -2.48 1.81 Allowed 'General case' 0 N--CA 1.538 3.93 0 O-C-N 125.563 1.79 . . . . 0.0 111.375 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -165.7 154.28 11.45 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.44 152.0 19.64 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 124.057 0.848 . . . . 0.0 111.833 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -116.59 -177.64 3.23 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 126.55 2.406 . . . . 0.0 106.157 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 112.6 1.93 Allowed 'General case' 0 N--CA 1.515 2.791 0 O-C-N 124.499 1.124 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 154.17 46.68 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 125.147 1.529 . . . . 0.0 108.66 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.99 146.4 35.33 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.602 2.439 . . . . 0.0 104.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -141.07 144.89 35.2 Favored 'General case' 0 N--CA 1.526 3.365 0 O-C-N 125.382 1.676 . . . . 0.0 109.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.21 114.8 27.44 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 125.428 1.705 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.48 143.32 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.53 -176.64 4.1 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.99 96.22 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.74 1.275 . . . . 0.0 112.062 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.522 3.139 0 O-C-N 125.384 1.678 . . . . 0.0 111.275 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.86 27.29 69.21 Favored Glycine 0 N--CA 1.512 3.76 0 CA-C-O 117.67 -1.628 . . . . 0.0 115.778 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -74.38 147.53 42.05 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.02 74.35 1.63 Allowed Glycine 0 N--CA 1.515 3.925 0 O-C-N 124.958 1.411 . . . . 0.0 113.927 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.92 89.3 6.84 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.37 144.14 51.1 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.046 1.466 . . . . 0.0 110.861 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -79.92 149.92 30.71 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.213 1.571 . . . . 0.0 109.965 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -25.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 O-C-N 125.895 1.997 . . . . 0.0 112.445 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.22 -9.32 58.44 Favored 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.89 -8.86 59.55 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.145 0.903 . . . . 0.0 113.232 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -63.69 156.44 26.94 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -145.54 -43.01 0.22 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 125.464 1.728 . . . . 0.0 108.552 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 55.17 54.62 8.56 Favored 'General case' 0 N--CA 1.523 3.175 0 O-C-N 124.981 1.426 . . . . 0.0 114.627 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -71.51 151.42 43.91 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -115.6 145.56 42.57 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 126.182 2.176 . . . . 0.0 109.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.71 154.02 28.87 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 125.042 1.464 . . . . 0.0 107.923 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -134.45 12.67 3.8 Favored 'General case' 0 N--CA 1.525 3.294 0 O-C-N 125.878 1.986 . . . . 0.0 110.061 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.09 -50.76 0.1 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.344 -2.303 . . . . 0.0 107.344 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -4.66 0.04 OUTLIER Glycine 0 N--CA 1.504 3.167 0 CA-C-O 117.344 -1.809 . . . . 0.0 112.665 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.91 162.61 20.71 Favored 'General case' 0 N--CA 1.537 3.89 0 O-C-N 125.538 1.376 . . . . 0.0 110.485 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.56 85.26 0.06 OUTLIER Glycine 0 N--CA 1.507 3.428 0 O-C-N 124.722 1.264 . . . . 0.0 110.546 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -72.55 153.75 41.15 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.124 1.132 . . . . 0.0 110.481 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -158.46 139.81 13.36 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.878 1.361 . . . . 0.0 111.583 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -91.02 124.23 35.09 Favored 'General case' 0 N--CA 1.521 3.123 0 O-C-N 124.996 1.435 . . . . 0.0 111.026 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.41 150.05 18.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.68 140.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.83 125.15 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 O-C-N 125.54 1.775 . . . . 0.0 112.092 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -90.21 165.08 14.15 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.932 1.395 . . . . 0.0 109.013 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -67.57 -29.55 68.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 124.924 1.39 . . . . 0.0 112.618 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.23 144.05 32.0 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.55 1.781 . . . . 0.0 110.69 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.61 149.25 25.13 Favored 'General case' 0 N--CA 1.523 3.218 0 O-C-N 125.244 1.59 . . . . 0.0 111.774 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 m -71.24 103.85 2.94 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 125.666 1.854 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.57 157.6 52.75 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.959 1.412 . . . . 0.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -141.13 121.8 14.28 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.603 1.414 . . . . 0.0 110.449 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.517 2.886 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.04 0 CA-C-O 115.614 -2.77 . . . . 0.0 108.598 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -72.52 149.78 94.11 Favored 'Cis proline' 0 C--N 1.405 3.512 0 CA-C-N 123.118 3.459 . . . . 0.0 113.246 -0.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -72.26 137.37 46.73 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 125.396 1.685 . . . . 0.0 108.625 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -37.2 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 O-C-N 125.263 1.602 . . . . 0.0 112.196 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.98 -170.15 34.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 125.262 1.601 . . . . 0.0 109.602 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.91 112.8 2.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 126.049 1.676 . . . . 0.0 114.012 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.63 140.59 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 O-C-N 126.063 2.102 . . . . 0.0 107.201 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 148.75 21.8 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.581 1.8 . . . . 0.0 110.678 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.2 t -89.99 71.04 7.48 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.505 1.753 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.89 -32.56 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.292 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.6 -27.2 41.1 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.104 1.502 . . . . 0.0 110.992 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 145.24 98.2 Favored Pre-proline 0 N--CA 1.518 2.959 0 CA-C-O 114.736 -2.554 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -73.57 -45.25 0.42 Allowed 'Trans proline' 0 C--N 1.412 3.878 0 CA-C-N 124.217 2.542 . . . . 0.0 112.732 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.83 -45.59 42.41 Favored Glycine 0 N--CA 1.512 3.753 0 O-C-N 124.729 1.268 . . . . 0.0 112.657 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.73 174.88 49.88 Favored Glycine 1 N--CA 1.519 4.173 0 O-C-N 125.187 1.169 . . . . 0.0 111.736 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.6 m -69.96 145.49 51.82 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.868 0.981 . . . . 0.0 112.348 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -147.48 133.87 19.63 Favored 'General case' 0 N--CA 1.527 3.423 0 O-C-N 125.495 1.747 . . . . 0.0 108.403 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -79.88 135.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.028 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.53 133.13 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.71 139.92 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.23 146.0 6.94 Favored Glycine 0 N--CA 1.514 3.844 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.28 176.03 47.91 Favored Glycine 0 N--CA 1.501 2.969 0 O-C-N 124.833 0.96 . . . . 0.0 112.536 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -72.76 -22.07 60.91 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 113.636 -1.282 . . . . 0.0 112.533 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.01 -61.45 1.77 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 124.91 1.381 . . . . 0.0 112.643 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.29 6.64 0.03 OUTLIER Glycine 1 N--CA 1.523 4.451 0 CA-C-O 117.636 -1.647 . . . . 0.0 114.384 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.68 160.84 31.94 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 118.013 0.906 . . . . 0.0 111.071 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -152.58 157.3 40.84 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.06 1.475 . . . . 0.0 108.485 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.87 82.91 0.08 OUTLIER Glycine 0 N--CA 1.504 3.218 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -69.92 155.78 40.07 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 125.353 1.266 . . . . 0.0 112.042 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.82 98.23 1.48 Allowed 'General case' 0 N--CA 1.527 3.38 0 O-C-N 124.753 1.283 . . . . 0.0 110.505 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.46 151.32 44.08 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.21 176.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.386 0 O-C-N 126.365 2.29 . . . . 0.0 107.812 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -153.47 113.99 4.02 Favored 'General case' 0 N--CA 1.526 3.368 0 O-C-N 124.172 0.92 . . . . 0.0 110.641 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -70.8 154.37 41.9 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 124.424 1.078 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.311 -2.383 . . . . 0.0 109.694 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.586 0 CA-C-O 119.512 -0.28 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.97 122.15 26.36 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.758 1.286 . . . . 0.0 111.684 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.96 137.66 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.329 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.17 146.39 13.98 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 124.865 1.353 . . . . 0.0 110.57 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.8 144.08 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.137 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -155.99 110.66 2.12 Favored Pre-proline 0 N--CA 1.528 3.429 0 CA-C-O 114.981 -2.437 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.25 156.63 72.94 Favored 'Cis proline' 1 C--N 1.424 4.533 0 CA-C-N 125.344 2.944 . . . . 0.0 111.899 -2.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.8 -4.83 1.37 Allowed 'General case' 0 N--CA 1.531 3.594 0 O-C-N 125.46 1.725 . . . . 0.0 112.563 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -136.09 152.59 51.02 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 124.991 1.432 . . . . 0.0 110.093 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.98 28.92 67.74 Favored Glycine 0 N--CA 1.513 3.791 0 O-C-N 124.989 1.431 . . . . 0.0 113.274 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.12 152.83 41.03 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 125.205 1.179 . . . . 0.0 109.794 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.77 4.81 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.68 1.863 . . . . 0.0 109.102 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.66 136.29 57.38 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 124.952 1.408 . . . . 0.0 111.711 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 39.27 33.87 Favored Glycine 0 N--CA 1.511 3.643 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 156.94 38.75 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 125.718 1.481 . . . . 0.0 112.401 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -139.8 119.08 12.82 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 126.361 2.288 . . . . 0.0 105.074 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.26 155.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.043 0 O-C-N 126.053 2.095 . . . . 0.0 109.975 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.9 m -122.74 96.05 4.87 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 126.286 2.241 . . . . 0.0 106.362 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.63 147.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 p -137.85 165.54 26.24 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 126.051 2.094 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.73 15.79 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.502 1.751 . . . . 0.0 108.598 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -160.53 146.8 15.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.888 1.367 . . . . 0.0 108.947 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.69 87.72 0.17 Allowed Glycine 0 N--CA 1.508 3.457 0 O-C-N 125.054 1.471 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -156.89 153.64 28.49 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.713 1.478 . . . . 0.0 107.477 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 -20.24 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.792 1.307 . . . . 0.0 111.28 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.39 1.056 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -70.11 126.09 28.66 Favored 'General case' 0 N--CA 1.521 3.099 0 O-C-N 124.63 1.206 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -80.3 -14.19 58.58 Favored 'General case' 0 N--CA 1.531 3.585 0 O-C-N 124.392 1.058 . . . . 0.0 112.975 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.29 155.85 11.68 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.18 33.26 Favored 'General case' 0 N--CA 1.521 3.116 0 O-C-N 125.111 1.507 . . . . 0.0 111.376 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -179.31 3.66 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 126.594 2.434 . . . . 0.0 107.682 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.55 109.83 2.16 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 124.944 1.402 . . . . 0.0 108.447 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 139.47 23.18 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.595 1.185 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -84.0 145.3 28.59 Favored 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.79 144.59 31.24 Favored 'General case' 0 N--CA 1.529 3.49 0 O-C-N 125.009 1.443 . . . . 0.0 108.713 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.9 118.51 37.08 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.673 1.858 . . . . 0.0 113.202 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.64 135.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.7 mt -113.44 -173.63 2.3 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.54 70.1 Favored 'General case' 0 N--CA 1.518 2.927 0 O-C-N 124.506 1.129 . . . . 0.0 112.604 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -20.65 61.82 Favored 'General case' 0 N--CA 1.526 3.334 0 O-C-N 125.372 1.67 . . . . 0.0 111.948 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.1 24.34 59.73 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 118.237 -1.313 . . . . 0.0 114.244 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.34 144.7 44.35 Favored 'General case' 0 N--CA 1.521 3.118 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.12 118.21 7.27 Favored Glycine 0 N--CA 1.508 3.481 0 O-C-N 124.729 1.268 . . . . 0.0 112.669 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.91 107.36 8.25 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.3 m -147.83 156.09 42.35 Favored 'General case' 0 N--CA 1.526 3.363 0 O-C-N 124.665 1.228 . . . . 0.0 110.112 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -83.44 147.39 27.88 Favored 'General case' 0 N--CA 1.517 2.922 0 O-C-N 125.451 1.72 . . . . 0.0 109.734 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -24.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.46 0 O-C-N 125.753 1.908 . . . . 0.0 112.933 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.89 -17.02 62.14 Favored 'General case' 0 N--CA 1.521 3.084 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.89 -5.65 55.93 Favored 'General case' 0 N--CA 1.537 3.877 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.58 161.84 14.0 Favored 'General case' 0 N--CA 1.533 3.699 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -152.15 -50.14 0.11 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 125.853 1.971 . . . . 0.0 108.093 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 56.82 49.59 13.94 Favored 'General case' 0 N--CA 1.522 3.148 0 O-C-N 125.505 1.753 . . . . 0.0 113.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -67.04 135.2 53.33 Favored 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -91.26 138.16 31.8 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 124.911 1.382 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.83 152.95 29.42 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 124.994 1.434 . . . . 0.0 107.774 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -140.98 6.01 1.96 Allowed 'General case' 0 N--CA 1.529 3.521 0 O-C-N 125.578 1.798 . . . . 0.0 111.768 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.07 22.39 0.05 OUTLIER Glycine 0 N--CA 1.509 3.563 0 O-C-N 124.075 0.859 . . . . 0.0 110.993 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.12 26.41 72.39 Favored Glycine 0 N--CA 1.508 3.454 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.149 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.75 154.66 43.68 Favored 'General case' 1 N--CA 1.54 4.07 0 O-C-N 125.217 1.186 . . . . 0.0 108.372 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 140.88 4.51 Favored Glycine 0 N--CA 1.509 3.55 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -135.54 150.49 49.75 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 125.734 1.491 . . . . 0.0 108.318 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -159.59 139.18 11.42 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 124.962 1.414 . . . . 0.0 111.884 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -93.31 135.62 34.36 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 125.147 1.53 . . . . 0.0 108.827 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.44 154.11 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 O-C-N 125.557 1.785 . . . . 0.0 106.949 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.91 138.92 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.13 139.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 O-C-N 125.394 1.684 . . . . 0.0 111.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -90.0 163.57 14.87 Favored 'General case' 0 N--CA 1.52 3.035 0 O-C-N 125.584 1.802 . . . . 0.0 106.434 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -62.38 -39.12 92.16 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.843 1.339 . . . . 0.0 111.144 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.36 153.93 35.79 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 126.36 2.287 . . . . 0.0 109.94 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -156.31 148.97 23.78 Favored 'General case' 0 N--CA 1.529 3.496 0 O-C-N 124.966 1.416 . . . . 0.0 111.663 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.05 107.01 2.55 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 125.56 1.787 . . . . 0.0 111.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.44 99.05 0.87 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.737 1.273 . . . . 0.0 110.153 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -93.33 103.6 15.82 Favored 'General case' 0 N--CA 1.524 3.242 0 O-C-N 125.294 1.232 . . . . 0.0 112.635 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.519 3.007 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.767 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.589 4.703 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.91 168.83 72.67 Favored 'Cis proline' 0 N--CA 1.527 3.467 0 CA-C-N 123.099 3.449 . . . . 0.0 112.51 -6.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.47 128.15 34.67 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 125.303 1.627 . . . . 0.0 110.537 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -78.66 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 CA-C-O 116.993 -1.479 . . . . 0.0 112.487 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.86 -171.35 42.27 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-N 120.271 1.396 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.64 128.15 35.41 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.665 1.45 . . . . 0.0 113.399 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.85 142.62 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 O-C-N 126.179 2.174 . . . . 0.0 106.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.48 146.32 36.16 Favored 'General case' 0 N--CA 1.529 3.525 0 O-C-N 126.079 2.112 . . . . 0.0 111.445 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.8 m -74.33 79.11 1.85 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 125.521 1.763 . . . . 0.0 111.896 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -37.33 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.66 -28.52 40.78 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 125.424 1.703 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.07 139.5 95.39 Favored Pre-proline 0 N--CA 1.515 2.817 0 CA-C-O 114.472 -2.68 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.97 -43.03 0.63 Allowed 'Trans proline' 0 C--N 1.41 3.809 0 CA-C-N 124.575 2.67 . . . . 0.0 112.786 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.72 61.58 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 124.862 1.351 . . . . 0.0 112.374 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.08 154.43 19.28 Favored Glycine 1 N--CA 1.518 4.101 0 O-C-N 125.287 1.228 . . . . 0.0 111.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.6 m -69.9 140.14 53.09 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 124.856 0.974 . . . . 0.0 111.683 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -145.54 139.27 26.62 Favored 'General case' 0 N--CA 1.526 3.337 0 O-C-N 125.369 1.668 . . . . 0.0 108.596 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.84 133.6 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.0 133.72 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.96 143.87 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.312 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.92 137.47 3.21 Favored Glycine 1 N--CA 1.52 4.268 0 O-C-N 124.151 0.907 . . . . 0.0 111.566 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.81 -160.42 35.6 Favored Glycine 1 N--CA 1.518 4.103 0 O-C-N 125.48 1.341 . . . . 0.0 112.405 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.51 -25.03 62.95 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 125.443 1.319 . . . . 0.0 112.941 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -70.88 -32.7 69.76 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.799 1.312 . . . . 0.0 110.436 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.72 14.09 44.79 Favored Glycine 0 N--CA 1.516 3.998 0 O-C-N 125.747 1.904 . . . . 0.0 113.16 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.5 103.24 3.45 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -73.05 173.68 8.99 Favored 'General case' 0 N--CA 1.519 3.011 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.13 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.09 80.13 0.08 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -67.86 154.32 41.83 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 125.307 1.239 . . . . 0.0 113.495 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.17 95.57 0.86 Allowed 'General case' 0 N--CA 1.523 3.212 0 O-C-N 125.127 1.517 . . . . 0.0 108.586 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.34 156.04 39.85 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 173.13 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.689 0 O-C-N 126.663 2.477 . . . . 0.0 107.153 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.6 m -155.19 116.0 3.91 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.056 0.848 . . . . 0.0 110.445 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -69.96 150.26 46.89 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 124.611 1.194 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.674 0 CA-C-O 116.389 -2.339 . . . . 0.0 111.516 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.677 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.09 129.8 5.26 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 124.937 1.398 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.48 144.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -160.24 144.06 14.06 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 124.927 1.392 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.11 142.28 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.062 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.25 112.86 1.72 Allowed Pre-proline 0 N--CA 1.527 3.403 0 CA-C-O 114.892 -2.48 . . . . 0.0 110.082 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -64.28 151.31 73.18 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.428 2.974 . . . . 0.0 112.102 -4.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.97 -8.89 1.58 Allowed 'General case' 0 N--CA 1.528 3.463 0 O-C-N 125.943 2.027 . . . . 0.0 112.817 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.2 p -132.73 151.58 51.95 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.321 1.638 . . . . 0.0 110.106 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.99 31.8 66.59 Favored Glycine 0 N--CA 1.514 3.881 0 O-C-N 124.993 1.433 . . . . 0.0 112.457 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.87 153.99 39.64 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 125.432 1.313 . . . . 0.0 110.234 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.88 -173.89 3.27 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 126.032 2.083 . . . . 0.0 108.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -66.56 128.94 38.18 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.644 1.215 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.08 28.71 69.89 Favored Glycine 0 N--CA 1.514 3.853 0 O-C-N 124.667 1.229 . . . . 0.0 112.794 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.39 127.21 31.87 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 124.924 1.014 . . . . 0.0 112.618 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 m -87.08 130.07 34.65 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 125.307 1.629 . . . . 0.0 106.803 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.63 143.49 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 125.607 1.817 . . . . 0.0 108.981 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.9 m -111.12 102.01 10.49 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 126.268 2.23 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.91 149.13 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.011 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -140.53 164.27 30.61 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 125.703 1.877 . . . . 0.0 110.174 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.24 145.33 14.84 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.53 1.769 . . . . 0.0 108.3 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -159.12 146.79 17.54 Favored 'General case' 0 N--CA 1.515 2.783 0 O-C-N 125.239 1.587 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.13 88.91 0.11 Allowed Glycine 0 N--CA 1.508 3.498 0 O-C-N 125.101 1.5 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -154.96 155.5 34.34 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 125.71 1.477 . . . . 0.0 107.783 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.1 -19.51 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.883 1.364 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -79.56 -51.16 9.66 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 124.427 1.08 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 p -70.87 119.97 15.78 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.894 1.371 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -79.79 -19.92 47.42 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 124.432 1.083 . . . . 0.0 112.909 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -166.38 150.09 7.39 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 125.233 1.583 . . . . 0.0 107.816 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.94 160.16 40.66 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 125.622 1.826 . . . . 0.0 110.373 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -151.14 129.75 12.25 Favored 'General case' 0 N--CA 1.517 2.913 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 121.78 24.25 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.651 1.219 . . . . 0.0 112.046 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 146.47 50.78 Favored 'General case' 0 N--CA 1.53 3.572 0 O-C-N 125.429 1.705 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.57 128.74 35.88 Favored 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.47 142.74 39.43 Favored 'General case' 0 N--CA 1.531 3.604 0 O-C-N 124.719 1.262 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.17 26.56 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 125.187 1.555 . . . . 0.0 111.181 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -79.33 122.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.142 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.95 -174.34 2.59 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.68 84.02 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 124.703 1.252 . . . . 0.0 110.84 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -21.45 59.79 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 125.434 1.709 . . . . 0.0 110.87 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.85 26.69 60.02 Favored Glycine 0 N--CA 1.513 3.789 0 CA-C-O 117.472 -1.738 . . . . 0.0 115.635 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -73.11 146.23 45.88 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.01 74.72 1.17 Allowed Glycine 0 N--CA 1.515 3.917 0 CA-C-O 118.114 -1.381 . . . . 0.0 115.854 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.08 97.88 9.56 Favored 'General case' 0 N--CA 1.515 2.816 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.21 143.3 49.85 Favored 'General case' 0 N--CA 1.527 3.414 0 O-C-N 124.874 1.359 . . . . 0.0 111.792 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -85.87 116.31 24.04 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 125.487 1.742 . . . . 0.0 108.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -65.53 -23.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.07 -12.18 61.45 Favored 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -79.89 -7.18 58.59 Favored 'General case' 1 N--CA 1.541 4.109 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -64.18 160.81 17.64 Favored 'General case' 0 N--CA 1.531 3.604 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -139.18 -52.42 0.55 Allowed 'General case' 0 N--CA 1.52 3.032 0 O-C-N 126.007 2.067 . . . . 0.0 108.071 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 45.58 116.1 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -171.22 144.04 1.98 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 m -65.07 157.0 29.68 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.806 1.316 . . . . 0.0 113.478 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.2 mt -79.5 147.67 32.13 Favored 'General case' 0 N--CA 1.513 2.703 0 O-C-N 125.326 1.641 . . . . 0.0 108.225 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -72.1 -26.04 61.99 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 124.637 1.211 . . . . 0.0 112.483 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.03 -36.5 0.05 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.51 19.67 0.02 OUTLIER Glycine 0 N--CA 1.502 3.076 0 CA-C-O 117.673 -1.626 . . . . 0.0 111.953 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 158.06 34.75 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.497 1.351 . . . . 0.0 109.146 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.37 139.63 4.2 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -142.35 151.16 41.63 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.74 134.98 5.42 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.96 1.412 . . . . 0.0 112.361 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 t -86.46 114.21 23.04 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 125.067 1.479 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.03 144.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 t -122.71 137.23 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.55 131.12 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 O-C-N 125.75 1.906 . . . . 0.0 113.005 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -90.12 161.83 15.59 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 125.225 1.578 . . . . 0.0 106.984 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -65.68 -32.85 74.64 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 124.727 1.267 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 m -131.29 150.21 52.24 Favored 'General case' 0 N--CA 1.528 3.427 0 O-C-N 125.991 2.057 . . . . 0.0 110.173 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -157.8 146.71 19.48 Favored 'General case' 0 N--CA 1.525 3.292 0 O-C-N 124.906 1.379 . . . . 0.0 111.518 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.4 m -69.25 113.0 6.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 125.608 1.818 . . . . 0.0 110.631 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.35 149.55 45.68 Favored Glycine 0 N--CA 1.513 3.828 0 O-C-N 124.974 1.421 . . . . 0.0 109.858 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -137.95 88.37 2.32 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.406 1.298 . . . . 0.0 108.551 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.518 2.964 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.316 -179.692 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.585 4.438 0 CA-C-O 115.305 -2.942 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.47 155.43 82.25 Favored 'Cis proline' 0 C--N 1.402 3.359 0 CA-C-N 123.948 3.874 . . . . 0.0 114.28 -1.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.79 134.14 48.22 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.604 1.815 . . . . 0.0 109.307 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -87.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.224 0 O-C-N 125.252 1.595 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.33 -174.71 42.51 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.97 118.56 12.05 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 125.663 1.449 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.06 133.33 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 O-C-N 125.989 2.056 . . . . 0.0 107.98 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.44 141.31 28.64 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 125.022 1.451 . . . . 0.0 111.338 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.3 t -83.5 72.51 10.26 Favored 'General case' 0 N--CA 1.513 2.724 0 O-C-N 125.232 1.583 . . . . 0.0 110.463 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.15 -32.73 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -79.66 -25.8 41.21 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.106 1.504 . . . . 0.0 111.252 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.96 150.71 97.66 Favored Pre-proline 0 N--CA 1.523 3.199 0 CA-C-O 115.101 -2.38 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.77 -48.79 0.22 Allowed 'Trans proline' 0 C--N 1.408 3.698 0 CA-C-N 123.711 2.361 . . . . 0.0 113.036 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.42 -46.95 24.01 Favored Glycine 0 N--CA 1.51 3.58 0 O-C-N 124.532 1.145 . . . . 0.0 112.558 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.82 172.43 48.85 Favored Glycine 1 N--CA 1.517 4.051 0 O-C-N 125.319 1.246 . . . . 0.0 110.89 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.7 m -70.11 153.42 43.17 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 124.783 0.931 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -157.78 135.24 10.39 Favored 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.77 137.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.857 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.81 131.7 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.16 140.23 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.61 -152.89 16.26 Favored Glycine 1 N--CA 1.517 4.097 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.64 -160.91 13.56 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -68.5 -34.09 75.29 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -125.07 -15.05 6.44 Favored 'General case' 1 N--CA 1.544 4.234 0 O-C-N 125.015 1.447 . . . . 0.0 111.835 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.41 -1.7 30.21 Favored Glycine 1 N--CA 1.527 4.755 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 63.89 173.09 0.18 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.903 1.281 . . . . 0.0 113.373 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -69.83 145.19 52.28 Favored 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.731 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.34 -64.14 2.47 Favored Glycine 0 N--CA 1.512 3.755 0 O-C-N 124.601 1.188 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 62.58 105.82 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.126 0 O-C-N 126.105 1.709 . . . . 0.0 113.568 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.25 95.8 1.27 Allowed 'General case' 0 N--CA 1.532 3.658 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.124 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.27 152.94 42.8 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.089 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pt -116.51 168.63 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 O-C-N 126.253 2.221 . . . . 0.0 108.748 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -140.94 157.57 45.17 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 124.851 1.344 . . . . 0.0 109.21 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -110.29 159.61 17.26 Favored 'General case' 0 N--CA 1.521 3.093 0 O-C-N 126.098 2.124 . . . . 0.0 109.826 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.312 0 CA-C-O 116.345 -2.364 . . . . 0.0 109.668 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 t -70.55 -29.46 65.93 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 125.128 1.518 . . . . 0.0 113.011 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.0 139.24 2.85 Favored 'General case' 0 N--CA 1.515 2.788 0 O-C-N 124.999 1.437 . . . . 0.0 109.359 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 131.78 35.98 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 124.947 1.404 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.88 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.72 141.48 7.39 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 124.773 1.295 . . . . 0.0 109.786 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.74 141.33 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 p -160.42 113.01 1.38 Allowed Pre-proline 0 CA--C 1.608 3.176 0 CA-C-O 115.053 -2.403 . . . . 0.0 109.927 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -65.14 153.21 77.27 Favored 'Cis proline' 1 C--N 1.425 4.595 0 CA-C-N 125.458 2.985 . . . . 0.0 111.222 -3.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.22 -8.65 1.15 Allowed 'General case' 0 N--CA 1.529 3.513 0 O-C-N 125.872 1.983 . . . . 0.0 113.063 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -129.45 153.98 47.41 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.486 1.741 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 28.25 68.39 Favored Glycine 1 N--CA 1.519 4.167 0 O-C-N 124.8 1.313 . . . . 0.0 113.118 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.47 155.75 33.6 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 125.146 1.144 . . . . 0.0 110.282 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.82 -178.52 5.85 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 125.656 1.847 . . . . 0.0 107.222 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.35 142.83 53.9 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 124.592 1.183 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.68 85.62 Favored Glycine 1 N--CA 1.521 4.337 0 O-C-N 124.981 1.426 . . . . 0.0 113.394 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.49 164.72 26.28 Favored 'General case' 0 N--CA 1.52 3.064 0 O-C-N 124.196 0.586 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 m -145.98 121.91 10.66 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.5 -178.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 O-C-N 125.667 1.855 . . . . 0.0 110.047 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -143.25 92.61 2.39 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.76 149.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 p -135.24 162.03 33.71 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 126.141 2.15 . . . . 0.0 109.044 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.5 16.82 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 125.307 1.63 . . . . 0.0 108.68 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -157.04 149.52 23.24 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 125.4 1.687 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 127.42 0.85 Allowed Glycine 1 N--CA 1.52 4.27 0 O-C-N 124.95 1.406 . . . . 0.0 111.988 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -147.98 161.62 40.98 Favored 'General case' 0 N--CA 1.522 3.154 0 C-N-CA 124.269 1.028 . . . . 0.0 109.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.95 -59.15 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.554 0 O-C-N 125.385 1.678 . . . . 0.0 108.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 -53.36 6.73 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.332 1.645 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.2 p -67.83 143.07 55.94 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 124.893 1.371 . . . . 0.0 112.273 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.535 3.801 0 O-C-N 125.689 1.868 . . . . 0.0 109.823 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -168.9 170.61 8.96 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.7 13.31 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 123.858 0.724 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.53 172.89 11.41 Favored 'General case' 0 N--CA 1.524 3.249 0 O-C-N 126.173 2.171 . . . . 0.0 106.212 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.95 66.99 1.31 Allowed 'General case' 0 N--CA 1.531 3.612 0 O-C-N 125.421 1.701 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.24 155.45 28.57 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -137.73 136.54 37.43 Favored 'General case' 0 N--CA 1.521 3.107 0 O-C-N 125.771 1.919 . . . . 0.0 106.669 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.0 m -141.31 150.22 42.24 Favored 'General case' 0 N--CA 1.532 3.635 0 O-C-N 124.584 1.177 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.17 115.7 28.85 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 126.096 2.122 . . . . 0.0 110.963 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.2 137.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -122.08 -175.05 3.03 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.767 1.917 . . . . 0.0 106.294 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.58 97.37 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.303 1.002 . . . . 0.0 111.993 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 -21.81 60.4 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.45 1.719 . . . . 0.0 111.163 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.37 24.42 73.15 Favored Glycine 0 N--CA 1.512 3.75 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.873 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -75.03 145.12 42.68 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.59 75.9 1.19 Allowed Glycine 1 N--CA 1.517 4.098 0 O-C-N 124.813 1.321 . . . . 0.0 114.296 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.83 96.36 8.2 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.35 139.92 52.91 Favored 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.028 1.455 . . . . 0.0 112.575 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -76.85 138.57 39.88 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 125.016 1.447 . . . . 0.0 109.369 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.08 -24.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 O-C-N 125.512 1.758 . . . . 0.0 114.613 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.16 -21.51 46.37 Favored 'General case' 0 N--CA 1.532 3.67 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -82.72 1.6 37.92 Favored 'General case' 1 N--CA 1.549 4.482 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -69.69 168.78 14.18 Favored 'General case' 0 N--CA 1.533 3.722 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -133.82 -63.93 0.72 Allowed 'General case' 0 N--CA 1.524 3.229 0 O-C-N 125.614 1.821 . . . . 0.0 109.996 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.41 98.5 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.029 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -157.51 150.01 22.85 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -65.74 167.74 8.82 Favored 'General case' 0 N--CA 1.52 3.07 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -79.29 141.95 36.58 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.7 t -71.54 -25.19 62.12 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 124.408 1.067 . . . . 0.0 112.985 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.55 -39.19 0.06 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.32 18.28 0.02 OUTLIER Glycine 0 N--CA 1.501 3.03 0 O-C-N 125.287 1.228 . . . . 0.0 111.593 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -144.03 165.36 27.99 Favored 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.32 79.98 0.08 OUTLIER Glycine 0 N--CA 1.513 3.799 0 O-C-N 124.074 0.859 . . . . 0.0 111.658 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -74.87 149.72 39.43 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 125.539 1.376 . . . . 0.0 108.986 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.27 137.56 7.17 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.904 1.378 . . . . 0.0 112.93 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -90.04 112.84 24.41 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 125.219 1.575 . . . . 0.0 110.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.75 147.06 13.7 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.125 0 O-C-N 125.385 1.678 . . . . 0.0 107.012 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.28 150.01 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 125.855 1.972 . . . . 0.0 106.705 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.65 92.06 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 125.525 1.766 . . . . 0.0 110.009 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -86.56 154.14 21.29 Favored 'General case' 0 N--CA 1.523 3.218 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.001 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.522 3.135 0 O-C-N 124.721 1.263 . . . . 0.0 113.473 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -156.23 147.06 21.99 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 124.616 1.197 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.87 149.53 21.74 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.879 1.362 . . . . 0.0 111.669 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.0 m -69.47 105.53 2.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.779 1.925 . . . . 0.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.3 159.67 53.45 Favored Glycine 0 N--CA 1.514 3.842 0 O-C-N 124.665 1.228 . . . . 0.0 111.235 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 119.05 14.41 Favored 'General case' 0 N--CA 1.527 3.404 0 O-C-N 125.596 1.409 . . . . 0.0 108.384 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.11 111.5 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 O-C-N 124.797 1.311 . . . . 0.0 107.607 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.2 169.49 0.02 OUTLIER Pre-proline 2 N--CA 1.567 5.377 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.23 -13.34 30.9 Favored 'Trans proline' 1 C--N 1.425 4.592 0 CA-C-N 123.884 2.423 . . . . 0.0 113.953 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.56 -39.27 32.23 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.44 -164.32 52.24 Favored Glycine 2 CA--C 1.583 4.34 0 CA-C-O 115.688 -2.729 . . . . 0.0 109.042 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -67.78 156.49 86.42 Favored 'Cis proline' 0 C--N 1.403 3.446 0 CA-C-N 123.668 3.734 . . . . 0.0 114.291 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.34 142.01 52.21 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 125.512 1.757 . . . . 0.0 109.301 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -38.51 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 O-C-N 125.231 1.582 . . . . 0.0 112.581 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.84 -166.68 23.79 Favored Glycine 0 N--CA 1.501 2.976 0 O-C-N 125.568 1.793 . . . . 0.0 108.93 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.75 116.92 5.64 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 125.823 1.543 . . . . 0.0 113.757 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.43 138.62 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 O-C-N 125.969 2.043 . . . . 0.0 107.407 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.21 144.48 28.12 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 125.303 1.627 . . . . 0.0 110.711 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.4 t -80.36 -32.81 37.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 125.05 1.469 . . . . 0.0 112.77 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.09 -25.65 63.62 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.62 -25.28 41.48 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.408 1.068 . . . . 0.0 113.244 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 91.39 Favored Pre-proline 0 N--CA 1.531 3.604 0 CA-C-O 115.573 -2.156 . . . . 0.0 112.025 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.84 -49.26 0.25 Allowed 'Trans proline' 0 C--N 1.413 3.938 0 CA-C-N 123.305 2.216 . . . . 0.0 113.612 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.55 -42.28 55.69 Favored Glycine 0 N--CA 1.511 3.655 0 O-C-N 124.627 1.205 . . . . 0.0 112.477 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.57 175.38 49.2 Favored Glycine 1 N--CA 1.518 4.116 0 O-C-N 125.163 1.155 . . . . 0.0 111.291 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.8 m -70.02 144.82 52.13 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.569 0.805 . . . . 0.0 112.453 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -146.12 127.67 15.1 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 125.806 1.941 . . . . 0.0 107.235 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.77 137.09 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -129.48 134.61 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.34 136.9 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.9 152.88 10.53 Favored Glycine 0 N--CA 1.509 3.541 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.78 -176.75 49.72 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 125.346 1.262 . . . . 0.0 111.804 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -76.57 -16.6 59.56 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.003 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.98 -65.79 0.68 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 124.67 1.231 . . . . 0.0 112.526 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.74 12.85 0.02 OUTLIER Glycine 0 N--CA 1.515 3.924 0 CA-C-O 118.568 -1.129 . . . . 0.0 112.505 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.36 156.44 39.09 Favored 'General case' 0 N--CA 1.521 3.119 0 O-C-N 124.702 0.884 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -153.9 158.81 41.29 Favored 'General case' 0 N--CA 1.522 3.147 0 O-C-N 124.758 1.286 . . . . 0.0 109.236 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.96 82.91 0.07 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -67.29 155.39 39.0 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 125.421 1.306 . . . . 0.0 113.377 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.69 101.79 1.5 Allowed 'General case' 0 N--CA 1.527 3.415 0 O-C-N 124.655 1.222 . . . . 0.0 110.426 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 155.37 40.72 Favored 'General case' 0 N--CA 1.514 2.732 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.78 177.1 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 126.476 2.36 . . . . 0.0 107.735 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 p -156.13 124.2 5.7 Favored 'General case' 0 N--CA 1.524 3.244 0 O-C-N 123.972 0.795 . . . . 0.0 111.674 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -75.3 158.22 33.18 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 124.11 0.882 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.715 0 CA-C-O 116.31 -2.383 . . . . 0.0 111.338 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -143.42 5.92 1.45 Allowed 'General case' 0 N--CA 1.526 3.347 0 O-C-N 125.985 2.053 . . . . 0.0 110.634 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.4 -173.23 0.11 Allowed 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 124.786 1.234 . . . . 0.0 114.284 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.22 123.7 3.54 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.676 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.9 146.81 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.57 140.89 16.61 Favored 'General case' 0 N--CA 1.518 2.929 0 O-C-N 125.166 1.541 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.53 144.57 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -160.88 111.85 1.3 Allowed Pre-proline 0 N--CA 1.524 3.228 0 CA-C-O 115.054 -2.403 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.41 151.78 70.21 Favored 'Cis proline' 1 C--N 1.425 4.594 0 CA-C-N 125.286 2.924 . . . . 0.0 112.439 -3.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -3.56 2.0 Favored 'General case' 0 N--CA 1.528 3.452 0 O-C-N 125.98 2.05 . . . . 0.0 112.881 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.1 p -138.42 151.16 47.2 Favored 'General case' 0 N--CA 1.528 3.467 0 O-C-N 124.686 1.241 . . . . 0.0 109.89 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.24 32.25 68.8 Favored Glycine 1 N--CA 1.517 4.045 0 O-C-N 125.036 1.46 . . . . 0.0 112.879 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.8 mt -73.11 155.21 39.93 Favored 'General case' 0 N--CA 1.514 2.747 0 O-C-N 125.456 1.327 . . . . 0.0 110.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.31 -176.29 3.84 Favored 'General case' 0 N--CA 1.518 2.973 0 O-C-N 126.07 2.107 . . . . 0.0 108.574 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 127.49 32.81 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 124.75 1.281 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.95 28.95 71.16 Favored Glycine 0 N--CA 1.516 3.99 0 O-C-N 124.811 1.32 . . . . 0.0 112.977 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.14 123.81 23.68 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 124.935 1.021 . . . . 0.0 112.649 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -79.88 128.03 32.96 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.7 143.54 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 O-C-N 125.596 1.81 . . . . 0.0 109.178 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 m -107.1 102.92 12.22 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 126.231 2.207 . . . . 0.0 110.602 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.81 147.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.5 158.47 43.02 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.23 2.206 . . . . 0.0 108.717 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.28 141.56 12.32 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.244 1.59 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -165.31 122.52 1.51 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.516 1.76 . . . . 0.0 107.875 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 172.16 -90.56 0.09 OUTLIER Glycine 0 N--CA 1.506 3.337 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER 58.9 146.62 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.963 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.88 -37.74 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -136.84 -30.09 0.9 Allowed 'General case' 0 N--CA 1.527 3.416 0 O-C-N 126.007 2.067 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -73.36 109.46 6.9 Favored 'General case' 0 N--CA 1.523 3.19 0 O-C-N 124.658 1.224 . . . . 0.0 109.325 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.64 7.54 41.06 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.827 1.33 . . . . 0.0 112.726 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -160.46 167.72 26.66 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 124.398 1.061 . . . . 0.0 109.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.15 145.13 26.12 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.265 1.603 . . . . 0.0 109.898 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.1 m -142.0 169.77 16.97 Favored 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.38 4.46 Favored 'General case' 0 N--CA 1.527 3.411 0 O-C-N 124.23 0.956 . . . . 0.0 112.229 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.28 139.85 21.57 Favored 'General case' 0 N--CA 1.538 3.931 0 O-C-N 125.262 1.601 . . . . 0.0 109.551 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -87.83 148.74 24.52 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.3 m -142.42 149.54 39.44 Favored 'General case' 0 N--CA 1.524 3.268 0 O-C-N 125.581 1.801 . . . . 0.0 108.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.0 124.77 51.24 Favored 'General case' 0 N--CA 1.526 3.344 0 O-C-N 126.083 2.114 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -76.45 145.52 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.63 -175.76 3.56 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.41 -49.93 69.6 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.54 1.15 . . . . 0.0 111.654 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -23.59 59.9 Favored 'General case' 0 N--CA 1.528 3.431 0 O-C-N 125.564 1.79 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.0 32.93 60.13 Favored Glycine 0 N--CA 1.508 3.49 0 CA-C-O 116.921 -2.044 . . . . 0.0 117.187 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -75.79 150.2 37.78 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.75 89.33 0.38 Allowed Glycine 0 N--CA 1.511 3.676 0 O-C-N 124.722 1.264 . . . . 0.0 113.496 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.34 95.66 6.66 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.45 137.86 47.41 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 125.247 1.592 . . . . 0.0 111.223 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -78.91 117.82 20.35 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.94 1.4 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -21.48 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.369 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.97 -17.44 64.44 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 118.165 2.654 . . . . 0.0 118.165 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -83.04 2.06 36.91 Favored 'General case' 1 N--CA 1.55 4.533 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.38 167.38 12.67 Favored 'General case' 0 N--CA 1.53 3.552 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -146.17 -60.06 0.31 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 126.057 2.098 . . . . 0.0 107.264 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 45.44 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.757 1.911 . . . . 0.0 116.129 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.14 149.98 31.93 Favored 'General case' 0 N--CA 1.528 3.465 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.72 160.77 22.15 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.935 1.397 . . . . 0.0 114.759 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.39 149.82 31.54 Favored 'General case' 0 N--CA 1.517 2.9 0 O-C-N 125.178 1.549 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -76.31 -24.44 54.34 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.025 1.453 . . . . 0.0 112.217 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.2 -30.89 0.05 OUTLIER Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.16 3.66 0.02 OUTLIER Glycine 0 N--CA 1.512 3.749 0 CA-C-O 117.595 -1.67 . . . . 0.0 112.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.22 165.22 23.84 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.19 79.36 0.08 OUTLIER Glycine 0 N--CA 1.514 3.873 0 O-C-N 124.296 0.998 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m -75.03 155.7 37.0 Favored 'General case' 0 N--CA 1.517 2.902 0 O-C-N 125.311 1.242 . . . . 0.0 109.872 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.84 135.81 6.66 Favored 'General case' 0 N--CA 1.524 3.267 0 O-C-N 124.611 1.195 . . . . 0.0 113.065 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -84.49 114.24 21.79 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 124.875 1.359 . . . . 0.0 110.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.42 149.49 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.35 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 N-CA-C 102.395 -3.187 . . . . 0.0 102.395 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.67 125.18 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 O-C-N 125.543 1.777 . . . . 0.0 112.511 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -90.17 159.58 16.68 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.886 1.366 . . . . 0.0 107.73 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -66.24 -32.89 74.59 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.713 1.258 . . . . 0.0 111.952 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 148.41 52.01 Favored 'General case' 0 N--CA 1.529 3.476 0 O-C-N 125.944 2.028 . . . . 0.0 109.763 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.17 145.44 19.42 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.714 1.259 . . . . 0.0 111.926 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -70.45 106.07 3.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.744 1.903 . . . . 0.0 109.037 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.58 151.42 49.48 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.028 1.455 . . . . 0.0 110.739 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -139.98 121.3 14.95 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 125.803 1.531 . . . . 0.0 109.018 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.08 146.77 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.52 -50.93 82.52 Favored Pre-proline 0 N--CA 1.537 3.885 0 N-CA-C 121.082 3.734 . . . . 0.0 121.082 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.4 -60.8 0.11 Allowed 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 125.113 2.862 . . . . 0.0 115.174 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.12 -47.33 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.622 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.9 -168.44 39.33 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-O 115.564 -2.798 . . . . 0.0 109.133 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -71.63 139.94 62.26 Favored 'Cis proline' 0 C--N 1.409 3.723 0 CA-C-N 123.19 3.495 . . . . 0.0 113.078 0.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.16 137.56 51.12 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 125.237 1.586 . . . . 0.0 109.583 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.92 -92.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.968 0 O-C-N 125.669 1.855 . . . . 0.0 110.616 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.31 -173.44 43.08 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.46 75.42 3.2 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 125.846 1.557 . . . . 0.0 112.349 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.16 141.74 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.828 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.96 156.05 18.26 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 125.375 1.672 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 t -73.8 -25.73 60.26 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.679 1.237 . . . . 0.0 112.887 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.15 -28.39 57.37 Favored 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -79.6 -21.63 44.75 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.341 1.026 . . . . 0.0 112.538 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.32 88.94 Favored Pre-proline 0 N--CA 1.531 3.578 0 CA-C-O 115.512 -2.185 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.76 -45.44 0.52 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.332 2.226 . . . . 0.0 113.051 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.36 -101.94 0.14 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 124.836 1.335 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.52 159.31 10.55 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 63.3 m -71.23 145.06 49.85 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 125.481 1.342 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -144.4 133.21 22.46 Favored 'General case' 0 N--CA 1.533 3.69 0 O-C-N 125.254 1.596 . . . . 0.0 109.283 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mm -79.72 135.73 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.825 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -131.06 134.31 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.3 140.67 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.044 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.72 145.62 6.88 Favored Glycine 0 N--CA 1.51 3.585 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.69 -170.91 38.68 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.016 1.068 . . . . 0.0 112.405 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -75.07 -12.65 60.37 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.256 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 p -69.9 -70.66 0.27 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.693 1.245 . . . . 0.0 111.384 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.48 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.512 3.722 0 CA-C-O 118.699 -1.056 . . . . 0.0 111.903 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -66.05 119.74 11.92 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 125.039 1.082 . . . . 0.0 112.013 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -86.99 -175.49 5.38 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 125.151 1.532 . . . . 0.0 110.31 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.39 78.16 0.09 OUTLIER Glycine 0 N--CA 1.507 3.394 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.71 152.05 46.25 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.445 1.321 . . . . 0.0 112.946 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 98.36 1.08 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 124.843 1.339 . . . . 0.0 109.737 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 150.32 45.64 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.937 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.06 172.16 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 O-C-N 126.324 2.265 . . . . 0.0 107.08 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.5 m -156.38 118.29 3.94 Favored 'General case' 0 N--CA 1.528 3.447 0 O-C-N 124.153 0.908 . . . . 0.0 111.42 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.21 147.93 44.21 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.507 1.129 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.982 0 CA-C-O 116.08 -2.511 . . . . 0.0 112.815 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -70.44 -27.42 64.24 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 125.185 1.553 . . . . 0.0 113.293 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.02 -172.01 0.15 Allowed 'General case' 0 N--CA 1.533 3.685 0 O-C-N 125.103 1.502 . . . . 0.0 113.339 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.24 6.15 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.83 145.44 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -160.96 146.04 14.13 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 124.99 1.432 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.98 144.22 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.23 110.22 2.07 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 114.989 -2.434 . . . . 0.0 110.005 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.91 158.85 68.34 Favored 'Cis proline' 1 C--N 1.424 4.513 0 CA-C-N 125.158 2.878 . . . . 0.0 112.32 -3.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.0 -0.36 2.29 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 125.144 1.528 . . . . 0.0 112.831 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -140.05 151.74 45.65 Favored 'General case' 0 N--CA 1.528 3.462 0 O-C-N 124.74 1.275 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.49 30.95 68.45 Favored Glycine 0 N--CA 1.512 3.703 0 O-C-N 124.953 1.408 . . . . 0.0 113.553 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.58 154.59 39.74 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 125.373 1.278 . . . . 0.0 109.379 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.43 -177.37 3.96 Favored 'General case' 0 N--CA 1.523 3.216 0 O-C-N 125.769 1.918 . . . . 0.0 110.179 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.64 129.87 41.24 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 124.866 1.354 . . . . 0.0 111.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.34 77.18 Favored Glycine 0 N--CA 1.512 3.715 0 O-C-N 124.606 1.191 . . . . 0.0 113.549 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.27 136.11 44.53 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.721 0.895 . . . . 0.0 111.428 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 m -99.6 127.3 45.7 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 125.819 1.949 . . . . 0.0 106.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.87 149.21 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 125.752 1.908 . . . . 0.0 109.924 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 m -103.72 96.38 6.67 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 126.081 2.113 . . . . 0.0 110.648 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.9 147.32 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.119 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -133.91 162.41 32.1 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 125.857 1.973 . . . . 0.0 110.174 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.22 139.2 10.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 125.544 1.777 . . . . 0.0 106.977 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 p -160.59 153.39 21.16 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.749 1.281 . . . . 0.0 110.853 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.35 79.1 0.52 Allowed Glycine 0 N--CA 1.505 3.299 0 O-C-N 124.893 1.37 . . . . 0.0 113.157 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -79.51 173.26 12.77 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 125.677 1.457 . . . . 0.0 110.939 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.38 -38.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.438 1.086 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.99 -46.63 1.38 Allowed 'General case' 0 N--CA 1.525 3.317 0 O-C-N 126.15 2.156 . . . . 0.0 111.414 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.56 121.81 18.54 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 124.847 1.342 . . . . 0.0 113.321 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.02 3.44 38.83 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 125.479 1.737 . . . . 0.0 110.962 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.67 162.69 18.98 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.34 150.56 19.98 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 124.18 0.925 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.1 m -142.07 147.12 36.28 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 125.871 1.982 . . . . 0.0 107.079 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.62 125.04 48.21 Favored 'General case' 0 N--CA 1.526 3.327 0 O-C-N 125.91 2.006 . . . . 0.0 112.448 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -122.46 152.11 40.61 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.587 1.804 . . . . 0.0 107.983 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -135.78 63.26 1.6 Allowed 'General case' 0 N--CA 1.537 3.921 0 O-C-N 125.508 1.755 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 m -72.88 148.94 43.91 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.974 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.21 112.26 24.87 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 126.379 2.3 . . . . 0.0 109.712 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mm -75.54 123.7 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.1 mt -103.22 -173.39 2.3 Favored 'General case' 0 N--CA 1.528 3.473 0 O-C-N 125.223 1.577 . . . . 0.0 106.836 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.51 82.31 Favored 'General case' 0 N--CA 1.515 2.819 0 O-C-N 124.355 1.035 . . . . 0.0 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -21.5 59.86 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 125.192 1.558 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.83 59.45 Favored Glycine 0 N--CA 1.509 3.556 0 CA-C-O 117.49 -1.728 . . . . 0.0 115.118 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.9 142.1 49.51 Favored 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.15 76.06 1.28 Allowed Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.908 1.38 . . . . 0.0 114.37 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.33 97.86 11.44 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.213 1.184 . . . . 0.0 108.171 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 140.29 47.13 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 125.115 1.509 . . . . 0.0 110.896 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -77.11 133.11 39.11 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 125.263 1.602 . . . . 0.0 110.081 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.54 -14.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 O-C-N 125.12 1.512 . . . . 0.0 114.009 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.56 53.57 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.95 -3.12 50.46 Favored 'General case' 1 N--CA 1.546 4.361 0 O-C-N 124.255 0.972 . . . . 0.0 113.57 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -68.13 168.33 12.33 Favored 'General case' 0 N--CA 1.535 3.798 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -143.79 -66.63 0.35 Allowed 'General case' 0 N--CA 1.526 3.339 0 O-C-N 125.486 1.741 . . . . 0.0 109.194 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 52.22 127.81 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -172.84 145.43 1.45 Allowed 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -67.24 163.19 20.98 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.703 1.252 . . . . 0.0 112.657 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.25 149.38 31.88 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 124.83 1.331 . . . . 0.0 109.379 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -73.54 -26.85 61.04 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 124.896 1.372 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.89 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.62 14.43 0.02 OUTLIER Glycine 0 N--CA 1.51 3.609 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.902 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.6 160.16 41.15 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.32 86.46 0.07 OUTLIER Glycine 0 N--CA 1.51 3.63 0 O-C-N 124.49 1.119 . . . . 0.0 111.074 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -74.25 155.54 38.16 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 125.259 1.211 . . . . 0.0 109.189 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -157.6 135.51 10.79 Favored 'General case' 0 N--CA 1.53 3.565 0 O-C-N 124.69 1.244 . . . . 0.0 112.646 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 t -90.69 124.97 35.51 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 125.022 1.451 . . . . 0.0 108.522 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.73 144.57 32.96 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 O-C-N 125.47 1.731 . . . . 0.0 107.062 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 t -115.38 138.46 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.48 119.47 50.39 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.329 0 O-C-N 125.262 1.602 . . . . 0.0 111.777 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -90.46 162.59 15.0 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.078 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -67.35 -29.06 68.51 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.766 1.291 . . . . 0.0 111.766 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 t -148.31 154.3 39.82 Favored 'General case' 0 N--CA 1.533 3.706 0 O-C-N 124.853 1.345 . . . . 0.0 109.084 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -158.58 148.21 19.39 Favored 'General case' 0 N--CA 1.525 3.277 0 O-C-N 124.9 1.375 . . . . 0.0 111.675 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 m -67.95 100.54 0.98 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.783 1.927 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.59 155.41 51.17 Favored Glycine 0 N--CA 1.505 3.249 0 O-C-N 125.116 1.51 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -137.95 123.3 19.46 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 125.901 1.589 . . . . 0.0 107.602 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.0 144.73 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 O-C-N 125.266 1.604 . . . . 0.0 107.288 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.15 -49.33 94.56 Favored Pre-proline 0 N--CA 1.529 3.496 0 N-CA-C 121.256 3.799 . . . . 0.0 121.256 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.26 -55.33 0.62 Allowed 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 125.498 2.999 . . . . 0.0 115.511 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.05 -60.32 0.06 Allowed 'General case' 0 N--CA 1.536 3.862 0 O-C-N 124.478 1.111 . . . . 0.0 113.029 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.34 -169.07 42.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 115.595 -2.781 . . . . 0.0 108.53 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.26 152.39 97.18 Favored 'Cis proline' 0 N--CA 1.53 3.649 0 CA-C-N 123.267 3.533 . . . . 0.0 113.08 -1.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -67.35 143.7 56.22 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 125.341 1.651 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -31.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 O-C-N 125.668 1.855 . . . . 0.0 110.72 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.72 -169.03 36.62 Favored Glycine 0 N--CA 1.494 2.539 0 O-C-N 125.498 1.749 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.86 113.42 2.77 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 125.987 1.639 . . . . 0.0 113.886 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.47 132.14 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 O-C-N 126.152 2.158 . . . . 0.0 107.439 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.532 1.145 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 43.9 t -77.12 -30.74 55.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.841 1.338 . . . . 0.0 112.623 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.74 -24.01 62.54 Favored 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -26.59 41.17 Favored 'General case' 0 N--CA 1.533 3.72 0 O-C-N 124.21 0.944 . . . . 0.0 113.014 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.1 154.81 91.88 Favored Pre-proline 0 N--CA 1.53 3.528 0 CA-C-O 115.513 -2.184 . . . . 0.0 111.986 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.09 -51.16 0.17 Allowed 'Trans proline' 0 C--N 1.411 3.849 0 CA-C-N 123.396 2.249 . . . . 0.0 113.577 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 -36.4 57.9 Favored Glycine 0 N--CA 1.51 3.591 0 O-C-N 124.458 1.099 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.09 -179.31 53.0 Favored Glycine 0 N--CA 1.516 3.972 0 O-C-N 125.045 1.085 . . . . 0.0 111.038 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.8 m -70.77 146.63 49.66 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 124.619 0.834 . . . . 0.0 111.73 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -144.92 131.79 20.18 Favored 'General case' 0 N--CA 1.525 3.309 0 O-C-N 125.549 1.781 . . . . 0.0 107.123 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.73 130.28 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.01 134.56 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.83 137.74 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.951 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.41 142.71 5.11 Favored Glycine 0 N--CA 1.509 3.565 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.29 -165.78 40.78 Favored Glycine 0 N--CA 1.515 3.964 0 O-C-N 125.717 1.481 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -77.9 -16.71 58.02 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.358 1.269 . . . . 0.0 112.687 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 p -126.39 -18.31 4.92 Favored 'General case' 0 N--CA 1.528 3.451 0 O-C-N 125.378 1.673 . . . . 0.0 109.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.52 -7.65 65.01 Favored Glycine 1 N--CA 1.523 4.445 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.869 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.251 4.4 mm-40 62.15 -94.19 0.04 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 125.112 1.365 . . . . 0.0 112.644 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -162.44 156.53 21.27 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 123.826 0.704 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.22 92.12 0.12 Allowed Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 163.91 18.63 Favored 'General case' 0 N--CA 1.515 2.793 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.47 94.71 0.98 Allowed 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.588 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.59 144.13 55.73 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.95 172.22 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 126.381 2.3 . . . . 0.0 106.865 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 m -157.25 120.47 4.06 Favored 'General case' 0 N--CA 1.527 3.378 0 O-C-N 124.287 0.992 . . . . 0.0 111.374 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -73.65 154.24 39.8 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 124.595 1.185 . . . . 0.0 110.349 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.018 0 CA-C-O 116.306 -2.385 . . . . 0.0 112.569 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -144.63 11.38 1.44 Allowed 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.959 2.037 . . . . 0.0 110.099 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.4 168.45 19.2 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 124.016 0.822 . . . . 0.0 112.889 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.07 124.37 3.76 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.139 1.524 . . . . 0.0 109.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.8 137.98 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -163.32 122.75 2.12 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 124.715 1.259 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.1 149.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -154.56 106.87 2.37 Favored Pre-proline 0 N--CA 1.528 3.466 0 CA-C-O 115.308 -2.282 . . . . 0.0 109.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.65 163.01 48.21 Favored 'Cis proline' 2 C--N 1.427 4.696 0 CA-C-N 124.926 2.795 . . . . 0.0 113.025 -3.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.54 -8.18 0.98 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 124.765 1.291 . . . . 0.0 113.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -134.84 153.27 52.11 Favored 'General case' 0 N--CA 1.529 3.495 0 O-C-N 125.091 1.495 . . . . 0.0 110.389 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 28.88 66.42 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 124.926 1.392 . . . . 0.0 113.413 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.0 mt -73.59 154.44 39.79 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 125.289 1.229 . . . . 0.0 109.803 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.44 -175.71 3.39 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.944 2.027 . . . . 0.0 109.802 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.75 129.71 40.76 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.638 1.211 . . . . 0.0 112.014 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.71 28.55 68.92 Favored Glycine 0 N--CA 1.513 3.779 0 O-C-N 124.587 1.18 . . . . 0.0 112.54 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.36 139.81 48.1 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 125.07 1.1 . . . . 0.0 111.96 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.1 m -101.34 131.76 47.24 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 126.159 2.162 . . . . 0.0 105.19 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.95 145.47 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 O-C-N 125.651 1.845 . . . . 0.0 110.208 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.2 m -103.75 99.06 8.84 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 126.251 2.219 . . . . 0.0 109.92 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.79 144.13 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -139.24 155.86 47.49 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 126.018 2.073 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.16 152.23 20.43 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 125.026 1.454 . . . . 0.0 108.015 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -160.88 137.65 8.78 Favored 'General case' 0 N--CA 1.517 2.892 0 O-C-N 124.953 1.408 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.81 67.33 2.01 Favored Glycine 0 N--CA 1.511 3.643 0 O-C-N 124.926 1.391 . . . . 0.0 113.634 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -71.19 149.55 46.2 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 125.476 1.339 . . . . 0.0 110.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.85 -70.55 0.24 Allowed 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.81 -27.37 2.1 Favored 'General case' 1 N--CA 1.541 4.114 0 O-C-N 124.923 1.389 . . . . 0.0 110.633 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -59.27 114.54 2.7 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 125.02 1.45 . . . . 0.0 111.467 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.95 13.51 20.4 Favored 'General case' 0 N--CA 1.53 3.539 0 O-C-N 125.43 1.706 . . . . 0.0 112.756 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -161.85 158.55 25.68 Favored 'General case' 0 N--CA 1.524 3.242 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.13 143.59 13.95 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 124.283 0.989 . . . . 0.0 112.232 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.66 179.14 4.09 Favored 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.646 2.466 . . . . 0.0 105.965 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.44 99.22 2.88 Favored 'General case' 0 N--CA 1.525 3.312 0 O-C-N 125.245 1.59 . . . . 0.0 109.599 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -116.57 157.18 25.71 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.637 1.835 . . . . 0.0 108.742 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.25 121.8 17.32 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.6 m -123.87 151.83 43.03 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.381 1.676 . . . . 0.0 111.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.09 28.59 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 125.613 1.82 . . . . 0.0 110.58 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.3 141.29 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -128.94 -175.05 3.43 Favored 'General case' 0 N--CA 1.525 3.282 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.96 98.21 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 124.59 1.181 . . . . 0.0 112.093 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -22.41 60.67 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 125.283 1.614 . . . . 0.0 111.323 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.42 27.52 67.62 Favored Glycine 0 N--CA 1.513 3.773 0 CA-C-O 117.826 -1.541 . . . . 0.0 115.772 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -74.58 147.34 41.78 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.98 69.63 2.66 Favored Glycine 1 N--CA 1.517 4.073 0 O-C-N 124.937 1.398 . . . . 0.0 114.241 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 99.69 9.24 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.33 146.37 48.37 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 124.592 1.183 . . . . 0.0 111.055 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -83.76 127.1 33.55 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.663 1.852 . . . . 0.0 109.17 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.17 -24.6 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.87 -13.17 61.93 Favored 'General case' 1 N--CA 1.54 4.057 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.95 -6.18 57.03 Favored 'General case' 1 N--CA 1.539 4.017 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -67.44 165.57 16.37 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -146.24 -61.52 0.31 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 125.854 1.971 . . . . 0.0 107.243 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 56.55 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 125.564 1.79 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.42 148.37 19.78 Favored 'General case' 0 N--CA 1.531 3.621 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -70.15 165.86 21.15 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 124.665 1.228 . . . . 0.0 113.43 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.9 mt -79.54 151.0 30.95 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 124.566 1.166 . . . . 0.0 109.413 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.5 t -72.5 -31.37 65.31 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 124.834 1.334 . . . . 0.0 111.562 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.29 -31.56 0.05 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 18.59 0.03 OUTLIER Glycine 0 N--CA 1.51 3.623 0 CA-C-O 118.303 -1.276 . . . . 0.0 112.106 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -143.25 166.37 24.9 Favored 'General case' 0 N--CA 1.539 3.983 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.6 70.7 0.09 OUTLIER Glycine 0 N--CA 1.513 3.778 0 O-C-N 124.268 0.98 . . . . 0.0 111.869 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -74.3 149.55 40.63 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 125.261 1.212 . . . . 0.0 108.977 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -162.23 136.99 6.9 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 124.83 1.331 . . . . 0.0 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -84.23 132.08 34.68 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 125.014 1.446 . . . . 0.0 110.13 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.29 143.71 40.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.399 0 O-C-N 125.417 1.698 . . . . 0.0 106.854 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.1 t -113.02 133.41 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.27 126.02 58.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 O-C-N 125.573 1.796 . . . . 0.0 111.379 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -90.18 158.77 17.08 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 124.711 1.205 . . . . 0.0 108.624 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -69.97 -26.22 63.99 Favored 'General case' 0 N--CA 1.526 3.351 0 O-C-N 124.872 1.358 . . . . 0.0 112.146 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.49 145.88 32.11 Favored 'General case' 0 N--CA 1.527 3.409 0 O-C-N 125.067 1.48 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -157.29 148.95 22.22 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 124.938 1.398 . . . . 0.0 111.892 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.4 m -70.96 101.16 2.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 125.866 1.979 . . . . 0.0 108.404 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.86 152.81 51.75 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.124 1.515 . . . . 0.0 111.082 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -137.56 120.75 16.79 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 126.023 1.66 . . . . 0.0 109.083 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.49 148.55 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 O-C-N 125.303 1.627 . . . . 0.0 107.193 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.263 9.7 tpt -49.82 -55.42 23.69 Favored Pre-proline 0 N--CA 1.524 3.265 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.06 -64.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 125.028 2.831 . . . . 0.0 115.127 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.27 -43.04 0.05 OUTLIER 'General case' 0 N--CA 1.531 3.624 0 CA-C-N 119.136 0.88 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.39 -171.4 42.41 Favored Glycine 0 N--CA 1.515 3.904 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.438 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.92 138.93 56.66 Favored 'Cis proline' 0 C--N 1.41 3.77 0 CA-C-N 123.096 3.448 . . . . 0.0 112.795 0.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.03 138.64 54.62 Favored 'General case' 0 N--CA 1.516 2.873 0 O-C-N 125.21 1.569 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -36.84 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.145 0 O-C-N 125.397 1.686 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.15 -169.77 36.75 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 125.371 1.669 . . . . 0.0 109.24 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.3 108.37 0.91 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 126.004 1.65 . . . . 0.0 113.085 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.32 137.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.013 0 O-C-N 125.938 2.024 . . . . 0.0 108.189 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.62 139.79 36.05 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.986 1.429 . . . . 0.0 109.313 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 t -80.0 -21.84 43.18 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 124.831 1.332 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -73.43 -26.51 60.98 Favored 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -79.74 -22.98 42.61 Favored 'General case' 0 N--CA 1.532 3.643 0 O-C-N 124.487 1.117 . . . . 0.0 113.194 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.16 88.61 Favored Pre-proline 0 N--CA 1.533 3.709 0 CA-C-O 115.588 -2.149 . . . . 0.0 112.254 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.7 -49.7 0.25 Allowed 'Trans proline' 0 C--N 1.412 3.912 0 CA-C-N 123.335 2.227 . . . . 0.0 113.714 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.98 -38.75 59.82 Favored Glycine 0 N--CA 1.512 3.725 0 O-C-N 124.696 1.247 . . . . 0.0 111.791 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.42 52.57 Favored Glycine 0 N--CA 1.511 3.652 0 O-C-N 125.112 1.125 . . . . 0.0 112.241 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 152.17 40.17 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 124.883 0.99 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.49 132.45 12.49 Favored 'General case' 0 N--CA 1.521 3.115 0 O-C-N 125.893 1.996 . . . . 0.0 107.628 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -79.88 136.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.821 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.19 132.72 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -127.33 138.14 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.8 141.53 4.42 Favored Glycine 1 N--CA 1.517 4.089 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.15 -159.06 30.64 Favored Glycine 1 N--CA 1.518 4.132 0 O-C-N 125.198 1.175 . . . . 0.0 112.53 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.75 -8.75 59.57 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 125.625 1.426 . . . . 0.0 113.0 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -70.0 -70.88 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 124.913 1.383 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.16 -24.61 0.18 Allowed Glycine 0 N--CA 1.51 3.588 0 O-C-N 124.184 0.928 . . . . 0.0 111.328 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -65.66 120.77 13.55 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 125.086 1.109 . . . . 0.0 112.771 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -90.31 -169.9 2.57 Favored 'General case' 0 N--CA 1.517 2.911 0 O-C-N 125.317 1.635 . . . . 0.0 109.514 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.26 76.28 0.09 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.34 148.8 49.19 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.391 1.289 . . . . 0.0 112.605 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.3 99.36 1.05 Allowed 'General case' 0 N--CA 1.529 3.507 0 O-C-N 124.972 1.42 . . . . 0.0 110.165 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.38 144.66 49.76 Favored 'General case' 0 N--CA 1.514 2.725 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.628 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 169.16 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 O-C-N 126.287 2.242 . . . . 0.0 107.896 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 t -140.1 159.26 42.59 Favored 'General case' 0 N--CA 1.528 3.432 0 O-C-N 124.68 1.238 . . . . 0.0 110.248 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -107.92 163.22 13.32 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 126.14 2.15 . . . . 0.0 110.06 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.797 0 CA-C-O 116.336 -2.369 . . . . 0.0 111.268 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -70.01 -35.3 74.25 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 125.45 1.719 . . . . 0.0 112.266 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.85 123.18 1.19 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 125.518 1.761 . . . . 0.0 108.693 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.1 131.11 35.69 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 124.679 1.237 . . . . 0.0 111.06 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.85 140.49 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -163.7 143.18 8.2 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.973 1.421 . . . . 0.0 110.547 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.13 143.0 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.025 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -157.54 111.56 1.84 Allowed Pre-proline 0 N--CA 1.528 3.439 0 CA-C-O 114.903 -2.475 . . . . 0.0 109.839 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.03 153.03 76.86 Favored 'Cis proline' 1 C--N 1.424 4.519 0 CA-C-N 125.555 3.02 . . . . 0.0 111.57 -2.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.47 -6.58 1.54 Allowed 'General case' 0 N--CA 1.529 3.485 0 O-C-N 125.853 1.971 . . . . 0.0 112.638 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.4 p -134.36 151.55 51.29 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 125.164 1.54 . . . . 0.0 109.978 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.12 31.61 66.39 Favored Glycine 0 N--CA 1.511 3.679 0 O-C-N 125.027 1.454 . . . . 0.0 112.786 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 153.55 39.34 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.359 1.27 . . . . 0.0 109.968 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -176.07 4.16 Favored 'General case' 0 N--CA 1.524 3.232 0 O-C-N 125.834 1.959 . . . . 0.0 108.755 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.41 136.35 56.38 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.756 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.44 60.21 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.587 1.179 . . . . 0.0 111.709 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.98 150.66 43.87 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 125.216 1.186 . . . . 0.0 110.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -128.93 101.16 5.95 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 126.22 2.2 . . . . 0.0 107.382 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.82 157.4 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 O-C-N 126.076 2.11 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -128.48 96.45 4.42 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 126.171 2.169 . . . . 0.0 106.082 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.7 148.29 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -140.47 160.86 39.07 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 126.045 2.091 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 131.83 6.02 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -126.33 13.52 7.68 Favored 'General case' 0 N--CA 1.535 3.824 0 O-C-N 125.583 1.802 . . . . 0.0 112.979 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.02 158.34 30.33 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -141.92 -172.27 3.53 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 126.579 1.987 . . . . 0.0 107.361 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.82 -30.52 0.07 Allowed 'General case' 0 N--CA 1.514 2.768 0 O-C-N 124.369 1.043 . . . . 0.0 111.435 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -40.38 0.3 Allowed 'General case' 0 N--CA 1.527 3.396 0 O-C-N 125.399 1.687 . . . . 0.0 110.548 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 p -67.93 113.21 5.45 Favored 'General case' 0 N--CA 1.521 3.103 0 O-C-N 124.946 1.404 . . . . 0.0 112.011 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.65 7.93 39.19 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 124.741 1.276 . . . . 0.0 112.554 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.54 162.03 18.89 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.09 20.28 Favored 'General case' 0 N--CA 1.522 3.146 0 O-C-N 124.068 0.855 . . . . 0.0 111.552 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -144.65 142.25 29.97 Favored 'General case' 0 N--CA 1.52 3.041 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.04 130.78 55.48 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.676 1.86 . . . . 0.0 114.073 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.47 139.03 19.59 Favored 'General case' 0 N--CA 1.532 3.647 0 O-C-N 125.047 1.467 . . . . 0.0 109.619 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -100.4 150.14 22.92 Favored 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.9 m -144.23 143.23 30.95 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.047 1.467 . . . . 0.0 109.243 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.85 114.72 27.21 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 125.327 1.642 . . . . 0.0 110.881 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.76 120.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.127 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.88 -174.86 2.8 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.64 82.53 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 124.646 1.216 . . . . 0.0 112.404 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -21.9 60.81 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.151 1.532 . . . . 0.0 111.473 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.07 22.66 57.03 Favored Glycine 0 N--CA 1.511 3.679 0 CA-C-O 117.356 -1.802 . . . . 0.0 115.003 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -71.4 140.96 50.32 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 75.01 1.42 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-O 118.173 -1.349 . . . . 0.0 115.154 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.1 100.1 10.3 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.45 146.43 51.3 Favored 'General case' 0 N--CA 1.529 3.497 0 O-C-N 124.949 1.406 . . . . 0.0 110.836 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -91.04 123.82 34.8 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 125.854 1.972 . . . . 0.0 109.559 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.71 -25.71 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.46 -5.38 32.46 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -79.78 -12.57 59.77 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 123.898 0.749 . . . . 0.0 112.982 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.4 159.91 17.29 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -148.25 -44.65 0.16 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 125.685 1.866 . . . . 0.0 109.788 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 63.49 130.88 0.01 OUTLIER 'General case' 0 N--CA 1.534 3.726 0 O-C-N 125.466 1.729 . . . . 0.0 114.794 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.0 154.11 27.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.597 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.5 m -118.99 146.96 44.58 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 126.21 2.194 . . . . 0.0 108.347 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.61 155.16 28.24 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.957 1.411 . . . . 0.0 108.827 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.2 p -134.78 15.84 3.61 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 126.057 2.098 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.89 -62.33 0.1 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.77 24.76 0.02 OUTLIER Glycine 0 N--CA 1.507 3.406 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.6 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -138.45 153.52 48.84 Favored 'General case' 0 N--CA 1.536 3.86 0 O-C-N 125.164 1.156 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.24 74.63 0.06 OUTLIER Glycine 0 N--CA 1.513 3.775 0 O-C-N 124.542 1.151 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.29 150.98 39.93 Favored 'General case' 0 N--CA 1.519 2.987 0 O-C-N 125.045 1.085 . . . . 0.0 109.716 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -156.41 145.21 20.18 Favored 'General case' 0 N--CA 1.538 3.95 0 O-C-N 124.804 1.315 . . . . 0.0 111.232 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.4 m -101.8 136.54 41.46 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 125.942 2.026 . . . . 0.0 109.421 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.5 155.95 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 O-C-N 125.481 1.738 . . . . 0.0 106.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 134.65 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -131.58 126.13 57.33 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 O-C-N 125.353 1.658 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -90.31 159.77 16.48 Favored 'General case' 0 N--CA 1.525 3.307 0 O-C-N 124.692 1.245 . . . . 0.0 108.163 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -69.44 -24.07 63.76 Favored 'General case' 0 N--CA 1.527 3.408 0 O-C-N 124.402 1.064 . . . . 0.0 112.145 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.5 m -142.48 147.42 36.02 Favored 'General case' 0 N--CA 1.532 3.652 0 O-C-N 124.997 1.435 . . . . 0.0 109.564 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.37 148.46 19.93 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.638 1.211 . . . . 0.0 112.042 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.52 102.25 1.78 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 125.741 1.901 . . . . 0.0 109.186 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.01 155.09 51.53 Favored Glycine 0 N--CA 1.506 3.35 0 O-C-N 125.063 1.477 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -139.42 123.21 17.57 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 125.737 1.492 . . . . 0.0 108.258 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 147.81 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 O-C-N 125.15 1.531 . . . . 0.0 106.952 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.264 1.7 tmt? -53.18 -52.4 66.2 Favored Pre-proline 0 N--CA 1.526 3.342 0 N-CA-C 120.098 3.37 . . . . 0.0 120.098 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -66.34 -61.83 0.08 OUTLIER 'Trans proline' 0 C--N 1.397 3.089 0 CA-C-N 125.445 2.98 . . . . 0.0 115.1 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.13 -47.5 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.674 0 O-C-N 124.214 0.946 . . . . 0.0 112.815 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.65 -170.57 42.57 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-O 115.709 -2.717 . . . . 0.0 109.333 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.87 142.61 74.21 Favored 'Cis proline' 0 C--N 1.41 3.792 0 CA-C-N 123.003 3.401 . . . . 0.0 112.919 0.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.93 139.53 55.09 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 125.327 1.642 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.2 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 O-C-N 125.419 1.699 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.54 -167.87 34.23 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 125.444 1.715 . . . . 0.0 109.033 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.93 109.14 1.17 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 126.104 1.708 . . . . 0.0 112.842 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.86 137.08 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.935 0 O-C-N 126.093 2.12 . . . . 0.0 107.963 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.41 144.59 31.31 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 125.028 1.455 . . . . 0.0 110.027 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.5 t -75.99 -35.06 59.73 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 124.855 1.347 . . . . 0.0 112.783 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.38 -24.66 65.7 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -79.67 -24.66 41.66 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 124.252 0.97 . . . . 0.0 112.73 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.44 157.09 88.97 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 115.675 -2.107 . . . . 0.0 111.596 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.49 -50.17 0.19 Allowed 'Trans proline' 0 C--N 1.41 3.779 0 CA-C-N 123.25 2.196 . . . . 0.0 114.32 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.74 -41.37 56.59 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 124.486 1.116 . . . . 0.0 112.308 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.66 179.76 50.02 Favored Glycine 0 N--CA 1.51 3.599 0 O-C-N 125.212 1.184 . . . . 0.0 112.114 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.8 150.82 45.47 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.673 -1.264 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -159.37 134.48 8.21 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 mm -79.6 135.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 t -132.31 132.02 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 O-C-N 125.886 1.991 . . . . 0.0 105.835 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.3 145.97 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 100.978 -3.712 . . . . 0.0 100.978 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.75 139.17 4.12 Favored Glycine 0 N--CA 1.514 3.877 0 O-C-N 124.444 1.09 . . . . 0.0 111.567 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.51 -161.79 37.6 Favored Glycine 1 N--CA 1.517 4.083 0 O-C-N 125.688 1.464 . . . . 0.0 111.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -72.6 -25.17 61.22 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 125.362 1.272 . . . . 0.0 112.371 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -74.46 -25.71 59.58 Favored 'General case' 0 N--CA 1.522 3.142 0 O-C-N 124.464 1.103 . . . . 0.0 110.583 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.85 19.55 47.1 Favored Glycine 0 N--CA 1.512 3.741 0 O-C-N 125.208 1.567 . . . . 0.0 112.115 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -73.11 103.24 3.79 Favored 'General case' 0 N--CA 1.517 2.924 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -70.78 167.16 19.41 Favored 'General case' 0 N--CA 1.519 2.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.398 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.48 73.53 0.08 OUTLIER Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.92 164.46 19.8 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.12 102.19 0.87 Allowed 'General case' 0 N--CA 1.524 3.271 0 O-C-N 124.906 1.379 . . . . 0.0 109.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 154.23 42.17 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 123.984 0.802 . . . . 0.0 112.646 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.24 172.52 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 O-C-N 126.209 2.193 . . . . 0.0 107.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -157.84 131.54 7.89 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 123.993 0.808 . . . . 0.0 111.367 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.78 161.63 28.86 Favored 'General case' 0 N--CA 1.518 2.964 0 O-C-N 124.401 1.063 . . . . 0.0 110.859 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.344 -2.365 . . . . 0.0 109.805 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -70.09 -31.37 68.91 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 125.375 1.672 . . . . 0.0 112.846 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.84 120.47 14.82 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 125.517 1.761 . . . . 0.0 111.738 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.86 129.66 34.67 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 124.731 1.27 . . . . 0.0 111.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.41 139.75 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 102.097 -3.297 . . . . 0.0 102.097 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.39 142.49 9.78 Favored 'General case' 0 N--CA 1.514 2.748 0 O-C-N 124.943 1.402 . . . . 0.0 110.419 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -126.27 141.1 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.39 112.88 1.7 Allowed Pre-proline 0 N--CA 1.526 3.356 0 CA-C-O 114.889 -2.482 . . . . 0.0 110.136 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.53 150.49 73.32 Favored 'Cis proline' 1 C--N 1.423 4.455 0 CA-C-N 125.36 2.95 . . . . 0.0 111.927 -4.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.32 -13.68 1.79 Allowed 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.993 2.058 . . . . 0.0 112.724 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.1 p -127.56 153.91 45.81 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.776 1.922 . . . . 0.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.79 33.11 74.86 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 124.951 1.407 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 mt -75.05 153.75 38.28 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 125.338 1.258 . . . . 0.0 110.633 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.89 -173.96 3.24 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 126.245 2.215 . . . . 0.0 108.444 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.04 127.97 34.22 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.661 1.226 . . . . 0.0 112.849 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 29.48 72.4 Favored Glycine 0 N--CA 1.515 3.907 0 O-C-N 124.761 1.288 . . . . 0.0 113.094 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.56 125.16 26.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 125.021 1.071 . . . . 0.0 112.503 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.06 135.48 35.83 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.82 141.24 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.333 1.645 . . . . 0.0 108.828 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -109.1 102.68 11.63 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 126.236 2.21 . . . . 0.0 109.637 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 147.94 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -134.75 161.97 33.67 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 126.197 2.185 . . . . 0.0 109.503 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.19 14.4 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 125.51 1.756 . . . . 0.0 108.064 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.23 147.36 17.75 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.323 1.64 . . . . 0.0 109.311 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.06 87.51 0.16 Allowed Glycine 0 N--CA 1.509 3.521 0 O-C-N 125.114 1.509 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -156.21 152.4 27.77 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 125.741 1.495 . . . . 0.0 107.433 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.81 -18.64 0.05 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 124.871 1.357 . . . . 0.0 111.156 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.385 1.053 . . . . 0.0 110.247 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -72.53 121.46 19.7 Favored 'General case' 0 N--CA 1.518 2.965 0 O-C-N 124.615 1.197 . . . . 0.0 110.558 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -79.8 -17.11 54.16 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.349 1.031 . . . . 0.0 113.345 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -167.54 153.68 7.76 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.7 135.08 5.51 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 124.562 1.164 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -97.61 153.18 18.37 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 126.168 2.167 . . . . 0.0 108.471 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.88 120.87 41.43 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 126.399 2.312 . . . . 0.0 109.059 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.51 145.88 17.86 Favored 'General case' 0 N--CA 1.527 3.386 0 O-C-N 124.542 1.151 . . . . 0.0 112.362 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -96.17 148.9 22.22 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 125.373 1.671 . . . . 0.0 108.232 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.5 m -146.83 142.96 28.23 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.466 1.729 . . . . 0.0 108.088 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.44 123.63 42.69 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.451 1.72 . . . . 0.0 112.068 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.36 122.56 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.03 -174.48 2.7 Favored 'General case' 0 N--CA 1.526 3.329 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.69 81.63 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.627 1.204 . . . . 0.0 111.321 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -22.45 60.56 Favored 'General case' 0 N--CA 1.524 3.264 0 O-C-N 125.357 1.661 . . . . 0.0 111.181 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.96 25.69 55.14 Favored Glycine 0 N--CA 1.514 3.861 0 CA-C-O 117.54 -1.7 . . . . 0.0 115.485 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 144.63 46.79 Favored 'General case' 0 N--CA 1.526 3.343 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 75.14 1.51 Allowed Glycine 0 N--CA 1.515 3.911 0 CA-C-O 118.19 -1.339 . . . . 0.0 114.977 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.88 104.48 13.99 Favored 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.34 142.93 49.53 Favored 'General case' 0 N--CA 1.531 3.615 0 O-C-N 125.201 1.563 . . . . 0.0 112.396 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -83.39 116.96 22.72 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 125.344 1.652 . . . . 0.0 109.025 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.18 -23.75 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.21 62.15 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -79.87 -7.69 58.87 Favored 'General case' 1 N--CA 1.542 4.173 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -64.67 165.49 10.22 Favored 'General case' 0 N--CA 1.531 3.598 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -145.42 -52.99 0.27 Allowed 'General case' 0 N--CA 1.513 2.71 0 O-C-N 126.136 2.148 . . . . 0.0 107.052 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.6 t70 51.37 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.677 0 O-C-N 125.754 1.908 . . . . 0.0 116.139 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -157.55 147.26 20.28 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.2 p -66.7 157.44 32.67 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 124.841 1.338 . . . . 0.0 113.99 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.58 136.62 36.9 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 125.04 1.463 . . . . 0.0 108.139 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -70.07 -37.78 75.58 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.547 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.57 54.28 0.11 Allowed Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.318 1.636 . . . . 0.0 109.294 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.77 70.73 Favored Glycine 0 N--CA 1.507 3.404 0 O-C-N 125.518 1.363 . . . . 0.0 112.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.65 157.6 44.87 Favored 'General case' 0 N--CA 1.535 3.787 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.22 77.72 0.07 OUTLIER Glycine 0 N--CA 1.515 3.956 0 O-C-N 124.33 1.019 . . . . 0.0 112.38 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 m -75.76 150.83 37.7 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.232 1.195 . . . . 0.0 109.159 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.3 135.48 6.05 Favored 'General case' 0 N--CA 1.529 3.481 0 O-C-N 124.8 1.313 . . . . 0.0 112.973 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -80.81 113.17 18.83 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.923 1.389 . . . . 0.0 111.038 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.66 150.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.4 141.27 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.86 132.3 25.24 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 O-C-N 125.49 1.744 . . . . 0.0 112.279 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -90.22 162.91 15.01 Favored 'General case' 0 N--CA 1.526 3.355 0 O-C-N 125.141 1.526 . . . . 0.0 108.729 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -66.53 -24.59 66.4 Favored 'General case' 0 N--CA 1.525 3.293 0 O-C-N 124.322 1.014 . . . . 0.0 112.669 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -155.72 150.87 26.68 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 124.772 1.295 . . . . 0.0 108.587 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.45 150.03 26.21 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 124.941 1.401 . . . . 0.0 112.172 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 m -68.07 103.77 1.61 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.958 2.036 . . . . 0.0 109.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.23 154.38 52.55 Favored Glycine 0 N--CA 1.509 3.538 0 O-C-N 125.173 1.546 . . . . 0.0 111.177 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -137.44 123.0 19.72 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 126.002 1.648 . . . . 0.0 109.262 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.41 148.67 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.261 27.1 tpp -51.58 -54.77 35.81 Favored Pre-proline 0 N--CA 1.524 3.268 0 N-CA-C 119.421 3.119 . . . . 0.0 119.421 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -65.16 -63.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 0 CA-C-N 125.163 2.88 . . . . 0.0 115.575 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.17 -45.23 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.672 0 CA-C-N 119.316 0.962 . . . . 0.0 112.869 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.84 41.95 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 115.625 -2.764 . . . . 0.0 109.393 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.51 143.2 75.85 Favored 'Cis proline' 0 C--N 1.408 3.71 0 CA-C-N 123.057 3.429 . . . . 0.0 113.074 -0.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.29 137.95 53.44 Favored 'General case' 0 N--CA 1.515 2.803 0 O-C-N 125.306 1.629 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -37.66 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 O-C-N 125.351 1.657 . . . . 0.0 111.646 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.25 -169.75 32.2 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 125.456 1.723 . . . . 0.0 109.749 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.97 111.96 2.13 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 126.08 1.694 . . . . 0.0 113.423 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 142.28 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.974 0 O-C-N 125.988 2.055 . . . . 0.0 107.4 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.37 154.17 17.62 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 125.711 1.882 . . . . 0.0 109.127 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.9 -27.35 61.01 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 124.746 1.279 . . . . 0.0 112.948 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.93 -31.42 68.02 Favored 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.76 -19.56 48.4 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 124.64 1.213 . . . . 0.0 112.821 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.97 155.26 92.24 Favored Pre-proline 0 N--CA 1.53 3.57 0 CA-C-O 115.601 -2.143 . . . . 0.0 111.507 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -43.01 0.79 Allowed 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 123.407 2.253 . . . . 0.0 113.929 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.08 -104.5 0.1 OUTLIER Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.684 1.24 . . . . 0.0 111.329 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.53 147.14 4.96 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.9 m -73.75 159.08 33.47 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 125.077 1.104 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.34 147.3 12.44 Favored 'General case' 0 N--CA 1.518 2.947 0 O-C-N 124.497 1.123 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -79.64 121.2 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.05 120.14 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 t -116.33 132.76 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 101.408 -3.552 . . . . 0.0 101.408 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.4 138.12 3.56 Favored Glycine 1 N--CA 1.517 4.035 0 O-C-N 124.184 0.928 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.08 -166.26 41.48 Favored Glycine 0 N--CA 1.509 3.513 0 O-C-N 125.377 1.281 . . . . 0.0 112.556 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -80.08 -13.52 59.23 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 125.743 1.496 . . . . 0.0 112.856 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -70.0 -68.5 0.41 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 124.894 1.371 . . . . 0.0 111.751 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.68 -19.45 0.07 OUTLIER Glycine 0 N--CA 1.515 3.951 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.758 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.38 143.61 57.62 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.961 1.036 . . . . 0.0 112.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -111.72 -173.16 2.18 Favored 'General case' 0 N--CA 1.524 3.271 0 O-C-N 126.52 2.387 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.07 67.22 0.11 Allowed Glycine 0 N--CA 1.51 3.607 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -68.05 146.35 53.59 Favored 'General case' 0 N--CA 1.519 3.0 0 O-C-N 125.432 1.313 . . . . 0.0 112.926 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.13 109.78 1.03 Allowed 'General case' 0 N--CA 1.528 3.429 0 O-C-N 124.496 1.123 . . . . 0.0 109.633 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.49 170.75 16.14 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.414 1.072 . . . . 0.0 113.038 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -178.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 O-C-N 126.419 2.324 . . . . 0.0 107.99 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -161.19 119.65 2.44 Favored 'General case' 0 N--CA 1.516 2.842 0 O-C-N 124.35 1.031 . . . . 0.0 109.271 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.23 158.48 34.01 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.073 0.858 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 116.282 -2.399 . . . . 0.0 111.497 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t -167.47 -40.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.72 0 O-C-N 125.257 1.598 . . . . 0.0 109.568 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.87 116.68 8.81 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 125.845 1.966 . . . . 0.0 112.377 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.29 34.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 124.695 1.247 . . . . 0.0 111.168 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.13 139.31 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -161.63 146.82 13.44 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.731 1.269 . . . . 0.0 110.555 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.89 147.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.02 109.51 1.75 Allowed Pre-proline 0 N--CA 1.526 3.344 0 CA-C-O 115.343 -2.265 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.93 162.62 51.23 Favored 'Cis proline' 2 C--N 1.427 4.665 0 CA-C-N 124.908 2.789 . . . . 0.0 112.747 -3.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.15 -5.31 1.12 Allowed 'General case' 0 N--CA 1.537 3.894 0 O-C-N 124.655 1.222 . . . . 0.0 113.291 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.8 p -139.3 151.35 46.37 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.807 1.317 . . . . 0.0 109.669 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.76 32.84 70.57 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.985 1.428 . . . . 0.0 112.987 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.57 150.74 44.44 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 125.632 1.431 . . . . 0.0 109.984 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.73 178.68 4.24 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 126.059 2.1 . . . . 0.0 109.939 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.95 127.4 32.74 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 124.954 1.409 . . . . 0.0 111.335 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.56 25.98 74.83 Favored Glycine 0 N--CA 1.514 3.844 0 O-C-N 124.554 1.158 . . . . 0.0 113.285 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.54 140.97 48.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 124.753 0.913 . . . . 0.0 111.784 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -99.06 132.91 44.02 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.843 1.964 . . . . 0.0 105.816 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.48 147.19 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 125.399 1.687 . . . . 0.0 109.571 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -101.01 96.75 7.45 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 126.064 2.102 . . . . 0.0 110.369 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 t -79.92 147.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -138.57 165.81 25.94 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 125.754 1.909 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.85 15.88 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 125.696 1.873 . . . . 0.0 108.118 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.79 148.53 17.56 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.898 1.374 . . . . 0.0 109.469 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.91 87.79 0.18 Allowed Glycine 0 N--CA 1.508 3.468 0 O-C-N 125.198 1.561 . . . . 0.0 110.444 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -155.81 156.64 35.09 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 125.67 1.453 . . . . 0.0 107.551 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.11 -21.99 0.05 Allowed 'General case' 0 N--CA 1.52 3.042 0 O-C-N 124.621 1.201 . . . . 0.0 111.261 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -79.64 -54.87 5.46 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 124.474 1.109 . . . . 0.0 110.343 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -70.88 117.62 12.62 Favored 'General case' 0 N--CA 1.515 2.793 0 O-C-N 124.681 1.238 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.0 p -79.73 -16.61 55.3 Favored 'General case' 0 N--CA 1.527 3.401 0 O-C-N 124.091 0.869 . . . . 0.0 112.277 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.35 154.95 10.76 Favored 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.9 10.37 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.65 1.219 . . . . 0.0 111.241 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 m -112.54 151.46 29.98 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 126.501 2.375 . . . . 0.0 108.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.92 103.87 13.4 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 126.188 2.18 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -126.24 147.59 49.65 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 124.995 1.434 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.07 142.49 47.35 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 125.951 2.032 . . . . 0.0 106.451 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.3 m -137.13 138.9 40.79 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.356 1.66 . . . . 0.0 109.817 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.31 23.22 Favored 'General case' 0 N--CA 1.516 2.875 0 O-C-N 125.049 1.468 . . . . 0.0 112.143 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mm -77.36 121.36 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.3 mt -100.42 -173.15 2.34 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -47.23 78.61 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.535 1.147 . . . . 0.0 112.229 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.83 -21.33 61.7 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.24 1.588 . . . . 0.0 111.714 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.69 24.56 49.45 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.187 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -73.18 143.64 47.14 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 124.828 0.957 . . . . 0.0 108.641 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.75 72.58 2.2 Favored Glycine 0 N--CA 1.514 3.849 0 CA-C-O 118.105 -1.386 . . . . 0.0 115.165 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.0 108.82 15.81 Favored 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.6 144.89 48.17 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 124.891 1.37 . . . . 0.0 111.956 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.98 127.16 34.07 Favored 'General case' 0 N--CA 1.516 2.829 0 O-C-N 125.499 1.749 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.85 -28.45 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.6 -10.0 58.25 Favored 'General case' 0 N--CA 1.537 3.909 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -79.85 -7.71 58.87 Favored 'General case' 0 N--CA 1.539 3.986 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -65.55 165.98 11.32 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -145.85 -61.35 0.33 Allowed 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.906 2.004 . . . . 0.0 108.266 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 t70 59.43 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.492 0 O-C-N 125.333 1.645 . . . . 0.0 115.32 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -163.27 144.01 9.23 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 p -72.37 152.08 42.26 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 124.407 1.067 . . . . 0.0 112.462 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.52 151.65 30.63 Favored 'General case' 0 N--CA 1.52 3.057 0 O-C-N 124.738 1.274 . . . . 0.0 108.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -70.67 -28.74 65.01 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.813 1.321 . . . . 0.0 112.746 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.32 -36.22 0.06 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.25 28.31 0.04 OUTLIER Glycine 0 N--CA 1.502 3.04 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.667 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.96 156.75 45.47 Favored 'General case' 0 N--CA 1.534 3.74 0 O-C-N 125.288 1.228 . . . . 0.0 108.212 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.46 140.78 4.97 Favored Glycine 0 N--CA 1.502 3.096 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -136.72 150.84 48.65 Favored 'General case' 0 N--CA 1.526 3.345 0 O-C-N 125.722 1.483 . . . . 0.0 107.566 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.03 139.19 8.36 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 125.226 1.579 . . . . 0.0 112.863 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -87.26 118.98 27.05 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 125.063 1.477 . . . . 0.0 108.053 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.22 143.91 30.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.037 0 O-C-N 125.389 1.68 . . . . 0.0 106.641 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.93 139.03 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.47 117.6 43.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 O-C-N 125.23 1.581 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -90.35 157.32 17.69 Favored 'General case' 0 N--CA 1.522 3.173 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.549 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -68.71 -25.64 64.87 Favored 'General case' 0 N--CA 1.525 3.32 0 O-C-N 124.592 1.183 . . . . 0.0 112.106 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 m -148.94 147.56 28.77 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.871 1.357 . . . . 0.0 109.759 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -156.18 147.25 22.25 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 124.899 1.374 . . . . 0.0 111.77 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.62 106.35 2.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 125.8 1.937 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.99 157.25 52.92 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 124.688 1.243 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -142.5 106.34 4.7 Favored 'General case' 0 N--CA 1.517 2.898 0 O-C-N 125.53 1.37 . . . . 0.0 108.942 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.62 142.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.053 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.9 mtp -69.86 -37.26 7.55 Favored Pre-proline 1 N--CA 1.545 4.281 1 N-CA-C 122.965 4.431 . . . . 0.0 122.965 -179.234 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.03 -38.39 16.37 Favored 'Trans proline' 0 C--N 1.395 2.978 0 CA-C-N 125.99 3.175 . . . . 0.0 117.337 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.53 -39.98 0.06 Allowed 'General case' 0 N--CA 1.532 3.644 0 O-C-N 124.362 1.039 . . . . 0.0 111.741 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.5 -117.01 5.37 Favored Glycine 1 CA--C 1.595 5.04 0 CA-C-O 113.846 -3.752 . . . . 0.0 111.109 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.97 -47.54 0.31 Allowed 'Cis proline' 1 C--N 1.415 4.032 1 CA-C-N 125.937 4.869 . . . . 0.0 113.08 0.79 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.46 129.69 9.68 Favored 'General case' 0 N--CA 1.521 3.12 0 O-C-N 126.03 2.081 . . . . 0.0 108.882 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -36.79 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 125.16 1.537 . . . . 0.0 110.078 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.14 178.36 22.04 Favored Glycine 0 N--CA 1.508 3.498 0 O-C-N 126.166 2.166 . . . . 0.0 109.86 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.47 118.21 7.81 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.876 1.574 . . . . 0.0 113.305 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.41 135.69 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 O-C-N 126.239 2.212 . . . . 0.0 107.833 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 145.62 31.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 124.936 1.398 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.4 t -76.45 -28.45 56.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.745 1.278 . . . . 0.0 111.73 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.69 -27.48 61.25 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.68 -22.8 43.0 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.254 0.971 . . . . 0.0 112.848 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.24 155.21 92.81 Favored Pre-proline 0 N--CA 1.53 3.542 0 CA-C-O 115.423 -2.227 . . . . 0.0 111.297 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.86 -51.4 0.18 Allowed 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 123.466 2.274 . . . . 0.0 113.915 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.34 -43.43 38.27 Favored Glycine 0 N--CA 1.512 3.738 0 O-C-N 124.436 1.085 . . . . 0.0 112.555 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.19 171.6 48.09 Favored Glycine 0 N--CA 1.514 3.884 0 O-C-N 125.349 1.264 . . . . 0.0 110.926 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 25.9 m -70.29 150.27 46.54 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 124.95 1.03 . . . . 0.0 112.331 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -146.54 133.27 19.97 Favored 'General case' 0 N--CA 1.522 3.155 0 O-C-N 125.838 1.961 . . . . 0.0 107.689 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.0 mm -79.58 116.94 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.48 122.02 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 O-C-N 125.8 1.938 . . . . 0.0 106.457 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -118.38 130.33 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.31 138.45 3.51 Favored Glycine 1 N--CA 1.519 4.202 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.9 -170.54 43.18 Favored Glycine 0 N--CA 1.51 3.57 0 O-C-N 125.126 1.133 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -78.62 -16.72 57.03 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 113.174 -1.513 . . . . 0.0 113.066 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.94 -66.21 0.62 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.759 1.287 . . . . 0.0 112.557 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -7.52 0.05 OUTLIER Glycine 1 N--CA 1.517 4.051 0 CA-C-O 118.404 -1.22 . . . . 0.0 112.578 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.12 147.61 53.08 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.82 0.953 . . . . 0.0 111.265 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -142.81 168.03 20.67 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 125.855 1.972 . . . . 0.0 109.222 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.57 78.86 0.06 OUTLIER Glycine 0 N--CA 1.501 2.983 0 O-C-N 124.984 1.428 . . . . 0.0 109.901 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -67.92 159.47 30.49 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 125.343 1.261 . . . . 0.0 113.006 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.97 101.62 1.44 Allowed 'General case' 0 N--CA 1.529 3.503 0 O-C-N 124.38 1.05 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 148.91 45.18 Favored 'General case' 0 N--CA 1.511 2.576 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -118.06 170.63 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 O-C-N 126.272 2.232 . . . . 0.0 106.907 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -157.19 119.24 3.82 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 124.258 0.974 . . . . 0.0 111.322 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -73.22 154.88 40.06 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 124.604 1.19 . . . . 0.0 110.463 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.976 0 CA-C-O 116.722 -2.154 . . . . 0.0 112.513 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 t -167.56 91.62 0.36 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 125.36 1.663 . . . . 0.0 107.281 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.97 121.95 1.53 Allowed 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.792 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.91 129.07 34.19 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 124.723 1.264 . . . . 0.0 111.429 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.53 139.36 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.35 142.2 9.69 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 125.001 1.438 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.08 142.85 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 101.486 -3.524 . . . . 0.0 101.486 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -161.3 112.92 1.25 Allowed Pre-proline 0 N--CA 1.524 3.252 0 CA-C-O 115.015 -2.421 . . . . 0.0 110.212 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -63.19 150.64 68.13 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.337 2.942 . . . . 0.0 112.242 -4.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.18 -9.19 1.75 Allowed 'General case' 0 N--CA 1.528 3.439 0 O-C-N 125.964 2.04 . . . . 0.0 113.049 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.3 p -133.19 152.76 51.94 Favored 'General case' 0 N--CA 1.528 3.425 0 O-C-N 125.327 1.642 . . . . 0.0 109.657 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.2 29.53 68.49 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 125.008 1.443 . . . . 0.0 112.51 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.78 154.1 40.8 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 125.347 1.263 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 -175.39 3.57 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 126.184 2.178 . . . . 0.0 107.977 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.9 127.54 32.91 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 124.736 1.272 . . . . 0.0 112.61 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.48 29.72 69.64 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.856 1.347 . . . . 0.0 112.776 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.37 127.46 32.63 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.934 1.02 . . . . 0.0 112.627 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.97 134.04 35.35 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.12 146.44 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 O-C-N 125.281 1.613 . . . . 0.0 108.558 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 m -113.98 103.42 11.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 126.436 2.335 . . . . 0.0 109.689 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.85 147.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.06 159.92 40.48 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 126.139 2.149 . . . . 0.0 109.15 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.61 14.66 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 125.465 1.728 . . . . 0.0 108.143 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.33 148.67 18.43 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 125.314 1.634 . . . . 0.0 109.347 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.28 88.93 0.11 Allowed Glycine 0 N--CA 1.509 3.505 0 O-C-N 125.048 1.467 . . . . 0.0 111.446 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -155.39 150.97 27.31 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.73 -20.73 0.06 Allowed 'General case' 0 N--CA 1.52 3.046 0 O-C-N 124.738 1.274 . . . . 0.0 111.526 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 p -79.47 -45.05 20.13 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.434 1.084 . . . . 0.0 108.93 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 p -73.03 143.5 47.5 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 125.023 1.452 . . . . 0.0 108.64 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.16 11.84 15.33 Favored 'General case' 0 N--CA 1.536 3.84 0 O-C-N 125.774 1.921 . . . . 0.0 111.768 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -166.17 166.14 17.16 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.36 136.57 8.63 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.033 0.833 . . . . 0.0 111.513 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.97 177.06 7.72 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 126.316 2.26 . . . . 0.0 105.363 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.1 117.98 2.28 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.671 1.232 . . . . 0.0 109.393 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.3 136.53 9.75 Favored 'General case' 0 N--CA 1.527 3.376 0 O-C-N 125.031 1.457 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -82.2 152.5 26.41 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 124.911 1.382 . . . . 0.0 107.594 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -145.03 141.17 28.67 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 125.111 1.507 . . . . 0.0 109.174 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.3 118.77 31.23 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.439 1.712 . . . . 0.0 112.462 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.13 143.48 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.856 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.05 -176.11 3.9 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 124.713 1.258 . . . . 0.0 112.049 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -21.74 60.45 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.406 1.691 . . . . 0.0 111.297 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 26.35 71.43 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-O 117.696 -1.613 . . . . 0.0 115.8 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -74.32 147.53 42.18 Favored 'General case' 0 N--CA 1.528 3.428 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.49 74.34 1.74 Allowed Glycine 0 N--CA 1.515 3.955 0 O-C-N 124.886 1.366 . . . . 0.0 113.941 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.8 101.08 11.36 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.4 m -129.54 145.57 51.45 Favored 'General case' 0 N--CA 1.535 3.804 0 O-C-N 124.91 1.381 . . . . 0.0 112.644 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.96 125.05 28.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 125.074 1.484 . . . . 0.0 111.265 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.45 -24.03 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.88 -23.4 63.25 Favored 'General case' 0 N--CA 1.531 3.58 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -79.85 -19.18 48.99 Favored 'General case' 0 N--CA 1.532 3.667 0 O-C-N 124.508 1.13 . . . . 0.0 113.992 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.32 148.18 52.23 Favored 'General case' 1 N--CA 1.54 4.073 0 O-C-N 124.696 1.247 . . . . 0.0 111.296 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -144.87 -54.73 0.32 Allowed 'General case' 0 N--CA 1.522 3.167 0 O-C-N 125.627 1.829 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 67.71 128.58 0.02 OUTLIER 'General case' 1 N--CA 1.544 4.233 0 O-C-N 124.978 1.424 . . . . 0.0 113.194 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.95 147.88 18.55 Favored 'General case' 0 N--CA 1.515 2.789 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.173 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 m -75.99 151.49 37.2 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.998 1.436 . . . . 0.0 107.959 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.3 mt -79.41 127.13 31.72 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.85 1.344 . . . . 0.0 107.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -69.91 -38.5 76.3 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 124.368 1.043 . . . . 0.0 113.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 49.66 0.12 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.74 22.47 74.75 Favored Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.632 1.431 . . . . 0.0 112.926 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -141.85 156.67 45.53 Favored 'General case' 1 N--CA 1.544 4.234 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 77.94 0.06 OUTLIER Glycine 1 N--CA 1.52 4.244 0 O-C-N 124.149 0.906 . . . . 0.0 112.516 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -75.75 153.65 36.86 Favored 'General case' 0 N--CA 1.52 3.071 0 O-C-N 124.912 1.007 . . . . 0.0 109.74 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.63 138.09 5.99 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.806 1.316 . . . . 0.0 113.365 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.2 p -82.69 111.75 18.92 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.844 1.34 . . . . 0.0 109.866 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.29 151.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.38 139.95 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 129.65 16.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 O-C-N 125.52 1.762 . . . . 0.0 112.286 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -90.2 162.21 15.35 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.964 1.415 . . . . 0.0 107.812 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -65.73 -33.81 76.74 Favored 'General case' 0 N--CA 1.522 3.143 0 O-C-N 124.67 1.231 . . . . 0.0 111.779 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.8 151.87 48.56 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 125.761 1.913 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.09 148.85 20.72 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 124.586 1.179 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.58 101.26 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 125.941 2.025 . . . . 0.0 108.749 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.78 153.27 52.17 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 125.141 1.526 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -135.56 122.67 21.51 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 125.974 1.632 . . . . 0.0 109.023 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.12 147.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.7 mmt -51.89 -53.17 54.28 Favored Pre-proline 0 N--CA 1.531 3.607 0 N-CA-C 120.381 3.474 . . . . 0.0 120.381 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.58 -62.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.402 3.384 0 CA-C-N 125.233 2.905 . . . . 0.0 115.077 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.15 -46.63 0.05 OUTLIER 'General case' 0 N--CA 1.533 3.7 0 O-C-N 124.191 0.932 . . . . 0.0 112.823 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.66 -170.44 41.81 Favored Glycine 1 N--CA 1.516 4.028 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.28 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.65 144.2 79.11 Favored 'Cis proline' 0 C--N 1.41 3.797 0 CA-C-N 123.063 3.432 . . . . 0.0 113.072 -0.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.58 137.66 54.46 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 125.31 1.631 . . . . 0.0 110.494 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -36.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.203 0 O-C-N 125.448 1.718 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.05 -171.79 36.0 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 125.401 1.688 . . . . 0.0 109.695 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.48 110.83 1.57 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 126.039 1.67 . . . . 0.0 113.402 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.64 138.91 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.064 0 O-C-N 125.933 2.021 . . . . 0.0 107.82 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.88 158.13 16.47 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.442 1.714 . . . . 0.0 110.742 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.25 -30.27 57.81 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 124.931 1.394 . . . . 0.0 111.787 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.61 -28.26 67.6 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -30.63 40.87 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 124.429 1.08 . . . . 0.0 112.64 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.94 151.44 97.19 Favored Pre-proline 0 N--CA 1.527 3.419 0 CA-C-O 115.261 -2.304 . . . . 0.0 111.606 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.07 -44.5 0.45 Allowed 'Trans proline' 0 C--N 1.41 3.769 0 CA-C-N 123.643 2.337 . . . . 0.0 113.494 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.23 -45.4 55.73 Favored Glycine 0 N--CA 1.513 3.812 0 O-C-N 124.685 1.241 . . . . 0.0 112.81 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.55 160.37 29.87 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 125.319 1.246 . . . . 0.0 112.125 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.0 145.82 51.51 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 113.958 -1.121 . . . . 0.0 112.902 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.96 139.96 26.56 Favored 'General case' 0 N--CA 1.53 3.546 0 O-C-N 125.621 1.826 . . . . 0.0 108.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -79.9 127.58 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.447 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.93 137.4 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.92 141.49 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.275 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.88 142.65 5.7 Favored Glycine 1 N--CA 1.517 4.057 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -160.5 34.43 Favored Glycine 1 N--CA 1.517 4.081 0 O-C-N 125.469 1.335 . . . . 0.0 112.81 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -71.63 -23.6 61.72 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 125.374 1.279 . . . . 0.0 112.671 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.91 -32.72 71.16 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 124.775 1.297 . . . . 0.0 110.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.21 48.73 Favored Glycine 0 N--CA 1.515 3.93 0 O-C-N 125.809 1.943 . . . . 0.0 113.073 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.69 103.1 3.5 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -74.81 174.63 8.92 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.724 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.45 78.45 0.09 OUTLIER Glycine 0 N--CA 1.506 3.36 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -68.54 155.48 39.88 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.312 1.243 . . . . 0.0 113.292 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.45 100.35 1.18 Allowed 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.088 1.493 . . . . 0.0 109.107 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.14 158.0 34.1 Favored 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.14 176.65 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 O-C-N 126.568 2.418 . . . . 0.0 107.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.3 m -160.77 121.09 2.8 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.785 1.303 . . . . 0.0 109.78 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -72.78 156.73 38.61 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 124.554 1.159 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.627 0 CA-C-O 116.355 -2.358 . . . . 0.0 111.464 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -163.98 -40.92 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 O-C-N 125.442 1.714 . . . . 0.0 109.595 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 109.16 4.23 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.997 2.06 . . . . 0.0 111.302 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 126.95 31.69 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.47 1.106 . . . . 0.0 111.307 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.33 138.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.1 143.62 9.28 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 124.848 1.343 . . . . 0.0 110.135 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.33 144.03 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -161.84 112.87 1.19 Allowed Pre-proline 0 N--CA 1.524 3.242 0 CA-C-O 115.092 -2.385 . . . . 0.0 109.918 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.34 149.97 67.6 Favored 'Cis proline' 1 C--N 1.424 4.549 0 CA-C-N 125.25 2.911 . . . . 0.0 112.492 -4.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.85 -9.23 1.59 Allowed 'General case' 0 N--CA 1.528 3.437 0 O-C-N 125.916 2.01 . . . . 0.0 112.619 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.5 p -133.64 152.06 51.81 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.102 1.501 . . . . 0.0 109.648 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.31 65.2 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.023 1.452 . . . . 0.0 112.143 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 mt -73.29 154.23 40.24 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 125.349 1.264 . . . . 0.0 110.551 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.59 -175.36 3.63 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 126.274 2.234 . . . . 0.0 107.946 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.41 127.1 30.99 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.659 1.224 . . . . 0.0 112.735 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.32 28.2 72.86 Favored Glycine 0 N--CA 1.513 3.802 0 O-C-N 124.637 1.21 . . . . 0.0 113.318 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 125.52 27.61 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.945 1.027 . . . . 0.0 112.233 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -78.98 134.57 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.09 140.39 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.349 1.655 . . . . 0.0 108.401 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.6 m -107.36 101.77 11.11 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 126.15 2.156 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.87 148.03 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.997 0 N-CA-C 104.492 -2.411 . . . . 0.0 104.492 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -137.69 161.57 36.16 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.969 2.043 . . . . 0.0 109.463 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 146.22 15.51 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 125.467 1.73 . . . . 0.0 108.278 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.92 146.53 16.1 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 124.986 1.429 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.13 88.4 0.14 Allowed Glycine 0 N--CA 1.509 3.566 0 O-C-N 125.007 1.442 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -155.08 152.62 29.76 Favored 'General case' 0 N--CA 1.514 2.751 0 O-C-N 125.573 1.396 . . . . 0.0 107.408 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.76 -18.71 0.05 Allowed 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.774 1.297 . . . . 0.0 111.52 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.58 -53.39 6.9 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 124.309 1.006 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -71.27 129.77 39.71 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.665 1.228 . . . . 0.0 110.704 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -79.93 -28.61 39.72 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 t -154.67 172.26 18.19 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 125.144 1.527 . . . . 0.0 107.574 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.99 144.75 5.92 Favored 'General case' 0 N--CA 1.521 3.113 0 O-C-N 124.535 1.147 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -128.64 133.14 48.18 Favored 'General case' 0 N--CA 1.522 3.172 0 O-C-N 126.147 2.155 . . . . 0.0 107.108 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.46 107.5 19.19 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.922 1.389 . . . . 0.0 110.319 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -123.06 144.13 49.5 Favored 'General case' 0 N--CA 1.528 3.444 0 O-C-N 125.103 1.502 . . . . 0.0 110.568 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.77 141.1 46.96 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m -146.55 138.16 24.57 Favored 'General case' 0 N--CA 1.531 3.58 0 O-C-N 124.832 1.333 . . . . 0.0 110.427 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.58 118.45 29.22 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 125.172 1.545 . . . . 0.0 111.83 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mm -81.3 123.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.88 -177.9 3.91 Favored 'General case' 0 N--CA 1.523 3.183 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -44.51 77.84 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 124.769 1.293 . . . . 0.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -19.16 61.45 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 125.117 1.511 . . . . 0.0 112.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.34 9.98 78.38 Favored Glycine 1 N--CA 1.517 4.043 0 CA-C-O 116.933 -2.037 . . . . 0.0 115.881 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -71.38 137.0 48.02 Favored 'General case' 0 N--CA 1.529 3.484 0 CA-C-N 118.38 1.09 . . . . 0.0 108.228 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.16 106.13 1.81 Allowed Glycine 0 N--CA 1.51 3.598 0 CA-C-O 118.583 -1.121 . . . . 0.0 115.691 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.78 106.18 15.7 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -135.2 143.54 46.47 Favored 'General case' 0 N--CA 1.526 3.349 0 O-C-N 124.865 1.353 . . . . 0.0 110.875 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -84.33 141.03 31.2 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 125.377 1.673 . . . . 0.0 109.896 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.07 -25.06 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 O-C-N 125.537 1.773 . . . . 0.0 114.786 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.03 -22.46 49.18 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -81.49 -1.59 46.56 Favored 'General case' 1 N--CA 1.543 4.215 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.74 160.17 17.71 Favored 'General case' 0 N--CA 1.53 3.562 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -152.75 127.8 9.71 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 125.834 1.959 . . . . 0.0 106.46 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.21 136.6 44.43 Favored 'General case' 0 N--CA 1.524 3.239 0 O-C-N 126.076 2.11 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -160.08 154.29 23.44 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 124.732 1.27 . . . . 0.0 107.776 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 m -126.69 147.47 49.94 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 125.947 2.029 . . . . 0.0 108.212 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.64 150.51 30.95 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 125.016 1.447 . . . . 0.0 108.917 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -148.67 8.39 0.78 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 125.433 1.708 . . . . 0.0 110.037 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.92 22.92 0.05 OUTLIER Glycine 0 N--CA 1.509 3.537 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.34 13.89 82.43 Favored Glycine 0 N--CA 1.512 3.709 0 CA-C-O 117.516 -1.713 . . . . 0.0 114.372 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.42 161.59 34.15 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.83 75.64 0.07 OUTLIER Glycine 1 N--CA 1.516 4.026 0 O-C-N 124.367 1.042 . . . . 0.0 112.123 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.97 153.27 38.62 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.041 1.083 . . . . 0.0 110.162 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.64 138.04 5.96 Favored 'General case' 0 N--CA 1.533 3.705 0 O-C-N 124.918 1.386 . . . . 0.0 112.917 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -83.36 113.37 20.68 Favored 'General case' 0 N--CA 1.521 3.117 0 O-C-N 124.815 1.322 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.69 152.39 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.53 142.53 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.19 127.1 26.73 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.06 0 O-C-N 125.555 1.784 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -90.21 156.59 18.2 Favored 'General case' 0 N--CA 1.524 3.248 0 O-C-N 124.868 1.355 . . . . 0.0 108.467 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -68.46 -26.22 65.39 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 124.578 1.174 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.53 146.86 38.66 Favored 'General case' 0 N--CA 1.53 3.559 0 O-C-N 125.277 1.61 . . . . 0.0 109.795 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -155.79 146.65 22.21 Favored 'General case' 0 N--CA 1.525 3.28 0 O-C-N 124.838 1.336 . . . . 0.0 112.153 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -71.67 109.42 5.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 125.576 1.797 . . . . 0.0 110.038 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.05 145.55 39.8 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -129.65 85.06 2.26 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 125.893 1.584 . . . . 0.0 109.353 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.38 96.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.77 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.9 mtm 56.58 169.01 0.05 OUTLIER Pre-proline 2 N--CA 1.56 5.029 0 C-N-CA 126.298 1.839 . . . . 0.0 114.216 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.59 -11.31 29.55 Favored 'Trans proline' 1 C--N 1.433 5.013 0 CA-C-N 124.859 2.771 . . . . 0.0 114.446 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.52 -39.69 31.4 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 124.333 1.021 . . . . 0.0 113.55 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.96 -159.78 50.95 Favored Glycine 2 CA--C 1.586 4.52 0 CA-C-O 115.333 -2.926 . . . . 0.0 109.109 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.81 153.34 83.59 Favored 'Cis proline' 0 C--N 1.404 3.481 0 CA-C-N 124.005 3.902 . . . . 0.0 113.991 -0.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -71.12 137.03 48.5 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 125.578 1.799 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -39.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 O-C-N 125.039 1.462 . . . . 0.0 112.292 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.83 -172.21 21.56 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 125.68 1.863 . . . . 0.0 108.967 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 117.31 6.85 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 125.741 1.495 . . . . 0.0 113.817 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.86 133.46 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 O-C-N 126.132 2.145 . . . . 0.0 107.564 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.035 1.459 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.6 t -80.12 79.84 6.62 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 125.136 1.523 . . . . 0.0 110.397 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.42 -36.78 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.593 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.7 p -79.79 -19.31 48.88 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 125.325 1.64 . . . . 0.0 111.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 147.26 98.64 Favored Pre-proline 0 N--CA 1.519 2.986 0 CA-C-O 114.738 -2.553 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.13 -45.97 0.33 Allowed 'Trans proline' 0 C--N 1.408 3.677 0 CA-C-N 124.091 2.497 . . . . 0.0 112.876 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.47 -47.4 28.36 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.62 1.2 . . . . 0.0 112.764 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.7 162.74 37.69 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 125.496 1.351 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.99 148.1 49.31 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.794 0.937 . . . . 0.0 112.577 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -148.05 133.44 18.57 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 125.839 1.962 . . . . 0.0 107.319 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.85 134.67 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -130.78 134.15 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -128.61 130.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.35 152.16 10.39 Favored Glycine 0 N--CA 1.514 3.846 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -163.08 37.87 Favored Glycine 0 N--CA 1.509 3.565 0 O-C-N 125.735 1.491 . . . . 0.0 112.231 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.58 -6.7 59.14 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.952 1.619 . . . . 0.0 112.697 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.99 -68.12 0.44 Allowed 'General case' 0 N--CA 1.517 2.902 0 O-C-N 124.89 1.369 . . . . 0.0 111.783 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.33 -23.42 0.09 OUTLIER Glycine 1 N--CA 1.519 4.203 0 CA-C-O 118.562 -1.132 . . . . 0.0 112.981 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -67.27 150.45 49.03 Favored 'General case' 0 N--CA 1.525 3.287 0 O-C-N 124.988 1.052 . . . . 0.0 111.976 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.75 147.21 48.32 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 125.94 2.025 . . . . 0.0 109.802 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.38 -65.2 1.81 Allowed Glycine 0 N--CA 1.516 3.975 0 O-C-N 124.597 1.186 . . . . 0.0 113.821 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 66.65 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.536 3.849 0 C-N-CA 125.523 1.529 . . . . 0.0 112.75 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 106.26 1.23 Allowed 'General case' 0 N--CA 1.53 3.544 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 155.52 40.17 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 124.235 0.959 . . . . 0.0 112.586 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.17 167.78 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 126.481 2.363 . . . . 0.0 108.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -137.49 169.09 18.37 Favored 'General case' 0 N--CA 1.523 3.185 0 O-C-N 124.95 1.406 . . . . 0.0 109.301 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.38 148.01 52.62 Favored 'General case' 0 N--CA 1.522 3.171 0 O-C-N 126.246 2.216 . . . . 0.0 109.039 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.585 0 CA-C-O 116.365 -2.353 . . . . 0.0 111.385 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -75.49 -12.64 60.28 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.06 1.475 . . . . 0.0 114.226 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.95 156.92 36.18 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 124.73 1.269 . . . . 0.0 113.246 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.11 132.27 6.28 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.443 1.714 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.27 145.52 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -160.71 145.48 14.2 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 125.312 1.632 . . . . 0.0 109.867 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.22 147.32 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.59 108.74 1.64 Allowed Pre-proline 0 N--CA 1.526 3.342 0 CA-C-O 115.416 -2.23 . . . . 0.0 109.788 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -62.02 162.63 45.75 Favored 'Cis proline' 2 C--N 1.426 4.654 0 CA-C-N 124.905 2.788 . . . . 0.0 113.235 -3.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.26 -6.58 0.73 Allowed 'General case' 0 N--CA 1.534 3.743 0 O-C-N 124.764 1.29 . . . . 0.0 112.619 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -138.3 153.58 49.02 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 124.914 1.384 . . . . 0.0 109.551 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.58 30.19 66.83 Favored Glycine 0 N--CA 1.512 3.752 0 O-C-N 124.977 1.423 . . . . 0.0 113.201 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 mt -72.9 153.87 40.82 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 125.296 1.233 . . . . 0.0 109.83 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.15 -175.83 3.62 Favored 'General case' 0 N--CA 1.523 3.221 0 O-C-N 126.003 2.064 . . . . 0.0 109.772 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.11 131.05 45.03 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 124.675 1.234 . . . . 0.0 112.363 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.78 30.04 66.59 Favored Glycine 0 N--CA 1.514 3.896 0 O-C-N 124.699 1.249 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 146.3 48.62 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.154 1.149 . . . . 0.0 111.841 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -115.27 124.3 50.98 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.317 2.261 . . . . 0.0 105.4 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.22 151.53 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.204 0 O-C-N 125.892 1.995 . . . . 0.0 110.559 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -111.02 100.45 9.14 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 126.185 2.178 . . . . 0.0 108.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.78 145.27 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 160.89 36.13 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 126.102 2.126 . . . . 0.0 109.647 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.14 16.72 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 125.423 1.702 . . . . 0.0 108.378 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -156.37 144.91 19.98 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.39 1.681 . . . . 0.0 109.831 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.09 88.11 0.12 Allowed Glycine 0 N--CA 1.51 3.598 0 O-C-N 125.109 1.506 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -154.87 148.74 25.63 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 125.628 1.428 . . . . 0.0 108.036 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.35 -18.92 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 124.801 1.313 . . . . 0.0 111.256 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.6 -41.66 26.62 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 124.255 0.972 . . . . 0.0 110.743 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -67.24 142.11 57.03 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 125.224 1.578 . . . . 0.0 110.424 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 p -79.9 -26.06 40.36 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.956 1.41 . . . . 0.0 113.203 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -170.06 133.57 1.18 Allowed 'General case' 0 N--CA 1.516 2.839 0 O-C-N 124.585 1.178 . . . . 0.0 109.005 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.0 139.95 45.14 Favored 'General case' 0 N--CA 1.515 2.781 0 O-C-N 124.756 1.285 . . . . 0.0 111.411 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.75 169.62 17.38 Favored 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -162.19 126.36 3.19 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 124.925 1.391 . . . . 0.0 110.997 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 144.76 15.06 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.215 1.572 . . . . 0.0 110.434 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 148.54 25.92 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 125.367 1.667 . . . . 0.0 108.977 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -139.73 140.23 36.72 Favored 'General case' 0 N--CA 1.529 3.503 0 O-C-N 125.609 1.818 . . . . 0.0 109.752 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.38 27.46 Favored 'General case' 0 N--CA 1.517 2.887 0 O-C-N 125.15 1.531 . . . . 0.0 113.011 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.31 142.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.002 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -128.05 -176.38 3.77 Favored 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.26 89.85 Favored 'General case' 0 N--CA 1.515 2.787 0 O-C-N 124.811 1.319 . . . . 0.0 112.122 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -20.74 59.63 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 125.408 1.693 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.08 76.67 Favored Glycine 0 N--CA 1.511 3.648 0 CA-C-O 117.377 -1.79 . . . . 0.0 115.853 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -73.5 142.05 46.78 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 93.35 0.35 Allowed Glycine 0 N--CA 1.511 3.693 0 O-C-N 124.811 1.319 . . . . 0.0 114.322 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.23 101.2 10.76 Favored 'General case' 0 N--CA 1.518 2.936 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -138.34 154.44 48.97 Favored 'General case' 0 N--CA 1.527 3.393 0 O-C-N 124.441 1.088 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -99.64 107.24 19.31 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 126.572 2.42 . . . . 0.0 107.958 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.69 -16.76 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.134 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.41 63.78 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -86.42 8.14 22.94 Favored 'General case' 1 N--CA 1.55 4.54 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -69.32 169.69 11.78 Favored 'General case' 0 N--CA 1.534 3.747 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -137.94 -61.18 0.62 Allowed 'General case' 0 N--CA 1.516 2.825 0 O-C-N 125.705 1.878 . . . . 0.0 109.542 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 52.86 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.793 0 O-C-N 125.334 1.646 . . . . 0.0 115.014 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -156.06 153.04 28.78 Favored 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 m -62.0 157.67 18.17 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.44 145.73 33.15 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.911 1.382 . . . . 0.0 108.373 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -71.52 -33.01 68.82 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 124.664 1.227 . . . . 0.0 111.364 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.4 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.5 2.905 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.31 24.58 0.04 OUTLIER Glycine 0 N--CA 1.502 3.069 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.413 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.34 161.06 39.33 Favored 'General case' 0 N--CA 1.537 3.894 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.41 76.59 0.08 OUTLIER Glycine 0 N--CA 1.513 3.787 0 O-C-N 124.275 0.985 . . . . 0.0 112.054 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 m -74.42 147.54 41.95 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 125.284 1.226 . . . . 0.0 109.468 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.44 135.62 7.9 Favored 'General case' 0 N--CA 1.529 3.492 0 O-C-N 124.799 1.312 . . . . 0.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -86.76 114.4 23.4 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.133 1.521 . . . . 0.0 111.425 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.7 t -107.66 149.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.72 142.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.18 134.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 O-C-N 125.346 1.654 . . . . 0.0 112.78 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -90.27 166.69 13.19 Favored 'General case' 0 N--CA 1.517 2.921 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -65.58 -27.95 68.79 Favored 'General case' 0 N--CA 1.532 3.638 0 O-C-N 124.257 0.973 . . . . 0.0 111.896 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.7 151.51 41.42 Favored 'General case' 0 N--CA 1.525 3.319 0 O-C-N 125.53 1.769 . . . . 0.0 108.749 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.21 147.51 24.88 Favored 'General case' 0 N--CA 1.526 3.358 0 O-C-N 124.935 1.397 . . . . 0.0 111.72 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.7 m -65.8 108.44 2.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 125.791 1.932 . . . . 0.0 112.209 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.28 150.56 43.96 Favored Glycine 0 N--CA 1.513 3.774 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -133.92 90.36 2.69 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.589 1.405 . . . . 0.0 109.824 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.95 109.49 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.229 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.407 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.8 172.08 0.02 OUTLIER Pre-proline 2 N--CA 1.567 5.422 0 C-N-CA 126.652 1.981 . . . . 0.0 116.287 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.64 -13.64 29.94 Favored 'Trans proline' 1 C--N 1.425 4.588 0 CA-C-N 123.731 2.368 . . . . 0.0 114.095 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.69 -39.59 30.93 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.89 -161.62 51.2 Favored Glycine 2 CA--C 1.586 4.492 0 CA-C-O 115.442 -2.865 . . . . 0.0 108.658 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.73 156.43 82.71 Favored 'Cis proline' 0 C--N 1.402 3.378 0 CA-C-N 123.931 3.865 . . . . 0.0 114.131 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.17 138.69 52.03 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 125.623 1.827 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -40.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 O-C-N 125.011 1.444 . . . . 0.0 112.61 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.56 -175.11 23.29 Favored Glycine 0 N--CA 1.508 3.448 0 O-C-N 125.516 1.76 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 116.55 5.56 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 125.78 1.517 . . . . 0.0 113.883 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.53 138.46 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 126.046 2.091 . . . . 0.0 108.125 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.67 152.04 21.01 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 125.309 1.631 . . . . 0.0 110.84 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.2 m -75.46 -27.68 58.97 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.583 1.177 . . . . 0.0 111.507 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 -29.16 68.19 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.65 -30.69 41.32 Favored 'General case' 0 N--CA 1.528 3.455 0 O-C-N 124.408 1.068 . . . . 0.0 112.309 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.39 152.78 96.36 Favored Pre-proline 0 N--CA 1.527 3.4 0 CA-C-O 115.125 -2.369 . . . . 0.0 111.364 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -72.73 -47.77 0.34 Allowed 'Trans proline' 0 C--N 1.41 3.795 0 CA-C-N 123.624 2.33 . . . . 0.0 113.317 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.19 -48.24 26.39 Favored Glycine 0 N--CA 1.512 3.759 0 O-C-N 124.712 1.258 . . . . 0.0 111.976 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.13 166.84 38.65 Favored Glycine 0 N--CA 1.515 3.96 0 O-C-N 125.303 1.237 . . . . 0.0 112.404 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.95 151.31 45.77 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-N 114.014 -1.093 . . . . 0.0 112.617 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.61 145.82 19.09 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 125.247 1.592 . . . . 0.0 109.209 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.71 130.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 O-C-N 125.273 1.608 . . . . 0.0 107.16 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 t -123.47 131.12 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.74 142.19 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.44 -153.84 17.44 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.049 0.843 . . . . 0.0 111.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.38 -167.38 24.81 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -69.9 -20.36 63.37 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.26 -22.0 2.02 Favored 'General case' 0 N--CA 1.538 3.965 0 O-C-N 124.751 1.282 . . . . 0.0 111.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.64 -15.23 63.88 Favored Glycine 1 N--CA 1.524 4.542 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.342 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 168.2 0.26 Allowed 'General case' 1 N--CA 1.546 4.366 0 C-N-CA 124.741 1.216 . . . . 0.0 112.428 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -70.0 164.5 23.81 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.922 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.65 90.79 0.12 Allowed Glycine 0 N--CA 1.516 3.986 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.02 149.23 50.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 125.362 1.272 . . . . 0.0 113.619 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.85 0.97 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 124.958 1.411 . . . . 0.0 108.328 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.99 153.51 42.59 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.11 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.71 170.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.758 0 O-C-N 126.396 2.31 . . . . 0.0 107.608 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -156.95 118.22 3.72 Favored 'General case' 0 N--CA 1.525 3.278 0 O-C-N 124.283 0.99 . . . . 0.0 110.736 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -71.21 153.77 42.2 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.522 1.139 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 CA-C-O 116.249 -2.417 . . . . 0.0 109.752 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 t -167.52 92.13 0.38 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 125.335 1.647 . . . . 0.0 107.406 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.81 121.47 1.52 Allowed 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.551 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 127.0 31.75 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.687 1.242 . . . . 0.0 112.015 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.61 138.88 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.105 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.03 144.73 8.44 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.82 1.325 . . . . 0.0 110.574 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.45 147.5 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -158.18 108.87 1.72 Allowed Pre-proline 0 N--CA 1.525 3.28 0 CA-C-O 115.377 -2.249 . . . . 0.0 110.131 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.1 162.73 51.92 Favored 'Cis proline' 2 C--N 1.425 4.572 0 CA-C-N 124.812 2.754 . . . . 0.0 112.831 -4.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.6 -8.69 1.25 Allowed 'General case' 0 N--CA 1.535 3.823 0 O-C-N 124.753 1.283 . . . . 0.0 112.846 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -136.78 154.41 50.56 Favored 'General case' 0 N--CA 1.525 3.31 0 O-C-N 125.269 1.606 . . . . 0.0 108.556 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.29 30.26 62.97 Favored Glycine 0 N--CA 1.511 3.667 0 O-C-N 124.944 1.402 . . . . 0.0 111.943 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 mt -75.32 154.09 37.52 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 125.378 1.281 . . . . 0.0 109.411 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.09 -175.36 3.47 Favored 'General case' 0 N--CA 1.524 3.228 0 O-C-N 126.026 2.079 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.43 127.57 32.81 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 124.761 1.288 . . . . 0.0 112.521 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.6 28.97 71.65 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.56 1.162 . . . . 0.0 113.013 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.05 127.04 31.3 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 124.91 1.006 . . . . 0.0 112.564 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -89.27 129.93 35.75 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.67 148.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 O-C-N 125.168 1.542 . . . . 0.0 110.465 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -103.05 97.25 7.38 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 125.956 2.035 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.87 148.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.62 161.59 34.22 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 125.804 1.94 . . . . 0.0 110.466 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 139.82 11.15 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.526 1.766 . . . . 0.0 108.042 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.39 142.83 14.58 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 125.129 1.518 . . . . 0.0 109.473 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.82 97.32 0.05 OUTLIER Glycine 0 N--CA 1.512 3.719 0 O-C-N 125.229 1.581 . . . . 0.0 111.432 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -154.21 153.16 31.29 Favored 'General case' 0 N--CA 1.513 2.683 0 O-C-N 125.371 1.277 . . . . 0.0 108.076 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.2 -16.99 0.08 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 125.254 1.596 . . . . 0.0 111.166 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.54 -59.97 2.54 Favored 'General case' 0 N--CA 1.517 2.924 0 O-C-N 124.207 0.942 . . . . 0.0 109.402 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 119.23 15.72 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 124.717 1.26 . . . . 0.0 109.984 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 p -79.9 -13.1 59.63 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 124.466 1.104 . . . . 0.0 112.656 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -167.65 148.6 5.36 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.37 165.67 26.87 Favored 'General case' 0 N--CA 1.519 3.024 0 O-C-N 125.607 1.817 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -158.95 108.22 1.93 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.12 42.91 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 124.379 1.049 . . . . 0.0 113.385 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 143.71 11.51 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 124.897 1.373 . . . . 0.0 111.007 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 147.7 23.97 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.363 1.665 . . . . 0.0 106.756 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.81 144.57 33.99 Favored 'General case' 0 N--CA 1.527 3.399 0 O-C-N 125.434 1.709 . . . . 0.0 109.497 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.52 118.79 32.88 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.451 1.719 . . . . 0.0 111.809 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.7 139.59 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.08 -177.12 3.84 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 125.686 1.867 . . . . 0.0 106.376 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.02 97.8 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.466 1.104 . . . . 0.0 112.245 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -19.13 57.91 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 125.407 1.692 . . . . 0.0 111.206 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.67 78.55 Favored Glycine 0 N--CA 1.511 3.641 0 CA-C-O 117.316 -1.824 . . . . 0.0 115.992 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -73.66 143.62 46.19 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.42 87.84 0.42 Allowed Glycine 0 N--CA 1.514 3.861 0 O-C-N 124.859 1.349 . . . . 0.0 113.84 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.72 92.69 6.31 Favored 'General case' 0 N--CA 1.517 2.891 0 O-C-N 125.725 1.485 . . . . 0.0 107.593 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -129.14 146.57 51.04 Favored 'General case' 0 N--CA 1.527 3.412 0 O-C-N 125.028 1.455 . . . . 0.0 110.873 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -86.05 127.38 34.66 Favored 'General case' 0 N--CA 1.514 2.77 0 O-C-N 125.61 1.819 . . . . 0.0 111.233 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.66 -24.17 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.83 62.32 Favored 'General case' 0 N--CA 1.533 3.684 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.84 5.67 18.09 Favored 'General case' 0 N--CA 1.536 3.873 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -64.32 146.98 53.53 Favored 'General case' 0 N--CA 1.537 3.912 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.043 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -152.42 -64.29 0.16 Allowed 'General case' 0 N--CA 1.533 3.701 0 CA-C-O 117.138 -1.411 . . . . 0.0 114.525 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.72 159.7 29.59 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -136.92 -157.74 0.8 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 126.731 2.52 . . . . 0.0 105.692 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.8 p -53.04 144.5 15.07 Favored 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.5 132.72 36.41 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 125.124 1.515 . . . . 0.0 109.633 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -75.26 -32.77 61.17 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.116 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 48.51 0.13 Allowed Glycine 0 N--CA 1.505 3.235 0 O-C-N 125.158 1.536 . . . . 0.0 110.605 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 28.17 68.9 Favored Glycine 0 N--CA 1.507 3.404 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.271 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -143.1 154.0 43.48 Favored 'General case' 1 N--CA 1.544 4.256 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.9 79.0 0.06 OUTLIER Glycine 1 N--CA 1.517 4.039 0 O-C-N 124.393 1.058 . . . . 0.0 112.403 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -74.9 152.61 38.85 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.079 1.105 . . . . 0.0 108.905 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.51 141.83 7.84 Favored 'General case' 0 N--CA 1.526 3.352 0 O-C-N 124.808 1.317 . . . . 0.0 113.339 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -92.1 110.09 21.46 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.164 1.54 . . . . 0.0 108.541 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.83 149.72 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 O-C-N 125.187 1.554 . . . . 0.0 107.239 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.37 140.0 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.41 124.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 O-C-N 125.626 1.829 . . . . 0.0 112.115 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -90.22 161.48 15.69 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.836 1.335 . . . . 0.0 107.758 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -67.48 -32.4 73.2 Favored 'General case' 0 N--CA 1.518 2.95 0 O-C-N 124.664 1.227 . . . . 0.0 111.687 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.38 147.24 51.77 Favored 'General case' 0 N--CA 1.53 3.561 0 O-C-N 125.988 2.055 . . . . 0.0 109.97 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -157.74 147.75 20.4 Favored 'General case' 0 N--CA 1.528 3.44 0 O-C-N 124.805 1.316 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -72.31 101.53 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 125.78 1.925 . . . . 0.0 108.854 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 155.16 51.98 Favored Glycine 0 N--CA 1.51 3.59 0 O-C-N 124.979 1.425 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -140.53 119.91 13.07 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.696 1.468 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.9 t -71.3 132.92 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.1 mmt -52.87 -58.62 11.39 Favored Pre-proline 0 N--CA 1.534 3.757 0 CA-C-O 113.129 -3.32 . . . . 0.0 119.611 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -53.68 -57.34 1.97 Allowed 'Trans proline' 0 C--N 1.405 3.52 0 CA-C-N 125.65 3.054 . . . . 0.0 117.334 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.13 -53.33 0.05 Allowed 'General case' 0 N--CA 1.537 3.924 0 CA-C-N 119.962 1.255 . . . . 0.0 112.549 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.72 -168.7 39.27 Favored Glycine 1 N--CA 1.517 4.072 0 CA-C-O 115.561 -2.8 . . . . 0.0 108.683 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.66 148.69 92.33 Favored 'Cis proline' 0 N--CA 1.529 3.578 0 CA-C-N 123.172 3.486 . . . . 0.0 113.417 -0.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -73.55 132.61 43.04 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.241 1.588 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.42 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 O-C-N 125.105 1.503 . . . . 0.0 112.099 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 -170.19 37.32 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.22 110.65 1.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.97 1.629 . . . . 0.0 113.221 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.95 135.67 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 126.061 2.101 . . . . 0.0 108.335 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.73 154.53 28.49 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.916 1.385 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.5 t -78.83 -29.47 44.72 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 124.972 1.42 . . . . 0.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.29 -22.07 62.0 Favored 'General case' 0 N--CA 1.515 2.823 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.3 p -79.69 -28.7 40.66 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 124.303 1.002 . . . . 0.0 113.304 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.1 150.74 96.45 Favored Pre-proline 0 N--CA 1.529 3.501 0 CA-C-O 115.26 -2.305 . . . . 0.0 112.183 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -73.61 -46.36 0.35 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.613 2.326 . . . . 0.0 113.515 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.22 -43.98 61.56 Favored Glycine 0 N--CA 1.512 3.751 0 O-C-N 124.608 1.192 . . . . 0.0 112.885 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.7 160.62 30.56 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 125.198 1.175 . . . . 0.0 111.591 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.96 154.72 41.58 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.942 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -162.11 145.97 12.16 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.2 1.562 . . . . 0.0 108.592 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.69 135.99 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.1 t -134.4 132.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.51 140.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.85 -132.5 1.7 Allowed Glycine 1 N--CA 1.52 4.25 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.19 -158.19 15.78 Favored Glycine 0 N--CA 1.505 3.299 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.37 -13.28 61.07 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.61 -73.8 0.16 Allowed 'General case' 0 N--CA 1.522 3.138 0 O-C-N 124.685 1.241 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.85 -23.44 0.24 Allowed Glycine 1 N--CA 1.517 4.068 0 CA-C-O 118.617 -1.101 . . . . 0.0 112.229 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.7 108.83 1.83 Allowed 'General case' 0 N--CA 1.521 3.096 0 O-C-N 125.224 1.191 . . . . 0.0 112.325 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -80.12 153.72 28.51 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.615 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.92 -60.98 1.89 Allowed Glycine 1 N--CA 1.518 4.148 0 O-C-N 125.116 1.51 . . . . 0.0 111.479 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.85 121.14 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 125.609 1.563 . . . . 0.0 114.734 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.39 96.86 0.78 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.94 31.63 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.416 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.81 176.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.708 0 O-C-N 126.507 2.38 . . . . 0.0 107.14 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -163.65 115.01 1.4 Allowed 'General case' 0 N--CA 1.519 3.007 0 O-C-N 125.014 1.446 . . . . 0.0 109.01 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.43 153.31 43.11 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.48 1.112 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.273 0 CA-C-O 116.356 -2.358 . . . . 0.0 109.798 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -166.8 90.89 0.4 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.29 1.619 . . . . 0.0 107.091 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.79 80.04 0.18 Allowed 'General case' 0 N--CA 1.527 3.422 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.929 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 130.57 35.42 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.71 138.87 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.98 143.03 10.72 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 124.855 1.347 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.69 143.04 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -158.51 112.59 1.68 Allowed Pre-proline 0 N--CA 1.523 3.198 0 CA-C-O 114.945 -2.455 . . . . 0.0 109.66 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.04 150.16 75.01 Favored 'Cis proline' 1 C--N 1.423 4.448 0 CA-C-N 125.401 2.965 . . . . 0.0 112.113 -3.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.76 -16.98 1.47 Allowed 'General case' 0 N--CA 1.528 3.464 0 O-C-N 125.897 1.998 . . . . 0.0 112.496 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.58 151.37 44.85 Favored 'General case' 0 N--CA 1.525 3.282 0 O-C-N 125.765 1.916 . . . . 0.0 110.915 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.89 66.1 Favored Glycine 1 N--CA 1.517 4.095 0 O-C-N 124.91 1.381 . . . . 0.0 112.5 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.8 mt -74.15 154.42 39.11 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 125.481 1.342 . . . . 0.0 110.715 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.57 -175.3 3.61 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.393 2.308 . . . . 0.0 108.324 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.46 127.91 34.15 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.767 1.292 . . . . 0.0 112.894 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.75 71.64 Favored Glycine 0 N--CA 1.515 3.922 0 O-C-N 124.703 1.252 . . . . 0.0 113.174 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.51 123.26 22.78 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 124.841 0.965 . . . . 0.0 112.663 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 m -80.65 129.92 34.8 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.11 141.01 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 O-C-N 125.722 1.888 . . . . 0.0 109.249 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.1 m -105.61 101.66 11.16 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 126.145 2.153 . . . . 0.0 110.44 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.79 147.71 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.08 158.75 43.65 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.998 2.061 . . . . 0.0 109.072 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.34 16.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.302 1.626 . . . . 0.0 108.123 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -157.37 145.13 18.9 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 125.2 1.563 . . . . 0.0 109.714 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.6 86.1 0.17 Allowed Glycine 0 N--CA 1.507 3.422 0 O-C-N 125.181 1.55 . . . . 0.0 110.412 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -151.87 149.54 29.09 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 125.732 1.489 . . . . 0.0 108.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.19 -15.55 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.952 0 O-C-N 125.038 1.461 . . . . 0.0 111.166 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.43 -49.65 12.0 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 p -66.89 140.4 57.78 Favored 'General case' 0 N--CA 1.519 3.022 0 O-C-N 124.94 1.4 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -81.12 -18.41 46.55 Favored 'General case' 0 N--CA 1.524 3.226 0 O-C-N 125.051 1.469 . . . . 0.0 113.909 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 m -169.98 133.58 1.2 Allowed 'General case' 0 N--CA 1.518 2.972 0 O-C-N 124.704 1.253 . . . . 0.0 109.531 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.53 145.44 36.94 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.741 1.276 . . . . 0.0 110.072 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -154.15 156.46 37.22 Favored 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.42 115.79 9.0 Favored 'General case' 0 N--CA 1.524 3.243 0 O-C-N 125.1 1.5 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.05 153.56 31.48 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 125.713 1.883 . . . . 0.0 109.188 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -127.34 114.53 17.69 Favored 'General case' 0 N--CA 1.52 3.062 0 O-C-N 126.144 2.152 . . . . 0.0 106.041 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.3 m -126.08 157.03 39.02 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.689 1.868 . . . . 0.0 111.615 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.42 123.89 49.55 Favored 'General case' 0 N--CA 1.523 3.223 0 O-C-N 126.185 2.178 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -80.4 121.06 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 O-C-N 125.076 1.485 . . . . 0.0 107.736 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.53 -175.84 3.2 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.85 -44.83 84.3 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 124.64 1.212 . . . . 0.0 111.799 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.25 61.26 Favored 'General case' 0 N--CA 1.526 3.366 0 O-C-N 125.261 1.601 . . . . 0.0 111.556 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.64 22.57 57.99 Favored Glycine 0 N--CA 1.516 3.972 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.512 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -72.95 142.37 47.81 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.37 72.83 2.29 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.803 1.314 . . . . 0.0 113.311 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.97 12.04 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 124.865 0.979 . . . . 0.0 108.442 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.95 140.7 46.93 Favored 'General case' 0 N--CA 1.521 3.091 0 O-C-N 125.218 1.574 . . . . 0.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -81.78 115.0 20.8 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 125.354 1.659 . . . . 0.0 107.885 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.12 -16.43 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.19 63.04 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -84.16 4.03 32.34 Favored 'General case' 1 N--CA 1.55 4.53 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -68.64 169.94 10.19 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -138.39 -67.37 0.47 Allowed 'General case' 0 N--CA 1.517 2.886 0 O-C-N 125.876 1.985 . . . . 0.0 108.461 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 52.83 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -156.11 153.02 28.67 Favored 'General case' 0 N--CA 1.523 3.212 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -60.4 156.0 16.9 Favored 'General case' 0 N--CA 1.517 2.902 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.48 144.33 34.11 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.9 1.375 . . . . 0.0 107.954 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -72.39 -25.94 61.69 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.379 1.05 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.68 -39.58 0.08 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.13 24.93 0.04 OUTLIER Glycine 0 N--CA 1.501 3.033 0 O-C-N 125.324 1.25 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.24 158.7 43.43 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.69 77.52 0.08 OUTLIER Glycine 0 N--CA 1.513 3.816 0 O-C-N 124.399 1.062 . . . . 0.0 112.04 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -74.69 151.22 39.26 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.232 1.195 . . . . 0.0 109.205 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.11 140.05 7.47 Favored 'General case' 0 N--CA 1.533 3.702 0 O-C-N 124.748 1.28 . . . . 0.0 113.305 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -90.29 122.18 32.97 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 125.188 1.555 . . . . 0.0 110.039 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.08 146.6 24.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 O-C-N 125.722 1.889 . . . . 0.0 107.067 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.47 123.89 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.45 126.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 125.615 1.822 . . . . 0.0 111.196 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -90.25 160.11 16.35 Favored 'General case' 0 N--CA 1.525 3.324 0 O-C-N 124.809 1.318 . . . . 0.0 108.179 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -69.51 -27.27 65.04 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.472 1.107 . . . . 0.0 111.755 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.2 m -139.46 147.61 41.59 Favored 'General case' 0 N--CA 1.529 3.507 0 O-C-N 125.315 1.634 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.26 149.18 22.5 Favored 'General case' 0 N--CA 1.523 3.192 0 O-C-N 124.676 1.235 . . . . 0.0 111.583 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 117.34 9.72 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 125.999 2.062 . . . . 0.0 109.124 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.22 145.46 41.07 Favored Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.8 124.5 15.97 Favored 'General case' 0 N--CA 1.522 3.165 0 O-C-N 125.365 1.274 . . . . 0.0 109.148 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.54 98.27 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.066 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.254 21.4 ttp -58.08 -56.58 33.45 Favored Pre-proline 0 N--CA 1.518 2.947 0 CA-C-O 114.057 -2.878 . . . . 0.0 117.436 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.81 -51.1 0.95 Allowed 'Trans proline' 0 C--N 1.392 2.865 0 CA-C-N 124.612 2.683 . . . . 0.0 115.958 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.93 -72.53 0.4 Allowed 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.34 -176.47 44.63 Favored Glycine 2 CA--C 1.586 4.531 0 CA-C-O 116.814 -2.104 . . . . 0.0 110.128 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.16 173.19 50.62 Favored 'Cis proline' 0 N--CA 1.53 3.672 0 CA-C-N 122.795 3.298 . . . . 0.0 113.148 -6.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.52 133.56 55.85 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.087 1.492 . . . . 0.0 110.231 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -85.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 O-C-N 125.616 1.823 . . . . 0.0 111.55 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.71 -171.28 40.12 Favored Glycine 0 N--CA 1.504 3.17 0 CA-C-N 120.609 1.55 . . . . 0.0 109.974 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.68 116.72 7.19 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 125.841 1.553 . . . . 0.0 112.744 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.92 137.29 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 O-C-N 125.927 2.017 . . . . 0.0 107.873 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 145.91 26.8 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 125.311 1.632 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -23.02 45.06 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 124.884 1.365 . . . . 0.0 112.16 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.26 -30.13 57.72 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -79.65 -18.18 52.04 Favored 'General case' 0 N--CA 1.528 3.442 0 O-C-N 124.675 1.235 . . . . 0.0 112.601 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.89 156.89 86.16 Favored Pre-proline 0 N--CA 1.532 3.637 0 CA-C-O 115.771 -2.061 . . . . 0.0 111.757 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.23 -42.92 0.81 Allowed 'Trans proline' 0 C--N 1.407 3.63 0 CA-C-N 123.384 2.244 . . . . 0.0 114.707 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.58 -104.84 0.09 OUTLIER Glycine 0 N--CA 1.504 3.229 0 O-C-N 124.741 1.276 . . . . 0.0 111.627 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.98 161.19 20.02 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 143.4 40.5 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 125.659 1.447 . . . . 0.0 107.957 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -147.6 132.27 17.87 Favored 'General case' 0 N--CA 1.533 3.71 0 O-C-N 125.09 1.494 . . . . 0.0 109.802 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -79.8 134.66 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.45 129.27 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.92 140.17 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.58 -144.37 7.89 Favored Glycine 0 N--CA 1.512 3.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.12 -163.18 25.58 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.39 -18.78 62.33 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -126.94 -13.54 5.74 Favored 'General case' 0 N--CA 1.531 3.616 0 O-C-N 125.278 1.611 . . . . 0.0 109.004 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.42 66.36 Favored Glycine 1 N--CA 1.524 4.509 0 CA-C-O 118.895 -0.947 . . . . 0.0 114.344 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.253 23.9 mt-10 62.7 -85.36 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 125.676 1.59 . . . . 0.0 114.17 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -152.96 157.19 40.23 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 125.056 1.472 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.57 68.23 0.28 Allowed Glycine 0 N--CA 1.512 3.725 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.39 151.01 47.32 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 125.569 1.393 . . . . 0.0 114.359 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.67 102.22 1.34 Allowed 'General case' 0 N--CA 1.526 3.361 0 O-C-N 124.914 1.384 . . . . 0.0 109.625 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.07 28.61 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.24 170.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.917 0 O-C-N 126.369 2.293 . . . . 0.0 107.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -161.05 124.3 3.28 Favored 'General case' 0 N--CA 1.521 3.111 0 O-C-N 124.587 1.179 . . . . 0.0 110.434 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.44 156.8 38.67 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 124.501 1.126 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.357 0 CA-C-O 116.319 -2.378 . . . . 0.0 109.76 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.3 t -70.04 -37.0 75.46 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 125.433 1.708 . . . . 0.0 111.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.07 116.98 10.14 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.711 1.882 . . . . 0.0 111.991 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.9 140.01 36.89 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 124.639 1.212 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 139.93 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.97 146.65 19.17 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 124.85 1.344 . . . . 0.0 110.362 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.9 143.9 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.46 109.73 2.03 Favored Pre-proline 0 N--CA 1.528 3.473 0 CA-C-O 115.017 -2.42 . . . . 0.0 109.822 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.17 159.64 62.45 Favored 'Cis proline' 1 C--N 1.425 4.576 0 CA-C-N 125.279 2.921 . . . . 0.0 112.591 -2.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.14 -1.46 1.36 Allowed 'General case' 0 N--CA 1.531 3.576 0 O-C-N 125.033 1.458 . . . . 0.0 112.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -139.49 152.0 46.62 Favored 'General case' 0 N--CA 1.526 3.373 0 O-C-N 124.744 1.277 . . . . 0.0 110.159 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.35 30.67 69.04 Favored Glycine 0 N--CA 1.511 3.695 0 O-C-N 124.877 1.361 . . . . 0.0 113.556 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.6 154.16 40.91 Favored 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.342 1.26 . . . . 0.0 110.1 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.6 -174.37 3.22 Favored 'General case' 0 N--CA 1.522 3.137 0 O-C-N 125.877 1.986 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.04 129.02 38.54 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 124.635 1.21 . . . . 0.0 112.23 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.83 28.67 70.34 Favored Glycine 0 N--CA 1.514 3.864 0 O-C-N 124.704 1.252 . . . . 0.0 112.763 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 126.96 31.11 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 125.065 1.097 . . . . 0.0 112.245 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -88.91 134.27 34.02 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.77 147.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.191 0 O-C-N 125.295 1.622 . . . . 0.0 110.426 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 m -104.93 96.31 6.45 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 126.145 2.153 . . . . 0.0 108.842 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.86 147.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.998 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 p -135.31 164.77 26.97 Favored 'General case' 0 N--CA 1.518 2.972 0 O-C-N 125.944 2.027 . . . . 0.0 110.011 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.12 148.45 16.94 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.611 1.82 . . . . 0.0 108.161 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.34 145.28 16.25 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 124.993 1.433 . . . . 0.0 110.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 143.99 5.55 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 124.939 1.399 . . . . 0.0 112.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.02 168.41 20.05 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.177 1.163 . . . . 0.0 108.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.6 -37.22 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 124.979 1.424 . . . . 0.0 110.546 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.91 -46.69 1.96 Allowed 'General case' 0 N--CA 1.526 3.371 0 O-C-N 126.192 2.183 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.2 p -67.43 153.98 42.44 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 124.785 1.303 . . . . 0.0 112.299 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.33 -2.48 1.81 Allowed 'General case' 0 N--CA 1.538 3.93 0 O-C-N 125.563 1.79 . . . . 0.0 111.375 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -165.7 154.28 11.45 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.44 152.0 19.64 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 124.057 0.848 . . . . 0.0 111.833 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -116.59 -177.64 3.23 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 126.55 2.406 . . . . 0.0 106.157 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 112.6 1.93 Allowed 'General case' 0 N--CA 1.515 2.791 0 O-C-N 124.499 1.124 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 154.17 46.68 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 125.147 1.529 . . . . 0.0 108.66 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.99 146.4 35.33 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.602 2.439 . . . . 0.0 104.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -141.07 144.89 35.2 Favored 'General case' 0 N--CA 1.526 3.365 0 O-C-N 125.382 1.676 . . . . 0.0 109.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.21 114.8 27.44 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 125.428 1.705 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.48 143.32 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.53 -176.64 4.1 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.99 96.22 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.74 1.275 . . . . 0.0 112.062 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.522 3.139 0 O-C-N 125.384 1.678 . . . . 0.0 111.275 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.86 27.29 69.21 Favored Glycine 0 N--CA 1.512 3.76 0 CA-C-O 117.67 -1.628 . . . . 0.0 115.778 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -74.38 147.53 42.05 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.02 74.35 1.63 Allowed Glycine 0 N--CA 1.515 3.925 0 O-C-N 124.958 1.411 . . . . 0.0 113.927 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.92 89.3 6.84 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.37 144.14 51.1 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.046 1.466 . . . . 0.0 110.861 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -79.92 149.92 30.71 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.213 1.571 . . . . 0.0 109.965 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -25.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 O-C-N 125.895 1.997 . . . . 0.0 112.445 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.22 -9.32 58.44 Favored 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.89 -8.86 59.55 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.145 0.903 . . . . 0.0 113.232 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -63.69 156.44 26.94 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -145.54 -43.01 0.22 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 125.464 1.728 . . . . 0.0 108.552 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 55.17 54.62 8.56 Favored 'General case' 0 N--CA 1.523 3.175 0 O-C-N 124.981 1.426 . . . . 0.0 114.627 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -71.51 151.42 43.91 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -115.6 145.56 42.57 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 126.182 2.176 . . . . 0.0 109.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.71 154.02 28.87 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 125.042 1.464 . . . . 0.0 107.923 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -134.45 12.67 3.8 Favored 'General case' 0 N--CA 1.525 3.294 0 O-C-N 125.878 1.986 . . . . 0.0 110.061 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.09 -50.76 0.1 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.344 -2.303 . . . . 0.0 107.344 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -4.66 0.04 OUTLIER Glycine 0 N--CA 1.504 3.167 0 CA-C-O 117.344 -1.809 . . . . 0.0 112.665 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.91 162.61 20.71 Favored 'General case' 0 N--CA 1.537 3.89 0 O-C-N 125.538 1.376 . . . . 0.0 110.485 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.56 85.26 0.06 OUTLIER Glycine 0 N--CA 1.507 3.428 0 O-C-N 124.722 1.264 . . . . 0.0 110.546 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -72.55 153.75 41.15 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.124 1.132 . . . . 0.0 110.481 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -158.46 139.81 13.36 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.878 1.361 . . . . 0.0 111.583 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -91.02 124.23 35.09 Favored 'General case' 0 N--CA 1.521 3.123 0 O-C-N 124.996 1.435 . . . . 0.0 111.026 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.41 150.05 18.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.68 140.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.83 125.15 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 O-C-N 125.54 1.775 . . . . 0.0 112.092 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -90.21 165.08 14.15 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.932 1.395 . . . . 0.0 109.013 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -67.57 -29.55 68.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 124.924 1.39 . . . . 0.0 112.618 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.23 144.05 32.0 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.55 1.781 . . . . 0.0 110.69 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.61 149.25 25.13 Favored 'General case' 0 N--CA 1.523 3.218 0 O-C-N 125.244 1.59 . . . . 0.0 111.774 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 m -71.24 103.85 2.94 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 125.666 1.854 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.57 157.6 52.75 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.959 1.412 . . . . 0.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -141.13 121.8 14.28 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.603 1.414 . . . . 0.0 110.449 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 t -71.06 133.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.886 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.279 24.7 ttm -53.56 -59.16 10.16 Favored Pre-proline 0 N--CA 1.532 3.653 0 CA-C-O 113.267 -3.254 . . . . 0.0 118.678 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -52.7 -57.28 2.16 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 125.386 2.959 . . . . 0.0 117.725 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -56.3 0.06 Allowed 'General case' 0 N--CA 1.537 3.915 0 CA-C-N 120.049 1.295 . . . . 0.0 112.344 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.22 -169.32 41.03 Favored Glycine 1 N--CA 1.517 4.04 0 CA-C-O 115.614 -2.77 . . . . 0.0 108.598 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -72.52 149.78 94.11 Favored 'Cis proline' 0 C--N 1.405 3.512 0 CA-C-N 123.118 3.459 . . . . 0.0 113.246 -0.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -72.26 137.37 46.73 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 125.396 1.685 . . . . 0.0 108.625 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -37.2 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 O-C-N 125.263 1.602 . . . . 0.0 112.196 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.98 -170.15 34.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 125.262 1.601 . . . . 0.0 109.602 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.91 112.8 2.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 126.049 1.676 . . . . 0.0 114.012 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.63 140.59 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 O-C-N 126.063 2.102 . . . . 0.0 107.201 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 148.75 21.8 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.581 1.8 . . . . 0.0 110.678 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.2 t -89.99 71.04 7.48 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.505 1.753 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.89 -32.56 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.292 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.6 -27.2 41.1 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.104 1.502 . . . . 0.0 110.992 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 145.24 98.2 Favored Pre-proline 0 N--CA 1.518 2.959 0 CA-C-O 114.736 -2.554 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -73.57 -45.25 0.42 Allowed 'Trans proline' 0 C--N 1.412 3.878 0 CA-C-N 124.217 2.542 . . . . 0.0 112.732 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.83 -45.59 42.41 Favored Glycine 0 N--CA 1.512 3.753 0 O-C-N 124.729 1.268 . . . . 0.0 112.657 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.73 174.88 49.88 Favored Glycine 1 N--CA 1.519 4.173 0 O-C-N 125.187 1.169 . . . . 0.0 111.736 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.6 m -69.96 145.49 51.82 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.868 0.981 . . . . 0.0 112.348 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -147.48 133.87 19.63 Favored 'General case' 0 N--CA 1.527 3.423 0 O-C-N 125.495 1.747 . . . . 0.0 108.403 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -79.88 135.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.028 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.53 133.13 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.71 139.92 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.23 146.0 6.94 Favored Glycine 0 N--CA 1.514 3.844 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.28 176.03 47.91 Favored Glycine 0 N--CA 1.501 2.969 0 O-C-N 124.833 0.96 . . . . 0.0 112.536 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -72.76 -22.07 60.91 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 113.636 -1.282 . . . . 0.0 112.533 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.01 -61.45 1.77 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 124.91 1.381 . . . . 0.0 112.643 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.29 6.64 0.03 OUTLIER Glycine 1 N--CA 1.523 4.451 0 CA-C-O 117.636 -1.647 . . . . 0.0 114.384 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.68 160.84 31.94 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 118.013 0.906 . . . . 0.0 111.071 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -152.58 157.3 40.84 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.06 1.475 . . . . 0.0 108.485 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.87 82.91 0.08 OUTLIER Glycine 0 N--CA 1.504 3.218 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -69.92 155.78 40.07 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 125.353 1.266 . . . . 0.0 112.042 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.82 98.23 1.48 Allowed 'General case' 0 N--CA 1.527 3.38 0 O-C-N 124.753 1.283 . . . . 0.0 110.505 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.46 151.32 44.08 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.21 176.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.386 0 O-C-N 126.365 2.29 . . . . 0.0 107.812 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -153.47 113.99 4.02 Favored 'General case' 0 N--CA 1.526 3.368 0 O-C-N 124.172 0.92 . . . . 0.0 110.641 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -70.8 154.37 41.9 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 124.424 1.078 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.311 -2.383 . . . . 0.0 109.694 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -163.15 89.95 0.65 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 125.669 1.856 . . . . 0.0 107.066 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.58 120.94 14.28 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.613 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.97 122.15 26.36 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.758 1.286 . . . . 0.0 111.684 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.96 137.66 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.329 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.17 146.39 13.98 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 124.865 1.353 . . . . 0.0 110.57 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.8 144.08 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.137 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -155.99 110.66 2.12 Favored Pre-proline 0 N--CA 1.528 3.429 0 CA-C-O 114.981 -2.437 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.25 156.63 72.94 Favored 'Cis proline' 1 C--N 1.424 4.533 0 CA-C-N 125.344 2.944 . . . . 0.0 111.899 -2.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.8 -4.83 1.37 Allowed 'General case' 0 N--CA 1.531 3.594 0 O-C-N 125.46 1.725 . . . . 0.0 112.563 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -136.09 152.59 51.02 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 124.991 1.432 . . . . 0.0 110.093 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.98 28.92 67.74 Favored Glycine 0 N--CA 1.513 3.791 0 O-C-N 124.989 1.431 . . . . 0.0 113.274 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.12 152.83 41.03 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 125.205 1.179 . . . . 0.0 109.794 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.77 4.81 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.68 1.863 . . . . 0.0 109.102 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.66 136.29 57.38 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 124.952 1.408 . . . . 0.0 111.711 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 39.27 33.87 Favored Glycine 0 N--CA 1.511 3.643 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 156.94 38.75 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 125.718 1.481 . . . . 0.0 112.401 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -139.8 119.08 12.82 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 126.361 2.288 . . . . 0.0 105.074 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.26 155.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.043 0 O-C-N 126.053 2.095 . . . . 0.0 109.975 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.9 m -122.74 96.05 4.87 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 126.286 2.241 . . . . 0.0 106.362 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.63 147.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 p -137.85 165.54 26.24 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 126.051 2.094 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.73 15.79 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.502 1.751 . . . . 0.0 108.598 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -160.53 146.8 15.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.888 1.367 . . . . 0.0 108.947 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.69 87.72 0.17 Allowed Glycine 0 N--CA 1.508 3.457 0 O-C-N 125.054 1.471 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -156.89 153.64 28.49 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.713 1.478 . . . . 0.0 107.477 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 -20.24 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.792 1.307 . . . . 0.0 111.28 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.39 1.056 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -70.11 126.09 28.66 Favored 'General case' 0 N--CA 1.521 3.099 0 O-C-N 124.63 1.206 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -80.3 -14.19 58.58 Favored 'General case' 0 N--CA 1.531 3.585 0 O-C-N 124.392 1.058 . . . . 0.0 112.975 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.29 155.85 11.68 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.18 33.26 Favored 'General case' 0 N--CA 1.521 3.116 0 O-C-N 125.111 1.507 . . . . 0.0 111.376 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -179.31 3.66 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 126.594 2.434 . . . . 0.0 107.682 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.55 109.83 2.16 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 124.944 1.402 . . . . 0.0 108.447 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 139.47 23.18 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.595 1.185 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -84.0 145.3 28.59 Favored 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.79 144.59 31.24 Favored 'General case' 0 N--CA 1.529 3.49 0 O-C-N 125.009 1.443 . . . . 0.0 108.713 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.9 118.51 37.08 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.673 1.858 . . . . 0.0 113.202 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.64 135.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.7 mt -113.44 -173.63 2.3 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.54 70.1 Favored 'General case' 0 N--CA 1.518 2.927 0 O-C-N 124.506 1.129 . . . . 0.0 112.604 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -20.65 61.82 Favored 'General case' 0 N--CA 1.526 3.334 0 O-C-N 125.372 1.67 . . . . 0.0 111.948 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.1 24.34 59.73 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 118.237 -1.313 . . . . 0.0 114.244 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.34 144.7 44.35 Favored 'General case' 0 N--CA 1.521 3.118 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.12 118.21 7.27 Favored Glycine 0 N--CA 1.508 3.481 0 O-C-N 124.729 1.268 . . . . 0.0 112.669 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.91 107.36 8.25 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.3 m -147.83 156.09 42.35 Favored 'General case' 0 N--CA 1.526 3.363 0 O-C-N 124.665 1.228 . . . . 0.0 110.112 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -83.44 147.39 27.88 Favored 'General case' 0 N--CA 1.517 2.922 0 O-C-N 125.451 1.72 . . . . 0.0 109.734 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -24.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.46 0 O-C-N 125.753 1.908 . . . . 0.0 112.933 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.89 -17.02 62.14 Favored 'General case' 0 N--CA 1.521 3.084 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.89 -5.65 55.93 Favored 'General case' 0 N--CA 1.537 3.877 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.58 161.84 14.0 Favored 'General case' 0 N--CA 1.533 3.699 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -152.15 -50.14 0.11 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 125.853 1.971 . . . . 0.0 108.093 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 56.82 49.59 13.94 Favored 'General case' 0 N--CA 1.522 3.148 0 O-C-N 125.505 1.753 . . . . 0.0 113.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -67.04 135.2 53.33 Favored 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -91.26 138.16 31.8 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 124.911 1.382 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.83 152.95 29.42 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 124.994 1.434 . . . . 0.0 107.774 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -140.98 6.01 1.96 Allowed 'General case' 0 N--CA 1.529 3.521 0 O-C-N 125.578 1.798 . . . . 0.0 111.768 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.07 22.39 0.05 OUTLIER Glycine 0 N--CA 1.509 3.563 0 O-C-N 124.075 0.859 . . . . 0.0 110.993 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.12 26.41 72.39 Favored Glycine 0 N--CA 1.508 3.454 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.149 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.75 154.66 43.68 Favored 'General case' 1 N--CA 1.54 4.07 0 O-C-N 125.217 1.186 . . . . 0.0 108.372 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 140.88 4.51 Favored Glycine 0 N--CA 1.509 3.55 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -135.54 150.49 49.75 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 125.734 1.491 . . . . 0.0 108.318 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -159.59 139.18 11.42 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 124.962 1.414 . . . . 0.0 111.884 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -93.31 135.62 34.36 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 125.147 1.53 . . . . 0.0 108.827 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.44 154.11 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 O-C-N 125.557 1.785 . . . . 0.0 106.949 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.91 138.92 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.13 139.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 O-C-N 125.394 1.684 . . . . 0.0 111.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -90.0 163.57 14.87 Favored 'General case' 0 N--CA 1.52 3.035 0 O-C-N 125.584 1.802 . . . . 0.0 106.434 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -62.38 -39.12 92.16 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.843 1.339 . . . . 0.0 111.144 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.36 153.93 35.79 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 126.36 2.287 . . . . 0.0 109.94 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -156.31 148.97 23.78 Favored 'General case' 0 N--CA 1.529 3.496 0 O-C-N 124.966 1.416 . . . . 0.0 111.663 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.05 107.01 2.55 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 125.56 1.787 . . . . 0.0 111.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.44 99.05 0.87 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.737 1.273 . . . . 0.0 110.153 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -93.33 103.6 15.82 Favored 'General case' 0 N--CA 1.524 3.242 0 O-C-N 125.294 1.232 . . . . 0.0 112.635 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.53 107.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.007 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.256 17.6 ttt -63.8 -58.95 12.8 Favored Pre-proline 0 N--CA 1.519 2.987 0 CA-C-O 114.345 -2.741 . . . . 0.0 117.515 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.76 -50.72 0.8 Allowed 'Trans proline' 0 C--N 1.395 2.991 0 CA-C-N 124.796 2.748 . . . . 0.0 117.515 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.9 -72.14 0.42 Allowed 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.35 -178.64 47.07 Favored Glycine 2 CA--C 1.589 4.703 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.781 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.91 168.83 72.67 Favored 'Cis proline' 0 N--CA 1.527 3.467 0 CA-C-N 123.099 3.449 . . . . 0.0 112.51 -6.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.47 128.15 34.67 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 125.303 1.627 . . . . 0.0 110.537 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -78.66 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 CA-C-O 116.993 -1.479 . . . . 0.0 112.487 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.86 -171.35 42.27 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-N 120.271 1.396 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.64 128.15 35.41 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.665 1.45 . . . . 0.0 113.399 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.85 142.62 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 O-C-N 126.179 2.174 . . . . 0.0 106.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.48 146.32 36.16 Favored 'General case' 0 N--CA 1.529 3.525 0 O-C-N 126.079 2.112 . . . . 0.0 111.445 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.8 m -74.33 79.11 1.85 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 125.521 1.763 . . . . 0.0 111.896 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -37.33 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.66 -28.52 40.78 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 125.424 1.703 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.07 139.5 95.39 Favored Pre-proline 0 N--CA 1.515 2.817 0 CA-C-O 114.472 -2.68 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.97 -43.03 0.63 Allowed 'Trans proline' 0 C--N 1.41 3.809 0 CA-C-N 124.575 2.67 . . . . 0.0 112.786 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.72 61.58 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 124.862 1.351 . . . . 0.0 112.374 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.08 154.43 19.28 Favored Glycine 1 N--CA 1.518 4.101 0 O-C-N 125.287 1.228 . . . . 0.0 111.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.6 m -69.9 140.14 53.09 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 124.856 0.974 . . . . 0.0 111.683 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -145.54 139.27 26.62 Favored 'General case' 0 N--CA 1.526 3.337 0 O-C-N 125.369 1.668 . . . . 0.0 108.596 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.84 133.6 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.0 133.72 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.96 143.87 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.312 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.92 137.47 3.21 Favored Glycine 1 N--CA 1.52 4.268 0 O-C-N 124.151 0.907 . . . . 0.0 111.566 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.81 -160.42 35.6 Favored Glycine 1 N--CA 1.518 4.103 0 O-C-N 125.48 1.341 . . . . 0.0 112.405 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.51 -25.03 62.95 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 125.443 1.319 . . . . 0.0 112.941 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -70.88 -32.7 69.76 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.799 1.312 . . . . 0.0 110.436 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.72 14.09 44.79 Favored Glycine 0 N--CA 1.516 3.998 0 O-C-N 125.747 1.904 . . . . 0.0 113.16 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.5 103.24 3.45 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -73.05 173.68 8.99 Favored 'General case' 0 N--CA 1.519 3.011 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.13 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.09 80.13 0.08 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -67.86 154.32 41.83 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 125.307 1.239 . . . . 0.0 113.495 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.17 95.57 0.86 Allowed 'General case' 0 N--CA 1.523 3.212 0 O-C-N 125.127 1.517 . . . . 0.0 108.586 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.34 156.04 39.85 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 173.13 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.689 0 O-C-N 126.663 2.477 . . . . 0.0 107.153 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.6 m -155.19 116.0 3.91 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.056 0.848 . . . . 0.0 110.445 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -69.96 150.26 46.89 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 124.611 1.194 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.674 0 CA-C-O 116.389 -2.339 . . . . 0.0 111.516 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 p -69.87 -33.01 71.68 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 125.418 1.698 . . . . 0.0 112.622 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.8 170.8 14.58 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 125.036 1.46 . . . . 0.0 112.63 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.09 129.8 5.26 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 124.937 1.398 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.48 144.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -160.24 144.06 14.06 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 124.927 1.392 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.11 142.28 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.062 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.25 112.86 1.72 Allowed Pre-proline 0 N--CA 1.527 3.403 0 CA-C-O 114.892 -2.48 . . . . 0.0 110.082 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -64.28 151.31 73.18 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.428 2.974 . . . . 0.0 112.102 -4.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.97 -8.89 1.58 Allowed 'General case' 0 N--CA 1.528 3.463 0 O-C-N 125.943 2.027 . . . . 0.0 112.817 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.2 p -132.73 151.58 51.95 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.321 1.638 . . . . 0.0 110.106 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.99 31.8 66.59 Favored Glycine 0 N--CA 1.514 3.881 0 O-C-N 124.993 1.433 . . . . 0.0 112.457 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.87 153.99 39.64 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 125.432 1.313 . . . . 0.0 110.234 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.88 -173.89 3.27 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 126.032 2.083 . . . . 0.0 108.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -66.56 128.94 38.18 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.644 1.215 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.08 28.71 69.89 Favored Glycine 0 N--CA 1.514 3.853 0 O-C-N 124.667 1.229 . . . . 0.0 112.794 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.39 127.21 31.87 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 124.924 1.014 . . . . 0.0 112.618 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 m -87.08 130.07 34.65 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 125.307 1.629 . . . . 0.0 106.803 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.63 143.49 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 125.607 1.817 . . . . 0.0 108.981 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.9 m -111.12 102.01 10.49 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 126.268 2.23 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.91 149.13 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.011 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -140.53 164.27 30.61 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 125.703 1.877 . . . . 0.0 110.174 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.24 145.33 14.84 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.53 1.769 . . . . 0.0 108.3 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -159.12 146.79 17.54 Favored 'General case' 0 N--CA 1.515 2.783 0 O-C-N 125.239 1.587 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.13 88.91 0.11 Allowed Glycine 0 N--CA 1.508 3.498 0 O-C-N 125.101 1.5 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -154.96 155.5 34.34 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 125.71 1.477 . . . . 0.0 107.783 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.1 -19.51 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.883 1.364 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -79.56 -51.16 9.66 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 124.427 1.08 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 p -70.87 119.97 15.78 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.894 1.371 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -79.79 -19.92 47.42 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 124.432 1.083 . . . . 0.0 112.909 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -166.38 150.09 7.39 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 125.233 1.583 . . . . 0.0 107.816 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.94 160.16 40.66 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 125.622 1.826 . . . . 0.0 110.373 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -151.14 129.75 12.25 Favored 'General case' 0 N--CA 1.517 2.913 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 121.78 24.25 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.651 1.219 . . . . 0.0 112.046 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 146.47 50.78 Favored 'General case' 0 N--CA 1.53 3.572 0 O-C-N 125.429 1.705 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.57 128.74 35.88 Favored 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.47 142.74 39.43 Favored 'General case' 0 N--CA 1.531 3.604 0 O-C-N 124.719 1.262 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.17 26.56 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 125.187 1.555 . . . . 0.0 111.181 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -79.33 122.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.142 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.95 -174.34 2.59 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.68 84.02 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 124.703 1.252 . . . . 0.0 110.84 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -21.45 59.79 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 125.434 1.709 . . . . 0.0 110.87 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.85 26.69 60.02 Favored Glycine 0 N--CA 1.513 3.789 0 CA-C-O 117.472 -1.738 . . . . 0.0 115.635 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -73.11 146.23 45.88 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.01 74.72 1.17 Allowed Glycine 0 N--CA 1.515 3.917 0 CA-C-O 118.114 -1.381 . . . . 0.0 115.854 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.08 97.88 9.56 Favored 'General case' 0 N--CA 1.515 2.816 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.21 143.3 49.85 Favored 'General case' 0 N--CA 1.527 3.414 0 O-C-N 124.874 1.359 . . . . 0.0 111.792 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -85.87 116.31 24.04 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 125.487 1.742 . . . . 0.0 108.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -65.53 -23.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.07 -12.18 61.45 Favored 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -79.89 -7.18 58.59 Favored 'General case' 1 N--CA 1.541 4.109 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -64.18 160.81 17.64 Favored 'General case' 0 N--CA 1.531 3.604 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -139.18 -52.42 0.55 Allowed 'General case' 0 N--CA 1.52 3.032 0 O-C-N 126.007 2.067 . . . . 0.0 108.071 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 45.58 116.1 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -171.22 144.04 1.98 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 m -65.07 157.0 29.68 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.806 1.316 . . . . 0.0 113.478 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.2 mt -79.5 147.67 32.13 Favored 'General case' 0 N--CA 1.513 2.703 0 O-C-N 125.326 1.641 . . . . 0.0 108.225 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -72.1 -26.04 61.99 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 124.637 1.211 . . . . 0.0 112.483 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.03 -36.5 0.05 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.51 19.67 0.02 OUTLIER Glycine 0 N--CA 1.502 3.076 0 CA-C-O 117.673 -1.626 . . . . 0.0 111.953 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 158.06 34.75 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.497 1.351 . . . . 0.0 109.146 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.37 139.63 4.2 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -142.35 151.16 41.63 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.74 134.98 5.42 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.96 1.412 . . . . 0.0 112.361 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 t -86.46 114.21 23.04 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 125.067 1.479 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.03 144.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 t -122.71 137.23 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.55 131.12 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 O-C-N 125.75 1.906 . . . . 0.0 113.005 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -90.12 161.83 15.59 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 125.225 1.578 . . . . 0.0 106.984 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -65.68 -32.85 74.64 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 124.727 1.267 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 m -131.29 150.21 52.24 Favored 'General case' 0 N--CA 1.528 3.427 0 O-C-N 125.991 2.057 . . . . 0.0 110.173 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -157.8 146.71 19.48 Favored 'General case' 0 N--CA 1.525 3.292 0 O-C-N 124.906 1.379 . . . . 0.0 111.518 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.4 m -69.25 113.0 6.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 125.608 1.818 . . . . 0.0 110.631 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.35 149.55 45.68 Favored Glycine 0 N--CA 1.513 3.828 0 O-C-N 124.974 1.421 . . . . 0.0 109.858 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -137.95 88.37 2.32 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.406 1.298 . . . . 0.0 108.551 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 t -72.34 115.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.316 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.4 mmt 48.07 163.23 0.03 OUTLIER Pre-proline 2 N--CA 1.567 5.375 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.93 -14.08 43.15 Favored 'Trans proline' 1 C--N 1.427 4.659 0 CA-C-N 123.323 2.222 . . . . 0.0 114.868 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.72 -40.6 28.53 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.68 49.92 Favored Glycine 2 CA--C 1.585 4.438 0 CA-C-O 115.305 -2.942 . . . . 0.0 108.631 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.47 155.43 82.25 Favored 'Cis proline' 0 C--N 1.402 3.359 0 CA-C-N 123.948 3.874 . . . . 0.0 114.28 -1.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.79 134.14 48.22 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.604 1.815 . . . . 0.0 109.307 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -87.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.224 0 O-C-N 125.252 1.595 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.33 -174.71 42.51 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.97 118.56 12.05 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 125.663 1.449 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.06 133.33 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 O-C-N 125.989 2.056 . . . . 0.0 107.98 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.44 141.31 28.64 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 125.022 1.451 . . . . 0.0 111.338 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.3 t -83.5 72.51 10.26 Favored 'General case' 0 N--CA 1.513 2.724 0 O-C-N 125.232 1.583 . . . . 0.0 110.463 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.15 -32.73 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -79.66 -25.8 41.21 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.106 1.504 . . . . 0.0 111.252 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.96 150.71 97.66 Favored Pre-proline 0 N--CA 1.523 3.199 0 CA-C-O 115.101 -2.38 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.77 -48.79 0.22 Allowed 'Trans proline' 0 C--N 1.408 3.698 0 CA-C-N 123.711 2.361 . . . . 0.0 113.036 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.42 -46.95 24.01 Favored Glycine 0 N--CA 1.51 3.58 0 O-C-N 124.532 1.145 . . . . 0.0 112.558 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.82 172.43 48.85 Favored Glycine 1 N--CA 1.517 4.051 0 O-C-N 125.319 1.246 . . . . 0.0 110.89 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.7 m -70.11 153.42 43.17 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 124.783 0.931 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -157.78 135.24 10.39 Favored 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.77 137.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.857 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.81 131.7 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.16 140.23 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.61 -152.89 16.26 Favored Glycine 1 N--CA 1.517 4.097 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.64 -160.91 13.56 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -68.5 -34.09 75.29 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -125.07 -15.05 6.44 Favored 'General case' 1 N--CA 1.544 4.234 0 O-C-N 125.015 1.447 . . . . 0.0 111.835 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.41 -1.7 30.21 Favored Glycine 1 N--CA 1.527 4.755 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 63.89 173.09 0.18 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.903 1.281 . . . . 0.0 113.373 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -69.83 145.19 52.28 Favored 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.731 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.34 -64.14 2.47 Favored Glycine 0 N--CA 1.512 3.755 0 O-C-N 124.601 1.188 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 62.58 105.82 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.126 0 O-C-N 126.105 1.709 . . . . 0.0 113.568 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.25 95.8 1.27 Allowed 'General case' 0 N--CA 1.532 3.658 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.124 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.27 152.94 42.8 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.089 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pt -116.51 168.63 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 O-C-N 126.253 2.221 . . . . 0.0 108.748 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -140.94 157.57 45.17 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 124.851 1.344 . . . . 0.0 109.21 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -110.29 159.61 17.26 Favored 'General case' 0 N--CA 1.521 3.093 0 O-C-N 126.098 2.124 . . . . 0.0 109.826 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.312 0 CA-C-O 116.345 -2.364 . . . . 0.0 109.668 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.788 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 131.78 35.98 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 124.947 1.404 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.88 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.72 141.48 7.39 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 124.773 1.295 . . . . 0.0 109.786 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.74 141.33 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 p -160.42 113.01 1.38 Allowed Pre-proline 0 CA--C 1.608 3.176 0 CA-C-O 115.053 -2.403 . . . . 0.0 109.927 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -65.14 153.21 77.27 Favored 'Cis proline' 1 C--N 1.425 4.595 0 CA-C-N 125.458 2.985 . . . . 0.0 111.222 -3.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.22 -8.65 1.15 Allowed 'General case' 0 N--CA 1.529 3.513 0 O-C-N 125.872 1.983 . . . . 0.0 113.063 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -129.45 153.98 47.41 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.486 1.741 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 28.25 68.39 Favored Glycine 1 N--CA 1.519 4.167 0 O-C-N 124.8 1.313 . . . . 0.0 113.118 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.47 155.75 33.6 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 125.146 1.144 . . . . 0.0 110.282 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.82 -178.52 5.85 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 125.656 1.847 . . . . 0.0 107.222 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.35 142.83 53.9 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 124.592 1.183 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.68 85.62 Favored Glycine 1 N--CA 1.521 4.337 0 O-C-N 124.981 1.426 . . . . 0.0 113.394 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.49 164.72 26.28 Favored 'General case' 0 N--CA 1.52 3.064 0 O-C-N 124.196 0.586 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 m -145.98 121.91 10.66 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.5 -178.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 O-C-N 125.667 1.855 . . . . 0.0 110.047 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -143.25 92.61 2.39 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.76 149.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 p -135.24 162.03 33.71 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 126.141 2.15 . . . . 0.0 109.044 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.5 16.82 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 125.307 1.63 . . . . 0.0 108.68 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -157.04 149.52 23.24 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 125.4 1.687 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 127.42 0.85 Allowed Glycine 1 N--CA 1.52 4.27 0 O-C-N 124.95 1.406 . . . . 0.0 111.988 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -147.98 161.62 40.98 Favored 'General case' 0 N--CA 1.522 3.154 0 C-N-CA 124.269 1.028 . . . . 0.0 109.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.95 -59.15 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.554 0 O-C-N 125.385 1.678 . . . . 0.0 108.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 -53.36 6.73 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.332 1.645 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.2 p -67.83 143.07 55.94 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 124.893 1.371 . . . . 0.0 112.273 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.535 3.801 0 O-C-N 125.689 1.868 . . . . 0.0 109.823 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -168.9 170.61 8.96 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.7 13.31 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 123.858 0.724 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.53 172.89 11.41 Favored 'General case' 0 N--CA 1.524 3.249 0 O-C-N 126.173 2.171 . . . . 0.0 106.212 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.95 66.99 1.31 Allowed 'General case' 0 N--CA 1.531 3.612 0 O-C-N 125.421 1.701 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.24 155.45 28.57 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -137.73 136.54 37.43 Favored 'General case' 0 N--CA 1.521 3.107 0 O-C-N 125.771 1.919 . . . . 0.0 106.669 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.0 m -141.31 150.22 42.24 Favored 'General case' 0 N--CA 1.532 3.635 0 O-C-N 124.584 1.177 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.17 115.7 28.85 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 126.096 2.122 . . . . 0.0 110.963 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.2 137.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -122.08 -175.05 3.03 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.767 1.917 . . . . 0.0 106.294 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.58 97.37 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.303 1.002 . . . . 0.0 111.993 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 -21.81 60.4 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.45 1.719 . . . . 0.0 111.163 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.37 24.42 73.15 Favored Glycine 0 N--CA 1.512 3.75 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.873 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -75.03 145.12 42.68 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.59 75.9 1.19 Allowed Glycine 1 N--CA 1.517 4.098 0 O-C-N 124.813 1.321 . . . . 0.0 114.296 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.83 96.36 8.2 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.35 139.92 52.91 Favored 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.028 1.455 . . . . 0.0 112.575 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 50' ' ' ALA . 13.7 t30 -76.85 138.57 39.88 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 125.016 1.447 . . . . 0.0 109.369 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.08 -24.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 O-C-N 125.512 1.758 . . . . 0.0 114.613 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -79.16 -21.51 46.37 Favored 'General case' 0 N--CA 1.532 3.67 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' H ' HD22 ' A' ' 48' ' ' ASN . 19.0 mt-10 -82.72 1.6 37.92 Favored 'General case' 1 N--CA 1.549 4.482 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -69.69 168.78 14.18 Favored 'General case' 0 N--CA 1.533 3.722 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -133.82 -63.93 0.72 Allowed 'General case' 0 N--CA 1.524 3.229 0 O-C-N 125.614 1.821 . . . . 0.0 109.996 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.41 98.5 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.029 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -157.51 150.01 22.85 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -65.74 167.74 8.82 Favored 'General case' 0 N--CA 1.52 3.07 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -79.29 141.95 36.58 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.7 t -71.54 -25.19 62.12 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 124.408 1.067 . . . . 0.0 112.985 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.55 -39.19 0.06 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.32 18.28 0.02 OUTLIER Glycine 0 N--CA 1.501 3.03 0 O-C-N 125.287 1.228 . . . . 0.0 111.593 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -144.03 165.36 27.99 Favored 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.32 79.98 0.08 OUTLIER Glycine 0 N--CA 1.513 3.799 0 O-C-N 124.074 0.859 . . . . 0.0 111.658 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -74.87 149.72 39.43 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 125.539 1.376 . . . . 0.0 108.986 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.27 137.56 7.17 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.904 1.378 . . . . 0.0 112.93 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -90.04 112.84 24.41 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 125.219 1.575 . . . . 0.0 110.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.75 147.06 13.7 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.125 0 O-C-N 125.385 1.678 . . . . 0.0 107.012 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.28 150.01 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 125.855 1.972 . . . . 0.0 106.705 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.65 92.06 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 125.525 1.766 . . . . 0.0 110.009 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -86.56 154.14 21.29 Favored 'General case' 0 N--CA 1.523 3.218 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.001 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.522 3.135 0 O-C-N 124.721 1.263 . . . . 0.0 113.473 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -156.23 147.06 21.99 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 124.616 1.197 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.87 149.53 21.74 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.879 1.362 . . . . 0.0 111.669 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.0 m -69.47 105.53 2.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.779 1.925 . . . . 0.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.3 159.67 53.45 Favored Glycine 0 N--CA 1.514 3.842 0 O-C-N 124.665 1.228 . . . . 0.0 111.235 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 119.05 14.41 Favored 'General case' 0 N--CA 1.527 3.404 0 O-C-N 125.596 1.409 . . . . 0.0 108.384 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t . . . . . 0 N--CA 1.535 3.776 0 O-C-N 124.797 1.311 . . . . 0.0 107.607 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.583 4.34 0 CA-C-O 115.688 -2.729 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -67.78 156.49 86.42 Favored 'Cis proline' 0 C--N 1.403 3.446 0 CA-C-N 123.668 3.734 . . . . 0.0 114.291 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.34 142.01 52.21 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 125.512 1.757 . . . . 0.0 109.301 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -38.51 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 O-C-N 125.231 1.582 . . . . 0.0 112.581 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.84 -166.68 23.79 Favored Glycine 0 N--CA 1.501 2.976 0 O-C-N 125.568 1.793 . . . . 0.0 108.93 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.75 116.92 5.64 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 125.823 1.543 . . . . 0.0 113.757 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.43 138.62 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 O-C-N 125.969 2.043 . . . . 0.0 107.407 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.21 144.48 28.12 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 125.303 1.627 . . . . 0.0 110.711 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.4 t -80.36 -32.81 37.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 125.05 1.469 . . . . 0.0 112.77 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.09 -25.65 63.62 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.62 -25.28 41.48 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.408 1.068 . . . . 0.0 113.244 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 91.39 Favored Pre-proline 0 N--CA 1.531 3.604 0 CA-C-O 115.573 -2.156 . . . . 0.0 112.025 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.84 -49.26 0.25 Allowed 'Trans proline' 0 C--N 1.413 3.938 0 CA-C-N 123.305 2.216 . . . . 0.0 113.612 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.55 -42.28 55.69 Favored Glycine 0 N--CA 1.511 3.655 0 O-C-N 124.627 1.205 . . . . 0.0 112.477 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.57 175.38 49.2 Favored Glycine 1 N--CA 1.518 4.116 0 O-C-N 125.163 1.155 . . . . 0.0 111.291 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.8 m -70.02 144.82 52.13 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.569 0.805 . . . . 0.0 112.453 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -146.12 127.67 15.1 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 125.806 1.941 . . . . 0.0 107.235 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.77 137.09 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -129.48 134.61 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.34 136.9 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.9 152.88 10.53 Favored Glycine 0 N--CA 1.509 3.541 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.78 -176.75 49.72 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 125.346 1.262 . . . . 0.0 111.804 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -76.57 -16.6 59.56 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.003 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.98 -65.79 0.68 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 124.67 1.231 . . . . 0.0 112.526 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.74 12.85 0.02 OUTLIER Glycine 0 N--CA 1.515 3.924 0 CA-C-O 118.568 -1.129 . . . . 0.0 112.505 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.36 156.44 39.09 Favored 'General case' 0 N--CA 1.521 3.119 0 O-C-N 124.702 0.884 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -153.9 158.81 41.29 Favored 'General case' 0 N--CA 1.522 3.147 0 O-C-N 124.758 1.286 . . . . 0.0 109.236 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.96 82.91 0.07 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -67.29 155.39 39.0 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 125.421 1.306 . . . . 0.0 113.377 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.69 101.79 1.5 Allowed 'General case' 0 N--CA 1.527 3.415 0 O-C-N 124.655 1.222 . . . . 0.0 110.426 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 155.37 40.72 Favored 'General case' 0 N--CA 1.514 2.732 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.78 177.1 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 126.476 2.36 . . . . 0.0 107.735 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 p -156.13 124.2 5.7 Favored 'General case' 0 N--CA 1.524 3.244 0 O-C-N 123.972 0.795 . . . . 0.0 111.674 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -75.3 158.22 33.18 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 124.11 0.882 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.715 0 CA-C-O 116.31 -2.383 . . . . 0.0 111.338 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.534 3.752 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.22 123.7 3.54 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.676 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.9 146.81 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.57 140.89 16.61 Favored 'General case' 0 N--CA 1.518 2.929 0 O-C-N 125.166 1.541 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.53 144.57 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -160.88 111.85 1.3 Allowed Pre-proline 0 N--CA 1.524 3.228 0 CA-C-O 115.054 -2.403 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.41 151.78 70.21 Favored 'Cis proline' 1 C--N 1.425 4.594 0 CA-C-N 125.286 2.924 . . . . 0.0 112.439 -3.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -3.56 2.0 Favored 'General case' 0 N--CA 1.528 3.452 0 O-C-N 125.98 2.05 . . . . 0.0 112.881 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.1 p -138.42 151.16 47.2 Favored 'General case' 0 N--CA 1.528 3.467 0 O-C-N 124.686 1.241 . . . . 0.0 109.89 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.24 32.25 68.8 Favored Glycine 1 N--CA 1.517 4.045 0 O-C-N 125.036 1.46 . . . . 0.0 112.879 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.8 mt -73.11 155.21 39.93 Favored 'General case' 0 N--CA 1.514 2.747 0 O-C-N 125.456 1.327 . . . . 0.0 110.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.31 -176.29 3.84 Favored 'General case' 0 N--CA 1.518 2.973 0 O-C-N 126.07 2.107 . . . . 0.0 108.574 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 127.49 32.81 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 124.75 1.281 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.95 28.95 71.16 Favored Glycine 0 N--CA 1.516 3.99 0 O-C-N 124.811 1.32 . . . . 0.0 112.977 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.14 123.81 23.68 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 124.935 1.021 . . . . 0.0 112.649 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -79.88 128.03 32.96 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.7 143.54 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 O-C-N 125.596 1.81 . . . . 0.0 109.178 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 m -107.1 102.92 12.22 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 126.231 2.207 . . . . 0.0 110.602 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.81 147.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.5 158.47 43.02 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.23 2.206 . . . . 0.0 108.717 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.28 141.56 12.32 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.244 1.59 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -165.31 122.52 1.51 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.516 1.76 . . . . 0.0 107.875 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 172.16 -90.56 0.09 OUTLIER Glycine 0 N--CA 1.506 3.337 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER 58.9 146.62 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.963 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.88 -37.74 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -136.84 -30.09 0.9 Allowed 'General case' 0 N--CA 1.527 3.416 0 O-C-N 126.007 2.067 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -73.36 109.46 6.9 Favored 'General case' 0 N--CA 1.523 3.19 0 O-C-N 124.658 1.224 . . . . 0.0 109.325 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.64 7.54 41.06 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.827 1.33 . . . . 0.0 112.726 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -160.46 167.72 26.66 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 124.398 1.061 . . . . 0.0 109.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.15 145.13 26.12 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.265 1.603 . . . . 0.0 109.898 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.1 m -142.0 169.77 16.97 Favored 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.38 4.46 Favored 'General case' 0 N--CA 1.527 3.411 0 O-C-N 124.23 0.956 . . . . 0.0 112.229 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.28 139.85 21.57 Favored 'General case' 0 N--CA 1.538 3.931 0 O-C-N 125.262 1.601 . . . . 0.0 109.551 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -87.83 148.74 24.52 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.3 m -142.42 149.54 39.44 Favored 'General case' 0 N--CA 1.524 3.268 0 O-C-N 125.581 1.801 . . . . 0.0 108.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.0 124.77 51.24 Favored 'General case' 0 N--CA 1.526 3.344 0 O-C-N 126.083 2.114 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -76.45 145.52 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.63 -175.76 3.56 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.41 -49.93 69.6 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.54 1.15 . . . . 0.0 111.654 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -23.59 59.9 Favored 'General case' 0 N--CA 1.528 3.431 0 O-C-N 125.564 1.79 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.0 32.93 60.13 Favored Glycine 0 N--CA 1.508 3.49 0 CA-C-O 116.921 -2.044 . . . . 0.0 117.187 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -75.79 150.2 37.78 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.75 89.33 0.38 Allowed Glycine 0 N--CA 1.511 3.676 0 O-C-N 124.722 1.264 . . . . 0.0 113.496 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.34 95.66 6.66 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.45 137.86 47.41 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 125.247 1.592 . . . . 0.0 111.223 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -78.91 117.82 20.35 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.94 1.4 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -21.48 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.369 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.97 -17.44 64.44 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 118.165 2.654 . . . . 0.0 118.165 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -83.04 2.06 36.91 Favored 'General case' 1 N--CA 1.55 4.533 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.38 167.38 12.67 Favored 'General case' 0 N--CA 1.53 3.552 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -146.17 -60.06 0.31 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 126.057 2.098 . . . . 0.0 107.264 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 45.44 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.757 1.911 . . . . 0.0 116.129 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.14 149.98 31.93 Favored 'General case' 0 N--CA 1.528 3.465 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.72 160.77 22.15 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.935 1.397 . . . . 0.0 114.759 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.39 149.82 31.54 Favored 'General case' 0 N--CA 1.517 2.9 0 O-C-N 125.178 1.549 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -76.31 -24.44 54.34 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.025 1.453 . . . . 0.0 112.217 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.2 -30.89 0.05 OUTLIER Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.16 3.66 0.02 OUTLIER Glycine 0 N--CA 1.512 3.749 0 CA-C-O 117.595 -1.67 . . . . 0.0 112.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.22 165.22 23.84 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.19 79.36 0.08 OUTLIER Glycine 0 N--CA 1.514 3.873 0 O-C-N 124.296 0.998 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m -75.03 155.7 37.0 Favored 'General case' 0 N--CA 1.517 2.902 0 O-C-N 125.311 1.242 . . . . 0.0 109.872 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.84 135.81 6.66 Favored 'General case' 0 N--CA 1.524 3.267 0 O-C-N 124.611 1.195 . . . . 0.0 113.065 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -84.49 114.24 21.79 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 124.875 1.359 . . . . 0.0 110.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.42 149.49 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.35 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 N-CA-C 102.395 -3.187 . . . . 0.0 102.395 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.67 125.18 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 O-C-N 125.543 1.777 . . . . 0.0 112.511 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -90.17 159.58 16.68 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.886 1.366 . . . . 0.0 107.73 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -66.24 -32.89 74.59 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.713 1.258 . . . . 0.0 111.952 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 148.41 52.01 Favored 'General case' 0 N--CA 1.529 3.476 0 O-C-N 125.944 2.028 . . . . 0.0 109.763 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.17 145.44 19.42 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.714 1.259 . . . . 0.0 111.926 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -70.45 106.07 3.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.744 1.903 . . . . 0.0 109.037 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.58 151.42 49.48 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.028 1.455 . . . . 0.0 110.739 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -139.98 121.3 14.95 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 125.803 1.531 . . . . 0.0 109.018 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.524 3.264 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.987 0 CA-C-O 115.564 -2.798 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -71.63 139.94 62.26 Favored 'Cis proline' 0 C--N 1.409 3.723 0 CA-C-N 123.19 3.495 . . . . 0.0 113.078 0.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.16 137.56 51.12 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 125.237 1.586 . . . . 0.0 109.583 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.92 -92.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.968 0 O-C-N 125.669 1.855 . . . . 0.0 110.616 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.31 -173.44 43.08 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.46 75.42 3.2 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 125.846 1.557 . . . . 0.0 112.349 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.16 141.74 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.828 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.96 156.05 18.26 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 125.375 1.672 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 t -73.8 -25.73 60.26 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.679 1.237 . . . . 0.0 112.887 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.15 -28.39 57.37 Favored 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -79.6 -21.63 44.75 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.341 1.026 . . . . 0.0 112.538 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.32 88.94 Favored Pre-proline 0 N--CA 1.531 3.578 0 CA-C-O 115.512 -2.185 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.76 -45.44 0.52 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.332 2.226 . . . . 0.0 113.051 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.36 -101.94 0.14 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 124.836 1.335 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.52 159.31 10.55 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 63.3 m -71.23 145.06 49.85 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 125.481 1.342 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -144.4 133.21 22.46 Favored 'General case' 0 N--CA 1.533 3.69 0 O-C-N 125.254 1.596 . . . . 0.0 109.283 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mm -79.72 135.73 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.825 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -131.06 134.31 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.3 140.67 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.044 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.72 145.62 6.88 Favored Glycine 0 N--CA 1.51 3.585 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.69 -170.91 38.68 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.016 1.068 . . . . 0.0 112.405 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -75.07 -12.65 60.37 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.256 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 p -69.9 -70.66 0.27 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.693 1.245 . . . . 0.0 111.384 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.48 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.512 3.722 0 CA-C-O 118.699 -1.056 . . . . 0.0 111.903 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -66.05 119.74 11.92 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 125.039 1.082 . . . . 0.0 112.013 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -86.99 -175.49 5.38 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 125.151 1.532 . . . . 0.0 110.31 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.39 78.16 0.09 OUTLIER Glycine 0 N--CA 1.507 3.394 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.71 152.05 46.25 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.445 1.321 . . . . 0.0 112.946 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 98.36 1.08 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 124.843 1.339 . . . . 0.0 109.737 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 150.32 45.64 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.937 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.06 172.16 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 O-C-N 126.324 2.265 . . . . 0.0 107.08 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.5 m -156.38 118.29 3.94 Favored 'General case' 0 N--CA 1.528 3.447 0 O-C-N 124.153 0.908 . . . . 0.0 111.42 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.21 147.93 44.21 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.507 1.129 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.982 0 CA-C-O 116.08 -2.511 . . . . 0.0 112.815 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.533 3.685 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.24 6.15 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.83 145.44 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -160.96 146.04 14.13 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 124.99 1.432 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.98 144.22 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.23 110.22 2.07 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 114.989 -2.434 . . . . 0.0 110.005 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.91 158.85 68.34 Favored 'Cis proline' 1 C--N 1.424 4.513 0 CA-C-N 125.158 2.878 . . . . 0.0 112.32 -3.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.0 -0.36 2.29 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 125.144 1.528 . . . . 0.0 112.831 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -140.05 151.74 45.65 Favored 'General case' 0 N--CA 1.528 3.462 0 O-C-N 124.74 1.275 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.49 30.95 68.45 Favored Glycine 0 N--CA 1.512 3.703 0 O-C-N 124.953 1.408 . . . . 0.0 113.553 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.58 154.59 39.74 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 125.373 1.278 . . . . 0.0 109.379 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.43 -177.37 3.96 Favored 'General case' 0 N--CA 1.523 3.216 0 O-C-N 125.769 1.918 . . . . 0.0 110.179 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.64 129.87 41.24 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 124.866 1.354 . . . . 0.0 111.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.34 77.18 Favored Glycine 0 N--CA 1.512 3.715 0 O-C-N 124.606 1.191 . . . . 0.0 113.549 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.27 136.11 44.53 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.721 0.895 . . . . 0.0 111.428 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 m -99.6 127.3 45.7 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 125.819 1.949 . . . . 0.0 106.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.87 149.21 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 125.752 1.908 . . . . 0.0 109.924 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 m -103.72 96.38 6.67 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 126.081 2.113 . . . . 0.0 110.648 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.9 147.32 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.119 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -133.91 162.41 32.1 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 125.857 1.973 . . . . 0.0 110.174 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.22 139.2 10.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 125.544 1.777 . . . . 0.0 106.977 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 p -160.59 153.39 21.16 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.749 1.281 . . . . 0.0 110.853 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.35 79.1 0.52 Allowed Glycine 0 N--CA 1.505 3.299 0 O-C-N 124.893 1.37 . . . . 0.0 113.157 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -79.51 173.26 12.77 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 125.677 1.457 . . . . 0.0 110.939 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.38 -38.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.438 1.086 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.99 -46.63 1.38 Allowed 'General case' 0 N--CA 1.525 3.317 0 O-C-N 126.15 2.156 . . . . 0.0 111.414 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.56 121.81 18.54 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 124.847 1.342 . . . . 0.0 113.321 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.02 3.44 38.83 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 125.479 1.737 . . . . 0.0 110.962 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.67 162.69 18.98 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.34 150.56 19.98 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 124.18 0.925 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.1 m -142.07 147.12 36.28 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 125.871 1.982 . . . . 0.0 107.079 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.62 125.04 48.21 Favored 'General case' 0 N--CA 1.526 3.327 0 O-C-N 125.91 2.006 . . . . 0.0 112.448 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -122.46 152.11 40.61 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.587 1.804 . . . . 0.0 107.983 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -135.78 63.26 1.6 Allowed 'General case' 0 N--CA 1.537 3.921 0 O-C-N 125.508 1.755 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 m -72.88 148.94 43.91 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.974 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.21 112.26 24.87 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 126.379 2.3 . . . . 0.0 109.712 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mm -75.54 123.7 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.1 mt -103.22 -173.39 2.3 Favored 'General case' 0 N--CA 1.528 3.473 0 O-C-N 125.223 1.577 . . . . 0.0 106.836 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.51 82.31 Favored 'General case' 0 N--CA 1.515 2.819 0 O-C-N 124.355 1.035 . . . . 0.0 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -21.5 59.86 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 125.192 1.558 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.83 59.45 Favored Glycine 0 N--CA 1.509 3.556 0 CA-C-O 117.49 -1.728 . . . . 0.0 115.118 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.9 142.1 49.51 Favored 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.15 76.06 1.28 Allowed Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.908 1.38 . . . . 0.0 114.37 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.33 97.86 11.44 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.213 1.184 . . . . 0.0 108.171 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 140.29 47.13 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 125.115 1.509 . . . . 0.0 110.896 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -77.11 133.11 39.11 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 125.263 1.602 . . . . 0.0 110.081 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.54 -14.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 O-C-N 125.12 1.512 . . . . 0.0 114.009 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.56 53.57 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.95 -3.12 50.46 Favored 'General case' 1 N--CA 1.546 4.361 0 O-C-N 124.255 0.972 . . . . 0.0 113.57 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -68.13 168.33 12.33 Favored 'General case' 0 N--CA 1.535 3.798 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -143.79 -66.63 0.35 Allowed 'General case' 0 N--CA 1.526 3.339 0 O-C-N 125.486 1.741 . . . . 0.0 109.194 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 52.22 127.81 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -172.84 145.43 1.45 Allowed 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -67.24 163.19 20.98 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.703 1.252 . . . . 0.0 112.657 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.25 149.38 31.88 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 124.83 1.331 . . . . 0.0 109.379 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -73.54 -26.85 61.04 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 124.896 1.372 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.89 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.62 14.43 0.02 OUTLIER Glycine 0 N--CA 1.51 3.609 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.902 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.6 160.16 41.15 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.32 86.46 0.07 OUTLIER Glycine 0 N--CA 1.51 3.63 0 O-C-N 124.49 1.119 . . . . 0.0 111.074 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -74.25 155.54 38.16 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 125.259 1.211 . . . . 0.0 109.189 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -157.6 135.51 10.79 Favored 'General case' 0 N--CA 1.53 3.565 0 O-C-N 124.69 1.244 . . . . 0.0 112.646 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 t -90.69 124.97 35.51 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 125.022 1.451 . . . . 0.0 108.522 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.73 144.57 32.96 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 O-C-N 125.47 1.731 . . . . 0.0 107.062 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 t -115.38 138.46 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.48 119.47 50.39 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.329 0 O-C-N 125.262 1.602 . . . . 0.0 111.777 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -90.46 162.59 15.0 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.078 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -67.35 -29.06 68.51 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.766 1.291 . . . . 0.0 111.766 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 t -148.31 154.3 39.82 Favored 'General case' 0 N--CA 1.533 3.706 0 O-C-N 124.853 1.345 . . . . 0.0 109.084 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -158.58 148.21 19.39 Favored 'General case' 0 N--CA 1.525 3.277 0 O-C-N 124.9 1.375 . . . . 0.0 111.675 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 m -67.95 100.54 0.98 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.783 1.927 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.59 155.41 51.17 Favored Glycine 0 N--CA 1.505 3.249 0 O-C-N 125.116 1.51 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -137.95 123.3 19.46 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 125.901 1.589 . . . . 0.0 107.602 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.523 3.216 0 O-C-N 125.266 1.604 . . . . 0.0 107.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.521 4.348 0 CA-C-O 115.595 -2.781 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.26 152.39 97.18 Favored 'Cis proline' 0 N--CA 1.53 3.649 0 CA-C-N 123.267 3.533 . . . . 0.0 113.08 -1.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -67.35 143.7 56.22 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 125.341 1.651 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -31.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 O-C-N 125.668 1.855 . . . . 0.0 110.72 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.72 -169.03 36.62 Favored Glycine 0 N--CA 1.494 2.539 0 O-C-N 125.498 1.749 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.86 113.42 2.77 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 125.987 1.639 . . . . 0.0 113.886 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.47 132.14 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 O-C-N 126.152 2.158 . . . . 0.0 107.439 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.532 1.145 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 43.9 t -77.12 -30.74 55.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.841 1.338 . . . . 0.0 112.623 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.74 -24.01 62.54 Favored 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -26.59 41.17 Favored 'General case' 0 N--CA 1.533 3.72 0 O-C-N 124.21 0.944 . . . . 0.0 113.014 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.1 154.81 91.88 Favored Pre-proline 0 N--CA 1.53 3.528 0 CA-C-O 115.513 -2.184 . . . . 0.0 111.986 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.09 -51.16 0.17 Allowed 'Trans proline' 0 C--N 1.411 3.849 0 CA-C-N 123.396 2.249 . . . . 0.0 113.577 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 -36.4 57.9 Favored Glycine 0 N--CA 1.51 3.591 0 O-C-N 124.458 1.099 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.09 -179.31 53.0 Favored Glycine 0 N--CA 1.516 3.972 0 O-C-N 125.045 1.085 . . . . 0.0 111.038 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.8 m -70.77 146.63 49.66 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 124.619 0.834 . . . . 0.0 111.73 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -144.92 131.79 20.18 Favored 'General case' 0 N--CA 1.525 3.309 0 O-C-N 125.549 1.781 . . . . 0.0 107.123 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.73 130.28 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.01 134.56 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.83 137.74 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.951 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.41 142.71 5.11 Favored Glycine 0 N--CA 1.509 3.565 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.29 -165.78 40.78 Favored Glycine 0 N--CA 1.515 3.964 0 O-C-N 125.717 1.481 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -77.9 -16.71 58.02 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.358 1.269 . . . . 0.0 112.687 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 p -126.39 -18.31 4.92 Favored 'General case' 0 N--CA 1.528 3.451 0 O-C-N 125.378 1.673 . . . . 0.0 109.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.52 -7.65 65.01 Favored Glycine 1 N--CA 1.523 4.445 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.869 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.251 4.4 mm-40 62.15 -94.19 0.04 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 125.112 1.365 . . . . 0.0 112.644 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -162.44 156.53 21.27 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 123.826 0.704 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.22 92.12 0.12 Allowed Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 163.91 18.63 Favored 'General case' 0 N--CA 1.515 2.793 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.47 94.71 0.98 Allowed 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.588 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.59 144.13 55.73 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.95 172.22 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 126.381 2.3 . . . . 0.0 106.865 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 m -157.25 120.47 4.06 Favored 'General case' 0 N--CA 1.527 3.378 0 O-C-N 124.287 0.992 . . . . 0.0 111.374 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -73.65 154.24 39.8 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 124.595 1.185 . . . . 0.0 110.349 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.018 0 CA-C-O 116.306 -2.385 . . . . 0.0 112.569 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 2.797 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.07 124.37 3.76 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.139 1.524 . . . . 0.0 109.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.8 137.98 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -163.32 122.75 2.12 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 124.715 1.259 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.1 149.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -154.56 106.87 2.37 Favored Pre-proline 0 N--CA 1.528 3.466 0 CA-C-O 115.308 -2.282 . . . . 0.0 109.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.65 163.01 48.21 Favored 'Cis proline' 2 C--N 1.427 4.696 0 CA-C-N 124.926 2.795 . . . . 0.0 113.025 -3.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.54 -8.18 0.98 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 124.765 1.291 . . . . 0.0 113.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -134.84 153.27 52.11 Favored 'General case' 0 N--CA 1.529 3.495 0 O-C-N 125.091 1.495 . . . . 0.0 110.389 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 28.88 66.42 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 124.926 1.392 . . . . 0.0 113.413 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.0 mt -73.59 154.44 39.79 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 125.289 1.229 . . . . 0.0 109.803 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.44 -175.71 3.39 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.944 2.027 . . . . 0.0 109.802 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.75 129.71 40.76 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.638 1.211 . . . . 0.0 112.014 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.71 28.55 68.92 Favored Glycine 0 N--CA 1.513 3.779 0 O-C-N 124.587 1.18 . . . . 0.0 112.54 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.36 139.81 48.1 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 125.07 1.1 . . . . 0.0 111.96 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.1 m -101.34 131.76 47.24 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 126.159 2.162 . . . . 0.0 105.19 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.95 145.47 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 O-C-N 125.651 1.845 . . . . 0.0 110.208 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.2 m -103.75 99.06 8.84 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 126.251 2.219 . . . . 0.0 109.92 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.79 144.13 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -139.24 155.86 47.49 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 126.018 2.073 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.16 152.23 20.43 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 125.026 1.454 . . . . 0.0 108.015 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -160.88 137.65 8.78 Favored 'General case' 0 N--CA 1.517 2.892 0 O-C-N 124.953 1.408 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.81 67.33 2.01 Favored Glycine 0 N--CA 1.511 3.643 0 O-C-N 124.926 1.391 . . . . 0.0 113.634 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -71.19 149.55 46.2 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 125.476 1.339 . . . . 0.0 110.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.85 -70.55 0.24 Allowed 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.81 -27.37 2.1 Favored 'General case' 1 N--CA 1.541 4.114 0 O-C-N 124.923 1.389 . . . . 0.0 110.633 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -59.27 114.54 2.7 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 125.02 1.45 . . . . 0.0 111.467 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.95 13.51 20.4 Favored 'General case' 0 N--CA 1.53 3.539 0 O-C-N 125.43 1.706 . . . . 0.0 112.756 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -161.85 158.55 25.68 Favored 'General case' 0 N--CA 1.524 3.242 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.13 143.59 13.95 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 124.283 0.989 . . . . 0.0 112.232 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.66 179.14 4.09 Favored 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.646 2.466 . . . . 0.0 105.965 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.44 99.22 2.88 Favored 'General case' 0 N--CA 1.525 3.312 0 O-C-N 125.245 1.59 . . . . 0.0 109.599 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -116.57 157.18 25.71 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.637 1.835 . . . . 0.0 108.742 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.25 121.8 17.32 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.6 m -123.87 151.83 43.03 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.381 1.676 . . . . 0.0 111.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.09 28.59 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 125.613 1.82 . . . . 0.0 110.58 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.3 141.29 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -128.94 -175.05 3.43 Favored 'General case' 0 N--CA 1.525 3.282 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.96 98.21 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 124.59 1.181 . . . . 0.0 112.093 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -22.41 60.67 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 125.283 1.614 . . . . 0.0 111.323 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.42 27.52 67.62 Favored Glycine 0 N--CA 1.513 3.773 0 CA-C-O 117.826 -1.541 . . . . 0.0 115.772 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -74.58 147.34 41.78 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.98 69.63 2.66 Favored Glycine 1 N--CA 1.517 4.073 0 O-C-N 124.937 1.398 . . . . 0.0 114.241 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 99.69 9.24 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.33 146.37 48.37 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 124.592 1.183 . . . . 0.0 111.055 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 50' ' ' ALA . 13.5 t30 -83.76 127.1 33.55 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.663 1.852 . . . . 0.0 109.17 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.17 -24.6 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -67.87 -13.17 61.93 Favored 'General case' 1 N--CA 1.54 4.057 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.95 -6.18 57.03 Favored 'General case' 1 N--CA 1.539 4.017 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -67.44 165.57 16.37 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -146.24 -61.52 0.31 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 125.854 1.971 . . . . 0.0 107.243 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 56.55 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 125.564 1.79 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.42 148.37 19.78 Favored 'General case' 0 N--CA 1.531 3.621 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -70.15 165.86 21.15 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 124.665 1.228 . . . . 0.0 113.43 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.9 mt -79.54 151.0 30.95 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 124.566 1.166 . . . . 0.0 109.413 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.5 t -72.5 -31.37 65.31 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 124.834 1.334 . . . . 0.0 111.562 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.29 -31.56 0.05 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 18.59 0.03 OUTLIER Glycine 0 N--CA 1.51 3.623 0 CA-C-O 118.303 -1.276 . . . . 0.0 112.106 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -143.25 166.37 24.9 Favored 'General case' 0 N--CA 1.539 3.983 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.6 70.7 0.09 OUTLIER Glycine 0 N--CA 1.513 3.778 0 O-C-N 124.268 0.98 . . . . 0.0 111.869 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -74.3 149.55 40.63 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 125.261 1.212 . . . . 0.0 108.977 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -162.23 136.99 6.9 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 124.83 1.331 . . . . 0.0 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -84.23 132.08 34.68 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 125.014 1.446 . . . . 0.0 110.13 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.29 143.71 40.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.399 0 O-C-N 125.417 1.698 . . . . 0.0 106.854 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.1 t -113.02 133.41 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.27 126.02 58.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 O-C-N 125.573 1.796 . . . . 0.0 111.379 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -90.18 158.77 17.08 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 124.711 1.205 . . . . 0.0 108.624 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -69.97 -26.22 63.99 Favored 'General case' 0 N--CA 1.526 3.351 0 O-C-N 124.872 1.358 . . . . 0.0 112.146 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.49 145.88 32.11 Favored 'General case' 0 N--CA 1.527 3.409 0 O-C-N 125.067 1.48 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -157.29 148.95 22.22 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 124.938 1.398 . . . . 0.0 111.892 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.4 m -70.96 101.16 2.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 125.866 1.979 . . . . 0.0 108.404 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.86 152.81 51.75 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.124 1.515 . . . . 0.0 111.082 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -137.56 120.75 16.79 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 126.023 1.66 . . . . 0.0 109.083 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.526 3.35 0 O-C-N 125.303 1.627 . . . . 0.0 107.193 -179.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.904 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.92 138.93 56.66 Favored 'Cis proline' 0 C--N 1.41 3.77 0 CA-C-N 123.096 3.448 . . . . 0.0 112.795 0.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.03 138.64 54.62 Favored 'General case' 0 N--CA 1.516 2.873 0 O-C-N 125.21 1.569 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -36.84 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.145 0 O-C-N 125.397 1.686 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.15 -169.77 36.75 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 125.371 1.669 . . . . 0.0 109.24 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.3 108.37 0.91 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 126.004 1.65 . . . . 0.0 113.085 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.32 137.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.013 0 O-C-N 125.938 2.024 . . . . 0.0 108.189 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.62 139.79 36.05 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.986 1.429 . . . . 0.0 109.313 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 t -80.0 -21.84 43.18 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 124.831 1.332 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -73.43 -26.51 60.98 Favored 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -79.74 -22.98 42.61 Favored 'General case' 0 N--CA 1.532 3.643 0 O-C-N 124.487 1.117 . . . . 0.0 113.194 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.16 88.61 Favored Pre-proline 0 N--CA 1.533 3.709 0 CA-C-O 115.588 -2.149 . . . . 0.0 112.254 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.7 -49.7 0.25 Allowed 'Trans proline' 0 C--N 1.412 3.912 0 CA-C-N 123.335 2.227 . . . . 0.0 113.714 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.98 -38.75 59.82 Favored Glycine 0 N--CA 1.512 3.725 0 O-C-N 124.696 1.247 . . . . 0.0 111.791 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.42 52.57 Favored Glycine 0 N--CA 1.511 3.652 0 O-C-N 125.112 1.125 . . . . 0.0 112.241 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 152.17 40.17 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 124.883 0.99 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.49 132.45 12.49 Favored 'General case' 0 N--CA 1.521 3.115 0 O-C-N 125.893 1.996 . . . . 0.0 107.628 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -79.88 136.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.821 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.19 132.72 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -127.33 138.14 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.8 141.53 4.42 Favored Glycine 1 N--CA 1.517 4.089 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.15 -159.06 30.64 Favored Glycine 1 N--CA 1.518 4.132 0 O-C-N 125.198 1.175 . . . . 0.0 112.53 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -8.75 59.57 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 125.625 1.426 . . . . 0.0 113.0 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -70.0 -70.88 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 124.913 1.383 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.16 -24.61 0.18 Allowed Glycine 0 N--CA 1.51 3.588 0 O-C-N 124.184 0.928 . . . . 0.0 111.328 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -65.66 120.77 13.55 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 125.086 1.109 . . . . 0.0 112.771 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -90.31 -169.9 2.57 Favored 'General case' 0 N--CA 1.517 2.911 0 O-C-N 125.317 1.635 . . . . 0.0 109.514 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.26 76.28 0.09 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.34 148.8 49.19 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.391 1.289 . . . . 0.0 112.605 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.3 99.36 1.05 Allowed 'General case' 0 N--CA 1.529 3.507 0 O-C-N 124.972 1.42 . . . . 0.0 110.165 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.38 144.66 49.76 Favored 'General case' 0 N--CA 1.514 2.725 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.628 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 169.16 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 O-C-N 126.287 2.242 . . . . 0.0 107.896 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 t -140.1 159.26 42.59 Favored 'General case' 0 N--CA 1.528 3.432 0 O-C-N 124.68 1.238 . . . . 0.0 110.248 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -107.92 163.22 13.32 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 126.14 2.15 . . . . 0.0 110.06 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.797 0 CA-C-O 116.336 -2.369 . . . . 0.0 111.268 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.514 2.745 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.1 131.11 35.69 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 124.679 1.237 . . . . 0.0 111.06 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.85 140.49 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -163.7 143.18 8.2 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.973 1.421 . . . . 0.0 110.547 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.13 143.0 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.025 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -157.54 111.56 1.84 Allowed Pre-proline 0 N--CA 1.528 3.439 0 CA-C-O 114.903 -2.475 . . . . 0.0 109.839 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.03 153.03 76.86 Favored 'Cis proline' 1 C--N 1.424 4.519 0 CA-C-N 125.555 3.02 . . . . 0.0 111.57 -2.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.47 -6.58 1.54 Allowed 'General case' 0 N--CA 1.529 3.485 0 O-C-N 125.853 1.971 . . . . 0.0 112.638 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.4 p -134.36 151.55 51.29 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 125.164 1.54 . . . . 0.0 109.978 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.12 31.61 66.39 Favored Glycine 0 N--CA 1.511 3.679 0 O-C-N 125.027 1.454 . . . . 0.0 112.786 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 153.55 39.34 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.359 1.27 . . . . 0.0 109.968 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -176.07 4.16 Favored 'General case' 0 N--CA 1.524 3.232 0 O-C-N 125.834 1.959 . . . . 0.0 108.755 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.41 136.35 56.38 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.756 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.44 60.21 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.587 1.179 . . . . 0.0 111.709 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.98 150.66 43.87 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 125.216 1.186 . . . . 0.0 110.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -128.93 101.16 5.95 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 126.22 2.2 . . . . 0.0 107.382 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.82 157.4 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 O-C-N 126.076 2.11 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -128.48 96.45 4.42 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 126.171 2.169 . . . . 0.0 106.082 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.7 148.29 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -140.47 160.86 39.07 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 126.045 2.091 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 131.83 6.02 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -126.33 13.52 7.68 Favored 'General case' 0 N--CA 1.535 3.824 0 O-C-N 125.583 1.802 . . . . 0.0 112.979 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.02 158.34 30.33 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -141.92 -172.27 3.53 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 126.579 1.987 . . . . 0.0 107.361 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.82 -30.52 0.07 Allowed 'General case' 0 N--CA 1.514 2.768 0 O-C-N 124.369 1.043 . . . . 0.0 111.435 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -40.38 0.3 Allowed 'General case' 0 N--CA 1.527 3.396 0 O-C-N 125.399 1.687 . . . . 0.0 110.548 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 p -67.93 113.21 5.45 Favored 'General case' 0 N--CA 1.521 3.103 0 O-C-N 124.946 1.404 . . . . 0.0 112.011 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.65 7.93 39.19 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 124.741 1.276 . . . . 0.0 112.554 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.54 162.03 18.89 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.09 20.28 Favored 'General case' 0 N--CA 1.522 3.146 0 O-C-N 124.068 0.855 . . . . 0.0 111.552 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -144.65 142.25 29.97 Favored 'General case' 0 N--CA 1.52 3.041 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.04 130.78 55.48 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.676 1.86 . . . . 0.0 114.073 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.47 139.03 19.59 Favored 'General case' 0 N--CA 1.532 3.647 0 O-C-N 125.047 1.467 . . . . 0.0 109.619 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -100.4 150.14 22.92 Favored 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.9 m -144.23 143.23 30.95 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.047 1.467 . . . . 0.0 109.243 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.85 114.72 27.21 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 125.327 1.642 . . . . 0.0 110.881 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.76 120.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.127 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.88 -174.86 2.8 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.64 82.53 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 124.646 1.216 . . . . 0.0 112.404 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -21.9 60.81 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.151 1.532 . . . . 0.0 111.473 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.07 22.66 57.03 Favored Glycine 0 N--CA 1.511 3.679 0 CA-C-O 117.356 -1.802 . . . . 0.0 115.003 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -71.4 140.96 50.32 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 75.01 1.42 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-O 118.173 -1.349 . . . . 0.0 115.154 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.1 100.1 10.3 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.45 146.43 51.3 Favored 'General case' 0 N--CA 1.529 3.497 0 O-C-N 124.949 1.406 . . . . 0.0 110.836 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -91.04 123.82 34.8 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 125.854 1.972 . . . . 0.0 109.559 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.71 -25.71 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.46 -5.38 32.46 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -79.78 -12.57 59.77 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 123.898 0.749 . . . . 0.0 112.982 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.4 159.91 17.29 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -148.25 -44.65 0.16 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 125.685 1.866 . . . . 0.0 109.788 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 63.49 130.88 0.01 OUTLIER 'General case' 0 N--CA 1.534 3.726 0 O-C-N 125.466 1.729 . . . . 0.0 114.794 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.0 154.11 27.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.597 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.5 m -118.99 146.96 44.58 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 126.21 2.194 . . . . 0.0 108.347 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.61 155.16 28.24 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.957 1.411 . . . . 0.0 108.827 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.2 p -134.78 15.84 3.61 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 126.057 2.098 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.89 -62.33 0.1 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.77 24.76 0.02 OUTLIER Glycine 0 N--CA 1.507 3.406 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.6 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -138.45 153.52 48.84 Favored 'General case' 0 N--CA 1.536 3.86 0 O-C-N 125.164 1.156 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.24 74.63 0.06 OUTLIER Glycine 0 N--CA 1.513 3.775 0 O-C-N 124.542 1.151 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.29 150.98 39.93 Favored 'General case' 0 N--CA 1.519 2.987 0 O-C-N 125.045 1.085 . . . . 0.0 109.716 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -156.41 145.21 20.18 Favored 'General case' 0 N--CA 1.538 3.95 0 O-C-N 124.804 1.315 . . . . 0.0 111.232 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.4 m -101.8 136.54 41.46 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 125.942 2.026 . . . . 0.0 109.421 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.5 155.95 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 O-C-N 125.481 1.738 . . . . 0.0 106.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 134.65 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -131.58 126.13 57.33 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 O-C-N 125.353 1.658 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -90.31 159.77 16.48 Favored 'General case' 0 N--CA 1.525 3.307 0 O-C-N 124.692 1.245 . . . . 0.0 108.163 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -69.44 -24.07 63.76 Favored 'General case' 0 N--CA 1.527 3.408 0 O-C-N 124.402 1.064 . . . . 0.0 112.145 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.5 m -142.48 147.42 36.02 Favored 'General case' 0 N--CA 1.532 3.652 0 O-C-N 124.997 1.435 . . . . 0.0 109.564 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.37 148.46 19.93 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.638 1.211 . . . . 0.0 112.042 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.52 102.25 1.78 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 125.741 1.901 . . . . 0.0 109.186 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.01 155.09 51.53 Favored Glycine 0 N--CA 1.506 3.35 0 O-C-N 125.063 1.477 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -139.42 123.21 17.57 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 125.737 1.492 . . . . 0.0 108.258 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.525 3.308 0 O-C-N 125.15 1.531 . . . . 0.0 106.952 -179.85 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.069 0 CA-C-O 115.709 -2.717 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.87 142.61 74.21 Favored 'Cis proline' 0 C--N 1.41 3.792 0 CA-C-N 123.003 3.401 . . . . 0.0 112.919 0.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.93 139.53 55.09 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 125.327 1.642 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.2 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 O-C-N 125.419 1.699 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.54 -167.87 34.23 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 125.444 1.715 . . . . 0.0 109.033 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.93 109.14 1.17 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 126.104 1.708 . . . . 0.0 112.842 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.86 137.08 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.935 0 O-C-N 126.093 2.12 . . . . 0.0 107.963 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.41 144.59 31.31 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 125.028 1.455 . . . . 0.0 110.027 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.5 t -75.99 -35.06 59.73 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 124.855 1.347 . . . . 0.0 112.783 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.38 -24.66 65.7 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -79.67 -24.66 41.66 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 124.252 0.97 . . . . 0.0 112.73 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.44 157.09 88.97 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 115.675 -2.107 . . . . 0.0 111.596 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.49 -50.17 0.19 Allowed 'Trans proline' 0 C--N 1.41 3.779 0 CA-C-N 123.25 2.196 . . . . 0.0 114.32 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.74 -41.37 56.59 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 124.486 1.116 . . . . 0.0 112.308 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.66 179.76 50.02 Favored Glycine 0 N--CA 1.51 3.599 0 O-C-N 125.212 1.184 . . . . 0.0 112.114 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.8 150.82 45.47 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.673 -1.264 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -159.37 134.48 8.21 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 mm -79.6 135.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 t -132.31 132.02 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 O-C-N 125.886 1.991 . . . . 0.0 105.835 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.3 145.97 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 100.978 -3.712 . . . . 0.0 100.978 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.75 139.17 4.12 Favored Glycine 0 N--CA 1.514 3.877 0 O-C-N 124.444 1.09 . . . . 0.0 111.567 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.51 -161.79 37.6 Favored Glycine 1 N--CA 1.517 4.083 0 O-C-N 125.688 1.464 . . . . 0.0 111.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -72.6 -25.17 61.22 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 125.362 1.272 . . . . 0.0 112.371 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -74.46 -25.71 59.58 Favored 'General case' 0 N--CA 1.522 3.142 0 O-C-N 124.464 1.103 . . . . 0.0 110.583 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.85 19.55 47.1 Favored Glycine 0 N--CA 1.512 3.741 0 O-C-N 125.208 1.567 . . . . 0.0 112.115 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -73.11 103.24 3.79 Favored 'General case' 0 N--CA 1.517 2.924 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -70.78 167.16 19.41 Favored 'General case' 0 N--CA 1.519 2.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.398 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.48 73.53 0.08 OUTLIER Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.92 164.46 19.8 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.12 102.19 0.87 Allowed 'General case' 0 N--CA 1.524 3.271 0 O-C-N 124.906 1.379 . . . . 0.0 109.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 154.23 42.17 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 123.984 0.802 . . . . 0.0 112.646 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.24 172.52 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 O-C-N 126.209 2.193 . . . . 0.0 107.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -157.84 131.54 7.89 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 123.993 0.808 . . . . 0.0 111.367 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.78 161.63 28.86 Favored 'General case' 0 N--CA 1.518 2.964 0 O-C-N 124.401 1.063 . . . . 0.0 110.859 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.344 -2.365 . . . . 0.0 109.805 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.486 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.86 129.66 34.67 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 124.731 1.27 . . . . 0.0 111.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.41 139.75 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 102.097 -3.297 . . . . 0.0 102.097 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.39 142.49 9.78 Favored 'General case' 0 N--CA 1.514 2.748 0 O-C-N 124.943 1.402 . . . . 0.0 110.419 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -126.27 141.1 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.39 112.88 1.7 Allowed Pre-proline 0 N--CA 1.526 3.356 0 CA-C-O 114.889 -2.482 . . . . 0.0 110.136 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.53 150.49 73.32 Favored 'Cis proline' 1 C--N 1.423 4.455 0 CA-C-N 125.36 2.95 . . . . 0.0 111.927 -4.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.32 -13.68 1.79 Allowed 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.993 2.058 . . . . 0.0 112.724 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.1 p -127.56 153.91 45.81 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.776 1.922 . . . . 0.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.79 33.11 74.86 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 124.951 1.407 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 mt -75.05 153.75 38.28 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 125.338 1.258 . . . . 0.0 110.633 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.89 -173.96 3.24 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 126.245 2.215 . . . . 0.0 108.444 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.04 127.97 34.22 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.661 1.226 . . . . 0.0 112.849 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 29.48 72.4 Favored Glycine 0 N--CA 1.515 3.907 0 O-C-N 124.761 1.288 . . . . 0.0 113.094 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.56 125.16 26.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 125.021 1.071 . . . . 0.0 112.503 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.06 135.48 35.83 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.82 141.24 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.333 1.645 . . . . 0.0 108.828 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -109.1 102.68 11.63 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 126.236 2.21 . . . . 0.0 109.637 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 147.94 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -134.75 161.97 33.67 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 126.197 2.185 . . . . 0.0 109.503 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.19 14.4 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 125.51 1.756 . . . . 0.0 108.064 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.23 147.36 17.75 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.323 1.64 . . . . 0.0 109.311 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.06 87.51 0.16 Allowed Glycine 0 N--CA 1.509 3.521 0 O-C-N 125.114 1.509 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -156.21 152.4 27.77 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 125.741 1.495 . . . . 0.0 107.433 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.81 -18.64 0.05 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 124.871 1.357 . . . . 0.0 111.156 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.385 1.053 . . . . 0.0 110.247 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -72.53 121.46 19.7 Favored 'General case' 0 N--CA 1.518 2.965 0 O-C-N 124.615 1.197 . . . . 0.0 110.558 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -79.8 -17.11 54.16 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.349 1.031 . . . . 0.0 113.345 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -167.54 153.68 7.76 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.7 135.08 5.51 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 124.562 1.164 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -97.61 153.18 18.37 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 126.168 2.167 . . . . 0.0 108.471 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.88 120.87 41.43 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 126.399 2.312 . . . . 0.0 109.059 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.51 145.88 17.86 Favored 'General case' 0 N--CA 1.527 3.386 0 O-C-N 124.542 1.151 . . . . 0.0 112.362 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -96.17 148.9 22.22 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 125.373 1.671 . . . . 0.0 108.232 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.5 m -146.83 142.96 28.23 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.466 1.729 . . . . 0.0 108.088 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.44 123.63 42.69 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.451 1.72 . . . . 0.0 112.068 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.36 122.56 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.03 -174.48 2.7 Favored 'General case' 0 N--CA 1.526 3.329 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.69 81.63 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.627 1.204 . . . . 0.0 111.321 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -22.45 60.56 Favored 'General case' 0 N--CA 1.524 3.264 0 O-C-N 125.357 1.661 . . . . 0.0 111.181 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.96 25.69 55.14 Favored Glycine 0 N--CA 1.514 3.861 0 CA-C-O 117.54 -1.7 . . . . 0.0 115.485 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 144.63 46.79 Favored 'General case' 0 N--CA 1.526 3.343 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 75.14 1.51 Allowed Glycine 0 N--CA 1.515 3.911 0 CA-C-O 118.19 -1.339 . . . . 0.0 114.977 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.88 104.48 13.99 Favored 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.34 142.93 49.53 Favored 'General case' 0 N--CA 1.531 3.615 0 O-C-N 125.201 1.563 . . . . 0.0 112.396 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -83.39 116.96 22.72 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 125.344 1.652 . . . . 0.0 109.025 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.18 -23.75 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.21 62.15 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -79.87 -7.69 58.87 Favored 'General case' 1 N--CA 1.542 4.173 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -64.67 165.49 10.22 Favored 'General case' 0 N--CA 1.531 3.598 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -145.42 -52.99 0.27 Allowed 'General case' 0 N--CA 1.513 2.71 0 O-C-N 126.136 2.148 . . . . 0.0 107.052 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.6 t70 51.37 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.677 0 O-C-N 125.754 1.908 . . . . 0.0 116.139 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -157.55 147.26 20.28 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.2 p -66.7 157.44 32.67 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 124.841 1.338 . . . . 0.0 113.99 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.58 136.62 36.9 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 125.04 1.463 . . . . 0.0 108.139 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -70.07 -37.78 75.58 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.547 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.57 54.28 0.11 Allowed Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.318 1.636 . . . . 0.0 109.294 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.77 70.73 Favored Glycine 0 N--CA 1.507 3.404 0 O-C-N 125.518 1.363 . . . . 0.0 112.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.65 157.6 44.87 Favored 'General case' 0 N--CA 1.535 3.787 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.22 77.72 0.07 OUTLIER Glycine 0 N--CA 1.515 3.956 0 O-C-N 124.33 1.019 . . . . 0.0 112.38 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 m -75.76 150.83 37.7 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.232 1.195 . . . . 0.0 109.159 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.3 135.48 6.05 Favored 'General case' 0 N--CA 1.529 3.481 0 O-C-N 124.8 1.313 . . . . 0.0 112.973 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -80.81 113.17 18.83 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.923 1.389 . . . . 0.0 111.038 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.66 150.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.4 141.27 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.86 132.3 25.24 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 O-C-N 125.49 1.744 . . . . 0.0 112.279 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -90.22 162.91 15.01 Favored 'General case' 0 N--CA 1.526 3.355 0 O-C-N 125.141 1.526 . . . . 0.0 108.729 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -66.53 -24.59 66.4 Favored 'General case' 0 N--CA 1.525 3.293 0 O-C-N 124.322 1.014 . . . . 0.0 112.669 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -155.72 150.87 26.68 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 124.772 1.295 . . . . 0.0 108.587 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.45 150.03 26.21 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 124.941 1.401 . . . . 0.0 112.172 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 m -68.07 103.77 1.61 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.958 2.036 . . . . 0.0 109.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.23 154.38 52.55 Favored Glycine 0 N--CA 1.509 3.538 0 O-C-N 125.173 1.546 . . . . 0.0 111.177 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -137.44 123.0 19.72 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 126.002 1.648 . . . . 0.0 109.262 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.524 3.232 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.515 3.93 0 CA-C-O 115.625 -2.764 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.51 143.2 75.85 Favored 'Cis proline' 0 C--N 1.408 3.71 0 CA-C-N 123.057 3.429 . . . . 0.0 113.074 -0.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.29 137.95 53.44 Favored 'General case' 0 N--CA 1.515 2.803 0 O-C-N 125.306 1.629 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -37.66 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 O-C-N 125.351 1.657 . . . . 0.0 111.646 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.25 -169.75 32.2 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 125.456 1.723 . . . . 0.0 109.749 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.97 111.96 2.13 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 126.08 1.694 . . . . 0.0 113.423 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 142.28 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.974 0 O-C-N 125.988 2.055 . . . . 0.0 107.4 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.37 154.17 17.62 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 125.711 1.882 . . . . 0.0 109.127 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.9 -27.35 61.01 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 124.746 1.279 . . . . 0.0 112.948 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.93 -31.42 68.02 Favored 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.76 -19.56 48.4 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 124.64 1.213 . . . . 0.0 112.821 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.97 155.26 92.24 Favored Pre-proline 0 N--CA 1.53 3.57 0 CA-C-O 115.601 -2.143 . . . . 0.0 111.507 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -43.01 0.79 Allowed 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 123.407 2.253 . . . . 0.0 113.929 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.08 -104.5 0.1 OUTLIER Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.684 1.24 . . . . 0.0 111.329 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.53 147.14 4.96 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.9 m -73.75 159.08 33.47 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 125.077 1.104 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.34 147.3 12.44 Favored 'General case' 0 N--CA 1.518 2.947 0 O-C-N 124.497 1.123 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -79.64 121.2 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.05 120.14 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 t -116.33 132.76 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 101.408 -3.552 . . . . 0.0 101.408 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.4 138.12 3.56 Favored Glycine 1 N--CA 1.517 4.035 0 O-C-N 124.184 0.928 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.08 -166.26 41.48 Favored Glycine 0 N--CA 1.509 3.513 0 O-C-N 125.377 1.281 . . . . 0.0 112.556 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -80.08 -13.52 59.23 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 125.743 1.496 . . . . 0.0 112.856 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -70.0 -68.5 0.41 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 124.894 1.371 . . . . 0.0 111.751 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.68 -19.45 0.07 OUTLIER Glycine 0 N--CA 1.515 3.951 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.758 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.38 143.61 57.62 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.961 1.036 . . . . 0.0 112.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -111.72 -173.16 2.18 Favored 'General case' 0 N--CA 1.524 3.271 0 O-C-N 126.52 2.387 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.07 67.22 0.11 Allowed Glycine 0 N--CA 1.51 3.607 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -68.05 146.35 53.59 Favored 'General case' 0 N--CA 1.519 3.0 0 O-C-N 125.432 1.313 . . . . 0.0 112.926 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.13 109.78 1.03 Allowed 'General case' 0 N--CA 1.528 3.429 0 O-C-N 124.496 1.123 . . . . 0.0 109.633 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.49 170.75 16.14 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.414 1.072 . . . . 0.0 113.038 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -178.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 O-C-N 126.419 2.324 . . . . 0.0 107.99 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -161.19 119.65 2.44 Favored 'General case' 0 N--CA 1.516 2.842 0 O-C-N 124.35 1.031 . . . . 0.0 109.271 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.23 158.48 34.01 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.073 0.858 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 116.282 -2.399 . . . . 0.0 111.497 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.505 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.29 34.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 124.695 1.247 . . . . 0.0 111.168 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.13 139.31 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -161.63 146.82 13.44 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.731 1.269 . . . . 0.0 110.555 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.89 147.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.02 109.51 1.75 Allowed Pre-proline 0 N--CA 1.526 3.344 0 CA-C-O 115.343 -2.265 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.93 162.62 51.23 Favored 'Cis proline' 2 C--N 1.427 4.665 0 CA-C-N 124.908 2.789 . . . . 0.0 112.747 -3.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.15 -5.31 1.12 Allowed 'General case' 0 N--CA 1.537 3.894 0 O-C-N 124.655 1.222 . . . . 0.0 113.291 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.8 p -139.3 151.35 46.37 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.807 1.317 . . . . 0.0 109.669 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.76 32.84 70.57 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.985 1.428 . . . . 0.0 112.987 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.57 150.74 44.44 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 125.632 1.431 . . . . 0.0 109.984 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.73 178.68 4.24 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 126.059 2.1 . . . . 0.0 109.939 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.95 127.4 32.74 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 124.954 1.409 . . . . 0.0 111.335 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.56 25.98 74.83 Favored Glycine 0 N--CA 1.514 3.844 0 O-C-N 124.554 1.158 . . . . 0.0 113.285 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.54 140.97 48.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 124.753 0.913 . . . . 0.0 111.784 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -99.06 132.91 44.02 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.843 1.964 . . . . 0.0 105.816 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.48 147.19 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 125.399 1.687 . . . . 0.0 109.571 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -101.01 96.75 7.45 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 126.064 2.102 . . . . 0.0 110.369 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 t -79.92 147.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -138.57 165.81 25.94 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 125.754 1.909 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.85 15.88 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 125.696 1.873 . . . . 0.0 108.118 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.79 148.53 17.56 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.898 1.374 . . . . 0.0 109.469 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.91 87.79 0.18 Allowed Glycine 0 N--CA 1.508 3.468 0 O-C-N 125.198 1.561 . . . . 0.0 110.444 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -155.81 156.64 35.09 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 125.67 1.453 . . . . 0.0 107.551 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.11 -21.99 0.05 Allowed 'General case' 0 N--CA 1.52 3.042 0 O-C-N 124.621 1.201 . . . . 0.0 111.261 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -79.64 -54.87 5.46 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 124.474 1.109 . . . . 0.0 110.343 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -70.88 117.62 12.62 Favored 'General case' 0 N--CA 1.515 2.793 0 O-C-N 124.681 1.238 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.0 p -79.73 -16.61 55.3 Favored 'General case' 0 N--CA 1.527 3.401 0 O-C-N 124.091 0.869 . . . . 0.0 112.277 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.35 154.95 10.76 Favored 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.9 10.37 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.65 1.219 . . . . 0.0 111.241 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 m -112.54 151.46 29.98 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 126.501 2.375 . . . . 0.0 108.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.92 103.87 13.4 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 126.188 2.18 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -126.24 147.59 49.65 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 124.995 1.434 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.07 142.49 47.35 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 125.951 2.032 . . . . 0.0 106.451 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.3 m -137.13 138.9 40.79 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.356 1.66 . . . . 0.0 109.817 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.31 23.22 Favored 'General case' 0 N--CA 1.516 2.875 0 O-C-N 125.049 1.468 . . . . 0.0 112.143 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mm -77.36 121.36 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.3 mt -100.42 -173.15 2.34 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -47.23 78.61 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.535 1.147 . . . . 0.0 112.229 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.83 -21.33 61.7 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.24 1.588 . . . . 0.0 111.714 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.69 24.56 49.45 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.187 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -73.18 143.64 47.14 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 124.828 0.957 . . . . 0.0 108.641 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.75 72.58 2.2 Favored Glycine 0 N--CA 1.514 3.849 0 CA-C-O 118.105 -1.386 . . . . 0.0 115.165 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.0 108.82 15.81 Favored 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.6 144.89 48.17 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 124.891 1.37 . . . . 0.0 111.956 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.98 127.16 34.07 Favored 'General case' 0 N--CA 1.516 2.829 0 O-C-N 125.499 1.749 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.85 -28.45 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.6 -10.0 58.25 Favored 'General case' 0 N--CA 1.537 3.909 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -79.85 -7.71 58.87 Favored 'General case' 0 N--CA 1.539 3.986 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -65.55 165.98 11.32 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -145.85 -61.35 0.33 Allowed 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.906 2.004 . . . . 0.0 108.266 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 t70 59.43 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.492 0 O-C-N 125.333 1.645 . . . . 0.0 115.32 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -163.27 144.01 9.23 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 p -72.37 152.08 42.26 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 124.407 1.067 . . . . 0.0 112.462 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.52 151.65 30.63 Favored 'General case' 0 N--CA 1.52 3.057 0 O-C-N 124.738 1.274 . . . . 0.0 108.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -70.67 -28.74 65.01 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.813 1.321 . . . . 0.0 112.746 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.32 -36.22 0.06 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.25 28.31 0.04 OUTLIER Glycine 0 N--CA 1.502 3.04 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.667 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.96 156.75 45.47 Favored 'General case' 0 N--CA 1.534 3.74 0 O-C-N 125.288 1.228 . . . . 0.0 108.212 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.46 140.78 4.97 Favored Glycine 0 N--CA 1.502 3.096 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -136.72 150.84 48.65 Favored 'General case' 0 N--CA 1.526 3.345 0 O-C-N 125.722 1.483 . . . . 0.0 107.566 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.03 139.19 8.36 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 125.226 1.579 . . . . 0.0 112.863 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -87.26 118.98 27.05 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 125.063 1.477 . . . . 0.0 108.053 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.22 143.91 30.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.037 0 O-C-N 125.389 1.68 . . . . 0.0 106.641 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.93 139.03 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.47 117.6 43.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 O-C-N 125.23 1.581 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -90.35 157.32 17.69 Favored 'General case' 0 N--CA 1.522 3.173 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.549 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -68.71 -25.64 64.87 Favored 'General case' 0 N--CA 1.525 3.32 0 O-C-N 124.592 1.183 . . . . 0.0 112.106 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 m -148.94 147.56 28.77 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.871 1.357 . . . . 0.0 109.759 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -156.18 147.25 22.25 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 124.899 1.374 . . . . 0.0 111.77 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.62 106.35 2.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 125.8 1.937 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.99 157.25 52.92 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 124.688 1.243 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -142.5 106.34 4.7 Favored 'General case' 0 N--CA 1.517 2.898 0 O-C-N 125.53 1.37 . . . . 0.0 108.942 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.52 3.053 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.595 5.04 0 CA-C-O 113.846 -3.752 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.97 -47.54 0.31 Allowed 'Cis proline' 1 C--N 1.415 4.032 1 CA-C-N 125.937 4.869 . . . . 0.0 113.08 0.79 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.46 129.69 9.68 Favored 'General case' 0 N--CA 1.521 3.12 0 O-C-N 126.03 2.081 . . . . 0.0 108.882 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -36.79 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 125.16 1.537 . . . . 0.0 110.078 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.14 178.36 22.04 Favored Glycine 0 N--CA 1.508 3.498 0 O-C-N 126.166 2.166 . . . . 0.0 109.86 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.47 118.21 7.81 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.876 1.574 . . . . 0.0 113.305 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.41 135.69 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 O-C-N 126.239 2.212 . . . . 0.0 107.833 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 145.62 31.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 124.936 1.398 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.4 t -76.45 -28.45 56.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.745 1.278 . . . . 0.0 111.73 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.69 -27.48 61.25 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.68 -22.8 43.0 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.254 0.971 . . . . 0.0 112.848 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.24 155.21 92.81 Favored Pre-proline 0 N--CA 1.53 3.542 0 CA-C-O 115.423 -2.227 . . . . 0.0 111.297 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.86 -51.4 0.18 Allowed 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 123.466 2.274 . . . . 0.0 113.915 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.34 -43.43 38.27 Favored Glycine 0 N--CA 1.512 3.738 0 O-C-N 124.436 1.085 . . . . 0.0 112.555 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.19 171.6 48.09 Favored Glycine 0 N--CA 1.514 3.884 0 O-C-N 125.349 1.264 . . . . 0.0 110.926 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 25.9 m -70.29 150.27 46.54 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 124.95 1.03 . . . . 0.0 112.331 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -146.54 133.27 19.97 Favored 'General case' 0 N--CA 1.522 3.155 0 O-C-N 125.838 1.961 . . . . 0.0 107.689 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.0 mm -79.58 116.94 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.48 122.02 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 O-C-N 125.8 1.938 . . . . 0.0 106.457 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -118.38 130.33 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.31 138.45 3.51 Favored Glycine 1 N--CA 1.519 4.202 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.9 -170.54 43.18 Favored Glycine 0 N--CA 1.51 3.57 0 O-C-N 125.126 1.133 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.62 -16.72 57.03 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 113.174 -1.513 . . . . 0.0 113.066 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.94 -66.21 0.62 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.759 1.287 . . . . 0.0 112.557 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -7.52 0.05 OUTLIER Glycine 1 N--CA 1.517 4.051 0 CA-C-O 118.404 -1.22 . . . . 0.0 112.578 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.12 147.61 53.08 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.82 0.953 . . . . 0.0 111.265 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -142.81 168.03 20.67 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 125.855 1.972 . . . . 0.0 109.222 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.57 78.86 0.06 OUTLIER Glycine 0 N--CA 1.501 2.983 0 O-C-N 124.984 1.428 . . . . 0.0 109.901 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -67.92 159.47 30.49 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 125.343 1.261 . . . . 0.0 113.006 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.97 101.62 1.44 Allowed 'General case' 0 N--CA 1.529 3.503 0 O-C-N 124.38 1.05 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 148.91 45.18 Favored 'General case' 0 N--CA 1.511 2.576 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -118.06 170.63 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 O-C-N 126.272 2.232 . . . . 0.0 106.907 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -157.19 119.24 3.82 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 124.258 0.974 . . . . 0.0 111.322 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -73.22 154.88 40.06 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 124.604 1.19 . . . . 0.0 110.463 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.976 0 CA-C-O 116.722 -2.154 . . . . 0.0 112.513 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.69 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.91 129.07 34.19 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 124.723 1.264 . . . . 0.0 111.429 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.53 139.36 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.35 142.2 9.69 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 125.001 1.438 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.08 142.85 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 101.486 -3.524 . . . . 0.0 101.486 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -161.3 112.92 1.25 Allowed Pre-proline 0 N--CA 1.524 3.252 0 CA-C-O 115.015 -2.421 . . . . 0.0 110.212 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -63.19 150.64 68.13 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.337 2.942 . . . . 0.0 112.242 -4.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.18 -9.19 1.75 Allowed 'General case' 0 N--CA 1.528 3.439 0 O-C-N 125.964 2.04 . . . . 0.0 113.049 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.3 p -133.19 152.76 51.94 Favored 'General case' 0 N--CA 1.528 3.425 0 O-C-N 125.327 1.642 . . . . 0.0 109.657 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.2 29.53 68.49 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 125.008 1.443 . . . . 0.0 112.51 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.78 154.1 40.8 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 125.347 1.263 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 -175.39 3.57 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 126.184 2.178 . . . . 0.0 107.977 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.9 127.54 32.91 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 124.736 1.272 . . . . 0.0 112.61 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.48 29.72 69.64 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.856 1.347 . . . . 0.0 112.776 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.37 127.46 32.63 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.934 1.02 . . . . 0.0 112.627 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.97 134.04 35.35 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.12 146.44 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 O-C-N 125.281 1.613 . . . . 0.0 108.558 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 m -113.98 103.42 11.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 126.436 2.335 . . . . 0.0 109.689 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.85 147.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.06 159.92 40.48 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 126.139 2.149 . . . . 0.0 109.15 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.61 14.66 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 125.465 1.728 . . . . 0.0 108.143 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.33 148.67 18.43 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 125.314 1.634 . . . . 0.0 109.347 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.28 88.93 0.11 Allowed Glycine 0 N--CA 1.509 3.505 0 O-C-N 125.048 1.467 . . . . 0.0 111.446 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -155.39 150.97 27.31 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.73 -20.73 0.06 Allowed 'General case' 0 N--CA 1.52 3.046 0 O-C-N 124.738 1.274 . . . . 0.0 111.526 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 p -79.47 -45.05 20.13 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.434 1.084 . . . . 0.0 108.93 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 p -73.03 143.5 47.5 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 125.023 1.452 . . . . 0.0 108.64 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.16 11.84 15.33 Favored 'General case' 0 N--CA 1.536 3.84 0 O-C-N 125.774 1.921 . . . . 0.0 111.768 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -166.17 166.14 17.16 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.36 136.57 8.63 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.033 0.833 . . . . 0.0 111.513 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.97 177.06 7.72 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 126.316 2.26 . . . . 0.0 105.363 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.1 117.98 2.28 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.671 1.232 . . . . 0.0 109.393 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.3 136.53 9.75 Favored 'General case' 0 N--CA 1.527 3.376 0 O-C-N 125.031 1.457 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -82.2 152.5 26.41 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 124.911 1.382 . . . . 0.0 107.594 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -145.03 141.17 28.67 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 125.111 1.507 . . . . 0.0 109.174 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.3 118.77 31.23 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.439 1.712 . . . . 0.0 112.462 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.13 143.48 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.856 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.05 -176.11 3.9 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 124.713 1.258 . . . . 0.0 112.049 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -21.74 60.45 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.406 1.691 . . . . 0.0 111.297 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 26.35 71.43 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-O 117.696 -1.613 . . . . 0.0 115.8 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -74.32 147.53 42.18 Favored 'General case' 0 N--CA 1.528 3.428 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.49 74.34 1.74 Allowed Glycine 0 N--CA 1.515 3.955 0 O-C-N 124.886 1.366 . . . . 0.0 113.941 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.8 101.08 11.36 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.4 m -129.54 145.57 51.45 Favored 'General case' 0 N--CA 1.535 3.804 0 O-C-N 124.91 1.381 . . . . 0.0 112.644 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.96 125.05 28.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 125.074 1.484 . . . . 0.0 111.265 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.45 -24.03 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.88 -23.4 63.25 Favored 'General case' 0 N--CA 1.531 3.58 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -79.85 -19.18 48.99 Favored 'General case' 0 N--CA 1.532 3.667 0 O-C-N 124.508 1.13 . . . . 0.0 113.992 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.32 148.18 52.23 Favored 'General case' 1 N--CA 1.54 4.073 0 O-C-N 124.696 1.247 . . . . 0.0 111.296 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -144.87 -54.73 0.32 Allowed 'General case' 0 N--CA 1.522 3.167 0 O-C-N 125.627 1.829 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 67.71 128.58 0.02 OUTLIER 'General case' 1 N--CA 1.544 4.233 0 O-C-N 124.978 1.424 . . . . 0.0 113.194 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.95 147.88 18.55 Favored 'General case' 0 N--CA 1.515 2.789 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.173 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 m -75.99 151.49 37.2 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.998 1.436 . . . . 0.0 107.959 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.3 mt -79.41 127.13 31.72 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.85 1.344 . . . . 0.0 107.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -69.91 -38.5 76.3 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 124.368 1.043 . . . . 0.0 113.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 49.66 0.12 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.74 22.47 74.75 Favored Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.632 1.431 . . . . 0.0 112.926 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -141.85 156.67 45.53 Favored 'General case' 1 N--CA 1.544 4.234 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 77.94 0.06 OUTLIER Glycine 1 N--CA 1.52 4.244 0 O-C-N 124.149 0.906 . . . . 0.0 112.516 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -75.75 153.65 36.86 Favored 'General case' 0 N--CA 1.52 3.071 0 O-C-N 124.912 1.007 . . . . 0.0 109.74 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.63 138.09 5.99 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.806 1.316 . . . . 0.0 113.365 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.2 p -82.69 111.75 18.92 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.844 1.34 . . . . 0.0 109.866 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.29 151.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.38 139.95 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 129.65 16.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 O-C-N 125.52 1.762 . . . . 0.0 112.286 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -90.2 162.21 15.35 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.964 1.415 . . . . 0.0 107.812 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -65.73 -33.81 76.74 Favored 'General case' 0 N--CA 1.522 3.143 0 O-C-N 124.67 1.231 . . . . 0.0 111.779 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.8 151.87 48.56 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 125.761 1.913 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.09 148.85 20.72 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 124.586 1.179 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.58 101.26 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 125.941 2.025 . . . . 0.0 108.749 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.78 153.27 52.17 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 125.141 1.526 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -135.56 122.67 21.51 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 125.974 1.632 . . . . 0.0 109.023 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.522 3.168 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -179.886 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.028 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.65 144.2 79.11 Favored 'Cis proline' 0 C--N 1.41 3.797 0 CA-C-N 123.063 3.432 . . . . 0.0 113.072 -0.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.58 137.66 54.46 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 125.31 1.631 . . . . 0.0 110.494 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -36.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.203 0 O-C-N 125.448 1.718 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.05 -171.79 36.0 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 125.401 1.688 . . . . 0.0 109.695 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.48 110.83 1.57 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 126.039 1.67 . . . . 0.0 113.402 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.64 138.91 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.064 0 O-C-N 125.933 2.021 . . . . 0.0 107.82 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.88 158.13 16.47 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.442 1.714 . . . . 0.0 110.742 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.25 -30.27 57.81 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 124.931 1.394 . . . . 0.0 111.787 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.61 -28.26 67.6 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -30.63 40.87 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 124.429 1.08 . . . . 0.0 112.64 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.94 151.44 97.19 Favored Pre-proline 0 N--CA 1.527 3.419 0 CA-C-O 115.261 -2.304 . . . . 0.0 111.606 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.07 -44.5 0.45 Allowed 'Trans proline' 0 C--N 1.41 3.769 0 CA-C-N 123.643 2.337 . . . . 0.0 113.494 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.23 -45.4 55.73 Favored Glycine 0 N--CA 1.513 3.812 0 O-C-N 124.685 1.241 . . . . 0.0 112.81 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.55 160.37 29.87 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 125.319 1.246 . . . . 0.0 112.125 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.0 145.82 51.51 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 113.958 -1.121 . . . . 0.0 112.902 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.96 139.96 26.56 Favored 'General case' 0 N--CA 1.53 3.546 0 O-C-N 125.621 1.826 . . . . 0.0 108.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -79.9 127.58 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.447 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.93 137.4 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.92 141.49 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.275 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.88 142.65 5.7 Favored Glycine 1 N--CA 1.517 4.057 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -160.5 34.43 Favored Glycine 1 N--CA 1.517 4.081 0 O-C-N 125.469 1.335 . . . . 0.0 112.81 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -71.63 -23.6 61.72 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 125.374 1.279 . . . . 0.0 112.671 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.91 -32.72 71.16 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 124.775 1.297 . . . . 0.0 110.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.21 48.73 Favored Glycine 0 N--CA 1.515 3.93 0 O-C-N 125.809 1.943 . . . . 0.0 113.073 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.69 103.1 3.5 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -74.81 174.63 8.92 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.724 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.45 78.45 0.09 OUTLIER Glycine 0 N--CA 1.506 3.36 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -68.54 155.48 39.88 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.312 1.243 . . . . 0.0 113.292 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.45 100.35 1.18 Allowed 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.088 1.493 . . . . 0.0 109.107 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.14 158.0 34.1 Favored 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.14 176.65 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 O-C-N 126.568 2.418 . . . . 0.0 107.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.3 m -160.77 121.09 2.8 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.785 1.303 . . . . 0.0 109.78 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -72.78 156.73 38.61 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 124.554 1.159 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.627 0 CA-C-O 116.355 -2.358 . . . . 0.0 111.464 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.426 0 N-CA-C 111.302 0.112 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 126.95 31.69 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.47 1.106 . . . . 0.0 111.307 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.33 138.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.1 143.62 9.28 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 124.848 1.343 . . . . 0.0 110.135 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.33 144.03 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -161.84 112.87 1.19 Allowed Pre-proline 0 N--CA 1.524 3.242 0 CA-C-O 115.092 -2.385 . . . . 0.0 109.918 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.34 149.97 67.6 Favored 'Cis proline' 1 C--N 1.424 4.549 0 CA-C-N 125.25 2.911 . . . . 0.0 112.492 -4.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.85 -9.23 1.59 Allowed 'General case' 0 N--CA 1.528 3.437 0 O-C-N 125.916 2.01 . . . . 0.0 112.619 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.5 p -133.64 152.06 51.81 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.102 1.501 . . . . 0.0 109.648 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.31 65.2 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.023 1.452 . . . . 0.0 112.143 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 mt -73.29 154.23 40.24 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 125.349 1.264 . . . . 0.0 110.551 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.59 -175.36 3.63 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 126.274 2.234 . . . . 0.0 107.946 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.41 127.1 30.99 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.659 1.224 . . . . 0.0 112.735 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.32 28.2 72.86 Favored Glycine 0 N--CA 1.513 3.802 0 O-C-N 124.637 1.21 . . . . 0.0 113.318 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 125.52 27.61 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.945 1.027 . . . . 0.0 112.233 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -78.98 134.57 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.09 140.39 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.349 1.655 . . . . 0.0 108.401 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.6 m -107.36 101.77 11.11 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 126.15 2.156 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.87 148.03 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.997 0 N-CA-C 104.492 -2.411 . . . . 0.0 104.492 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -137.69 161.57 36.16 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.969 2.043 . . . . 0.0 109.463 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 146.22 15.51 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 125.467 1.73 . . . . 0.0 108.278 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.92 146.53 16.1 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 124.986 1.429 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.13 88.4 0.14 Allowed Glycine 0 N--CA 1.509 3.566 0 O-C-N 125.007 1.442 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -155.08 152.62 29.76 Favored 'General case' 0 N--CA 1.514 2.751 0 O-C-N 125.573 1.396 . . . . 0.0 107.408 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.76 -18.71 0.05 Allowed 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.774 1.297 . . . . 0.0 111.52 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.58 -53.39 6.9 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 124.309 1.006 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -71.27 129.77 39.71 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.665 1.228 . . . . 0.0 110.704 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -79.93 -28.61 39.72 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 t -154.67 172.26 18.19 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 125.144 1.527 . . . . 0.0 107.574 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.99 144.75 5.92 Favored 'General case' 0 N--CA 1.521 3.113 0 O-C-N 124.535 1.147 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -128.64 133.14 48.18 Favored 'General case' 0 N--CA 1.522 3.172 0 O-C-N 126.147 2.155 . . . . 0.0 107.108 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.46 107.5 19.19 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.922 1.389 . . . . 0.0 110.319 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -123.06 144.13 49.5 Favored 'General case' 0 N--CA 1.528 3.444 0 O-C-N 125.103 1.502 . . . . 0.0 110.568 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.77 141.1 46.96 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m -146.55 138.16 24.57 Favored 'General case' 0 N--CA 1.531 3.58 0 O-C-N 124.832 1.333 . . . . 0.0 110.427 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.58 118.45 29.22 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 125.172 1.545 . . . . 0.0 111.83 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mm -81.3 123.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.88 -177.9 3.91 Favored 'General case' 0 N--CA 1.523 3.183 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -44.51 77.84 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 124.769 1.293 . . . . 0.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -19.16 61.45 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 125.117 1.511 . . . . 0.0 112.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.34 9.98 78.38 Favored Glycine 1 N--CA 1.517 4.043 0 CA-C-O 116.933 -2.037 . . . . 0.0 115.881 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -71.38 137.0 48.02 Favored 'General case' 0 N--CA 1.529 3.484 0 CA-C-N 118.38 1.09 . . . . 0.0 108.228 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.16 106.13 1.81 Allowed Glycine 0 N--CA 1.51 3.598 0 CA-C-O 118.583 -1.121 . . . . 0.0 115.691 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.78 106.18 15.7 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -135.2 143.54 46.47 Favored 'General case' 0 N--CA 1.526 3.349 0 O-C-N 124.865 1.353 . . . . 0.0 110.875 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.528 HD21 ' HB3' ' A' ' 50' ' ' ALA . 15.0 t30 -84.33 141.03 31.2 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 125.377 1.673 . . . . 0.0 109.896 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.07 -25.06 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 O-C-N 125.537 1.773 . . . . 0.0 114.786 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -78.03 -22.46 49.18 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' H ' HD22 ' A' ' 48' ' ' ASN . 16.9 mt-10 -81.49 -1.59 46.56 Favored 'General case' 1 N--CA 1.543 4.215 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.74 160.17 17.71 Favored 'General case' 0 N--CA 1.53 3.562 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -152.75 127.8 9.71 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 125.834 1.959 . . . . 0.0 106.46 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.21 136.6 44.43 Favored 'General case' 0 N--CA 1.524 3.239 0 O-C-N 126.076 2.11 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -160.08 154.29 23.44 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 124.732 1.27 . . . . 0.0 107.776 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 m -126.69 147.47 49.94 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 125.947 2.029 . . . . 0.0 108.212 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.64 150.51 30.95 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 125.016 1.447 . . . . 0.0 108.917 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -148.67 8.39 0.78 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 125.433 1.708 . . . . 0.0 110.037 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.92 22.92 0.05 OUTLIER Glycine 0 N--CA 1.509 3.537 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.34 13.89 82.43 Favored Glycine 0 N--CA 1.512 3.709 0 CA-C-O 117.516 -1.713 . . . . 0.0 114.372 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.42 161.59 34.15 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.83 75.64 0.07 OUTLIER Glycine 1 N--CA 1.516 4.026 0 O-C-N 124.367 1.042 . . . . 0.0 112.123 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.97 153.27 38.62 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.041 1.083 . . . . 0.0 110.162 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.64 138.04 5.96 Favored 'General case' 0 N--CA 1.533 3.705 0 O-C-N 124.918 1.386 . . . . 0.0 112.917 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -83.36 113.37 20.68 Favored 'General case' 0 N--CA 1.521 3.117 0 O-C-N 124.815 1.322 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.69 152.39 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.53 142.53 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.19 127.1 26.73 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.06 0 O-C-N 125.555 1.784 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -90.21 156.59 18.2 Favored 'General case' 0 N--CA 1.524 3.248 0 O-C-N 124.868 1.355 . . . . 0.0 108.467 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -68.46 -26.22 65.39 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 124.578 1.174 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.53 146.86 38.66 Favored 'General case' 0 N--CA 1.53 3.559 0 O-C-N 125.277 1.61 . . . . 0.0 109.795 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -155.79 146.65 22.21 Favored 'General case' 0 N--CA 1.525 3.28 0 O-C-N 124.838 1.336 . . . . 0.0 112.153 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -71.67 109.42 5.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 125.576 1.797 . . . . 0.0 110.038 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.05 145.55 39.8 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -129.65 85.06 2.26 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 125.893 1.584 . . . . 0.0 109.353 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 N--CA 1.524 3.268 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.77 -179.632 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.52 0 CA-C-O 115.333 -2.926 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.81 153.34 83.59 Favored 'Cis proline' 0 C--N 1.404 3.481 0 CA-C-N 124.005 3.902 . . . . 0.0 113.991 -0.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -71.12 137.03 48.5 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 125.578 1.799 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -39.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 O-C-N 125.039 1.462 . . . . 0.0 112.292 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.83 -172.21 21.56 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 125.68 1.863 . . . . 0.0 108.967 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 117.31 6.85 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 125.741 1.495 . . . . 0.0 113.817 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.86 133.46 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 O-C-N 126.132 2.145 . . . . 0.0 107.564 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.035 1.459 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.6 t -80.12 79.84 6.62 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 125.136 1.523 . . . . 0.0 110.397 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.42 -36.78 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.593 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.7 p -79.79 -19.31 48.88 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 125.325 1.64 . . . . 0.0 111.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 147.26 98.64 Favored Pre-proline 0 N--CA 1.519 2.986 0 CA-C-O 114.738 -2.553 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.13 -45.97 0.33 Allowed 'Trans proline' 0 C--N 1.408 3.677 0 CA-C-N 124.091 2.497 . . . . 0.0 112.876 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.47 -47.4 28.36 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.62 1.2 . . . . 0.0 112.764 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.7 162.74 37.69 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 125.496 1.351 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.99 148.1 49.31 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.794 0.937 . . . . 0.0 112.577 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -148.05 133.44 18.57 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 125.839 1.962 . . . . 0.0 107.319 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.85 134.67 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -130.78 134.15 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -128.61 130.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.35 152.16 10.39 Favored Glycine 0 N--CA 1.514 3.846 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -163.08 37.87 Favored Glycine 0 N--CA 1.509 3.565 0 O-C-N 125.735 1.491 . . . . 0.0 112.231 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.58 -6.7 59.14 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.952 1.619 . . . . 0.0 112.697 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.99 -68.12 0.44 Allowed 'General case' 0 N--CA 1.517 2.902 0 O-C-N 124.89 1.369 . . . . 0.0 111.783 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.33 -23.42 0.09 OUTLIER Glycine 1 N--CA 1.519 4.203 0 CA-C-O 118.562 -1.132 . . . . 0.0 112.981 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -67.27 150.45 49.03 Favored 'General case' 0 N--CA 1.525 3.287 0 O-C-N 124.988 1.052 . . . . 0.0 111.976 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.75 147.21 48.32 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 125.94 2.025 . . . . 0.0 109.802 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.38 -65.2 1.81 Allowed Glycine 0 N--CA 1.516 3.975 0 O-C-N 124.597 1.186 . . . . 0.0 113.821 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 66.65 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.536 3.849 0 C-N-CA 125.523 1.529 . . . . 0.0 112.75 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 106.26 1.23 Allowed 'General case' 0 N--CA 1.53 3.544 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 155.52 40.17 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 124.235 0.959 . . . . 0.0 112.586 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.17 167.78 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 126.481 2.363 . . . . 0.0 108.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -137.49 169.09 18.37 Favored 'General case' 0 N--CA 1.523 3.185 0 O-C-N 124.95 1.406 . . . . 0.0 109.301 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.38 148.01 52.62 Favored 'General case' 0 N--CA 1.522 3.171 0 O-C-N 126.246 2.216 . . . . 0.0 109.039 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.585 0 CA-C-O 116.365 -2.353 . . . . 0.0 111.385 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.606 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.11 132.27 6.28 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.443 1.714 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.27 145.52 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -160.71 145.48 14.2 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 125.312 1.632 . . . . 0.0 109.867 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.22 147.32 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.59 108.74 1.64 Allowed Pre-proline 0 N--CA 1.526 3.342 0 CA-C-O 115.416 -2.23 . . . . 0.0 109.788 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -62.02 162.63 45.75 Favored 'Cis proline' 2 C--N 1.426 4.654 0 CA-C-N 124.905 2.788 . . . . 0.0 113.235 -3.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.26 -6.58 0.73 Allowed 'General case' 0 N--CA 1.534 3.743 0 O-C-N 124.764 1.29 . . . . 0.0 112.619 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -138.3 153.58 49.02 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 124.914 1.384 . . . . 0.0 109.551 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.58 30.19 66.83 Favored Glycine 0 N--CA 1.512 3.752 0 O-C-N 124.977 1.423 . . . . 0.0 113.201 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 mt -72.9 153.87 40.82 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 125.296 1.233 . . . . 0.0 109.83 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.15 -175.83 3.62 Favored 'General case' 0 N--CA 1.523 3.221 0 O-C-N 126.003 2.064 . . . . 0.0 109.772 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.11 131.05 45.03 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 124.675 1.234 . . . . 0.0 112.363 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.78 30.04 66.59 Favored Glycine 0 N--CA 1.514 3.896 0 O-C-N 124.699 1.249 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 146.3 48.62 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.154 1.149 . . . . 0.0 111.841 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -115.27 124.3 50.98 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.317 2.261 . . . . 0.0 105.4 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.22 151.53 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.204 0 O-C-N 125.892 1.995 . . . . 0.0 110.559 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -111.02 100.45 9.14 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 126.185 2.178 . . . . 0.0 108.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.78 145.27 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 160.89 36.13 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 126.102 2.126 . . . . 0.0 109.647 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.14 16.72 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 125.423 1.702 . . . . 0.0 108.378 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -156.37 144.91 19.98 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.39 1.681 . . . . 0.0 109.831 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.09 88.11 0.12 Allowed Glycine 0 N--CA 1.51 3.598 0 O-C-N 125.109 1.506 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -154.87 148.74 25.63 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 125.628 1.428 . . . . 0.0 108.036 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.35 -18.92 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 124.801 1.313 . . . . 0.0 111.256 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.6 -41.66 26.62 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 124.255 0.972 . . . . 0.0 110.743 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -67.24 142.11 57.03 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 125.224 1.578 . . . . 0.0 110.424 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 p -79.9 -26.06 40.36 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.956 1.41 . . . . 0.0 113.203 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -170.06 133.57 1.18 Allowed 'General case' 0 N--CA 1.516 2.839 0 O-C-N 124.585 1.178 . . . . 0.0 109.005 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.0 139.95 45.14 Favored 'General case' 0 N--CA 1.515 2.781 0 O-C-N 124.756 1.285 . . . . 0.0 111.411 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.75 169.62 17.38 Favored 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -162.19 126.36 3.19 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 124.925 1.391 . . . . 0.0 110.997 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 144.76 15.06 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.215 1.572 . . . . 0.0 110.434 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 148.54 25.92 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 125.367 1.667 . . . . 0.0 108.977 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -139.73 140.23 36.72 Favored 'General case' 0 N--CA 1.529 3.503 0 O-C-N 125.609 1.818 . . . . 0.0 109.752 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.38 27.46 Favored 'General case' 0 N--CA 1.517 2.887 0 O-C-N 125.15 1.531 . . . . 0.0 113.011 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.31 142.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.002 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -128.05 -176.38 3.77 Favored 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.26 89.85 Favored 'General case' 0 N--CA 1.515 2.787 0 O-C-N 124.811 1.319 . . . . 0.0 112.122 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -20.74 59.63 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 125.408 1.693 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.08 76.67 Favored Glycine 0 N--CA 1.511 3.648 0 CA-C-O 117.377 -1.79 . . . . 0.0 115.853 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -73.5 142.05 46.78 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 93.35 0.35 Allowed Glycine 0 N--CA 1.511 3.693 0 O-C-N 124.811 1.319 . . . . 0.0 114.322 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.23 101.2 10.76 Favored 'General case' 0 N--CA 1.518 2.936 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -138.34 154.44 48.97 Favored 'General case' 0 N--CA 1.527 3.393 0 O-C-N 124.441 1.088 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -99.64 107.24 19.31 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 126.572 2.42 . . . . 0.0 107.958 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.69 -16.76 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.134 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.41 63.78 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -86.42 8.14 22.94 Favored 'General case' 1 N--CA 1.55 4.54 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -69.32 169.69 11.78 Favored 'General case' 0 N--CA 1.534 3.747 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -137.94 -61.18 0.62 Allowed 'General case' 0 N--CA 1.516 2.825 0 O-C-N 125.705 1.878 . . . . 0.0 109.542 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 52.86 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.793 0 O-C-N 125.334 1.646 . . . . 0.0 115.014 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -156.06 153.04 28.78 Favored 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 m -62.0 157.67 18.17 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.44 145.73 33.15 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.911 1.382 . . . . 0.0 108.373 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -71.52 -33.01 68.82 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 124.664 1.227 . . . . 0.0 111.364 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.4 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.5 2.905 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.31 24.58 0.04 OUTLIER Glycine 0 N--CA 1.502 3.069 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.413 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.34 161.06 39.33 Favored 'General case' 0 N--CA 1.537 3.894 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.41 76.59 0.08 OUTLIER Glycine 0 N--CA 1.513 3.787 0 O-C-N 124.275 0.985 . . . . 0.0 112.054 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 m -74.42 147.54 41.95 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 125.284 1.226 . . . . 0.0 109.468 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.44 135.62 7.9 Favored 'General case' 0 N--CA 1.529 3.492 0 O-C-N 124.799 1.312 . . . . 0.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -86.76 114.4 23.4 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.133 1.521 . . . . 0.0 111.425 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.7 t -107.66 149.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.72 142.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.18 134.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 O-C-N 125.346 1.654 . . . . 0.0 112.78 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -90.27 166.69 13.19 Favored 'General case' 0 N--CA 1.517 2.921 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -65.58 -27.95 68.79 Favored 'General case' 0 N--CA 1.532 3.638 0 O-C-N 124.257 0.973 . . . . 0.0 111.896 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.7 151.51 41.42 Favored 'General case' 0 N--CA 1.525 3.319 0 O-C-N 125.53 1.769 . . . . 0.0 108.749 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.21 147.51 24.88 Favored 'General case' 0 N--CA 1.526 3.358 0 O-C-N 124.935 1.397 . . . . 0.0 111.72 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.7 m -65.8 108.44 2.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 125.791 1.932 . . . . 0.0 112.209 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.28 150.56 43.96 Favored Glycine 0 N--CA 1.513 3.774 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -133.92 90.36 2.69 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.589 1.405 . . . . 0.0 109.824 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 N--CA 1.524 3.229 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.407 -179.808 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.492 0 CA-C-O 115.442 -2.865 . . . . 0.0 108.658 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.73 156.43 82.71 Favored 'Cis proline' 0 C--N 1.402 3.378 0 CA-C-N 123.931 3.865 . . . . 0.0 114.131 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.17 138.69 52.03 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 125.623 1.827 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -40.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 O-C-N 125.011 1.444 . . . . 0.0 112.61 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.56 -175.11 23.29 Favored Glycine 0 N--CA 1.508 3.448 0 O-C-N 125.516 1.76 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 116.55 5.56 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 125.78 1.517 . . . . 0.0 113.883 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.53 138.46 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 126.046 2.091 . . . . 0.0 108.125 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.67 152.04 21.01 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 125.309 1.631 . . . . 0.0 110.84 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.2 m -75.46 -27.68 58.97 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.583 1.177 . . . . 0.0 111.507 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 -29.16 68.19 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.65 -30.69 41.32 Favored 'General case' 0 N--CA 1.528 3.455 0 O-C-N 124.408 1.068 . . . . 0.0 112.309 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.39 152.78 96.36 Favored Pre-proline 0 N--CA 1.527 3.4 0 CA-C-O 115.125 -2.369 . . . . 0.0 111.364 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -72.73 -47.77 0.34 Allowed 'Trans proline' 0 C--N 1.41 3.795 0 CA-C-N 123.624 2.33 . . . . 0.0 113.317 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.19 -48.24 26.39 Favored Glycine 0 N--CA 1.512 3.759 0 O-C-N 124.712 1.258 . . . . 0.0 111.976 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.13 166.84 38.65 Favored Glycine 0 N--CA 1.515 3.96 0 O-C-N 125.303 1.237 . . . . 0.0 112.404 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.95 151.31 45.77 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-N 114.014 -1.093 . . . . 0.0 112.617 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.61 145.82 19.09 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 125.247 1.592 . . . . 0.0 109.209 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.71 130.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 O-C-N 125.273 1.608 . . . . 0.0 107.16 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 t -123.47 131.12 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.74 142.19 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.44 -153.84 17.44 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.049 0.843 . . . . 0.0 111.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.38 -167.38 24.81 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -69.9 -20.36 63.37 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.26 -22.0 2.02 Favored 'General case' 0 N--CA 1.538 3.965 0 O-C-N 124.751 1.282 . . . . 0.0 111.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.64 -15.23 63.88 Favored Glycine 1 N--CA 1.524 4.542 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.342 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 168.2 0.26 Allowed 'General case' 1 N--CA 1.546 4.366 0 C-N-CA 124.741 1.216 . . . . 0.0 112.428 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -70.0 164.5 23.81 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.922 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.65 90.79 0.12 Allowed Glycine 0 N--CA 1.516 3.986 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.02 149.23 50.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 125.362 1.272 . . . . 0.0 113.619 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.85 0.97 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 124.958 1.411 . . . . 0.0 108.328 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.99 153.51 42.59 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.11 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.71 170.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.758 0 O-C-N 126.396 2.31 . . . . 0.0 107.608 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -156.95 118.22 3.72 Favored 'General case' 0 N--CA 1.525 3.278 0 O-C-N 124.283 0.99 . . . . 0.0 110.736 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -71.21 153.77 42.2 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.522 1.139 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 CA-C-O 116.249 -2.417 . . . . 0.0 109.752 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.724 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 127.0 31.75 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.687 1.242 . . . . 0.0 112.015 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.61 138.88 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.105 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.03 144.73 8.44 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.82 1.325 . . . . 0.0 110.574 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.45 147.5 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -158.18 108.87 1.72 Allowed Pre-proline 0 N--CA 1.525 3.28 0 CA-C-O 115.377 -2.249 . . . . 0.0 110.131 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.1 162.73 51.92 Favored 'Cis proline' 2 C--N 1.425 4.572 0 CA-C-N 124.812 2.754 . . . . 0.0 112.831 -4.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.6 -8.69 1.25 Allowed 'General case' 0 N--CA 1.535 3.823 0 O-C-N 124.753 1.283 . . . . 0.0 112.846 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -136.78 154.41 50.56 Favored 'General case' 0 N--CA 1.525 3.31 0 O-C-N 125.269 1.606 . . . . 0.0 108.556 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.29 30.26 62.97 Favored Glycine 0 N--CA 1.511 3.667 0 O-C-N 124.944 1.402 . . . . 0.0 111.943 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 mt -75.32 154.09 37.52 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 125.378 1.281 . . . . 0.0 109.411 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.09 -175.36 3.47 Favored 'General case' 0 N--CA 1.524 3.228 0 O-C-N 126.026 2.079 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.43 127.57 32.81 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 124.761 1.288 . . . . 0.0 112.521 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.6 28.97 71.65 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.56 1.162 . . . . 0.0 113.013 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.05 127.04 31.3 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 124.91 1.006 . . . . 0.0 112.564 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -89.27 129.93 35.75 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.67 148.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 O-C-N 125.168 1.542 . . . . 0.0 110.465 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -103.05 97.25 7.38 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 125.956 2.035 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.87 148.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.62 161.59 34.22 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 125.804 1.94 . . . . 0.0 110.466 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 139.82 11.15 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.526 1.766 . . . . 0.0 108.042 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.39 142.83 14.58 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 125.129 1.518 . . . . 0.0 109.473 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.82 97.32 0.05 OUTLIER Glycine 0 N--CA 1.512 3.719 0 O-C-N 125.229 1.581 . . . . 0.0 111.432 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -154.21 153.16 31.29 Favored 'General case' 0 N--CA 1.513 2.683 0 O-C-N 125.371 1.277 . . . . 0.0 108.076 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.2 -16.99 0.08 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 125.254 1.596 . . . . 0.0 111.166 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.54 -59.97 2.54 Favored 'General case' 0 N--CA 1.517 2.924 0 O-C-N 124.207 0.942 . . . . 0.0 109.402 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 119.23 15.72 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 124.717 1.26 . . . . 0.0 109.984 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 p -79.9 -13.1 59.63 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 124.466 1.104 . . . . 0.0 112.656 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -167.65 148.6 5.36 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.37 165.67 26.87 Favored 'General case' 0 N--CA 1.519 3.024 0 O-C-N 125.607 1.817 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -158.95 108.22 1.93 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.12 42.91 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 124.379 1.049 . . . . 0.0 113.385 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 143.71 11.51 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 124.897 1.373 . . . . 0.0 111.007 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 147.7 23.97 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.363 1.665 . . . . 0.0 106.756 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.81 144.57 33.99 Favored 'General case' 0 N--CA 1.527 3.399 0 O-C-N 125.434 1.709 . . . . 0.0 109.497 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.52 118.79 32.88 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.451 1.719 . . . . 0.0 111.809 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.7 139.59 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.08 -177.12 3.84 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 125.686 1.867 . . . . 0.0 106.376 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.02 97.8 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.466 1.104 . . . . 0.0 112.245 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -19.13 57.91 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 125.407 1.692 . . . . 0.0 111.206 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.67 78.55 Favored Glycine 0 N--CA 1.511 3.641 0 CA-C-O 117.316 -1.824 . . . . 0.0 115.992 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -73.66 143.62 46.19 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.42 87.84 0.42 Allowed Glycine 0 N--CA 1.514 3.861 0 O-C-N 124.859 1.349 . . . . 0.0 113.84 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.72 92.69 6.31 Favored 'General case' 0 N--CA 1.517 2.891 0 O-C-N 125.725 1.485 . . . . 0.0 107.593 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -129.14 146.57 51.04 Favored 'General case' 0 N--CA 1.527 3.412 0 O-C-N 125.028 1.455 . . . . 0.0 110.873 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -86.05 127.38 34.66 Favored 'General case' 0 N--CA 1.514 2.77 0 O-C-N 125.61 1.819 . . . . 0.0 111.233 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.66 -24.17 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.83 62.32 Favored 'General case' 0 N--CA 1.533 3.684 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.84 5.67 18.09 Favored 'General case' 0 N--CA 1.536 3.873 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -64.32 146.98 53.53 Favored 'General case' 0 N--CA 1.537 3.912 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.043 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -152.42 -64.29 0.16 Allowed 'General case' 0 N--CA 1.533 3.701 0 CA-C-O 117.138 -1.411 . . . . 0.0 114.525 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.72 159.7 29.59 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -136.92 -157.74 0.8 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 126.731 2.52 . . . . 0.0 105.692 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.8 p -53.04 144.5 15.07 Favored 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.5 132.72 36.41 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 125.124 1.515 . . . . 0.0 109.633 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -75.26 -32.77 61.17 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.116 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 48.51 0.13 Allowed Glycine 0 N--CA 1.505 3.235 0 O-C-N 125.158 1.536 . . . . 0.0 110.605 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 28.17 68.9 Favored Glycine 0 N--CA 1.507 3.404 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.271 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -143.1 154.0 43.48 Favored 'General case' 1 N--CA 1.544 4.256 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.9 79.0 0.06 OUTLIER Glycine 1 N--CA 1.517 4.039 0 O-C-N 124.393 1.058 . . . . 0.0 112.403 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -74.9 152.61 38.85 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.079 1.105 . . . . 0.0 108.905 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.51 141.83 7.84 Favored 'General case' 0 N--CA 1.526 3.352 0 O-C-N 124.808 1.317 . . . . 0.0 113.339 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -92.1 110.09 21.46 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.164 1.54 . . . . 0.0 108.541 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.83 149.72 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 O-C-N 125.187 1.554 . . . . 0.0 107.239 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.37 140.0 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.41 124.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 O-C-N 125.626 1.829 . . . . 0.0 112.115 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -90.22 161.48 15.69 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.836 1.335 . . . . 0.0 107.758 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -67.48 -32.4 73.2 Favored 'General case' 0 N--CA 1.518 2.95 0 O-C-N 124.664 1.227 . . . . 0.0 111.687 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.38 147.24 51.77 Favored 'General case' 0 N--CA 1.53 3.561 0 O-C-N 125.988 2.055 . . . . 0.0 109.97 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -157.74 147.75 20.4 Favored 'General case' 0 N--CA 1.528 3.44 0 O-C-N 124.805 1.316 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -72.31 101.53 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 125.78 1.925 . . . . 0.0 108.854 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 155.16 51.98 Favored Glycine 0 N--CA 1.51 3.59 0 O-C-N 124.979 1.425 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -140.53 119.91 13.07 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.696 1.468 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.515 2.803 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.072 0 CA-C-O 115.561 -2.8 . . . . 0.0 108.683 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.66 148.69 92.33 Favored 'Cis proline' 0 N--CA 1.529 3.578 0 CA-C-N 123.172 3.486 . . . . 0.0 113.417 -0.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -73.55 132.61 43.04 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.241 1.588 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.42 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 O-C-N 125.105 1.503 . . . . 0.0 112.099 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 -170.19 37.32 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.22 110.65 1.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.97 1.629 . . . . 0.0 113.221 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.95 135.67 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 126.061 2.101 . . . . 0.0 108.335 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.73 154.53 28.49 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.916 1.385 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.5 t -78.83 -29.47 44.72 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 124.972 1.42 . . . . 0.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.29 -22.07 62.0 Favored 'General case' 0 N--CA 1.515 2.823 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.3 p -79.69 -28.7 40.66 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 124.303 1.002 . . . . 0.0 113.304 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.1 150.74 96.45 Favored Pre-proline 0 N--CA 1.529 3.501 0 CA-C-O 115.26 -2.305 . . . . 0.0 112.183 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -73.61 -46.36 0.35 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.613 2.326 . . . . 0.0 113.515 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.22 -43.98 61.56 Favored Glycine 0 N--CA 1.512 3.751 0 O-C-N 124.608 1.192 . . . . 0.0 112.885 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.7 160.62 30.56 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 125.198 1.175 . . . . 0.0 111.591 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.96 154.72 41.58 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.942 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -162.11 145.97 12.16 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.2 1.562 . . . . 0.0 108.592 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.69 135.99 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.1 t -134.4 132.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.51 140.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.85 -132.5 1.7 Allowed Glycine 1 N--CA 1.52 4.25 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.19 -158.19 15.78 Favored Glycine 0 N--CA 1.505 3.299 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -73.37 -13.28 61.07 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.61 -73.8 0.16 Allowed 'General case' 0 N--CA 1.522 3.138 0 O-C-N 124.685 1.241 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.85 -23.44 0.24 Allowed Glycine 1 N--CA 1.517 4.068 0 CA-C-O 118.617 -1.101 . . . . 0.0 112.229 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.7 108.83 1.83 Allowed 'General case' 0 N--CA 1.521 3.096 0 O-C-N 125.224 1.191 . . . . 0.0 112.325 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -80.12 153.72 28.51 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.615 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.92 -60.98 1.89 Allowed Glycine 1 N--CA 1.518 4.148 0 O-C-N 125.116 1.51 . . . . 0.0 111.479 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.85 121.14 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 125.609 1.563 . . . . 0.0 114.734 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.39 96.86 0.78 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.94 31.63 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.416 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.81 176.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.708 0 O-C-N 126.507 2.38 . . . . 0.0 107.14 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -163.65 115.01 1.4 Allowed 'General case' 0 N--CA 1.519 3.007 0 O-C-N 125.014 1.446 . . . . 0.0 109.01 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.43 153.31 43.11 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.48 1.112 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.273 0 CA-C-O 116.356 -2.358 . . . . 0.0 109.798 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.527 3.422 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 130.57 35.42 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.71 138.87 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.98 143.03 10.72 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 124.855 1.347 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.69 143.04 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -158.51 112.59 1.68 Allowed Pre-proline 0 N--CA 1.523 3.198 0 CA-C-O 114.945 -2.455 . . . . 0.0 109.66 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.04 150.16 75.01 Favored 'Cis proline' 1 C--N 1.423 4.448 0 CA-C-N 125.401 2.965 . . . . 0.0 112.113 -3.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.76 -16.98 1.47 Allowed 'General case' 0 N--CA 1.528 3.464 0 O-C-N 125.897 1.998 . . . . 0.0 112.496 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.58 151.37 44.85 Favored 'General case' 0 N--CA 1.525 3.282 0 O-C-N 125.765 1.916 . . . . 0.0 110.915 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.89 66.1 Favored Glycine 1 N--CA 1.517 4.095 0 O-C-N 124.91 1.381 . . . . 0.0 112.5 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.8 mt -74.15 154.42 39.11 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 125.481 1.342 . . . . 0.0 110.715 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.57 -175.3 3.61 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.393 2.308 . . . . 0.0 108.324 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.46 127.91 34.15 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.767 1.292 . . . . 0.0 112.894 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.75 71.64 Favored Glycine 0 N--CA 1.515 3.922 0 O-C-N 124.703 1.252 . . . . 0.0 113.174 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.51 123.26 22.78 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 124.841 0.965 . . . . 0.0 112.663 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 m -80.65 129.92 34.8 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.11 141.01 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 O-C-N 125.722 1.888 . . . . 0.0 109.249 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.1 m -105.61 101.66 11.16 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 126.145 2.153 . . . . 0.0 110.44 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.79 147.71 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.08 158.75 43.65 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.998 2.061 . . . . 0.0 109.072 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.34 16.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.302 1.626 . . . . 0.0 108.123 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -157.37 145.13 18.9 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 125.2 1.563 . . . . 0.0 109.714 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.6 86.1 0.17 Allowed Glycine 0 N--CA 1.507 3.422 0 O-C-N 125.181 1.55 . . . . 0.0 110.412 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -151.87 149.54 29.09 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 125.732 1.489 . . . . 0.0 108.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.19 -15.55 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.952 0 O-C-N 125.038 1.461 . . . . 0.0 111.166 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.43 -49.65 12.0 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 p -66.89 140.4 57.78 Favored 'General case' 0 N--CA 1.519 3.022 0 O-C-N 124.94 1.4 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -81.12 -18.41 46.55 Favored 'General case' 0 N--CA 1.524 3.226 0 O-C-N 125.051 1.469 . . . . 0.0 113.909 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 m -169.98 133.58 1.2 Allowed 'General case' 0 N--CA 1.518 2.972 0 O-C-N 124.704 1.253 . . . . 0.0 109.531 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.53 145.44 36.94 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.741 1.276 . . . . 0.0 110.072 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -154.15 156.46 37.22 Favored 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.42 115.79 9.0 Favored 'General case' 0 N--CA 1.524 3.243 0 O-C-N 125.1 1.5 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.05 153.56 31.48 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 125.713 1.883 . . . . 0.0 109.188 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -127.34 114.53 17.69 Favored 'General case' 0 N--CA 1.52 3.062 0 O-C-N 126.144 2.152 . . . . 0.0 106.041 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.3 m -126.08 157.03 39.02 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.689 1.868 . . . . 0.0 111.615 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.42 123.89 49.55 Favored 'General case' 0 N--CA 1.523 3.223 0 O-C-N 126.185 2.178 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -80.4 121.06 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 O-C-N 125.076 1.485 . . . . 0.0 107.736 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.53 -175.84 3.2 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.85 -44.83 84.3 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 124.64 1.212 . . . . 0.0 111.799 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.25 61.26 Favored 'General case' 0 N--CA 1.526 3.366 0 O-C-N 125.261 1.601 . . . . 0.0 111.556 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.64 22.57 57.99 Favored Glycine 0 N--CA 1.516 3.972 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.512 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -72.95 142.37 47.81 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.37 72.83 2.29 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.803 1.314 . . . . 0.0 113.311 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.97 12.04 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 124.865 0.979 . . . . 0.0 108.442 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.95 140.7 46.93 Favored 'General case' 0 N--CA 1.521 3.091 0 O-C-N 125.218 1.574 . . . . 0.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -81.78 115.0 20.8 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 125.354 1.659 . . . . 0.0 107.885 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.12 -16.43 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.19 63.04 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -84.16 4.03 32.34 Favored 'General case' 1 N--CA 1.55 4.53 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -68.64 169.94 10.19 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -138.39 -67.37 0.47 Allowed 'General case' 0 N--CA 1.517 2.886 0 O-C-N 125.876 1.985 . . . . 0.0 108.461 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 52.83 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -156.11 153.02 28.67 Favored 'General case' 0 N--CA 1.523 3.212 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -60.4 156.0 16.9 Favored 'General case' 0 N--CA 1.517 2.902 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.48 144.33 34.11 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.9 1.375 . . . . 0.0 107.954 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -72.39 -25.94 61.69 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.379 1.05 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.68 -39.58 0.08 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.13 24.93 0.04 OUTLIER Glycine 0 N--CA 1.501 3.033 0 O-C-N 125.324 1.25 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.24 158.7 43.43 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.69 77.52 0.08 OUTLIER Glycine 0 N--CA 1.513 3.816 0 O-C-N 124.399 1.062 . . . . 0.0 112.04 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -74.69 151.22 39.26 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.232 1.195 . . . . 0.0 109.205 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.11 140.05 7.47 Favored 'General case' 0 N--CA 1.533 3.702 0 O-C-N 124.748 1.28 . . . . 0.0 113.305 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -90.29 122.18 32.97 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 125.188 1.555 . . . . 0.0 110.039 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.08 146.6 24.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 O-C-N 125.722 1.889 . . . . 0.0 107.067 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.47 123.89 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.45 126.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 125.615 1.822 . . . . 0.0 111.196 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -90.25 160.11 16.35 Favored 'General case' 0 N--CA 1.525 3.324 0 O-C-N 124.809 1.318 . . . . 0.0 108.179 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -69.51 -27.27 65.04 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.472 1.107 . . . . 0.0 111.755 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.2 m -139.46 147.61 41.59 Favored 'General case' 0 N--CA 1.529 3.507 0 O-C-N 125.315 1.634 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.26 149.18 22.5 Favored 'General case' 0 N--CA 1.523 3.192 0 O-C-N 124.676 1.235 . . . . 0.0 111.583 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 117.34 9.72 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 125.999 2.062 . . . . 0.0 109.124 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.22 145.46 41.07 Favored Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.8 124.5 15.97 Favored 'General case' 0 N--CA 1.522 3.165 0 O-C-N 125.365 1.274 . . . . 0.0 109.148 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.52 3.066 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.725 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.586 4.531 0 CA-C-O 116.814 -2.104 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.16 173.19 50.62 Favored 'Cis proline' 0 N--CA 1.53 3.672 0 CA-C-N 122.795 3.298 . . . . 0.0 113.148 -6.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.52 133.56 55.85 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.087 1.492 . . . . 0.0 110.231 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -85.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 O-C-N 125.616 1.823 . . . . 0.0 111.55 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.71 -171.28 40.12 Favored Glycine 0 N--CA 1.504 3.17 0 CA-C-N 120.609 1.55 . . . . 0.0 109.974 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.68 116.72 7.19 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 125.841 1.553 . . . . 0.0 112.744 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.92 137.29 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 O-C-N 125.927 2.017 . . . . 0.0 107.873 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 145.91 26.8 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 125.311 1.632 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -23.02 45.06 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 124.884 1.365 . . . . 0.0 112.16 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.26 -30.13 57.72 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -79.65 -18.18 52.04 Favored 'General case' 0 N--CA 1.528 3.442 0 O-C-N 124.675 1.235 . . . . 0.0 112.601 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.89 156.89 86.16 Favored Pre-proline 0 N--CA 1.532 3.637 0 CA-C-O 115.771 -2.061 . . . . 0.0 111.757 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.23 -42.92 0.81 Allowed 'Trans proline' 0 C--N 1.407 3.63 0 CA-C-N 123.384 2.244 . . . . 0.0 114.707 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.58 -104.84 0.09 OUTLIER Glycine 0 N--CA 1.504 3.229 0 O-C-N 124.741 1.276 . . . . 0.0 111.627 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.98 161.19 20.02 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 143.4 40.5 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 125.659 1.447 . . . . 0.0 107.957 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -147.6 132.27 17.87 Favored 'General case' 0 N--CA 1.533 3.71 0 O-C-N 125.09 1.494 . . . . 0.0 109.802 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -79.8 134.66 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.45 129.27 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.92 140.17 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.58 -144.37 7.89 Favored Glycine 0 N--CA 1.512 3.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.12 -163.18 25.58 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.39 -18.78 62.33 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -126.94 -13.54 5.74 Favored 'General case' 0 N--CA 1.531 3.616 0 O-C-N 125.278 1.611 . . . . 0.0 109.004 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.42 66.36 Favored Glycine 1 N--CA 1.524 4.509 0 CA-C-O 118.895 -0.947 . . . . 0.0 114.344 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.253 23.9 mt-10 62.7 -85.36 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 125.676 1.59 . . . . 0.0 114.17 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -152.96 157.19 40.23 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 125.056 1.472 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.57 68.23 0.28 Allowed Glycine 0 N--CA 1.512 3.725 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.39 151.01 47.32 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 125.569 1.393 . . . . 0.0 114.359 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.67 102.22 1.34 Allowed 'General case' 0 N--CA 1.526 3.361 0 O-C-N 124.914 1.384 . . . . 0.0 109.625 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.07 28.61 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.24 170.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.917 0 O-C-N 126.369 2.293 . . . . 0.0 107.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -161.05 124.3 3.28 Favored 'General case' 0 N--CA 1.521 3.111 0 O-C-N 124.587 1.179 . . . . 0.0 110.434 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.44 156.8 38.67 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 124.501 1.126 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.357 0 CA-C-O 116.319 -2.378 . . . . 0.0 109.76 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.9 140.01 36.89 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 124.639 1.212 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 139.93 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.97 146.65 19.17 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 124.85 1.344 . . . . 0.0 110.362 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.9 143.9 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.46 109.73 2.03 Favored Pre-proline 0 N--CA 1.528 3.473 0 CA-C-O 115.017 -2.42 . . . . 0.0 109.822 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.17 159.64 62.45 Favored 'Cis proline' 1 C--N 1.425 4.576 0 CA-C-N 125.279 2.921 . . . . 0.0 112.591 -2.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.14 -1.46 1.36 Allowed 'General case' 0 N--CA 1.531 3.576 0 O-C-N 125.033 1.458 . . . . 0.0 112.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -139.49 152.0 46.62 Favored 'General case' 0 N--CA 1.526 3.373 0 O-C-N 124.744 1.277 . . . . 0.0 110.159 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.35 30.67 69.04 Favored Glycine 0 N--CA 1.511 3.695 0 O-C-N 124.877 1.361 . . . . 0.0 113.556 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.6 154.16 40.91 Favored 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.342 1.26 . . . . 0.0 110.1 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.6 -174.37 3.22 Favored 'General case' 0 N--CA 1.522 3.137 0 O-C-N 125.877 1.986 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.04 129.02 38.54 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 124.635 1.21 . . . . 0.0 112.23 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.83 28.67 70.34 Favored Glycine 0 N--CA 1.514 3.864 0 O-C-N 124.704 1.252 . . . . 0.0 112.763 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 126.96 31.11 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 125.065 1.097 . . . . 0.0 112.245 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -88.91 134.27 34.02 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.77 147.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.191 0 O-C-N 125.295 1.622 . . . . 0.0 110.426 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 m -104.93 96.31 6.45 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 126.145 2.153 . . . . 0.0 108.842 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.86 147.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.998 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 p -135.31 164.77 26.97 Favored 'General case' 0 N--CA 1.518 2.972 0 O-C-N 125.944 2.027 . . . . 0.0 110.011 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.12 148.45 16.94 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.611 1.82 . . . . 0.0 108.161 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.34 145.28 16.25 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 124.993 1.433 . . . . 0.0 110.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 143.99 5.55 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 124.939 1.399 . . . . 0.0 112.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.02 168.41 20.05 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.177 1.163 . . . . 0.0 108.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.6 -37.22 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 124.979 1.424 . . . . 0.0 110.546 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.91 -46.69 1.96 Allowed 'General case' 0 N--CA 1.526 3.371 0 O-C-N 126.192 2.183 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.2 p -67.43 153.98 42.44 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 124.785 1.303 . . . . 0.0 112.299 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.33 -2.48 1.81 Allowed 'General case' 0 N--CA 1.538 3.93 0 O-C-N 125.563 1.79 . . . . 0.0 111.375 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -165.7 154.28 11.45 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.44 152.0 19.64 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 124.057 0.848 . . . . 0.0 111.833 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -116.59 -177.64 3.23 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 126.55 2.406 . . . . 0.0 106.157 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 112.6 1.93 Allowed 'General case' 0 N--CA 1.515 2.791 0 O-C-N 124.499 1.124 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 154.17 46.68 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 125.147 1.529 . . . . 0.0 108.66 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.99 146.4 35.33 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.602 2.439 . . . . 0.0 104.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -141.07 144.89 35.2 Favored 'General case' 0 N--CA 1.526 3.365 0 O-C-N 125.382 1.676 . . . . 0.0 109.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.21 114.8 27.44 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 125.428 1.705 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.48 143.32 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.53 -176.64 4.1 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.99 96.22 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.74 1.275 . . . . 0.0 112.062 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.522 3.139 0 O-C-N 125.384 1.678 . . . . 0.0 111.275 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.86 27.29 69.21 Favored Glycine 0 N--CA 1.512 3.76 0 CA-C-O 117.67 -1.628 . . . . 0.0 115.778 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -74.38 147.53 42.05 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.02 74.35 1.63 Allowed Glycine 0 N--CA 1.515 3.925 0 O-C-N 124.958 1.411 . . . . 0.0 113.927 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.92 89.3 6.84 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.37 144.14 51.1 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.046 1.466 . . . . 0.0 110.861 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -79.92 149.92 30.71 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.213 1.571 . . . . 0.0 109.965 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -25.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 O-C-N 125.895 1.997 . . . . 0.0 112.445 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.22 -9.32 58.44 Favored 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.89 -8.86 59.55 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.145 0.903 . . . . 0.0 113.232 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -63.69 156.44 26.94 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -145.54 -43.01 0.22 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 125.464 1.728 . . . . 0.0 108.552 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 55.17 54.62 8.56 Favored 'General case' 0 N--CA 1.523 3.175 0 O-C-N 124.981 1.426 . . . . 0.0 114.627 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -71.51 151.42 43.91 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -115.6 145.56 42.57 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 126.182 2.176 . . . . 0.0 109.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.71 154.02 28.87 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 125.042 1.464 . . . . 0.0 107.923 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -134.45 12.67 3.8 Favored 'General case' 0 N--CA 1.525 3.294 0 O-C-N 125.878 1.986 . . . . 0.0 110.061 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.09 -50.76 0.1 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.344 -2.303 . . . . 0.0 107.344 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -4.66 0.04 OUTLIER Glycine 0 N--CA 1.504 3.167 0 CA-C-O 117.344 -1.809 . . . . 0.0 112.665 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.91 162.61 20.71 Favored 'General case' 0 N--CA 1.537 3.89 0 O-C-N 125.538 1.376 . . . . 0.0 110.485 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.56 85.26 0.06 OUTLIER Glycine 0 N--CA 1.507 3.428 0 O-C-N 124.722 1.264 . . . . 0.0 110.546 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -72.55 153.75 41.15 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.124 1.132 . . . . 0.0 110.481 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -158.46 139.81 13.36 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.878 1.361 . . . . 0.0 111.583 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -91.02 124.23 35.09 Favored 'General case' 0 N--CA 1.521 3.123 0 O-C-N 124.996 1.435 . . . . 0.0 111.026 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.41 150.05 18.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.68 140.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.83 125.15 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 O-C-N 125.54 1.775 . . . . 0.0 112.092 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -90.21 165.08 14.15 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.932 1.395 . . . . 0.0 109.013 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -67.57 -29.55 68.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 124.924 1.39 . . . . 0.0 112.618 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.23 144.05 32.0 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.55 1.781 . . . . 0.0 110.69 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.61 149.25 25.13 Favored 'General case' 0 N--CA 1.523 3.218 0 O-C-N 125.244 1.59 . . . . 0.0 111.774 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 m -71.24 103.85 2.94 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 125.666 1.854 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.57 157.6 52.75 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.959 1.412 . . . . 0.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -141.13 121.8 14.28 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.603 1.414 . . . . 0.0 110.449 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.517 2.886 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.517 4.04 0 CA-C-O 115.614 -2.77 . . . . 0.0 108.598 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -72.52 149.78 94.11 Favored 'Cis proline' 0 C--N 1.405 3.512 0 CA-C-N 123.118 3.459 . . . . 0.0 113.246 -0.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -72.26 137.37 46.73 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 125.396 1.685 . . . . 0.0 108.625 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -37.2 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 O-C-N 125.263 1.602 . . . . 0.0 112.196 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.98 -170.15 34.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 125.262 1.601 . . . . 0.0 109.602 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.91 112.8 2.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 126.049 1.676 . . . . 0.0 114.012 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.63 140.59 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 O-C-N 126.063 2.102 . . . . 0.0 107.201 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 148.75 21.8 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.581 1.8 . . . . 0.0 110.678 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.2 t -89.99 71.04 7.48 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.505 1.753 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.89 -32.56 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.292 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.6 -27.2 41.1 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.104 1.502 . . . . 0.0 110.992 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 145.24 98.2 Favored Pre-proline 0 N--CA 1.518 2.959 0 CA-C-O 114.736 -2.554 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -73.57 -45.25 0.42 Allowed 'Trans proline' 0 C--N 1.412 3.878 0 CA-C-N 124.217 2.542 . . . . 0.0 112.732 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.83 -45.59 42.41 Favored Glycine 0 N--CA 1.512 3.753 0 O-C-N 124.729 1.268 . . . . 0.0 112.657 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.73 174.88 49.88 Favored Glycine 1 N--CA 1.519 4.173 0 O-C-N 125.187 1.169 . . . . 0.0 111.736 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.6 m -69.96 145.49 51.82 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.868 0.981 . . . . 0.0 112.348 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -147.48 133.87 19.63 Favored 'General case' 0 N--CA 1.527 3.423 0 O-C-N 125.495 1.747 . . . . 0.0 108.403 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -79.88 135.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.028 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.53 133.13 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.71 139.92 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.23 146.0 6.94 Favored Glycine 0 N--CA 1.514 3.844 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.28 176.03 47.91 Favored Glycine 0 N--CA 1.501 2.969 0 O-C-N 124.833 0.96 . . . . 0.0 112.536 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -72.76 -22.07 60.91 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 113.636 -1.282 . . . . 0.0 112.533 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.01 -61.45 1.77 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 124.91 1.381 . . . . 0.0 112.643 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.29 6.64 0.03 OUTLIER Glycine 1 N--CA 1.523 4.451 0 CA-C-O 117.636 -1.647 . . . . 0.0 114.384 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.68 160.84 31.94 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 118.013 0.906 . . . . 0.0 111.071 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -152.58 157.3 40.84 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.06 1.475 . . . . 0.0 108.485 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.87 82.91 0.08 OUTLIER Glycine 0 N--CA 1.504 3.218 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -69.92 155.78 40.07 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 125.353 1.266 . . . . 0.0 112.042 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.82 98.23 1.48 Allowed 'General case' 0 N--CA 1.527 3.38 0 O-C-N 124.753 1.283 . . . . 0.0 110.505 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.46 151.32 44.08 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.21 176.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.386 0 O-C-N 126.365 2.29 . . . . 0.0 107.812 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -153.47 113.99 4.02 Favored 'General case' 0 N--CA 1.526 3.368 0 O-C-N 124.172 0.92 . . . . 0.0 110.641 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -70.8 154.37 41.9 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 124.424 1.078 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.311 -2.383 . . . . 0.0 109.694 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 2.586 0 CA-C-O 119.512 -0.28 . . . . 0.0 111.613 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.97 122.15 26.36 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.758 1.286 . . . . 0.0 111.684 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.96 137.66 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.329 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.17 146.39 13.98 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 124.865 1.353 . . . . 0.0 110.57 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.8 144.08 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.137 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -155.99 110.66 2.12 Favored Pre-proline 0 N--CA 1.528 3.429 0 CA-C-O 114.981 -2.437 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.25 156.63 72.94 Favored 'Cis proline' 1 C--N 1.424 4.533 0 CA-C-N 125.344 2.944 . . . . 0.0 111.899 -2.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.8 -4.83 1.37 Allowed 'General case' 0 N--CA 1.531 3.594 0 O-C-N 125.46 1.725 . . . . 0.0 112.563 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -136.09 152.59 51.02 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 124.991 1.432 . . . . 0.0 110.093 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.98 28.92 67.74 Favored Glycine 0 N--CA 1.513 3.791 0 O-C-N 124.989 1.431 . . . . 0.0 113.274 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.12 152.83 41.03 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 125.205 1.179 . . . . 0.0 109.794 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.77 4.81 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.68 1.863 . . . . 0.0 109.102 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.66 136.29 57.38 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 124.952 1.408 . . . . 0.0 111.711 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 39.27 33.87 Favored Glycine 0 N--CA 1.511 3.643 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 156.94 38.75 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 125.718 1.481 . . . . 0.0 112.401 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -139.8 119.08 12.82 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 126.361 2.288 . . . . 0.0 105.074 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.26 155.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.043 0 O-C-N 126.053 2.095 . . . . 0.0 109.975 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.9 m -122.74 96.05 4.87 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 126.286 2.241 . . . . 0.0 106.362 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.63 147.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 p -137.85 165.54 26.24 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 126.051 2.094 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.73 15.79 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.502 1.751 . . . . 0.0 108.598 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -160.53 146.8 15.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.888 1.367 . . . . 0.0 108.947 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.69 87.72 0.17 Allowed Glycine 0 N--CA 1.508 3.457 0 O-C-N 125.054 1.471 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -156.89 153.64 28.49 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.713 1.478 . . . . 0.0 107.477 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 -20.24 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.792 1.307 . . . . 0.0 111.28 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.39 1.056 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -70.11 126.09 28.66 Favored 'General case' 0 N--CA 1.521 3.099 0 O-C-N 124.63 1.206 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -80.3 -14.19 58.58 Favored 'General case' 0 N--CA 1.531 3.585 0 O-C-N 124.392 1.058 . . . . 0.0 112.975 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.29 155.85 11.68 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.18 33.26 Favored 'General case' 0 N--CA 1.521 3.116 0 O-C-N 125.111 1.507 . . . . 0.0 111.376 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -179.31 3.66 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 126.594 2.434 . . . . 0.0 107.682 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.55 109.83 2.16 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 124.944 1.402 . . . . 0.0 108.447 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 139.47 23.18 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.595 1.185 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -84.0 145.3 28.59 Favored 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.79 144.59 31.24 Favored 'General case' 0 N--CA 1.529 3.49 0 O-C-N 125.009 1.443 . . . . 0.0 108.713 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.9 118.51 37.08 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.673 1.858 . . . . 0.0 113.202 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.64 135.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.7 mt -113.44 -173.63 2.3 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.54 70.1 Favored 'General case' 0 N--CA 1.518 2.927 0 O-C-N 124.506 1.129 . . . . 0.0 112.604 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -20.65 61.82 Favored 'General case' 0 N--CA 1.526 3.334 0 O-C-N 125.372 1.67 . . . . 0.0 111.948 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.1 24.34 59.73 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 118.237 -1.313 . . . . 0.0 114.244 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.34 144.7 44.35 Favored 'General case' 0 N--CA 1.521 3.118 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.12 118.21 7.27 Favored Glycine 0 N--CA 1.508 3.481 0 O-C-N 124.729 1.268 . . . . 0.0 112.669 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.91 107.36 8.25 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.3 m -147.83 156.09 42.35 Favored 'General case' 0 N--CA 1.526 3.363 0 O-C-N 124.665 1.228 . . . . 0.0 110.112 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.456 HD22 ' H ' ' A' ' 50' ' ' ALA . 1.2 t30 -83.44 147.39 27.88 Favored 'General case' 0 N--CA 1.517 2.922 0 O-C-N 125.451 1.72 . . . . 0.0 109.734 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -24.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.46 0 O-C-N 125.753 1.908 . . . . 0.0 112.933 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' H ' HD22 ' A' ' 48' ' ' ASN . . . -71.89 -17.02 62.14 Favored 'General case' 0 N--CA 1.521 3.084 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.89 -5.65 55.93 Favored 'General case' 0 N--CA 1.537 3.877 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.58 161.84 14.0 Favored 'General case' 0 N--CA 1.533 3.699 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -152.15 -50.14 0.11 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 125.853 1.971 . . . . 0.0 108.093 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 56.82 49.59 13.94 Favored 'General case' 0 N--CA 1.522 3.148 0 O-C-N 125.505 1.753 . . . . 0.0 113.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -67.04 135.2 53.33 Favored 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -91.26 138.16 31.8 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 124.911 1.382 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.83 152.95 29.42 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 124.994 1.434 . . . . 0.0 107.774 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -140.98 6.01 1.96 Allowed 'General case' 0 N--CA 1.529 3.521 0 O-C-N 125.578 1.798 . . . . 0.0 111.768 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.07 22.39 0.05 OUTLIER Glycine 0 N--CA 1.509 3.563 0 O-C-N 124.075 0.859 . . . . 0.0 110.993 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.12 26.41 72.39 Favored Glycine 0 N--CA 1.508 3.454 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.149 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.75 154.66 43.68 Favored 'General case' 1 N--CA 1.54 4.07 0 O-C-N 125.217 1.186 . . . . 0.0 108.372 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 140.88 4.51 Favored Glycine 0 N--CA 1.509 3.55 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -135.54 150.49 49.75 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 125.734 1.491 . . . . 0.0 108.318 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -159.59 139.18 11.42 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 124.962 1.414 . . . . 0.0 111.884 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -93.31 135.62 34.36 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 125.147 1.53 . . . . 0.0 108.827 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.44 154.11 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 O-C-N 125.557 1.785 . . . . 0.0 106.949 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.91 138.92 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.13 139.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 O-C-N 125.394 1.684 . . . . 0.0 111.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -90.0 163.57 14.87 Favored 'General case' 0 N--CA 1.52 3.035 0 O-C-N 125.584 1.802 . . . . 0.0 106.434 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -62.38 -39.12 92.16 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.843 1.339 . . . . 0.0 111.144 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.36 153.93 35.79 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 126.36 2.287 . . . . 0.0 109.94 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -156.31 148.97 23.78 Favored 'General case' 0 N--CA 1.529 3.496 0 O-C-N 124.966 1.416 . . . . 0.0 111.663 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.05 107.01 2.55 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 125.56 1.787 . . . . 0.0 111.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.44 99.05 0.87 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.737 1.273 . . . . 0.0 110.153 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -93.33 103.6 15.82 Favored 'General case' 0 N--CA 1.524 3.242 0 O-C-N 125.294 1.232 . . . . 0.0 112.635 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.519 3.007 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.767 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.589 4.703 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.91 168.83 72.67 Favored 'Cis proline' 0 N--CA 1.527 3.467 0 CA-C-N 123.099 3.449 . . . . 0.0 112.51 -6.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.47 128.15 34.67 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 125.303 1.627 . . . . 0.0 110.537 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -78.66 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 CA-C-O 116.993 -1.479 . . . . 0.0 112.487 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.86 -171.35 42.27 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-N 120.271 1.396 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.64 128.15 35.41 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.665 1.45 . . . . 0.0 113.399 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.85 142.62 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 O-C-N 126.179 2.174 . . . . 0.0 106.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.48 146.32 36.16 Favored 'General case' 0 N--CA 1.529 3.525 0 O-C-N 126.079 2.112 . . . . 0.0 111.445 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.8 m -74.33 79.11 1.85 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 125.521 1.763 . . . . 0.0 111.896 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -37.33 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.66 -28.52 40.78 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 125.424 1.703 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.07 139.5 95.39 Favored Pre-proline 0 N--CA 1.515 2.817 0 CA-C-O 114.472 -2.68 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.97 -43.03 0.63 Allowed 'Trans proline' 0 C--N 1.41 3.809 0 CA-C-N 124.575 2.67 . . . . 0.0 112.786 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.72 61.58 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 124.862 1.351 . . . . 0.0 112.374 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.08 154.43 19.28 Favored Glycine 1 N--CA 1.518 4.101 0 O-C-N 125.287 1.228 . . . . 0.0 111.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.6 m -69.9 140.14 53.09 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 124.856 0.974 . . . . 0.0 111.683 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -145.54 139.27 26.62 Favored 'General case' 0 N--CA 1.526 3.337 0 O-C-N 125.369 1.668 . . . . 0.0 108.596 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.84 133.6 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.0 133.72 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.96 143.87 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.312 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.92 137.47 3.21 Favored Glycine 1 N--CA 1.52 4.268 0 O-C-N 124.151 0.907 . . . . 0.0 111.566 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.81 -160.42 35.6 Favored Glycine 1 N--CA 1.518 4.103 0 O-C-N 125.48 1.341 . . . . 0.0 112.405 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -70.51 -25.03 62.95 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 125.443 1.319 . . . . 0.0 112.941 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -70.88 -32.7 69.76 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.799 1.312 . . . . 0.0 110.436 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.72 14.09 44.79 Favored Glycine 0 N--CA 1.516 3.998 0 O-C-N 125.747 1.904 . . . . 0.0 113.16 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.5 103.24 3.45 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -73.05 173.68 8.99 Favored 'General case' 0 N--CA 1.519 3.011 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.13 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.09 80.13 0.08 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -67.86 154.32 41.83 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 125.307 1.239 . . . . 0.0 113.495 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.17 95.57 0.86 Allowed 'General case' 0 N--CA 1.523 3.212 0 O-C-N 125.127 1.517 . . . . 0.0 108.586 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.34 156.04 39.85 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 173.13 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.689 0 O-C-N 126.663 2.477 . . . . 0.0 107.153 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.6 m -155.19 116.0 3.91 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.056 0.848 . . . . 0.0 110.445 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -69.96 150.26 46.89 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 124.611 1.194 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.674 0 CA-C-O 116.389 -2.339 . . . . 0.0 111.516 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 2.677 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.09 129.8 5.26 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 124.937 1.398 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.48 144.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -160.24 144.06 14.06 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 124.927 1.392 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.11 142.28 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.062 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.25 112.86 1.72 Allowed Pre-proline 0 N--CA 1.527 3.403 0 CA-C-O 114.892 -2.48 . . . . 0.0 110.082 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -64.28 151.31 73.18 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.428 2.974 . . . . 0.0 112.102 -4.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.97 -8.89 1.58 Allowed 'General case' 0 N--CA 1.528 3.463 0 O-C-N 125.943 2.027 . . . . 0.0 112.817 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.2 p -132.73 151.58 51.95 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.321 1.638 . . . . 0.0 110.106 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.99 31.8 66.59 Favored Glycine 0 N--CA 1.514 3.881 0 O-C-N 124.993 1.433 . . . . 0.0 112.457 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.87 153.99 39.64 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 125.432 1.313 . . . . 0.0 110.234 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.88 -173.89 3.27 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 126.032 2.083 . . . . 0.0 108.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -66.56 128.94 38.18 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.644 1.215 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.08 28.71 69.89 Favored Glycine 0 N--CA 1.514 3.853 0 O-C-N 124.667 1.229 . . . . 0.0 112.794 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.39 127.21 31.87 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 124.924 1.014 . . . . 0.0 112.618 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 m -87.08 130.07 34.65 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 125.307 1.629 . . . . 0.0 106.803 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.63 143.49 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 125.607 1.817 . . . . 0.0 108.981 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.9 m -111.12 102.01 10.49 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 126.268 2.23 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.91 149.13 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.011 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -140.53 164.27 30.61 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 125.703 1.877 . . . . 0.0 110.174 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.24 145.33 14.84 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.53 1.769 . . . . 0.0 108.3 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -159.12 146.79 17.54 Favored 'General case' 0 N--CA 1.515 2.783 0 O-C-N 125.239 1.587 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.13 88.91 0.11 Allowed Glycine 0 N--CA 1.508 3.498 0 O-C-N 125.101 1.5 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -154.96 155.5 34.34 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 125.71 1.477 . . . . 0.0 107.783 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.1 -19.51 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.883 1.364 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -79.56 -51.16 9.66 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 124.427 1.08 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 p -70.87 119.97 15.78 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.894 1.371 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -79.79 -19.92 47.42 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 124.432 1.083 . . . . 0.0 112.909 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -166.38 150.09 7.39 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 125.233 1.583 . . . . 0.0 107.816 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.94 160.16 40.66 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 125.622 1.826 . . . . 0.0 110.373 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -151.14 129.75 12.25 Favored 'General case' 0 N--CA 1.517 2.913 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 121.78 24.25 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.651 1.219 . . . . 0.0 112.046 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 146.47 50.78 Favored 'General case' 0 N--CA 1.53 3.572 0 O-C-N 125.429 1.705 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.57 128.74 35.88 Favored 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.47 142.74 39.43 Favored 'General case' 0 N--CA 1.531 3.604 0 O-C-N 124.719 1.262 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.17 26.56 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 125.187 1.555 . . . . 0.0 111.181 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -79.33 122.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.142 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.95 -174.34 2.59 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.68 84.02 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 124.703 1.252 . . . . 0.0 110.84 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -21.45 59.79 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 125.434 1.709 . . . . 0.0 110.87 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.85 26.69 60.02 Favored Glycine 0 N--CA 1.513 3.789 0 CA-C-O 117.472 -1.738 . . . . 0.0 115.635 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -73.11 146.23 45.88 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.01 74.72 1.17 Allowed Glycine 0 N--CA 1.515 3.917 0 CA-C-O 118.114 -1.381 . . . . 0.0 115.854 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.08 97.88 9.56 Favored 'General case' 0 N--CA 1.515 2.816 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.21 143.3 49.85 Favored 'General case' 0 N--CA 1.527 3.414 0 O-C-N 124.874 1.359 . . . . 0.0 111.792 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -85.87 116.31 24.04 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 125.487 1.742 . . . . 0.0 108.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -65.53 -23.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.07 -12.18 61.45 Favored 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -79.89 -7.18 58.59 Favored 'General case' 1 N--CA 1.541 4.109 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -64.18 160.81 17.64 Favored 'General case' 0 N--CA 1.531 3.604 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -139.18 -52.42 0.55 Allowed 'General case' 0 N--CA 1.52 3.032 0 O-C-N 126.007 2.067 . . . . 0.0 108.071 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 45.58 116.1 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -171.22 144.04 1.98 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 m -65.07 157.0 29.68 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.806 1.316 . . . . 0.0 113.478 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.2 mt -79.5 147.67 32.13 Favored 'General case' 0 N--CA 1.513 2.703 0 O-C-N 125.326 1.641 . . . . 0.0 108.225 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -72.1 -26.04 61.99 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 124.637 1.211 . . . . 0.0 112.483 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.03 -36.5 0.05 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.51 19.67 0.02 OUTLIER Glycine 0 N--CA 1.502 3.076 0 CA-C-O 117.673 -1.626 . . . . 0.0 111.953 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 158.06 34.75 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.497 1.351 . . . . 0.0 109.146 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.37 139.63 4.2 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -142.35 151.16 41.63 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.74 134.98 5.42 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.96 1.412 . . . . 0.0 112.361 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 t -86.46 114.21 23.04 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 125.067 1.479 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.03 144.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 t -122.71 137.23 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.55 131.12 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 O-C-N 125.75 1.906 . . . . 0.0 113.005 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -90.12 161.83 15.59 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 125.225 1.578 . . . . 0.0 106.984 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -65.68 -32.85 74.64 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 124.727 1.267 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 m -131.29 150.21 52.24 Favored 'General case' 0 N--CA 1.528 3.427 0 O-C-N 125.991 2.057 . . . . 0.0 110.173 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -157.8 146.71 19.48 Favored 'General case' 0 N--CA 1.525 3.292 0 O-C-N 124.906 1.379 . . . . 0.0 111.518 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.4 m -69.25 113.0 6.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 125.608 1.818 . . . . 0.0 110.631 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.35 149.55 45.68 Favored Glycine 0 N--CA 1.513 3.828 0 O-C-N 124.974 1.421 . . . . 0.0 109.858 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -137.95 88.37 2.32 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.406 1.298 . . . . 0.0 108.551 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.518 2.964 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.316 -179.692 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.585 4.438 0 CA-C-O 115.305 -2.942 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.47 155.43 82.25 Favored 'Cis proline' 0 C--N 1.402 3.359 0 CA-C-N 123.948 3.874 . . . . 0.0 114.28 -1.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.79 134.14 48.22 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.604 1.815 . . . . 0.0 109.307 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -87.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.224 0 O-C-N 125.252 1.595 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.33 -174.71 42.51 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.97 118.56 12.05 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 125.663 1.449 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.06 133.33 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 O-C-N 125.989 2.056 . . . . 0.0 107.98 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.44 141.31 28.64 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 125.022 1.451 . . . . 0.0 111.338 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.3 t -83.5 72.51 10.26 Favored 'General case' 0 N--CA 1.513 2.724 0 O-C-N 125.232 1.583 . . . . 0.0 110.463 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.15 -32.73 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -79.66 -25.8 41.21 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.106 1.504 . . . . 0.0 111.252 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.96 150.71 97.66 Favored Pre-proline 0 N--CA 1.523 3.199 0 CA-C-O 115.101 -2.38 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.77 -48.79 0.22 Allowed 'Trans proline' 0 C--N 1.408 3.698 0 CA-C-N 123.711 2.361 . . . . 0.0 113.036 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.42 -46.95 24.01 Favored Glycine 0 N--CA 1.51 3.58 0 O-C-N 124.532 1.145 . . . . 0.0 112.558 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.82 172.43 48.85 Favored Glycine 1 N--CA 1.517 4.051 0 O-C-N 125.319 1.246 . . . . 0.0 110.89 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.7 m -70.11 153.42 43.17 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 124.783 0.931 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -157.78 135.24 10.39 Favored 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.77 137.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.857 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.81 131.7 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.16 140.23 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.61 -152.89 16.26 Favored Glycine 1 N--CA 1.517 4.097 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.64 -160.91 13.56 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -68.5 -34.09 75.29 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -125.07 -15.05 6.44 Favored 'General case' 1 N--CA 1.544 4.234 0 O-C-N 125.015 1.447 . . . . 0.0 111.835 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.41 -1.7 30.21 Favored Glycine 1 N--CA 1.527 4.755 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 63.89 173.09 0.18 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.903 1.281 . . . . 0.0 113.373 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -69.83 145.19 52.28 Favored 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.731 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.34 -64.14 2.47 Favored Glycine 0 N--CA 1.512 3.755 0 O-C-N 124.601 1.188 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 62.58 105.82 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.126 0 O-C-N 126.105 1.709 . . . . 0.0 113.568 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.25 95.8 1.27 Allowed 'General case' 0 N--CA 1.532 3.658 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.124 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.27 152.94 42.8 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.089 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pt -116.51 168.63 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 O-C-N 126.253 2.221 . . . . 0.0 108.748 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -140.94 157.57 45.17 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 124.851 1.344 . . . . 0.0 109.21 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -110.29 159.61 17.26 Favored 'General case' 0 N--CA 1.521 3.093 0 O-C-N 126.098 2.124 . . . . 0.0 109.826 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.312 0 CA-C-O 116.345 -2.364 . . . . 0.0 109.668 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 t -70.55 -29.46 65.93 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 125.128 1.518 . . . . 0.0 113.011 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.0 139.24 2.85 Favored 'General case' 0 N--CA 1.515 2.788 0 O-C-N 124.999 1.437 . . . . 0.0 109.359 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.81 131.78 35.98 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 124.947 1.404 . . . . 0.0 110.609 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -131.88 143.78 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.073 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.72 141.48 7.39 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 124.773 1.295 . . . . 0.0 109.786 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 t -121.74 141.33 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.306 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 p -160.42 113.01 1.38 Allowed Pre-proline 0 CA--C 1.608 3.176 0 CA-C-O 115.053 -2.403 . . . . 0.0 109.927 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -65.14 153.21 77.27 Favored 'Cis proline' 1 C--N 1.425 4.595 0 CA-C-N 125.458 2.985 . . . . 0.0 111.222 -3.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.22 -8.65 1.15 Allowed 'General case' 0 N--CA 1.529 3.513 0 O-C-N 125.872 1.983 . . . . 0.0 113.063 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -129.45 153.98 47.41 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.486 1.741 . . . . 0.0 110.86 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.28 28.25 68.39 Favored Glycine 1 N--CA 1.519 4.167 0 O-C-N 124.8 1.313 . . . . 0.0 113.118 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 mt -76.47 155.75 33.6 Favored 'General case' 0 N--CA 1.513 2.682 0 O-C-N 125.146 1.144 . . . . 0.0 110.282 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.82 -178.52 5.85 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 125.656 1.847 . . . . 0.0 107.222 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -69.35 142.83 53.9 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 124.592 1.183 . . . . 0.0 110.409 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.68 85.62 Favored Glycine 1 N--CA 1.521 4.337 0 O-C-N 124.981 1.426 . . . . 0.0 113.394 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.49 164.72 26.28 Favored 'General case' 0 N--CA 1.52 3.064 0 O-C-N 124.196 0.586 . . . . 0.0 111.153 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 m -145.98 121.91 10.66 Favored 'General case' 0 N--CA 1.511 2.608 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.5 -178.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.06 0 O-C-N 125.667 1.855 . . . . 0.0 110.047 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.0 m -143.25 92.61 2.39 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.6 t -79.76 149.39 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.659 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 p -135.24 162.03 33.71 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 126.141 2.15 . . . . 0.0 109.044 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.21 148.5 16.82 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 125.307 1.63 . . . . 0.0 108.68 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -157.04 149.52 23.24 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 125.4 1.687 . . . . 0.0 109.657 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.33 127.42 0.85 Allowed Glycine 1 N--CA 1.52 4.27 0 O-C-N 124.95 1.406 . . . . 0.0 111.988 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -147.98 161.62 40.98 Favored 'General case' 0 N--CA 1.522 3.154 0 C-N-CA 124.269 1.028 . . . . 0.0 109.818 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -168.95 -59.15 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.554 0 O-C-N 125.385 1.678 . . . . 0.0 108.529 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -80.24 -53.36 6.73 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.332 1.645 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.2 p -67.83 143.07 55.94 Favored 'General case' 0 N--CA 1.509 2.525 0 O-C-N 124.893 1.371 . . . . 0.0 112.273 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.535 3.801 0 O-C-N 125.689 1.868 . . . . 0.0 109.823 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -168.9 170.61 8.96 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.66 141.7 13.31 Favored 'General case' 0 N--CA 1.516 2.832 0 O-C-N 123.858 0.724 . . . . 0.0 111.194 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.53 172.89 11.41 Favored 'General case' 0 N--CA 1.524 3.249 0 O-C-N 126.173 2.171 . . . . 0.0 106.212 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.95 66.99 1.31 Allowed 'General case' 0 N--CA 1.531 3.612 0 O-C-N 125.421 1.701 . . . . 0.0 110.44 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -79.24 155.45 28.57 Favored 'General case' 0 N--CA 1.522 3.168 0 CA-C-N 113.239 -1.8 . . . . 0.0 109.872 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -137.73 136.54 37.43 Favored 'General case' 0 N--CA 1.521 3.107 0 O-C-N 125.771 1.919 . . . . 0.0 106.669 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 36.0 m -141.31 150.22 42.24 Favored 'General case' 0 N--CA 1.532 3.635 0 O-C-N 124.584 1.177 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.17 115.7 28.85 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 126.096 2.122 . . . . 0.0 110.963 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mm -79.2 137.43 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mt -122.08 -175.05 3.03 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.767 1.917 . . . . 0.0 106.294 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.91 -42.58 97.37 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.303 1.002 . . . . 0.0 111.993 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.4 -21.81 60.4 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.45 1.719 . . . . 0.0 111.163 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.37 24.42 73.15 Favored Glycine 0 N--CA 1.512 3.75 0 CA-C-O 117.621 -1.655 . . . . 0.0 115.873 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -75.03 145.12 42.68 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.59 75.9 1.19 Allowed Glycine 1 N--CA 1.517 4.098 0 O-C-N 124.813 1.321 . . . . 0.0 114.296 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.83 96.36 8.2 Favored 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.35 139.92 52.91 Favored 'General case' 0 N--CA 1.528 3.441 0 O-C-N 125.028 1.455 . . . . 0.0 112.575 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 50' ' ' ALA . 13.7 t30 -76.85 138.57 39.88 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 125.016 1.447 . . . . 0.0 109.369 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.08 -24.11 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 O-C-N 125.512 1.758 . . . . 0.0 114.613 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -79.16 -21.51 46.37 Favored 'General case' 0 N--CA 1.532 3.67 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' H ' HD22 ' A' ' 48' ' ' ASN . 19.0 mt-10 -82.72 1.6 37.92 Favored 'General case' 1 N--CA 1.549 4.482 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -69.69 168.78 14.18 Favored 'General case' 0 N--CA 1.533 3.722 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -133.82 -63.93 0.72 Allowed 'General case' 0 N--CA 1.524 3.229 0 O-C-N 125.614 1.821 . . . . 0.0 109.996 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t70 53.41 98.5 0.01 OUTLIER 'General case' 1 N--CA 1.54 4.029 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -157.51 150.01 22.85 Favored 'General case' 0 N--CA 1.523 3.223 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.9 p -65.74 167.74 8.82 Favored 'General case' 0 N--CA 1.52 3.07 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.1 mt -79.29 141.95 36.58 Favored 'General case' 0 N--CA 1.518 2.971 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.7 t -71.54 -25.19 62.12 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 124.408 1.067 . . . . 0.0 112.985 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.55 -39.19 0.06 OUTLIER Glycine 0 N--CA 1.496 2.639 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.32 18.28 0.02 OUTLIER Glycine 0 N--CA 1.501 3.03 0 O-C-N 125.287 1.228 . . . . 0.0 111.593 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -144.03 165.36 27.99 Favored 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.32 79.98 0.08 OUTLIER Glycine 0 N--CA 1.513 3.799 0 O-C-N 124.074 0.859 . . . . 0.0 111.658 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -74.87 149.72 39.43 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 125.539 1.376 . . . . 0.0 108.986 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.27 137.56 7.17 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.904 1.378 . . . . 0.0 112.93 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -90.04 112.84 24.41 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 125.219 1.575 . . . . 0.0 110.213 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.75 147.06 13.7 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.125 0 O-C-N 125.385 1.678 . . . . 0.0 107.012 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.28 150.01 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 125.855 1.972 . . . . 0.0 106.705 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.65 92.06 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.539 3.99 0 O-C-N 125.525 1.766 . . . . 0.0 110.009 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -86.56 154.14 21.29 Favored 'General case' 0 N--CA 1.523 3.218 0 CA-C-N 113.946 -1.479 . . . . 0.0 109.001 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -67.01 -20.97 65.96 Favored 'General case' 0 N--CA 1.522 3.135 0 O-C-N 124.721 1.263 . . . . 0.0 113.473 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -156.23 147.06 21.99 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 124.616 1.197 . . . . 0.0 109.645 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.87 149.53 21.74 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.879 1.362 . . . . 0.0 111.669 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.0 m -69.47 105.53 2.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 125.779 1.925 . . . . 0.0 110.047 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.3 159.67 53.45 Favored Glycine 0 N--CA 1.514 3.842 0 O-C-N 124.665 1.228 . . . . 0.0 111.235 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 119.05 14.41 Favored 'General case' 0 N--CA 1.527 3.404 0 O-C-N 125.596 1.409 . . . . 0.0 108.384 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.11 111.5 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 O-C-N 124.797 1.311 . . . . 0.0 107.607 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.2 169.49 0.02 OUTLIER Pre-proline 2 N--CA 1.567 5.377 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.23 -13.34 30.9 Favored 'Trans proline' 1 C--N 1.425 4.592 0 CA-C-N 123.884 2.423 . . . . 0.0 113.953 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.56 -39.27 32.23 Favored 'General case' 0 N--CA 1.51 2.528 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.44 -164.32 52.24 Favored Glycine 2 CA--C 1.583 4.34 0 CA-C-O 115.688 -2.729 . . . . 0.0 109.042 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -67.78 156.49 86.42 Favored 'Cis proline' 0 C--N 1.403 3.446 0 CA-C-N 123.668 3.734 . . . . 0.0 114.291 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -70.34 142.01 52.21 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 125.512 1.757 . . . . 0.0 109.301 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -38.51 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.49 0 O-C-N 125.231 1.582 . . . . 0.0 112.581 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.84 -166.68 23.79 Favored Glycine 0 N--CA 1.501 2.976 0 O-C-N 125.568 1.793 . . . . 0.0 108.93 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.75 116.92 5.64 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 125.823 1.543 . . . . 0.0 113.757 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.43 138.62 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 O-C-N 125.969 2.043 . . . . 0.0 107.407 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.21 144.48 28.12 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 125.303 1.627 . . . . 0.0 110.711 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 30.4 t -80.36 -32.81 37.65 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 125.05 1.469 . . . . 0.0 112.77 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.09 -25.65 63.62 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.62 -25.28 41.48 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.408 1.068 . . . . 0.0 113.244 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 155.46 91.39 Favored Pre-proline 0 N--CA 1.531 3.604 0 CA-C-O 115.573 -2.156 . . . . 0.0 112.025 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -72.84 -49.26 0.25 Allowed 'Trans proline' 0 C--N 1.413 3.938 0 CA-C-N 123.305 2.216 . . . . 0.0 113.612 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.55 -42.28 55.69 Favored Glycine 0 N--CA 1.511 3.655 0 O-C-N 124.627 1.205 . . . . 0.0 112.477 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 80.57 175.38 49.2 Favored Glycine 1 N--CA 1.518 4.116 0 O-C-N 125.163 1.155 . . . . 0.0 111.291 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.8 m -70.02 144.82 52.13 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.569 0.805 . . . . 0.0 112.453 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -146.12 127.67 15.1 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 125.806 1.941 . . . . 0.0 107.235 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.0 mm -79.77 137.09 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.556 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -129.48 134.61 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.525 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.34 136.9 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.358 0 N-CA-C 103.33 -2.841 . . . . 0.0 103.33 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 177.9 152.88 10.53 Favored Glycine 0 N--CA 1.509 3.541 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.78 -176.75 49.72 Favored Glycine 0 N--CA 1.508 3.471 0 O-C-N 125.346 1.262 . . . . 0.0 111.804 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -76.57 -16.6 59.56 Favored 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 113.9 -1.15 . . . . 0.0 113.003 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.98 -65.79 0.68 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 124.67 1.231 . . . . 0.0 112.526 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.74 12.85 0.02 OUTLIER Glycine 0 N--CA 1.515 3.924 0 CA-C-O 118.568 -1.129 . . . . 0.0 112.505 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -72.36 156.44 39.09 Favored 'General case' 0 N--CA 1.521 3.119 0 O-C-N 124.702 0.884 . . . . 0.0 109.857 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -153.9 158.81 41.29 Favored 'General case' 0 N--CA 1.522 3.147 0 O-C-N 124.758 1.286 . . . . 0.0 109.236 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.96 82.91 0.07 OUTLIER Glycine 0 N--CA 1.504 3.224 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -67.29 155.39 39.0 Favored 'General case' 0 N--CA 1.513 2.702 0 O-C-N 125.421 1.306 . . . . 0.0 113.377 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.69 101.79 1.5 Allowed 'General case' 0 N--CA 1.527 3.415 0 O-C-N 124.655 1.222 . . . . 0.0 110.426 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 155.37 40.72 Favored 'General case' 0 N--CA 1.514 2.732 0 CA-C-N 115.14 -0.936 . . . . 0.0 112.678 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 pt -116.78 177.1 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 126.476 2.36 . . . . 0.0 107.735 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 p -156.13 124.2 5.7 Favored 'General case' 0 N--CA 1.524 3.244 0 O-C-N 123.972 0.795 . . . . 0.0 111.674 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -75.3 158.22 33.18 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 124.11 0.882 . . . . 0.0 110.518 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.512 3.715 0 CA-C-O 116.31 -2.383 . . . . 0.0 111.338 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.349 -0.358 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -143.42 5.92 1.45 Allowed 'General case' 0 N--CA 1.526 3.347 0 O-C-N 125.985 2.053 . . . . 0.0 110.634 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.4 -173.23 0.11 Allowed 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 124.786 1.234 . . . . 0.0 114.284 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.22 123.7 3.54 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.676 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -117.9 146.81 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 103.312 -2.847 . . . . 0.0 103.312 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.57 140.89 16.61 Favored 'General case' 0 N--CA 1.518 2.929 0 O-C-N 125.166 1.541 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -128.53 144.57 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 N-CA-C 103.091 -2.929 . . . . 0.0 103.091 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -160.88 111.85 1.3 Allowed Pre-proline 0 N--CA 1.524 3.228 0 CA-C-O 115.054 -2.403 . . . . 0.0 109.745 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.41 151.78 70.21 Favored 'Cis proline' 1 C--N 1.425 4.594 0 CA-C-N 125.286 2.924 . . . . 0.0 112.439 -3.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.96 -3.56 2.0 Favored 'General case' 0 N--CA 1.528 3.452 0 O-C-N 125.98 2.05 . . . . 0.0 112.881 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.1 p -138.42 151.16 47.2 Favored 'General case' 0 N--CA 1.528 3.467 0 O-C-N 124.686 1.241 . . . . 0.0 109.89 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.24 32.25 68.8 Favored Glycine 1 N--CA 1.517 4.045 0 O-C-N 125.036 1.46 . . . . 0.0 112.879 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.8 mt -73.11 155.21 39.93 Favored 'General case' 0 N--CA 1.514 2.747 0 O-C-N 125.456 1.327 . . . . 0.0 110.364 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.31 -176.29 3.84 Favored 'General case' 0 N--CA 1.518 2.973 0 O-C-N 126.07 2.107 . . . . 0.0 108.574 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -67.17 127.49 32.81 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 124.75 1.281 . . . . 0.0 112.376 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.95 28.95 71.16 Favored Glycine 0 N--CA 1.516 3.99 0 O-C-N 124.811 1.32 . . . . 0.0 112.977 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.14 123.81 23.68 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 124.935 1.021 . . . . 0.0 112.649 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.1 m -79.88 128.03 32.96 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.7 143.54 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 O-C-N 125.596 1.81 . . . . 0.0 109.178 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.3 m -107.1 102.92 12.22 Favored 'General case' 0 N--CA 1.513 2.715 0 O-C-N 126.231 2.207 . . . . 0.0 110.602 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.81 147.21 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.5 158.47 43.02 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.23 2.206 . . . . 0.0 108.717 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.28 141.56 12.32 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 125.244 1.59 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -165.31 122.52 1.51 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.516 1.76 . . . . 0.0 107.875 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 172.16 -90.56 0.09 OUTLIER Glycine 0 N--CA 1.506 3.337 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . 0.284 0.0 OUTLIER 58.9 146.62 0.01 OUTLIER 'General case' 0 N--CA 1.538 3.963 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.88 -37.74 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.495 0 CA-C-N 113.9 -1.5 . . . . 0.0 109.411 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -136.84 -30.09 0.9 Allowed 'General case' 0 N--CA 1.527 3.416 0 O-C-N 126.007 2.067 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -73.36 109.46 6.9 Favored 'General case' 0 N--CA 1.523 3.19 0 O-C-N 124.658 1.224 . . . . 0.0 109.325 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.64 7.54 41.06 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.827 1.33 . . . . 0.0 112.726 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -160.46 167.72 26.66 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 124.398 1.061 . . . . 0.0 109.065 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.15 145.13 26.12 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.265 1.603 . . . . 0.0 109.898 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.1 m -142.0 169.77 16.97 Favored 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.18 125.38 4.46 Favored 'General case' 0 N--CA 1.527 3.411 0 O-C-N 124.23 0.956 . . . . 0.0 112.229 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.28 139.85 21.57 Favored 'General case' 0 N--CA 1.538 3.931 0 O-C-N 125.262 1.601 . . . . 0.0 109.551 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -87.83 148.74 24.52 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 35.3 m -142.42 149.54 39.44 Favored 'General case' 0 N--CA 1.524 3.268 0 O-C-N 125.581 1.801 . . . . 0.0 108.579 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -109.0 124.77 51.24 Favored 'General case' 0 N--CA 1.526 3.344 0 O-C-N 126.083 2.114 . . . . 0.0 111.896 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.7 mm -76.45 145.52 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.63 -175.76 3.56 Favored 'General case' 0 N--CA 1.525 3.321 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.41 -49.93 69.6 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.54 1.15 . . . . 0.0 111.654 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.63 -23.59 59.9 Favored 'General case' 0 N--CA 1.528 3.431 0 O-C-N 125.564 1.79 . . . . 0.0 110.219 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.0 32.93 60.13 Favored Glycine 0 N--CA 1.508 3.49 0 CA-C-O 116.921 -2.044 . . . . 0.0 117.187 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -75.79 150.2 37.78 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.75 89.33 0.38 Allowed Glycine 0 N--CA 1.511 3.676 0 O-C-N 124.722 1.264 . . . . 0.0 113.496 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.34 95.66 6.66 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.45 137.86 47.41 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 125.247 1.592 . . . . 0.0 111.223 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -78.91 117.82 20.35 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.94 1.4 . . . . 0.0 109.49 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 m -65.76 -21.48 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.369 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.97 -17.44 64.44 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 118.165 2.654 . . . . 0.0 118.165 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -83.04 2.06 36.91 Favored 'General case' 1 N--CA 1.55 4.533 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -67.38 167.38 12.67 Favored 'General case' 0 N--CA 1.53 3.552 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -146.17 -60.06 0.31 Allowed 'General case' 0 N--CA 1.511 2.59 0 O-C-N 126.057 2.098 . . . . 0.0 107.264 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.2 t70 45.44 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.757 1.911 . . . . 0.0 116.129 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.14 149.98 31.93 Favored 'General case' 0 N--CA 1.528 3.465 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.72 160.77 22.15 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.935 1.397 . . . . 0.0 114.759 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.39 149.82 31.54 Favored 'General case' 0 N--CA 1.517 2.9 0 O-C-N 125.178 1.549 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.0 t -76.31 -24.44 54.34 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.025 1.453 . . . . 0.0 112.217 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.2 -30.89 0.05 OUTLIER Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.16 3.66 0.02 OUTLIER Glycine 0 N--CA 1.512 3.749 0 CA-C-O 117.595 -1.67 . . . . 0.0 112.98 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -131.22 165.22 23.84 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.19 79.36 0.08 OUTLIER Glycine 0 N--CA 1.514 3.873 0 O-C-N 124.296 0.998 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 m -75.03 155.7 37.0 Favored 'General case' 0 N--CA 1.517 2.902 0 O-C-N 125.311 1.242 . . . . 0.0 109.872 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.84 135.81 6.66 Favored 'General case' 0 N--CA 1.524 3.267 0 O-C-N 124.611 1.195 . . . . 0.0 113.065 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 t -84.49 114.24 21.79 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 124.875 1.359 . . . . 0.0 110.167 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.42 149.49 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -124.35 140.27 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 N-CA-C 102.395 -3.187 . . . . 0.0 102.395 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.67 125.18 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 O-C-N 125.543 1.777 . . . . 0.0 112.511 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -90.17 159.58 16.68 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.886 1.366 . . . . 0.0 107.73 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -66.24 -32.89 74.59 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.713 1.258 . . . . 0.0 111.952 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 148.41 52.01 Favored 'General case' 0 N--CA 1.529 3.476 0 O-C-N 125.944 2.028 . . . . 0.0 109.763 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -157.17 145.44 19.42 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.714 1.259 . . . . 0.0 111.926 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 m -70.45 106.07 3.29 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.744 1.903 . . . . 0.0 109.037 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.58 151.42 49.48 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.028 1.455 . . . . 0.0 110.739 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -139.98 121.3 14.95 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 125.803 1.531 . . . . 0.0 109.018 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.08 146.77 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.52 -50.93 82.52 Favored Pre-proline 0 N--CA 1.537 3.885 0 N-CA-C 121.082 3.734 . . . . 0.0 121.082 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -65.4 -60.8 0.11 Allowed 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 125.113 2.862 . . . . 0.0 115.174 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.12 -47.33 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.656 0 O-C-N 124.195 0.934 . . . . 0.0 112.622 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.9 -168.44 39.33 Favored Glycine 0 N--CA 1.516 3.987 0 CA-C-O 115.564 -2.798 . . . . 0.0 109.133 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -71.63 139.94 62.26 Favored 'Cis proline' 0 C--N 1.409 3.723 0 CA-C-N 123.19 3.495 . . . . 0.0 113.078 0.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.16 137.56 51.12 Favored 'General case' 0 N--CA 1.513 2.679 0 O-C-N 125.237 1.586 . . . . 0.0 109.583 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.92 -92.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.968 0 O-C-N 125.669 1.855 . . . . 0.0 110.616 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.31 -173.44 43.08 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.46 75.42 3.2 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 125.846 1.557 . . . . 0.0 112.349 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.16 141.74 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 CA-C-N 113.759 -1.564 . . . . 0.0 108.828 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.96 156.05 18.26 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 125.375 1.672 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 19.8 t -73.8 -25.73 60.26 Favored 'General case' 0 N--CA 1.509 2.515 0 O-C-N 124.679 1.237 . . . . 0.0 112.887 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.15 -28.39 57.37 Favored 'General case' 0 N--CA 1.515 2.782 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -79.6 -21.63 44.75 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.341 1.026 . . . . 0.0 112.538 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.5 156.32 88.94 Favored Pre-proline 0 N--CA 1.531 3.578 0 CA-C-O 115.512 -2.185 . . . . 0.0 111.711 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.76 -45.44 0.52 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.332 2.226 . . . . 0.0 113.051 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -76.36 -101.94 0.14 Allowed Glycine 0 N--CA 1.5 2.948 0 O-C-N 124.836 1.335 . . . . 0.0 110.555 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.52 159.31 10.55 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 63.3 m -71.23 145.06 49.85 Favored 'General case' 0 N--CA 1.507 2.376 0 O-C-N 125.481 1.342 . . . . 0.0 110.044 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -144.4 133.21 22.46 Favored 'General case' 0 N--CA 1.533 3.69 0 O-C-N 125.254 1.596 . . . . 0.0 109.283 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 mm -79.72 135.73 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.825 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -131.06 134.31 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.444 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 t -128.3 140.67 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.044 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.72 145.62 6.88 Favored Glycine 0 N--CA 1.51 3.585 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.69 -170.91 38.68 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.016 1.068 . . . . 0.0 112.405 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -75.07 -12.65 60.37 Favored 'General case' 0 N--CA 1.51 2.567 0 CA-C-N 113.736 -1.232 . . . . 0.0 113.256 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.5 p -69.9 -70.66 0.27 Allowed 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.693 1.245 . . . . 0.0 111.384 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 166.48 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.512 3.722 0 CA-C-O 118.699 -1.056 . . . . 0.0 111.903 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -66.05 119.74 11.92 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 125.039 1.082 . . . . 0.0 112.013 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -86.99 -175.49 5.38 Favored 'General case' 0 N--CA 1.519 2.988 0 O-C-N 125.151 1.532 . . . . 0.0 110.31 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.39 78.16 0.09 OUTLIER Glycine 0 N--CA 1.507 3.394 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -67.71 152.05 46.25 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.445 1.321 . . . . 0.0 112.946 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 98.36 1.08 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 124.843 1.339 . . . . 0.0 109.737 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.07 150.32 45.64 Favored 'General case' 0 N--CA 1.513 2.699 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.937 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.06 172.16 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 O-C-N 126.324 2.265 . . . . 0.0 107.08 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.5 m -156.38 118.29 3.94 Favored 'General case' 0 N--CA 1.528 3.447 0 O-C-N 124.153 0.908 . . . . 0.0 111.42 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.21 147.93 44.21 Favored 'General case' 0 N--CA 1.509 2.516 0 O-C-N 124.507 1.129 . . . . 0.0 110.099 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.982 0 CA-C-O 116.08 -2.511 . . . . 0.0 112.815 179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.9 p -70.44 -27.42 64.24 Favored 'General case' 0 N--CA 1.509 2.523 0 O-C-N 125.185 1.553 . . . . 0.0 113.293 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.02 -172.01 0.15 Allowed 'General case' 0 N--CA 1.533 3.685 0 O-C-N 125.103 1.502 . . . . 0.0 113.339 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.23 132.24 6.15 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 118.98 -0.533 . . . . 0.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -131.83 145.44 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 N-CA-C 102.261 -3.237 . . . . 0.0 102.261 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -160.96 146.04 14.13 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 124.99 1.432 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.98 144.22 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.23 110.22 2.07 Favored Pre-proline 0 N--CA 1.528 3.462 0 CA-C-O 114.989 -2.434 . . . . 0.0 110.005 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.91 158.85 68.34 Favored 'Cis proline' 1 C--N 1.424 4.513 0 CA-C-N 125.158 2.878 . . . . 0.0 112.32 -3.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.0 -0.36 2.29 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 125.144 1.528 . . . . 0.0 112.831 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -140.05 151.74 45.65 Favored 'General case' 0 N--CA 1.528 3.462 0 O-C-N 124.74 1.275 . . . . 0.0 109.567 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.49 30.95 68.45 Favored Glycine 0 N--CA 1.512 3.703 0 O-C-N 124.953 1.408 . . . . 0.0 113.553 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.58 154.59 39.74 Favored 'General case' 0 N--CA 1.516 2.835 0 O-C-N 125.373 1.278 . . . . 0.0 109.379 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -126.43 -177.37 3.96 Favored 'General case' 0 N--CA 1.523 3.216 0 O-C-N 125.769 1.918 . . . . 0.0 110.179 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.64 129.87 41.24 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 124.866 1.354 . . . . 0.0 111.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.09 24.34 77.18 Favored Glycine 0 N--CA 1.512 3.715 0 O-C-N 124.606 1.191 . . . . 0.0 113.549 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.27 136.11 44.53 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.721 0.895 . . . . 0.0 111.428 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 m -99.6 127.3 45.7 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 125.819 1.949 . . . . 0.0 106.335 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.87 149.21 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.147 0 O-C-N 125.752 1.908 . . . . 0.0 109.924 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 m -103.72 96.38 6.67 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 126.081 2.113 . . . . 0.0 110.648 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.9 147.32 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.119 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.1 p -133.91 162.41 32.1 Favored 'General case' 0 N--CA 1.514 2.743 0 O-C-N 125.857 1.973 . . . . 0.0 110.174 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.22 139.2 10.65 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 125.544 1.777 . . . . 0.0 106.977 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 p -160.59 153.39 21.16 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.749 1.281 . . . . 0.0 110.853 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 73.35 79.1 0.52 Allowed Glycine 0 N--CA 1.505 3.299 0 O-C-N 124.893 1.37 . . . . 0.0 113.157 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -79.51 173.26 12.77 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 125.677 1.457 . . . . 0.0 110.939 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -165.38 -38.24 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.438 1.086 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.99 -46.63 1.38 Allowed 'General case' 0 N--CA 1.525 3.317 0 O-C-N 126.15 2.156 . . . . 0.0 111.414 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 p -70.56 121.81 18.54 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 124.847 1.342 . . . . 0.0 113.321 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.02 3.44 38.83 Favored 'General case' 0 N--CA 1.525 3.306 0 O-C-N 125.479 1.737 . . . . 0.0 110.962 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.67 162.69 18.98 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.34 150.56 19.98 Favored 'General case' 0 N--CA 1.524 3.23 0 O-C-N 124.18 0.925 . . . . 0.0 111.234 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.1 m -142.07 147.12 36.28 Favored 'General case' 0 N--CA 1.523 3.219 0 O-C-N 125.871 1.982 . . . . 0.0 107.079 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -101.62 125.04 48.21 Favored 'General case' 0 N--CA 1.526 3.327 0 O-C-N 125.91 2.006 . . . . 0.0 112.448 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -122.46 152.11 40.61 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.587 1.804 . . . . 0.0 107.983 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -135.78 63.26 1.6 Allowed 'General case' 0 N--CA 1.537 3.921 0 O-C-N 125.508 1.755 . . . . 0.0 111.389 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.7 m -72.88 148.94 43.91 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.974 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.21 112.26 24.87 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 126.379 2.3 . . . . 0.0 109.712 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mm -75.54 123.7 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.781 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.1 mt -103.22 -173.39 2.3 Favored 'General case' 0 N--CA 1.528 3.473 0 O-C-N 125.223 1.577 . . . . 0.0 106.836 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.51 82.31 Favored 'General case' 0 N--CA 1.515 2.819 0 O-C-N 124.355 1.035 . . . . 0.0 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.11 -21.5 59.86 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 125.192 1.558 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.83 59.45 Favored Glycine 0 N--CA 1.509 3.556 0 CA-C-O 117.49 -1.728 . . . . 0.0 115.118 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -71.9 142.1 49.51 Favored 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.15 76.06 1.28 Allowed Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.908 1.38 . . . . 0.0 114.37 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.33 97.86 11.44 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.213 1.184 . . . . 0.0 108.171 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.52 140.29 47.13 Favored 'General case' 0 N--CA 1.525 3.297 0 O-C-N 125.115 1.509 . . . . 0.0 110.896 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -77.11 133.11 39.11 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 125.263 1.602 . . . . 0.0 110.081 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.54 -14.4 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.399 0 O-C-N 125.12 1.512 . . . . 0.0 114.009 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.56 53.57 Favored 'General case' 0 N--CA 1.539 3.98 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -80.95 -3.12 50.46 Favored 'General case' 1 N--CA 1.546 4.361 0 O-C-N 124.255 0.972 . . . . 0.0 113.57 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -68.13 168.33 12.33 Favored 'General case' 0 N--CA 1.535 3.798 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -143.79 -66.63 0.35 Allowed 'General case' 0 N--CA 1.526 3.339 0 O-C-N 125.486 1.741 . . . . 0.0 109.194 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 52.22 127.81 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -172.84 145.43 1.45 Allowed 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 m -67.24 163.19 20.98 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.703 1.252 . . . . 0.0 112.657 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 17.9 mt -79.25 149.38 31.88 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 124.83 1.331 . . . . 0.0 109.379 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -73.54 -26.85 61.04 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 124.896 1.372 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.89 -31.6 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.62 14.43 0.02 OUTLIER Glycine 0 N--CA 1.51 3.609 0 CA-C-O 117.687 -1.618 . . . . 0.0 112.902 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.6 160.16 41.15 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.32 86.46 0.07 OUTLIER Glycine 0 N--CA 1.51 3.63 0 O-C-N 124.49 1.119 . . . . 0.0 111.074 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -74.25 155.54 38.16 Favored 'General case' 0 N--CA 1.517 2.897 0 O-C-N 125.259 1.211 . . . . 0.0 109.189 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -157.6 135.51 10.79 Favored 'General case' 0 N--CA 1.53 3.565 0 O-C-N 124.69 1.244 . . . . 0.0 112.646 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 t -90.69 124.97 35.51 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 125.022 1.451 . . . . 0.0 108.522 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 t -123.73 144.57 32.96 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.072 0 O-C-N 125.47 1.731 . . . . 0.0 107.062 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 t -115.38 138.46 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.2 m -128.48 119.47 50.39 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.329 0 O-C-N 125.262 1.602 . . . . 0.0 111.777 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -90.46 162.59 15.0 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.078 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -67.35 -29.06 68.51 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.766 1.291 . . . . 0.0 111.766 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.0 t -148.31 154.3 39.82 Favored 'General case' 0 N--CA 1.533 3.706 0 O-C-N 124.853 1.345 . . . . 0.0 109.084 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -158.58 148.21 19.39 Favored 'General case' 0 N--CA 1.525 3.277 0 O-C-N 124.9 1.375 . . . . 0.0 111.675 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.3 m -67.95 100.54 0.98 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 125.783 1.927 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.59 155.41 51.17 Favored Glycine 0 N--CA 1.505 3.249 0 O-C-N 125.116 1.51 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -137.95 123.3 19.46 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 125.901 1.589 . . . . 0.0 107.602 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.0 144.73 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.216 0 O-C-N 125.266 1.604 . . . . 0.0 107.288 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.15 -49.33 94.56 Favored Pre-proline 0 N--CA 1.529 3.496 0 N-CA-C 121.256 3.799 . . . . 0.0 121.256 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -64.26 -55.33 0.62 Allowed 'Trans proline' 0 C--N 1.397 3.104 0 CA-C-N 125.498 2.999 . . . . 0.0 115.511 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.05 -60.32 0.06 Allowed 'General case' 0 N--CA 1.536 3.862 0 O-C-N 124.478 1.111 . . . . 0.0 113.029 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.34 -169.07 42.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 115.595 -2.781 . . . . 0.0 108.53 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -72.26 152.39 97.18 Favored 'Cis proline' 0 N--CA 1.53 3.649 0 CA-C-N 123.267 3.533 . . . . 0.0 113.08 -1.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -67.35 143.7 56.22 Favored 'General case' 0 N--CA 1.517 2.903 0 O-C-N 125.341 1.651 . . . . 0.0 111.044 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.66 -31.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.003 0 O-C-N 125.668 1.855 . . . . 0.0 110.72 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.72 -169.03 36.62 Favored Glycine 0 N--CA 1.494 2.539 0 O-C-N 125.498 1.749 . . . . 0.0 109.395 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.86 113.42 2.77 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 125.987 1.639 . . . . 0.0 113.886 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.47 132.14 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 O-C-N 126.152 2.158 . . . . 0.0 107.439 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.59 148.98 36.65 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.532 1.145 . . . . 0.0 110.538 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 43.9 t -77.12 -30.74 55.35 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 124.841 1.338 . . . . 0.0 112.623 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -70.74 -24.01 62.54 Favored 'General case' 0 N--CA 1.514 2.767 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.61 -26.59 41.17 Favored 'General case' 0 N--CA 1.533 3.72 0 O-C-N 124.21 0.944 . . . . 0.0 113.014 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.1 154.81 91.88 Favored Pre-proline 0 N--CA 1.53 3.528 0 CA-C-O 115.513 -2.184 . . . . 0.0 111.986 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.09 -51.16 0.17 Allowed 'Trans proline' 0 C--N 1.411 3.849 0 CA-C-N 123.396 2.249 . . . . 0.0 113.577 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.8 -36.4 57.9 Favored Glycine 0 N--CA 1.51 3.591 0 O-C-N 124.458 1.099 . . . . 0.0 112.371 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 79.09 -179.31 53.0 Favored Glycine 0 N--CA 1.516 3.972 0 O-C-N 125.045 1.085 . . . . 0.0 111.038 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.8 m -70.77 146.63 49.66 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 124.619 0.834 . . . . 0.0 111.73 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -144.92 131.79 20.18 Favored 'General case' 0 N--CA 1.525 3.309 0 O-C-N 125.549 1.781 . . . . 0.0 107.123 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -79.73 130.28 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.01 134.56 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -129.83 137.74 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.951 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.41 142.71 5.11 Favored Glycine 0 N--CA 1.509 3.565 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.29 -165.78 40.78 Favored Glycine 0 N--CA 1.515 3.964 0 O-C-N 125.717 1.481 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -77.9 -16.71 58.02 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.358 1.269 . . . . 0.0 112.687 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 21.6 p -126.39 -18.31 4.92 Favored 'General case' 0 N--CA 1.528 3.451 0 O-C-N 125.378 1.673 . . . . 0.0 109.091 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.52 -7.65 65.01 Favored Glycine 1 N--CA 1.523 4.445 0 CA-C-O 118.656 -1.08 . . . . 0.0 114.869 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.251 4.4 mm-40 62.15 -94.19 0.04 OUTLIER 'General case' 0 N--CA 1.527 3.411 0 C-N-CA 125.112 1.365 . . . . 0.0 112.644 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -162.44 156.53 21.27 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 123.826 0.704 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.22 92.12 0.12 Allowed Glycine 0 N--CA 1.515 3.956 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.91 163.91 18.63 Favored 'General case' 0 N--CA 1.515 2.793 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.47 94.71 0.98 Allowed 'General case' 0 N--CA 1.522 3.14 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.588 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.59 144.13 55.73 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -117.95 172.22 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.679 0 O-C-N 126.381 2.3 . . . . 0.0 106.865 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 m -157.25 120.47 4.06 Favored 'General case' 0 N--CA 1.527 3.378 0 O-C-N 124.287 0.992 . . . . 0.0 111.374 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -73.65 154.24 39.8 Favored 'General case' 0 N--CA 1.508 2.441 0 O-C-N 124.595 1.185 . . . . 0.0 110.349 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.516 4.018 0 CA-C-O 116.306 -2.385 . . . . 0.0 112.569 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.6 p -144.63 11.38 1.44 Allowed 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.959 2.037 . . . . 0.0 110.099 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.4 168.45 19.2 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 124.016 0.822 . . . . 0.0 112.889 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.07 124.37 3.76 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 125.139 1.524 . . . . 0.0 109.953 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.8 137.98 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 N-CA-C 103.216 -2.883 . . . . 0.0 103.216 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -163.32 122.75 2.12 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 124.715 1.259 . . . . 0.0 110.378 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.1 149.06 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -154.56 106.87 2.37 Favored Pre-proline 0 N--CA 1.528 3.466 0 CA-C-O 115.308 -2.282 . . . . 0.0 109.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.65 163.01 48.21 Favored 'Cis proline' 2 C--N 1.427 4.696 0 CA-C-N 124.926 2.795 . . . . 0.0 113.025 -3.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.54 -8.18 0.98 Allowed 'General case' 0 N--CA 1.533 3.689 0 O-C-N 124.765 1.291 . . . . 0.0 113.221 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.8 p -134.84 153.27 52.11 Favored 'General case' 0 N--CA 1.529 3.495 0 O-C-N 125.091 1.495 . . . . 0.0 110.389 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.67 28.88 66.42 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 124.926 1.392 . . . . 0.0 113.413 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.0 mt -73.59 154.44 39.79 Favored 'General case' 0 N--CA 1.516 2.865 0 O-C-N 125.289 1.229 . . . . 0.0 109.803 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.44 -175.71 3.39 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.944 2.027 . . . . 0.0 109.802 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -67.75 129.71 40.76 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.638 1.211 . . . . 0.0 112.014 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.71 28.55 68.92 Favored Glycine 0 N--CA 1.513 3.779 0 O-C-N 124.587 1.18 . . . . 0.0 112.54 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.36 139.81 48.1 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 125.07 1.1 . . . . 0.0 111.96 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.1 m -101.34 131.76 47.24 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 126.159 2.162 . . . . 0.0 105.19 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.95 145.47 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.052 0 O-C-N 125.651 1.845 . . . . 0.0 110.208 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.2 m -103.75 99.06 8.84 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 126.251 2.219 . . . . 0.0 109.92 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.79 144.13 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 103.878 -2.638 . . . . 0.0 103.878 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 p -139.24 155.86 47.49 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 126.018 2.073 . . . . 0.0 110.052 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.16 152.23 20.43 Favored 'General case' 0 N--CA 1.513 2.718 0 O-C-N 125.026 1.454 . . . . 0.0 108.015 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 p -160.88 137.65 8.78 Favored 'General case' 0 N--CA 1.517 2.892 0 O-C-N 124.953 1.408 . . . . 0.0 111.356 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.81 67.33 2.01 Favored Glycine 0 N--CA 1.511 3.643 0 O-C-N 124.926 1.391 . . . . 0.0 113.634 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -71.19 149.55 46.2 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 125.476 1.339 . . . . 0.0 110.411 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.85 -70.55 0.24 Allowed 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.81 -27.37 2.1 Favored 'General case' 1 N--CA 1.541 4.114 0 O-C-N 124.923 1.389 . . . . 0.0 110.633 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 p -59.27 114.54 2.7 Favored 'General case' 0 N--CA 1.522 3.149 0 O-C-N 125.02 1.45 . . . . 0.0 111.467 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -92.95 13.51 20.4 Favored 'General case' 0 N--CA 1.53 3.539 0 O-C-N 125.43 1.706 . . . . 0.0 112.756 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 m -161.85 158.55 25.68 Favored 'General case' 0 N--CA 1.524 3.242 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.13 143.59 13.95 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 124.283 0.989 . . . . 0.0 112.232 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.66 179.14 4.09 Favored 'General case' 0 N--CA 1.514 2.741 0 O-C-N 126.646 2.466 . . . . 0.0 105.965 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.44 99.22 2.88 Favored 'General case' 0 N--CA 1.525 3.312 0 O-C-N 125.245 1.59 . . . . 0.0 109.599 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -116.57 157.18 25.71 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.637 1.835 . . . . 0.0 108.742 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.25 121.8 17.32 Favored 'General case' 0 N--CA 1.511 2.596 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.6 m -123.87 151.83 43.03 Favored 'General case' 0 N--CA 1.527 3.375 0 O-C-N 125.381 1.676 . . . . 0.0 111.249 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.09 28.59 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 125.613 1.82 . . . . 0.0 110.58 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.3 141.29 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.938 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -128.94 -175.05 3.43 Favored 'General case' 0 N--CA 1.525 3.282 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.6 -42.96 98.21 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 124.59 1.181 . . . . 0.0 112.093 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -22.41 60.67 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 125.283 1.614 . . . . 0.0 111.323 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.42 27.52 67.62 Favored Glycine 0 N--CA 1.513 3.773 0 CA-C-O 117.826 -1.541 . . . . 0.0 115.772 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -74.58 147.34 41.78 Favored 'General case' 0 N--CA 1.526 3.371 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.98 69.63 2.66 Favored Glycine 1 N--CA 1.517 4.073 0 O-C-N 124.937 1.398 . . . . 0.0 114.241 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.95 99.69 9.24 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.33 146.37 48.37 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 124.592 1.183 . . . . 0.0 111.055 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 50' ' ' ALA . 13.5 t30 -83.76 127.1 33.55 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.663 1.852 . . . . 0.0 109.17 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 m -65.17 -24.6 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -67.87 -13.17 61.93 Favored 'General case' 1 N--CA 1.54 4.057 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -79.95 -6.18 57.03 Favored 'General case' 1 N--CA 1.539 4.017 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -67.44 165.57 16.37 Favored 'General case' 0 N--CA 1.529 3.521 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.0 m80 -146.24 -61.52 0.31 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 125.854 1.971 . . . . 0.0 107.243 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 56.55 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 O-C-N 125.564 1.79 . . . . 0.0 115.095 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -158.42 148.37 19.78 Favored 'General case' 0 N--CA 1.531 3.621 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -70.15 165.86 21.15 Favored 'General case' 0 N--CA 1.516 2.844 0 O-C-N 124.665 1.228 . . . . 0.0 113.43 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.9 mt -79.54 151.0 30.95 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 124.566 1.166 . . . . 0.0 109.413 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.5 t -72.5 -31.37 65.31 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 124.834 1.334 . . . . 0.0 111.562 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.29 -31.56 0.05 OUTLIER Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.12 18.59 0.03 OUTLIER Glycine 0 N--CA 1.51 3.623 0 CA-C-O 118.303 -1.276 . . . . 0.0 112.106 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -143.25 166.37 24.9 Favored 'General case' 0 N--CA 1.539 3.983 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.6 70.7 0.09 OUTLIER Glycine 0 N--CA 1.513 3.778 0 O-C-N 124.268 0.98 . . . . 0.0 111.869 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -74.3 149.55 40.63 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 125.261 1.212 . . . . 0.0 108.977 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -162.23 136.99 6.9 Favored 'General case' 1 N--CA 1.543 4.203 0 O-C-N 124.83 1.331 . . . . 0.0 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -84.23 132.08 34.68 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 125.014 1.446 . . . . 0.0 110.13 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.29 143.71 40.34 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.399 0 O-C-N 125.417 1.698 . . . . 0.0 106.854 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.1 t -113.02 133.41 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 m -131.27 126.02 58.07 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.126 0 O-C-N 125.573 1.796 . . . . 0.0 111.379 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -90.18 158.77 17.08 Favored 'General case' 0 N--CA 1.525 3.281 0 C-N-CA 124.711 1.205 . . . . 0.0 108.624 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -69.97 -26.22 63.99 Favored 'General case' 0 N--CA 1.526 3.351 0 O-C-N 124.872 1.358 . . . . 0.0 112.146 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.49 145.88 32.11 Favored 'General case' 0 N--CA 1.527 3.409 0 O-C-N 125.067 1.48 . . . . 0.0 109.229 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -157.29 148.95 22.22 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 124.938 1.398 . . . . 0.0 111.892 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.4 m -70.96 101.16 2.11 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 125.866 1.979 . . . . 0.0 108.404 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.86 152.81 51.75 Favored Glycine 0 N--CA 1.509 3.531 0 O-C-N 125.124 1.515 . . . . 0.0 111.082 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -137.56 120.75 16.79 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 126.023 1.66 . . . . 0.0 109.083 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.49 148.55 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 O-C-N 125.303 1.627 . . . . 0.0 107.193 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.263 9.7 tpt -49.82 -55.42 23.69 Favored Pre-proline 0 N--CA 1.524 3.265 0 N-CA-C 119.505 3.15 . . . . 0.0 119.505 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -65.06 -64.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.398 3.14 0 CA-C-N 125.028 2.831 . . . . 0.0 115.127 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.27 -43.04 0.05 OUTLIER 'General case' 0 N--CA 1.531 3.624 0 CA-C-N 119.136 0.88 . . . . 0.0 112.665 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.39 -171.4 42.41 Favored Glycine 0 N--CA 1.515 3.904 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.438 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -71.92 138.93 56.66 Favored 'Cis proline' 0 C--N 1.41 3.77 0 CA-C-N 123.096 3.448 . . . . 0.0 112.795 0.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -69.03 138.64 54.62 Favored 'General case' 0 N--CA 1.516 2.873 0 O-C-N 125.21 1.569 . . . . 0.0 110.214 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -36.84 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.145 0 O-C-N 125.397 1.686 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.15 -169.77 36.75 Favored Glycine 0 N--CA 1.497 2.721 0 O-C-N 125.371 1.669 . . . . 0.0 109.24 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.3 108.37 0.91 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 126.004 1.65 . . . . 0.0 113.085 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -131.32 137.35 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.013 0 O-C-N 125.938 2.024 . . . . 0.0 108.189 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.62 139.79 36.05 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 124.986 1.429 . . . . 0.0 109.313 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.0 t -80.0 -21.84 43.18 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 124.831 1.332 . . . . 0.0 112.556 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -73.43 -26.51 60.98 Favored 'General case' 0 N--CA 1.513 2.703 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.3 p -79.74 -22.98 42.61 Favored 'General case' 0 N--CA 1.532 3.643 0 O-C-N 124.487 1.117 . . . . 0.0 113.194 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.11 156.16 88.61 Favored Pre-proline 0 N--CA 1.533 3.709 0 CA-C-O 115.588 -2.149 . . . . 0.0 112.254 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -72.7 -49.7 0.25 Allowed 'Trans proline' 0 C--N 1.412 3.912 0 CA-C-N 123.335 2.227 . . . . 0.0 113.714 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.98 -38.75 59.82 Favored Glycine 0 N--CA 1.512 3.725 0 O-C-N 124.696 1.247 . . . . 0.0 111.791 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.42 52.57 Favored Glycine 0 N--CA 1.511 3.652 0 O-C-N 125.112 1.125 . . . . 0.0 112.241 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.95 152.17 40.17 Favored 'General case' 0 N--CA 1.514 2.766 0 O-C-N 124.883 0.99 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -153.49 132.45 12.49 Favored 'General case' 0 N--CA 1.521 3.115 0 O-C-N 125.893 1.996 . . . . 0.0 107.628 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -79.88 136.18 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.821 0 N-CA-C 102.475 -3.157 . . . . 0.0 102.475 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.3 t -131.19 132.72 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.567 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.0 t -127.33 138.14 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.214 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 178.8 141.53 4.42 Favored Glycine 1 N--CA 1.517 4.089 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.15 -159.06 30.64 Favored Glycine 1 N--CA 1.518 4.132 0 O-C-N 125.198 1.175 . . . . 0.0 112.53 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -8.75 59.57 Favored 'General case' 0 N--CA 1.511 2.595 0 O-C-N 125.625 1.426 . . . . 0.0 113.0 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.0 p -70.0 -70.88 0.26 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 124.913 1.383 . . . . 0.0 110.867 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.16 -24.61 0.18 Allowed Glycine 0 N--CA 1.51 3.588 0 O-C-N 124.184 0.928 . . . . 0.0 111.328 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -65.66 120.77 13.55 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 125.086 1.109 . . . . 0.0 112.771 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -90.31 -169.9 2.57 Favored 'General case' 0 N--CA 1.517 2.911 0 O-C-N 125.317 1.635 . . . . 0.0 109.514 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.26 76.28 0.09 OUTLIER Glycine 0 N--CA 1.509 3.548 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.34 148.8 49.19 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 125.391 1.289 . . . . 0.0 112.605 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.3 99.36 1.05 Allowed 'General case' 0 N--CA 1.529 3.507 0 O-C-N 124.972 1.42 . . . . 0.0 110.165 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.38 144.66 49.76 Favored 'General case' 0 N--CA 1.514 2.725 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.628 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 169.16 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.775 0 O-C-N 126.287 2.242 . . . . 0.0 107.896 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 t -140.1 159.26 42.59 Favored 'General case' 0 N--CA 1.528 3.432 0 O-C-N 124.68 1.238 . . . . 0.0 110.248 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -107.92 163.22 13.32 Favored 'General case' 0 N--CA 1.518 2.949 0 O-C-N 126.14 2.15 . . . . 0.0 110.06 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.513 3.797 0 CA-C-O 116.336 -2.369 . . . . 0.0 111.268 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -70.01 -35.3 74.25 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 125.45 1.719 . . . . 0.0 112.266 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -166.85 123.18 1.19 Allowed 'General case' 0 N--CA 1.514 2.745 0 O-C-N 125.518 1.761 . . . . 0.0 108.693 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.1 131.11 35.69 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 124.679 1.237 . . . . 0.0 111.06 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.85 140.49 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.993 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -163.7 143.18 8.2 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.973 1.421 . . . . 0.0 110.547 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -121.13 143.0 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.025 0 N-CA-C 102.285 -3.228 . . . . 0.0 102.285 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -157.54 111.56 1.84 Allowed Pre-proline 0 N--CA 1.528 3.439 0 CA-C-O 114.903 -2.475 . . . . 0.0 109.839 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.03 153.03 76.86 Favored 'Cis proline' 1 C--N 1.424 4.519 0 CA-C-N 125.555 3.02 . . . . 0.0 111.57 -2.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.47 -6.58 1.54 Allowed 'General case' 0 N--CA 1.529 3.485 0 O-C-N 125.853 1.971 . . . . 0.0 112.638 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.4 p -134.36 151.55 51.29 Favored 'General case' 0 N--CA 1.522 3.126 0 O-C-N 125.164 1.54 . . . . 0.0 109.978 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.12 31.61 66.39 Favored Glycine 0 N--CA 1.511 3.679 0 O-C-N 125.027 1.454 . . . . 0.0 112.786 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.5 mt -74.28 153.55 39.34 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.359 1.27 . . . . 0.0 109.968 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -176.07 4.16 Favored 'General case' 0 N--CA 1.524 3.232 0 O-C-N 125.834 1.959 . . . . 0.0 108.755 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.41 136.35 56.38 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.756 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.51 30.44 60.21 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.587 1.179 . . . . 0.0 111.709 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.98 150.66 43.87 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 125.216 1.186 . . . . 0.0 110.45 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 m -128.93 101.16 5.95 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 126.22 2.2 . . . . 0.0 107.382 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 m -89.82 157.4 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 O-C-N 126.076 2.11 . . . . 0.0 109.671 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.3 m -128.48 96.45 4.42 Favored 'General case' 0 N--CA 1.512 2.673 0 O-C-N 126.171 2.169 . . . . 0.0 106.082 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.7 148.29 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -140.47 160.86 39.07 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 126.045 2.091 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 131.83 6.02 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.4 m -126.33 13.52 7.68 Favored 'General case' 0 N--CA 1.535 3.824 0 O-C-N 125.583 1.802 . . . . 0.0 112.979 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -170.02 158.34 30.33 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -141.92 -172.27 3.53 Favored 'General case' 0 N--CA 1.515 2.81 0 O-C-N 126.579 1.987 . . . . 0.0 107.361 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.82 -30.52 0.07 Allowed 'General case' 0 N--CA 1.514 2.768 0 O-C-N 124.369 1.043 . . . . 0.0 111.435 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.59 -40.38 0.3 Allowed 'General case' 0 N--CA 1.527 3.396 0 O-C-N 125.399 1.687 . . . . 0.0 110.548 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 p -67.93 113.21 5.45 Favored 'General case' 0 N--CA 1.521 3.103 0 O-C-N 124.946 1.404 . . . . 0.0 112.011 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.65 7.93 39.19 Favored 'General case' 0 N--CA 1.533 3.698 0 O-C-N 124.741 1.276 . . . . 0.0 112.554 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -165.54 162.03 18.89 Favored 'General case' 0 N--CA 1.526 3.357 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.14 152.09 20.28 Favored 'General case' 0 N--CA 1.522 3.146 0 O-C-N 124.068 0.855 . . . . 0.0 111.552 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 27.5 m -144.65 142.25 29.97 Favored 'General case' 0 N--CA 1.52 3.041 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.04 130.78 55.48 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.676 1.86 . . . . 0.0 114.073 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.47 139.03 19.59 Favored 'General case' 0 N--CA 1.532 3.647 0 O-C-N 125.047 1.467 . . . . 0.0 109.619 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -100.4 150.14 22.92 Favored 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.9 m -144.23 143.23 30.95 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 125.047 1.467 . . . . 0.0 109.243 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.85 114.72 27.21 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 125.327 1.642 . . . . 0.0 110.881 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.2 mm -78.76 120.97 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.127 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.88 -174.86 2.8 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.38 -44.64 82.53 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 124.646 1.216 . . . . 0.0 112.404 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -21.9 60.81 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.151 1.532 . . . . 0.0 111.473 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.07 22.66 57.03 Favored Glycine 0 N--CA 1.511 3.679 0 CA-C-O 117.356 -1.802 . . . . 0.0 115.003 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -71.4 140.96 50.32 Favored 'General case' 0 N--CA 1.523 3.213 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 75.01 1.42 Allowed Glycine 1 N--CA 1.516 4.001 0 CA-C-O 118.173 -1.349 . . . . 0.0 115.154 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.1 100.1 10.3 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 m -129.45 146.43 51.3 Favored 'General case' 0 N--CA 1.529 3.497 0 O-C-N 124.949 1.406 . . . . 0.0 110.836 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -91.04 123.82 34.8 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 125.854 1.972 . . . . 0.0 109.559 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -64.71 -25.71 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.286 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.46 -5.38 32.46 Favored 'General case' 0 N--CA 1.532 3.645 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -79.78 -12.57 59.77 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 123.898 0.749 . . . . 0.0 112.982 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.4 159.91 17.29 Favored 'General case' 0 N--CA 1.529 3.51 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -148.25 -44.65 0.16 Allowed 'General case' 0 N--CA 1.513 2.721 0 O-C-N 125.685 1.866 . . . . 0.0 109.788 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 63.49 130.88 0.01 OUTLIER 'General case' 0 N--CA 1.534 3.726 0 O-C-N 125.466 1.729 . . . . 0.0 114.794 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -158.0 154.11 27.18 Favored 'General case' 0 N--CA 1.518 2.937 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.597 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.5 m -118.99 146.96 44.58 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 126.21 2.194 . . . . 0.0 108.347 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.61 155.16 28.24 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.957 1.411 . . . . 0.0 108.827 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.2 p -134.78 15.84 3.61 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 126.057 2.098 . . . . 0.0 110.609 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.89 -62.33 0.1 OUTLIER Glycine 0 N--CA 1.495 2.614 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 168.77 24.76 0.02 OUTLIER Glycine 0 N--CA 1.507 3.406 0 CA-C-O 118.082 -1.399 . . . . 0.0 111.6 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -138.45 153.52 48.84 Favored 'General case' 0 N--CA 1.536 3.86 0 O-C-N 125.164 1.156 . . . . 0.0 108.763 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.24 74.63 0.06 OUTLIER Glycine 0 N--CA 1.513 3.775 0 O-C-N 124.542 1.151 . . . . 0.0 112.188 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.29 150.98 39.93 Favored 'General case' 0 N--CA 1.519 2.987 0 O-C-N 125.045 1.085 . . . . 0.0 109.716 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -156.41 145.21 20.18 Favored 'General case' 0 N--CA 1.538 3.95 0 O-C-N 124.804 1.315 . . . . 0.0 111.232 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.4 m -101.8 136.54 41.46 Favored 'General case' 0 N--CA 1.519 2.986 0 O-C-N 125.942 2.026 . . . . 0.0 109.421 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.5 155.95 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 O-C-N 125.481 1.738 . . . . 0.0 106.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.83 134.65 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.592 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.6 m -131.58 126.13 57.33 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 O-C-N 125.353 1.658 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -90.31 159.77 16.48 Favored 'General case' 0 N--CA 1.525 3.307 0 O-C-N 124.692 1.245 . . . . 0.0 108.163 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -69.44 -24.07 63.76 Favored 'General case' 0 N--CA 1.527 3.408 0 O-C-N 124.402 1.064 . . . . 0.0 112.145 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.5 m -142.48 147.42 36.02 Favored 'General case' 0 N--CA 1.532 3.652 0 O-C-N 124.997 1.435 . . . . 0.0 109.564 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -158.37 148.46 19.93 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.638 1.211 . . . . 0.0 112.042 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.52 102.25 1.78 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 125.741 1.901 . . . . 0.0 109.186 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.01 155.09 51.53 Favored Glycine 0 N--CA 1.506 3.35 0 O-C-N 125.063 1.477 . . . . 0.0 111.092 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -139.42 123.21 17.57 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 125.737 1.492 . . . . 0.0 108.258 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 147.81 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 O-C-N 125.15 1.531 . . . . 0.0 106.952 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.264 1.7 tmt? -53.18 -52.4 66.2 Favored Pre-proline 0 N--CA 1.526 3.342 0 N-CA-C 120.098 3.37 . . . . 0.0 120.098 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -66.34 -61.83 0.08 OUTLIER 'Trans proline' 0 C--N 1.397 3.089 0 CA-C-N 125.445 2.98 . . . . 0.0 115.1 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.13 -47.5 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.674 0 O-C-N 124.214 0.946 . . . . 0.0 112.815 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.65 -170.57 42.57 Favored Glycine 1 N--CA 1.517 4.069 0 CA-C-O 115.709 -2.717 . . . . 0.0 109.333 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -71.87 142.61 74.21 Favored 'Cis proline' 0 C--N 1.41 3.792 0 CA-C-N 123.003 3.401 . . . . 0.0 112.919 0.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -68.93 139.53 55.09 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 125.327 1.642 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.92 -37.2 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 O-C-N 125.419 1.699 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.54 -167.87 34.23 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 125.444 1.715 . . . . 0.0 109.033 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.93 109.14 1.17 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 126.104 1.708 . . . . 0.0 112.842 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.86 137.08 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.935 0 O-C-N 126.093 2.12 . . . . 0.0 107.963 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.41 144.59 31.31 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 125.028 1.455 . . . . 0.0 110.027 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.5 t -75.99 -35.06 59.73 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 124.855 1.347 . . . . 0.0 112.783 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -67.38 -24.66 65.7 Favored 'General case' 0 N--CA 1.514 2.775 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -79.67 -24.66 41.66 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 124.252 0.97 . . . . 0.0 112.73 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.44 157.09 88.97 Favored Pre-proline 0 N--CA 1.532 3.656 0 CA-C-O 115.675 -2.107 . . . . 0.0 111.596 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -73.49 -50.17 0.19 Allowed 'Trans proline' 0 C--N 1.41 3.779 0 CA-C-N 123.25 2.196 . . . . 0.0 114.32 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.74 -41.37 56.59 Favored Glycine 0 N--CA 1.512 3.714 0 O-C-N 124.486 1.116 . . . . 0.0 112.308 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.66 179.76 50.02 Favored Glycine 0 N--CA 1.51 3.599 0 O-C-N 125.212 1.184 . . . . 0.0 112.114 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.2 m -70.8 150.82 45.47 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 113.673 -1.264 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -159.37 134.48 8.21 Favored 'General case' 0 N--CA 1.521 3.117 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.3 mm -79.6 135.83 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.172 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 5.0 t -132.31 132.02 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.497 0 O-C-N 125.886 1.991 . . . . 0.0 105.835 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.6 t -118.3 145.97 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.201 0 N-CA-C 100.978 -3.712 . . . . 0.0 100.978 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.75 139.17 4.12 Favored Glycine 0 N--CA 1.514 3.877 0 O-C-N 124.444 1.09 . . . . 0.0 111.567 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.51 -161.79 37.6 Favored Glycine 1 N--CA 1.517 4.083 0 O-C-N 125.688 1.464 . . . . 0.0 111.79 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -72.6 -25.17 61.22 Favored 'General case' 0 N--CA 1.51 2.556 0 O-C-N 125.362 1.272 . . . . 0.0 112.371 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.7 p -74.46 -25.71 59.58 Favored 'General case' 0 N--CA 1.522 3.142 0 O-C-N 124.464 1.103 . . . . 0.0 110.583 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.85 19.55 47.1 Favored Glycine 0 N--CA 1.512 3.741 0 O-C-N 125.208 1.567 . . . . 0.0 112.115 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -73.11 103.24 3.79 Favored 'General case' 0 N--CA 1.517 2.924 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -70.78 167.16 19.41 Favored 'General case' 0 N--CA 1.519 2.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.398 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.48 73.53 0.08 OUTLIER Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.92 164.46 19.8 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.12 102.19 0.87 Allowed 'General case' 0 N--CA 1.524 3.271 0 O-C-N 124.906 1.379 . . . . 0.0 109.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 154.23 42.17 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 123.984 0.802 . . . . 0.0 112.646 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.24 172.52 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 O-C-N 126.209 2.193 . . . . 0.0 107.04 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 m -157.84 131.54 7.89 Favored 'General case' 0 N--CA 1.526 3.328 0 O-C-N 123.993 0.808 . . . . 0.0 111.367 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.78 161.63 28.86 Favored 'General case' 0 N--CA 1.518 2.964 0 O-C-N 124.401 1.063 . . . . 0.0 110.859 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.344 -2.365 . . . . 0.0 109.805 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 p -70.09 -31.37 68.91 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 125.375 1.672 . . . . 0.0 112.846 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.84 120.47 14.82 Favored 'General case' 0 N--CA 1.509 2.486 0 O-C-N 125.517 1.761 . . . . 0.0 111.738 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.86 129.66 34.67 Favored 'General case' 0 N--CA 1.508 2.435 0 O-C-N 124.731 1.27 . . . . 0.0 111.859 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.41 139.75 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.075 0 N-CA-C 102.097 -3.297 . . . . 0.0 102.097 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.39 142.49 9.78 Favored 'General case' 0 N--CA 1.514 2.748 0 O-C-N 124.943 1.402 . . . . 0.0 110.419 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -126.27 141.1 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.39 112.88 1.7 Allowed Pre-proline 0 N--CA 1.526 3.356 0 CA-C-O 114.889 -2.482 . . . . 0.0 110.136 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -64.53 150.49 73.32 Favored 'Cis proline' 1 C--N 1.423 4.455 0 CA-C-N 125.36 2.95 . . . . 0.0 111.927 -4.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.32 -13.68 1.79 Allowed 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.993 2.058 . . . . 0.0 112.724 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.1 p -127.56 153.91 45.81 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.776 1.922 . . . . 0.0 110.193 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.79 33.11 74.86 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 124.951 1.407 . . . . 0.0 112.342 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 mt -75.05 153.75 38.28 Favored 'General case' 0 N--CA 1.513 2.676 0 O-C-N 125.338 1.258 . . . . 0.0 110.633 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.89 -173.96 3.24 Favored 'General case' 0 N--CA 1.519 3.003 0 O-C-N 126.245 2.215 . . . . 0.0 108.444 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.04 127.97 34.22 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.661 1.226 . . . . 0.0 112.849 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.0 29.48 72.4 Favored Glycine 0 N--CA 1.515 3.907 0 O-C-N 124.761 1.288 . . . . 0.0 113.094 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.56 125.16 26.78 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 125.021 1.071 . . . . 0.0 112.503 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.06 135.48 35.83 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.82 141.24 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.333 1.645 . . . . 0.0 108.828 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.4 m -109.1 102.68 11.63 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 126.236 2.21 . . . . 0.0 109.637 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 147.94 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 p -134.75 161.97 33.67 Favored 'General case' 0 N--CA 1.511 2.621 0 O-C-N 126.197 2.185 . . . . 0.0 109.503 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.19 14.4 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 125.51 1.756 . . . . 0.0 108.064 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.23 147.36 17.75 Favored 'General case' 0 N--CA 1.51 2.541 0 O-C-N 125.323 1.64 . . . . 0.0 109.311 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.06 87.51 0.16 Allowed Glycine 0 N--CA 1.509 3.521 0 O-C-N 125.114 1.509 . . . . 0.0 110.841 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -156.21 152.4 27.77 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 125.741 1.495 . . . . 0.0 107.433 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.81 -18.64 0.05 Allowed 'General case' 0 N--CA 1.517 2.916 0 O-C-N 124.871 1.357 . . . . 0.0 111.156 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.45 -56.4 4.35 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.385 1.053 . . . . 0.0 110.247 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 p -72.53 121.46 19.7 Favored 'General case' 0 N--CA 1.518 2.965 0 O-C-N 124.615 1.197 . . . . 0.0 110.558 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -79.8 -17.11 54.16 Favored 'General case' 0 N--CA 1.527 3.379 0 O-C-N 124.349 1.031 . . . . 0.0 113.345 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -167.54 153.68 7.76 Favored 'General case' 0 N--CA 1.517 2.879 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.7 135.08 5.51 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 124.562 1.164 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 m -97.61 153.18 18.37 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 126.168 2.167 . . . . 0.0 108.471 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.88 120.87 41.43 Favored 'General case' 0 N--CA 1.52 3.058 0 O-C-N 126.399 2.312 . . . . 0.0 109.059 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.51 145.88 17.86 Favored 'General case' 0 N--CA 1.527 3.386 0 O-C-N 124.542 1.151 . . . . 0.0 112.362 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -96.17 148.9 22.22 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 125.373 1.671 . . . . 0.0 108.232 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 49.5 m -146.83 142.96 28.23 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.466 1.729 . . . . 0.0 108.088 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.44 123.63 42.69 Favored 'General case' 0 N--CA 1.525 3.308 0 O-C-N 125.451 1.72 . . . . 0.0 112.068 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -80.36 122.56 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.3 mt -100.03 -174.48 2.7 Favored 'General case' 0 N--CA 1.526 3.329 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.75 -45.69 81.63 Favored 'General case' 0 N--CA 1.515 2.822 0 O-C-N 124.627 1.204 . . . . 0.0 111.321 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.1 -22.45 60.56 Favored 'General case' 0 N--CA 1.524 3.264 0 O-C-N 125.357 1.661 . . . . 0.0 111.181 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.96 25.69 55.14 Favored Glycine 0 N--CA 1.514 3.861 0 CA-C-O 117.54 -1.7 . . . . 0.0 115.485 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.17 144.63 46.79 Favored 'General case' 0 N--CA 1.526 3.343 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.86 75.14 1.51 Allowed Glycine 0 N--CA 1.515 3.911 0 CA-C-O 118.19 -1.339 . . . . 0.0 114.977 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.88 104.48 13.99 Favored 'General case' 0 N--CA 1.517 2.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.34 142.93 49.53 Favored 'General case' 0 N--CA 1.531 3.615 0 O-C-N 125.201 1.563 . . . . 0.0 112.396 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -83.39 116.96 22.72 Favored 'General case' 0 N--CA 1.511 2.601 0 O-C-N 125.344 1.652 . . . . 0.0 109.025 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.18 -23.75 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.45 -13.21 62.15 Favored 'General case' 0 N--CA 1.534 3.758 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -79.87 -7.69 58.87 Favored 'General case' 1 N--CA 1.542 4.173 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -64.67 165.49 10.22 Favored 'General case' 0 N--CA 1.531 3.598 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -145.42 -52.99 0.27 Allowed 'General case' 0 N--CA 1.513 2.71 0 O-C-N 126.136 2.148 . . . . 0.0 107.052 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.6 t70 51.37 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.533 3.677 0 O-C-N 125.754 1.908 . . . . 0.0 116.139 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -157.55 147.26 20.28 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.2 p -66.7 157.44 32.67 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 124.841 1.338 . . . . 0.0 113.99 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 22.9 mt -79.58 136.62 36.9 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 125.04 1.463 . . . . 0.0 108.139 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.8 m -70.07 -37.78 75.58 Favored 'General case' 0 N--CA 1.509 2.52 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.547 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.57 54.28 0.11 Allowed Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.318 1.636 . . . . 0.0 109.294 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.08 23.77 70.73 Favored Glycine 0 N--CA 1.507 3.404 0 O-C-N 125.518 1.363 . . . . 0.0 112.812 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -141.65 157.6 44.87 Favored 'General case' 0 N--CA 1.535 3.787 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.22 77.72 0.07 OUTLIER Glycine 0 N--CA 1.515 3.956 0 O-C-N 124.33 1.019 . . . . 0.0 112.38 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.5 m -75.76 150.83 37.7 Favored 'General case' 0 N--CA 1.513 2.7 0 O-C-N 125.232 1.195 . . . . 0.0 109.159 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.3 135.48 6.05 Favored 'General case' 0 N--CA 1.529 3.481 0 O-C-N 124.8 1.313 . . . . 0.0 112.973 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 p -80.81 113.17 18.83 Favored 'General case' 0 N--CA 1.518 2.933 0 O-C-N 124.923 1.389 . . . . 0.0 111.038 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 t -110.66 150.68 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.4 141.27 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.86 132.3 25.24 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 O-C-N 125.49 1.744 . . . . 0.0 112.279 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -90.22 162.91 15.01 Favored 'General case' 0 N--CA 1.526 3.355 0 O-C-N 125.141 1.526 . . . . 0.0 108.729 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -66.53 -24.59 66.4 Favored 'General case' 0 N--CA 1.525 3.293 0 O-C-N 124.322 1.014 . . . . 0.0 112.669 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 p -155.72 150.87 26.68 Favored 'General case' 0 N--CA 1.517 2.913 0 O-C-N 124.772 1.295 . . . . 0.0 108.587 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -155.45 150.03 26.21 Favored 'General case' 0 N--CA 1.523 3.188 0 O-C-N 124.941 1.401 . . . . 0.0 112.172 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 m -68.07 103.77 1.61 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.958 2.036 . . . . 0.0 109.093 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.23 154.38 52.55 Favored Glycine 0 N--CA 1.509 3.538 0 O-C-N 125.173 1.546 . . . . 0.0 111.177 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -137.44 123.0 19.72 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 126.002 1.648 . . . . 0.0 109.262 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.41 148.67 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.261 27.1 tpp -51.58 -54.77 35.81 Favored Pre-proline 0 N--CA 1.524 3.268 0 N-CA-C 119.421 3.119 . . . . 0.0 119.421 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -65.16 -63.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.397 3.092 0 CA-C-N 125.163 2.88 . . . . 0.0 115.575 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.17 -45.23 0.05 OUTLIER 'General case' 0 N--CA 1.532 3.672 0 CA-C-N 119.316 0.962 . . . . 0.0 112.869 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.7 -170.84 41.95 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 115.625 -2.764 . . . . 0.0 109.393 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -71.51 143.2 75.85 Favored 'Cis proline' 0 C--N 1.408 3.71 0 CA-C-N 123.057 3.429 . . . . 0.0 113.074 -0.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -69.29 137.95 53.44 Favored 'General case' 0 N--CA 1.515 2.803 0 O-C-N 125.306 1.629 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -37.66 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.174 0 O-C-N 125.351 1.657 . . . . 0.0 111.646 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.25 -169.75 32.2 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 125.456 1.723 . . . . 0.0 109.749 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.97 111.96 2.13 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 126.08 1.694 . . . . 0.0 113.423 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 142.28 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.974 0 O-C-N 125.988 2.055 . . . . 0.0 107.4 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.37 154.17 17.62 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 125.711 1.882 . . . . 0.0 109.127 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 48.4 t -73.9 -27.35 61.01 Favored 'General case' 0 N--CA 1.508 2.47 0 O-C-N 124.746 1.279 . . . . 0.0 112.948 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.93 -31.42 68.02 Favored 'General case' 0 N--CA 1.511 2.614 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.76 -19.56 48.4 Favored 'General case' 0 N--CA 1.53 3.548 0 O-C-N 124.64 1.213 . . . . 0.0 112.821 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.97 155.26 92.24 Favored Pre-proline 0 N--CA 1.53 3.57 0 CA-C-O 115.601 -2.143 . . . . 0.0 111.507 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -73.18 -43.01 0.79 Allowed 'Trans proline' 0 C--N 1.409 3.747 0 CA-C-N 123.407 2.253 . . . . 0.0 113.929 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -75.08 -104.5 0.1 OUTLIER Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.684 1.24 . . . . 0.0 111.329 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.53 147.14 4.96 Favored Glycine 0 N--CA 1.505 3.292 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.9 m -73.75 159.08 33.47 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 125.077 1.104 . . . . 0.0 111.137 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.34 147.3 12.44 Favored 'General case' 0 N--CA 1.518 2.947 0 O-C-N 124.497 1.123 . . . . 0.0 109.592 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 mm -79.64 121.2 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -113.05 120.14 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 t -116.33 132.76 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 101.408 -3.552 . . . . 0.0 101.408 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.4 138.12 3.56 Favored Glycine 1 N--CA 1.517 4.035 0 O-C-N 124.184 0.928 . . . . 0.0 110.965 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.08 -166.26 41.48 Favored Glycine 0 N--CA 1.509 3.513 0 O-C-N 125.377 1.281 . . . . 0.0 112.556 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -80.08 -13.52 59.23 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 125.743 1.496 . . . . 0.0 112.856 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.2 p -70.0 -68.5 0.41 Allowed 'General case' 0 N--CA 1.515 2.795 0 O-C-N 124.894 1.371 . . . . 0.0 111.751 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 169.68 -19.45 0.07 OUTLIER Glycine 0 N--CA 1.515 3.951 0 CA-C-O 118.398 -1.223 . . . . 0.0 112.758 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.38 143.61 57.62 Favored 'General case' 0 N--CA 1.523 3.206 0 O-C-N 124.961 1.036 . . . . 0.0 112.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -111.72 -173.16 2.18 Favored 'General case' 0 N--CA 1.524 3.271 0 O-C-N 126.52 2.387 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.07 67.22 0.11 Allowed Glycine 0 N--CA 1.51 3.607 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -68.05 146.35 53.59 Favored 'General case' 0 N--CA 1.519 3.0 0 O-C-N 125.432 1.313 . . . . 0.0 112.926 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.13 109.78 1.03 Allowed 'General case' 0 N--CA 1.528 3.429 0 O-C-N 124.496 1.123 . . . . 0.0 109.633 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.49 170.75 16.14 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.414 1.072 . . . . 0.0 113.038 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -178.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 O-C-N 126.419 2.324 . . . . 0.0 107.99 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 p -161.19 119.65 2.44 Favored 'General case' 0 N--CA 1.516 2.842 0 O-C-N 124.35 1.031 . . . . 0.0 109.271 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -74.23 158.48 34.01 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.073 0.858 . . . . 0.0 111.127 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.695 0 CA-C-O 116.282 -2.399 . . . . 0.0 111.497 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t -167.47 -40.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.72 0 O-C-N 125.257 1.598 . . . . 0.0 109.568 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.87 116.68 8.81 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 125.845 1.966 . . . . 0.0 112.377 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.05 129.29 34.38 Favored 'General case' 0 N--CA 1.509 2.512 0 O-C-N 124.695 1.247 . . . . 0.0 111.168 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -131.13 139.31 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.208 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -161.63 146.82 13.44 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.731 1.269 . . . . 0.0 110.555 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.89 147.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.197 0 N-CA-C 102.132 -3.284 . . . . 0.0 102.132 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.02 109.51 1.75 Allowed Pre-proline 0 N--CA 1.526 3.344 0 CA-C-O 115.343 -2.265 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.93 162.62 51.23 Favored 'Cis proline' 2 C--N 1.427 4.665 0 CA-C-N 124.908 2.789 . . . . 0.0 112.747 -3.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.15 -5.31 1.12 Allowed 'General case' 0 N--CA 1.537 3.894 0 O-C-N 124.655 1.222 . . . . 0.0 113.291 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.8 p -139.3 151.35 46.37 Favored 'General case' 0 N--CA 1.529 3.498 0 O-C-N 124.807 1.317 . . . . 0.0 109.669 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.76 32.84 70.57 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.985 1.428 . . . . 0.0 112.987 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 mt -71.57 150.74 44.44 Favored 'General case' 0 N--CA 1.513 2.714 0 O-C-N 125.632 1.431 . . . . 0.0 109.984 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -111.73 178.68 4.24 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 126.059 2.1 . . . . 0.0 109.939 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.95 127.4 32.74 Favored 'General case' 0 N--CA 1.509 2.494 0 O-C-N 124.954 1.409 . . . . 0.0 111.335 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.56 25.98 74.83 Favored Glycine 0 N--CA 1.514 3.844 0 O-C-N 124.554 1.158 . . . . 0.0 113.285 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.54 140.97 48.46 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 124.753 0.913 . . . . 0.0 111.784 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -99.06 132.91 44.02 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.843 1.964 . . . . 0.0 105.816 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.48 147.19 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.138 0 O-C-N 125.399 1.687 . . . . 0.0 109.571 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -101.01 96.75 7.45 Favored 'General case' 0 N--CA 1.508 2.443 0 O-C-N 126.064 2.102 . . . . 0.0 110.369 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 t -79.92 147.6 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.8 p -138.57 165.81 25.94 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 125.754 1.909 . . . . 0.0 110.528 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.85 15.88 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 125.696 1.873 . . . . 0.0 108.118 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.79 148.53 17.56 Favored 'General case' 0 N--CA 1.514 2.772 0 O-C-N 124.898 1.374 . . . . 0.0 109.469 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.91 87.79 0.18 Allowed Glycine 0 N--CA 1.508 3.468 0 O-C-N 125.198 1.561 . . . . 0.0 110.444 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -155.81 156.64 35.09 Favored 'General case' 0 N--CA 1.511 2.623 0 O-C-N 125.67 1.453 . . . . 0.0 107.551 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.11 -21.99 0.05 Allowed 'General case' 0 N--CA 1.52 3.042 0 O-C-N 124.621 1.201 . . . . 0.0 111.261 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 p -79.64 -54.87 5.46 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 124.474 1.109 . . . . 0.0 110.343 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -70.88 117.62 12.62 Favored 'General case' 0 N--CA 1.515 2.793 0 O-C-N 124.681 1.238 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.0 p -79.73 -16.61 55.3 Favored 'General case' 0 N--CA 1.527 3.401 0 O-C-N 124.091 0.869 . . . . 0.0 112.277 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.35 154.95 10.76 Favored 'General case' 0 N--CA 1.516 2.833 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.78 141.9 10.37 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.65 1.219 . . . . 0.0 111.241 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.1 m -112.54 151.46 29.98 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 126.501 2.375 . . . . 0.0 108.266 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -106.92 103.87 13.4 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 126.188 2.18 . . . . 0.0 110.233 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.6 mt -126.24 147.59 49.65 Favored 'General case' 0 N--CA 1.531 3.586 0 O-C-N 124.995 1.434 . . . . 0.0 110.282 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.07 142.49 47.35 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 125.951 2.032 . . . . 0.0 106.451 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.3 m -137.13 138.9 40.79 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.356 1.66 . . . . 0.0 109.817 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.61 115.31 23.22 Favored 'General case' 0 N--CA 1.516 2.875 0 O-C-N 125.049 1.468 . . . . 0.0 112.143 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.8 mm -77.36 121.36 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.3 mt -100.42 -173.15 2.34 Favored 'General case' 0 N--CA 1.527 3.396 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -47.23 78.61 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.535 1.147 . . . . 0.0 112.229 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.83 -21.33 61.7 Favored 'General case' 0 N--CA 1.529 3.508 0 O-C-N 125.24 1.588 . . . . 0.0 111.714 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.69 24.56 49.45 Favored Glycine 0 N--CA 1.515 3.93 0 CA-C-O 117.934 -1.481 . . . . 0.0 115.187 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -73.18 143.64 47.14 Favored 'General case' 0 N--CA 1.523 3.195 0 O-C-N 124.828 0.957 . . . . 0.0 108.641 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.75 72.58 2.2 Favored Glycine 0 N--CA 1.514 3.849 0 CA-C-O 118.105 -1.386 . . . . 0.0 115.165 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.0 108.82 15.81 Favored 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.6 144.89 48.17 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 124.891 1.37 . . . . 0.0 111.956 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.98 127.16 34.07 Favored 'General case' 0 N--CA 1.516 2.829 0 O-C-N 125.499 1.749 . . . . 0.0 110.249 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.85 -28.45 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.6 -10.0 58.25 Favored 'General case' 0 N--CA 1.537 3.909 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -79.85 -7.71 58.87 Favored 'General case' 0 N--CA 1.539 3.986 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -65.55 165.98 11.32 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -145.85 -61.35 0.33 Allowed 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.906 2.004 . . . . 0.0 108.266 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 t70 59.43 112.3 0.01 OUTLIER 'General case' 0 N--CA 1.529 3.492 0 O-C-N 125.333 1.645 . . . . 0.0 115.32 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -163.27 144.01 9.23 Favored 'General case' 0 N--CA 1.526 3.332 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.1 p -72.37 152.08 42.26 Favored 'General case' 0 N--CA 1.51 2.537 0 O-C-N 124.407 1.067 . . . . 0.0 112.462 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.52 151.65 30.63 Favored 'General case' 0 N--CA 1.52 3.057 0 O-C-N 124.738 1.274 . . . . 0.0 108.11 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 36.1 t -70.67 -28.74 65.01 Favored 'General case' 0 N--CA 1.512 2.658 0 O-C-N 124.813 1.321 . . . . 0.0 112.746 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.32 -36.22 0.06 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 177.25 28.31 0.04 OUTLIER Glycine 0 N--CA 1.502 3.04 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.667 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -141.96 156.75 45.47 Favored 'General case' 0 N--CA 1.534 3.74 0 O-C-N 125.288 1.228 . . . . 0.0 108.212 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.46 140.78 4.97 Favored Glycine 0 N--CA 1.502 3.096 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -136.72 150.84 48.65 Favored 'General case' 0 N--CA 1.526 3.345 0 O-C-N 125.722 1.483 . . . . 0.0 107.566 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.03 139.19 8.36 Favored 'General case' 0 N--CA 1.519 3.006 0 O-C-N 125.226 1.579 . . . . 0.0 112.863 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -87.26 118.98 27.05 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 125.063 1.477 . . . . 0.0 108.053 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.22 143.91 30.57 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.037 0 O-C-N 125.389 1.68 . . . . 0.0 106.641 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.93 139.03 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 104.724 -2.325 . . . . 0.0 104.724 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.2 m -129.47 117.6 43.09 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.012 0 O-C-N 125.23 1.581 . . . . 0.0 110.135 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -90.35 157.32 17.69 Favored 'General case' 0 N--CA 1.522 3.173 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.549 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -68.71 -25.64 64.87 Favored 'General case' 0 N--CA 1.525 3.32 0 O-C-N 124.592 1.183 . . . . 0.0 112.106 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 m -148.94 147.56 28.77 Favored 'General case' 0 N--CA 1.528 3.428 0 O-C-N 124.871 1.357 . . . . 0.0 109.759 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -156.18 147.25 22.25 Favored 'General case' 0 N--CA 1.527 3.391 0 O-C-N 124.899 1.374 . . . . 0.0 111.77 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.62 106.35 2.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 125.8 1.937 . . . . 0.0 110.516 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.99 157.25 52.92 Favored Glycine 0 N--CA 1.515 3.963 0 O-C-N 124.688 1.243 . . . . 0.0 111.225 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -142.5 106.34 4.7 Favored 'General case' 0 N--CA 1.517 2.898 0 O-C-N 125.53 1.37 . . . . 0.0 108.942 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.62 142.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.053 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 35.9 mtp -69.86 -37.26 7.55 Favored Pre-proline 1 N--CA 1.545 4.281 1 N-CA-C 122.965 4.431 . . . . 0.0 122.965 -179.234 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.03 -38.39 16.37 Favored 'Trans proline' 0 C--N 1.395 2.978 0 CA-C-N 125.99 3.175 . . . . 0.0 117.337 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.53 -39.98 0.06 Allowed 'General case' 0 N--CA 1.532 3.644 0 O-C-N 124.362 1.039 . . . . 0.0 111.741 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.5 -117.01 5.37 Favored Glycine 1 CA--C 1.595 5.04 0 CA-C-O 113.846 -3.752 . . . . 0.0 111.109 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -72.97 -47.54 0.31 Allowed 'Cis proline' 1 C--N 1.415 4.032 1 CA-C-N 125.937 4.869 . . . . 0.0 113.08 0.79 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -154.46 129.69 9.68 Favored 'General case' 0 N--CA 1.521 3.12 0 O-C-N 126.03 2.081 . . . . 0.0 108.882 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -36.79 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 O-C-N 125.16 1.537 . . . . 0.0 110.078 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.14 178.36 22.04 Favored Glycine 0 N--CA 1.508 3.498 0 O-C-N 126.166 2.166 . . . . 0.0 109.86 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.47 118.21 7.81 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.876 1.574 . . . . 0.0 113.305 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -129.41 135.69 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 O-C-N 126.239 2.212 . . . . 0.0 107.833 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.67 145.62 31.54 Favored 'General case' 0 N--CA 1.512 2.672 0 O-C-N 124.936 1.398 . . . . 0.0 110.76 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.4 t -76.45 -28.45 56.58 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.745 1.278 . . . . 0.0 111.73 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.69 -27.48 61.25 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.68 -22.8 43.0 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 124.254 0.971 . . . . 0.0 112.848 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.24 155.21 92.81 Favored Pre-proline 0 N--CA 1.53 3.542 0 CA-C-O 115.423 -2.227 . . . . 0.0 111.297 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -72.86 -51.4 0.18 Allowed 'Trans proline' 0 C--N 1.408 3.668 0 CA-C-N 123.466 2.274 . . . . 0.0 113.915 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.34 -43.43 38.27 Favored Glycine 0 N--CA 1.512 3.738 0 O-C-N 124.436 1.085 . . . . 0.0 112.555 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.19 171.6 48.09 Favored Glycine 0 N--CA 1.514 3.884 0 O-C-N 125.349 1.264 . . . . 0.0 110.926 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 25.9 m -70.29 150.27 46.54 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 124.95 1.03 . . . . 0.0 112.331 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -146.54 133.27 19.97 Favored 'General case' 0 N--CA 1.522 3.155 0 O-C-N 125.838 1.961 . . . . 0.0 107.689 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.0 mm -79.58 116.94 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.0 t -111.48 122.02 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.175 0 O-C-N 125.8 1.938 . . . . 0.0 106.457 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.7 t -118.38 130.33 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.518 0 N-CA-C 102.086 -3.302 . . . . 0.0 102.086 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.31 138.45 3.51 Favored Glycine 1 N--CA 1.519 4.202 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -80.9 -170.54 43.18 Favored Glycine 0 N--CA 1.51 3.57 0 O-C-N 125.126 1.133 . . . . 0.0 112.78 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -78.62 -16.72 57.03 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 113.174 -1.513 . . . . 0.0 113.066 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.94 -66.21 0.62 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.759 1.287 . . . . 0.0 112.557 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.78 -7.52 0.05 OUTLIER Glycine 1 N--CA 1.517 4.051 0 CA-C-O 118.404 -1.22 . . . . 0.0 112.578 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -66.12 147.61 53.08 Favored 'General case' 0 N--CA 1.519 3.012 0 O-C-N 124.82 0.953 . . . . 0.0 111.265 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -142.81 168.03 20.67 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 125.855 1.972 . . . . 0.0 109.222 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.57 78.86 0.06 OUTLIER Glycine 0 N--CA 1.501 2.983 0 O-C-N 124.984 1.428 . . . . 0.0 109.901 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -67.92 159.47 30.49 Favored 'General case' 0 N--CA 1.515 2.79 0 O-C-N 125.343 1.261 . . . . 0.0 113.006 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.97 101.62 1.44 Allowed 'General case' 0 N--CA 1.529 3.503 0 O-C-N 124.38 1.05 . . . . 0.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 148.91 45.18 Favored 'General case' 0 N--CA 1.511 2.576 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.749 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -118.06 170.63 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 O-C-N 126.272 2.232 . . . . 0.0 106.907 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 m -157.19 119.24 3.82 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 124.258 0.974 . . . . 0.0 111.322 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -73.22 154.88 40.06 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 124.604 1.19 . . . . 0.0 110.463 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.516 3.976 0 CA-C-O 116.722 -2.154 . . . . 0.0 112.513 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 t -167.56 91.62 0.36 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 125.36 1.663 . . . . 0.0 107.281 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.97 121.95 1.53 Allowed 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.792 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.91 129.07 34.19 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 124.723 1.264 . . . . 0.0 111.429 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.53 139.36 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.037 0 N-CA-C 102.298 -3.223 . . . . 0.0 102.298 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -162.35 142.2 9.69 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 125.001 1.438 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.08 142.85 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.1 0 N-CA-C 101.486 -3.524 . . . . 0.0 101.486 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 t -161.3 112.92 1.25 Allowed Pre-proline 0 N--CA 1.524 3.252 0 CA-C-O 115.015 -2.421 . . . . 0.0 110.212 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -63.19 150.64 68.13 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.337 2.942 . . . . 0.0 112.242 -4.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.18 -9.19 1.75 Allowed 'General case' 0 N--CA 1.528 3.439 0 O-C-N 125.964 2.04 . . . . 0.0 113.049 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.3 p -133.19 152.76 51.94 Favored 'General case' 0 N--CA 1.528 3.425 0 O-C-N 125.327 1.642 . . . . 0.0 109.657 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.2 29.53 68.49 Favored Glycine 0 N--CA 1.514 3.862 0 O-C-N 125.008 1.443 . . . . 0.0 112.51 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.4 mt -72.78 154.1 40.8 Favored 'General case' 0 N--CA 1.512 2.63 0 O-C-N 125.347 1.263 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.58 -175.39 3.57 Favored 'General case' 0 N--CA 1.515 2.797 0 O-C-N 126.184 2.178 . . . . 0.0 107.977 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.9 127.54 32.91 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 124.736 1.272 . . . . 0.0 112.61 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.48 29.72 69.64 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.856 1.347 . . . . 0.0 112.776 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.37 127.46 32.63 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 124.934 1.02 . . . . 0.0 112.627 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 m -81.97 134.04 35.35 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.12 146.44 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.407 0 O-C-N 125.281 1.613 . . . . 0.0 108.558 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.0 m -113.98 103.42 11.14 Favored 'General case' 0 N--CA 1.513 2.699 0 O-C-N 126.436 2.335 . . . . 0.0 109.689 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -79.85 147.69 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.934 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.06 159.92 40.48 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 126.139 2.149 . . . . 0.0 109.15 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.08 144.61 14.66 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 125.465 1.728 . . . . 0.0 108.143 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.33 148.67 18.43 Favored 'General case' 0 N--CA 1.51 2.565 0 O-C-N 125.314 1.634 . . . . 0.0 109.347 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.28 88.93 0.11 Allowed Glycine 0 N--CA 1.509 3.505 0 O-C-N 125.048 1.467 . . . . 0.0 111.446 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -155.39 150.97 27.31 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.73 -20.73 0.06 Allowed 'General case' 0 N--CA 1.52 3.046 0 O-C-N 124.738 1.274 . . . . 0.0 111.526 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.7 p -79.47 -45.05 20.13 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.434 1.084 . . . . 0.0 108.93 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 p -73.03 143.5 47.5 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 125.023 1.452 . . . . 0.0 108.64 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.16 11.84 15.33 Favored 'General case' 0 N--CA 1.536 3.84 0 O-C-N 125.774 1.921 . . . . 0.0 111.768 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -166.17 166.14 17.16 Favored 'General case' 0 N--CA 1.525 3.292 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.36 136.57 8.63 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.033 0.833 . . . . 0.0 111.513 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.97 177.06 7.72 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 126.316 2.26 . . . . 0.0 105.363 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.1 117.98 2.28 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.671 1.232 . . . . 0.0 109.393 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.3 136.53 9.75 Favored 'General case' 0 N--CA 1.527 3.376 0 O-C-N 125.031 1.457 . . . . 0.0 110.941 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -82.2 152.5 26.41 Favored 'General case' 0 N--CA 1.509 2.495 0 O-C-N 124.911 1.382 . . . . 0.0 107.594 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 57.6 m -145.03 141.17 28.67 Favored 'General case' 0 N--CA 1.528 3.433 0 O-C-N 125.111 1.507 . . . . 0.0 109.174 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.3 118.77 31.23 Favored 'General case' 0 N--CA 1.517 2.878 0 O-C-N 125.439 1.712 . . . . 0.0 112.462 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mm -79.13 143.48 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.856 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.05 -176.11 3.9 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.514 2.754 0 O-C-N 124.713 1.258 . . . . 0.0 112.049 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -21.74 60.45 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.406 1.691 . . . . 0.0 111.297 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.88 26.35 71.43 Favored Glycine 0 N--CA 1.513 3.78 0 CA-C-O 117.696 -1.613 . . . . 0.0 115.8 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -74.32 147.53 42.18 Favored 'General case' 0 N--CA 1.528 3.428 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.49 74.34 1.74 Allowed Glycine 0 N--CA 1.515 3.955 0 O-C-N 124.886 1.366 . . . . 0.0 113.941 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -83.8 101.08 11.36 Favored 'General case' 0 N--CA 1.513 2.704 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.4 m -129.54 145.57 51.45 Favored 'General case' 0 N--CA 1.535 3.804 0 O-C-N 124.91 1.381 . . . . 0.0 112.644 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -74.96 125.05 28.08 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 125.074 1.484 . . . . 0.0 111.265 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.45 -24.03 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.88 -23.4 63.25 Favored 'General case' 0 N--CA 1.531 3.58 0 N-CA-C 116.212 1.93 . . . . 0.0 116.212 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -79.85 -19.18 48.99 Favored 'General case' 0 N--CA 1.532 3.667 0 O-C-N 124.508 1.13 . . . . 0.0 113.992 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -66.32 148.18 52.23 Favored 'General case' 1 N--CA 1.54 4.073 0 O-C-N 124.696 1.247 . . . . 0.0 111.296 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -144.87 -54.73 0.32 Allowed 'General case' 0 N--CA 1.522 3.167 0 O-C-N 125.627 1.829 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 67.71 128.58 0.02 OUTLIER 'General case' 1 N--CA 1.544 4.233 0 O-C-N 124.978 1.424 . . . . 0.0 113.194 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -158.95 147.88 18.55 Favored 'General case' 0 N--CA 1.515 2.789 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.173 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 m -75.99 151.49 37.2 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 124.998 1.436 . . . . 0.0 107.959 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.3 mt -79.41 127.13 31.72 Favored 'General case' 0 N--CA 1.524 3.252 0 O-C-N 124.85 1.344 . . . . 0.0 107.55 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 t -69.91 -38.5 76.3 Favored 'General case' 0 N--CA 1.512 2.638 0 O-C-N 124.368 1.043 . . . . 0.0 113.496 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.55 49.66 0.12 Allowed Glycine 0 N--CA 1.501 3.03 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.74 22.47 74.75 Favored Glycine 0 N--CA 1.503 3.132 0 O-C-N 125.632 1.431 . . . . 0.0 112.926 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -141.85 156.67 45.53 Favored 'General case' 1 N--CA 1.544 4.234 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 77.94 0.06 OUTLIER Glycine 1 N--CA 1.52 4.244 0 O-C-N 124.149 0.906 . . . . 0.0 112.516 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -75.75 153.65 36.86 Favored 'General case' 0 N--CA 1.52 3.071 0 O-C-N 124.912 1.007 . . . . 0.0 109.74 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.63 138.09 5.99 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.806 1.316 . . . . 0.0 113.365 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.2 p -82.69 111.75 18.92 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.844 1.34 . . . . 0.0 109.866 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 t -109.29 151.3 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.864 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.38 139.95 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 N-CA-C 103.027 -2.953 . . . . 0.0 103.027 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.35 129.65 16.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.107 0 O-C-N 125.52 1.762 . . . . 0.0 112.286 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -90.2 162.21 15.35 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.964 1.415 . . . . 0.0 107.812 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -65.73 -33.81 76.74 Favored 'General case' 0 N--CA 1.522 3.143 0 O-C-N 124.67 1.231 . . . . 0.0 111.779 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.8 151.87 48.56 Favored 'General case' 0 N--CA 1.528 3.456 0 O-C-N 125.761 1.913 . . . . 0.0 109.001 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.09 148.85 20.72 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 124.586 1.179 . . . . 0.0 111.78 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.1 m -69.58 101.26 1.58 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 125.941 2.025 . . . . 0.0 108.749 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.78 153.27 52.17 Favored Glycine 0 N--CA 1.508 3.484 0 O-C-N 125.141 1.526 . . . . 0.0 111.167 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -135.56 122.67 21.51 Favored 'General case' 0 N--CA 1.515 2.784 0 O-C-N 125.974 1.632 . . . . 0.0 109.023 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.12 147.17 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.168 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.7 mmt -51.89 -53.17 54.28 Favored Pre-proline 0 N--CA 1.531 3.607 0 N-CA-C 120.381 3.474 . . . . 0.0 120.381 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.58 -62.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.402 3.384 0 CA-C-N 125.233 2.905 . . . . 0.0 115.077 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -160.15 -46.63 0.05 OUTLIER 'General case' 0 N--CA 1.533 3.7 0 O-C-N 124.191 0.932 . . . . 0.0 112.823 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.66 -170.44 41.81 Favored Glycine 1 N--CA 1.516 4.028 0 CA-C-O 115.673 -2.737 . . . . 0.0 109.28 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.65 144.2 79.11 Favored 'Cis proline' 0 C--N 1.41 3.797 0 CA-C-N 123.063 3.432 . . . . 0.0 113.072 -0.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -68.58 137.66 54.46 Favored 'General case' 0 N--CA 1.512 2.668 0 O-C-N 125.31 1.631 . . . . 0.0 110.494 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -36.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.203 0 O-C-N 125.448 1.718 . . . . 0.0 111.56 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.05 -171.79 36.0 Favored Glycine 0 N--CA 1.5 2.948 0 O-C-N 125.401 1.688 . . . . 0.0 109.695 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.48 110.83 1.57 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 126.039 1.67 . . . . 0.0 113.402 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 p -132.64 138.91 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.064 0 O-C-N 125.933 2.021 . . . . 0.0 107.82 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -91.88 158.13 16.47 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.442 1.714 . . . . 0.0 110.742 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 66.2 m -76.25 -30.27 57.81 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 124.931 1.394 . . . . 0.0 111.787 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -67.61 -28.26 67.6 Favored 'General case' 0 N--CA 1.513 2.677 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.6 p -79.75 -30.63 40.87 Favored 'General case' 0 N--CA 1.528 3.448 0 O-C-N 124.429 1.08 . . . . 0.0 112.64 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.94 151.44 97.19 Favored Pre-proline 0 N--CA 1.527 3.419 0 CA-C-O 115.261 -2.304 . . . . 0.0 111.606 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.07 -44.5 0.45 Allowed 'Trans proline' 0 C--N 1.41 3.769 0 CA-C-N 123.643 2.337 . . . . 0.0 113.494 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.23 -45.4 55.73 Favored Glycine 0 N--CA 1.513 3.812 0 O-C-N 124.685 1.241 . . . . 0.0 112.81 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.55 160.37 29.87 Favored Glycine 0 N--CA 1.515 3.923 0 O-C-N 125.319 1.246 . . . . 0.0 112.125 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 86.3 m -70.0 145.82 51.51 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 113.958 -1.121 . . . . 0.0 112.902 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -145.96 139.96 26.56 Favored 'General case' 0 N--CA 1.53 3.546 0 O-C-N 125.621 1.826 . . . . 0.0 108.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 mm -79.9 127.58 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.447 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.93 137.4 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.92 141.49 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.275 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.88 142.65 5.7 Favored Glycine 1 N--CA 1.517 4.057 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -160.5 34.43 Favored Glycine 1 N--CA 1.517 4.081 0 O-C-N 125.469 1.335 . . . . 0.0 112.81 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -71.63 -23.6 61.72 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 125.374 1.279 . . . . 0.0 112.671 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -69.91 -32.72 71.16 Favored 'General case' 0 N--CA 1.521 3.097 0 O-C-N 124.775 1.297 . . . . 0.0 110.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.5 12.21 48.73 Favored Glycine 0 N--CA 1.515 3.93 0 O-C-N 125.809 1.943 . . . . 0.0 113.073 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -72.69 103.1 3.5 Favored 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -74.81 174.63 8.92 Favored 'General case' 0 N--CA 1.519 2.985 0 CA-C-N 114.711 -1.132 . . . . 0.0 112.724 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.45 78.45 0.09 OUTLIER Glycine 0 N--CA 1.506 3.36 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -68.54 155.48 39.88 Favored 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.312 1.243 . . . . 0.0 113.292 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.45 100.35 1.18 Allowed 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.088 1.493 . . . . 0.0 109.107 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.14 158.0 34.1 Favored 'General case' 0 N--CA 1.517 2.885 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.14 176.65 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 O-C-N 126.568 2.418 . . . . 0.0 107.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.3 m -160.77 121.09 2.8 Favored 'General case' 0 N--CA 1.519 2.992 0 O-C-N 124.785 1.303 . . . . 0.0 109.78 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -72.78 156.73 38.61 Favored 'General case' 0 N--CA 1.515 2.799 0 O-C-N 124.554 1.159 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.627 0 CA-C-O 116.355 -2.358 . . . . 0.0 111.464 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -163.98 -40.92 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 O-C-N 125.442 1.714 . . . . 0.0 109.595 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 109.16 4.23 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.997 2.06 . . . . 0.0 111.302 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 126.95 31.69 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.47 1.106 . . . . 0.0 111.307 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.33 138.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 102.608 -3.108 . . . . 0.0 102.608 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -163.1 143.62 9.28 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 124.848 1.343 . . . . 0.0 110.135 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.7 t -120.33 144.03 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.989 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 t -161.84 112.87 1.19 Allowed Pre-proline 0 N--CA 1.524 3.242 0 CA-C-O 115.092 -2.385 . . . . 0.0 109.918 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -63.34 149.97 67.6 Favored 'Cis proline' 1 C--N 1.424 4.549 0 CA-C-N 125.25 2.911 . . . . 0.0 112.492 -4.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.85 -9.23 1.59 Allowed 'General case' 0 N--CA 1.528 3.437 0 O-C-N 125.916 2.01 . . . . 0.0 112.619 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 71.5 p -133.64 152.06 51.81 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.102 1.501 . . . . 0.0 109.648 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.31 65.2 Favored Glycine 0 N--CA 1.514 3.869 0 O-C-N 125.023 1.452 . . . . 0.0 112.143 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 mt -73.29 154.23 40.24 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 125.349 1.264 . . . . 0.0 110.551 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.59 -175.36 3.63 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 126.274 2.234 . . . . 0.0 107.946 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.41 127.1 30.99 Favored 'General case' 0 N--CA 1.515 2.777 0 O-C-N 124.659 1.224 . . . . 0.0 112.735 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.32 28.2 72.86 Favored Glycine 0 N--CA 1.513 3.802 0 O-C-N 124.637 1.21 . . . . 0.0 113.318 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 125.52 27.61 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 124.945 1.027 . . . . 0.0 112.233 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.5 m -78.98 134.57 36.8 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.09 140.39 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.346 0 O-C-N 125.349 1.655 . . . . 0.0 108.401 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.6 m -107.36 101.77 11.11 Favored 'General case' 0 N--CA 1.515 2.795 0 O-C-N 126.15 2.156 . . . . 0.0 110.557 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.87 148.03 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.997 0 N-CA-C 104.492 -2.411 . . . . 0.0 104.492 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -137.69 161.57 36.16 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.969 2.043 . . . . 0.0 109.463 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.17 146.22 15.51 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 125.467 1.73 . . . . 0.0 108.278 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.92 146.53 16.1 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 124.986 1.429 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.13 88.4 0.14 Allowed Glycine 0 N--CA 1.509 3.566 0 O-C-N 125.007 1.442 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -155.08 152.62 29.76 Favored 'General case' 0 N--CA 1.514 2.751 0 O-C-N 125.573 1.396 . . . . 0.0 107.408 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.76 -18.71 0.05 Allowed 'General case' 0 N--CA 1.52 3.038 0 O-C-N 124.774 1.297 . . . . 0.0 111.52 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.58 -53.39 6.9 Favored 'General case' 0 N--CA 1.52 3.032 0 O-C-N 124.309 1.006 . . . . 0.0 110.255 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -71.27 129.77 39.71 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.665 1.228 . . . . 0.0 110.704 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.9 t -79.93 -28.61 39.72 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.6 t -154.67 172.26 18.19 Favored 'General case' 0 N--CA 1.531 3.6 0 O-C-N 125.144 1.527 . . . . 0.0 107.574 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.99 144.75 5.92 Favored 'General case' 0 N--CA 1.521 3.113 0 O-C-N 124.535 1.147 . . . . 0.0 110.744 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 m -128.64 133.14 48.18 Favored 'General case' 0 N--CA 1.522 3.172 0 O-C-N 126.147 2.155 . . . . 0.0 107.108 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.46 107.5 19.19 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.922 1.389 . . . . 0.0 110.319 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.3 mt -123.06 144.13 49.5 Favored 'General case' 0 N--CA 1.528 3.444 0 O-C-N 125.103 1.502 . . . . 0.0 110.568 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.77 141.1 46.96 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 77.6 m -146.55 138.16 24.57 Favored 'General case' 0 N--CA 1.531 3.58 0 O-C-N 124.832 1.333 . . . . 0.0 110.427 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -89.58 118.45 29.22 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 125.172 1.545 . . . . 0.0 111.83 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.3 mm -81.3 123.19 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.7 mt -97.88 -177.9 3.91 Favored 'General case' 0 N--CA 1.523 3.183 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.62 -44.51 77.84 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 124.769 1.293 . . . . 0.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.71 -19.16 61.45 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 125.117 1.511 . . . . 0.0 112.012 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.34 9.98 78.38 Favored Glycine 1 N--CA 1.517 4.043 0 CA-C-O 116.933 -2.037 . . . . 0.0 115.881 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 -71.38 137.0 48.02 Favored 'General case' 0 N--CA 1.529 3.484 0 CA-C-N 118.38 1.09 . . . . 0.0 108.228 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.16 106.13 1.81 Allowed Glycine 0 N--CA 1.51 3.598 0 CA-C-O 118.583 -1.121 . . . . 0.0 115.691 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.78 106.18 15.7 Favored 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.5 m -135.2 143.54 46.47 Favored 'General case' 0 N--CA 1.526 3.349 0 O-C-N 124.865 1.353 . . . . 0.0 110.875 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.528 HD21 ' HB3' ' A' ' 50' ' ' ALA . 15.0 t30 -84.33 141.03 31.2 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 125.377 1.673 . . . . 0.0 109.896 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.07 -25.06 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.584 0 O-C-N 125.537 1.773 . . . . 0.0 114.786 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -78.03 -22.46 49.18 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' H ' HD22 ' A' ' 48' ' ' ASN . 16.9 mt-10 -81.49 -1.59 46.56 Favored 'General case' 1 N--CA 1.543 4.215 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.74 160.17 17.71 Favored 'General case' 0 N--CA 1.53 3.562 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -152.75 127.8 9.71 Favored 'General case' 0 N--CA 1.508 2.463 0 O-C-N 125.834 1.959 . . . . 0.0 106.46 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.21 136.6 44.43 Favored 'General case' 0 N--CA 1.524 3.239 0 O-C-N 126.076 2.11 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -160.08 154.29 23.44 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 124.732 1.27 . . . . 0.0 107.776 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 m -126.69 147.47 49.94 Favored 'General case' 0 N--CA 1.518 2.944 0 O-C-N 125.947 2.029 . . . . 0.0 108.212 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.64 150.51 30.95 Favored 'General case' 0 N--CA 1.512 2.647 0 O-C-N 125.016 1.447 . . . . 0.0 108.917 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.2 t -148.67 8.39 0.78 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 125.433 1.708 . . . . 0.0 110.037 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.92 22.92 0.05 OUTLIER Glycine 0 N--CA 1.509 3.537 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.34 13.89 82.43 Favored Glycine 0 N--CA 1.512 3.709 0 CA-C-O 117.516 -1.713 . . . . 0.0 114.372 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -133.42 161.59 34.15 Favored 'General case' 1 N--CA 1.541 4.111 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.83 75.64 0.07 OUTLIER Glycine 1 N--CA 1.516 4.026 0 O-C-N 124.367 1.042 . . . . 0.0 112.123 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -74.97 153.27 38.62 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.041 1.083 . . . . 0.0 110.162 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.64 138.04 5.96 Favored 'General case' 0 N--CA 1.533 3.705 0 O-C-N 124.918 1.386 . . . . 0.0 112.917 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -83.36 113.37 20.68 Favored 'General case' 0 N--CA 1.521 3.117 0 O-C-N 124.815 1.322 . . . . 0.0 110.812 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.69 152.39 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.833 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.53 142.53 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.19 127.1 26.73 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.06 0 O-C-N 125.555 1.784 . . . . 0.0 112.496 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -90.21 156.59 18.2 Favored 'General case' 0 N--CA 1.524 3.248 0 O-C-N 124.868 1.355 . . . . 0.0 108.467 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -68.46 -26.22 65.39 Favored 'General case' 0 N--CA 1.523 3.193 0 O-C-N 124.578 1.174 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.53 146.86 38.66 Favored 'General case' 0 N--CA 1.53 3.559 0 O-C-N 125.277 1.61 . . . . 0.0 109.795 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -155.79 146.65 22.21 Favored 'General case' 0 N--CA 1.525 3.28 0 O-C-N 124.838 1.336 . . . . 0.0 112.153 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.2 m -71.67 109.42 5.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 125.576 1.797 . . . . 0.0 110.038 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.05 145.55 39.8 Favored Glycine 0 N--CA 1.514 3.852 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -129.65 85.06 2.26 Favored 'General case' 0 N--CA 1.53 3.531 0 O-C-N 125.893 1.584 . . . . 0.0 109.353 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.38 96.92 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.524 3.268 0 CA-C-N 113.758 -1.564 . . . . 0.0 108.77 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.9 mtm 56.58 169.01 0.05 OUTLIER Pre-proline 2 N--CA 1.56 5.029 0 C-N-CA 126.298 1.839 . . . . 0.0 114.216 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.59 -11.31 29.55 Favored 'Trans proline' 1 C--N 1.433 5.013 0 CA-C-N 124.859 2.771 . . . . 0.0 114.446 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.52 -39.69 31.4 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 124.333 1.021 . . . . 0.0 113.55 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.96 -159.78 50.95 Favored Glycine 2 CA--C 1.586 4.52 0 CA-C-O 115.333 -2.926 . . . . 0.0 109.109 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.81 153.34 83.59 Favored 'Cis proline' 0 C--N 1.404 3.481 0 CA-C-N 124.005 3.902 . . . . 0.0 113.991 -0.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -71.12 137.03 48.5 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 125.578 1.799 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -39.14 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 O-C-N 125.039 1.462 . . . . 0.0 112.292 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.83 -172.21 21.56 Favored Glycine 0 N--CA 1.504 3.173 0 O-C-N 125.68 1.863 . . . . 0.0 108.967 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.0 117.31 6.85 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 125.741 1.495 . . . . 0.0 113.817 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.86 133.46 66.16 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.111 0 O-C-N 126.132 2.145 . . . . 0.0 107.564 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.01 136.28 33.14 Favored 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.035 1.459 . . . . 0.0 111.163 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 41.6 t -80.12 79.84 6.62 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 125.136 1.523 . . . . 0.0 110.397 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.42 -36.78 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.233 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.593 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.7 p -79.79 -19.31 48.88 Favored 'General case' 0 N--CA 1.514 2.762 0 O-C-N 125.325 1.64 . . . . 0.0 111.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.72 147.26 98.64 Favored Pre-proline 0 N--CA 1.519 2.986 0 CA-C-O 114.738 -2.553 . . . . 0.0 110.949 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.13 -45.97 0.33 Allowed 'Trans proline' 0 C--N 1.408 3.677 0 CA-C-N 124.091 2.497 . . . . 0.0 112.876 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.47 -47.4 28.36 Favored Glycine 0 N--CA 1.51 3.589 0 O-C-N 124.62 1.2 . . . . 0.0 112.764 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 86.7 162.74 37.69 Favored Glycine 1 N--CA 1.517 4.056 0 O-C-N 125.496 1.351 . . . . 0.0 110.715 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.4 m -69.99 148.1 49.31 Favored 'General case' 0 N--CA 1.508 2.467 0 O-C-N 124.794 0.937 . . . . 0.0 112.577 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -148.05 133.44 18.57 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 125.839 1.962 . . . . 0.0 107.319 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.85 134.67 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.639 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -130.78 134.15 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 N-CA-C 104.751 -2.315 . . . . 0.0 104.751 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 t -128.61 130.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 N-CA-C 102.264 -3.236 . . . . 0.0 102.264 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 179.35 152.16 10.39 Favored Glycine 0 N--CA 1.514 3.846 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.43 -163.08 37.87 Favored Glycine 0 N--CA 1.509 3.565 0 O-C-N 125.735 1.491 . . . . 0.0 112.231 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -85.58 -6.7 59.14 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 125.952 1.619 . . . . 0.0 112.697 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.1 p -69.99 -68.12 0.44 Allowed 'General case' 0 N--CA 1.517 2.902 0 O-C-N 124.89 1.369 . . . . 0.0 111.783 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.33 -23.42 0.09 OUTLIER Glycine 1 N--CA 1.519 4.203 0 CA-C-O 118.562 -1.132 . . . . 0.0 112.981 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -67.27 150.45 49.03 Favored 'General case' 0 N--CA 1.525 3.287 0 O-C-N 124.988 1.052 . . . . 0.0 111.976 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.75 147.21 48.32 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 125.94 2.025 . . . . 0.0 109.802 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.38 -65.2 1.81 Allowed Glycine 0 N--CA 1.516 3.975 0 O-C-N 124.597 1.186 . . . . 0.0 113.821 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 66.65 116.06 0.03 OUTLIER 'General case' 0 N--CA 1.536 3.849 0 C-N-CA 125.523 1.529 . . . . 0.0 112.75 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.9 106.26 1.23 Allowed 'General case' 0 N--CA 1.53 3.544 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.572 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.16 155.52 40.17 Favored 'General case' 0 N--CA 1.512 2.631 0 O-C-N 124.235 0.959 . . . . 0.0 112.586 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.17 167.78 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 126.481 2.363 . . . . 0.0 108.12 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 t -137.49 169.09 18.37 Favored 'General case' 0 N--CA 1.523 3.185 0 O-C-N 124.95 1.406 . . . . 0.0 109.301 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -131.38 148.01 52.62 Favored 'General case' 0 N--CA 1.522 3.171 0 O-C-N 126.246 2.216 . . . . 0.0 109.039 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 3.585 0 CA-C-O 116.365 -2.353 . . . . 0.0 111.385 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m -75.49 -12.64 60.28 Favored 'General case' 0 N--CA 1.516 2.857 0 O-C-N 125.06 1.475 . . . . 0.0 114.226 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.95 156.92 36.18 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 124.73 1.269 . . . . 0.0 113.246 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.11 132.27 6.28 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 125.443 1.714 . . . . 0.0 110.245 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.3 t -114.27 145.52 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.994 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 m -160.71 145.48 14.2 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 125.312 1.632 . . . . 0.0 109.867 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.22 147.32 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 t -158.59 108.74 1.64 Allowed Pre-proline 0 N--CA 1.526 3.342 0 CA-C-O 115.416 -2.23 . . . . 0.0 109.788 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -62.02 162.63 45.75 Favored 'Cis proline' 2 C--N 1.426 4.654 0 CA-C-N 124.905 2.788 . . . . 0.0 113.235 -3.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.26 -6.58 0.73 Allowed 'General case' 0 N--CA 1.534 3.743 0 O-C-N 124.764 1.29 . . . . 0.0 112.619 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.7 p -138.3 153.58 49.02 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 124.914 1.384 . . . . 0.0 109.551 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.58 30.19 66.83 Favored Glycine 0 N--CA 1.512 3.752 0 O-C-N 124.977 1.423 . . . . 0.0 113.201 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.8 mt -72.9 153.87 40.82 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 125.296 1.233 . . . . 0.0 109.83 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.15 -175.83 3.62 Favored 'General case' 0 N--CA 1.523 3.221 0 O-C-N 126.003 2.064 . . . . 0.0 109.772 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.11 131.05 45.03 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 124.675 1.234 . . . . 0.0 112.363 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.78 30.04 66.59 Favored Glycine 0 N--CA 1.514 3.896 0 O-C-N 124.699 1.249 . . . . 0.0 112.473 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 146.3 48.62 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 125.154 1.149 . . . . 0.0 111.841 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.4 m -115.27 124.3 50.98 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.317 2.261 . . . . 0.0 105.4 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 m -122.22 151.53 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.204 0 O-C-N 125.892 1.995 . . . . 0.0 110.559 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 m -111.02 100.45 9.14 Favored 'General case' 0 N--CA 1.516 2.831 0 O-C-N 126.185 2.178 . . . . 0.0 108.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 t -79.78 145.27 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.55 160.89 36.13 Favored 'General case' 0 N--CA 1.514 2.731 0 O-C-N 126.102 2.126 . . . . 0.0 109.647 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.14 16.72 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 125.423 1.702 . . . . 0.0 108.378 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 m -156.37 144.91 19.98 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.39 1.681 . . . . 0.0 109.831 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.09 88.11 0.12 Allowed Glycine 0 N--CA 1.51 3.598 0 O-C-N 125.109 1.506 . . . . 0.0 111.093 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -154.87 148.74 25.63 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 125.628 1.428 . . . . 0.0 108.036 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.35 -18.92 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 O-C-N 124.801 1.313 . . . . 0.0 111.256 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.6 -41.66 26.62 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 124.255 0.972 . . . . 0.0 110.743 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 p -67.24 142.11 57.03 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 125.224 1.578 . . . . 0.0 110.424 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 p -79.9 -26.06 40.36 Favored 'General case' 0 N--CA 1.529 3.501 0 O-C-N 124.956 1.41 . . . . 0.0 113.203 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -170.06 133.57 1.18 Allowed 'General case' 0 N--CA 1.516 2.839 0 O-C-N 124.585 1.178 . . . . 0.0 109.005 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.0 139.95 45.14 Favored 'General case' 0 N--CA 1.515 2.781 0 O-C-N 124.756 1.285 . . . . 0.0 111.411 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.75 169.62 17.38 Favored 'General case' 0 N--CA 1.521 3.083 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -162.19 126.36 3.19 Favored 'General case' 0 N--CA 1.519 2.979 0 O-C-N 124.925 1.391 . . . . 0.0 110.997 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 144.76 15.06 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.215 1.572 . . . . 0.0 110.434 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.69 148.54 25.92 Favored 'General case' 0 N--CA 1.527 3.42 0 O-C-N 125.367 1.667 . . . . 0.0 108.977 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -139.73 140.23 36.72 Favored 'General case' 0 N--CA 1.529 3.503 0 O-C-N 125.609 1.818 . . . . 0.0 109.752 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.55 117.38 27.46 Favored 'General case' 0 N--CA 1.517 2.887 0 O-C-N 125.15 1.531 . . . . 0.0 113.011 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.8 mm -80.31 142.36 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.002 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mt -128.05 -176.38 3.77 Favored 'General case' 0 N--CA 1.523 3.22 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.99 -44.26 89.85 Favored 'General case' 0 N--CA 1.515 2.787 0 O-C-N 124.811 1.319 . . . . 0.0 112.122 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.84 -20.74 59.63 Favored 'General case' 0 N--CA 1.516 2.858 0 O-C-N 125.408 1.693 . . . . 0.0 111.207 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.08 76.67 Favored Glycine 0 N--CA 1.511 3.648 0 CA-C-O 117.377 -1.79 . . . . 0.0 115.853 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -73.5 142.05 46.78 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -69.3 93.35 0.35 Allowed Glycine 0 N--CA 1.511 3.693 0 O-C-N 124.811 1.319 . . . . 0.0 114.322 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.23 101.2 10.76 Favored 'General case' 0 N--CA 1.518 2.936 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.4 m -138.34 154.44 48.97 Favored 'General case' 0 N--CA 1.527 3.393 0 O-C-N 124.441 1.088 . . . . 0.0 110.356 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -99.64 107.24 19.31 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 126.572 2.42 . . . . 0.0 107.958 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.7 m -67.69 -16.76 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.134 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.41 63.78 Favored 'General case' 0 N--CA 1.52 3.038 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -86.42 8.14 22.94 Favored 'General case' 1 N--CA 1.55 4.54 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -69.32 169.69 11.78 Favored 'General case' 0 N--CA 1.534 3.747 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -137.94 -61.18 0.62 Allowed 'General case' 0 N--CA 1.516 2.825 0 O-C-N 125.705 1.878 . . . . 0.0 109.542 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 52.86 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.535 3.793 0 O-C-N 125.334 1.646 . . . . 0.0 115.014 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -156.06 153.04 28.78 Favored 'General case' 0 N--CA 1.528 3.475 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 m -62.0 157.67 18.17 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 115.135 1.532 . . . . 0.0 115.135 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.44 145.73 33.15 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.911 1.382 . . . . 0.0 108.373 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 t -71.52 -33.01 68.82 Favored 'General case' 0 N--CA 1.512 2.636 0 O-C-N 124.664 1.227 . . . . 0.0 111.364 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.4 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.5 2.905 0 N-CA-C 107.848 -2.101 . . . . 0.0 107.848 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.31 24.58 0.04 OUTLIER Glycine 0 N--CA 1.502 3.069 0 CA-C-O 118.494 -1.17 . . . . 0.0 110.413 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.34 161.06 39.33 Favored 'General case' 0 N--CA 1.537 3.894 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -174.41 76.59 0.08 OUTLIER Glycine 0 N--CA 1.513 3.787 0 O-C-N 124.275 0.985 . . . . 0.0 112.054 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 m -74.42 147.54 41.95 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 125.284 1.226 . . . . 0.0 109.468 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.44 135.62 7.9 Favored 'General case' 0 N--CA 1.529 3.492 0 O-C-N 124.799 1.312 . . . . 0.0 112.613 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 m -86.76 114.4 23.4 Favored 'General case' 0 N--CA 1.515 2.778 0 O-C-N 125.133 1.521 . . . . 0.0 111.425 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.7 t -107.66 149.47 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.822 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.72 142.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.18 134.7 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 O-C-N 125.346 1.654 . . . . 0.0 112.78 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -90.27 166.69 13.19 Favored 'General case' 0 N--CA 1.517 2.921 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.9 ttp85 -65.58 -27.95 68.79 Favored 'General case' 0 N--CA 1.532 3.638 0 O-C-N 124.257 0.973 . . . . 0.0 111.896 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.7 151.51 41.42 Favored 'General case' 0 N--CA 1.525 3.319 0 O-C-N 125.53 1.769 . . . . 0.0 108.749 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -154.21 147.51 24.88 Favored 'General case' 0 N--CA 1.526 3.358 0 O-C-N 124.935 1.397 . . . . 0.0 111.72 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.7 m -65.8 108.44 2.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 125.791 1.932 . . . . 0.0 112.209 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.28 150.56 43.96 Favored Glycine 0 N--CA 1.513 3.774 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -133.92 90.36 2.69 Favored 'General case' 0 N--CA 1.531 3.607 0 O-C-N 125.589 1.405 . . . . 0.0 109.824 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 38.8 t -73.95 109.49 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.229 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.407 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.8 172.08 0.02 OUTLIER Pre-proline 2 N--CA 1.567 5.422 0 C-N-CA 126.652 1.981 . . . . 0.0 116.287 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.64 -13.64 29.94 Favored 'Trans proline' 1 C--N 1.425 4.588 0 CA-C-N 123.731 2.368 . . . . 0.0 114.095 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.69 -39.59 30.93 Favored 'General case' 0 N--CA 1.512 2.627 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.89 -161.62 51.2 Favored Glycine 2 CA--C 1.586 4.492 0 CA-C-O 115.442 -2.865 . . . . 0.0 108.658 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.73 156.43 82.71 Favored 'Cis proline' 0 C--N 1.402 3.378 0 CA-C-N 123.931 3.865 . . . . 0.0 114.131 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -70.17 138.69 52.03 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 125.623 1.827 . . . . 0.0 109.492 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.98 -40.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 O-C-N 125.011 1.444 . . . . 0.0 112.61 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.56 -175.11 23.29 Favored Glycine 0 N--CA 1.508 3.448 0 O-C-N 125.516 1.76 . . . . 0.0 109.538 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.25 116.55 5.56 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 125.78 1.517 . . . . 0.0 113.883 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.53 138.46 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 O-C-N 126.046 2.091 . . . . 0.0 108.125 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -90.67 152.04 21.01 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 125.309 1.631 . . . . 0.0 110.84 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.2 m -75.46 -27.68 58.97 Favored 'General case' 0 N--CA 1.513 2.717 0 O-C-N 124.583 1.177 . . . . 0.0 111.507 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.9 -29.16 68.19 Favored 'General case' 0 N--CA 1.512 2.667 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 p -79.65 -30.69 41.32 Favored 'General case' 0 N--CA 1.528 3.455 0 O-C-N 124.408 1.068 . . . . 0.0 112.309 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -68.39 152.78 96.36 Favored Pre-proline 0 N--CA 1.527 3.4 0 CA-C-O 115.125 -2.369 . . . . 0.0 111.364 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -72.73 -47.77 0.34 Allowed 'Trans proline' 0 C--N 1.41 3.795 0 CA-C-N 123.624 2.33 . . . . 0.0 113.317 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -72.19 -48.24 26.39 Favored Glycine 0 N--CA 1.512 3.759 0 O-C-N 124.712 1.258 . . . . 0.0 111.976 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.13 166.84 38.65 Favored Glycine 0 N--CA 1.515 3.96 0 O-C-N 125.303 1.237 . . . . 0.0 112.404 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 65.5 m -69.95 151.31 45.77 Favored 'General case' 0 N--CA 1.506 2.35 0 CA-C-N 114.014 -1.093 . . . . 0.0 112.617 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.61 145.82 19.09 Favored 'General case' 0 N--CA 1.526 3.333 0 O-C-N 125.247 1.592 . . . . 0.0 109.209 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.71 130.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.767 0 O-C-N 125.273 1.608 . . . . 0.0 107.16 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 t -123.47 131.12 73.66 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.74 142.19 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 174.44 -153.84 17.44 Favored Glycine 0 N--CA 1.512 3.756 0 O-C-N 124.049 0.843 . . . . 0.0 111.181 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -164.38 -167.38 24.81 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 108.491 -1.843 . . . . 0.0 108.491 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -69.9 -20.36 63.37 Favored 'General case' 0 N--CA 1.512 2.662 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.26 -22.0 2.02 Favored 'General case' 0 N--CA 1.538 3.965 0 O-C-N 124.751 1.282 . . . . 0.0 111.385 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.64 -15.23 63.88 Favored Glycine 1 N--CA 1.524 4.542 0 CA-C-O 118.051 -1.416 . . . . 0.0 116.342 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.97 168.2 0.26 Allowed 'General case' 1 N--CA 1.546 4.366 0 C-N-CA 124.741 1.216 . . . . 0.0 112.428 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -70.0 164.5 23.81 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.922 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -155.65 90.79 0.12 Allowed Glycine 0 N--CA 1.516 3.986 0 N-CA-C 108.211 -1.955 . . . . 0.0 108.211 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.02 149.23 50.91 Favored 'General case' 0 N--CA 1.512 2.665 0 O-C-N 125.362 1.272 . . . . 0.0 113.619 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.24 93.85 0.97 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 124.958 1.411 . . . . 0.0 108.328 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.99 153.51 42.59 Favored 'General case' 0 N--CA 1.513 2.706 0 CA-C-N 114.811 -1.086 . . . . 0.0 113.11 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.71 170.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.758 0 O-C-N 126.396 2.31 . . . . 0.0 107.608 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.4 m -156.95 118.22 3.72 Favored 'General case' 0 N--CA 1.525 3.278 0 O-C-N 124.283 0.99 . . . . 0.0 110.736 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -71.21 153.77 42.2 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.522 1.139 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.247 0 CA-C-O 116.249 -2.417 . . . . 0.0 109.752 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 t -167.52 92.13 0.38 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 125.335 1.647 . . . . 0.0 107.406 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -164.81 121.47 1.52 Allowed 'General case' 0 N--CA 1.513 2.724 0 CA-C-N 114.219 -1.355 . . . . 0.0 108.551 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.0 127.0 31.75 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.687 1.242 . . . . 0.0 112.015 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.61 138.88 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.105 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.03 144.73 8.44 Favored 'General case' 0 N--CA 1.519 2.996 0 O-C-N 124.82 1.325 . . . . 0.0 110.574 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.45 147.5 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.146 0 N-CA-C 102.062 -3.31 . . . . 0.0 102.062 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -158.18 108.87 1.72 Allowed Pre-proline 0 N--CA 1.525 3.28 0 CA-C-O 115.377 -2.249 . . . . 0.0 110.131 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.1 162.73 51.92 Favored 'Cis proline' 2 C--N 1.425 4.572 0 CA-C-N 124.812 2.754 . . . . 0.0 112.831 -4.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.6 -8.69 1.25 Allowed 'General case' 0 N--CA 1.535 3.823 0 O-C-N 124.753 1.283 . . . . 0.0 112.846 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -136.78 154.41 50.56 Favored 'General case' 0 N--CA 1.525 3.31 0 O-C-N 125.269 1.606 . . . . 0.0 108.556 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.29 30.26 62.97 Favored Glycine 0 N--CA 1.511 3.667 0 O-C-N 124.944 1.402 . . . . 0.0 111.943 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.9 mt -75.32 154.09 37.52 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 125.378 1.281 . . . . 0.0 109.411 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.09 -175.36 3.47 Favored 'General case' 0 N--CA 1.524 3.228 0 O-C-N 126.026 2.079 . . . . 0.0 109.829 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.43 127.57 32.81 Favored 'General case' 0 N--CA 1.51 2.57 0 O-C-N 124.761 1.288 . . . . 0.0 112.521 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.6 28.97 71.65 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.56 1.162 . . . . 0.0 113.013 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.05 127.04 31.3 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 124.91 1.006 . . . . 0.0 112.564 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -89.27 129.93 35.75 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.67 148.23 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 O-C-N 125.168 1.542 . . . . 0.0 110.465 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 m -103.05 97.25 7.38 Favored 'General case' 0 N--CA 1.514 2.771 0 O-C-N 125.956 2.035 . . . . 0.0 109.701 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 t -79.87 148.3 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.005 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.62 161.59 34.22 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 125.804 1.94 . . . . 0.0 110.466 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.19 139.82 11.15 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 125.526 1.766 . . . . 0.0 108.042 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 m -159.39 142.83 14.58 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 125.129 1.518 . . . . 0.0 109.473 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.82 97.32 0.05 OUTLIER Glycine 0 N--CA 1.512 3.719 0 O-C-N 125.229 1.581 . . . . 0.0 111.432 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -154.21 153.16 31.29 Favored 'General case' 0 N--CA 1.513 2.683 0 O-C-N 125.371 1.277 . . . . 0.0 108.076 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.2 -16.99 0.08 Allowed 'General case' 0 N--CA 1.515 2.822 0 O-C-N 125.254 1.596 . . . . 0.0 111.166 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 p -79.54 -59.97 2.54 Favored 'General case' 0 N--CA 1.517 2.924 0 O-C-N 124.207 0.942 . . . . 0.0 109.402 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 p -71.84 119.23 15.72 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 124.717 1.26 . . . . 0.0 109.984 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.3 p -79.9 -13.1 59.63 Favored 'General case' 0 N--CA 1.526 3.357 0 O-C-N 124.466 1.104 . . . . 0.0 112.656 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 p -167.65 148.6 5.36 Favored 'General case' 0 N--CA 1.512 2.626 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.37 165.67 26.87 Favored 'General case' 0 N--CA 1.519 3.024 0 O-C-N 125.607 1.817 . . . . 0.0 110.45 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.1 m -158.95 108.22 1.93 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 102.868 -3.012 . . . . 0.0 102.868 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 131.12 42.91 Favored 'General case' 0 N--CA 1.514 2.732 0 O-C-N 124.379 1.049 . . . . 0.0 113.385 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.73 143.71 11.51 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 124.897 1.373 . . . . 0.0 111.007 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.46 147.7 23.97 Favored 'General case' 0 N--CA 1.512 2.641 0 O-C-N 125.363 1.665 . . . . 0.0 106.756 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 65.7 m -141.81 144.57 33.99 Favored 'General case' 0 N--CA 1.527 3.399 0 O-C-N 125.434 1.709 . . . . 0.0 109.497 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.52 118.79 32.88 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.451 1.719 . . . . 0.0 111.809 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.7 139.59 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.806 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mt -126.08 -177.12 3.84 Favored 'General case' 0 N--CA 1.531 3.589 0 O-C-N 125.686 1.867 . . . . 0.0 106.376 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.02 97.8 Favored 'General case' 0 N--CA 1.514 2.758 0 O-C-N 124.466 1.104 . . . . 0.0 112.245 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -19.13 57.91 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 125.407 1.692 . . . . 0.0 111.206 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.31 22.67 78.55 Favored Glycine 0 N--CA 1.511 3.641 0 CA-C-O 117.316 -1.824 . . . . 0.0 115.992 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -73.66 143.62 46.19 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.42 87.84 0.42 Allowed Glycine 0 N--CA 1.514 3.861 0 O-C-N 124.859 1.349 . . . . 0.0 113.84 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.72 92.69 6.31 Favored 'General case' 0 N--CA 1.517 2.891 0 O-C-N 125.725 1.485 . . . . 0.0 107.593 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.3 m -129.14 146.57 51.04 Favored 'General case' 0 N--CA 1.527 3.412 0 O-C-N 125.028 1.455 . . . . 0.0 110.873 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -86.05 127.38 34.66 Favored 'General case' 0 N--CA 1.514 2.77 0 O-C-N 125.61 1.819 . . . . 0.0 111.233 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 m -71.66 -24.17 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.49 -17.83 62.32 Favored 'General case' 0 N--CA 1.533 3.684 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -81.84 5.67 18.09 Favored 'General case' 0 N--CA 1.536 3.873 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -64.32 146.98 53.53 Favored 'General case' 0 N--CA 1.537 3.912 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.043 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -152.42 -64.29 0.16 Allowed 'General case' 0 N--CA 1.533 3.701 0 CA-C-O 117.138 -1.411 . . . . 0.0 114.525 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.72 159.7 29.59 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -136.92 -157.74 0.8 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 126.731 2.52 . . . . 0.0 105.692 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 55.8 p -53.04 144.5 15.07 Favored 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.5 132.72 36.41 Favored 'General case' 0 N--CA 1.517 2.923 0 O-C-N 125.124 1.515 . . . . 0.0 109.633 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -75.26 -32.77 61.17 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.116 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 48.51 0.13 Allowed Glycine 0 N--CA 1.505 3.235 0 O-C-N 125.158 1.536 . . . . 0.0 110.605 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.09 28.17 68.9 Favored Glycine 0 N--CA 1.507 3.404 0 CA-C-O 118.011 -1.438 . . . . 0.0 114.271 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -143.1 154.0 43.48 Favored 'General case' 1 N--CA 1.544 4.256 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.9 79.0 0.06 OUTLIER Glycine 1 N--CA 1.517 4.039 0 O-C-N 124.393 1.058 . . . . 0.0 112.403 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -74.9 152.61 38.85 Favored 'General case' 0 N--CA 1.522 3.128 0 O-C-N 125.079 1.105 . . . . 0.0 108.905 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.51 141.83 7.84 Favored 'General case' 0 N--CA 1.526 3.352 0 O-C-N 124.808 1.317 . . . . 0.0 113.339 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 t -92.1 110.09 21.46 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.164 1.54 . . . . 0.0 108.541 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.83 149.72 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.847 0 O-C-N 125.187 1.554 . . . . 0.0 107.239 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.37 140.0 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.4 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.41 124.89 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.902 0 O-C-N 125.626 1.829 . . . . 0.0 112.115 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -90.22 161.48 15.69 Favored 'General case' 0 N--CA 1.524 3.229 0 O-C-N 124.836 1.335 . . . . 0.0 107.758 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -67.48 -32.4 73.2 Favored 'General case' 0 N--CA 1.518 2.95 0 O-C-N 124.664 1.227 . . . . 0.0 111.687 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.38 147.24 51.77 Favored 'General case' 0 N--CA 1.53 3.561 0 O-C-N 125.988 2.055 . . . . 0.0 109.97 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -157.74 147.75 20.4 Favored 'General case' 0 N--CA 1.528 3.44 0 O-C-N 124.805 1.316 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.3 m -72.31 101.53 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 125.78 1.925 . . . . 0.0 108.854 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.63 155.16 51.98 Favored Glycine 0 N--CA 1.51 3.59 0 O-C-N 124.979 1.425 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -140.53 119.91 13.07 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 125.696 1.468 . . . . 0.0 110.235 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 37.9 t -71.3 132.92 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.803 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.1 mmt -52.87 -58.62 11.39 Favored Pre-proline 0 N--CA 1.534 3.757 0 CA-C-O 113.129 -3.32 . . . . 0.0 119.611 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -53.68 -57.34 1.97 Allowed 'Trans proline' 0 C--N 1.405 3.52 0 CA-C-N 125.65 3.054 . . . . 0.0 117.334 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.13 -53.33 0.05 Allowed 'General case' 0 N--CA 1.537 3.924 0 CA-C-N 119.962 1.255 . . . . 0.0 112.549 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.72 -168.7 39.27 Favored Glycine 1 N--CA 1.517 4.072 0 CA-C-O 115.561 -2.8 . . . . 0.0 108.683 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -72.66 148.69 92.33 Favored 'Cis proline' 0 N--CA 1.529 3.578 0 CA-C-N 123.172 3.486 . . . . 0.0 113.417 -0.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -73.55 132.61 43.04 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 125.241 1.588 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -37.42 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 O-C-N 125.105 1.503 . . . . 0.0 112.099 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 89.11 -170.19 37.32 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.22 110.65 1.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.97 1.629 . . . . 0.0 113.221 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -129.95 135.67 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.996 0 O-C-N 126.061 2.101 . . . . 0.0 108.335 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -79.73 154.53 28.49 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.916 1.385 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 50.5 t -78.83 -29.47 44.72 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 124.972 1.42 . . . . 0.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.29 -22.07 62.0 Favored 'General case' 0 N--CA 1.515 2.823 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.3 p -79.69 -28.7 40.66 Favored 'General case' 0 N--CA 1.531 3.599 0 O-C-N 124.303 1.002 . . . . 0.0 113.304 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.1 150.74 96.45 Favored Pre-proline 0 N--CA 1.529 3.501 0 CA-C-O 115.26 -2.305 . . . . 0.0 112.183 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -73.61 -46.36 0.35 Allowed 'Trans proline' 0 C--N 1.41 3.792 0 CA-C-N 123.613 2.326 . . . . 0.0 113.515 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.22 -43.98 61.56 Favored Glycine 0 N--CA 1.512 3.751 0 O-C-N 124.608 1.192 . . . . 0.0 112.885 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.7 160.62 30.56 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 125.198 1.175 . . . . 0.0 111.591 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 13.8 m -69.96 154.72 41.58 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-N 114.544 -0.828 . . . . 0.0 112.942 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -162.11 145.97 12.16 Favored 'General case' 0 N--CA 1.523 3.177 0 O-C-N 125.2 1.562 . . . . 0.0 108.592 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.2 mm -79.69 135.99 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.771 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 90.1 t -134.4 132.33 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.236 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.51 140.46 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -177.85 -132.5 1.7 Allowed Glycine 1 N--CA 1.52 4.25 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.19 -158.19 15.78 Favored Glycine 0 N--CA 1.505 3.299 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -73.37 -13.28 61.07 Favored 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.61 -73.8 0.16 Allowed 'General case' 0 N--CA 1.522 3.138 0 O-C-N 124.685 1.241 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.85 -23.44 0.24 Allowed Glycine 1 N--CA 1.517 4.068 0 CA-C-O 118.617 -1.101 . . . . 0.0 112.229 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.7 108.83 1.83 Allowed 'General case' 0 N--CA 1.521 3.096 0 O-C-N 125.224 1.191 . . . . 0.0 112.325 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -80.12 153.72 28.51 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.615 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.92 -60.98 1.89 Allowed Glycine 1 N--CA 1.518 4.148 0 O-C-N 125.116 1.51 . . . . 0.0 111.479 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 m120 63.85 121.14 0.02 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 125.609 1.563 . . . . 0.0 114.734 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.39 96.86 0.78 Allowed 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.62 160.94 31.63 Favored 'General case' 0 N--CA 1.511 2.613 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.416 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.0 pt -119.81 176.19 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.708 0 O-C-N 126.507 2.38 . . . . 0.0 107.14 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 m -163.65 115.01 1.4 Allowed 'General case' 0 N--CA 1.519 3.007 0 O-C-N 125.014 1.446 . . . . 0.0 109.01 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -70.43 153.31 43.11 Favored 'General case' 0 N--CA 1.513 2.709 0 O-C-N 124.48 1.112 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.273 0 CA-C-O 116.356 -2.358 . . . . 0.0 109.798 179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -166.8 90.89 0.4 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 125.29 1.619 . . . . 0.0 107.091 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.79 80.04 0.18 Allowed 'General case' 0 N--CA 1.527 3.422 0 CA-C-N 114.187 -1.37 . . . . 0.0 113.929 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.84 130.57 35.42 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.884 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.71 138.87 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.98 143.03 10.72 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 124.855 1.347 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.69 143.04 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m -158.51 112.59 1.68 Allowed Pre-proline 0 N--CA 1.523 3.198 0 CA-C-O 114.945 -2.455 . . . . 0.0 109.66 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.04 150.16 75.01 Favored 'Cis proline' 1 C--N 1.423 4.448 0 CA-C-N 125.401 2.965 . . . . 0.0 112.113 -3.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.76 -16.98 1.47 Allowed 'General case' 0 N--CA 1.528 3.464 0 O-C-N 125.897 1.998 . . . . 0.0 112.496 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.58 151.37 44.85 Favored 'General case' 0 N--CA 1.525 3.282 0 O-C-N 125.765 1.916 . . . . 0.0 110.915 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.15 31.89 66.1 Favored Glycine 1 N--CA 1.517 4.095 0 O-C-N 124.91 1.381 . . . . 0.0 112.5 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.8 mt -74.15 154.42 39.11 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 125.481 1.342 . . . . 0.0 110.715 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.57 -175.3 3.61 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 126.393 2.308 . . . . 0.0 108.324 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.46 127.91 34.15 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 124.767 1.292 . . . . 0.0 112.894 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.79 28.75 71.64 Favored Glycine 0 N--CA 1.515 3.922 0 O-C-N 124.703 1.252 . . . . 0.0 113.174 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.51 123.26 22.78 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 124.841 0.965 . . . . 0.0 112.663 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 m -80.65 129.92 34.8 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -131.11 141.01 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 O-C-N 125.722 1.888 . . . . 0.0 109.249 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.1 m -105.61 101.66 11.16 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 126.145 2.153 . . . . 0.0 110.44 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.0 t -79.79 147.71 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.08 158.75 43.65 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.998 2.061 . . . . 0.0 109.072 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.14 148.34 16.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 125.302 1.626 . . . . 0.0 108.123 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -157.37 145.13 18.9 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 125.2 1.563 . . . . 0.0 109.714 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.6 86.1 0.17 Allowed Glycine 0 N--CA 1.507 3.422 0 O-C-N 125.181 1.55 . . . . 0.0 110.412 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -151.87 149.54 29.09 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 125.732 1.489 . . . . 0.0 108.335 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -162.19 -15.55 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.952 0 O-C-N 125.038 1.461 . . . . 0.0 111.166 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 p -79.43 -49.65 12.0 Favored 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.86 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 p -66.89 140.4 57.78 Favored 'General case' 0 N--CA 1.519 3.022 0 O-C-N 124.94 1.4 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -81.12 -18.41 46.55 Favored 'General case' 0 N--CA 1.524 3.226 0 O-C-N 125.051 1.469 . . . . 0.0 113.909 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 m -169.98 133.58 1.2 Allowed 'General case' 0 N--CA 1.518 2.972 0 O-C-N 124.704 1.253 . . . . 0.0 109.531 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.53 145.44 36.94 Favored 'General case' 0 N--CA 1.516 2.855 0 O-C-N 124.741 1.276 . . . . 0.0 110.072 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.3 m -154.15 156.46 37.22 Favored 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.42 115.79 9.0 Favored 'General case' 0 N--CA 1.524 3.243 0 O-C-N 125.1 1.5 . . . . 0.0 111.127 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.9 mt -116.05 153.56 31.48 Favored 'General case' 0 N--CA 1.528 3.45 0 O-C-N 125.713 1.883 . . . . 0.0 109.188 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -127.34 114.53 17.69 Favored 'General case' 0 N--CA 1.52 3.062 0 O-C-N 126.144 2.152 . . . . 0.0 106.041 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 10.3 m -126.08 157.03 39.02 Favored 'General case' 0 N--CA 1.526 3.374 0 O-C-N 125.689 1.868 . . . . 0.0 111.615 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.42 123.89 49.55 Favored 'General case' 0 N--CA 1.523 3.223 0 O-C-N 126.185 2.178 . . . . 0.0 110.219 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -80.4 121.06 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 O-C-N 125.076 1.485 . . . . 0.0 107.736 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.5 mt -98.53 -175.84 3.2 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.85 -44.83 84.3 Favored 'General case' 0 N--CA 1.516 2.843 0 O-C-N 124.64 1.212 . . . . 0.0 111.799 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.25 61.26 Favored 'General case' 0 N--CA 1.526 3.366 0 O-C-N 125.261 1.601 . . . . 0.0 111.556 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.64 22.57 57.99 Favored Glycine 0 N--CA 1.516 3.972 0 CA-C-O 117.604 -1.664 . . . . 0.0 115.512 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -72.95 142.37 47.81 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.37 72.83 2.29 Favored Glycine 0 N--CA 1.515 3.948 0 O-C-N 124.803 1.314 . . . . 0.0 113.311 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.97 12.04 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 124.865 0.979 . . . . 0.0 108.442 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -133.95 140.7 46.93 Favored 'General case' 0 N--CA 1.521 3.091 0 O-C-N 125.218 1.574 . . . . 0.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -81.78 115.0 20.8 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 125.354 1.659 . . . . 0.0 107.885 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.5 m -65.12 -16.43 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.22 0 N-CA-C 116.187 1.921 . . . . 0.0 116.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.3 -20.19 63.04 Favored 'General case' 0 N--CA 1.526 3.361 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -84.16 4.03 32.34 Favored 'General case' 1 N--CA 1.55 4.53 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -68.64 169.94 10.19 Favored 'General case' 0 N--CA 1.534 3.742 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -138.39 -67.37 0.47 Allowed 'General case' 0 N--CA 1.517 2.886 0 O-C-N 125.876 1.985 . . . . 0.0 108.461 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.9 t70 52.83 101.22 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -156.11 153.02 28.67 Favored 'General case' 0 N--CA 1.523 3.212 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.0 p -60.4 156.0 16.9 Favored 'General case' 0 N--CA 1.517 2.902 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.48 144.33 34.11 Favored 'General case' 0 N--CA 1.515 2.785 0 O-C-N 124.9 1.375 . . . . 0.0 107.954 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -72.39 -25.94 61.69 Favored 'General case' 0 N--CA 1.517 2.877 0 O-C-N 124.379 1.05 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.68 -39.58 0.08 OUTLIER Glycine 0 N--CA 1.496 2.678 0 N-CA-C 107.21 -2.356 . . . . 0.0 107.21 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.13 24.93 0.04 OUTLIER Glycine 0 N--CA 1.501 3.033 0 O-C-N 125.324 1.25 . . . . 0.0 110.294 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.24 158.7 43.43 Favored 'General case' 0 N--CA 1.536 3.865 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.69 77.52 0.08 OUTLIER Glycine 0 N--CA 1.513 3.816 0 O-C-N 124.399 1.062 . . . . 0.0 112.04 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.6 m -74.69 151.22 39.26 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 125.232 1.195 . . . . 0.0 109.205 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.11 140.05 7.47 Favored 'General case' 0 N--CA 1.533 3.702 0 O-C-N 124.748 1.28 . . . . 0.0 113.305 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 m -90.29 122.18 32.97 Favored 'General case' 0 N--CA 1.518 2.926 0 O-C-N 125.188 1.555 . . . . 0.0 110.039 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.08 146.6 24.65 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 O-C-N 125.722 1.889 . . . . 0.0 107.067 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.47 123.89 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.672 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.45 126.97 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 125.615 1.822 . . . . 0.0 111.196 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -90.25 160.11 16.35 Favored 'General case' 0 N--CA 1.525 3.324 0 O-C-N 124.809 1.318 . . . . 0.0 108.179 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -69.51 -27.27 65.04 Favored 'General case' 0 N--CA 1.523 3.208 0 O-C-N 124.472 1.107 . . . . 0.0 111.755 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.2 m -139.46 147.61 41.59 Favored 'General case' 0 N--CA 1.529 3.507 0 O-C-N 125.315 1.634 . . . . 0.0 109.636 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.26 149.18 22.5 Favored 'General case' 0 N--CA 1.523 3.192 0 O-C-N 124.676 1.235 . . . . 0.0 111.583 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.1 m -67.99 117.34 9.72 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 125.999 2.062 . . . . 0.0 109.124 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.22 145.46 41.07 Favored Glycine 0 N--CA 1.508 3.482 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -141.8 124.5 15.97 Favored 'General case' 0 N--CA 1.522 3.165 0 O-C-N 125.365 1.274 . . . . 0.0 109.148 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.54 98.27 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.066 0 N-CA-C 102.335 -3.209 . . . . 0.0 102.335 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.254 21.4 ttp -58.08 -56.58 33.45 Favored Pre-proline 0 N--CA 1.518 2.947 0 CA-C-O 114.057 -2.878 . . . . 0.0 117.436 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -66.81 -51.1 0.95 Allowed 'Trans proline' 0 C--N 1.392 2.865 0 CA-C-N 124.612 2.683 . . . . 0.0 115.958 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -79.93 -72.53 0.4 Allowed 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.34 -176.47 44.63 Favored Glycine 2 CA--C 1.586 4.531 0 CA-C-O 116.814 -2.104 . . . . 0.0 110.128 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -71.16 173.19 50.62 Favored 'Cis proline' 0 N--CA 1.53 3.672 0 CA-C-N 122.795 3.298 . . . . 0.0 113.148 -6.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.52 133.56 55.85 Favored 'General case' 0 N--CA 1.514 2.775 0 O-C-N 125.087 1.492 . . . . 0.0 110.231 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.91 -85.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.048 0 O-C-N 125.616 1.823 . . . . 0.0 111.55 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.71 -171.28 40.12 Favored Glycine 0 N--CA 1.504 3.17 0 CA-C-N 120.609 1.55 . . . . 0.0 109.974 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.68 116.72 7.19 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 125.841 1.553 . . . . 0.0 112.744 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.92 137.29 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.009 0 O-C-N 125.927 2.017 . . . . 0.0 107.873 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.17 145.91 26.8 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 125.311 1.632 . . . . 0.0 109.286 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.9 -23.02 45.06 Favored 'General case' 0 N--CA 1.512 2.652 0 O-C-N 124.884 1.365 . . . . 0.0 112.16 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -76.26 -30.13 57.72 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.8 p -79.65 -18.18 52.04 Favored 'General case' 0 N--CA 1.528 3.442 0 O-C-N 124.675 1.235 . . . . 0.0 112.601 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.89 156.89 86.16 Favored Pre-proline 0 N--CA 1.532 3.637 0 CA-C-O 115.771 -2.061 . . . . 0.0 111.757 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.23 -42.92 0.81 Allowed 'Trans proline' 0 C--N 1.407 3.63 0 CA-C-N 123.384 2.244 . . . . 0.0 114.707 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -74.58 -104.84 0.09 OUTLIER Glycine 0 N--CA 1.504 3.229 0 O-C-N 124.741 1.276 . . . . 0.0 111.627 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 169.98 161.19 20.02 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.48 143.4 40.5 Favored 'General case' 0 N--CA 1.514 2.728 0 O-C-N 125.659 1.447 . . . . 0.0 107.957 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -147.6 132.27 17.87 Favored 'General case' 0 N--CA 1.533 3.71 0 O-C-N 125.09 1.494 . . . . 0.0 109.802 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.7 mm -79.8 134.66 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.904 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.4 t -121.45 129.27 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.275 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -128.92 140.17 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 172.58 -144.37 7.89 Favored Glycine 0 N--CA 1.512 3.747 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -172.12 -163.18 25.58 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.39 -18.78 62.33 Favored 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -126.94 -13.54 5.74 Favored 'General case' 0 N--CA 1.531 3.616 0 O-C-N 125.278 1.611 . . . . 0.0 109.004 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.4 -12.42 66.36 Favored Glycine 1 N--CA 1.524 4.509 0 CA-C-O 118.895 -0.947 . . . . 0.0 114.344 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . 0.253 23.9 mt-10 62.7 -85.36 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.378 0 C-N-CA 125.676 1.59 . . . . 0.0 114.17 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -152.96 157.19 40.23 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 125.056 1.472 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -157.57 68.23 0.28 Allowed Glycine 0 N--CA 1.512 3.725 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.39 151.01 47.32 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 125.569 1.393 . . . . 0.0 114.359 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.67 102.22 1.34 Allowed 'General case' 0 N--CA 1.526 3.361 0 O-C-N 124.914 1.384 . . . . 0.0 109.625 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.07 28.61 Favored 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.24 170.78 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.917 0 O-C-N 126.369 2.293 . . . . 0.0 107.267 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.0 m -161.05 124.3 3.28 Favored 'General case' 0 N--CA 1.521 3.111 0 O-C-N 124.587 1.179 . . . . 0.0 110.434 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -72.44 156.8 38.67 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 124.501 1.126 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.357 0 CA-C-O 116.319 -2.378 . . . . 0.0 109.76 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.3 t -70.04 -37.0 75.46 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 125.433 1.708 . . . . 0.0 111.836 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.07 116.98 10.14 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 125.711 1.882 . . . . 0.0 111.991 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.9 140.01 36.89 Favored 'General case' 0 N--CA 1.51 2.558 0 O-C-N 124.639 1.212 . . . . 0.0 110.594 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.41 139.93 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.061 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.97 146.65 19.17 Favored 'General case' 0 N--CA 1.52 3.061 0 O-C-N 124.85 1.344 . . . . 0.0 110.362 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.9 143.9 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -156.46 109.73 2.03 Favored Pre-proline 0 N--CA 1.528 3.473 0 CA-C-O 115.017 -2.42 . . . . 0.0 109.822 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -63.17 159.64 62.45 Favored 'Cis proline' 1 C--N 1.425 4.576 0 CA-C-N 125.279 2.921 . . . . 0.0 112.591 -2.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.14 -1.46 1.36 Allowed 'General case' 0 N--CA 1.531 3.576 0 O-C-N 125.033 1.458 . . . . 0.0 112.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -139.49 152.0 46.62 Favored 'General case' 0 N--CA 1.526 3.373 0 O-C-N 124.744 1.277 . . . . 0.0 110.159 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.35 30.67 69.04 Favored Glycine 0 N--CA 1.511 3.695 0 O-C-N 124.877 1.361 . . . . 0.0 113.556 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.6 154.16 40.91 Favored 'General case' 0 N--CA 1.519 2.978 0 O-C-N 125.342 1.26 . . . . 0.0 110.1 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -128.6 -174.37 3.22 Favored 'General case' 0 N--CA 1.522 3.137 0 O-C-N 125.877 1.986 . . . . 0.0 109.599 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.04 129.02 38.54 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 124.635 1.21 . . . . 0.0 112.23 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.83 28.67 70.34 Favored Glycine 0 N--CA 1.514 3.864 0 O-C-N 124.704 1.252 . . . . 0.0 112.763 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.42 126.96 31.11 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 125.065 1.097 . . . . 0.0 112.245 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.4 m -88.91 134.27 34.02 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.77 147.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.191 0 O-C-N 125.295 1.622 . . . . 0.0 110.426 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.7 m -104.93 96.31 6.45 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 126.145 2.153 . . . . 0.0 108.842 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.0 t -79.86 147.26 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.998 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.8 p -135.31 164.77 26.97 Favored 'General case' 0 N--CA 1.518 2.972 0 O-C-N 125.944 2.027 . . . . 0.0 110.011 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.12 148.45 16.94 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 125.611 1.82 . . . . 0.0 108.161 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -159.34 145.28 16.25 Favored 'General case' 0 N--CA 1.512 2.659 0 O-C-N 124.993 1.433 . . . . 0.0 110.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 143.99 5.55 Favored Glycine 1 N--CA 1.516 4.03 0 O-C-N 124.939 1.399 . . . . 0.0 112.158 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.02 168.41 20.05 Favored 'General case' 0 N--CA 1.526 3.33 0 O-C-N 125.177 1.163 . . . . 0.0 108.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.6 -37.22 0.02 OUTLIER 'General case' 0 N--CA 1.515 2.815 0 O-C-N 124.979 1.424 . . . . 0.0 110.546 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.91 -46.69 1.96 Allowed 'General case' 0 N--CA 1.526 3.371 0 O-C-N 126.192 2.183 . . . . 0.0 110.902 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 90.2 p -67.43 153.98 42.44 Favored 'General case' 0 N--CA 1.52 3.036 0 O-C-N 124.785 1.303 . . . . 0.0 112.299 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.7 t -138.33 -2.48 1.81 Allowed 'General case' 0 N--CA 1.538 3.93 0 O-C-N 125.563 1.79 . . . . 0.0 111.375 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -165.7 154.28 11.45 Favored 'General case' 0 N--CA 1.516 2.838 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.44 152.0 19.64 Favored 'General case' 0 N--CA 1.523 3.217 0 O-C-N 124.057 0.848 . . . . 0.0 111.833 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.1 m -116.59 -177.64 3.23 Favored 'General case' 0 N--CA 1.516 2.837 0 O-C-N 126.55 2.406 . . . . 0.0 106.157 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.66 112.6 1.93 Allowed 'General case' 0 N--CA 1.515 2.791 0 O-C-N 124.499 1.124 . . . . 0.0 109.253 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 154.17 46.68 Favored 'General case' 0 N--CA 1.531 3.592 0 O-C-N 125.147 1.529 . . . . 0.0 108.66 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.99 146.4 35.33 Favored 'General case' 0 N--CA 1.508 2.455 0 O-C-N 126.602 2.439 . . . . 0.0 104.688 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.2 m -141.07 144.89 35.2 Favored 'General case' 0 N--CA 1.526 3.365 0 O-C-N 125.382 1.676 . . . . 0.0 109.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.21 114.8 27.44 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 125.428 1.705 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.9 mm -77.48 143.32 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.874 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.53 -176.64 4.1 Favored 'General case' 0 N--CA 1.524 3.273 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.99 96.22 Favored 'General case' 0 N--CA 1.514 2.736 0 O-C-N 124.74 1.275 . . . . 0.0 112.062 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.06 -22.23 60.64 Favored 'General case' 0 N--CA 1.522 3.139 0 O-C-N 125.384 1.678 . . . . 0.0 111.275 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.86 27.29 69.21 Favored Glycine 0 N--CA 1.512 3.76 0 CA-C-O 117.67 -1.628 . . . . 0.0 115.778 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -74.38 147.53 42.05 Favored 'General case' 0 N--CA 1.527 3.405 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.02 74.35 1.63 Allowed Glycine 0 N--CA 1.515 3.925 0 O-C-N 124.958 1.411 . . . . 0.0 113.927 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.92 89.3 6.84 Favored 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 m -128.37 144.14 51.1 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.046 1.466 . . . . 0.0 110.861 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -79.92 149.92 30.71 Favored 'General case' 0 N--CA 1.512 2.637 0 O-C-N 125.213 1.571 . . . . 0.0 109.965 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.99 -25.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 O-C-N 125.895 1.997 . . . . 0.0 112.445 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.22 -9.32 58.44 Favored 'General case' 0 N--CA 1.523 3.205 0 N-CA-C 116.301 1.963 . . . . 0.0 116.301 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.89 -8.86 59.55 Favored 'General case' 0 N--CA 1.536 3.844 0 O-C-N 124.145 0.903 . . . . 0.0 113.232 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -63.69 156.44 26.94 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -145.54 -43.01 0.22 Allowed 'General case' 0 N--CA 1.525 3.313 0 O-C-N 125.464 1.728 . . . . 0.0 108.552 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 t70 55.17 54.62 8.56 Favored 'General case' 0 N--CA 1.523 3.175 0 O-C-N 124.981 1.426 . . . . 0.0 114.627 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -71.51 151.42 43.91 Favored 'General case' 0 N--CA 1.509 2.512 0 CA-C-N 113.769 -1.56 . . . . 0.0 110.734 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.2 m -115.6 145.56 42.57 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 126.182 2.176 . . . . 0.0 109.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.1 mt -79.71 154.02 28.87 Favored 'General case' 0 N--CA 1.516 2.827 0 O-C-N 125.042 1.464 . . . . 0.0 107.923 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -134.45 12.67 3.8 Favored 'General case' 0 N--CA 1.525 3.294 0 O-C-N 125.878 1.986 . . . . 0.0 110.061 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 177.09 -50.76 0.1 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 107.344 -2.303 . . . . 0.0 107.344 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.64 -4.66 0.04 OUTLIER Glycine 0 N--CA 1.504 3.167 0 CA-C-O 117.344 -1.809 . . . . 0.0 112.665 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -121.91 162.61 20.71 Favored 'General case' 0 N--CA 1.537 3.89 0 O-C-N 125.538 1.376 . . . . 0.0 110.485 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 179.56 85.26 0.06 OUTLIER Glycine 0 N--CA 1.507 3.428 0 O-C-N 124.722 1.264 . . . . 0.0 110.546 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -72.55 153.75 41.15 Favored 'General case' 0 N--CA 1.521 3.075 0 O-C-N 125.124 1.132 . . . . 0.0 110.481 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -158.46 139.81 13.36 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.878 1.361 . . . . 0.0 111.583 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 t -91.02 124.23 35.09 Favored 'General case' 0 N--CA 1.521 3.123 0 O-C-N 124.996 1.435 . . . . 0.0 111.026 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 t -116.41 150.05 18.49 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.119 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.68 140.26 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.738 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.83 125.15 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.991 0 O-C-N 125.54 1.775 . . . . 0.0 112.092 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -90.21 165.08 14.15 Favored 'General case' 0 N--CA 1.52 3.069 0 O-C-N 124.932 1.395 . . . . 0.0 109.013 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -67.57 -29.55 68.94 Favored 'General case' 0 N--CA 1.518 2.967 0 O-C-N 124.924 1.39 . . . . 0.0 112.618 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.23 144.05 32.0 Favored 'General case' 0 N--CA 1.529 3.48 0 O-C-N 125.55 1.781 . . . . 0.0 110.69 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -155.61 149.25 25.13 Favored 'General case' 0 N--CA 1.523 3.218 0 O-C-N 125.244 1.59 . . . . 0.0 111.774 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 m -71.24 103.85 2.94 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 125.666 1.854 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.57 157.6 52.75 Favored Glycine 0 N--CA 1.511 3.691 0 O-C-N 124.959 1.412 . . . . 0.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -141.13 121.8 14.28 Favored 'General case' 0 N--CA 1.515 2.821 0 O-C-N 125.603 1.414 . . . . 0.0 110.449 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 31.3 t -71.06 133.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.886 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.279 24.7 ttm -53.56 -59.16 10.16 Favored Pre-proline 0 N--CA 1.532 3.653 0 CA-C-O 113.267 -3.254 . . . . 0.0 118.678 -179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -52.7 -57.28 2.16 Favored 'Trans proline' 0 C--N 1.4 3.261 0 CA-C-N 125.386 2.959 . . . . 0.0 117.725 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.11 -56.3 0.06 Allowed 'General case' 0 N--CA 1.537 3.915 0 CA-C-N 120.049 1.295 . . . . 0.0 112.344 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.22 -169.32 41.03 Favored Glycine 1 N--CA 1.517 4.04 0 CA-C-O 115.614 -2.77 . . . . 0.0 108.598 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -72.52 149.78 94.11 Favored 'Cis proline' 0 C--N 1.405 3.512 0 CA-C-N 123.118 3.459 . . . . 0.0 113.246 -0.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -72.26 137.37 46.73 Favored 'General case' 0 N--CA 1.511 2.618 0 O-C-N 125.396 1.685 . . . . 0.0 108.625 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.82 -37.2 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 O-C-N 125.263 1.602 . . . . 0.0 112.196 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.98 -170.15 34.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 125.262 1.601 . . . . 0.0 109.602 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.91 112.8 2.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 126.049 1.676 . . . . 0.0 114.012 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.9 p -130.63 140.59 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.031 0 O-C-N 126.063 2.102 . . . . 0.0 107.201 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.52 148.75 21.8 Favored 'General case' 0 N--CA 1.515 2.802 0 O-C-N 125.581 1.8 . . . . 0.0 110.678 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 53.2 t -89.99 71.04 7.48 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.505 1.753 . . . . 0.0 109.612 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.89 -32.56 0.05 OUTLIER 'General case' 0 N--CA 1.525 3.292 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.6 -27.2 41.1 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.104 1.502 . . . . 0.0 110.992 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.56 145.24 98.2 Favored Pre-proline 0 N--CA 1.518 2.959 0 CA-C-O 114.736 -2.554 . . . . 0.0 111.033 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -73.57 -45.25 0.42 Allowed 'Trans proline' 0 C--N 1.412 3.878 0 CA-C-N 124.217 2.542 . . . . 0.0 112.732 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.83 -45.59 42.41 Favored Glycine 0 N--CA 1.512 3.753 0 O-C-N 124.729 1.268 . . . . 0.0 112.657 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 81.73 174.88 49.88 Favored Glycine 1 N--CA 1.519 4.173 0 O-C-N 125.187 1.169 . . . . 0.0 111.736 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 70.6 m -69.96 145.49 51.82 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 124.868 0.981 . . . . 0.0 112.348 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -147.48 133.87 19.63 Favored 'General case' 0 N--CA 1.527 3.423 0 O-C-N 125.495 1.747 . . . . 0.0 108.403 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -79.88 135.76 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.028 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.5 t -133.53 133.13 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.874 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 t -131.71 139.92 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -179.23 146.0 6.94 Favored Glycine 0 N--CA 1.514 3.844 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -74.28 176.03 47.91 Favored Glycine 0 N--CA 1.501 2.969 0 O-C-N 124.833 0.96 . . . . 0.0 112.536 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -72.76 -22.07 60.91 Favored 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 113.636 -1.282 . . . . 0.0 112.533 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.8 p -70.01 -61.45 1.77 Allowed 'General case' 0 N--CA 1.516 2.836 0 O-C-N 124.91 1.381 . . . . 0.0 112.643 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 172.29 6.64 0.03 OUTLIER Glycine 1 N--CA 1.523 4.451 0 CA-C-O 117.636 -1.647 . . . . 0.0 114.384 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -71.68 160.84 31.94 Favored 'General case' 0 N--CA 1.531 3.616 0 CA-C-N 118.013 0.906 . . . . 0.0 111.071 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -152.58 157.3 40.84 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.06 1.475 . . . . 0.0 108.485 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -172.87 82.91 0.08 OUTLIER Glycine 0 N--CA 1.504 3.218 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -69.92 155.78 40.07 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 125.353 1.266 . . . . 0.0 112.042 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.82 98.23 1.48 Allowed 'General case' 0 N--CA 1.527 3.38 0 O-C-N 124.753 1.283 . . . . 0.0 110.505 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.46 151.32 44.08 Favored 'General case' 0 N--CA 1.509 2.516 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.21 176.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.386 0 O-C-N 126.365 2.29 . . . . 0.0 107.812 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.9 m -153.47 113.99 4.02 Favored 'General case' 0 N--CA 1.526 3.368 0 O-C-N 124.172 0.92 . . . . 0.0 110.641 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -70.8 154.37 41.9 Favored 'General case' 0 N--CA 1.514 2.763 0 O-C-N 124.424 1.078 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.342 0 CA-C-O 116.311 -2.383 . . . . 0.0 109.694 -179.961 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.377 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -163.15 89.95 0.65 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 125.669 1.856 . . . . 0.0 107.066 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.58 120.94 14.28 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.613 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.97 122.15 26.36 Favored 'General case' 0 N--CA 1.509 2.497 0 O-C-N 124.758 1.286 . . . . 0.0 111.684 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -125.96 137.66 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.329 0 N-CA-C 101.783 -3.414 . . . . 0.0 101.783 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.7 p -161.17 146.39 13.98 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 124.865 1.353 . . . . 0.0 110.57 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -123.8 144.08 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.137 0 N-CA-C 102.494 -3.15 . . . . 0.0 102.494 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -155.99 110.66 2.12 Favored Pre-proline 0 N--CA 1.528 3.429 0 CA-C-O 114.981 -2.437 . . . . 0.0 109.883 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -64.25 156.63 72.94 Favored 'Cis proline' 1 C--N 1.424 4.533 0 CA-C-N 125.344 2.944 . . . . 0.0 111.899 -2.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.8 -4.83 1.37 Allowed 'General case' 0 N--CA 1.531 3.594 0 O-C-N 125.46 1.725 . . . . 0.0 112.563 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 82.0 p -136.09 152.59 51.02 Favored 'General case' 0 N--CA 1.524 3.272 0 O-C-N 124.991 1.432 . . . . 0.0 110.093 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.98 28.92 67.74 Favored Glycine 0 N--CA 1.513 3.791 0 O-C-N 124.989 1.431 . . . . 0.0 113.274 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.9 mt -73.12 152.83 41.03 Favored 'General case' 0 N--CA 1.516 2.86 0 O-C-N 125.205 1.179 . . . . 0.0 109.794 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.77 4.81 Favored 'General case' 0 N--CA 1.526 3.354 0 O-C-N 125.68 1.863 . . . . 0.0 109.102 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.66 136.29 57.38 Favored 'General case' 0 N--CA 1.52 3.047 0 O-C-N 124.952 1.408 . . . . 0.0 111.711 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.88 39.27 33.87 Favored Glycine 0 N--CA 1.511 3.643 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.81 156.94 38.75 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 125.718 1.481 . . . . 0.0 112.401 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 m -139.8 119.08 12.82 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 126.361 2.288 . . . . 0.0 105.074 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.6 m -119.26 155.15 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.043 0 O-C-N 126.053 2.095 . . . . 0.0 109.975 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.9 m -122.74 96.05 4.87 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 126.286 2.241 . . . . 0.0 106.362 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.9 t -79.63 147.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.72 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.2 p -137.85 165.54 26.24 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 126.051 2.094 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.18 146.73 15.79 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 125.502 1.751 . . . . 0.0 108.598 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 p -160.53 146.8 15.28 Favored 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.888 1.367 . . . . 0.0 108.947 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.69 87.72 0.17 Allowed Glycine 0 N--CA 1.508 3.457 0 O-C-N 125.054 1.471 . . . . 0.0 110.529 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -156.89 153.64 28.49 Favored 'General case' 0 N--CA 1.511 2.613 0 O-C-N 125.713 1.478 . . . . 0.0 107.477 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -161.5 -20.24 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 O-C-N 124.792 1.307 . . . . 0.0 111.28 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 p -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.518 2.937 0 O-C-N 124.39 1.056 . . . . 0.0 111.124 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 p -70.11 126.09 28.66 Favored 'General case' 0 N--CA 1.521 3.099 0 O-C-N 124.63 1.206 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -80.3 -14.19 58.58 Favored 'General case' 0 N--CA 1.531 3.585 0 O-C-N 124.392 1.058 . . . . 0.0 112.975 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 p -166.29 155.85 11.68 Favored 'General case' 0 N--CA 1.519 3.015 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.23 147.18 33.26 Favored 'General case' 0 N--CA 1.521 3.116 0 O-C-N 125.111 1.507 . . . . 0.0 111.376 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.09 -179.31 3.66 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 126.594 2.434 . . . . 0.0 107.682 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.55 109.83 2.16 Favored 'General case' 0 N--CA 1.515 2.809 0 O-C-N 124.944 1.402 . . . . 0.0 108.447 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.41 139.47 23.18 Favored 'General case' 0 N--CA 1.534 3.737 0 O-C-N 124.595 1.185 . . . . 0.0 111.519 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -84.0 145.3 28.59 Favored 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 78.2 m -144.79 144.59 31.24 Favored 'General case' 0 N--CA 1.529 3.49 0 O-C-N 125.009 1.443 . . . . 0.0 108.713 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.9 118.51 37.08 Favored 'General case' 0 N--CA 1.522 3.169 0 O-C-N 125.673 1.858 . . . . 0.0 113.202 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.64 135.81 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.923 0 N-CA-C 104.117 -2.549 . . . . 0.0 104.117 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.7 mt -113.44 -173.63 2.3 Favored 'General case' 0 N--CA 1.527 3.383 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.88 -49.54 70.1 Favored 'General case' 0 N--CA 1.518 2.927 0 O-C-N 124.506 1.129 . . . . 0.0 112.604 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.8 -20.65 61.82 Favored 'General case' 0 N--CA 1.526 3.334 0 O-C-N 125.372 1.67 . . . . 0.0 111.948 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.1 24.34 59.73 Favored Glycine 0 N--CA 1.512 3.721 0 CA-C-O 118.237 -1.313 . . . . 0.0 114.244 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.34 144.7 44.35 Favored 'General case' 0 N--CA 1.521 3.118 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.12 118.21 7.27 Favored Glycine 0 N--CA 1.508 3.481 0 O-C-N 124.729 1.268 . . . . 0.0 112.669 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.91 107.36 8.25 Favored 'General case' 0 N--CA 1.522 3.144 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.3 m -147.83 156.09 42.35 Favored 'General case' 0 N--CA 1.526 3.363 0 O-C-N 124.665 1.228 . . . . 0.0 110.112 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.456 HD22 ' H ' ' A' ' 50' ' ' ALA . 1.2 t30 -83.44 147.39 27.88 Favored 'General case' 0 N--CA 1.517 2.922 0 O-C-N 125.451 1.72 . . . . 0.0 109.734 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.06 -24.85 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.46 0 O-C-N 125.753 1.908 . . . . 0.0 112.933 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' H ' HD22 ' A' ' 48' ' ' ASN . . . -71.89 -17.02 62.14 Favored 'General case' 0 N--CA 1.521 3.084 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.89 -5.65 55.93 Favored 'General case' 0 N--CA 1.537 3.877 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -63.58 161.84 14.0 Favored 'General case' 0 N--CA 1.533 3.699 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -152.15 -50.14 0.11 Allowed 'General case' 0 N--CA 1.515 2.782 0 O-C-N 125.853 1.971 . . . . 0.0 108.093 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 t70 56.82 49.59 13.94 Favored 'General case' 0 N--CA 1.522 3.148 0 O-C-N 125.505 1.753 . . . . 0.0 113.185 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -67.04 135.2 53.33 Favored 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 113.434 -1.712 . . . . 0.0 112.373 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -91.26 138.16 31.8 Favored 'General case' 0 N--CA 1.514 2.746 0 O-C-N 124.911 1.382 . . . . 0.0 110.859 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.83 152.95 29.42 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 124.994 1.434 . . . . 0.0 107.774 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -140.98 6.01 1.96 Allowed 'General case' 0 N--CA 1.529 3.521 0 O-C-N 125.578 1.798 . . . . 0.0 111.768 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.07 22.39 0.05 OUTLIER Glycine 0 N--CA 1.509 3.563 0 O-C-N 124.075 0.859 . . . . 0.0 110.993 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.12 26.41 72.39 Favored Glycine 0 N--CA 1.508 3.454 0 CA-C-O 118.227 -1.318 . . . . 0.0 113.149 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -143.75 154.66 43.68 Favored 'General case' 1 N--CA 1.54 4.07 0 O-C-N 125.217 1.186 . . . . 0.0 108.372 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -179.47 140.88 4.51 Favored Glycine 0 N--CA 1.509 3.55 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -135.54 150.49 49.75 Favored 'General case' 0 N--CA 1.531 3.583 0 O-C-N 125.734 1.491 . . . . 0.0 108.318 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 t -159.59 139.18 11.42 Favored 'General case' 0 N--CA 1.533 3.716 0 O-C-N 124.962 1.414 . . . . 0.0 111.884 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 t -93.31 135.62 34.36 Favored 'General case' 0 N--CA 1.516 2.838 0 O-C-N 125.147 1.53 . . . . 0.0 108.827 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -132.44 154.11 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.893 0 O-C-N 125.557 1.785 . . . . 0.0 106.949 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.91 138.92 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 N-CA-C 103.316 -2.846 . . . . 0.0 103.316 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.13 139.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.898 0 O-C-N 125.394 1.684 . . . . 0.0 111.86 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -90.0 163.57 14.87 Favored 'General case' 0 N--CA 1.52 3.035 0 O-C-N 125.584 1.802 . . . . 0.0 106.434 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -62.38 -39.12 92.16 Favored 'General case' 0 N--CA 1.516 2.862 0 O-C-N 124.843 1.339 . . . . 0.0 111.144 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.36 153.93 35.79 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 126.36 2.287 . . . . 0.0 109.94 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -156.31 148.97 23.78 Favored 'General case' 0 N--CA 1.529 3.496 0 O-C-N 124.966 1.416 . . . . 0.0 111.663 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.0 m -68.05 107.01 2.55 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 125.56 1.787 . . . . 0.0 111.367 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.44 99.05 0.87 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.737 1.273 . . . . 0.0 110.153 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -93.33 103.6 15.82 Favored 'General case' 0 N--CA 1.524 3.242 0 O-C-N 125.294 1.232 . . . . 0.0 112.635 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 t -78.53 107.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.007 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . 0.256 17.6 ttt -63.8 -58.95 12.8 Favored Pre-proline 0 N--CA 1.519 2.987 0 CA-C-O 114.345 -2.741 . . . . 0.0 117.515 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.76 -50.72 0.8 Allowed 'Trans proline' 0 C--N 1.395 2.991 0 CA-C-N 124.796 2.748 . . . . 0.0 117.515 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.9 -72.14 0.42 Allowed 'General case' 0 N--CA 1.519 3.009 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.35 -178.64 47.07 Favored Glycine 2 CA--C 1.589 4.703 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.781 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.91 168.83 72.67 Favored 'Cis proline' 0 N--CA 1.527 3.467 0 CA-C-N 123.099 3.449 . . . . 0.0 112.51 -6.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -62.47 128.15 34.67 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 125.303 1.627 . . . . 0.0 110.537 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -78.66 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 CA-C-O 116.993 -1.479 . . . . 0.0 112.487 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.86 -171.35 42.27 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-N 120.271 1.396 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.64 128.15 35.41 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.665 1.45 . . . . 0.0 113.399 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.7 p -132.85 142.62 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 O-C-N 126.179 2.174 . . . . 0.0 106.094 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.48 146.32 36.16 Favored 'General case' 0 N--CA 1.529 3.525 0 O-C-N 126.079 2.112 . . . . 0.0 111.445 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 75.8 m -74.33 79.11 1.85 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 125.521 1.763 . . . . 0.0 111.896 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -37.33 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.326 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.332 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 p -79.66 -28.52 40.78 Favored 'General case' 0 N--CA 1.519 2.985 0 O-C-N 125.424 1.703 . . . . 0.0 110.86 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.07 139.5 95.39 Favored Pre-proline 0 N--CA 1.515 2.817 0 CA-C-O 114.472 -2.68 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -73.97 -43.03 0.63 Allowed 'Trans proline' 0 C--N 1.41 3.809 0 CA-C-N 124.575 2.67 . . . . 0.0 112.786 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -71.09 -40.72 61.58 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 124.862 1.351 . . . . 0.0 112.374 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 84.08 154.43 19.28 Favored Glycine 1 N--CA 1.518 4.101 0 O-C-N 125.287 1.228 . . . . 0.0 111.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 47.6 m -69.9 140.14 53.09 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 124.856 0.974 . . . . 0.0 111.683 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -145.54 139.27 26.62 Favored 'General case' 0 N--CA 1.526 3.337 0 O-C-N 125.369 1.668 . . . . 0.0 108.596 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.9 mm -79.84 133.6 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.818 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.0 t -135.0 133.72 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.6 t -115.96 143.87 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.312 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.92 137.47 3.21 Favored Glycine 1 N--CA 1.52 4.268 0 O-C-N 124.151 0.907 . . . . 0.0 111.566 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.81 -160.42 35.6 Favored Glycine 1 N--CA 1.518 4.103 0 O-C-N 125.48 1.341 . . . . 0.0 112.405 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -70.51 -25.03 62.95 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 125.443 1.319 . . . . 0.0 112.941 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.4 p -70.88 -32.7 69.76 Favored 'General case' 0 N--CA 1.524 3.269 0 O-C-N 124.799 1.312 . . . . 0.0 110.436 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.72 14.09 44.79 Favored Glycine 0 N--CA 1.516 3.998 0 O-C-N 125.747 1.904 . . . . 0.0 113.16 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.5 103.24 3.45 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -73.05 173.68 8.99 Favored 'General case' 0 N--CA 1.519 3.011 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.13 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.09 80.13 0.08 OUTLIER Glycine 0 N--CA 1.505 3.239 0 N-CA-C 108.304 -1.919 . . . . 0.0 108.304 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -67.86 154.32 41.83 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 125.307 1.239 . . . . 0.0 113.495 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.17 95.57 0.86 Allowed 'General case' 0 N--CA 1.523 3.212 0 O-C-N 125.127 1.517 . . . . 0.0 108.586 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.34 156.04 39.85 Favored 'General case' 0 N--CA 1.512 2.659 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 pt -119.7 173.13 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.689 0 O-C-N 126.663 2.477 . . . . 0.0 107.153 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.6 m -155.19 116.0 3.91 Favored 'General case' 0 N--CA 1.525 3.323 0 O-C-N 124.056 0.848 . . . . 0.0 110.445 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -69.96 150.26 46.89 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 124.611 1.194 . . . . 0.0 111.109 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.511 3.674 0 CA-C-O 116.389 -2.339 . . . . 0.0 111.516 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 p -69.87 -33.01 71.68 Favored 'General case' 0 N--CA 1.512 2.644 0 O-C-N 125.418 1.698 . . . . 0.0 112.622 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.8 170.8 14.58 Favored 'General case' 0 N--CA 1.513 2.677 0 O-C-N 125.036 1.46 . . . . 0.0 112.63 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.09 129.8 5.26 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 124.937 1.398 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -130.48 144.38 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -160.24 144.06 14.06 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 124.927 1.392 . . . . 0.0 110.238 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -122.11 142.28 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.062 0 N-CA-C 102.831 -3.026 . . . . 0.0 102.831 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -158.25 112.86 1.72 Allowed Pre-proline 0 N--CA 1.527 3.403 0 CA-C-O 114.892 -2.48 . . . . 0.0 110.082 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -64.28 151.31 73.18 Favored 'Cis proline' 1 C--N 1.423 4.494 0 CA-C-N 125.428 2.974 . . . . 0.0 112.102 -4.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.97 -8.89 1.58 Allowed 'General case' 0 N--CA 1.528 3.463 0 O-C-N 125.943 2.027 . . . . 0.0 112.817 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.2 p -132.73 151.58 51.95 Favored 'General case' 0 N--CA 1.526 3.346 0 O-C-N 125.321 1.638 . . . . 0.0 110.106 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.99 31.8 66.59 Favored Glycine 0 N--CA 1.514 3.881 0 O-C-N 124.993 1.433 . . . . 0.0 112.457 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.87 153.99 39.64 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 125.432 1.313 . . . . 0.0 110.234 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.88 -173.89 3.27 Favored 'General case' 0 N--CA 1.518 2.941 0 O-C-N 126.032 2.083 . . . . 0.0 108.404 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -66.56 128.94 38.18 Favored 'General case' 0 N--CA 1.513 2.681 0 O-C-N 124.644 1.215 . . . . 0.0 112.345 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.08 28.71 69.89 Favored Glycine 0 N--CA 1.514 3.853 0 O-C-N 124.667 1.229 . . . . 0.0 112.794 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.39 127.21 31.87 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 124.924 1.014 . . . . 0.0 112.618 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 m -87.08 130.07 34.65 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 125.307 1.629 . . . . 0.0 106.803 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.63 143.49 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 O-C-N 125.607 1.817 . . . . 0.0 108.981 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.9 m -111.12 102.01 10.49 Favored 'General case' 0 N--CA 1.519 2.984 0 O-C-N 126.268 2.23 . . . . 0.0 110.661 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.91 149.13 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.011 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.0 p -140.53 164.27 30.61 Favored 'General case' 0 N--CA 1.519 3.016 0 O-C-N 125.703 1.877 . . . . 0.0 110.174 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.24 145.33 14.84 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 125.53 1.769 . . . . 0.0 108.3 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 m -159.12 146.79 17.54 Favored 'General case' 0 N--CA 1.515 2.783 0 O-C-N 125.239 1.587 . . . . 0.0 109.381 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.13 88.91 0.11 Allowed Glycine 0 N--CA 1.508 3.498 0 O-C-N 125.101 1.5 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -154.96 155.5 34.34 Favored 'General case' 0 N--CA 1.51 2.555 0 O-C-N 125.71 1.477 . . . . 0.0 107.783 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.1 -19.51 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 O-C-N 124.883 1.364 . . . . 0.0 110.937 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -79.56 -51.16 9.66 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 124.427 1.08 . . . . 0.0 110.24 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 p -70.87 119.97 15.78 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 124.894 1.371 . . . . 0.0 110.96 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -79.79 -19.92 47.42 Favored 'General case' 0 N--CA 1.523 3.215 0 O-C-N 124.432 1.083 . . . . 0.0 112.909 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.2 m -166.38 150.09 7.39 Favored 'General case' 0 N--CA 1.51 2.557 0 O-C-N 125.233 1.583 . . . . 0.0 107.816 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.94 160.16 40.66 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 125.622 1.826 . . . . 0.0 110.373 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 m -151.14 129.75 12.25 Favored 'General case' 0 N--CA 1.517 2.913 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.37 121.78 24.25 Favored 'General case' 0 N--CA 1.521 3.092 0 O-C-N 124.651 1.219 . . . . 0.0 112.046 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 146.47 50.78 Favored 'General case' 0 N--CA 1.53 3.572 0 O-C-N 125.429 1.705 . . . . 0.0 110.593 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -133.57 128.74 35.88 Favored 'General case' 0 N--CA 1.513 2.718 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 63.5 m -138.47 142.74 39.43 Favored 'General case' 0 N--CA 1.531 3.604 0 O-C-N 124.719 1.262 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.17 26.56 Favored 'General case' 0 N--CA 1.519 2.981 0 O-C-N 125.187 1.555 . . . . 0.0 111.181 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.6 mm -79.33 122.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.142 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.2 mt -100.95 -174.34 2.59 Favored 'General case' 0 N--CA 1.526 3.339 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.02 -44.68 84.02 Favored 'General case' 0 N--CA 1.514 2.769 0 O-C-N 124.703 1.252 . . . . 0.0 110.84 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.23 -21.45 59.79 Favored 'General case' 0 N--CA 1.524 3.253 0 O-C-N 125.434 1.709 . . . . 0.0 110.87 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.85 26.69 60.02 Favored Glycine 0 N--CA 1.513 3.789 0 CA-C-O 117.472 -1.738 . . . . 0.0 115.635 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -73.11 146.23 45.88 Favored 'General case' 0 N--CA 1.528 3.445 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.01 74.72 1.17 Allowed Glycine 0 N--CA 1.515 3.917 0 CA-C-O 118.114 -1.381 . . . . 0.0 115.854 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.08 97.88 9.56 Favored 'General case' 0 N--CA 1.515 2.816 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -132.21 143.3 49.85 Favored 'General case' 0 N--CA 1.527 3.414 0 O-C-N 124.874 1.359 . . . . 0.0 111.792 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -85.87 116.31 24.04 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 125.487 1.742 . . . . 0.0 108.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.6 m -65.53 -23.81 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.07 -12.18 61.45 Favored 'General case' 0 N--CA 1.532 3.658 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -79.89 -7.18 58.59 Favored 'General case' 1 N--CA 1.541 4.109 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -64.18 160.81 17.64 Favored 'General case' 0 N--CA 1.531 3.604 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -139.18 -52.42 0.55 Allowed 'General case' 0 N--CA 1.52 3.032 0 O-C-N 126.007 2.067 . . . . 0.0 108.071 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.9 t70 45.58 116.1 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -171.22 144.04 1.98 Allowed 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.3 m -65.07 157.0 29.68 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 124.806 1.316 . . . . 0.0 113.478 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 21.2 mt -79.5 147.67 32.13 Favored 'General case' 0 N--CA 1.513 2.703 0 O-C-N 125.326 1.641 . . . . 0.0 108.225 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -72.1 -26.04 61.99 Favored 'General case' 0 N--CA 1.515 2.811 0 O-C-N 124.637 1.211 . . . . 0.0 112.483 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.03 -36.5 0.05 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 107.929 -2.069 . . . . 0.0 107.929 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.51 19.67 0.02 OUTLIER Glycine 0 N--CA 1.502 3.076 0 CA-C-O 117.673 -1.626 . . . . 0.0 111.953 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 158.06 34.75 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 125.497 1.351 . . . . 0.0 109.146 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.37 139.63 4.2 Favored Glycine 0 N--CA 1.505 3.242 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -142.35 151.16 41.63 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -162.74 134.98 5.42 Favored 'General case' 0 N--CA 1.521 3.109 0 O-C-N 124.96 1.412 . . . . 0.0 112.361 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 t -86.46 114.21 23.04 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 125.067 1.479 . . . . 0.0 110.325 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.03 144.86 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.0 t -122.71 137.23 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.686 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.55 131.12 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.906 0 O-C-N 125.75 1.906 . . . . 0.0 113.005 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -90.12 161.83 15.59 Favored 'General case' 0 N--CA 1.519 2.982 0 O-C-N 125.225 1.578 . . . . 0.0 106.984 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -65.68 -32.85 74.64 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 124.727 1.267 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 m -131.29 150.21 52.24 Favored 'General case' 0 N--CA 1.528 3.427 0 O-C-N 125.991 2.057 . . . . 0.0 110.173 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -157.8 146.71 19.48 Favored 'General case' 0 N--CA 1.525 3.292 0 O-C-N 124.906 1.379 . . . . 0.0 111.518 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.4 m -69.25 113.0 6.19 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 125.608 1.818 . . . . 0.0 110.631 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.35 149.55 45.68 Favored Glycine 0 N--CA 1.513 3.828 0 O-C-N 124.974 1.421 . . . . 0.0 109.858 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -137.95 88.37 2.32 Favored 'General case' 0 N--CA 1.526 3.367 0 O-C-N 125.406 1.298 . . . . 0.0 108.551 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 27.6 t -72.34 115.59 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.964 0 CA-C-N 113.685 -1.598 . . . . 0.0 108.316 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.4 mmt 48.07 163.23 0.03 OUTLIER Pre-proline 2 N--CA 1.567 5.375 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.93 -14.08 43.15 Favored 'Trans proline' 1 C--N 1.427 4.659 0 CA-C-N 123.323 2.222 . . . . 0.0 114.868 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.72 -40.6 28.53 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.68 49.92 Favored Glycine 2 CA--C 1.585 4.438 0 CA-C-O 115.305 -2.942 . . . . 0.0 108.631 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -66.47 155.43 82.25 Favored 'Cis proline' 0 C--N 1.402 3.359 0 CA-C-N 123.948 3.874 . . . . 0.0 114.28 -1.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -69.79 134.14 48.22 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 125.604 1.815 . . . . 0.0 109.307 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.82 -87.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.523 3.224 0 O-C-N 125.252 1.595 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 167.33 -174.71 42.51 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.97 118.56 12.05 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 125.663 1.449 . . . . 0.0 112.379 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.06 133.33 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.205 0 O-C-N 125.989 2.056 . . . . 0.0 107.98 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -88.44 141.31 28.64 Favored 'General case' 0 N--CA 1.513 2.694 0 O-C-N 125.022 1.451 . . . . 0.0 111.338 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 51.3 t -83.5 72.51 10.26 Favored 'General case' 0 N--CA 1.513 2.724 0 O-C-N 125.232 1.583 . . . . 0.0 110.463 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -164.15 -32.73 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.118 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.4 p -79.66 -25.8 41.21 Favored 'General case' 0 N--CA 1.519 3.001 0 O-C-N 125.106 1.504 . . . . 0.0 111.252 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.96 150.71 97.66 Favored Pre-proline 0 N--CA 1.523 3.199 0 CA-C-O 115.101 -2.38 . . . . 0.0 111.236 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.77 -48.79 0.22 Allowed 'Trans proline' 0 C--N 1.408 3.698 0 CA-C-N 123.711 2.361 . . . . 0.0 113.036 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.42 -46.95 24.01 Favored Glycine 0 N--CA 1.51 3.58 0 O-C-N 124.532 1.145 . . . . 0.0 112.558 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 83.82 172.43 48.85 Favored Glycine 1 N--CA 1.517 4.051 0 O-C-N 125.319 1.246 . . . . 0.0 110.89 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 22.7 m -70.11 153.42 43.17 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 124.783 0.931 . . . . 0.0 112.388 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -157.78 135.24 10.39 Favored 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.77 137.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.857 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.3 t -132.81 131.7 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.16 140.23 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 173.61 -152.89 16.26 Favored Glycine 1 N--CA 1.517 4.097 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.779 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.64 -160.91 13.56 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -68.5 -34.09 75.29 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.1 p -125.07 -15.05 6.44 Favored 'General case' 1 N--CA 1.544 4.234 0 O-C-N 125.015 1.447 . . . . 0.0 111.835 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.41 -1.7 30.21 Favored Glycine 1 N--CA 1.527 4.755 0 N-CA-C 116.831 1.493 . . . . 0.0 116.831 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 63.89 173.09 0.18 Allowed 'General case' 1 N--CA 1.544 4.235 0 C-N-CA 124.903 1.281 . . . . 0.0 113.373 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -69.83 145.19 52.28 Favored 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.731 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.34 -64.14 2.47 Favored Glycine 0 N--CA 1.512 3.755 0 O-C-N 124.601 1.188 . . . . 0.0 110.851 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 62.58 105.82 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.126 0 O-C-N 126.105 1.709 . . . . 0.0 113.568 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.25 95.8 1.27 Allowed 'General case' 0 N--CA 1.532 3.658 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.124 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.27 152.94 42.8 Favored 'General case' 0 N--CA 1.513 2.691 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.089 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.8 pt -116.51 168.63 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 O-C-N 126.253 2.221 . . . . 0.0 108.748 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -140.94 157.57 45.17 Favored 'General case' 0 N--CA 1.523 3.209 0 O-C-N 124.851 1.344 . . . . 0.0 109.21 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -110.29 159.61 17.26 Favored 'General case' 0 N--CA 1.521 3.093 0 O-C-N 126.098 2.124 . . . . 0.0 109.826 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 3.312 0 CA-C-O 116.345 -2.364 . . . . 0.0 109.668 -179.966 . . . . . . . . 0 0 . 1 stop_ save_